Citrus Sinensis ID: 041718
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.959 | 0.361 | 0.520 | 8e-88 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.959 | 0.347 | 0.467 | 1e-78 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.925 | 0.324 | 0.405 | 9e-65 | |
| Q9SYA0 | 804 | G-type lectin S-receptor- | no | no | 0.928 | 0.340 | 0.413 | 4e-64 | |
| O64776 | 792 | G-type lectin S-receptor- | no | no | 0.925 | 0.344 | 0.423 | 5e-64 | |
| O64780 | 814 | G-type lectin S-receptor- | no | no | 0.935 | 0.339 | 0.418 | 7e-64 | |
| O64777 | 806 | G-type lectin S-receptor- | no | no | 0.932 | 0.341 | 0.405 | 8e-64 | |
| O64771 | 809 | G-type lectin S-receptor- | no | no | 0.925 | 0.337 | 0.410 | 4e-63 | |
| O64782 | 805 | G-type lectin S-receptor- | no | no | 0.932 | 0.341 | 0.424 | 1e-62 | |
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.938 | 0.337 | 0.406 | 2e-61 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 323 bits (829), Expect = 8e-88, Method: Compositional matrix adjust.
Identities = 166/319 (52%), Positives = 217/319 (68%), Gaps = 36/319 (11%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKS-RGYV--DWSQGCVRDKSLNYSR-QDG 56
D CD Y LCG+YG C I+ P C+CLKGF K+ + +V DWS+GCVR L+ + +DG
Sbjct: 289 DSCDQYTLCGSYGSCNINESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDG 348
Query: 57 FIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELID 116
F+K + +KLPD SW K+M+LNEC + CL + +C AY+ IR G GC +WFG+LID
Sbjct: 349 FLKISKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLID 408
Query: 117 MRDFPDAGQDLYIRMSASEIEN-------------RNMDLELPLFELATIANATDNFSIN 163
+R++ + GQDLY+R+++SEIE DLELP +L T++ AT FS
Sbjct: 409 IREYNENGQDLYVRLASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAG 468
Query: 164 NKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 216
NKLG+GGFG VYK E+AVKRLS+ S QG++E KNE+ L +KLQHRNLVK+LG C
Sbjct: 469 NKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYC 528
Query: 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276
+ EE++LIYE+ PNKSL+SFIF D+ER + LDW KR II G ARG++
Sbjct: 529 VDEEERMLIYEYQPNKSLDSFIF------------DKERRRELDWPKRVEIIKGIARGML 576
Query: 277 YLHQDSKLRIIHRDLKASN 295
YLH+DS+LRIIHRDLKASN
Sbjct: 577 YLHEDSRLRIIHRDLKASN 595
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 1e-78, Method: Compositional matrix adjust.
Identities = 165/353 (46%), Positives = 207/353 (58%), Gaps = 70/353 (19%)
Query: 1 DLCDTYALCGAYGICIISG--MPVCQCLKGFKQKSRGYVDWSQG---CVRDKSLNYSRQD 55
D CD Y++CGAY +C I+ P C CL+GFK KS + S+G CV + N ++D
Sbjct: 290 DECDYYSICGAYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKD 349
Query: 56 GFIKFTAMKLPDATRSW--VSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGE 113
F+KF +KLPD + SW M L +C KC + SC AY N+ IR G GC +WFG+
Sbjct: 350 AFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGD 409
Query: 114 LIDMRDFPDAGQDLYIRMSASEIENRNM-------------------------------- 141
L+DMR++ GQD+YIRM ++IE +
Sbjct: 410 LVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRY 469
Query: 142 ------------DLELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKR 182
DL+LP+F+ TI+ ATD+FS N LG GGFG VYK EIAVKR
Sbjct: 470 RGENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKR 529
Query: 183 LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENF 242
LS S QG++E KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSL+ FIF
Sbjct: 530 LSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIF--- 586
Query: 243 VLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D+ R LDW KR +II G ARG++YLHQDS+LRIIHRDLKA N
Sbjct: 587 ---------DERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 247 bits (630), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 153/377 (40%), Positives = 201/377 (53%), Gaps = 104/377 (27%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGFKQKSRGYVD---WSQGCVRDKSLNYSRQ----- 54
CD Y CG +G C P C+C+KGF K+ + WS GC+R L RQ
Sbjct: 298 CDAYGRCGRFGSCHAGENPPCKCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSN 357
Query: 55 -------DGFIKFTAMKLP-DATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSG 106
DGF+K MK+P A RS S+ + C + CLD+ SC AY +Y RG G
Sbjct: 358 GGGGGKADGFLKLQKMKVPISAERSEASEQV----CPKVCLDNCSCTAY--AYDRG--IG 409
Query: 107 CAMWFGELIDMRDF---------------------------------------------- 120
C +W G+L+DM+ F
Sbjct: 410 CMLWSGDLVDMQSFLGSGIDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACR 469
Query: 121 -----PDAGQD-----LYIRMSASEIENRNMD-----LELPLFELATIANATDNFSINNK 165
P +D ++ RM A +N + ELPLFE +A +TD+FS+ NK
Sbjct: 470 KYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNK 529
Query: 166 LGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218
LG+GGFG VYK EIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI+
Sbjct: 530 LGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIE 589
Query: 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYL 278
GEE++L+YE+MP KSL++++F D + KILDW RF+I+ G RG++YL
Sbjct: 590 GEERMLVYEYMPKKSLDAYLF------------DPMKQKILDWKTRFNIMEGICRGLLYL 637
Query: 279 HQDSKLRIIHRDLKASN 295
H+DS+L+IIHRDLKASN
Sbjct: 638 HRDSRLKIIHRDLKASN 654
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYA0|Y1150_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61500 OS=Arabidopsis thaliana GN=At1g61500 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (625), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 149/360 (41%), Positives = 205/360 (56%), Gaps = 86/360 (23%)
Query: 2 LCDTYALCGAYGICIISGMPVCQCLKGFKQKS-----RGYVDWSQGCVRDKSL----NYS 52
LCD Y CG +G+C++S P+C+C +GF KS RG +W+ GCVR L N +
Sbjct: 282 LCDFYGACGPFGLCVMSPSPMCKCFRGFVPKSVEEWKRG--NWTGGCVRHTELDCLGNST 339
Query: 53 RQDG--FIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMW 110
+D F + +K PD + S+N EC ++C+ + SC+A+ +YI+G GC +W
Sbjct: 340 GEDADDFHQIANIKPPDFYE--FASSVNAEECHQRCVHNCSCLAF--AYIKG--IGCLVW 393
Query: 111 FGELIDMRDFPDAGQDLYIRMSASEIENRNM----------------------------- 141
+L+D F G+ L IR++ SE++
Sbjct: 394 NQDLMDAVQFSATGELLSIRLARSELDGNKRKKTIVASIVSLTLFMILGFTAFGVWRCRV 453
Query: 142 -------------DLE------LPLFELATIANATDNFSINNKLGEGGFGLVYK------ 176
DL+ L F++ TI NAT+NFS++NKLG+GGFG VYK
Sbjct: 454 EHIAHISKDAWKNDLKPQDVPGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDG 513
Query: 177 -EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235
EIAVKRLS S QG +E NE++L SKLQHRNLV++LGCCI+ EEKLLIYEFM NKSL+
Sbjct: 514 KEIAVKRLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLD 573
Query: 236 SFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+F+F++ ++R +I DW KRF II G ARG++YLH DS+LR+IHRDLK SN
Sbjct: 574 TFLFDS-----------RKRLEI-DWPKRFDIIQGIARGLLYLHHDSRLRVIHRDLKVSN 621
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64776|Y1144_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61440 OS=Arabidopsis thaliana GN=At1g61440 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 244 bits (624), Expect = 5e-64, Method: Compositional matrix adjust.
Identities = 150/354 (42%), Positives = 199/354 (56%), Gaps = 81/354 (22%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGFKQKS-----RGYVDWSQGCVRDKSL----NYSR 53
CD Y +CG +G C+IS P C+C KGF KS RG +W+ GC R L N +
Sbjct: 275 CDIYGVCGPFGFCVISDPPKCKCFKGFVPKSIEEWKRG--NWTSGCARRTELHCQGNSTG 332
Query: 54 QDGFIKFTA--MKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWF 111
+D + T +K PD + S++ C++ CL + SC+A+ +YI G GC MW
Sbjct: 333 KDANVFHTVPNIKPPDFYE--YANSVDAEGCYQSCLHNCSCLAF--AYI--PGIGCLMWS 386
Query: 112 GELIDMRDFPDAGQDLYIRMSASE--IENRNM---------------------------- 141
+L+D F G+ L IR++ SE + R M
Sbjct: 387 KDLMDTMQFSAGGEILSIRLAHSELDVHKRKMTIVASTVSLTLFVILGFATFGFWRNRVK 446
Query: 142 -------DLE------LPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVK 181
DL+ L FE+ TI AT NFS++NKLG GGFG VYK EIAVK
Sbjct: 447 HHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVK 506
Query: 182 RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN 241
RLS SEQG +E NE++L SKLQHRNLV++LGCC++G+EKLLIYEFM NKSL++F+F +
Sbjct: 507 RLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGS 566
Query: 242 FVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++R + LDW KRF II G RG++YLH+DS+LR+IHRDLK SN
Sbjct: 567 -----------RKRLE-LDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSN 608
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64780|Y1614_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61400 OS=Arabidopsis thaliana GN=At1g61400 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 244 bits (622), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 149/356 (41%), Positives = 199/356 (55%), Gaps = 80/356 (22%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGFKQKS---RGYVDWSQGCVRDKSL----NYSRQD 55
CD Y +CG +G C+IS P C+C KGF KS +W+ GCVR L N + +D
Sbjct: 292 CDIYGVCGPFGFCVISVPPKCKCFKGFIPKSIEEWKTGNWTSGCVRRSELHCQGNSTGKD 351
Query: 56 GFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELI 115
+ T + + S++ EC + CL++ SC+A+ +YI G GC MW +L+
Sbjct: 352 ANVFHTVPNIKPPDFYEYADSVDAEECQQNCLNNCSCLAF--AYI--PGIGCLMWSKDLM 407
Query: 116 DMRDFPDAGQDLYIRMSASEIEN------------------------------------- 138
D F G+ L IR++ SE++
Sbjct: 408 DTVQFAAGGELLSIRLARSELDVNKRKKTIIAITVSLTLFVILGFTAFGFWRRRVEQNAL 467
Query: 139 ------RNMDLE------LPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIA 179
RN DL+ L FE+ TI AT+NFS++NKLG GGFG VYK EIA
Sbjct: 468 ISEDAWRN-DLQTQDVPGLEYFEMNTIQTATNNFSLSNKLGHGGFGSVYKGKLQDGREIA 526
Query: 180 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIF 239
VKRLS SEQG +E NE++L SKLQHRNLV++LGCC++G EKLLIYEFM NKSL++F+F
Sbjct: 527 VKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYEFMKNKSLDTFVF 586
Query: 240 ENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ ++R +I DW KRF II G ARG++YLH+DS+LRIIHRDLK SN
Sbjct: 587 DS-----------KKRLEI-DWPKRFDIIQGIARGLLYLHRDSRLRIIHRDLKVSN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64777|Y1643_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61430 OS=Arabidopsis thaliana GN=At1g61430 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 146/360 (40%), Positives = 194/360 (53%), Gaps = 85/360 (23%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGF-----KQKSRGYVDWSQGCVRDKSL----NYSR 53
CD Y +CG +G+C++S P C+C KGF K+ +G +W+ GCVR L N S
Sbjct: 281 CDIYGVCGPFGLCVVSIPPKCKCFKGFVPKFAKEWKKG--NWTSGCVRRTELHCQGNSSG 338
Query: 54 QDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGE 113
+D + +T + + S N EC + CL + SC+A+ SYI G GC MW +
Sbjct: 339 KDANVFYTVPNIKPPDFYEYANSQNAEECHQNCLHNCSCLAF--SYI--PGIGCLMWSKD 394
Query: 114 LIDMRDFPDAGQDLYIRMSASEIE--NRNMDL---------------------------- 143
L+D R F AG+ L IR++ SE++ R M +
Sbjct: 395 LMDTRQFSAAGELLSIRLARSELDVNKRKMTIVASTVSLTLFVIFGFAAFGFWRCRVEHN 454
Query: 144 ------------------ELPLFELATIANATDNFSINNKLGEGGFGLVYK--------- 176
L FE+ I AT+NFS++NKLG GGFG VYK
Sbjct: 455 AHISNDAWRNFLQSQDVPGLEFFEMNAIQTATNNFSLSNKLGPGGFGSVYKARNGKLQDG 514
Query: 177 -EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235
EIAVKRLS S QG +E NE++L SKLQHRNLV++LGCC++G EKLLIY F+ NKSL+
Sbjct: 515 REIAVKRLSSSSGQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSLD 574
Query: 236 SFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+F+F D + LDW KRF II G ARG++YLH+DS+LR+IHRDLK SN
Sbjct: 575 TFVF------------DARKKLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSN 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64771|Y1148_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61480 OS=Arabidopsis thaliana GN=At1g61480 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 150/365 (41%), Positives = 200/365 (54%), Gaps = 92/365 (25%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGFKQKS-----RGYVDWSQGCVRDKSL------NY 51
CD Y CG +GIC++S P C+C KGF KS RG +W+ GCVR L N
Sbjct: 282 CDIYGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKRG--NWTDGCVRHTELHCQGNTNG 339
Query: 52 SRQDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWF 111
+GF +K PD + ++ C++ CL + SC+A+ +YI G GC MW
Sbjct: 340 KTVNGFYHVANIKPPDFYE--FASFVDAEGCYQICLHNCSCLAF--AYING--IGCLMWN 393
Query: 112 GELIDMRDFPDAGQDLYIRMSASEI----------------------------------- 136
+L+D F G+ L IR+++SE+
Sbjct: 394 QDLMDAVQFSAGGEILSIRLASSELGGNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVK 453
Query: 137 -------------ENRNMDLE------LPLFELATIANATDNFSINNKLGEGGFGLVYK- 176
E N DLE L FE+ TI ATDNFS++NKLG+GGFG VYK
Sbjct: 454 HTVSAKISKIASKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKG 513
Query: 177 ------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230
EIAVKRLS S QG +E NE++L SKLQH+NLV++LGCCI+GEE+LL+YEF+
Sbjct: 514 KLQDGKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLL 573
Query: 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRD 290
NKSL++F+F++ ++R +I DW KRF+II G ARG+ YLH+DS LR+IHRD
Sbjct: 574 NKSLDTFLFDS-----------RKRLEI-DWPKRFNIIEGIARGLHYLHRDSCLRVIHRD 621
Query: 291 LKASN 295
LK SN
Sbjct: 622 LKVSN 626
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 151/356 (42%), Positives = 195/356 (54%), Gaps = 81/356 (22%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQ----- 54
CD Y CG YG+C+ S P C+CLKGF KS G +W+ GCVR L+ +
Sbjct: 281 CDLYGRCGPYGLCVRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKT 340
Query: 55 -----DGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAM 109
D F + T +K PD + + +N +C++ CL + SC A+ +YI G GC +
Sbjct: 341 QGKDTDIFYRMTDVKTPDLHQ--FASFLNAEQCYQGCLGNCSCTAF--AYI--SGIGCLV 394
Query: 110 WFGELIDMRDFPDAGQDLYIRMSASE---------IENRNMDLELPL------------- 147
W GEL D F +G+ L+IR+++SE I + L + L
Sbjct: 395 WNGELADTVQFLSSGEFLFIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYR 454
Query: 148 ---------------------FELATIANATDNFSINNKLGEGGFGLVYK-------EIA 179
FE+ TI AT+NFS +NKLG+GGFG VYK EI
Sbjct: 455 AKQNDAWKNGFERQDVSGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIG 514
Query: 180 VKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIF 239
VKRL+ S QG +E NE+ L SKLQHRNLV+LLG CI GEEKLLIYEFM NKSL+ FIF
Sbjct: 515 VKRLASSSGQGTEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIF 574
Query: 240 ENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + F LDW KRF+II G ARG++YLH+DS+LR+IHRDLK SN
Sbjct: 575 DPCL-----KFE-------LDWPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSN 618
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 147/362 (40%), Positives = 189/362 (52%), Gaps = 85/362 (23%)
Query: 3 CDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQ----- 54
CD Y CG + C P+C C++GF+ ++ +WS GC R L RQ
Sbjct: 294 CDNYRRCGEFATCNPRKNPLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGS 353
Query: 55 -DGFIKFTAMKLPD-ATRSWVSKSMNLNECWEKCLDDSSCMAYTNS-------------- 98
DGF++ MKLPD A RS S+ EC CL SC+A +
Sbjct: 354 ADGFLRLRRMKLPDFARRSEASEP----ECLRTCLQTCSCIAAAHGLGYGCMIWNGSLVD 409
Query: 99 -----------YIRGEGS------------------------GCAMWFGELIDMRDFPDA 123
YIR S C + ++ +
Sbjct: 410 SQELSASGLDLYIRLAHSEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKK 469
Query: 124 GQD---LYIRMSASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK---- 176
G+D ++ R+ A N+ ELPLFE +A AT+NFS+ NKLG+GGFG VYK
Sbjct: 470 GRDAEQIFERVEALAGGNKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQ 529
Query: 177 ---EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 233
EIAVKRLS+ S QGL+EL NEV++ SKLQHRNLVKLLGCCI GEE++L+YEFMP KS
Sbjct: 530 EGQEIAVKRLSRASGQGLEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKS 589
Query: 234 LNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293
L+ ++F D R K+LDW RF+II G RG++YLH+DS+LRIIHRDLKA
Sbjct: 590 LDYYLF------------DSRRAKLLDWKTRFNIINGICRGLLYLHRDSRLRIIHRDLKA 637
Query: 294 SN 295
SN
Sbjct: 638 SN 639
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | ||||||
| 224113157 | 786 | predicted protein [Populus trichocarpa] | 0.959 | 0.360 | 0.613 | 1e-105 | |
| 224113153 | 785 | predicted protein [Populus trichocarpa] | 0.959 | 0.360 | 0.619 | 1e-104 | |
| 449458261 | 814 | PREDICTED: receptor-like serine/threonin | 0.959 | 0.347 | 0.546 | 1e-100 | |
| 449476944 | 1267 | PREDICTED: receptor-like serine/threonin | 0.959 | 0.223 | 0.546 | 2e-99 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.955 | 0.343 | 0.552 | 2e-99 | |
| 356546914 | 788 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.359 | 0.575 | 1e-98 | |
| 224115138 | 500 | predicted protein [Populus trichocarpa] | 0.935 | 0.552 | 0.594 | 2e-98 | |
| 224113149 | 820 | predicted protein [Populus trichocarpa] | 0.955 | 0.343 | 0.537 | 2e-97 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.351 | 0.605 | 2e-97 | |
| 356545219 | 855 | PREDICTED: G-type lectin S-receptor-like | 0.959 | 0.330 | 0.559 | 3e-96 |
| >gi|224113157|ref|XP_002332644.1| predicted protein [Populus trichocarpa] gi|222832839|gb|EEE71316.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 386 bits (992), Expect = e-105, Method: Compositional matrix adjust.
Identities = 194/316 (61%), Positives = 231/316 (73%), Gaps = 33/316 (10%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQDGF 57
D CD YA CGA G CII+ +P+C+CLK FK KS +DWS GCVR+K LN + DGF
Sbjct: 296 DSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGF 355
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
+K+ +K PDAT SW++KSMNLNEC KCL + SCMAY+NS +RG GSGC +W+G+LID+
Sbjct: 356 VKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGDLIDI 415
Query: 118 RDFPDAGQDLYIRMSASE-----------IENRNMDLELPLFELATIANATDNFSINNKL 166
R FP GQ+LYIRM+ SE + N DLELP FE A I NAT+NFSI NKL
Sbjct: 416 RQFPAGGQELYIRMNPSESAEMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIKNKL 475
Query: 167 GEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219
G+GGFG VYK EIAVKRLS S QG KE KNEVIL +KLQHRNLVKLLGC IQ
Sbjct: 476 GQGGFGPVYKGTLEDGQEIAVKRLSMSSRQGSKEFKNEVILINKLQHRNLVKLLGCSIQR 535
Query: 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLH 279
EE+LL+YE+MPNKSL+SF+F DQ + K+LDWSKRF+IICG ARG++YLH
Sbjct: 536 EERLLVYEYMPNKSLDSFLF------------DQTKSKLLDWSKRFNIICGIARGLLYLH 583
Query: 280 QDSKLRIIHRDLKASN 295
QDS+LRIIHRDLK+SN
Sbjct: 584 QDSRLRIIHRDLKSSN 599
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113153|ref|XP_002332643.1| predicted protein [Populus trichocarpa] gi|222832838|gb|EEE71315.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 385 bits (989), Expect = e-104, Method: Compositional matrix adjust.
Identities = 195/315 (61%), Positives = 230/315 (73%), Gaps = 32/315 (10%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQDGF 57
D CD YA CGA G CII+ +P+C+CLK FK KS +DWS GCVR+K LN + DGF
Sbjct: 296 DSCDNYASCGANGNCIINDLPICRCLKKFKPKSPEKWNLMDWSDGCVRNKPLNCQKGDGF 355
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
+K+ +K PDAT SW++KSMNLNEC KCL + SCMAY+NS +RG GSGC +W+G LID+
Sbjct: 356 VKYLGLKWPDATHSWLNKSMNLNECRAKCLQNCSCMAYSNSDVRGGGSGCIIWYGGLIDI 415
Query: 118 RDFPDAGQDLYIRMSASEIE----------NRNMDLELPLFELATIANATDNFSINNKLG 167
R FP GQ+LYIRM+ SE E N DLELP FE A I NAT+NFSI NKLG
Sbjct: 416 RQFPAGGQELYIRMNPSESEMDQQNDQITDGENEDLELPQFEFAKIVNATNNFSIENKLG 475
Query: 168 EGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220
+GGFG VYK EIAVKRLS S QG KE KNEVIL +KLQHRNLVKLLGC IQ E
Sbjct: 476 QGGFGPVYKGTLEDGQEIAVKRLSMSSGQGSKEFKNEVILINKLQHRNLVKLLGCSIQRE 535
Query: 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280
E+LL+YE+MPNKSL+SF+F DQ + K+LDWSKRF+IICG ARG++YLHQ
Sbjct: 536 ERLLVYEYMPNKSLDSFLF------------DQTKSKLLDWSKRFNIICGIARGLLYLHQ 583
Query: 281 DSKLRIIHRDLKASN 295
DS+LRIIHRDLK+SN
Sbjct: 584 DSRLRIIHRDLKSSN 598
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458261|ref|XP_004146866.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 369 bits (947), Expect = e-100, Method: Compositional matrix adjust.
Identities = 193/353 (54%), Positives = 231/353 (65%), Gaps = 70/353 (19%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFK---QKSRGYVDWSQGCVRDKSLNYSRQDGF 57
D CDTY++CGA+G C I +P CQCL GF Q+ +D+++GCVR+K LN S + GF
Sbjct: 287 DYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGF 346
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
K +KLPD +SWV++SM+LNEC EKCL + SC+A+ N+ IRG GSGCA+WFGEL+D+
Sbjct: 347 AKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDI 406
Query: 118 RDFPDAGQDLYIRMSASEIENRNM------------------------------------ 141
+ GQDLY+RM ASE+E +
Sbjct: 407 KVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKLEA 466
Query: 142 ------------DLELPLFELATIANATDNFSINNKLGEGGFGLVY-------KEIAVKR 182
DLELPLF LATI+NATDNFS NKLGEGGFG V+ KEIAVKR
Sbjct: 467 TGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKR 526
Query: 183 LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENF 242
LS S QG E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSL+SFIF
Sbjct: 527 LSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIF--- 583
Query: 243 VLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D R K+LDWSKRF+IICG ARG++YLHQDS+LRIIHRDLKASN
Sbjct: 584 ---------DSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASN 627
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449476944|ref|XP_004154883.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 368 bits (945), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 193/353 (54%), Positives = 231/353 (65%), Gaps = 70/353 (19%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFK---QKSRGYVDWSQGCVRDKSLNYSRQDGF 57
D CDTY++CGA+G C I +P CQCL GF Q+ +D+++GCVR+K LN S + GF
Sbjct: 287 DYCDTYSVCGAFGSCDIEQVPACQCLFGFHPNVQEKWNLMDYTEGCVRNKPLNCSDKTGF 346
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
K +KLPD +SWV++SM+LNEC EKCL + SC+A+ N+ IRG GSGCA+WFGEL+D+
Sbjct: 347 AKLPGLKLPDTKQSWVNESMSLNECREKCLRNCSCVAFANTDIRGSGSGCAIWFGELVDI 406
Query: 118 RDFPDAGQDLYIRMSASEIENRNM------------------------------------ 141
+ GQDLY+RM ASE+E +
Sbjct: 407 KVVRRGGQDLYVRMLASELETKKTSSVAVGVIVGAAALLILGLLLIGFYVIRSKRRKLEA 466
Query: 142 ------------DLELPLFELATIANATDNFSINNKLGEGGFGLVY-------KEIAVKR 182
DLELPLF LATI+NATDNFS NKLGEGGFG V+ KEIAVKR
Sbjct: 467 TGAGKDLEGQEDDLELPLFNLATISNATDNFSNFNKLGEGGFGAVFRGRLTDGKEIAVKR 526
Query: 183 LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENF 242
LS S QG E KNEVIL +KLQHRNLVKLLGCCIQGEEK+LIYE+MPNKSL+SFIF
Sbjct: 527 LSSYSRQGTDEFKNEVILIAKLQHRNLVKLLGCCIQGEEKMLIYEYMPNKSLDSFIF--- 583
Query: 243 VLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D R K+LDWSKRF+IICG ARG++YLHQDS+LRIIHRDLKASN
Sbjct: 584 ---------DSARKKLLDWSKRFNIICGVARGILYLHQDSRLRIIHRDLKASN 627
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 367 bits (943), Expect = 2e-99, Method: Compositional matrix adjust.
Identities = 196/355 (55%), Positives = 233/355 (65%), Gaps = 73/355 (20%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQDGF 57
D CDTY LCGAYG CI+S PVCQCL+ F +S +DWS+GCVR+K L+ + DGF
Sbjct: 291 DYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPRSPESWNSMDWSKGCVRNKPLDCQKGDGF 350
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
+K+ +KLPDAT SWV+K+MNL EC KCL + SCMAYT + I+ E SGCA+WFG+LID+
Sbjct: 351 VKYVGLKLPDATNSWVNKTMNLKECRSKCLQNCSCMAYTATNIK-ERSGCAVWFGDLIDI 409
Query: 118 RDFPDAGQDLYIRMSASEI----------------------------------------- 136
R F AGQ++YIR++ASE
Sbjct: 410 RQFSAAGQEIYIRLNASESRAKAASKIKMTVGSALSIFVACGILLVAYYIFKRKAKHIGG 469
Query: 137 ---ENRNMD------LELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAV 180
EN +D LELPLF+ TIA AT+ FS NNKLGEGGFG VYK EIA
Sbjct: 470 NREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAA 529
Query: 181 KRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFE 240
K LS+ S QGL E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSL+SFIF
Sbjct: 530 KTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIF- 588
Query: 241 NFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
DQ R K+LDWSKRF IICG ARG++YLHQDS+LRI+HRDLKASN
Sbjct: 589 -----------DQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASN 632
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546914|ref|XP_003541865.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 365 bits (937), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 184/320 (57%), Positives = 231/320 (72%), Gaps = 37/320 (11%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQK---SRGYVDWSQGCVRDKSLN--YSRQD 55
DLCD+Y+LCGA C+IS PVCQCL+GFK K + +DWS GC+R+K L+ +D
Sbjct: 295 DLCDSYSLCGANANCVISDSPVCQCLQGFKPKLPEAWSSMDWSHGCIRNKELSCENKNKD 354
Query: 56 GFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELI 115
GF K T +K PD T SW+ +++ L EC KCLD+ SCMAY NS I G+GSGCAMWFG+LI
Sbjct: 355 GFNKLTLLKTPDTTHSWLDQTIGLEECKAKCLDNCSCMAYANSDISGQGSGCAMWFGDLI 414
Query: 116 DMRDFPDAGQDLYIRMSASEIE--------NRNM-----DLELPLFELATIANATDNFSI 162
D+R F GQD+Y+R+ ASE+E N+N D++LP+F+L+TIA AT NF++
Sbjct: 415 DIRQFAAGGQDVYVRIDASELERSDFSIKSNQNSGMQVDDMDLPVFDLSTIAKATSNFTV 474
Query: 163 NNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 215
NK+GEGGFG VY+ EIAVKRLS S QGL E KNEV L +KLQHRNLVKLLGC
Sbjct: 475 KNKIGEGGFGPVYRGSLTDGQEIAVKRLSASSGQGLTEFKNEVKLIAKLQHRNLVKLLGC 534
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGV 275
C++GEEK+L+YE+M N SL+SFIF D++R LDWSKRF+IICG A+G+
Sbjct: 535 CLEGEEKMLVYEYMLNGSLDSFIF------------DEQRSGSLDWSKRFNIICGIAKGL 582
Query: 276 MYLHQDSKLRIIHRDLKASN 295
+YLHQDS+LRIIHRDLKASN
Sbjct: 583 LYLHQDSRLRIIHRDLKASN 602
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115138|ref|XP_002316952.1| predicted protein [Populus trichocarpa] gi|222860017|gb|EEE97564.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 365 bits (936), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 189/318 (59%), Positives = 218/318 (68%), Gaps = 42/318 (13%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQDGF 57
D CD Y LCG G CI+S MPVCQCL FK KS +DWSQGCVR+K L + DGF
Sbjct: 15 DYCDNYGLCGVNGNCIMSAMPVCQCLAKFKPKSVEAWNTMDWSQGCVRNKELECQKGDGF 74
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
IK +K+PDAT SWV+K+MNL EC KCL + SCMAYTN IRG GSGCA+WFG+LID+
Sbjct: 75 IKLDGLKVPDATDSWVNKTMNLKECRAKCLQNCSCMAYTNLDIRGRGSGCAIWFGDLIDI 134
Query: 118 RDFPDAGQDLYIRMSASEIE-------------NRNMDLELPLFELATIANATDNFSINN 164
R P GQ LY+R+ ASEIE + DLELPLFE IANAT NFSINN
Sbjct: 135 RQVPIGGQTLYVRLHASEIEAKAKPKIRIAKDKGKKEDLELPLFEFTAIANATSNFSINN 194
Query: 165 KLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
KLGEGG+G VYK EIAVKRLS+ S QGL E KNE+IL +KLQHRNLVKLLGCCI
Sbjct: 195 KLGEGGYGPVYKGKLVDGQEIAVKRLSRSSRQGLNEFKNEMILLNKLQHRNLVKLLGCCI 254
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277
+ +EK+LIYE+MPN SL+SFIF + F+II G ARG++Y
Sbjct: 255 ERDEKMLIYEYMPNGSLDSFIFSTGL-------------------SHFNIISGIARGLLY 295
Query: 278 LHQDSKLRIIHRDLKASN 295
LHQDS+LRIIHRDLKASN
Sbjct: 296 LHQDSRLRIIHRDLKASN 313
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113149|ref|XP_002332642.1| predicted protein [Populus trichocarpa] gi|222832837|gb|EEE71314.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 362 bits (928), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 194/361 (53%), Positives = 232/361 (64%), Gaps = 79/361 (21%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQDGF 57
D CDTY+LCGAYG CIIS PVC+CL+ F KS +DWSQGCVR+K L+ + DGF
Sbjct: 285 DYCDTYSLCGAYGNCIISQSPVCECLEKFTPKSPESWNSMDWSQGCVRNKPLDCQKGDGF 344
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
+K+ +KLPDAT SWV+K+MNL EC CL++ SCMAYT + I+ E SGCA+WFG+LID+
Sbjct: 345 VKYVGLKLPDATNSWVNKTMNLKECRSICLENCSCMAYTATNIK-ERSGCAIWFGDLIDI 403
Query: 118 RDFPDAGQDLYIRMSASEI----------------------------------------- 136
P AGQ++YIRM+ASE
Sbjct: 404 TQLPAAGQEIYIRMNASESSECLSLVLMAVGIALSIFVACGILLVAYYIFKRKAKLIGKV 463
Query: 137 ---------ENRNMD------LELPLFELATIANATDNFSINNKLGEGGFGLVYK----- 176
EN +D LELPLF+ TIA AT+ FS NNKLGEGGFG VYK
Sbjct: 464 TLTAFSNREENDQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLED 523
Query: 177 --EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234
EIA K S+ S QG+ E KNEVIL +KLQHRNLVKLLGCCIQGEEK+L+YE+MPNKSL
Sbjct: 524 GQEIAAKTHSRSSGQGINEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSL 583
Query: 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294
+SFIF DQ R ++LDWSKRF IICG ARG++YLHQDS+LRI+HRDLKAS
Sbjct: 584 DSFIF------------DQTRGELLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKAS 631
Query: 295 N 295
N
Sbjct: 632 N 632
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 361 bits (926), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 190/314 (60%), Positives = 218/314 (69%), Gaps = 31/314 (9%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQK---SRGYVDWSQGCVRDKSLNYSRQDGF 57
D CD+YALCGAY C I P C C+KGF K +DWS GCVR SL+ + DGF
Sbjct: 316 DDCDSYALCGAYSTCNIHRSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGF 375
Query: 58 IKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117
+K + +KLPD SW ++SMNL EC CL + SC AYTNS I+G GSGC +WFG+LID+
Sbjct: 376 VKCSGVKLPDTRNSWFNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDV 435
Query: 118 RDFPDAGQDLYIRMSASEIE---------NRNMDLELPLFELATIANATDNFSINNKLGE 168
++F + GQD YIRM+ASE+E R DLELPLF+L TI NAT NFS NNKLGE
Sbjct: 436 KEFTENGQDFYIRMAASELELNNEGAETNERQEDLELPLFDLDTILNATHNFSRNNKLGE 495
Query: 169 GGFGLVY-------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221
GGFG VY KEIAVKRLSK S QGL E KNEVI SKLQHRNLVKLLGCCI GEE
Sbjct: 496 GGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEE 555
Query: 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD 281
K+LIYE+MPNKSLN FIF D + +LDW KRF II G ARG++YLHQD
Sbjct: 556 KMLIYEYMPNKSLNFFIF------------DGIQSMVLDWPKRFVIINGIARGLLYLHQD 603
Query: 282 SKLRIIHRDLKASN 295
S+LRIIHRDLKA N
Sbjct: 604 SRLRIIHRDLKADN 617
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545219|ref|XP_003541042.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 3e-96, Method: Compositional matrix adjust.
Identities = 178/318 (55%), Positives = 227/318 (71%), Gaps = 35/318 (11%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKSR---GYVDWSQGCVRDKSLNYSRQ--D 55
D CD Y CGAYG C+I+G +CQCL GF KS DW+QGC R++ LN + + D
Sbjct: 283 DNCDYYGTCGAYGTCLITGSQICQCLAGFSPKSPQAWNSSDWTQGCTRNQPLNCTNKLND 342
Query: 56 GFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELI 115
GF+K +K+PD T +W+ +++ L EC KCL++ SCMAYTNS IRGEGSGC MWFG+LI
Sbjct: 343 GFMKVEGVKVPDTTHTWLDETIGLGECRMKCLNNCSCMAYTNSDIRGEGSGCVMWFGDLI 402
Query: 116 DMRDFPDAGQDLYIRMSASEIENRNM-----------DLELPLFELATIANATDNFSINN 164
D+R F + GQDLYIRM +SE+E ++ +++LPL +L+TI ATDNFSINN
Sbjct: 403 DIRQFENDGQDLYIRMDSSELEYSDIVRDQNRGGSEENIDLPLLDLSTIVIATDNFSINN 462
Query: 165 KLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
K+GEGGFG VYK EIAVKRLS+ S QG+ E KNEV L +KLQHRNLVKLLGCC+
Sbjct: 463 KIGEGGFGPVYKGRLVSGQEIAVKRLSRGSGQGMTEFKNEVKLIAKLQHRNLVKLLGCCV 522
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277
Q ++++L+YE+M N+SL+ IF D + K+LDW KRF+IICG ARG++Y
Sbjct: 523 QEQDRMLVYEYMTNRSLDWLIF------------DDTKSKLLDWPKRFNIICGIARGLLY 570
Query: 278 LHQDSKLRIIHRDLKASN 295
LHQDS+LRIIHRDLKASN
Sbjct: 571 LHQDSRLRIIHRDLKASN 588
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 295 | ||||||
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.481 | 0.174 | 0.621 | 3.9e-76 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.498 | 0.174 | 0.578 | 7.4e-75 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.498 | 0.172 | 0.560 | 1.5e-74 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.576 | 0.200 | 0.523 | 2.6e-74 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.474 | 0.168 | 0.572 | 3.2e-63 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.471 | 0.175 | 0.588 | 1.5e-62 | |
| TAIR|locus:2197724 | 806 | AT1G61430 [Arabidopsis thalian | 0.467 | 0.171 | 0.561 | 3.8e-62 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.501 | 0.174 | 0.559 | 1.2e-61 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.522 | 0.190 | 0.531 | 1.3e-61 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.461 | 0.168 | 0.6 | 1.7e-61 |
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 460 (167.0 bits), Expect = 3.9e-76, Sum P(2) = 3.9e-76
Identities = 100/161 (62%), Positives = 117/161 (72%)
Query: 142 DLELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKEL 194
DL+LP+F+ TI+ ATD+FS N LG GGFG VYK EIAVKRLS S QG++E
Sbjct: 482 DLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEF 541
Query: 195 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE 254
KNEV L +KLQHRNLV+LLGCCIQGEE +LIYE+MPNKSL+ FIF D+
Sbjct: 542 KNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIF------------DER 589
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R LDW KR +II G ARG++YLHQDS+LRIIHRDLKA N
Sbjct: 590 RSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGN 630
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 7.4e-75, Sum P(2) = 7.4e-75
Identities = 96/166 (57%), Positives = 116/166 (69%)
Query: 137 ENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQ 189
E ++ LELPL EL +A AT+NFS +NKLG+GGFG+VYK EIAVKRLSK+S Q
Sbjct: 496 EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQ 555
Query: 190 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRS 249
G E NEV L +KLQH NLV+LLGCC+ EK+LIYE++ N SL+S +F
Sbjct: 556 GTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLF---------- 605
Query: 250 FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
DQ R L+W KRF II G ARG++YLHQDS+ RIIHRDLKASN
Sbjct: 606 --DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASN 649
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 1.5e-74, Sum P(2) = 1.5e-74
Identities = 93/166 (56%), Positives = 112/166 (67%)
Query: 137 ENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQ 189
EN DLELPL E +A AT+NFS NKLG+GGFG+VYK E+AVKRLSK S Q
Sbjct: 503 ENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQ 562
Query: 190 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRS 249
G E KNEV L ++LQH NLV+LL CC+ EK+LIYE++ N SL+S +F
Sbjct: 563 GTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF---------- 612
Query: 250 FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D+ R L+W RF II G ARG++YLHQDS+ RIIHRDLKASN
Sbjct: 613 --DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASN 656
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 2.6e-74, Sum P(2) = 2.6e-74
Identities = 100/191 (52%), Positives = 126/191 (65%)
Query: 114 LIDMRDFPDAGQDLYIRMSASEI--ENRNMDLELPLFELATIANATDNFSINNKLGEGGF 171
++D+ D+ + ++ S S EN+ LELPL E +A AT+NFS +NKLG+GGF
Sbjct: 475 IVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGF 534
Query: 172 GLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224
G+VYK EIAVKRLSK+S QG E NEV L +KLQH NLV+LLGCC+ EK+L
Sbjct: 535 GIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKML 594
Query: 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKL 284
IYE++ N SL+S +F DQ R L+W KRF II G ARG++YLHQDS+
Sbjct: 595 IYEYLENLSLDSHLF------------DQTRSSNLNWQKRFDIINGIARGLLYLHQDSRC 642
Query: 285 RIIHRDLKASN 295
RIIHRDLKASN
Sbjct: 643 RIIHRDLKASN 653
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 443 (161.0 bits), Expect = 3.2e-63, Sum P(2) = 3.2e-63
Identities = 91/159 (57%), Positives = 117/159 (73%)
Query: 144 ELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKN 196
ELPLFE +A AT+NFSI NKLG+GGFG VYK +IAVKRLS+ S QG++E N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 197 EVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC 256
EV++ SKLQHRNLV+LLG CI+GEE++L+YEFMP L++++F D +
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLF------------DPVKQ 603
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++LDW RF+II G RG+MYLH+DS+L+IIHRDLKASN
Sbjct: 604 RLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASN 642
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 446 (162.1 bits), Expect = 1.5e-62, Sum P(2) = 1.5e-62
Identities = 93/158 (58%), Positives = 116/158 (73%)
Query: 145 LPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNE 197
L FE+ TI AT NFS++NKLG GGFG VYK EIAVKRLS SEQG +E NE
Sbjct: 463 LEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQDGREIAVKRLSSSSEQGKQEFMNE 522
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
++L SKLQHRNLV++LGCC++G+EKLLIYEFM NKSL++F+F + ++R +
Sbjct: 523 IVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKSLDTFVFGS-----------RKRLE 571
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
LDW KRF II G RG++YLH+DS+LR+IHRDLK SN
Sbjct: 572 -LDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSN 608
|
|
| TAIR|locus:2197724 AT1G61430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 3.8e-62, Sum P(2) = 3.8e-62
Identities = 91/162 (56%), Positives = 113/162 (69%)
Query: 145 LPLFELATIANATDNFSINNKLGEGGFGLVYK----------EIAVKRLSKISEQGLKEL 194
L FE+ I AT+NFS++NKLG GGFG VYK EIAVKRLS S QG +E
Sbjct: 474 LEFFEMNAIQTATNNFSLSNKLGPGGFGSVYKARNGKLQDGREIAVKRLSSSSGQGKQEF 533
Query: 195 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE 254
NE++L SKLQHRNLV++LGCC++G EKLLIY F+ NKSL++F+F+
Sbjct: 534 MNEIVLISKLQHRNLVRVLGCCVEGTEKLLIYGFLKNKSLDTFVFD-------------A 580
Query: 255 RCKI-LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R K+ LDW KRF II G ARG++YLH+DS+LR+IHRDLK SN
Sbjct: 581 RKKLELDWPKRFEIIEGIARGLLYLHRDSRLRVIHRDLKVSN 622
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 1.2e-61, Sum P(2) = 1.2e-61
Identities = 94/168 (55%), Positives = 119/168 (70%)
Query: 136 IENRNMDL-ELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKIS 187
IE + ++ ELP+F L IA AT++F N+LG GGFG VYK EIAVKRLS S
Sbjct: 504 IEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKS 563
Query: 188 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLM 247
QG+ E KNE+IL +KLQHRNLV+LLGCC +GEEK+L+YE+MPNKSL+ F+F
Sbjct: 564 GQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLF-------- 615
Query: 248 RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D+ + ++DW RF II G ARG++YLH+DS+LRIIHRDLK SN
Sbjct: 616 ----DETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSN 659
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.3e-61, Sum P(2) = 1.3e-61
Identities = 94/177 (53%), Positives = 128/177 (72%)
Query: 130 RMSASEIENRNMDLE----LPLFELATIANATDNFSINNKLGEGGFGLVYK-------EI 178
++++ E N +++ + L FE+ TI ATDNFS++NKLG+GGFG VYK EI
Sbjct: 462 KIASKEAWNNDLEPQDVSGLKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEI 521
Query: 179 AVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFI 238
AVKRLS S QG +E NE++L SKLQH+NLV++LGCCI+GEE+LL+YEF+ NKSL++F+
Sbjct: 522 AVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFL 581
Query: 239 FENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
F++ ++R +I DW KRF+II G ARG+ YLH+DS LR+IHRDLK SN
Sbjct: 582 FDS-----------RKRLEI-DWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSN 626
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 1.7e-61, Sum P(2) = 1.7e-61
Identities = 93/155 (60%), Positives = 110/155 (70%)
Query: 148 FELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVIL 200
FE+ TI AT+NFS +NKLG+GGFG VYK EI VKRL+ S QG +E NE+ L
Sbjct: 476 FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITL 535
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
SKLQHRNLV+LLG CI GEEKLLIYEFM NKSL+ FIF+ + F LD
Sbjct: 536 ISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCL-----KFE-------LD 583
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
W KRF+II G ARG++YLH+DS+LR+IHRDLK SN
Sbjct: 584 WPKRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSN 618
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 295 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-26 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-24 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-21 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 3e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-19 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-19 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 4e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-11 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-09 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-05 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-04 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-04 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 0.001 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.002 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.002 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 0.003 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.003 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.003 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.003 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.004 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.004 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-26
Identities = 52/148 (35%), Positives = 69/148 (46%), Gaps = 29/148 (19%)
Query: 161 SINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 207
++ KLGEG FG VYK E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+VKLLG C + E +++ E+MP L ++ +N R K L S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-------------RPKELSLSDLLSF 108
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
ARG+ YL IHRDL A N
Sbjct: 109 ALQIARGMEYLES---KNFIHRDLAARN 133
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 102 bits (258), Expect = 5e-26
Identities = 49/148 (33%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 161 SINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHR 207
++ KLGEG FG VYK E+AVK L + SEQ ++E E + KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+VKLLG C + E ++ E+M L S++ ++ L S
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--------------RKNRPKLSLSDLLSF 107
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
ARG+ YL IHRDL A N
Sbjct: 108 ALQIARGMEYLES---KNFIHRDLAARN 132
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 3e-24
Identities = 45/144 (31%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 164 NKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 211
KLGEG FG VYK E+AVK L + SE+ K+ E + KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
LLG C + E L+ E+M L ++ ++ R L
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKS------RPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ YL + +HRDL A N
Sbjct: 115 AKGMEYLA---SKKFVHRDLAARN 135
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 9e-24
Identities = 45/139 (32%), Positives = 58/139 (41%), Gaps = 26/139 (18%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 216
LGEGGFG VY K++A+K + K L E L E+ + KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276
L+ E+ SL + EN L + I+ G+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE--------------GKLSEDEILRILLQILEGLE 106
Query: 277 YLHQDSKLRIIHRDLKASN 295
YLH IIHRDLK N
Sbjct: 107 YLHS---NGIIHRDLKPEN 122
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (226), Expect = 2e-21
Identities = 48/149 (32%), Positives = 68/149 (45%), Gaps = 30/149 (20%)
Query: 160 FSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQH 206
+ KLGEG FG VYK ++AVK L + SE+ +E E + KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
N+V+LLG C QGE ++ E+MP L F+ ++ + L
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--------------RKHGEKLTLKDLLQ 106
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A+G+ YL SK +HRDL A N
Sbjct: 107 MALQIAKGMEYLE--SK-NFVHRDLAARN 132
|
Length = 258 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-21
Identities = 33/65 (50%), Positives = 44/65 (67%), Gaps = 1/65 (1%)
Query: 53 RQDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFG 112
DGF++ MKLPD T + V +S+ L EC ++CL + SC AY + IRG GSGC +W G
Sbjct: 3 GGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIWTG 61
Query: 113 ELIDM 117
EL+DM
Sbjct: 62 ELVDM 66
|
Length = 66 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 46/151 (30%), Positives = 70/151 (46%), Gaps = 34/151 (22%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 208
++ LG G FG VY + +AVK LS SE+ L+ L+ E+ + S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 209 LVKLLGCCIQGEEK-LLIY-EFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKR 264
+V+ G E+ L I+ E++ SL+S + F ++R + Q IL
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----IL----- 111
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH I+HRD+K +N
Sbjct: 112 --------EGLAYLHS---NGIVHRDIKGAN 131
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-20
Identities = 49/150 (32%), Positives = 77/150 (51%), Gaps = 34/150 (22%)
Query: 159 NFSINNKLGEGGFGLVYKEI--------AVKRLS--KISEQGLKELKNEVILFSKLQHRN 208
N+ + + +G G FG+VYK + A+K++S KI E+ LK + E+ L L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 209 LVKLLGCCIQGEEKLLIY-EFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRF 265
+VK +G I+ + L I E+ N SL I F F +L+ +V Q +L
Sbjct: 61 IVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ----VL------ 109
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH+ +IHRD+KA+N
Sbjct: 110 -------QGLAYLHEQG---VIHRDIKAAN 129
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 27/145 (18%)
Query: 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 210
+ I KLGEG FG VY +A+K + K + +E + E+ + KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L ++ L+ E+ L + + L+ D+ R +
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE-----DEAR----------FYLRQ 105
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ YLH I+HRDLK N
Sbjct: 106 ILSALEYLH---SKGIVHRDLKPEN 127
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-19
Identities = 38/146 (26%), Positives = 57/146 (39%), Gaps = 28/146 (19%)
Query: 160 FSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 209
+ + KLG G FG VYK +AVK L K + + + E+ + +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V+L+ + L+ E+ L ++ L + I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---------------GPLSEDEAKKIAL 105
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
RG+ YLH IIHRDLK N
Sbjct: 106 QILRGLEYLH---SNGIIHRDLKPEN 128
|
Length = 260 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-18
Identities = 31/88 (35%), Positives = 43/88 (48%), Gaps = 10/88 (11%)
Query: 43 CVRDKSLNYSRQDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRG 102
C D S DGF+K +KLPD + +++L EC E CL + SC AY +
Sbjct: 5 CGGDGS-----TDGFLKLPDVKLPD--NASAITAISLEECREACLSNCSCTAYAYNNG-- 55
Query: 103 EGSGCAMWFGELIDMRDFPDAGQDLYIR 130
GC +W G L ++R G LY+R
Sbjct: 56 -SGGCLLWNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 7e-17
Identities = 44/144 (30%), Positives = 73/144 (50%), Gaps = 25/144 (17%)
Query: 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
F I K+G+GGFG VYK E+A+K + S++ +++ NE+ + K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
G ++ +E ++ EF SL L++S + L S+ ++
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSL---------KDLLKS-----TNQTLTESQIAYVCKEL 107
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH IIHRD+KA+N
Sbjct: 108 LKGLEYLH---SNGIIHRDIKAAN 128
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-16
Identities = 38/144 (26%), Positives = 62/144 (43%), Gaps = 18/144 (12%)
Query: 166 LGEGGFGLVYK-------------EIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 211
LGEG FG V+ +AVK L + + ++ + E L + QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
G C +G+ ++++E+M + LN F+ + L S+ I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGP-DAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
A G++YL + +HRDL N
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRN 152
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 32/165 (19%)
Query: 142 DLELPLFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKE 193
+L+ L ++ + + + + K+GEG G VY KE+A+K++ ++ +Q +
Sbjct: 3 ELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKEL 61
Query: 194 LKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQ 253
+ NE+++ +H N+V + G+E ++ E+M SL I +NFV +
Sbjct: 62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV-RMNEP---- 116
Query: 254 ERCKILDWSKRFHI--ICG-TARGVMYLHQDSKLRIIHRDLKASN 295
I +C +G+ YLH +IHRD+K+ N
Sbjct: 117 ------------QIAYVCREVLQGLEYLHS---QNVIHRDIKSDN 146
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 47/152 (30%), Positives = 69/152 (45%), Gaps = 32/152 (21%)
Query: 166 LGEGGFGLVYK-------------EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 211
LGEG FG VYK +A+K L + +E ++ E + E L S LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRS--------FVDQERCKILDWSK 263
LLG C + + +++E++ + L+ F+ + S D+ LD S
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFL-------VRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
HI A G+ YL S +HRDL A N
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARN 154
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 16/144 (11%)
Query: 165 KLGEGGFGLVYKE-------------IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+LGEG FG V+ +AVK L + SE ++ + E L + LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
G C +G L+++E+M + LN F+ + + + + L + I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
A G++YL + L +HRDL N
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRN 152
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 23/143 (16%)
Query: 160 FSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212
F++ KLG G FG V++ +A+K L ++ + EV +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
C GE +I E M SL +F +RS ++L + + C A
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAF---------LRS----PEGQVLPVASLIDMACQVA 114
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
G+ YL + IHRDL A N
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARN 134
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-12
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 18/150 (12%)
Query: 159 NFSINNKLGEGGFGLVYKE-------------IAVKRLSKISEQGLKELKNEVILFSKLQ 205
N + +LGEG FG V+ +AVK L S+ K+ E L + LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H ++VK G C++G+ ++++E+M + LN F+ + ++ + R L S+
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVL--MAEGNRPAELTQSQML 123
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
HI A G++YL + +HRDL N
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRN 150
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.9 bits (159), Expect = 4e-12
Identities = 38/146 (26%), Positives = 60/146 (41%), Gaps = 24/146 (16%)
Query: 159 NFSINNKLGEGGFGLVY-----KEIAVKRLSK---ISEQGLKELKNEVILFSKLQH-RNL 209
++ I KLGEG FG VY K +A+K L+K + ++ E+ + + L H N+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
VKL L+ E++ SL + + + S+ I+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE------------SEALFILA 108
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+ YLH IIHRD+K N
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPEN 131
|
Length = 384 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-12
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 37/146 (25%)
Query: 166 LGEGGFGLVY--------KEIAVKR-----LSKISEQGLKELKNEVILFSKLQHRNLVKL 212
LG+G FG VY +E+AVK+ S +++ + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 213 LGCCIQGEEKLLIY-EFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDWSKRFHIIC 269
G C++ +E L I+ E+MP S+ + LT + R + Q IL+
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ----ILE--------- 115
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
GV YLH + I+HRD+K +N
Sbjct: 116 ----GVEYLHSN---MIVHRDIKGAN 134
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 27/144 (18%)
Query: 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
F I KLGEG +G VYK +A+K + E+ L+E+ E+ + + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
G + + ++ E+ S V +M+ K L + I+ T
Sbjct: 63 YYGSYFKNTDLWIVMEYC---GAGS------VSDIMKI-----TNKTLTEEEIAAILYQT 108
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH + IHRD+KA N
Sbjct: 109 LKGLEYLHS---NKKIHRDIKAGN 129
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 31/143 (21%)
Query: 166 LGEGGFGLVYK------------EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 212
LG G FG VYK +A+K L + S + KE+ +E + + + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
LG C+ + LI + MP L ++ + + + + +L+W + A
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNH------KDNIGSQ--YLLNWCVQI------A 119
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL + R++HRDL A N
Sbjct: 120 KGMSYL---EEKRLVHRDLAARN 139
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 37/146 (25%)
Query: 166 LGEGGFGLVY-------------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212
LG G FG VY KE+++ + ++ +K+L+ E+ L SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 213 LGCCIQGEEKLLIY-EFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
LG + E+ L I+ E +P SL + + +F ++R + Q IL
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ----ILL--------- 113
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH +HRD+K +N
Sbjct: 114 ----GLEYLHDR---NTVHRDIKGAN 132
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-11
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 52 SRQDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLD-DSSCMAYTNSYIRGEGSGCAMW 110
D F++ KLP +R +S +L EC KCL+ + SC ++T + GC +W
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNN---GTKGCLLW 56
Query: 111 -FGELIDMRDFPDAGQDLYIR 130
L D R FP G DLY +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 41/144 (28%), Positives = 63/144 (43%), Gaps = 23/144 (15%)
Query: 166 LGEGGFGLV-------------YKEIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVK 211
LG G FG V + VK L K ++ E + E+ +F KL H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
LLG C + E +I E+ L F L +S ++ + L ++ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQF------LRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
A G+ +L S R +HRDL A N
Sbjct: 127 ALGMDHL---SNARFVHRDLAARN 147
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 31/142 (21%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
LG+G +G+VY IA+K + + + ++ L E+ L S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRS----FVDQERCKILDWSKRFHIICGTAR 273
+ + E +P SL++ L+RS D E+ I+ ++K+
Sbjct: 76 ENGFFKIFMEQVPGGSLSA---------LLRSKWGPLKDNEQ-TIIFYTKQI------LE 119
Query: 274 GVMYLHQDSKLRIIHRDLKASN 295
G+ YLH +I+HRD+K N
Sbjct: 120 GLKYLHD---NQIVHRDIKGDN 138
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 4e-11
Identities = 16/33 (48%), Positives = 20/33 (60%)
Query: 1 DLCDTYALCGAYGICIISGMPVCQCLKGFKQKS 33
D CD Y CG YG C ++ P C C+KGF K+
Sbjct: 78 DQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 45/147 (30%), Positives = 64/147 (43%), Gaps = 32/147 (21%)
Query: 164 NKLGEGGFGLVYK------------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLV 210
+LGEG FG V ++AVK L+ EQ + + E+ + L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 211 KLLGCC--IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
K G C G LI E++P+ SL + L R ++L +S + I
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDY--------LQRHRDQINLKRLLLFSSQ---I 118
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
C +G+ YL R IHRDL A N
Sbjct: 119 C---KGMDYLGS---QRYIHRDLAARN 139
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 25/154 (16%)
Query: 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILF 201
D+ ++ LG G FG VY+ ++AVK L + SEQ + E ++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
SK H+N+V+L+G + + ++ E M L SF+ EN R ER L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLREN------RP--RPERPSSLTM 115
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G YL ++ IHRD+ A N
Sbjct: 116 KDLLFCARDVAKGCKYLEEN---HFIHRDIAARN 146
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-11
Identities = 48/147 (32%), Positives = 64/147 (43%), Gaps = 30/147 (20%)
Query: 166 LGEGGFGLVYK--------------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRN 208
LG G FG VY+ +AVK L K E+ KE E L S H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
+VKLLG C+ E + +I E M L S+ L + V++ +L + I
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSY--------LRDARVERFGPPLLTLKELLDIC 112
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G +YL Q + IHRDL A N
Sbjct: 113 LDVAKGCVYLEQ---MHFIHRDLAARN 136
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 35/147 (23%)
Query: 164 NKLGEGGFGLVY-------KEIAVKRLS------KISEQGLKELKNEVILFSKLQHRNLV 210
LG+G +G VY + IAVK++ +E+ ++L+ EV L L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRFHII 268
+ LG C+ + EF+P S++S + F + + Q ILD
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ----ILD-------- 113
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
GV YLH + ++HRD+K +N
Sbjct: 114 -----GVAYLHNNC---VVHRDIKGNN 132
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 24/151 (15%)
Query: 166 LGEGGFGLVYKE-------------IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVK 211
+G+G FG V++ +AVK L + S + + E L ++ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI-------LDWSKR 264
LLG C G+ L++E+M LN F+ + L +++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I A G+ YL S+ + +HRDL N
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRN 160
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 21/150 (14%)
Query: 162 INNKLGEGGFGLVYKE-------------IAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
+ +LGEG FG V+ +AVK L + K+ + E L + LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI---LDWSKRF 265
+VK G C G+ ++++E+M + LN F+ + ++ VD + + L S+
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI--LVDGQPRQAKGELGLSQML 126
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
HI A G++YL + +HRDL N
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRN 153
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 39/149 (26%)
Query: 166 LGEGGFGLVY--------KEIAVKR--LSKISEQG-------LKELKNEVILFSKLQHRN 208
+G G FG VY + +AVK+ L +S L L E+ L +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRFH 266
+V+ LG + + + E++P S+ + + + F TL+R+FV Q
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------------- 114
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH IIHRD+K +N
Sbjct: 115 ----ILKGLNYLHNRG---IIHRDIKGAN 136
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 42/153 (27%)
Query: 160 FSINNKLGEGGFGLVYKEIAVKRLSKISEQGLKELKN-------------EVILFSKLQH 206
+ KLGEG +G+VYK + LK+++ E+ L +L+H
Sbjct: 1 YEKLEKLGEGTYGVVYK---ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH 57
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFI---FENFVLTLMRSFVDQERCKILDWS 262
N+VKLL I E KL L++E+ + L ++ L++S +
Sbjct: 58 PNIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIM----------- 104
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ G A Y H RI+HRDLK N
Sbjct: 105 --YQLLRGLA----YCHSH---RILHRDLKPQN 128
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 43/164 (26%), Positives = 64/164 (39%), Gaps = 49/164 (29%)
Query: 160 FSINNKLGEGGFGLVYK-----------EIAVK--RLSKISEQGLKELKNEVILFSKLQH 206
+ LGEG FG V + ++AVK +L + ++E +E H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 207 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLNSFIF--------ENFVL-TLMRSFV 251
N++KL+G C + ++I FM + L+SF+ E L TL++ V
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 252 DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D A G+ YL S IHRDL A N
Sbjct: 121 D------------------IALGMEYL---SNRNFIHRDLAARN 143
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 45/140 (32%), Positives = 65/140 (46%), Gaps = 27/140 (19%)
Query: 165 KLGEGGFGLVYK-------EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC 215
K+G+G FG VYK E+AVK R + + K L+ IL + H N+VKL+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEIL-KQYDHPNIVKLIGV 60
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGV 275
C+Q + ++ E +P SL LT +R ++ K K + A G+
Sbjct: 61 CVQKQPIYIVMELVPGGSL---------LTFLRKKKNRLTVK-----KLLQMSLDAAAGM 106
Query: 276 MYLHQDSKLRIIHRDLKASN 295
YL + IHRDL A N
Sbjct: 107 EYLESKN---CIHRDLAARN 123
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 45/153 (29%), Positives = 64/153 (41%), Gaps = 36/153 (23%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK---ISEQGLKELKNEVILFSKL-Q 205
D+F +GEG F V KE A+K L K I E+ +K +K E + ++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 206 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWS 262
H ++KL Q EE L + E+ PN L +I + + R + + IL
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE----ILL-- 113
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ YLH IIHRDLK N
Sbjct: 114 -----------ALEYLHS---KGIIHRDLKPEN 132
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 31/144 (21%)
Query: 164 NKLGEGGFGLVYK-----------EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVK 211
+LG G FG V K E+AVK L + K E E + ++L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
L+G C +GE +L+ E P L ++ + R + + + + H +
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKR------REIPVSD---LKELA---HQV--- 104
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
A G+ YL +SK +HRDL A N
Sbjct: 105 AMGMAYL--ESK-HFVHRDLAARN 125
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 39/144 (27%), Positives = 64/144 (44%), Gaps = 32/144 (22%)
Query: 164 NKLGEGGFGLVYKEI--------AVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 213
NK+G G FG VY + AVK R+ + +KE+ +E+ + L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVL--TLMRSFVDQERCKILDWSKRFHIICGT 271
G + E+ + E+ +L + +L ++R + Q +L
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ----LL------------ 109
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH I+HRD+K +N
Sbjct: 110 -EGLAYLHSH---GIVHRDIKPAN 129
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 41/154 (26%), Positives = 61/154 (39%), Gaps = 40/154 (25%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 207
+ LG+G G+VYK A+K++ E+ K+L E+ L S +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESP 59
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSF------IFENFVLTLMRSFVDQERCKILDW 261
+VK G + E ++ E+M SL I E + + R +IL
Sbjct: 60 YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR--------QILK- 110
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH K IIHRD+K SN
Sbjct: 111 ------------GLDYLHT--KRHIIHRDIKPSN 130
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 29/150 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRL-SKISEQGLKELKNEVILFSKLQ 205
+I +G G FG V + ++A+K L + S++ + E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N+++L G + ++I E+M N SL+ F+ EN D + +
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN----------DGK----FTVGQLV 109
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ G A G+ YL S++ +HRDL A N
Sbjct: 110 GMLRGIASGMKYL---SEMNYVHRDLAARN 136
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 159 NFSINNKLGEGGFGLV-------------YKEIAVKRLSKISEQG-LKELKNEVILFSKL 204
N + LGEG FG V Y +AVK L + + L++L +E L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVL---------TLMRSFVDQER 255
H +++KL G C Q LLI E+ SL SF+ E+ + S++D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ L +RG+ YL ++++++HRDL A N
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARN 157
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 42/146 (28%), Positives = 71/146 (48%), Gaps = 18/146 (12%)
Query: 165 KLGEGGFGLVYK-------------EIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLV 210
+LGE FG VYK +A+K L +E L+E K+E ++ S+LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK-ILDWSKRFHIIC 269
LLG + + +I+ + + L+ F+ + + S D + K L+ + HI+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
A G+ +L S ++H+DL N
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRN 154
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 38/143 (26%), Positives = 56/143 (39%), Gaps = 24/143 (16%)
Query: 160 FSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212
+ KLG G FG V+ ++AVK L K + E + KL+H LV+L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
C + E ++ E+M SL F+ +++D + A
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSG-------EGKKLRLPQLVDMA------AQIA 113
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
G+ YL IHRDL A N
Sbjct: 114 EGMAYLES---RNYIHRDLAARN 133
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 4e-09
Identities = 41/159 (25%), Positives = 66/159 (41%), Gaps = 48/159 (30%)
Query: 159 NFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ I ++G+G FG VY KEI LS +SE+ ++ NEV + KL
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI---DLSNMSEKEREDALNEVKILKKLN 57
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK-------- 257
H N++K + + ++ E+ L+ I +++ K
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI--------------KKQKKEGKPFPEE 103
Query: 258 -ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
ILDW F +C + YLH +I+HRD+K N
Sbjct: 104 QILDW---FVQLC---LALKYLHSR---KILHRDIKPQN 133
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 37/152 (24%)
Query: 159 NFSINNKLGEGGFGLVYKE--------IAVK--RLSKISEQGLKELKNEVILFSKLQHRN 208
NF K+GEG +G+VYK +A+K RL +E E+ L +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 209 LVKLLGCCIQGEEKL-LIYEFMPNKSLNSFI----FENFVLTLMRSFVDQERCKILDWSK 263
+VKLL I E KL L++EF+ ++ L F+ L L++S++ Q
Sbjct: 61 IVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ---------- 108
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ + H R++HRDLK N
Sbjct: 109 -------LLQGLAFCHSH---RVLHRDLKPQN 130
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 45/146 (30%), Positives = 61/146 (41%), Gaps = 36/146 (24%)
Query: 166 LGEGGFGLVY------------KEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKL 212
LGEG FG V + +AVK L + Q K E+ + L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 213 LGCCIQGEEK--LLIYEFMPNKSLNSFIFENFV-LTLMRSFVDQERCKILDWSKRFHIIC 269
GCC + K LI E++P SL ++ ++ + L + F Q IC
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ--------------IC 117
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH IHRDL A N
Sbjct: 118 ---EGMAYLHSQ---HYIHRDLAARN 137
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-09
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 25/143 (17%)
Query: 161 SINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212
++ +KLG G +G VY +AVK L K ++E E + +++H NLV+L
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
LG C + +I EFM +L ++ E +++ ++ ++ +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLREC----------NRQ---EVNAVVLLYMATQIS 114
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
+ YL + + IHRDL A N
Sbjct: 115 SAMEYLEKKN---FIHRDLAARN 134
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (132), Expect = 9e-09
Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 31/142 (21%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLG 214
LG+G FG V K A+K L K I + ++ E + S++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 215 CCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR 273
Q EEKL L+ E+ P L + + +E + ++ +
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL---------FSHLS----KEGRFSEERARFY--AAEIVL 104
Query: 274 GVMYLHQDSKLRIIHRDLKASN 295
+ YLH L II+RDLK N
Sbjct: 105 ALEYLHS---LGIIYRDLKPEN 123
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 40/147 (27%), Positives = 62/147 (42%), Gaps = 29/147 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 208
++ ++G G FGLV+ ++A+K R +SE+ E E + KL H
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQVMMKLSHPK 60
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
LV+L G C + L++EFM + L+ + L R QE +
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDY------LRAQRGKFSQETL--------LGMC 106
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YL + +IHRDL A N
Sbjct: 107 LDVCEGMAYLESSN---VIHRDLAARN 130
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 37/147 (25%)
Query: 166 LGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLL 213
LG+G FG V +AVK+L + + L++ + E+ + LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 214 GCCIQ-GEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC---KILDWSKRFHII 268
G C G L L+ E++P SL ++ ++ +ER K+L ++ + I
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-----------RERLDHRKLLLYASQ---I 117
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
C +G+ YL R +HRDL N
Sbjct: 118 C---KGMEYL---GSKRYVHRDLATRN 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 29/154 (18%)
Query: 165 KLGEGGFGLVY----------------------KEIAVKRL-SKISEQGLKELKNEVILF 201
KLGEG FG V+ +AVK L + +++ + E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
S+L++ N+++LLG C+ + +I E+M N LN F+ + + + +F +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES---TFTHANNIPSVSI 128
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ A G+ YL + L +HRDL N
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRN 159
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 16/143 (11%)
Query: 166 LGEGGFGLVYK----------EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 213
+GEG FG V K + A+KR+ + S+ ++ E+ + KL H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTA 272
G C L E+ P+ +L F+ ++ VL +F + L + H A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
RG+ YL Q + IHRDL A N
Sbjct: 135 RGMDYLSQK---QFIHRDLAARN 154
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 36/145 (24%)
Query: 165 KLGEGGFGLVYKE--------IAVKRLSK------ISEQGLKELKNEVILFSKLQHRNLV 210
K+GEG +G+VYK +A+K++ I + L+E+K L +L H N++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
KLL + L++EFM + + L++ R + L S +
Sbjct: 62 KLLDVFRHKGDLYLVFEFM----------DTDLYKLIKD-----RQRGLPESLIKSYLYQ 106
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+G+ + H I+HRDLK N
Sbjct: 107 LLQGLAFCHSH---GILHRDLKPEN 128
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 45/162 (27%), Positives = 70/162 (43%), Gaps = 59/162 (36%)
Query: 164 NKLGEGGFGLVYKE--------IAVKRLS-KISEQG--LKELKNEVILFSKLQ---HRNL 209
++GEG +G VYK +A+K++ +SE+G L L+ E+ L +L+ H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 210 VKLLGCC--IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQ------ERC----- 256
V+LL C + + +L + +FE VDQ +C
Sbjct: 64 VRLLDVCHGPRTDRELKLT----------LVFE---------HVDQDLATYLSKCPKPGL 104
Query: 257 ---KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I D ++ RGV +LH RI+HRDLK N
Sbjct: 105 PPETIKDLMRQL------LRGVDFLHSH---RIVHRDLKPQN 137
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 25/137 (18%)
Query: 166 LGEGGFGLVY------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219
+G+G FG V +++AVK L K + E + + L+H NLV+LLG +QG
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI-LDWSKRFHIICGTARGVMYL 278
++ E+M SL + +RS + R I L F + G+ YL
Sbjct: 73 NPLYIVTEYMAKGSL---------VDYLRS---RGRAVITLAQQLGFAL--DVCEGMEYL 118
Query: 279 HQDSKLRIIHRDLKASN 295
+ K +HRDL A N
Sbjct: 119 --EEK-NFVHRDLAARN 132
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 45/151 (29%), Positives = 68/151 (45%), Gaps = 29/151 (19%)
Query: 155 NATDNFSINNKLGEGGFGLVYK----EIAVKRLSKI----SEQGLKELKNEVILFSKLQH 206
N D + I +LG+G FG VYK E + +KI SE+ L++ E+ + S+ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 207 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N+V L E KL I EF +L+S + E L R + +
Sbjct: 62 PNIVGLYEAYFY-ENKLWILIEFCDGGALDSIMLE-----LERGLTEPQ----------I 105
Query: 266 HIIC-GTARGVMYLHQDSKLRIIHRDLKASN 295
+C + +LH ++IHRDLKA N
Sbjct: 106 RYVCRQMLEALNFLHSH---KVIHRDLKAGN 133
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 38/152 (25%)
Query: 159 NFSINNKLGEGGFGLVYK--------EIAVKRLS------KISEQGLKELKNEVILFSKL 204
+ I ++GEG G+V+K +A+K+++ I Q L+E+K
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQAC 56
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
QH +VKLL G +L+ E+MP+ L+ + + R + + K
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD-----EERPLPEAQ-------VKS 103
Query: 265 F-HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ +GV Y+H I+HRDLK +N
Sbjct: 104 YMRMLL---KGVAYMH---ANGIMHRDLKPAN 129
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 40/160 (25%)
Query: 156 ATDNFSINNKLGEGGFGLVYK--EIAVKR---LSKISEQGLKEL-----KNEVILFSKLQ 205
++ I KLGEG FG VYK +I R L KI K+ E+ + KL+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65
Query: 206 HRNLVKLLGCCI-----QGEEKLLIYEFMP--NKSLNSFIFENFVLTLMRSFVDQERC-- 256
H N+V L+ + ++ +Y P + L+ + EN + L S Q +C
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-LLENPSVKLTES---QIKCYM 121
Query: 257 -KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++L+ G+ YLH++ I+HRD+KA+N
Sbjct: 122 LQLLE-------------GINYLHEN---HILHRDIKAAN 145
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 27/150 (18%)
Query: 155 NATDNFSINNKLGEGGFGLVYKE--------IAVKRLSKISEQGLKELKNEVILFSKLQH 206
+ + + I +LG+G FG VYK A K + SE+ L++ E+ + + H
Sbjct: 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
+VKLLG + ++ EF P ++++ + E L R + +
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE-----LDRGLTEPQ----------IQ 113
Query: 267 IICGTA-RGVMYLHQDSKLRIIHRDLKASN 295
+IC + YLH ++IIHRDLKA N
Sbjct: 114 VICRQMLEALQYLHS---MKIIHRDLKAGN 140
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 155 NATDNFSINNKLGEGGFGLVYKEI--------AVKRLSKISEQGLKELKNEVILFSKL-Q 205
+ T F + +GEG +G VYK A+K + I ++ +E+K E + K
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSN 61
Query: 206 HRNLVKLLGCCIQ-----GEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
H N+ G I+ +++L L+ E S V L++ + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS---------VTDLVKGLRKKGKRLKE 112
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+W +I+ T RG+ YLH++ ++IHRD+K N
Sbjct: 113 EWIA--YILRETLRGLAYLHEN---KVIHRDIKGQN 143
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 31/143 (21%)
Query: 166 LGEGGFGLVYKEI------------AVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 212
LG G FG VYK I A+K L++ + + E +E ++ + + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
LG C+ + L+ + MP+ L ++ E+ + + + +L+W + A
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEH------KDNIGSQL--LLNWCVQI------A 119
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
+G+MYL + R++HRDL A N
Sbjct: 120 KGMMYLEER---RLVHRDLAARN 139
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 27/150 (18%)
Query: 155 NATDNFSINNKLGEGGFGLVYKE--------IAVKRLSKISEQGLKELKNEVILFSKLQH 206
N + + I +LG+G FG VYK A K + SE+ L++ E+ + + H
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
N+VKLL ++ EF ++++ + E L R + +
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-----LERPLTEPQ----------IR 106
Query: 267 IICG-TARGVMYLHQDSKLRIIHRDLKASN 295
++C T + YLH++ +IIHRDLKA N
Sbjct: 107 VVCKQTLEALNYLHEN---KIIHRDLKAGN 133
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 34/145 (23%)
Query: 165 KLGEGGFGLVYKE--------IAVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 214
K+GEG +G+VYK +A+K++ SE +G+ E+ L +LQH N+V L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 215 CCIQGEEKLLIYEFMP---NKSLNSFIFENFV-LTLMRSFVDQERCKILDWSKRFHIICG 270
+Q LI+EF+ K L+S ++ L++S++ Q IL
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ----ILQ---------- 112
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
G+++ H R++HRDLK N
Sbjct: 113 ---GILFCHSR---RVLHRDLKPQN 131
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 36/149 (24%), Positives = 67/149 (44%), Gaps = 42/149 (28%)
Query: 166 LGEGGFGLVYKE--------IAVKRLSKI----SEQG--LKELKNEVILFSKLQHRNLVK 211
LG G F Y+ +AVK+++ + SEQ ++ L+ E+ L ++L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFI-----FENFVLTLMRSFVDQERCKILDWSKRFH 266
+LG + L E+M S++ + F+ V+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----------------NYTE 110
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ RG+ YLH++ +IIHRD+K +N
Sbjct: 111 QLL---RGLSYLHEN---QIIHRDVKGAN 133
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 27/149 (18%)
Query: 160 FSINNKLGEGGFGLVY-----KEIAVKRLSKISEQGLKELK-NEVI-------LFSKLQH 206
+ + +LG+G FG VY K +A +RL + E + EL NE + L SKL H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
+VK ++ + +I E+ + L+ + E L + ++ +W
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEE-----LKHTGKTLSENQVCEW----- 111
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
GV Y+HQ RI+HRDLKA N
Sbjct: 112 -FIQLLLGVHYMHQR---RILHRDLKAKN 136
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 43/159 (27%), Positives = 61/159 (38%), Gaps = 38/159 (23%)
Query: 165 KLGEGGFGLVY-KE-----------------------IAVKRLSK-ISEQGLKELKNEVI 199
KLGEG FG V+ E +AVK L S+ ++ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC--- 256
+ S+L N+ +LLG C +I E+M N LN F+ +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQK-------HVAETSGLACNS 124
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
K L +S ++ A G+ YL L +HRDL N
Sbjct: 125 KSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN 160
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (122), Expect = 3e-07
Identities = 35/152 (23%), Positives = 65/152 (42%), Gaps = 38/152 (25%)
Query: 160 FSINNKLGEGGFGLVYKE--------IAVKRLSKISE------QGLKELKNEVILFSKLQ 205
+ ++GEG +G VYK +A+K++ +E ++E+K L KL+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLR 56
Query: 206 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
H N+V+L + +++E+M + L + ++ Q +C
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS----PEVKFTESQIKC------- 104
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YLH + I+HRD+K SN
Sbjct: 105 ---YMKQLLEGLQYLHSN---GILHRDIKGSN 130
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 37/152 (24%)
Query: 159 NFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQGLKELK-NEVILFSKLQHRNL 209
NF KLGEG + VYK EI A+K + +E+G E+ L +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 210 VKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFV-----LTLMRSFVDQERCKILDWSK 263
V+L I E KL L++E+M +K L ++ + V ++SF Q
Sbjct: 61 VRLHDV-IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQ---------- 108
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ + H++ R++HRDLK N
Sbjct: 109 -------LLKGIAFCHEN---RVLHRDLKPQN 130
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 44/153 (28%), Positives = 65/153 (42%), Gaps = 32/153 (20%)
Query: 165 KLGEGGFGLVYKE------------IAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVK 211
+LGE FG +YK +A+K L I+ Q E + E L ++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC---------KILDWS 262
LLG Q + +++E++ L+ F+ +MRS C LD
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFL-------IMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
HI A G+ YL S +H+DL A N
Sbjct: 125 DFLHIAIQIAAGMEYL---SSHFFVHKDLAARN 154
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 44/161 (27%), Positives = 72/161 (44%), Gaps = 33/161 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRL-SKISEQGLKELKNEVILFSK 203
D ++ LGEG FG V K +AVK L +E+ L +L +E+ +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFI--------FENFVLTLMRSFVDQE 254
+ +H+N++ LLG C Q ++ E+ + +L F+ + + R +
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP--RPPEETL 129
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
K L S + + ARG+ +L SK + IHRDL A N
Sbjct: 130 TQKDL-VSFAYQV----ARGMEFL--ASK-KCIHRDLAARN 162
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 37/154 (24%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 205
N+ + LG G FG VY +E+AVK++ S+ + + + L+ E+ L L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 206 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDW 261
H +V+ GC EEK L E+MP S+ + LT + R + Q IL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ----IL-- 116
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+GV YLH + I+HRD+K +N
Sbjct: 117 -----------QGVSYLHSN---MIVHRDIKGAN 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 37/148 (25%), Positives = 67/148 (45%), Gaps = 34/148 (22%)
Query: 160 FSINNKLGEGGFGLVYKEIAVKRLSKI----------SEQGLKELKNEVILFSKLQHRNL 209
F++ +G+G FG VYK I KR +++ +E +++++ E+ S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAI-DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQER--CKILDWSKRFHI 267
K G ++G + +I E+ S L L++ E IL
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS---------CLDLLKPGKLDETYIAFIL------RE 106
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YLH++ K IHRD+KA+N
Sbjct: 107 VL---LGLEYLHEEGK---IHRDIKAAN 128
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 31/142 (21%)
Query: 166 LGEGGFGLVYKEI--------AVKRLSKISEQG-LKELKNEVILFSKLQH---RNLVKLL 213
+G G +G VY+ A+K ++ + + +++ EV L S+L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR 273
G ++G +I E+ S V TLM++ E+ + II
Sbjct: 69 GSYLKGPRLWIIMEYAEGGS---------VRTLMKAGPIAEKYISV-------IIREVLV 112
Query: 274 GVMYLHQDSKLRIIHRDLKASN 295
+ Y+H+ +IHRD+KA+N
Sbjct: 113 ALKYIHKVG---VIHRDIKAAN 131
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 26/147 (17%)
Query: 159 NFSINNKLGEGGFGLVYKEI--------AVKR--LSKISEQGLKELKNEVILFSKLQHRN 208
+F I NK+G+G FG+V+K + A+K+ LSK++ + +E +E + +KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
+++ + + ++ E+ N L+ L++ + + W RF I
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHK---------LLKMQRGRPLPEDQVW--RFFI- 108
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ +LH +I+HRD+K+ N
Sbjct: 109 -QILLGLAHLH---SKKILHRDIKSLN 131
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 7e-07
Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 37/154 (24%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRL-----SKISEQGLKELKNEVILFSKLQ 205
N+ + LG+G FG VY +E+AVK++ S + + + L+ E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 206 HRNLVKLLGCCIQGEEKLL--IYEFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDW 261
H +V+ GC E+ L E MP S+ + LT + R + Q IL+
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ----ILE- 117
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
GV YLH + I+HRD+K +N
Sbjct: 118 ------------GVSYLHSN---MIVHRDIKGAN 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 30/150 (20%)
Query: 159 NFSINNKLGEGGFGLVYKEIAVKRLSKISEQGLKELK-------------NEVILFSKLQ 205
+F + KLG+G +G VYK VKRLS LKE+ NE+ + + +
Sbjct: 1 DFKVLKKLGKGSYGSVYK---VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N++ + G + ++ E+ P L+ I + R + ++ W
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKR---KKKRKLIPEQ----EIWR--- 107
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I RG+ LH+ +I+HRDLK++N
Sbjct: 108 -IFIQLLRGLQALHE---QKILHRDLKSAN 133
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-07
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 42/151 (27%)
Query: 166 LGEGGFGLVY--------KEIAVKRL---SKISEQG-------LKELKNEVILFSKLQHR 207
+G+G +G VY + +AVK++ + I+ + +K L++E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 208 NLVKLLGCCIQGEEKLLIY-EFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKR 264
N+V+ LG EE L I+ E++P S+ S + + F L+R F +Q
Sbjct: 69 NIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ----------- 116
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH I+HRDLKA N
Sbjct: 117 ------VLEGLAYLHSKG---ILHRDLKADN 138
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 37/147 (25%), Positives = 54/147 (36%), Gaps = 37/147 (25%)
Query: 165 KLGEGGFGLVYK-----------EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKL 212
KLG+G FG+V + +AVK L + + E + L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG-- 270
G + + + E P + S +D+ R L +C
Sbjct: 62 YGVVLTHPLMM-VTELAP----------------LGSLLDRLRKDALG-HFLISTLCDYA 103
Query: 271 --TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ YL R IHRDL A N
Sbjct: 104 VQIANGMRYLESK---RFIHRDLAARN 127
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 39/144 (27%), Positives = 63/144 (43%), Gaps = 33/144 (22%)
Query: 165 KLGEGGFGLVYKE--------IAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLLG 214
K+GEG +G+VYK +A+K RL E E+ L +L H N+V+LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 215 CCIQGEEKLLIYEFMP---NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
+ L++EF+ K ++S L++S++ Q +
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQ--------------LL-- 109
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
+G+ Y H R++HRDLK N
Sbjct: 110 -QGIAYCHSH---RVLHRDLKPQN 129
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 33/154 (21%)
Query: 157 TDNFSINNKLGEGGFGLVYKEI--------AVKRL-------SKISEQGLKELKNEVILF 201
NF I K+G+G F +VYK I A+K++ +K + LKE+ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+L H N++K L I+ E ++ E L+ I + F Q+R ++
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMI---------KHFKKQKR--LIPE 105
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + ++H RI+HRD+K +N
Sbjct: 106 RTIWKYFVQLCSALEHMHSK---RIMHRDIKPAN 136
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-07
Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 32/145 (22%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
DNF K+GEG G+V +++AVK++ +Q + L NEV++ QH N+
Sbjct: 22 DNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V++ + G+E ++ EF+ +L + T R +Q +C
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIAT-----------VC 121
Query: 270 -GTARGVMYLHQDSKLRIIHRDLKA 293
+ + +LH +IHRD+K+
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKS 143
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 42/155 (27%)
Query: 159 NFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQG---LKELKNEVILFSKLQHR 207
F N++GEG +G+VY+ EI A+K++ +E+ + L+ E+ L L+H
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR-FH 266
N+V+L E + K L+S IF L+ + +Q+ +LD F
Sbjct: 67 NIVELK-------------EVVVGKHLDS-IF------LVMEYCEQDLASLLDNMPTPFS 106
Query: 267 ------IICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ RG+ YLH++ IIHRDLK SN
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSN 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 29/139 (20%)
Query: 166 LGEGGFGLVYK-------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 216
LG G FG+V+ ++A+K + + +SE E E + KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKVMMKLSHPNLVQLYGVC 68
Query: 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276
+ ++ E+M N L +++ +ER L + +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--------------RERKGKLGTEWLLDMCSDVCEAME 114
Query: 277 YLHQDSKLRIIHRDLKASN 295
YL + IHRDL A N
Sbjct: 115 YLESNG---FIHRDLAARN 130
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 37/138 (26%), Positives = 54/138 (39%), Gaps = 24/138 (17%)
Query: 165 KLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
KLG G FG V++ +AVK L K K+ E + KL+H L++L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277
E ++ E M SL ++ + L + + A G+ Y
Sbjct: 72 LEEPIYIVTELMKYGSL-------------LEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 278 LHQDSKLRIIHRDLKASN 295
L + IHRDL A N
Sbjct: 119 LEAQN---YIHRDLAARN 133
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 26/148 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKR--LSKISEQGLKELKNEVILFSKLQHR 207
D++ + +G G +VY ++A+KR L K + EL+ EV S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHP 59
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+VK + G+E L+ ++ SL L +M+S + LD + +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSL---------LDIMKSSYPR---GGLDEAIIATV 107
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +G+ YLH + IHRD+KA N
Sbjct: 108 LKEVLKGLEYLHSN---GQIHRDIKAGN 132
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 28/155 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSK---ISEQGLKELKNEVILF 201
+ ++ +LG+G FG+VY+ +A+K +++ + E+ E NE +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVM 63
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+ ++V+LLG G+ L++ E M L S+ L R +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSY------LRSRRPEAENNPGLGPPT 117
Query: 262 SKRFHIICG-TARGVMYLHQDSKLRIIHRDLKASN 295
++F + A G+ YL + +HRDL A N
Sbjct: 118 LQKFIQMAAEIADGMAYLAA---KKFVHRDLAARN 149
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 42/152 (27%), Positives = 64/152 (42%), Gaps = 45/152 (29%)
Query: 164 NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKN-----EVILFSKLQHRNLV 210
KLGEG + +VYK +A+K++ + K+ N E+ L +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL-DWSKRF---H 266
LL F ++N V M + D E K++ D S
Sbjct: 66 GLLDV------------FGHKSNIN------LVFEFMET--DLE--KVIKDKSIVLTPAD 103
Query: 267 IIC---GTARGVMYLHQDSKLRIIHRDLKASN 295
I T RG+ YLH + I+HRDLK +N
Sbjct: 104 IKSYMLMTLRGLEYLHSNW---ILHRDLKPNN 132
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 37/158 (23%), Positives = 77/158 (48%), Gaps = 29/158 (18%)
Query: 147 LFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELK-NE 197
L + ++ + ++ K+G+G G VY +E+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
+++ + +H N+V L + G+E ++ E++ SL + E + + V +E +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L+ +LH + ++IHRD+K+ N
Sbjct: 127 ALE----------------FLHSN---QVIHRDIKSDN 145
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 33/147 (22%), Positives = 63/147 (42%), Gaps = 27/147 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNL 209
+++ + ++G G +G VYK E+ ++ K+ + ++ E+ + + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 210 VKLLGCCIQGEEKLLI-YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
V G +KL I E+ SL + Q L + ++
Sbjct: 63 VAYFG-SYLRRDKLWIVMEYCGGGSL--------------QDIYQVTRGPLSELQIAYVC 107
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
T +G+ YLH+ K IHRD+K +N
Sbjct: 108 RETLKGLAYLHETGK---IHRDIKGAN 131
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 34/144 (23%)
Query: 165 KLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKN----EVILFSKLQHRNLVKL 212
+GEG +G+V K +A+K+ + + K +K E+ + +L+H NLV L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD--KMVKKIAMREIRMLKQLRHENLVNL 65
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC-KILDWSKRFHIICGT 271
+ + + L++EF+ + L+ E + L D+ R K L F I+
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGL-----DESRVRKYL-----FQIL--- 110
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
RG+ + H + IIHRD+K N
Sbjct: 111 -RGIEFCHSHN---IIHRDIKPEN 130
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 37/158 (23%), Positives = 78/158 (49%), Gaps = 29/158 (18%)
Query: 147 LFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELK-NE 197
L + +I + ++ K+G+G G V+ +E+A+K+++ + +Q KEL NE
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN-LQKQPKKELIINE 66
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
+++ +L++ N+V L + G+E ++ E++ SL + E + + V +E +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQ 126
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L+ +LH + ++IHRD+K+ N
Sbjct: 127 ALE----------------FLHAN---QVIHRDIKSDN 145
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 25/138 (18%)
Query: 166 LGEGGFGLVYK-------EIAVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGCCI 217
LG+G FG V+K +AVK + Q LK + +E + + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277
Q + ++ E +P L+ +R D+ + K L +F + A G+ Y
Sbjct: 63 QRQPIYIVMELVPGGDF---------LSFLRKKKDELKTKQL---VKFAL--DAAAGMAY 108
Query: 278 LHQDSKLRIIHRDLKASN 295
L +SK IHRDL A N
Sbjct: 109 L--ESK-NCIHRDLAARN 123
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 4e-06
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 37/147 (25%)
Query: 166 LGEGGFGLVY--------KEIAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLVKL 212
LG+G FG VY +E+A K++ S + + + L+ E+ L LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 213 LGCCI-QGEEKLLIY-EFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDWSKRFHII 268
GC + E+ L I+ E+MP S+ + LT + R + Q IL+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ----ILE-------- 117
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH + I+HRD+K +N
Sbjct: 118 -----GMSYLHSN---MIVHRDIKGAN 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 35/152 (23%)
Query: 158 DNFSINNKLGEGGFGLVYKE--------IAVK--RLSKISEQGLKELKNEVILFSKLQHR 207
D + K+GEG +G+VYK IA+K RL + E E+ L ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 208 NLVKLLGCCIQGEEKL-LIYEFMP---NKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
N+V+L + E++L L++E++ K ++S L+++++ Q IL
Sbjct: 62 NIVRLQD-VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----IL---- 112
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
RG+ Y H R++HRDLK N
Sbjct: 113 ---------RGIAYCHSH---RVLHRDLKPQN 132
|
Length = 294 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-06
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 24/145 (16%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ + KLG G FG V+ ++AVK L K ++ E L LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L + E +I E+M SL F+ + ++ K++D+S +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-------KLIDFSAQI----- 112
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ Y+ + IHRDL+A+N
Sbjct: 113 -AEGMAYIE---RKNYIHRDLRAAN 133
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 41/145 (28%), Positives = 60/145 (41%), Gaps = 33/145 (22%)
Query: 164 NKLGEGGFGLVYKE--------IAVKRL-----SKISEQGLKELKNEVILFSKLQHRNLV 210
+LG G G+V K +AVK + I +Q L+EL IL K +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD---ILH-KCNSPYIV 62
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
G + + E+M SL+ L ++ + + IL K I
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKI------LKEVQGRIPER---IL--GK---IAVA 108
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH K +IIHRD+K SN
Sbjct: 109 VLKGLTYLH--EKHKIIHRDVKPSN 131
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 43/160 (26%), Positives = 66/160 (41%), Gaps = 32/160 (20%)
Query: 165 KLGEGGFGLVYK------------------------EIAVKRL-SKISEQGLKELKNEVI 199
KLGEG FG V+ +AVK L ++ + EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLM---RSFVDQERC 256
+ S+L+ N+++LLG C+ + +I E+M N LN F+ + + V C
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 257 -KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +S H+ A G+ YL S L +HRDL N
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRN 168
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 37/146 (25%)
Query: 166 LGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 212
LG G FG VYK +A+K L + S + KE+ +E + + + + ++ +L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC---KILDWSKRFHIIC 269
LG C+ + LI + MP L ++ E+ ++ +L+W +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREH-----------KDNIGSQYLLNWCVQI---- 118
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ YL + R++HRDL A N
Sbjct: 119 --AKGMNYLEER---RLVHRDLAARN 139
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 35/150 (23%), Positives = 62/150 (41%), Gaps = 32/150 (21%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQGLKELKN----EVILFSKLQ 205
+ + + +GEG +G+V K EI A+K+ K SE +++K EV + +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDD-EDVKKTALREVKVLRQLR 58
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N+V L + L++E++ L +L + + + W
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE-------LLEASPGGLPPDAVRSYIWQ--- 108
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + Y H IIHRD+K N
Sbjct: 109 -----LLQAIAYCH---SHNIIHRDIKPEN 130
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 27/159 (16%)
Query: 158 DNFSINNKLGEGGFGLVY------------KE---IAVKRLS-KISEQGLKELKNEVILF 201
D ++ LGEG FG V KE +AVK L +E+ L +L +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 202 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF----VDQERC 256
+ +H+N++ LLG C Q +I E+ +L ++ + S+ V E+
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D + + ARG+ YL + + IHRDL A N
Sbjct: 135 TFKDLVSCTYQV---ARGMEYL---ASQKCIHRDLAARN 167
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 8e-06
Identities = 39/146 (26%), Positives = 64/146 (43%), Gaps = 29/146 (19%)
Query: 162 INNKLGEGGFGLVYK-----------EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNL 209
I +G G FG V + +A+K L S +E+ ++ +E + + H N+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+ L G + ++I EFM N +L+SF+ +N + V R
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-------------- 113
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
G A G+ YL S++ +HRDL A N
Sbjct: 114 GIAAGMKYL---SEMNYVHRDLAARN 136
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 24/155 (15%)
Query: 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLK-ELKNEVILF 201
A + +++ +LG+G FG+VY+ +A+K +++ + + E NE +
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+ ++V+LLG QG+ L+I E M L S+ L +R ++ +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY------LRSLRPEMENNPVQAPPS 117
Query: 262 SKRFHIICG-TARGVMYLHQDSKLRIIHRDLKASN 295
K+ + G A G+ YL+ + + +HRDL A N
Sbjct: 118 LKKMIQMAGEIADGMAYLNAN---KFVHRDLAARN 149
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-06
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 30/153 (19%)
Query: 161 SINNKLGEGGFGLVYK----------EIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 208
++ LGEG FG V + ++AVK +++ + +++ +E + + H N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 209 LVKLLGCCIQGEEK------LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
+++L+G C+Q E ++I FM + L+SF+ L D + L
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-------LYSRLGDCP--QYLPTQ 112
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A G+ YL S IHRDL A N
Sbjct: 113 MLVKFMTDIASGMEYL---SSKSFIHRDLAARN 142
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 27/139 (19%)
Query: 165 KLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 216
K+GEG G+V K++AVK++ +Q + L NEV++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276
+ G+E ++ EF+ +L ++T R +++E+ + S R +
Sbjct: 89 LVGDELWVVMEFLEGGALTD------IVTHTR--MNEEQIATVCLS--------VLRALS 132
Query: 277 YLHQDSKLRIIHRDLKASN 295
YLH +IHRD+K+ +
Sbjct: 133 YLHNQG---VIHRDIKSDS 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 9e-06
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 35/154 (22%)
Query: 160 FSINNKLGEGGFGLVYK----------EIAVKRL--SKISEQGLKELK-NEVILFSKLQH 206
+ I +G G +G VYK E A+K+ K G+ + E+ L +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 207 RNLVKLLGCCIQGEEKL--LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW--- 261
N+V L+ ++ +K L++++ E+ + +++ +R I
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA----------EHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
S + I+ GV YLH + ++HRDLK +N
Sbjct: 112 SLLWQILN----GVHYLHSN---WVLHRDLKPAN 138
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 40/163 (24%), Positives = 67/163 (41%), Gaps = 32/163 (19%)
Query: 158 DNFSINNKLGEGGFGLVY------------KE------------IAVKRL-SKISEQGLK 192
+ KLGEG FG V+ K+ +AVK L ++
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 193 ELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVD 252
+ E+ + S+L+ N+++LL CI + +I E+M N LN F+ + + +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH----EPQEAAE 120
Query: 253 QERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + +S + A G+ YL S L +HRDL N
Sbjct: 121 KADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN 160
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 30/137 (21%), Positives = 51/137 (37%), Gaps = 24/137 (17%)
Query: 166 LGEGGFGLVYKE------IAVKR--LSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
+ + K +AVK+ L S++ LK L+ E+I +LQH N++ + I
Sbjct: 10 FEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277
E ++ M S + +F L + I+ + Y
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-------------ILKDVLNALDY 116
Query: 278 LHQDSKLRIIHRDLKAS 294
+H IHR +KAS
Sbjct: 117 IH---SKGFIHRSVKAS 130
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 36/140 (25%), Positives = 65/140 (46%), Gaps = 29/140 (20%)
Query: 165 KLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 216
K+GEG G+V +++AVK + +Q + L NEV++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA-RGV 275
+ GEE ++ EF+ +L V Q R ++ +C + + +
Sbjct: 88 LVGEELWVLMEFLQGGALT-------------DIVSQTRLN----EEQIATVCESVLQAL 130
Query: 276 MYLHQDSKLRIIHRDLKASN 295
YLH +IHRD+K+ +
Sbjct: 131 CYLHSQG---VIHRDIKSDS 147
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYKE---------------IAVKRLS-KISEQGLKELKNEVILF 201
D + LGEG FG V + +AVK L +++ L +L +E+ L
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 202 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKIL 259
+ +H+N++ LLG C Q +I E+ +L F+ +F + + + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ARG+ YL +S+ R IHRDL A N
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARN 164
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 40/156 (25%), Positives = 61/156 (39%), Gaps = 59/156 (37%)
Query: 165 KLGEGGFGLVYKEIAVKRLSKISEQ--GLKELK------------NEVILFSKLQHRNLV 210
KLGEG + VYK SK++ Q LKE++ E L L+H N+V
Sbjct: 12 KLGEGSYATVYKGR-----SKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR------ 264
L I ++ L + +FE ++D + + +D
Sbjct: 67 -TLHDIIHTKKTL------------TLVFE---------YLDTDLKQYMDDCGGGLSMHN 104
Query: 265 -----FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
F ++ RG+ Y HQ R++HRDLK N
Sbjct: 105 VRLFLFQLL----RGLAYCHQR---RVLHRDLKPQN 133
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 39/145 (26%), Positives = 63/145 (43%), Gaps = 28/145 (19%)
Query: 164 NKLGEGGFGLVYKEIAVKRLSKISEQGLKELK-----NEVILFSK-------LQHRNLVK 211
+++G G FG V R + +KEL+ +E +LF + L H N+++
Sbjct: 1 DEIGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVD-QERCKILDWSKRFHIICG 270
LG CI+ LL+ EF P L +++ N + + D +R + C
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR-----------MACE 108
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+++LHQ IH DL N
Sbjct: 109 VASGLLWLHQ---ADFIHSDLALRN 130
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 43/143 (30%), Positives = 67/143 (46%), Gaps = 33/143 (23%)
Query: 165 KLGEGGFGLVYKEI--------AVKRLSKISEQGLK-ELKNEVILFSKLQHRNLVKLLGC 215
KLGEG + VYK I A+K +S +E+G+ E L L+H N+V LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHD 70
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR---FHIICGTA 272
I +E L +F+FE ++ T + ++ Q + ++ R F ++
Sbjct: 71 IIHTKETL------------TFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLL---- 113
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
RG+ Y+H I+HRDLK N
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQN 133
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 31/149 (20%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRLSK---ISEQGLKELKNEVILFSKLQHR 207
+F + +G+G FG V K A+K ++K + + ++ + NE + +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 208 NLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
LV L Q EE + L+ + + L + L+ F +E+ K
Sbjct: 61 FLVNLWYS-FQDEENMYLVVDLLLGGDLR------YHLSQKVKF-SEEQVKF-------- 104
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
IC + YLH SK IIHRD+K N
Sbjct: 105 WICEIVLALEYLH--SK-GIIHRDIKPDN 130
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 37/158 (23%), Positives = 77/158 (48%), Gaps = 29/158 (18%)
Query: 147 LFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELK-NE 197
L + ++ + ++ K+G+G G VY +E+A+K+++ + +Q KEL NE
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN-LQQQPKKELIINE 66
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
+++ + ++ N+V L + G+E ++ E++ SL + E + + V +E +
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 126
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
LD +LH + ++IHRD+K+ N
Sbjct: 127 ALD----------------FLHSN---QVIHRDIKSDN 145
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 29/147 (19%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ + KLG G FG V+ ++A+K L K + E L +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIF--ENFVLTLMRSFVDQERCKILDWSKRFHII 268
+L Q E +I E+M N SL F+ E LT+ K++D + +
Sbjct: 65 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTIN---------KLIDMAAQ---- 110
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
A G+ ++ + + IHRDL+A+N
Sbjct: 111 --IAEGMAFIERKN---YIHRDLRAAN 132
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 33/150 (22%), Positives = 64/150 (42%), Gaps = 38/150 (25%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
LG G GLV+ K +AVK++ Q +K E+ + +L H N+VK
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 218 QGEEKLLIYEFM-----PNKSLNSFIFENFVLTLMRSFVDQERCKIL-------DWSKRF 265
+YE + + E + +++ +++ + +L + ++ F
Sbjct: 67 -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ RG+ Y+H + ++HRDLK +N
Sbjct: 120 --MYQLLRGLKYIHSAN---VLHRDLKPAN 144
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 36/145 (24%), Positives = 61/145 (42%), Gaps = 36/145 (24%)
Query: 166 LGEGGFG-------------LVYKEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212
LG+G FG +V+KE+ + RLS E+ ++ NE+++ S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS---EKERRDALNEIVILSLLQHPNIIAY 64
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVL--TLMRSFVDQERCKILDWSKRFHIICG 270
FM + +L I + TL V Q+ ++ + +
Sbjct: 65 YN------------HFMDDNTL--LIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQ 109
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
V Y+H+ I+HRD+K N
Sbjct: 110 IVSAVSYIHKAG---ILHRDIKTLN 131
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 25/124 (20%)
Query: 178 IAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235
+AVK+LS+ ++ K E++L + H+N++ LL F P KSL
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLE 96
Query: 236 SFIFENFVLTLMRSFVDQERCKI----LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291
F V+ LM D C++ LD + +++ G+ +LH IIHRDL
Sbjct: 97 EFQDVYLVMELM----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 149
Query: 292 KASN 295
K SN
Sbjct: 150 KPSN 153
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 158 DNFSINNKLGEGGFGLVYKEI----------AVKRLSKI-SEQGLKELKNEVILFSKL-Q 205
++ + +GEG FG V + + A+K L + SE ++ E+ + KL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE-RCKILDWSKR 264
H N++ LLG C + E+ P +L F+ ++ VL +F + L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
A G+ YL S+ + IHRDL A N
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARN 149
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 33/144 (22%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 215
+G G G+V + +A+K+LS+ ++ K E++L + H+N++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI----LDWSKRFHIICGT 271
F P KSL F V+ LM D C++ LD + +++
Sbjct: 85 ------------FTPQKSLEEFQDVYLVMELM----DANLCQVIQMELDHERMSYLLYQM 128
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
G+ +LH IIHRDLK SN
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSN 149
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 33/144 (22%)
Query: 166 LGEGGFGLV--------YKEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGC 215
+G G G+V + +A+K+LS+ ++ K E++L + H+N++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI----LDWSKRFHIICGT 271
F P KSL F V+ LM D C++ LD + +++
Sbjct: 92 ------------FTPQKSLEEFQDVYIVMELM----DANLCQVIQMELDHERMSYLLYQM 135
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
G+ +LH IIHRDLK SN
Sbjct: 136 LCGIKHLHSAG---IIHRDLKPSN 156
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 41/150 (27%), Positives = 64/150 (42%), Gaps = 35/150 (23%)
Query: 160 FSINNKLGEGGFGLVY-------KEI-AVKRLSKISEQGLKE---LKNEVILFSKLQHRN 208
F I ++G+GG+G V+ EI A+KR+ K L E + E + + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 209 LVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
LVKLL Q +E L L E++P + + VL+ + RF++
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS--------------EDHARFYM 107
Query: 268 ICGTARGVMYLHQDS--KLRIIHRDLKASN 295
M+ D+ +L IHRDLK N
Sbjct: 108 A------EMFEAVDALHELGYIHRDLKPEN 131
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 31/143 (21%)
Query: 166 LGEGGFGLVYKEI------------AVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKL 212
LG G FG V+K I A+K + + Q +E+ + ++ L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
LG C G L+ + P SL + ++ R +D +R +L+W + A
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQH------RDSLDPQR--LLNWCVQI------A 119
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL + R++HR+L A N
Sbjct: 120 KGMYYLEEH---RMVHRNLAARN 139
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 35/143 (24%)
Query: 165 KLGEGGFGLVY-------KEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 215
+LG G FG+V+ ++A+K +++ +SE+ E E + KL H LV+L G
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLVQLYGV 67
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFEN---FVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
C Q + ++ EFM N L +++ + ++ S Q+ C+
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC-QDVCE--------------- 111
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
G+ YL ++S IHRDL A N
Sbjct: 112 -GMEYLERNS---FIHRDLAARN 130
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 42/153 (27%), Positives = 60/153 (39%), Gaps = 31/153 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKE-LKNEVILFSK 203
+N S LG G FG V + ++AVK L + +E L +E+ + S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
L H N+V LLG C G L+I E+ L +F+ R L
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-------------RESFLTLE 141
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ +L + IHRDL A N
Sbjct: 142 DLLSFSYQVAKGMAFLASKN---CIHRDLAARN 171
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 4e-05
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 50/160 (31%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQG----LKELKNEVILFSKLQ 205
D + N++ EG +G+VY+ EI A+K+L K+ ++ + L+ E+ + KLQ
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLR-EINILLKLQ 62
Query: 206 HRNLVKL----LGCCIQGEEKLLIYEFMPN--KSLNSFIFENF----VLTLMRSFVDQER 255
H N+V + +G + ++ ++ E++ + KSL + + F V LM +
Sbjct: 63 HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLL---- 116
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
GV +LH + I+HRDLK SN
Sbjct: 117 -----------------SGVAHLHDNW---ILHRDLKTSN 136
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 28/150 (18%)
Query: 155 NATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISE-QGLKELKNEVILFSKLQH 206
N ++F + ++G G +G VYK E+A ++ K+ + ++ E+I+ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMR-SFVDQERCKILDWSKRF 265
N+V G ++ ++ + EF SL L+ + ++V +E
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE----------- 114
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
T +G+ YLH K +HRD+K +N
Sbjct: 115 -----TLQGLYYLHSKGK---MHRDIKGAN 136
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 16/118 (13%)
Query: 178 IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF 237
+ + L +E+ LK L+NEV+L +H N++ G +I FM S NS
Sbjct: 30 VRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANS- 88
Query: 238 IFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L++++ + + L + I+ G RG+ YLHQ+ IHR++KAS+
Sbjct: 89 --------LLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASH 131
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 38/138 (27%), Positives = 57/138 (41%), Gaps = 27/138 (19%)
Query: 142 DLELPLFELATIANATDNFSINNKLGEGGFGLVYKEIAVKRLSKISEQGLKELKNEVILF 201
D+ L E I+ S K + G V KEI ++ I +E+
Sbjct: 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS-------SEIADM 737
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
KLQH N+VKL+G C + LI+E++ K+L S + N L W
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRN-----------------LSW 779
Query: 262 SKRFHIICGTARGVMYLH 279
+R I G A+ + +LH
Sbjct: 780 ERRRKIAIGIAKALRFLH 797
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 41/158 (25%), Positives = 67/158 (42%), Gaps = 21/158 (13%)
Query: 156 ATDNFSINNKLGEGGFGLVY---------------KEIAVKRL-SKISEQGLKELKNEVI 199
D + LGEG FG V ++AVK L S +E+ L +L +E+
Sbjct: 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75
Query: 200 LFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCK 257
+ + +H+N++ LLG C Q +I E+ +L ++ + + Q +
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEE 135
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L + ARG+ YL + + IHRDL A N
Sbjct: 136 QLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 170
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 28/142 (19%)
Query: 166 LGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 215
+G G +G V ++A+K+LS+ S K E+ L + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQ-ERCKIL-DWSKRFHIICGTAR 273
F P SL F V LM + ++ +C+ L D +F ++ R
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILR 129
Query: 274 GVMYLHQDSKLRIIHRDLKASN 295
G+ Y+H IIHRDLK SN
Sbjct: 130 GLKYIHS---AGIIHRDLKPSN 148
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 24/157 (15%)
Query: 153 IANATDNFSINNKLGEGGFGLVYKEIAVKRLSKISEQGL-KELKN------------EVI 199
IA + D ++++ L EG FG ++ I + E+ K +K+ E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 200 LFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI 258
L L H+N++ +L CI+ E ++Y +M +L F L R + +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF------LQQCR-LGEANNPQA 113
Query: 259 LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L + H+ A G+ YLH K +IH+D+ A N
Sbjct: 114 LSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARN 147
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 29/160 (18%)
Query: 150 LATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEV-IL 200
L ++ + TD + I +G+G +G VYK AVK L IS+ +E++ E IL
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 201 FSKLQHRNLVKLLGCCIQ-----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQER 255
S H N+VK G + G + L+ E S+ V L+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE-----LVKGLLI------C 121
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ LD + +I+ G G+ +LH + RIIHRD+K +N
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNN 158
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 11/89 (12%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
DNF K+GEG G+V K +AVK++ +Q + L NEV++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFI 238
V++ + G+E ++ EF+ +L +
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV 108
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 27/157 (17%)
Query: 160 FSINNKLGEGGFGLVYK---------------EIAVKRLSK-ISEQGLKELKNEVILFSK 203
++ LGEG FG V +AVK L +++ L +L +E+ +
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
+ +H+N++ LLG C Q ++ E+ +L ++ + SF + CK+ +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF---DTCKLPEEQ 130
Query: 263 KRFH--IICG--TARGVMYLHQDSKLRIIHRDLKASN 295
F + C ARG+ YL + + IHRDL A N
Sbjct: 131 LTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARN 164
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 34/145 (23%)
Query: 166 LGEGGFGLVY---------KEI--AVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLL 213
+G+G FG VY ++I AVK L++I++ + +++ E I+ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 214 GCCIQGE-EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG-- 270
G C+ E L++ +M + L +FI RS K L I G
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI---------RSETHNPTVKDL-------IGFGLQ 106
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ YL + +HRDL A N
Sbjct: 107 VAKGMEYLASK---KFVHRDLAARN 128
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 36/124 (29%), Positives = 56/124 (45%), Gaps = 25/124 (20%)
Query: 178 IAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235
+A+K+LS+ + K E++L + H+N++ LL F P KSL
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQKSLE 91
Query: 236 SFIFENFVLTLMRSFVDQERCKI----LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291
F V+ LM D C++ LD + +++ G+ +LH IIHRDL
Sbjct: 92 EFQDVYLVMELM----DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144
Query: 292 KASN 295
K SN
Sbjct: 145 KPSN 148
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 8e-05
Identities = 40/145 (27%), Positives = 61/145 (42%), Gaps = 35/145 (24%)
Query: 165 KLGEGGFGLVYK-------EI-AVKR----LSKISE-QGLKELKNEVILFSKLQ-HRNLV 210
+LG+G FG VY E+ A+K+ E L+E+K+ KL H N+V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS----LRKLNEHPNIV 61
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
KL + +E ++E+M E + LM+ + K S II
Sbjct: 62 KLKEVFRENDELYFVFEYM----------EGNLYQLMK----DRKGKPFSESVIRSIIYQ 107
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+G+ ++H K HRDLK N
Sbjct: 108 ILQGLAHIH---KHGFFHRDLKPEN 129
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 27/143 (18%)
Query: 160 FSINNKLGEGGFGLVY------KEIAVKRLS-KISEQGLKELKNEVILFSKLQHRNLVKL 212
++ +GEG FG V +++AVK + ++ Q E E + +KL H+NLV+L
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRL 64
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
LG I ++ E M +L NF+ T R+ V ++L +S + A
Sbjct: 65 LG-VILHNGLYIVMELMSKGNL-----VNFLRTRGRALVSV--IQLLQFS--LDV----A 110
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
G+ YL +SK +++HRDL A N
Sbjct: 111 EGMEYL--ESK-KLVHRDLAARN 130
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-05
Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ + KLG G FG V+ ++AVK + K ++ E + LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
KL + E +I EFM SL F+ + Q K++D+S +
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSD-------EGSKQPLPKLIDFSAQI----- 111
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ ++ Q + IHRDL+A+N
Sbjct: 112 -AEGMAFIEQRN---YIHRDLRAAN 132
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 9e-05
Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 29/147 (19%)
Query: 160 FSINNKLGEGGFGLVY--------KEIAVKRLS---KISEQGLKELKNEVILFSKLQHRN 208
F+ ++G G FG VY + +A+K++S K S + +++ EV +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
++ GC ++ L+ E+ + S + E V ++ + ++ + H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSA--SDLLE----------VHKKPLQEVEIAAITH-- 132
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
G +G+ YLH + +IHRD+KA N
Sbjct: 133 -GALQGLAYLHSHN---MIHRDIKAGN 155
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 39/142 (27%), Positives = 72/142 (50%), Gaps = 30/142 (21%)
Query: 165 KLGEGGFGLVYK-------EI-AVKRLSKISE-QGLKELK-NEVILFSKLQHRNLVKLLG 214
K+GEG +G V+K EI A+KR+ + +G+ E+ L +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 215 CCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR 273
+ ++KL L++E+ ++ L + F++ +D E K S F ++ +
Sbjct: 67 -VLHSDKKLTLVFEYC-DQDLKKY-FDS-----CNGDIDPEIVK----SFMFQLL----K 110
Query: 274 GVMYLHQDSKLRIIHRDLKASN 295
G+ + H ++HRDLK N
Sbjct: 111 GLAFCHSH---NVLHRDLKPQN 129
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 39/147 (26%), Positives = 70/147 (47%), Gaps = 29/147 (19%)
Query: 160 FSINNKLGEGGFGLVY--------KEIAVKRLS---KISEQGLKELKNEVILFSKLQHRN 208
FS ++G G FG VY + +A+K++S K S + +++ EV KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
++ GC ++ L+ E+ + S + E V ++ + ++ + H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSA--SDLLE----------VHKKPLQEVEIAAVTH-- 122
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
G +G+ YLH + +IHRD+KA N
Sbjct: 123 -GALQGLAYLHSHN---MIHRDVKAGN 145
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 33/142 (23%), Positives = 65/142 (45%), Gaps = 29/142 (20%)
Query: 166 LGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLL 213
+G G FG V++ +A+K L +E+ ++ +E + + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR 273
G + + ++I E+M N +L+ ++ ++ D E + ++ G A
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDH----------DGEFSSY----QLVGMLRGIAA 118
Query: 274 GVMYLHQDSKLRIIHRDLKASN 295
G+ YL S + +HRDL A N
Sbjct: 119 GMKYL---SDMNYVHRDLAARN 137
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 166 LGEGGFGLVYKEI------------AVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKL 212
LG G FG VYK I A+K L + S + KE+ +E + + + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
LG C+ + L+ + MP L ++ EN + + + +L+W + A
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVREN------KDRIGSQ--DLLNWCVQI------A 119
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL + +R++HRDL A N
Sbjct: 120 KGMSYLEE---VRLVHRDLAARN 139
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 32/145 (22%)
Query: 166 LGEGGFGLVY------------KEIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKL 212
LGEG FG V +++AVK L S + +LK E+ + L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 213 LGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
G C + LI EF+P+ SL ++ N ++ + L ++ + IC
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--------QQLKYAVQ---IC- 119
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL + +HRDL A N
Sbjct: 120 --KGMDYL---GSRQYVHRDLAARN 139
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 36/139 (25%), Positives = 59/139 (42%), Gaps = 29/139 (20%)
Query: 161 SINNKLGEGGFGLVYKEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218
+I+ + GE ++A+K+LS+ SE K E+ L +QH N++ LL
Sbjct: 34 AIDKRTGE--------KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV--- 82
Query: 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS--KRFHIICGTARGVM 276
F S + F ++F L + D ++ S K +++ G+
Sbjct: 83 ---------FTSAVSGDEF--QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 277 YLHQDSKLRIIHRDLKASN 295
Y+H IIHRDLK N
Sbjct: 132 YIH---SAGIIHRDLKPGN 147
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 44/156 (28%), Positives = 69/156 (44%), Gaps = 28/156 (17%)
Query: 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGL--KELKNEVILF 201
TI + + + +G G +G V +AVK+LS+ + + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQ-ERC-KIL 259
++H N++ LL F P +SL F V LM + ++ +C K+
Sbjct: 71 KHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT 118
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D +F +I RG+ Y+H IIHRDLK SN
Sbjct: 119 DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSN 150
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 35/158 (22%), Positives = 77/158 (48%), Gaps = 29/158 (18%)
Query: 147 LFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELK-NE 197
L + ++ + ++ K+G+G G VY +E+A+++++ + +Q KEL NE
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINE 67
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
+++ + ++ N+V L + G+E ++ E++ SL + E + + V +E +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ 127
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L+ +LH + ++IHRD+K+ N
Sbjct: 128 ALE----------------FLHSN---QVIHRDIKSDN 146
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 32/144 (22%), Positives = 60/144 (41%), Gaps = 34/144 (23%)
Query: 166 LGEGGFGLVY-------------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212
+G G FG+V+ K+I V++++K + NE + L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK-ILDWSKRFHIICGT 271
++ + +++ E+ P +L +I Q+RC +LD H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--------------QKRCNSLLDEDTILHFFVQI 110
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
+ ++H I+HRDLK N
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQN 131
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 36/131 (27%), Positives = 54/131 (41%), Gaps = 14/131 (10%)
Query: 166 LGEGGFGLVYKEIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224
LGE G ++ VK L S Q + E + LQH NL++ LG C + LL
Sbjct: 13 LGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLL 72
Query: 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKL 284
+ EF P L ++ LM + + C A G+++LH+++
Sbjct: 73 VMEFCPLGDLKGYLRSCRKAELM-------TPDPTTLQR---MACEIALGLLHLHKNN-- 120
Query: 285 RIIHRDLKASN 295
IH DL N
Sbjct: 121 -FIHSDLALRN 130
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 41/153 (26%)
Query: 160 FSINNKLGEGGFGLVYKEIAVKR-------LSKI-----SEQGLKELKNEVILFSKL-QH 206
+ I KLG+G +G+V+K A+ R L KI + + E++ +L H
Sbjct: 9 YEILQKLGKGAYGIVWK--AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 207 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL-DWS 262
N+VKLL I+ E IY E+M L++ I R IL D
Sbjct: 67 PNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----------------RANILEDVH 108
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
KR+ I+ + + Y+H +IHRDLK SN
Sbjct: 109 KRY-IMYQLLKALKYIHSG---NVIHRDLKPSN 137
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 42/151 (27%), Positives = 64/151 (42%), Gaps = 34/151 (22%)
Query: 159 NFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ I K+GEG FG +Y KEI L+K+ + + K EVIL +K++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEID---LTKMPVKEKEASKKEVILLAKMK 57
Query: 206 HRNLVKLLGCCIQGEEKLLI-YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
H N+V Q +L I E+ L I + V +IL W
Sbjct: 58 HPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRI-------NRQRGVLFSEDQILSW--- 106
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ ++H D K I+HRD+K+ N
Sbjct: 107 ---FVQISLGLKHIH-DRK--ILHRDIKSQN 131
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 33/158 (20%), Positives = 57/158 (36%), Gaps = 49/158 (31%)
Query: 164 NKLGEGGFGLVYKEIAVKRLS-------------KISEQGLKELKNEVILFSKLQHRNLV 210
+G+G FG V K V+R S ++E+ ++L +EV + +L+H N+V
Sbjct: 6 ETIGKGSFGTVRK---VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 211 KLLGCCIQGEEKLLIYEFMP-------------NKSLNSFIFENFVLTLMRSFVDQERCK 257
+ I +Y M K +I E F+ ++ +
Sbjct: 63 RYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL--------TQ 113
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L H D ++HRDLK +N
Sbjct: 114 LLLALYECH------NR-----SDPGNTVLHRDLKPAN 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 36/143 (25%), Positives = 66/143 (46%), Gaps = 29/143 (20%)
Query: 164 NKLGEGGFGLVY--------KEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKL 212
+++G G FG VY + +AVK++S K + + +++ EV +L+H N ++
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
GC ++ L+ E+ + + +L + + K L + I G
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASD-------LLEVHK--------KPLQEVEIAAITHGAL 131
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH + IHRD+KA N
Sbjct: 132 QGLAYLHSHNM---IHRDIKAGN 151
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 38/150 (25%)
Query: 160 FSINNKLGEGGFGLVYKEI--------AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 210
F+ ++G+G FG VYK I A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIF-----ENFVLTLMRSFVDQERCKILDWSKRF 265
+ G ++G + +I E++ S + E ++ T++R +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-------------- 111
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH + K IHRD+KA+N
Sbjct: 112 -------KGLDYLHSERK---IHRDIKAAN 131
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 36/110 (32%), Positives = 49/110 (44%), Gaps = 21/110 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKE-LKNEVILFSK 203
DN LG G FG V + +AVK L + +E L +E+ + S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF------IFENFVLTL 246
L QH+N+V LLG C G L+I E+ L +F F NFV+ L
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMAL 147
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 29/149 (19%)
Query: 159 NFSINNKLGEGGFGLV---------YKEI--AVKRL-SKISEQGLKELKNEVILFSKLQH 206
I +G G FG V +EI A+K L + +E+ ++ +E + + H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
N++ L G + + +++ E+M N SL++F+ ++ + V R
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR----------- 113
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
G A G+ YL S + +HRDL A N
Sbjct: 114 ---GIASGMKYL---SDMGYVHRDLAARN 136
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 5e-04
Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 38/150 (25%)
Query: 160 FSINNKLGEGGFGLVYKEI--------AVKRLS-KISEQGLKELKNEVILFSKLQHRNLV 210
F+ ++G+G FG V+K I A+K + + +E +++++ E+ + S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 211 KLLGCCIQGEEKLLIYEFMPNKS----LNSFIFENF-VLTLMRSFVDQERCKILDWSKRF 265
K G ++G + +I E++ S L + F+ F + T+++ +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-------------- 111
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YLH + K IHRD+KA+N
Sbjct: 112 -------KGLDYLHSEKK---IHRDIKAAN 131
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 38/141 (26%), Positives = 63/141 (44%), Gaps = 26/141 (18%)
Query: 166 LGEGGFGLV--------YKEIAVKRLSKISEQGL--KELKNEVILFSKLQHRNLVKLLGC 215
+G G +G V +++AVK+LS+ + + + E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQ-ERCKILDWSKRFHIICGTARG 274
F P S+ +F V LM + ++ +C+ L +I RG
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130
Query: 275 VMYLHQDSKLRIIHRDLKASN 295
+ Y+H IIHRDLK SN
Sbjct: 131 LKYIHSAG---IIHRDLKPSN 148
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 31/139 (22%)
Query: 169 GGFGLVY---KEI-----AVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
G +G V+ K+ A+K + K I + + ++ E + S+ Q +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 218 QGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276
QG++ L L+ E++P L S +L + S D++ +I I +
Sbjct: 63 QGKKNLYLVMEYLPGGDLAS------LLENVGSL-DEDVARI--------YIAEIVLALE 107
Query: 277 YLHQDSKLRIIHRDLKASN 295
YLH IIHRDLK N
Sbjct: 108 YLHS---NGIIHRDLKPDN 123
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 49/164 (29%)
Query: 160 FSINNKLGEGGFGLV-----------YKEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 206
F++ LG+G FG V ++++AVK L S ++E E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 207 RNLVKLLGCCIQGEEK------LLIYEFMPNKSLNSFIF------ENFVL---TLMRSFV 251
N++KL+G ++ K ++I FM + L++F+ E F L TL+R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 252 DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D A G+ YL S IHRDL A N
Sbjct: 121 D------------------IASGMEYL---SSKNFIHRDLAARN 143
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 7e-04
Identities = 34/159 (21%), Positives = 64/159 (40%), Gaps = 50/159 (31%)
Query: 160 FSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKN---EVILFSKLQHRN 208
+ + +G G +G+V +++A+K++S + L + K E+ L L+H N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLRHEN 60
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSF--IFENFVLTLMRS----------FVDQERC 256
++ LL + + S F ++ V LM + + +
Sbjct: 61 IIGLL-------------DILRPPSPEDFNDVY--IVTELMETDLHKVIKSPQPLTDDHI 105
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + + RG+ YLH + +IHRDLK SN
Sbjct: 106 Q--------YFLYQILRGLKYLHSAN---VIHRDLKPSN 133
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 36/156 (23%)
Query: 160 FSINNKLGEGGFGLVY--------KEIAVKRLSK-ISEQGL--KELKNEVILFSKLQHRN 208
+ I +G+GG G VY + +A+K++ + +SE L K E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVL-TLMRSFVDQERCK--------IL 259
+V + C G+ +Y MP +I E + L +L++S +E +
Sbjct: 64 IVPVYSICSDGD---PVYYTMP------YI-EGYTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ FH IC T + Y+H SK ++HRDLK N
Sbjct: 114 AFLSIFHKICAT---IEYVH--SK-GVLHRDLKPDN 143
|
Length = 932 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 36/155 (23%), Positives = 68/155 (43%), Gaps = 24/155 (15%)
Query: 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILF 201
+ + ++ +LG+G FG+VY+ +AVK +++ S + E NE +
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
++V+LLG +G+ L++ E M + L S+ L +R + +
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY------LRSLRPEAENNPGRPPPT 117
Query: 262 SKRFHIICG-TARGVMYLHQDSKLRIIHRDLKASN 295
+ + A G+ YL+ + +HRDL A N
Sbjct: 118 LQEMIQMAAEIADGMAYLNAK---KFVHRDLAARN 149
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 33/183 (18%)
Query: 119 DFPDAGQDLYIRMSASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYKEI 178
D + D SASE ++ + D +P + A A+ +++ L G G V+ +
Sbjct: 32 DLEYSDDD-----SASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVF--V 84
Query: 179 AVKRLS------KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232
A K KI ++G + E +L + H +++++ + G ++ +P+
Sbjct: 85 ATKPGQPDPVVLKIGQKGTTLI--EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHY 139
Query: 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
S + + + LT R + L + I G+ YLH RIIHRD+K
Sbjct: 140 SSDLYTY----LTK--------RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVK 184
Query: 293 ASN 295
N
Sbjct: 185 TEN 187
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 29/140 (20%)
Query: 165 KLGEGGFGLV-------YKEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGC 215
+LG G FG+V ++A+K + + +SE E E + KL H LV+L G
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGV 67
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGV 275
C + ++ E+M N L +++ E+ + E CK G+
Sbjct: 68 CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL--EMCK------------DVCEGM 113
Query: 276 MYLHQDSKLRIIHRDLKASN 295
YL +SK + IHRDL A N
Sbjct: 114 AYL--ESK-QFIHRDLAARN 130
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 39/149 (26%), Positives = 64/149 (42%), Gaps = 43/149 (28%)
Query: 165 KLGEGGFGLVY--------KEIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLVKLL 213
++G G FG VY + +A+K++S K S + +++ EV +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR------FHI 267
GC ++ L+ E+ + S D IL+ K+
Sbjct: 82 GCYLREHTAWLVMEY-----------------CLGSASD-----ILEVHKKPLQEVEIAA 119
Query: 268 IC-GTARGVMYLHQDSKLRIIHRDLKASN 295
IC G +G+ YLH IHRD+KA N
Sbjct: 120 ICHGALQGLAYLHS---HERIHRDIKAGN 145
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 15/31 (48%), Positives = 19/31 (61%)
Query: 158 DNFSINNKLGEGGFGLVYKEIAVKRLSKISE 188
D+F + KLGEG FG+VYK V + SK
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEG 162
|
Length = 566 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 29/150 (19%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRLS---KISEQGLKELKNEVILFSKLQHR 207
NF I K+G G F VY K +A+K++ + + ++ E+ L +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC--KILDWSKRF 265
N++K L I+ E ++ E L+ I + F Q+R + W K F
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMI---------KYFKKQKRLIPERTVW-KYF 112
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+C H S+ R++HRD+K +N
Sbjct: 113 VQLCSAVE-----HMHSR-RVMHRDIKPAN 136
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 37/160 (23%), Positives = 65/160 (40%), Gaps = 37/160 (23%)
Query: 150 LATIANATDNFSINNKLGEGGFGLV--------YKEIAVKRLSK------ISEQGLKELK 195
T+ T+ + +G G FGLV + +A+K++ K ++++ +ELK
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 196 NEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQER 255
L L+H N++ L I E + + L+ + L + F+
Sbjct: 62 ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFL 114
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+IL RG+ Y+H ++HRDLK SN
Sbjct: 115 YQIL-------------RGLKYVHSAG---VVHRDLKPSN 138
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 30/151 (19%)
Query: 155 NATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQG--LKELKNEVILFSKLQ 205
N ++ + ++G G +G VYK E+A ++ K+ E G ++ E+ + + +
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLT-LMRSFVDQERCKILDWSKR 264
H N+V G + E+ + E+ SL L+ L ++V +E
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE---------- 114
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
T +G+ YLH K+ HRD+K +N
Sbjct: 115 ------TLQGLAYLHSKGKM---HRDIKGAN 136
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.002
Identities = 37/150 (24%), Positives = 64/150 (42%), Gaps = 30/150 (20%)
Query: 160 FSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVK 211
F + +G G +G VYK ++A ++ ++ +E+K E+ + K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 212 LLGCCIQ------GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
G I+ ++ L+ EF S+ I TL ++ +IL
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL------ 121
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
RG+ +LHQ ++IHRD+K N
Sbjct: 122 -------RGLSHLHQH---KVIHRDIKGQN 141
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 36/138 (26%), Positives = 58/138 (42%), Gaps = 25/138 (18%)
Query: 165 KLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
KLG+G FG V+ +A+K L K + E + KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277
E ++ E+M SL F+ E K L + + A G+ Y
Sbjct: 71 SEEPIYIVTEYMSKGSL-------------LDFLKGEMGKYLRLPQLVDMAAQIASGMAY 117
Query: 278 LHQDSKLRIIHRDLKASN 295
+ ++ +HRDL+A+N
Sbjct: 118 VE---RMNYVHRDLRAAN 132
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 29/150 (19%)
Query: 159 NFSINNKLGEGGFGLVYKE--------IAVKRLS---KISEQGLKELKNEVILFSKLQHR 207
NF I K+G G F VY+ +A+K++ + + + E+ L +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC--KILDWSKRF 265
N++K I+ E ++ E L+ I + F Q+R + W K F
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMI---------KHFKKQKRLIPEKTVW-KYF 112
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+C H S+ R++HRD+K +N
Sbjct: 113 VQLCSALE-----HMHSR-RVMHRDIKPAN 136
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.003
Identities = 35/140 (25%), Positives = 58/140 (41%), Gaps = 31/140 (22%)
Query: 166 LGEGGFGLVY------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219
+G+G FG V ++AVK + ++ + E + ++L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 220 EEKLLIY-EFMPNKSLNSFIFENFVLTLMRSFVDQERCK---ILDWSKRFHIICGTARGV 275
+ L I E+M SL VD R + +L +
Sbjct: 72 KGGLYIVTEYMAKGSL----------------VDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 276 MYLHQDSKLRIIHRDLKASN 295
YL ++ +HRDL A N
Sbjct: 116 EYLEANN---FVHRDLAARN 132
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 22/91 (24%), Positives = 44/91 (48%), Gaps = 15/91 (16%)
Query: 166 LGEGGFGLVYK---------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
LG+G F ++K E+ +K L K + + S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN 241
G C+ G+E +++ E++ SL++++ +N
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN 93
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 36/161 (22%), Positives = 66/161 (40%), Gaps = 30/161 (18%)
Query: 149 ELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILF 201
+L+ + + F + +G G +G VYK ++A ++ ++E +E+K E+ +
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 202 SKL-QHRNLVKLLGCCI------QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE 254
K HRN+ G I ++ L+ EF S+ + +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-----------KG 115
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
DW +I RG+ +LH ++IHRD+K N
Sbjct: 116 NALKEDWIA--YICREILRGLAHLHAH---KVIHRDIKGQN 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 29/148 (19%)
Query: 158 DNFSINNKLGEGGFGLVYKE--------IAVKRLSKISEQGLK-ELKNEVILFSKLQHRN 208
D++ KLGEG + VYK +A+K + E+G E L L+H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL-DWSKRFHI 267
+V L+++ + K + +FE +V T + ++D+ + + K F
Sbjct: 65 IV-------------LLHDIIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPENVKLF-- 108
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ RG+ Y+HQ I+HRDLK N
Sbjct: 109 LFQLLRGLSYIHQRY---ILHRDLKPQN 133
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.004
Identities = 35/160 (21%), Positives = 67/160 (41%), Gaps = 44/160 (27%)
Query: 155 NATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQ-----GLKELKNEVILF 201
+ + + +GEG +G+V ++A+K++S Q L+E+K +
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+ +H N++ I + + S SF V LM + + K++
Sbjct: 58 RRFKHENIIG-------------ILDIIRPPSFESFNDVYIVQELM----ETDLYKLIK- 99
Query: 262 SKRF---HI---ICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ HI + RG+ Y+H + ++HRDLK SN
Sbjct: 100 TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSN 136
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 50/157 (31%)
Query: 165 KLGEGGFGLVYKE---------IAVKRLS-KISEQG--LKELKNEVIL--FSKLQHRNLV 210
++GEG +G V+K +A+KR+ + E+G L ++ +L +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 211 KLLGCCIQG----EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
+L C E KL + +FE+ VDQ+ LD
Sbjct: 68 RLFDVCTVSRTDRETKL------------TLVFEH---------VDQDLTTYLDKVPEPG 106
Query: 267 IICGTARGVMY--------LHQDSKLRIIHRDLKASN 295
+ T + +M+ LH R++HRDLK N
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 140
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.94 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.93 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.92 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.91 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.91 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.9 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.9 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.89 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.89 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.89 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.89 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.88 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.88 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.88 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.88 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.88 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.88 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.88 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.88 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.87 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.87 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.87 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.87 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.87 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.87 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.87 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.87 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.86 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.86 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.86 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.86 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.86 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.86 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.86 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.85 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.85 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.85 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.85 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.85 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.85 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.85 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.85 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.85 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.85 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.85 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.85 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.85 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.85 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.85 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.85 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.85 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.85 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.85 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.85 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.84 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.84 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.84 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.84 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.84 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.84 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.84 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.84 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.84 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.84 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.84 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.84 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.84 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.84 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.84 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.84 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.84 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.84 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.84 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.84 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.84 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.84 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.84 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.84 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.84 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.84 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.83 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.83 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.83 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.83 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.83 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.83 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.83 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.83 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.83 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.83 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.83 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.83 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.83 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.83 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.83 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.83 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.83 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.83 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.83 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.83 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.83 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.83 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.82 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.82 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.82 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.82 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.82 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.82 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.82 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.82 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.82 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.82 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.82 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.82 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.82 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.82 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.82 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.82 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.82 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.82 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.82 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.82 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.82 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.82 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.82 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.82 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.82 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.82 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.82 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.82 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.82 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.82 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.82 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.82 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.82 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.82 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.82 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.82 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.82 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.82 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.82 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.82 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.82 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.81 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.81 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.81 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.81 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.81 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.81 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.81 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.81 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.81 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.81 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.81 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.81 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.81 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.81 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.81 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.81 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.81 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.81 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.81 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.81 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.81 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.81 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.81 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.81 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.81 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.81 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.8 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.8 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.8 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.8 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.8 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.8 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.8 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.8 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.8 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.8 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.8 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.8 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.8 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.8 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.8 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.8 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.8 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.8 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.8 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.8 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.79 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.79 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.79 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.79 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.79 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.79 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.79 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.79 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.79 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.79 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.79 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.79 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.79 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.79 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.79 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.79 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.79 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.79 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.79 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.79 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.79 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.79 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.79 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.79 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.79 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.79 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.79 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.78 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.78 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.78 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.78 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.78 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.78 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.78 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.78 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.78 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.78 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.78 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.78 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.78 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.78 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.78 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.78 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.78 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.78 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.78 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.77 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.77 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.77 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.77 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.77 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.77 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.77 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.77 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.77 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.77 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.77 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.77 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.77 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.77 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.77 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.77 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.76 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.76 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.76 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.76 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.76 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.76 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.76 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.76 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.76 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.76 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.76 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.76 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.75 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.75 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.75 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.75 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.75 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.75 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.75 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.75 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.75 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.75 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.75 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.75 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.75 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.75 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.74 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.74 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.74 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.74 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.74 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.74 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.74 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.74 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.73 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.73 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.73 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.73 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.72 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.72 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.72 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.72 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.72 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.71 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.71 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.71 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.71 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.7 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.7 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.7 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.7 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.7 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.7 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.7 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.7 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.69 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.69 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.69 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.69 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.68 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.68 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.67 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.67 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.65 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.65 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.65 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.64 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.63 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.62 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.61 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.59 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.59 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.59 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.58 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.58 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.56 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.56 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.55 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.55 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.55 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.55 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.54 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.54 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.52 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.51 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.51 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.5 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.5 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.49 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.47 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.45 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.42 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.4 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.39 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.39 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.38 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.36 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.35 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.3 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.28 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.28 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.23 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.22 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.02 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.0 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.74 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.51 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.47 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.45 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.44 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 98.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.29 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.26 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.25 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.23 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.72 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 97.71 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.56 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.56 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 97.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.17 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.01 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 96.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.91 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 96.52 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.98 | |
| PF07645 | 42 | EGF_CA: Calcium-binding EGF domain; InterPro: IPR0 | 95.84 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.02 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 94.64 | |
| cd00053 | 36 | EGF Epidermal growth factor domain, found in epide | 94.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 94.54 | |
| smart00179 | 39 | EGF_CA Calcium-binding EGF-like domain. | 93.71 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 93.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 93.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 92.83 | |
| PF12661 | 13 | hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E | 92.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 92.34 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 92.29 | |
| PF12947 | 36 | EGF_3: EGF domain; InterPro: IPR024731 This entry | 91.93 | |
| PF07974 | 32 | EGF_2: EGF-like domain; InterPro: IPR013111 A sequ | 91.81 | |
| cd00054 | 38 | EGF_CA Calcium-binding EGF-like domain, present in | 91.39 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 91.2 | |
| PF00024 | 79 | PAN_1: PAN domain This Prosite entry concerns appl | 91.08 | |
| PF01683 | 52 | EB: EB module; InterPro: IPR006149 The EB domain h | 90.98 | |
| PF00008 | 32 | EGF: EGF-like domain This is a sub-family of the P | 90.9 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 90.88 | |
| PF14295 | 51 | PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A. | 90.38 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 90.36 | |
| PF09064 | 34 | Tme5_EGF_like: Thrombomodulin like fifth domain, E | 89.6 | |
| PF12662 | 24 | cEGF: Complement Clr-like EGF-like | 89.49 | |
| smart00181 | 35 | EGF Epidermal growth factor-like domain. | 89.3 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 86.16 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 83.24 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 82.87 | |
| PF12946 | 37 | EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 | 82.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 80.45 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=236.04 Aligned_cols=139 Identities=51% Similarity=0.843 Sum_probs=124.1
Q ss_pred CccchhhhhhhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeE
Q 041718 144 ELPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC 216 (295)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 216 (295)
....|++.++..+|++|...+.||+|+||.||+ .||||++.....+...+|.+|+.+|++++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 466789999999999999999999999999996 6999988764332155699999999999999999999999
Q ss_pred EeCC-eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGE-EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+.+ +.+||||||++|+|.++|+. .... .|+|.+|++||.++|+||+|||....++||||||||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~------------~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssN 207 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHG------------KKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSN 207 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCC------------CCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHH
Confidence 9999 59999999999999999963 1112 78999999999999999999999988899999999988
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=211.17 Aligned_cols=122 Identities=30% Similarity=0.559 Sum_probs=112.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
...+|.+.++||.|+|++||+ .||||.+.+. .....+.+..|+.+|+.|+|||||+|++++..++.++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 456888889999999999997 7999999764 566778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||.+|+|..||. ....+++.+...++.|+|.||++||+++ ||||||||+|
T Consensus 88 MEyC~gGDLs~yi~---------------~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQN 139 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR---------------RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQN 139 (429)
T ss_pred EEeCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcce
Confidence 99999999999995 3347999999999999999999999998 9999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=195.55 Aligned_cols=122 Identities=28% Similarity=0.447 Sum_probs=104.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccH-------HhHHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE-------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 220 (295)
..+.|.+.+.||+|+||.|-. .||||++++... .......+|+++|++|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456778889999999999974 799999975211 12334579999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..|+||||++||+|.+++.. .+.+.+..-..++.|++.|+.|||++| |+||||||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---------------nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeN 306 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---------------NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPEN 306 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---------------ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcce
Confidence 99999999999999999853 345666777889999999999999999 9999999998
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=200.37 Aligned_cols=122 Identities=38% Similarity=0.675 Sum_probs=106.1
Q ss_pred ccccceeecccCccceeE------E-EEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-eeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK------E-IAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk------~-vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 228 (295)
++.+.+.||.|+||+||+ . ||||++.... ....++|.+|+.+|.+++|||||+++|++.+.. ...|||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456799999999997 4 9999997532 222679999999999999999999999999888 79999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++|+|.++|+. .....+++..++.|+.|||+||.|||++++ ||||||||+|
T Consensus 122 ~~~GsL~~~l~~-------------~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~N 173 (362)
T KOG0192|consen 122 MPGGSLSVLLHK-------------KRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDN 173 (362)
T ss_pred CCCCcHHHHHhh-------------cccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhh
Confidence 999999999952 135689999999999999999999999863 9999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=194.22 Aligned_cols=120 Identities=28% Similarity=0.419 Sum_probs=110.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..|...+.||+|||+.||+ .||+|++.+ ......+.+.+||+|.+.|+|||||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999996 699999976 24556788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|++++|..++. +.+.+++..+..++.||+.||.|||+++ |||||||..|
T Consensus 98 ELC~~~sL~el~K---------------rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGN 148 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---------------RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGN 148 (592)
T ss_pred EecCCccHHHHHH---------------hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhh
Confidence 9999999999883 4578999999999999999999999998 9999999877
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=183.97 Aligned_cols=122 Identities=28% Similarity=0.413 Sum_probs=110.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.|+. .+|+|++++. .....+...+|..+|.+++||+||+++-.|.+.+++||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 347899999999999999994 6899999762 33467788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+||+.||.|...|. +...+++..+..++.+|+.||.|||+++ ||||||||+|
T Consensus 103 Vld~~~GGeLf~hL~---------------~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPEN 155 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---------------REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPEN 155 (357)
T ss_pred EEeccCCccHHHHHH---------------hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence 999999999999883 3467889999999999999999999998 9999999998
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=180.98 Aligned_cols=120 Identities=29% Similarity=0.371 Sum_probs=106.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-eeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 227 (295)
+++...+.||+|..|+||| .+|+|.+.. .++...+++.+|+.++...+||+||+++|+|.... .+.|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 4566678999999999997 589999843 45677889999999999999999999999999988 5999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
||.+|||+.++. ..+.+++...-.|+.+|++||.|||+ ++ ||||||||+|
T Consensus 159 YMDgGSLd~~~k---------------~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsN 209 (364)
T KOG0581|consen 159 YMDGGSLDDILK---------------RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSN 209 (364)
T ss_pred hcCCCCHHHHHh---------------hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHH
Confidence 999999999984 22568999999999999999999996 55 9999999998
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-25 Score=176.11 Aligned_cols=124 Identities=33% Similarity=0.496 Sum_probs=111.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|-||.||. .||+|++.+. ..+..+++++|++|-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 457899999999999999995 6999999762 33456889999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||.+.|+|...|. ......+++.....++.|+|.||.|+|.++ ||||||||+|
T Consensus 100 ilEya~~gel~k~L~-------------~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpen 154 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQ-------------EGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPEN 154 (281)
T ss_pred EEEecCCchHHHHHH-------------hcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHH
Confidence 999999999999984 235567888889999999999999999987 9999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.9e-24 Score=188.21 Aligned_cols=126 Identities=31% Similarity=0.541 Sum_probs=111.0
Q ss_pred hhhhccccccceeecccCccceeE-----------E-EEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK-----------E-IAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk-----------~-vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 217 (295)
+.-..++..+.++||+|+||.||+ . ||||..+. .......+|.+|.++|++++|||||+++|+..
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 344556667779999999999995 2 79998874 34667889999999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+++||||+++||+|.++|.+ ....++..+++.++.++|.||+|||+++ +|||||.++|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k--------------~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARN 292 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKK--------------NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARN 292 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHH
Confidence 99999999999999999999953 2236999999999999999999999998 9999999887
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.3e-24 Score=196.48 Aligned_cols=134 Identities=31% Similarity=0.522 Sum_probs=111.9
Q ss_pred cccccceeecccCccceeE-------------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.+....+.||+|+||+||+ .||||.++... .+..++|++|+++|+.|+|||||+|+|.|.++++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 4556668999999999995 69999998754 458899999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+|||..|+|.+||+...+-.... .........|+..+.+.||.|||.||+||-++. +|||||..+|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~-~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRN 633 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKL-ASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRN 633 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccc-cCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhh
Confidence 9999999999999997543221100 000111455899999999999999999999887 9999999887
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-24 Score=186.67 Aligned_cols=123 Identities=30% Similarity=0.541 Sum_probs=108.9
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..+.+++.+.||+|.||.|+. .||+|.++.. ....++|.+|+.+|++|+|+|||+|+|++..+++++|||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 345567779999999999996 6999998753 34557888999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+.|+|.+||.. .....+...+.+.++.|||+||+||++++ +|||||.++|
T Consensus 283 m~~GsLl~yLr~-------------~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARN 333 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-------------REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARN 333 (468)
T ss_pred cccCcHHHHhhh-------------cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhh
Confidence 999999999952 34567888999999999999999999998 9999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=181.00 Aligned_cols=123 Identities=26% Similarity=0.404 Sum_probs=105.6
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--Cee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 222 (295)
...+.|..+++||+|.||.||| .||+|++... .+....-..+||.||++|+||||++|.+...+. ..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3446788889999999999997 6999998753 345566778999999999999999999998876 689
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+|||++ +|.-++. ...-.++..++..++.|++.||+|+|+++ |+|||||.+|
T Consensus 194 YlVFeYMdh-DL~GLl~--------------~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SN 248 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLS--------------SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSN 248 (560)
T ss_pred EEEEecccc-hhhhhhc--------------CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccc
Confidence 999999975 7777663 23457899999999999999999999998 9999999998
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-23 Score=179.52 Aligned_cols=124 Identities=25% Similarity=0.395 Sum_probs=103.5
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEecccc--------------HHhHHHHHHHHHHHhcCCCCcccc
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--------------EQGLKELKNEVILFSKLQHRNLVK 211 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--------------~~~~~~~~~Ei~~l~~l~h~niv~ 211 (295)
....+.|++.+.||+|.||.|.. .||||++.+.. ....+..++||.+|++++|+|||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 34567899999999999999974 69999997521 112357899999999999999999
Q ss_pred eeeeEEe--CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEec
Q 041718 212 LLGCCIQ--GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHR 289 (295)
Q Consensus 212 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHr 289 (295)
|+.+..+ .+.+|||+||+..|.+...- .....+.+.++.+++.+++.||+|||.++ ||||
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---------------~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHR 234 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---------------PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHR 234 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC---------------CCcccccHHHHHHHHHHHHHHHHHHHhcC---eecc
Confidence 9999875 56899999999998876421 12223899999999999999999999998 9999
Q ss_pred cCCCCC
Q 041718 290 DLKASN 295 (295)
Q Consensus 290 Dlkp~N 295 (295)
||||+|
T Consensus 235 DIKPsN 240 (576)
T KOG0585|consen 235 DIKPSN 240 (576)
T ss_pred ccchhh
Confidence 999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=176.15 Aligned_cols=128 Identities=23% Similarity=0.433 Sum_probs=108.2
Q ss_pred ccccccceeecccCccceeE--------EEEEEEec--cccHHhHHHHHHHHHHHhcCCCCcccceee-eEEeCCe-eEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLS--KISEQGLKELKNEVILFSKLQHRNLVKLLG-CCIQGEE-KLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~--~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~-~~~~~~~-~~l 224 (295)
..+|++.++||+|+||.||| .+|.|.+. ..+.+..+.+..|+.+|++|+|||||++++ .+.+.+. ++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35788999999999999998 57888775 346677889999999999999999999999 5555555 899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-CCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS-KLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-~~~iiHrDlkp~N 295 (295)
||||+.+|+|.+.|... ....+.+++.+.++++.|++.||..+|++= +..|+||||||.|
T Consensus 98 vmE~c~~GDLsqmIk~~-----------K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaN 158 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHF-----------KKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPAN 158 (375)
T ss_pred HHHhhcccCHHHHHHHH-----------HhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchh
Confidence 99999999999998642 234577999999999999999999999831 1239999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=168.10 Aligned_cols=121 Identities=27% Similarity=0.365 Sum_probs=109.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|.+.+.||.|+||+|.. .+|+|++++. .....+...+|..+|+.+.||++++|++.+.+.+++++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 46888999999999999984 5899999863 334567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||++||.|.++|+ +...+++..+..+|.||+.||+|||+++ ||+|||||+|
T Consensus 123 meyv~GGElFS~Lr---------------k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPEN 174 (355)
T KOG0616|consen 123 MEYVPGGELFSYLR---------------KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPEN 174 (355)
T ss_pred EeccCCccHHHHHH---------------hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHH
Confidence 99999999999995 3456889999999999999999999998 9999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=178.90 Aligned_cols=124 Identities=26% Similarity=0.351 Sum_probs=111.5
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
....++|.+++.||+|+||.||. .+|+|++++.. ....+..+.|-.+|....+++||+|+-.|.+.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34668999999999999999994 69999998743 34467788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||||++||++..+|. +...|++..+..++.+++.|++-||..| +|||||||+|
T Consensus 217 YLiMEylPGGD~mTLL~---------------~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdN 271 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLM---------------RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDN 271 (550)
T ss_pred EEEEEecCCccHHHHHH---------------hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhh
Confidence 99999999999999984 3467889999999999999999999998 9999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=179.38 Aligned_cols=123 Identities=24% Similarity=0.403 Sum_probs=108.4
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc----cH-HhHHHHHHHHHHHhcCC-CCcccceeeeEEeCC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI----SE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 220 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 220 (295)
...+.|.+.+.||+|+||.|+. .||+|++++. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999995 6999977652 11 34566778999999999 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+.+|+|.+++. ....+.+.....++.|++.|++|+|+++ |+||||||+|
T Consensus 94 ~~~ivmEy~~gGdL~~~i~---------------~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~EN 150 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV---------------NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPEN 150 (370)
T ss_pred eEEEEEEecCCccHHHHHH---------------HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHH
Confidence 9999999999999999994 2456888999999999999999999998 9999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.9e-24 Score=183.31 Aligned_cols=122 Identities=29% Similarity=0.448 Sum_probs=105.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHH-hHHHHHHHHHHHhcCC-CCcccceeeeEEeCC-eeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQ-GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE-EKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~-~~~l 224 (295)
..++|.++++||.|.||.||+ .||||++++.-.. ..---.+|+..|++|+ |||||+|.+.+.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 446899999999999999996 6999998752211 1122357999999999 999999999999988 9999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||| ..+|++++. .+...+++..+..|+.||++||+|+|.+| +.|||+||||
T Consensus 88 VfE~M-d~NLYqLmK--------------~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPEN 140 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMK--------------DRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPEN 140 (538)
T ss_pred eHHhh-hhhHHHHHh--------------hcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhh
Confidence 99999 568999885 24678999999999999999999999998 9999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-23 Score=181.99 Aligned_cols=119 Identities=29% Similarity=0.496 Sum_probs=108.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|.+.+.||+|+||.||| .||+|.+.+ ...+..+.+++|+++++.|+|||||.++++|++..++++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688889999999999997 699999976 355677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+.+ +|..+|. ....+++.....|+.+++.||.|||+++ |+|||+||+|
T Consensus 82 ~a~g-~L~~il~---------------~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqn 130 (808)
T KOG0597|consen 82 YAVG-DLFTILE---------------QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQN 130 (808)
T ss_pred hhhh-hHHHHHH---------------hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcce
Confidence 9976 9999984 3467999999999999999999999987 9999999987
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=170.26 Aligned_cols=122 Identities=25% Similarity=0.466 Sum_probs=107.1
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..+|++.+.||+|+||.||+ .+|+|.++.. +......+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 35788899999999999985 5889988753 33445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 84 v~e~~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~n 137 (266)
T cd05064 84 VTEYMSNGALDSFLRK--------------HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHK 137 (266)
T ss_pred EEEeCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhh
Confidence 9999999999998842 1246889999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=179.80 Aligned_cols=120 Identities=23% Similarity=0.330 Sum_probs=105.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|.+.+.||+|+||.||+ .+|||.+... .....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688899999999999996 6899988642 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~N 131 (377)
T cd05629 81 EFLPGGDLMTMLIK---------------YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDN 131 (377)
T ss_pred eCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 99999999998842 245788888899999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=183.45 Aligned_cols=127 Identities=30% Similarity=0.545 Sum_probs=112.4
Q ss_pred hhhhhhccccccceeecccCccceeE-----EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 151 ATIANATDNFSINNKLGEGGFGLVYK-----EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 151 ~~~~~~~~~~~~~~~lg~G~~g~Vyk-----~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++....+.+.+...||+|+||+||+ .||||.++. ..+...+.|++||.++++-+|.||+-++|++..+.. .
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 44455566778889999999999998 799999975 355678999999999999999999999999998777 9
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+.++++.+|+.+|+- ....++..+.+.||.|||+||.|||.++ |||||||..|
T Consensus 464 IiTqwCeGsSLY~hlHv--------------~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnN 518 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHV--------------QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNN 518 (678)
T ss_pred eeehhccCchhhhhccc--------------hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccc
Confidence 99999999999999962 2356888999999999999999999998 9999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-23 Score=180.53 Aligned_cols=123 Identities=31% Similarity=0.444 Sum_probs=108.6
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 222 (295)
....+|..++.||+|+|++|++ .+|||++.+ ..+...+-...|-.+|.+| .||.||+|+--|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446899999999999999995 799999975 2334455667788889999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|+||+++|+|.++|. +-..+++.....++.+|+.||+|||++| ||||||||+|
T Consensus 150 YFvLe~A~nGdll~~i~---------------K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPEN 204 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIK---------------KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPEN 204 (604)
T ss_pred EEEEEecCCCcHHHHHH---------------HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhh
Confidence 99999999999999995 3356888999999999999999999998 9999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.6e-23 Score=165.10 Aligned_cols=120 Identities=32% Similarity=0.527 Sum_probs=104.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
+.|...++||+|.||.||+ .||||+++.. .........+||.+|+.++|+||+.|+++|.+.+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577789999999999996 6999999753 22234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+ .+|+..|+ .+...++..+...++.++++||+|+|++. |+||||||.|
T Consensus 82 fm~-tdLe~vIk--------------d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnN 131 (318)
T KOG0659|consen 82 FMP-TDLEVVIK--------------DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNN 131 (318)
T ss_pred ecc-ccHHHHhc--------------ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccc
Confidence 996 58998885 34567899999999999999999999987 9999999998
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=178.75 Aligned_cols=119 Identities=22% Similarity=0.322 Sum_probs=105.4
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.|.+.+.||+|+||.||+ .+|+|++... .....+.+.+|+.++.+++|+|||++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999996 6899998652 23445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 82 ~~~gg~L~~~l~~---------------~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~N 131 (381)
T cd05626 82 YIPGGDMMSLLIR---------------MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDN 131 (381)
T ss_pred cCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHH
Confidence 9999999998842 245788888899999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=171.42 Aligned_cols=122 Identities=30% Similarity=0.433 Sum_probs=104.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC--eeEEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLLIY 226 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 226 (295)
..++...+.||+|+||.||. ..|||.+...+....+.+.+|+.+|.+|+|||||+++|...... .++|+|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 34577789999999999995 57999886543333778999999999999999999999855444 689999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ... .+++.....+..||++||+|||+++ ||||||||+|
T Consensus 96 Ey~~~GsL~~~~~~-------------~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~N 147 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKR-------------YGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPAN 147 (313)
T ss_pred eccCCCcHHHHHHH-------------cCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccce
Confidence 99999999999952 222 6999999999999999999999998 9999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=177.66 Aligned_cols=120 Identities=24% Similarity=0.350 Sum_probs=106.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|++.+. .......+..|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788899999999999995 6999998652 2234467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 E~~~gg~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~N 131 (363)
T cd05628 81 EFLPGGDMMTLLM---------------KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDN 131 (363)
T ss_pred cCCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHH
Confidence 9999999999884 2246889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=178.17 Aligned_cols=120 Identities=23% Similarity=0.349 Sum_probs=106.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .||||++... .......+.+|+.+|..++|+||+++++.+.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788999999999999995 6999998652 2234566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 E~~~~g~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~N 131 (364)
T cd05599 81 EYLPGGDMMTLLMK---------------KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDN 131 (364)
T ss_pred CCCCCcHHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 99999999998842 245889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=171.71 Aligned_cols=123 Identities=28% Similarity=0.346 Sum_probs=110.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++++.||.|.-|.||. .+|+|++.+. ..+...+...|-+||+.++||.++.|++.|+.++..+|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 46788889999999999995 6899999863 334556778899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+||+|..++. .+..+.+++..+..++.+|+-||+|||-.| ||.|||||+|
T Consensus 156 meyCpGGdL~~Lrq-------------kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPEN 209 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQ-------------KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPEN 209 (459)
T ss_pred EecCCCccHHHHHh-------------hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcce
Confidence 99999999998873 456778999999999999999999999998 9999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-23 Score=174.05 Aligned_cols=120 Identities=26% Similarity=0.475 Sum_probs=109.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
.+|.+.+.||+|.||.|-+ .||||.+++. ++++.-.+++||+||+.|+||||++++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4678889999999999975 7999999763 5667778999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||..+|.|++|+. ....|++.....++.||..|+.|.|.+. ++|||||.+|
T Consensus 133 EYaS~GeLYDYiS---------------er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLEN 183 (668)
T KOG0611|consen 133 EYASGGELYDYIS---------------ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLEN 183 (668)
T ss_pred EecCCccHHHHHH---------------HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhh
Confidence 9999999999994 3457999999999999999999999887 9999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=175.82 Aligned_cols=137 Identities=29% Similarity=0.422 Sum_probs=106.8
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC-
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG- 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~- 219 (295)
..++|.+.++||+|+||.||+ .||||++... .......+.+|+.++..+ +|||||++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456899999999999999996 3899988643 234456789999999999 899999999988764
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhh----------------------------------hhc-------------cc
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLM----------------------------------RSF-------------VD 252 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------~~~-------------~~ 252 (295)
...++||||+++|+|.+++......... ..+ ..
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4588999999999999999643210000 000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 253 QERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 253 ~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
......+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~N 204 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARN 204 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccce
Confidence 001235888999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-22 Score=171.18 Aligned_cols=136 Identities=29% Similarity=0.472 Sum_probs=109.3
Q ss_pred ccccccceeecccCccceeE------------------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccc
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 211 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 211 (295)
.++|.+.++||+|+||.||+ .||+|.+... ......++.+|+.+|.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 35788889999999999996 2899988653 3445678999999999999999999
Q ss_pred eeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhh----cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeE
Q 041718 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRS----FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRII 287 (295)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ii 287 (295)
+++++.+.+..++||||+++++|.+++........... .........++|.....++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 99999999999999999999999999853211100000 000112345889999999999999999999998 99
Q ss_pred eccCCCCC
Q 041718 288 HRDLKASN 295 (295)
Q Consensus 288 HrDlkp~N 295 (295)
||||||+|
T Consensus 161 H~dlkp~N 168 (304)
T cd05096 161 HRDLATRN 168 (304)
T ss_pred ccCcchhh
Confidence 99999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-22 Score=167.31 Aligned_cols=120 Identities=23% Similarity=0.378 Sum_probs=102.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
+.|..+.++|+|+||.||| .||||++.. .++...+-.++||.+|++|+|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4577789999999999997 699999865 234455667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++..-|.++= .....++......++.|+++|+.|+|+++ +|||||||+|
T Consensus 82 ~~dhTvL~eLe---------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPEN 131 (396)
T KOG0593|consen 82 YCDHTVLHELE---------------RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPEN 131 (396)
T ss_pred ecchHHHHHHH---------------hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhh
Confidence 99875554432 12345788889999999999999999998 9999999998
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=177.11 Aligned_cols=120 Identities=22% Similarity=0.320 Sum_probs=105.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|||.+.... ......+.+|+.+|++++|+||+++++.+.+.+..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999996 68999986422 233566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 81 E~~~~g~L~~~i~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~N 131 (376)
T cd05598 81 DYIPGGDMMSLLIR---------------LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDN 131 (376)
T ss_pred eCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHH
Confidence 99999999999842 245788888889999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.2e-22 Score=169.22 Aligned_cols=114 Identities=20% Similarity=0.363 Sum_probs=100.0
Q ss_pred eecccCccceeE--------------------------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccce
Q 041718 165 KLGEGGFGLVYK--------------------------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKL 212 (295)
Q Consensus 165 ~lg~G~~g~Vyk--------------------------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l 212 (295)
.||+|+||.||+ .||+|.+.........++..|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999995 278888865444456778899999999999999999
Q ss_pred eeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCC
Q 041718 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292 (295)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlk 292 (295)
++++.+.+..++||||+++|+|..++.. ....+++..++.++.|+++||+|||+++ |+|||||
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlk 144 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--------------EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVC 144 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCC
Confidence 9999999999999999999999988842 2346889999999999999999999987 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 145 p~N 147 (274)
T cd05076 145 AKN 147 (274)
T ss_pred ccc
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=171.78 Aligned_cols=120 Identities=22% Similarity=0.310 Sum_probs=105.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688899999999999996 5899998642 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 e~~~~~~L~~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 131 (291)
T cd05612 81 EYVPGGELFSYLRN---------------SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPEN 131 (291)
T ss_pred eCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHH
Confidence 99999999998842 245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=173.49 Aligned_cols=122 Identities=24% Similarity=0.327 Sum_probs=107.0
Q ss_pred hccccccceeecccCccceeE---------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 346799999999999999995 4899988642 2334567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 108 lv~Ey~~~g~L~~~i~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~N 161 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---------------NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPEN 161 (340)
T ss_pred EEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHH
Confidence 99999999999998842 245888999999999999999999998 9999999987
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=176.07 Aligned_cols=119 Identities=23% Similarity=0.314 Sum_probs=104.9
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.|.+.++||+|+||.||+ .+|+|.+... .......+.+|+.++++++|+|||++++.+.+.+..+||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999996 5899998652 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.+++.. ...+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 82 ~~~gg~L~~~l~~---------------~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~N 131 (382)
T cd05625 82 YIPGGDMMSLLIR---------------MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDN 131 (382)
T ss_pred CCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999999998842 235788888899999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=175.47 Aligned_cols=126 Identities=19% Similarity=0.244 Sum_probs=108.7
Q ss_pred hhhhhhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 151 ATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 151 ~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
..+....++|++.+.||+|+||.||+ .+|+|.+.+. .......+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 34445567899999999999999995 6899998642 223455688999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++||||+++|+|.+++.. ..+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~----------------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~N 172 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSN----------------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDN 172 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 999999999999999998831 24778888999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=175.81 Aligned_cols=137 Identities=27% Similarity=0.441 Sum_probs=110.2
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~ 220 (295)
..++|.+.++||+|+||.||+ .||||++... .....+.+.+|+.+|+++. |||||++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 356888999999999999995 3899998642 3344578999999999996 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhh------------------------------------------------------
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTL------------------------------------------------------ 246 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------ 246 (295)
..+|||||+++|+|.++|..+.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999875421100
Q ss_pred ---------------------------hhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 247 ---------------------------MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 247 ---------------------------~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+........+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N 267 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN 267 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence 000011112245889999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=172.22 Aligned_cols=121 Identities=23% Similarity=0.323 Sum_probs=106.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|.+.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++.+.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 36788999999999999996 5999998652 223456789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 97 ~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~N 148 (329)
T PTZ00263 97 LEFVVGGELFTHLRK---------------AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPEN 148 (329)
T ss_pred EcCCCCChHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHH
Confidence 999999999998842 245788888899999999999999998 9999999987
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=171.57 Aligned_cols=120 Identities=27% Similarity=0.405 Sum_probs=106.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .||+|+++.. .......+..|+.++..++||||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3688899999999999996 6899998752 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 e~~~g~~L~~~l~---------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 131 (333)
T cd05600 81 EYVPGGDFRTLLN---------------NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPEN 131 (333)
T ss_pred eCCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 9999999999884 2245788999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=175.64 Aligned_cols=136 Identities=30% Similarity=0.444 Sum_probs=108.7
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCe
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~ 221 (295)
.++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|..+ +|||||++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999985 4899998642 234556789999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhh--------------------------hhhc-------------------------
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTL--------------------------MRSF------------------------- 250 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~--------------------------~~~~------------------------- 250 (295)
.++||||+++|+|.+++........ +...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321000 0000
Q ss_pred ---------ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 251 ---------VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 251 ---------~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
........++|.....++.||+.||.|||+++ |+||||||+|
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 244 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARN 244 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhh
Confidence 00011235889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=174.57 Aligned_cols=123 Identities=20% Similarity=0.245 Sum_probs=106.5
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
....++|++.+.||+|+||.||+ .+|+|.+++. .....+.+..|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 33457899999999999999995 6899998642 223445678999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++|+|.+++.. ..+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 119 ~lv~Ey~~gg~L~~~l~~----------------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~N 172 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN----------------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDN 172 (370)
T ss_pred EEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 999999999999998841 24677888889999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=166.87 Aligned_cols=120 Identities=27% Similarity=0.330 Sum_probs=103.5
Q ss_pred cccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
|+..+.||+|+||.||+ .+|+|.+.... ......+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999996 69999886422 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|..++.. .....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 82 ~~~g~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~N 132 (285)
T cd05631 82 MNGGDLKFHIYN-------------MGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPEN 132 (285)
T ss_pred cCCCcHHHHHHh-------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHH
Confidence 999999887742 12245889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=170.34 Aligned_cols=121 Identities=21% Similarity=0.240 Sum_probs=105.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|.+.+. .....+.+..|+.++..++|+||+++++++.+.++.++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999995 6899998642 2334566889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 81 e~~~g~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 132 (331)
T cd05597 81 DYYVGGDLLTLLSK--------------FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDN 132 (331)
T ss_pred ecCCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHH
Confidence 99999999998842 2345888899999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=171.87 Aligned_cols=120 Identities=25% Similarity=0.361 Sum_probs=105.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|++... .......+..|+.++..++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999995 6899998642 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 E~~~gg~L~~~l~---------------~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~N 131 (360)
T cd05627 81 EFLPGGDMMTLLM---------------KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDN 131 (360)
T ss_pred eCCCCccHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHH
Confidence 9999999999884 2245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=173.00 Aligned_cols=137 Identities=32% Similarity=0.477 Sum_probs=109.7
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 220 (295)
..++|++.+.||+|+||.||+ .||+|.++.. .....+.+.+|+.+++.+ +|+|||++++++.+.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 346888999999999999995 5899998643 334456789999999999 8999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhh-----------------------------------------------------
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLM----------------------------------------------------- 247 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~----------------------------------------------------- 247 (295)
..++||||+++|+|.+++.........
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 999999999999999998643210000
Q ss_pred --hhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 248 --RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 248 --~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...........+++.....|+.||+.||+|||+++ |+||||||+|
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~N 242 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARN 242 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchhe
Confidence 00000112235888999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=175.54 Aligned_cols=122 Identities=29% Similarity=0.489 Sum_probs=110.2
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
+....|....+||+|+.|.||- .||||++........+-+.+|+.+|+.++|+|||++++.|...+++|.||
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 3446788889999999999994 79999998766667778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||++|+|.+++. ...+++.++..|..++++||+|||.++ |||||||.+|
T Consensus 350 Eym~ggsLTDvVt----------------~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDn 399 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT----------------KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDN 399 (550)
T ss_pred eecCCCchhhhhh----------------cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccce
Confidence 9999999999883 235899999999999999999999998 9999999987
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=172.04 Aligned_cols=127 Identities=19% Similarity=0.236 Sum_probs=108.9
Q ss_pred hhhhhhhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 218 (295)
+..+....++|++.+.||+|+||.||+ .+|+|.+... .....+.+..|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344455668999999999999999995 6899998642 22345567899999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~N 172 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDN 172 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence 9999999999999999998831 24677888889999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=168.59 Aligned_cols=114 Identities=22% Similarity=0.251 Sum_probs=100.3
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+.||+|+||.||+ .+|+|+++.. .......+.+|+.++++++||||+++++.+...+..+|||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999995 5999998752 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|.+++. ....+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 81 ~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~N 125 (323)
T cd05571 81 ELFFHLS---------------RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLEN 125 (323)
T ss_pred cHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHH
Confidence 9998884 2346889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=168.81 Aligned_cols=121 Identities=21% Similarity=0.225 Sum_probs=105.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|.+.+.||+|+||.||+ .+|+|.+.+. .......+..|+.++..++|+||+++++++.+.+..+|||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788999999999999995 5899998642 2234456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 Ey~~gg~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~N 132 (331)
T cd05624 81 DYYVGGDLLTLLSK--------------FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDN 132 (331)
T ss_pred eCCCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHH
Confidence 99999999999842 1245788899999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-22 Score=164.04 Aligned_cols=122 Identities=26% Similarity=0.391 Sum_probs=101.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~ 223 (295)
..++|..+++|++|+||.||+ .||+|+++... ....-.-.+||.+|.+++|||||.+..+... -+.+|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 446788899999999999997 69999997532 2223345789999999999999999998775 36799
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++ +|..++.. ....+...+...++.|+++||.|||.+- |+||||||+|
T Consensus 154 ~VMe~~Eh-DLksl~d~--------------m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SN 207 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMET--------------MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSN 207 (419)
T ss_pred eeHHHHHh-hHHHHHHh--------------ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhh
Confidence 99999975 88887742 2356888889999999999999999886 9999999998
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=181.29 Aligned_cols=126 Identities=31% Similarity=0.441 Sum_probs=108.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeE-Ee------C
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCC-IQ------G 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~-~~------~ 219 (295)
...++++.+.|.+|||+.||. .+|+|++-..++...+.+++||.+|++|+ |+|||.+++.. .. .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345677889999999999994 69999987668889999999999999998 99999999932 21 2
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
-+++|.||||++|.|-+++.. .....|++.++++|+.|+++|+++||.. ++||||||||-||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~-------------Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiEN 176 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNT-------------RLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIEN 176 (738)
T ss_pred eEEEeehhhccCCcHHHHHHH-------------HHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhh
Confidence 467899999999999999952 2334599999999999999999999998 5889999999998
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=168.20 Aligned_cols=114 Identities=21% Similarity=0.260 Sum_probs=100.0
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+.||+|+||.||+ .||+|.+... .......+.+|+.+++.++||||+++++.+...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4689999999996 5899998752 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|..++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~L~~~l~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~N 125 (323)
T cd05595 81 ELFFHLS---------------RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 125 (323)
T ss_pred cHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 9988774 2246889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=175.50 Aligned_cols=124 Identities=17% Similarity=0.194 Sum_probs=106.8
Q ss_pred cccccceeecccCccceeE---------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK---------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..|.+.+.||+|+||.||+ .||+|.+..........+.+|+.+|+.++|||||++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3488889999999999995 4788876554555567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.++|... ......+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 147 ~~gg~L~~~l~~~-----------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~N 199 (478)
T PTZ00267 147 GSGGDLNKQIKQR-----------LKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSAN 199 (478)
T ss_pred CCCCCHHHHHHHH-----------HhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHh
Confidence 9999999988531 112345788899999999999999999988 9999999998
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-21 Score=171.55 Aligned_cols=121 Identities=28% Similarity=0.456 Sum_probs=108.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHH---hHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQ---GLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 223 (295)
....|.+.+.||+|.||.||+ .+|+|.+.+.... ....+.+|+.+|++|. |||||++++.+.+.+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 446788889999999999996 6999999764332 4568999999999999 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||++.+|.|.+.|.. . .+++.....++.|++.++.|||+.+ |+||||||+|
T Consensus 113 lvmEL~~GGeLfd~i~~-------------~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN 165 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVK-------------K---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPEN 165 (382)
T ss_pred EEEEecCCchHHHHHHH-------------c---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHH
Confidence 99999999999999852 1 3889999999999999999999988 9999999998
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=167.99 Aligned_cols=114 Identities=23% Similarity=0.274 Sum_probs=100.5
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+.||+|+||.||+ .+|+|++... .......+.+|+.+++.++||||+++++.+...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999995 6999998752 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|..++. ....+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 81 ~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~N 125 (328)
T cd05593 81 ELFFHLS---------------RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLEN 125 (328)
T ss_pred CHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHH
Confidence 9988874 2246889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=165.03 Aligned_cols=121 Identities=27% Similarity=0.345 Sum_probs=104.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
+|++.+.||+|+||.||+ .||+|.+.... ......+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999996 58999986422 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.+++.. .....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 132 (285)
T cd05605 81 LMNGGDLKFHIYN-------------MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPEN 132 (285)
T ss_pred ccCCCcHHHHHHh-------------cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHH
Confidence 9999999988742 22345899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=166.13 Aligned_cols=122 Identities=25% Similarity=0.328 Sum_probs=106.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.+|++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46899999999999999996 5889988643 34456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ...+++.....++.|++.||.|||+++ .|+||||||+|
T Consensus 84 ~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~N 134 (331)
T cd06649 84 HMDGGSLDQVLKE---------------AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSN 134 (331)
T ss_pred cCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhh
Confidence 9999999998842 235788999999999999999999853 39999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=167.63 Aligned_cols=121 Identities=21% Similarity=0.277 Sum_probs=106.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|.+.+.||+|+||.||+ .+|+|+++.. .....+.+..|+.+++.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999996 6899998752 2234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 e~~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~N 132 (330)
T cd05601 81 EYQPGGDLLSLLNR--------------YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPEN 132 (330)
T ss_pred CCCCCCCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHh
Confidence 99999999998842 2246889999999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=165.39 Aligned_cols=120 Identities=27% Similarity=0.429 Sum_probs=103.2
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|.+.++||.|+||.||+ .||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5788999999999999996 68999886422 23345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++ ++|.+++.. ....+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 85 ~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~N 133 (288)
T cd07871 85 LD-SDLKQYLDN--------------CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQN 133 (288)
T ss_pred CC-cCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 97 589888742 2245788899999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=170.50 Aligned_cols=120 Identities=24% Similarity=0.373 Sum_probs=106.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|.+.+.||+|+||.||+ .||+|++... .......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3688899999999999996 6999998752 1234567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 e~~~~~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~N 131 (350)
T cd05573 81 EYMPGGDLMNLLIR---------------KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDN 131 (350)
T ss_pred cCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99999999998842 246888999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.6e-21 Score=161.02 Aligned_cols=120 Identities=30% Similarity=0.503 Sum_probs=105.0
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
++|++.+.||+|+||.||+ .+|+|.+... .....++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4678889999999999995 6899987642 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 83 ~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~n 130 (256)
T cd05114 83 NGCLLNYLRQ--------------RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARN 130 (256)
T ss_pred CCcHHHHHHh--------------CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcce
Confidence 9999998842 1235889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-21 Score=162.37 Aligned_cols=124 Identities=31% Similarity=0.572 Sum_probs=110.9
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
...+|++.++||.|+||.||+ .+|+|.+..........+..|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 456789999999999999996 5899998776555677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+|+||||+|
T Consensus 84 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~n 134 (261)
T cd05148 84 MEKGSLLAFLRS-------------PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARN 134 (261)
T ss_pred cccCCHHHHHhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcce
Confidence 999999999842 23456899999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=183.54 Aligned_cols=127 Identities=34% Similarity=0.570 Sum_probs=112.2
Q ss_pred cccccceeecccCccceeE-------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.+.+..+.||+|.||.||+ .||||.+++ .+.+...+|.+|..+|++++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 4456678999999999996 499999986 46788899999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++|||++|+|..||++.+..+ .....|.....+.|+.|||+|+.||+++. +|||||.++|
T Consensus 772 i~leyM~gGDL~sflr~~r~~~--------~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRN 832 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAP--------FQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARN 832 (1025)
T ss_pred EEehhcccCcHHHHHHhccccc--------CCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhh
Confidence 9999999999999997643321 12567899999999999999999999987 9999999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=166.10 Aligned_cols=112 Identities=23% Similarity=0.275 Sum_probs=99.2
Q ss_pred ecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||+|+||.||+ .+|+|.+... .......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999996 5899998642 334556788999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~N 123 (312)
T cd05585 81 FHHLQR---------------EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPEN 123 (312)
T ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHH
Confidence 998842 245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.2e-21 Score=166.87 Aligned_cols=121 Identities=19% Similarity=0.228 Sum_probs=105.2
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.++||+|+||.||+ .+|+|.+.+. .......+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3688899999999999996 5899998642 2233456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ey~~~g~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~N 132 (332)
T cd05623 81 DYYVGGDLLTLLSK--------------FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDN 132 (332)
T ss_pred eccCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 99999999999842 1245888899999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=160.88 Aligned_cols=115 Identities=20% Similarity=0.416 Sum_probs=100.3
Q ss_pred eeecccCccceeEE--------------------EEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 164 NKLGEGGFGLVYKE--------------------IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 164 ~~lg~G~~g~Vyk~--------------------vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
+.||+|+||.||+. +++|.+..........+..|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999962 7888876555555678889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|..++.. ....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 81 lv~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~N 135 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--------------KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKN 135 (262)
T ss_pred EEEecccCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCccc
Confidence 99999999999888741 2345889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=176.96 Aligned_cols=121 Identities=29% Similarity=0.447 Sum_probs=104.6
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeEE
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 224 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~~l 224 (295)
+...+.||+|+||.||+ .||||.++.. .....+...+|+++|++|+|+|||++++.-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44558899999999996 6999998763 345667788999999999999999999986543 35689
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||++|||..+|. ...+...|++...+.++.+++.||.|||+++ |+||||||.|
T Consensus 95 vmEyC~gGsL~~~L~------------~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~N 150 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLN------------SPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGN 150 (732)
T ss_pred EEeecCCCcHHHHhc------------CcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCc
Confidence 999999999999996 3456677999999999999999999999998 9999999998
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=165.47 Aligned_cols=122 Identities=23% Similarity=0.328 Sum_probs=106.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.++||+|+||.||+ .+|+|.+... .......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46899999999999999996 5788887642 34456779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ...+++.....++.|++.||.|||+.. .|+||||||+|
T Consensus 84 ~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~N 134 (333)
T cd06650 84 HMDGGSLDQVLKK---------------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSN 134 (333)
T ss_pred cCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhh
Confidence 9999999998842 235788888999999999999999742 39999999997
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-20 Score=159.88 Aligned_cols=121 Identities=28% Similarity=0.494 Sum_probs=106.8
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
++|++.+.||+|+||.||+ .+|||.++.. .......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5788899999999999995 4789988643 344566889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+|+||||+|
T Consensus 84 ~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~n 136 (266)
T cd05033 84 TEYMENGSLDKFLRE--------------NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARN 136 (266)
T ss_pred EEcCCCCCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 999999999999842 2236899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=165.44 Aligned_cols=118 Identities=21% Similarity=0.285 Sum_probs=101.4
Q ss_pred cceeeccc--CccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 162 INNKLGEG--GFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 162 ~~~~lg~G--~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
++++||+| +|+.||+ .||+|+++.. .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6788885 6999998642 2344567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~N 131 (327)
T cd08227 82 AYGSAKDLICT-------------HFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASH 131 (327)
T ss_pred CCCcHHHHHHh-------------hccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhh
Confidence 99999998842 12235889999999999999999999988 9999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=165.01 Aligned_cols=120 Identities=30% Similarity=0.519 Sum_probs=104.1
Q ss_pred cccccceeecccCccceeEE------------EEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYKE------------IAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk~------------vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.+|++.+.||+|+||.||+. ||+|.++.. .....+++..|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57899999999999999962 799998643 345567899999999999999999999998764 5779
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||+++|+|.+++.. ....+++...+.++.||+.||+|||+++ |+||||||+|
T Consensus 86 v~e~~~~g~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~N 139 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARN 139 (316)
T ss_pred eeecCCCCCHHHHHHh--------------ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 9999999999998852 2245888999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=164.45 Aligned_cols=114 Identities=22% Similarity=0.259 Sum_probs=99.4
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+.||+|+||.||+ .+|+|.+... .......+..|+.++..++||||+++++++...+..+|||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4689999999995 6899998752 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
+|..++. ....+++..+..++.||+.||.|||+ ++ |+||||||+|
T Consensus 81 ~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~N 126 (325)
T cd05594 81 ELFFHLS---------------RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLEN 126 (325)
T ss_pred cHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCe
Confidence 9988773 22468899999999999999999997 66 9999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=165.36 Aligned_cols=114 Identities=26% Similarity=0.286 Sum_probs=99.8
Q ss_pred eeecccCccceeE-----------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 164 NKLGEGGFGLVYK-----------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-----------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
+.||+|+||.||+ .+|+|++.... ......+..|+.+|++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999994 58999987532 2344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++. ....+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 82 ~~~L~~~l~---------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 128 (318)
T cd05582 82 GGDLFTRLS---------------KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPEN 128 (318)
T ss_pred CCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHH
Confidence 999998884 2245889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=172.89 Aligned_cols=122 Identities=32% Similarity=0.528 Sum_probs=104.9
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
+...+.++||+|.||.|.. .||||.++.... ....+|..|+++|.+|+|||||+|+|+|..++.+.+|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 4556779999999999985 699999987544 45589999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+|.+||..+. ...+.-.....|+.||+.||+||.+.+ +|||||.+.|
T Consensus 618 EnGDLnqFl~ahe-------------apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rN 667 (807)
T KOG1094|consen 618 ENGDLNQFLSAHE-------------LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRN 667 (807)
T ss_pred hcCcHHHHHHhcc-------------CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccc
Confidence 9999999996431 122344556679999999999999887 9999999987
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=160.46 Aligned_cols=122 Identities=30% Similarity=0.477 Sum_probs=107.4
Q ss_pred ccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
.++|++.++||+|+||.||+ .+|+|.+... ....+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999996 5899987643 234578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~L~~~l~~-------------~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~n 133 (261)
T cd05072 84 AKGSLLDFLKS-------------DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAAN 133 (261)
T ss_pred CCCcHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhh
Confidence 99999998842 23356888999999999999999999987 9999999987
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=161.10 Aligned_cols=121 Identities=30% Similarity=0.538 Sum_probs=105.8
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~ 223 (295)
.+|++.+.||+|+||.||+ .+|+|.+........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4788889999999999996 489999877666667889999999999999999999998653 34688
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 84 lv~e~~~~~~L~~~l~~--------------~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~n 138 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--------------HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRN 138 (284)
T ss_pred EEEEecCCCCHHHHHHh--------------cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhh
Confidence 99999999999998842 2245899999999999999999999998 9999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=164.22 Aligned_cols=121 Identities=30% Similarity=0.403 Sum_probs=103.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|.+.+.||+|+||.||+ .+|+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46899999999999999996 68999986432 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 84 ~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~N 133 (303)
T cd07869 84 YVH-TDLCQYMDK--------------HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQN 133 (303)
T ss_pred CCC-cCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 995 678777632 2245788889999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=160.24 Aligned_cols=119 Identities=29% Similarity=0.487 Sum_probs=98.9
Q ss_pred eeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.++|+||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3689999999995 4677776532 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|.+++.... .......++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~L~~~l~~~~----------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 130 (269)
T cd05042 81 DLKNYLRSNR----------GMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRN 130 (269)
T ss_pred cHHHHHHhcc----------ccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhh
Confidence 9999985321 111234567888899999999999999998 9999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=159.24 Aligned_cols=121 Identities=26% Similarity=0.475 Sum_probs=106.0
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.+|++.+.||+|+||.||+ .+|+|.++.. .....+.+..|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 5788889999999999995 3788887642 334567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ....+++.+.+.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~n 136 (267)
T cd05066 84 TEYMENGSLDAFLRK--------------HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARN 136 (267)
T ss_pred EEcCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeehhhchhc
Confidence 999999999998842 2245889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=161.39 Aligned_cols=123 Identities=28% Similarity=0.446 Sum_probs=101.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCc-ccceeeeEEeCC------
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGE------ 220 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~------ 220 (295)
..|...++||+|+||.||+ .||+|.+.-.. +.......+|+.+|++|+|+| ||+|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4566678899999999997 69999986432 234456689999999999999 999999999887
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++|+||+ .-+|..++.... .....++......++.|+++||+|||+++ |+||||||+|
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~-----------~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQN 150 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLP-----------KKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQN 150 (323)
T ss_pred eEEEEEEee-cccHHHHHHhcc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcce
Confidence 789999999 568999885310 00135666889999999999999999998 9999999998
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=160.32 Aligned_cols=135 Identities=29% Similarity=0.485 Sum_probs=110.8
Q ss_pred cccccceeecccCccceeE-------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
++|...++||+|+||.||+ .+|+|.+..........+.+|+.+++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 5677889999999999995 478888877666777899999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||+++++|.+++....................+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~n 152 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRN 152 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhh
Confidence 9999999999999864321110000000112245899999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=162.03 Aligned_cols=125 Identities=26% Similarity=0.391 Sum_probs=110.5
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
...++|++...||.|.-+.||+ .||||++.-. -......+++|+..|+.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3457899999999999999996 6999999742 223368999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|.||.+||+.++++..+ ...+++..+..|..++++||.|||.+| -||||||+.|
T Consensus 103 mpfMa~GS~ldIik~~~-------------~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgn 156 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY-------------PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGN 156 (516)
T ss_pred ehhhcCCcHHHHHHHHc-------------cccccHHHHHHHHHHHHHHHHHHHhcC---ceeccccccc
Confidence 99999999999997543 234888999999999999999999998 9999999987
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=165.11 Aligned_cols=119 Identities=21% Similarity=0.279 Sum_probs=103.4
Q ss_pred ccccceeecccCccceeE-----------EEEEEEeccc----cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 041718 159 NFSINNKLGEGGFGLVYK-----------EIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 222 (295)
+|++.+.||+|+||.||+ .+|+|++.+. .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999994 4899988642 223456788999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++|+|.+++. ....+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 81 ~lv~e~~~~g~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~N 135 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---------------QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLEN 135 (332)
T ss_pred EEEEeCCCCCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHH
Confidence 99999999999999884 2245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=160.67 Aligned_cols=134 Identities=32% Similarity=0.584 Sum_probs=111.5
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++|.+.+.||+|+||.||+ .+|+|.+..........+.+|+.++++++|+||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788899999999999995 37889887666666778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++........ ..........+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~N 150 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAV--LMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 150 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccc--cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcce
Confidence 99999999999999864321100 0001123345899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-21 Score=161.81 Aligned_cols=115 Identities=23% Similarity=0.452 Sum_probs=100.0
Q ss_pred eeecccCccceeEE---------------EEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 164 NKLGEGGFGLVYKE---------------IAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 164 ~~lg~G~~g~Vyk~---------------vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+.||+|+||.||+. +|+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999972 666776554445567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 81 ~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~n 130 (258)
T cd05078 81 VKFGSLDTYLKK--------------NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKN 130 (258)
T ss_pred CCCCcHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 999999999842 2236889999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-20 Score=158.78 Aligned_cols=121 Identities=28% Similarity=0.480 Sum_probs=106.9
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.+|++.+.||+|+||.||+ .||+|.+... ......+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4577889999999999995 3899998753 455667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ....+++.+++.++.|++.||.|||+++ ++|+||||+|
T Consensus 84 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~n 136 (269)
T cd05065 84 TEFMENGALDSFLRQ--------------NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARN 136 (269)
T ss_pred EecCCCCcHHHHHhh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChhe
Confidence 999999999998842 2345889999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=158.58 Aligned_cols=123 Identities=29% Similarity=0.471 Sum_probs=108.0
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.+.||+|++|.||+ .||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788899999999999996 68999886532 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 83 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~N 133 (261)
T cd05068 83 MKYGSLLEYLQG-------------GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARN 133 (261)
T ss_pred ccCCcHHHHHhc-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcce
Confidence 999999999842 22346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=164.67 Aligned_cols=117 Identities=27% Similarity=0.417 Sum_probs=99.5
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHH---hcCCCCcccceeeeEEeCCeeEEE
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILF---SKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l---~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
|++.+.||+|+||.||+ .||||.++.. .....+.+..|+.++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56789999999999996 5999998742 223345667776554 567899999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|..++. ...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~E~~~~~~L~~~~~----------------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~N 131 (324)
T cd05589 81 MEYAAGGDLMMHIH----------------TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDN 131 (324)
T ss_pred EcCCCCCcHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHH
Confidence 99999999988763 235899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=159.27 Aligned_cols=121 Identities=30% Similarity=0.503 Sum_probs=106.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
.+|.+.+.||+|+||.||+ .+|+|.+... .....++.+|+.++.+++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4678889999999999996 5899988653 344677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. .....+++..++.++.|++.||+|||+++ ++||||||+|
T Consensus 85 ~~~~L~~~~~~-------------~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~n 134 (263)
T cd05052 85 TYGNLLDYLRE-------------CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARN 134 (263)
T ss_pred CCCcHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcce
Confidence 99999998842 23346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=164.84 Aligned_cols=114 Identities=28% Similarity=0.392 Sum_probs=99.1
Q ss_pred eeecccCccceeE-----------EEEEEEeccc----cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 164 NKLGEGGFGLVYK-----------EIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-----------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+.||+|+||.||+ .+|+|.++.. .......+.+|+.+|+.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999995 4899998652 223345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++. ....+.+.....++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~~~~L~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 130 (323)
T cd05584 82 LSGGELFMHLE---------------REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPEN 130 (323)
T ss_pred CCCchHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 99999998884 2245778888889999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=161.50 Aligned_cols=123 Identities=30% Similarity=0.434 Sum_probs=110.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..++|.+.+.||.|+||.||+ .+|+|.+........+.+..|+.++++++|+||+++++.+......++|||
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 346789999999999999996 589999876666677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ....+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 83 ~~~~~~L~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~n 133 (280)
T cd06611 83 FCDGGALDSIMLE--------------LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGN 133 (280)
T ss_pred ccCCCcHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhh
Confidence 9999999998842 2245889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-20 Score=160.55 Aligned_cols=129 Identities=29% Similarity=0.457 Sum_probs=107.3
Q ss_pred cccccceeecccCccceeE-------------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
++|++.+.||.|+||.||+ .+++|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 5788889999999999995 4788887653333 4678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~------~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~N 147 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKD------EKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARN 147 (275)
T ss_pred EEEEecCCCcHHHHHHhccccc------ccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccce
Confidence 9999999999999985321000 0011236899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=160.86 Aligned_cols=131 Identities=28% Similarity=0.488 Sum_probs=109.2
Q ss_pred cccccceeecccCccceeE------------------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccce
Q 041718 158 DNFSINNKLGEGGFGLVYK------------------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKL 212 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l 212 (295)
++|++.+.||+|+||.||+ .+|+|.+... ......++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 5688999999999999995 3799988753 34556789999999999999999999
Q ss_pred eeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCC
Q 041718 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292 (295)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlk 292 (295)
++++...+..++||||+++++|.+++........ ........+++.+...++.|++.||+|||+++ |+|||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlk 157 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEA----AEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLA 157 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccc----cccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCC
Confidence 9999999999999999999999999864321100 00112345888999999999999999999998 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 158 p~N 160 (296)
T cd05095 158 TRN 160 (296)
T ss_pred hhe
Confidence 998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=158.25 Aligned_cols=120 Identities=29% Similarity=0.500 Sum_probs=105.4
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
++|++.+.||+|+||.||. .+|+|.+... ......+.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4688889999999999995 4899988643 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ....+++..++.++.||+.||.|||+++ |+|+||||+|
T Consensus 83 ~~~l~~~i~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~n 130 (256)
T cd05113 83 NGCLLNYLRE--------------HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARN 130 (256)
T ss_pred CCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcce
Confidence 9999998842 1235899999999999999999999998 9999999987
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=161.88 Aligned_cols=124 Identities=33% Similarity=0.529 Sum_probs=107.5
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 220 (295)
..++|.+.+.||+|+||.||+ .+|+|.++.. .....+.+.+|+.+++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 346788999999999999984 4889988653 334457899999999999 7999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++++|.+++.. .....+++.+...++.|++.||.|||+++ |+|+||||+|
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~-------------~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~N 171 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRR-------------KRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 171 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccce
Confidence 99999999999999998842 22234899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=164.07 Aligned_cols=119 Identities=24% Similarity=0.316 Sum_probs=102.6
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCC-cccceeeeEEeCCeeEEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 226 (295)
+|++.+.||+|+||.||+ .+|+|++... .....+.+..|+.++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999996 5999998752 234556788899999999765 6888999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 E~~~~g~L~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~N 131 (324)
T cd05587 81 EYVNGGDLMYHIQ---------------QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131 (324)
T ss_pred cCCCCCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 9999999998884 2245788999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=159.67 Aligned_cols=133 Identities=28% Similarity=0.471 Sum_probs=108.7
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 220 (295)
...++|++.+.||+|+||.||+ .+|+|.+... ......++.+|+.+++.++|+||+++++++.+..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3567899999999999999994 4899988642 3345567899999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++++|.+++...... .........+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~N 149 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPE-----MENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCcc-----ccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchhe
Confidence 999999999999999998532100 000011235688899999999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=160.89 Aligned_cols=116 Identities=28% Similarity=0.352 Sum_probs=99.1
Q ss_pred ecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||+|+||.||+ .+|+|.+.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999995 68999986422 22346678899999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++.. .......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~~~~-----------~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 127 (280)
T cd05608 81 RYHIYN-----------VDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPEN 127 (280)
T ss_pred HHHHHh-----------ccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 887742 1123356899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=164.07 Aligned_cols=114 Identities=24% Similarity=0.332 Sum_probs=99.6
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|+++.. .......+..|+.++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999995 6899999752 233456688999999988 799999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 g~L~~~~~---------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 126 (329)
T cd05588 81 GDLMFHMQ---------------RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDN 126 (329)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 99988773 2246899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=160.10 Aligned_cols=133 Identities=26% Similarity=0.441 Sum_probs=108.3
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 220 (295)
...++|++.+.||+|+||.||+ .+|+|.++.. .......+.+|+.++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 3457899999999999999995 4789987643 2334557889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++|+|.+++....... ........+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~n 149 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEA-----ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 149 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhcccc-----ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChhe
Confidence 9999999999999999995321100 00112345677888999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-21 Score=167.68 Aligned_cols=122 Identities=25% Similarity=0.425 Sum_probs=107.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe-eEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE-KLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 226 (295)
++|..++++|+|+||.++. .+++|.+.. ......+...+|+.++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999882 688888753 445556688999999999999999999999998888 99999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|++||+|.+.|.. .+...+++.....++.|++.|+.|||++. |+|||||++|
T Consensus 84 ~Y~eGg~l~~~i~~-------------~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~N 136 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE-------------QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCAN 136 (426)
T ss_pred eecCCCCHHHHHHH-------------HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhh
Confidence 99999999999953 34567899999999999999999999876 9999999987
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=160.90 Aligned_cols=133 Identities=28% Similarity=0.494 Sum_probs=108.6
Q ss_pred ccccccceeecccCccceeE----------------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCccccee
Q 041718 157 TDNFSINNKLGEGGFGLVYK----------------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLL 213 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk----------------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~ 213 (295)
.++|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35788999999999999995 3899988653 344566799999999999999999999
Q ss_pred eeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
+++...+..++||||+++++|.+++........ .........+++..++.++.|++.||.|||+++ ++||||||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp 157 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIEST---FTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLAT 157 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhcccccc---ccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccCh
Confidence 999999999999999999999999853210000 001112235789999999999999999999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 158 ~N 159 (295)
T cd05097 158 RN 159 (295)
T ss_pred hh
Confidence 98
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=160.99 Aligned_cols=120 Identities=25% Similarity=0.314 Sum_probs=104.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.+.||+|+||.||+ .+|+|.+... ......++.+|+.++.+++||||+++++.+.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999996 5788887642 344556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ...+++.....++.|++.||.|||+. + |+||||||+|
T Consensus 81 ~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~n 130 (308)
T cd06615 81 MDGGSLDQVLKK---------------AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSN 130 (308)
T ss_pred cCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHH
Confidence 999999999842 24578899999999999999999974 5 9999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.2e-20 Score=158.10 Aligned_cols=121 Identities=24% Similarity=0.408 Sum_probs=106.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|++.+.||+|+||.||+ .+|+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999996 5899988654444556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 88 ~~~~~L~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 136 (267)
T cd06646 88 CGGGSLQDIYH---------------VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGAN 136 (267)
T ss_pred CCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 99999999874 1235788999999999999999999987 9999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=158.97 Aligned_cols=118 Identities=38% Similarity=0.649 Sum_probs=100.7
Q ss_pred cceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 162 INNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+.+.||.|.||.||+ .|+||.++. ......+.+.+|+..+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 458899999999996 489999964 3445588999999999999999999999999988889999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.++|.. .....+++..+..|+.||+.||.|||+++ |+|+||+|+|
T Consensus 83 ~~~g~L~~~L~~-------------~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~n 133 (259)
T PF07714_consen 83 CPGGSLDDYLKS-------------KNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSN 133 (259)
T ss_dssp -TTEBHHHHHHH-------------TCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGG
T ss_pred cccccccccccc-------------ccccccccccccccccccccccccccccc---cccccccccc
Confidence 999999999953 23456899999999999999999999997 9999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=157.19 Aligned_cols=122 Identities=28% Similarity=0.515 Sum_probs=108.5
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.++|++.+.||.|+||.||+ .+|+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45788889999999999996 789999876433 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. .....+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 84 ~~~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~N 132 (256)
T cd05039 84 KGSLVDYLRS-------------RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARN 132 (256)
T ss_pred CCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccce
Confidence 9999998842 22236899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=159.42 Aligned_cols=135 Identities=30% Similarity=0.440 Sum_probs=107.7
Q ss_pred cccccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
++|++.+.||+|+||.||+ .+|+|.+.. ........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 5678889999999999996 478888864 234455788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhh-hhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLM-RSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~-~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++......... .... .......+++...+.++.|++.||.|||+++ |+||||||+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~n 154 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARN 154 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccce
Confidence 99999999999998532110000 0000 0011245889999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-20 Score=158.00 Aligned_cols=119 Identities=30% Similarity=0.454 Sum_probs=99.9
Q ss_pred eeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+.||+|+||.||+ .+|+|.++.. .......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 3689999999996 3788888653 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|.+++.... ......+++.....++.|++.||+|||+++ ++||||||+|
T Consensus 81 ~L~~~l~~~~----------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~n 130 (269)
T cd05087 81 DLKGYLRSCR----------KAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRN 130 (269)
T ss_pred cHHHHHHHhh----------hcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcce
Confidence 9999985321 112235677888899999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=160.95 Aligned_cols=114 Identities=30% Similarity=0.402 Sum_probs=104.8
Q ss_pred eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
+.||+|+|+.|-. ++|||++.+.......+..+|++++...+ |+||++|+++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 6899999999973 78999998877777888999999999885 99999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+.|. +.+.+++..+.+++.+|+.||.|||.++ |.||||||+|
T Consensus 164 LshI~---------------~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPEN 206 (463)
T KOG0607|consen 164 LSHIQ---------------KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPEN 206 (463)
T ss_pred HHHHH---------------HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccc
Confidence 99884 3466889999999999999999999999 9999999998
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=168.13 Aligned_cols=137 Identities=29% Similarity=0.447 Sum_probs=109.3
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG 219 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~ 219 (295)
...++|.+.++||+|+||.||+ .||+|+++.. .....+.+..|+.+|.++. |||||++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 3445778889999999999995 4899999753 2333457899999999997 99999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhh----------------------------------------------------
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLM---------------------------------------------------- 247 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------------------------------------------------- 247 (295)
+..++||||+++|+|.+++..+.....-
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999999754210000
Q ss_pred --------------------------------hhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 248 --------------------------------RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 248 --------------------------------~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
... .......+++.....|+.|++.||+|||+.+ |+||||||+|
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDT-LINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhh-hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 000 0012245788899999999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=161.58 Aligned_cols=136 Identities=32% Similarity=0.557 Sum_probs=108.6
Q ss_pred ccccccceeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (295)
.++|++.+.||+|+||.||+ .+|+|.++.. .......+.+|+.++.++ +|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35788889999999999996 3577776542 345567889999999999 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++........-... ........+++.+++.++.|++.||+|||+++ |+||||||+|
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~N 154 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 154 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchhe
Confidence 99999999999998643211100000 00112346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-20 Score=161.56 Aligned_cols=120 Identities=23% Similarity=0.388 Sum_probs=103.0
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .+|+|++... .....+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688899999999999996 5899988642 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++++++..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~N 130 (287)
T cd07848 81 YVEKNMLELLEE---------------MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPEN 130 (287)
T ss_pred cCCCCHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999877764431 2245888999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=159.43 Aligned_cols=135 Identities=30% Similarity=0.521 Sum_probs=110.3
Q ss_pred cccccceeecccCccceeE-------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.+|.+.+.||+|+||.||+ .+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 5688889999999999995 388888876666666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhh-hhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTL-MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++..+..... ............+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 153 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRN 153 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcce
Confidence 9999999999999964321100 000000112345899999999999999999999998 9999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-21 Score=165.02 Aligned_cols=118 Identities=29% Similarity=0.457 Sum_probs=93.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKLLI 225 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~lv 225 (295)
.|...+++|.|+||.||+ .||||+.-... +---+|+.+|++++|||||+|.-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466679999999999997 69999875422 12246899999999999999999887432 23589
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||| .+|.++++.+. .....++.....-+..||.+||.|||+.+ |+||||||+|
T Consensus 101 leymP-~tL~~~~r~~~-----------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqN 155 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYT-----------RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQN 155 (364)
T ss_pred HHhch-HHHHHHHHHHh-----------hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChhe
Confidence 99997 48988886321 12345666777789999999999999988 9999999998
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=167.27 Aligned_cols=115 Identities=23% Similarity=0.375 Sum_probs=100.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
...+|++.+.||+|+||.||+ .||+|.... ..+.+|+.+|++|+|||||++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346799999999999999996 689986532 356789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++. ++|..++. ....+++..++.|+.|++.||.|||+++ ||||||||+|
T Consensus 164 ~~~-~~L~~~l~---------------~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~N 212 (391)
T PHA03212 164 RYK-TDLYCYLA---------------AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAEN 212 (391)
T ss_pred cCC-CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHh
Confidence 995 78888773 1245789999999999999999999998 9999999998
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=166.81 Aligned_cols=117 Identities=28% Similarity=0.383 Sum_probs=100.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|...++||+|+||.||+ .||||.+... .......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 35677789999999999996 5899998642 33456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.... .+.+.....++.||+.||.|||+++ |+||||||+|
T Consensus 153 ~~~~~~L~~~~-------------------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 198 (353)
T PLN00034 153 FMDGGSLEGTH-------------------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSN 198 (353)
T ss_pred cCCCCcccccc-------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHH
Confidence 99999986432 2456677889999999999999998 9999999987
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.8e-20 Score=162.73 Aligned_cols=114 Identities=24% Similarity=0.332 Sum_probs=98.8
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++++. .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999996 5899998752 234456678899888776 899999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~L~~~~~---------------~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~N 126 (329)
T cd05618 81 GDLMFHMQ---------------RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 126 (329)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHH
Confidence 99988773 2246889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=166.84 Aligned_cols=124 Identities=27% Similarity=0.397 Sum_probs=108.6
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
......|.+.+.||+|.|+.|.. .||||.+++. .....+.+.+|+++|..|+|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34556889999999999999984 7999999863 3444566999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||..+|.++++|.. ...+.......++.|+..+++|+|+++ |+|||||++|
T Consensus 132 lV~eya~~ge~~~yl~~---------------~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eN 185 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVK---------------HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAEN 185 (596)
T ss_pred EEEEeccCchhHHHHHh---------------cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhh
Confidence 99999999999999953 234555778889999999999999998 9999999998
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=176.52 Aligned_cols=131 Identities=21% Similarity=0.385 Sum_probs=108.2
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|.+.++||+|+||.||+ .||+|++... .....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5788999999999999996 6899998642 2344567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++....... .........+++...+.++.||+.||+|||+++ |+||||||+|
T Consensus 82 EY~eGGSL~~lL~s~~~~~----~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeN 143 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKE----SLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDN 143 (932)
T ss_pred EcCCCCCHHHHHHHhhhcc----ccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchhe
Confidence 9999999999985321100 001112345678888999999999999999998 9999999998
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=161.51 Aligned_cols=136 Identities=29% Similarity=0.473 Sum_probs=109.0
Q ss_pred ccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 219 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 219 (295)
.++|.+.+.||+|+||.||+ .+|+|.+... ......++..|+.++.++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 46899999999999999995 3889988743 344567788999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++||||+++++|.+++..........-.. .......+++.+++.++.|++.||+|||+++ ++||||||+|
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 99999999999999999996421110000000 0012235899999999999999999999987 9999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=159.24 Aligned_cols=132 Identities=32% Similarity=0.459 Sum_probs=109.3
Q ss_pred ccccccceeecccCccceeE------------------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccc
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVK 211 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~ 211 (295)
..+|.+.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35788999999999999995 3789988653 3455678999999999999999999
Q ss_pred eeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC
Q 041718 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291 (295)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl 291 (295)
+++++...+..++++||+++++|.+++.......... ......+++...+.++.|++.||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL----ACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc----cccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 9999999999999999999999999986421100000 112246899999999999999999999988 999999
Q ss_pred CCCC
Q 041718 292 KASN 295 (295)
Q Consensus 292 kp~N 295 (295)
||+|
T Consensus 157 kp~N 160 (296)
T cd05051 157 ATRN 160 (296)
T ss_pred chhc
Confidence 9998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=159.33 Aligned_cols=135 Identities=29% Similarity=0.521 Sum_probs=108.0
Q ss_pred cccccceeecccCccceeE----------EEEEEEecc-ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK----------EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (295)
++|++.+.||+|+||.||+ .+++|.++. ......+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 5788899999999999996 258888764 2344567899999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||+++++|.+++............. .......+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~N 149 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARN 149 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcce
Confidence 99999999999996432111100000 0112245889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=161.93 Aligned_cols=119 Identities=24% Similarity=0.311 Sum_probs=101.7
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (295)
+|.+.+.||+|+||.||+ .+|+|.+.+. .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 578889999999999996 6899998752 223345667788888777 5899999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 E~~~~g~L~~~~~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 131 (323)
T cd05616 81 EYVNGGDLMYQIQ---------------QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131 (323)
T ss_pred cCCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHH
Confidence 9999999998874 2245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-20 Score=155.87 Aligned_cols=124 Identities=24% Similarity=0.452 Sum_probs=106.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|||.+.. ........+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999996 689998753 23445567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++... ......+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 82 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~n 136 (267)
T cd08228 82 ELADAGDLSQMIKYF-----------KKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPAN 136 (267)
T ss_pred EecCCCcHHHHHHHh-----------hhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHH
Confidence 999999999888421 112345788899999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.6e-20 Score=158.01 Aligned_cols=123 Identities=32% Similarity=0.470 Sum_probs=110.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..+.|++.++||.|+||.||+ .+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 446799999999999999996 689999877666777889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|..++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 90 ~~~~~~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~N 140 (292)
T cd06644 90 FCPGGAVDAIMLE--------------LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGN 140 (292)
T ss_pred cCCCCcHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcce
Confidence 9999999887742 2245889999999999999999999987 9999999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=158.66 Aligned_cols=120 Identities=26% Similarity=0.330 Sum_probs=103.3
Q ss_pred cccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
|+..+.||+|+||.||+ .+|+|.+.... ......+.+|+.+|.+++|+||+.+++.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999996 68999886422 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 82 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~N 132 (285)
T cd05632 82 MNGGDLKFHIYN-------------MGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPEN 132 (285)
T ss_pred ccCccHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHH
Confidence 999999988742 12346899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=155.29 Aligned_cols=115 Identities=26% Similarity=0.494 Sum_probs=100.9
Q ss_pred eeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
+.||+|+||.||+ .+|+|.+.. ........+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999996 489998754 2344567899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~n 124 (252)
T cd05084 81 LTFLRT--------------EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARN 124 (252)
T ss_pred HHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchhe
Confidence 998841 2345889999999999999999999988 9999999997
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-20 Score=156.71 Aligned_cols=122 Identities=31% Similarity=0.484 Sum_probs=105.1
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.++||+|+||.||+ .+|+|.+.... ....++.+|+.++++++|+||+++++++ ..+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEc
Confidence 346788999999999999996 69999887532 3456789999999999999999999986 45678999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++||||||+|
T Consensus 82 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~n 132 (260)
T cd05067 82 MENGSLVDFLKT-------------PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAAN 132 (260)
T ss_pred CCCCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHh
Confidence 999999998842 23456899999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=158.47 Aligned_cols=134 Identities=34% Similarity=0.529 Sum_probs=107.1
Q ss_pred ccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 159 NFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
+|++.+.||+|+||.||+ .+|+|.+... ......++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 477889999999999996 3778877643 33456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhh---------hhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLM---------RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||+++++|.+++......... ...........+++...+.++.|++.||.|||+++ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999998642111000 00011122346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.8e-20 Score=155.55 Aligned_cols=125 Identities=28% Similarity=0.410 Sum_probs=106.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
+++++.....||+|+||.||+ .+|+|.+........+.+.+|+.++++++|+||+++++++..++..++|+|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 445555567899999999996 489998876666677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++... ......++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 86 ~~~~~~L~~~l~~~------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~n 138 (268)
T cd06624 86 QVPGGSLSALLRSK------------WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDN 138 (268)
T ss_pred cCCCCCHHHHHHHh------------cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHH
Confidence 99999999988521 11112377888899999999999999988 9999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=158.20 Aligned_cols=120 Identities=28% Similarity=0.344 Sum_probs=103.1
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
|+..+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++|+|++.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999995 6899988642 223345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 82 ~~g~~L~~~l~~-------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~N 132 (285)
T cd05630 82 MNGGDLKFHIYH-------------MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPEN 132 (285)
T ss_pred cCCCcHHHHHHH-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHH
Confidence 999999988842 12245888999999999999999999987 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-20 Score=159.58 Aligned_cols=138 Identities=28% Similarity=0.479 Sum_probs=110.5
Q ss_pred hhccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 217 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 217 (295)
...++|.+.+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3457888999999999999994 3788887642 344567899999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.....++||||+++++|.+++............ ........+++.++..++.||+.||.|||+++ |+||||||+|
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 999999999999999999999643221110000 00112346889999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.9e-20 Score=155.76 Aligned_cols=122 Identities=25% Similarity=0.475 Sum_probs=106.9
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.++|+..+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 35778889999999999995 3788888643 34456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 84 v~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~N 137 (268)
T cd05063 84 ITEYMENGALDKYLRD--------------HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARN 137 (268)
T ss_pred EEEcCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhh
Confidence 9999999999998842 2245899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.8e-20 Score=156.40 Aligned_cols=129 Identities=33% Similarity=0.563 Sum_probs=108.5
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
..++|.+.+.||+|+||.||+ .+|+|.+... .......+..|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 346789999999999999995 3788877643 34445679999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++..... .......++|..++.++.||+.||+|||+++ ++||||||+|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~--------~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~n 146 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRP--------RPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARN 146 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccchhe
Confidence 9999999999999999854211 0112246899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=160.70 Aligned_cols=120 Identities=27% Similarity=0.451 Sum_probs=102.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|.+.+.||+|+||.||+ .+|+|.++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999996 58999886432 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++ +|.+++.. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 86 ~~~-~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~N 134 (309)
T cd07872 86 LDK-DLKQYMDD--------------CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQN 134 (309)
T ss_pred CCC-CHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 974 88877732 2345788899999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=159.46 Aligned_cols=123 Identities=23% Similarity=0.474 Sum_probs=108.7
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.....+|++.+.||+|+||.||+ .+|+|.+........+.+.+|+.+++.+.|+||+++++.+..+...++|
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 44556899999999999999996 6899988764445567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ..+++.+...++.|++.||+|||+.+ |+||||||+|
T Consensus 96 ~e~~~~~~L~~~~~~----------------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~N 146 (296)
T cd06654 96 MEYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDN 146 (296)
T ss_pred ecccCCCCHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999998731 34788899999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.5e-20 Score=155.64 Aligned_cols=123 Identities=31% Similarity=0.502 Sum_probs=108.1
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|.+.+.||+|+||.||+ .+|||.+... ....+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456889999999999999996 5899988753 23456789999999999999999999999998999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+|+||||+|
T Consensus 83 ~~~~~L~~~i~~-------------~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~n 133 (261)
T cd05034 83 MSKGSLLDFLKS-------------GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARN 133 (261)
T ss_pred cCCCCHHHHHhc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchhe
Confidence 999999999842 23346899999999999999999999998 9999999987
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=161.38 Aligned_cols=114 Identities=25% Similarity=0.363 Sum_probs=98.3
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++... .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999996 5899998752 234456677898888866 799999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~N 126 (321)
T cd05591 81 GDLMFQIQ---------------RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDN 126 (321)
T ss_pred CcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99998874 2245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-20 Score=159.39 Aligned_cols=123 Identities=24% Similarity=0.473 Sum_probs=109.1
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.....+|++.+.||+|+||.||+ .||+|.+........+.+.+|+.+++.++|+||+++++.+..++..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 44557899999999999999996 6899988754455567789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 95 ~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~N 145 (297)
T cd06656 95 MEYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDN 145 (297)
T ss_pred ecccCCCCHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999998731 34788899999999999999999987 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=162.47 Aligned_cols=118 Identities=22% Similarity=0.468 Sum_probs=99.6
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EEKL 223 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~ 223 (295)
+|++.+.||+|+||.||+ .||||++... .......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999996 6899988642 233456788999999999999999999987643 3579
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||++ ++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 lv~e~~~-~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 133 (338)
T cd07859 81 VVFELME-SDLHQVIK---------------ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKN 133 (338)
T ss_pred EEEecCC-CCHHHHHH---------------hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 9999995 68888773 2245889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.6e-21 Score=170.43 Aligned_cols=127 Identities=28% Similarity=0.460 Sum_probs=109.7
Q ss_pred hhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
++.....+..+..+||-|.||.||. .||||.|+. +.-..++|+.|.++|+.|+|||+|+|+|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 3344445677889999999999995 699999976 3456789999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+|||.+|+|.+||++ -....++-...+.++.||+.||+||..++ +|||||.++|
T Consensus 340 IiTEfM~yGNLLdYLRe-------------cnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARN 395 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRE-------------CNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARN 395 (1157)
T ss_pred EEEecccCccHHHHHHH-------------hchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhh
Confidence 99999999999999963 23344666677889999999999999988 9999999876
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.6e-20 Score=157.04 Aligned_cols=121 Identities=31% Similarity=0.505 Sum_probs=104.4
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--Cee
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 222 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 222 (295)
..|++.+.||+|+||.||. .+|+|.++.. .......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999984 5899998643 344567899999999999999999999998775 568
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 84 ~lv~e~~~g~~L~~~l~~--------------~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~N 139 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--------------NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARN 139 (284)
T ss_pred EEEEEccCCCCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchhe
Confidence 999999999999998842 2235899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-20 Score=157.36 Aligned_cols=135 Identities=30% Similarity=0.547 Sum_probs=110.2
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|.+.+.||+|+||.||+ .+|+|.++..... ..+.+.+|+.+|++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 35688889999999999995 3799998754333 567899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++........... ........+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~n 152 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLK-SPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRN 152 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhc-ccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccce
Confidence 999999999999999964321000000 01123356889999999999999999999998 9999999997
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=156.52 Aligned_cols=114 Identities=27% Similarity=0.358 Sum_probs=97.2
Q ss_pred ecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||+|+||.||+ .+|+|.+.... ......+..|+.++++++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999996 58999886421 12334566799999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 81 ~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~N 125 (277)
T cd05607 81 KYHIYN-------------VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPEN 125 (277)
T ss_pred HHHHHh-------------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHh
Confidence 888742 22345889999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=156.20 Aligned_cols=119 Identities=32% Similarity=0.483 Sum_probs=106.1
Q ss_pred cccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
|++.+.||+|+||.||+ .+++|.+........+.+.+|+.+++.++|+||+++++.+...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56778999999999996 5788888765666678899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 87 ~~l~~~~~~--------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~n 133 (282)
T cd06643 87 GAVDAVMLE--------------LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGN 133 (282)
T ss_pred CcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCccc
Confidence 999887741 2346899999999999999999999998 9999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-20 Score=161.27 Aligned_cols=119 Identities=24% Similarity=0.320 Sum_probs=101.7
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 226 (295)
+|...+.||+|+||.||+ .||+|++... .....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 366779999999999996 6999998752 2234566788999988885 577889999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 Ey~~~g~L~~~i~---------------~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~N 131 (323)
T cd05615 81 EYVNGGDLMYHIQ---------------QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDN 131 (323)
T ss_pred cCCCCCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 9999999998884 2245889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.7e-20 Score=176.57 Aligned_cols=131 Identities=23% Similarity=0.369 Sum_probs=108.4
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCe
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEE 221 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~ 221 (295)
....++|.+.+.||.|+||.||+ .+|+|.+.. ........+..|+.+|.+|+|||||++++++.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34557899999999999999996 588998764 234556789999999999999999999998864 456
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCC----CCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSK----LRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~----~~iiHrDlkp~N 295 (295)
++|||||+++++|.++|... ......+++..++.|+.||+.||.|||+.+. .+||||||||+|
T Consensus 89 lyIVMEY~~gGSL~~lL~k~-----------~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeN 155 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKC-----------YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQN 155 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHH-----------hhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHH
Confidence 89999999999999998531 1123468999999999999999999998531 249999999987
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=156.12 Aligned_cols=120 Identities=28% Similarity=0.482 Sum_probs=104.5
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.+|++.+.||+|+||.||+ .+|+|.+... ......+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4577889999999999996 5899987642 2234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ....+++...+.++.|++.||.|||+.+ |+||||||+|
T Consensus 83 ~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~n 130 (256)
T cd05059 83 NGCLLNYLRE--------------RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARN 130 (256)
T ss_pred CCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhh
Confidence 9999998842 1236899999999999999999999998 9999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.9e-20 Score=160.97 Aligned_cols=114 Identities=23% Similarity=0.314 Sum_probs=99.4
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|+++.. .....+.+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999995 6899999752 233456788999999888 699999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~L~~~~~---------------~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~N 126 (327)
T cd05617 81 GDLMFHMQ---------------RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDN 126 (327)
T ss_pred CcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99988773 2245899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.7e-20 Score=174.47 Aligned_cols=121 Identities=26% Similarity=0.366 Sum_probs=106.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|.+.++||.|+||.||+ .||||++... .......+..|+.++..++|+||+++++.+...+..+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 36789999999999999996 6999998642 234457889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++...+.|+.||+.||.|||.++ ||||||||+|
T Consensus 83 mEy~~g~~L~~li~~---------------~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~N 134 (669)
T cd05610 83 MEYLIGGDVKSLLHI---------------YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDN 134 (669)
T ss_pred EeCCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHH
Confidence 999999999998842 235788889999999999999999987 9999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=154.73 Aligned_cols=124 Identities=29% Similarity=0.514 Sum_probs=103.5
Q ss_pred cccceeecccCccceeE-----------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe-----
Q 041718 160 FSINNKLGEGGFGLVYK-----------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 221 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk-----------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 221 (295)
|.+.+.||+|+||.||+ .+|+|+++. ........+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56778999999999995 489998864 234456789999999999999999999998876554
Q ss_pred -eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 -KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++++||+++++|..++..... ......+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~N 143 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRL---------GGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhc---------cCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhe
Confidence 7999999999999998853210 112346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.3e-22 Score=158.13 Aligned_cols=122 Identities=28% Similarity=0.480 Sum_probs=104.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..+.|++.+.||+|.|+.|++ .+|+|+++. .+..+.+++.+|+.|-..|+|||||+|+..+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 346788889999999999996 467776642 3455788999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+|.|++|..-|- .....++......+.||+.+|.|.|.++ |||||+||+|
T Consensus 89 Fe~m~G~dl~~eIV---------------~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~n 140 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV---------------AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPEN 140 (355)
T ss_pred EecccchHHHHHHH---------------HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhh
Confidence 99999999966542 1134677788889999999999999998 9999999997
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=156.32 Aligned_cols=135 Identities=33% Similarity=0.538 Sum_probs=108.6
Q ss_pred cccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.+|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4788889999999999995 4889988643 3445677999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|||+++++|.+++............. .......+++...+.++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~N 154 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARN 154 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccce
Confidence 9999999999999986432111000000 0111256889999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=160.23 Aligned_cols=114 Identities=26% Similarity=0.380 Sum_probs=97.3
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .||||.++.. .....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999996 6999998752 12334566778888876 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|.+++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 g~L~~~l~---------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~N 126 (316)
T cd05619 81 GDLMFHIQ---------------SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDN 126 (316)
T ss_pred CcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHH
Confidence 99998884 2245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=154.93 Aligned_cols=117 Identities=27% Similarity=0.439 Sum_probs=97.6
Q ss_pred eecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCC
Q 041718 165 KLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 165 ~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (295)
.||+|+||.||+ .+++|.+... .....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999996 2456665542 23456789999999999999999999999999999999999999999
Q ss_pred HHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 234 LNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 234 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|.+++... ......+++.....++.||+.||.|||+.+ |+||||||+|
T Consensus 82 L~~~l~~~-----------~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~n 129 (268)
T cd05086 82 LKSYLSQE-----------QWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRN 129 (268)
T ss_pred HHHHHHhh-----------hcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccce
Confidence 99998531 111234667778899999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-20 Score=160.32 Aligned_cols=114 Identities=27% Similarity=0.320 Sum_probs=95.3
Q ss_pred eeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++.+.. ......+..|+. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999996 58999986421 223345555654 67889999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|..++. ....+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 81 ~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~N 126 (321)
T cd05603 81 GELFFHLQ---------------RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPEN 126 (321)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 99988773 2245778888899999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.1e-20 Score=160.11 Aligned_cols=114 Identities=25% Similarity=0.325 Sum_probs=96.0
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .||+|.++.. .....+.+..|..++.. ++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999996 5999998752 22344556667777765 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 g~L~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~N 126 (316)
T cd05592 81 GDLMFHIQ---------------SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDN 126 (316)
T ss_pred CcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHH
Confidence 99998874 2245888899999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=155.58 Aligned_cols=121 Identities=29% Similarity=0.474 Sum_probs=103.6
Q ss_pred ccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
..+|++.++||+|+||.||+ .+|+|.++... ...+.+.+|+.++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35689999999999999996 58999887522 23467899999999999999999999874 46689999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~N 132 (262)
T cd05071 83 SKGSLLDFLKG-------------EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 132 (262)
T ss_pred CCCcHHHHHhh-------------ccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCccc
Confidence 99999999842 22345789999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-20 Score=160.95 Aligned_cols=114 Identities=28% Similarity=0.384 Sum_probs=98.3
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|.+... .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999996 5899998642 223456677888888876 699999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 g~L~~~i~---------------~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~N 126 (320)
T cd05590 81 GDLMFHIQ---------------KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDN 126 (320)
T ss_pred chHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHH
Confidence 99998874 2245888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-20 Score=160.54 Aligned_cols=114 Identities=27% Similarity=0.320 Sum_probs=96.2
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4689999999995 5899998642 2233455666655 56789999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 81 ~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~N 126 (325)
T cd05604 81 GELFFHLQ---------------RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPEN 126 (325)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHH
Confidence 99988773 2346889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=152.46 Aligned_cols=121 Identities=22% Similarity=0.396 Sum_probs=105.5
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
+|++.+.||.|+||.||+ .+|+|.++. ......+.+..|+.++++++|+||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999995 689998754 23445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. .....+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 81 ~~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~n 130 (255)
T cd08219 81 DGGDLMQKIKL-------------QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKN 130 (255)
T ss_pred CCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcce
Confidence 99999988742 23345788999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=153.17 Aligned_cols=121 Identities=25% Similarity=0.456 Sum_probs=106.7
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|++|.||+ .+++|.+.. ........+.+|+.++++++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477789999999999996 589998753 3455677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++.....++.|++.||.|||+.+ |+|+||||+|
T Consensus 81 ~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~n 131 (256)
T cd08529 81 AENGDLHKLLKM-------------QRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLN 131 (256)
T ss_pred CCCCcHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcce
Confidence 999999999852 22356889999999999999999999987 9999999997
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-20 Score=155.09 Aligned_cols=113 Identities=24% Similarity=0.480 Sum_probs=96.4
Q ss_pred eeecccCccceeE------------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 164 NKLGEGGFGLVYK------------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 164 ~~lg~G~~g~Vyk------------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+.||+|+||.||+ .+++|.+...... ...+.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999995 1566766543222 6788999999999999999999999888 788999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 79 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~N 131 (259)
T cd05037 79 EEYVKFGPLDVFLHR--------------EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKN 131 (259)
T ss_pred EEcCCCCcHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccce
Confidence 999999999999852 1226889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.4e-20 Score=161.83 Aligned_cols=136 Identities=26% Similarity=0.418 Sum_probs=105.2
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC-C
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-E 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~-~ 220 (295)
.++|++.+.||+|+||.||+ .||||+++.. .......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999995 4899998653 234456788999999999 689999999987654 5
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhh-------------------hhhc-------------------------------
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTL-------------------MRSF------------------------------- 250 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~-------------------~~~~------------------------------- 250 (295)
..++||||+++|+|.+++........ ....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999864321000 0000
Q ss_pred --ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 251 --VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 251 --~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
........+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~N 209 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARN 209 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCe
Confidence 00001235789999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-20 Score=156.41 Aligned_cols=121 Identities=26% Similarity=0.457 Sum_probs=107.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|++.+.||+|+||.||+ .+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 35788889999999999995 6899988754445556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++. ....+++.+...++.|++.||.|||+++ |+|+||||+|
T Consensus 88 ~~~~~L~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 136 (267)
T cd06645 88 CGGGSLQDIYH---------------VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGAN 136 (267)
T ss_pred cCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 99999999884 2245889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-20 Score=157.15 Aligned_cols=136 Identities=29% Similarity=0.455 Sum_probs=109.4
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|++.+.||+|+||.||+ .+|+|.+... ......++.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 46788999999999999996 4788988643 344567799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhh-------cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRS-------FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~-------~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+||+++++|.+++........... .........+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999964321110000 000112245889999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=152.83 Aligned_cols=121 Identities=23% Similarity=0.406 Sum_probs=106.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|+..+.||.|+||.||. .+++|.+.. .+.....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999998874 688998754 2455667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 81 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~n 131 (256)
T cd08221 81 ANGGTLYDKIVR-------------QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLN 131 (256)
T ss_pred cCCCcHHHHHHh-------------ccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHh
Confidence 999999998842 22356889999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=155.53 Aligned_cols=117 Identities=34% Similarity=0.543 Sum_probs=101.0
Q ss_pred cccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEE
Q 041718 160 FSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLL 224 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~l 224 (295)
|++.+.||+|+||.||. .+|+|.+... .......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999963 5899988653 234567788999999999999999999987653 46889
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 v~e~~~~~~l~~~~~~----------------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~N 137 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----------------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARN 137 (283)
T ss_pred EecCCCCCCHHHHHHH----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChhe
Confidence 9999999999998831 24899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=158.66 Aligned_cols=136 Identities=30% Similarity=0.486 Sum_probs=108.7
Q ss_pred ccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 219 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 219 (295)
.++|.+.+.||+|+||.||+ .+|+|.+... .......+..|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 36788899999999999996 3889988642 344567789999999999 699999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++||||+++|+|.+++............ ........+++.+...++.|++.||.|||+++ |+||||||+|
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 9999999999999999999643211000000 00112346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.9e-20 Score=157.26 Aligned_cols=138 Identities=29% Similarity=0.449 Sum_probs=110.3
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEecc-ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 219 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 219 (295)
...++|++.+.||+|+||.||+ .+|+|.+.. .......++.+|+.++.++ +|+||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3446788899999999999995 478888764 2344556789999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..+++|||+++|+|..++............. .......+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 99999999999999999986432111000000 0123456899999999999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=166.88 Aligned_cols=120 Identities=26% Similarity=0.412 Sum_probs=107.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
.-|++++-||.|+-|.|.. .+|||++.+. .......+.+||.+|+.|.|||+++|++++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688889999999999983 7899999764 3344567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|.|+++|. ..+.+++....+++.||+.|+.|.|..+ |+||||||+|
T Consensus 92 Eyv~gGELFdylv---------------~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpEN 142 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---------------RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPEN 142 (786)
T ss_pred EecCCchhHHHHH---------------hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchh
Confidence 9999999999995 3467889999999999999999999988 9999999998
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=160.16 Aligned_cols=136 Identities=28% Similarity=0.454 Sum_probs=108.9
Q ss_pred ccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 219 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 219 (295)
..+|++.+.||+|+||.||+ .+|+|.+... .....+++.+|+.++.++ +|+||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35688999999999999994 3789987642 344567899999999999 799999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++++||+++|+|.+++............. .......++|.+++.++.|++.||.|||+++ |+||||||+|
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999986432111000000 0112345899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=154.16 Aligned_cols=122 Identities=30% Similarity=0.477 Sum_probs=105.4
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.++||+|+||.||+ .+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 346788999999999999996 4889987643 3345788999999999999999999999887 778999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 82 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~n 132 (260)
T cd05073 82 MAKGSLLDFLKS-------------DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAAN 132 (260)
T ss_pred CCCCcHHHHHHh-------------CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcce
Confidence 999999999842 23456788999999999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=156.44 Aligned_cols=114 Identities=18% Similarity=0.281 Sum_probs=98.2
Q ss_pred eeecccCccceeE------EEEEEEeccccH---HhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEEecCC
Q 041718 164 NKLGEGGFGLVYK------EIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMP 230 (295)
Q Consensus 164 ~~lg~G~~g~Vyk------~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 230 (295)
..|++|+++.||+ .||||.++.... ...+.+.+|+.+|.+++|||||++++++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 6799999999996 799999875322 225778899999999999999999999877 457899999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
+|+|.+++.. ...++|.....++.|++.||.|||+. + ++||||||+|
T Consensus 106 ~g~L~~~l~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~n 153 (283)
T PHA02988 106 RGYLREVLDK---------------EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVS 153 (283)
T ss_pred CCcHHHHHhh---------------CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhh
Confidence 9999999842 24688999999999999999999974 5 8899999987
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.4e-20 Score=161.05 Aligned_cols=137 Identities=28% Similarity=0.416 Sum_probs=106.1
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEe-C
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ-G 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~-~ 219 (295)
..++|++.+.||+|+||.||+ .||+|+++.. .....+.+..|+.++.++ +|+||+++++++.. +
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 446899999999999999995 4899988643 233456788899999999 89999999998764 4
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhh---hh-------------------------------------------cccc
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLM---RS-------------------------------------------FVDQ 253 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~-------------------------------------------~~~~ 253 (295)
...+++|||+++++|.++|......... .. -...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5788999999999999998642110000 00 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 254 ERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 254 ~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.....++|..+..++.||+.||+|||+++ |+||||||+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~N 203 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARN 203 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcce
Confidence 01236899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=154.72 Aligned_cols=121 Identities=28% Similarity=0.483 Sum_probs=103.8
Q ss_pred ccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
.++|++.++||+|+||.||+ .+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 45788899999999999995 58999886532 23467899999999999999999999875 56689999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~N 132 (260)
T cd05070 83 SKGSLLDFLKD-------------GEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSAN 132 (260)
T ss_pred CCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccce
Confidence 99999998842 22345889999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=153.12 Aligned_cols=124 Identities=25% Similarity=0.473 Sum_probs=107.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|.++. ......+.+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5788999999999999996 589998753 23344678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++... ......+++.++..++.|++.||.|||+.+ |+||||||+|
T Consensus 82 e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~n 136 (267)
T cd08224 82 ELADAGDLSRMIKHF-----------KKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPAN 136 (267)
T ss_pred ecCCCCCHHHHHHHh-----------cccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhh
Confidence 999999999988531 122345889999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.6e-20 Score=159.45 Aligned_cols=114 Identities=27% Similarity=0.368 Sum_probs=99.1
Q ss_pred eeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++++. .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999996 6899998752 233456678899998887 699999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|..++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~L~~~~~---------------~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~N 126 (318)
T cd05570 81 GDLMFHIQ---------------RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDN 126 (318)
T ss_pred CCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHH
Confidence 99988874 2246899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.3e-20 Score=161.89 Aligned_cols=115 Identities=28% Similarity=0.436 Sum_probs=100.4
Q ss_pred eeecccCcccee--------EEEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCC
Q 041718 164 NKLGEGGFGLVY--------KEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 164 ~~lg~G~~g~Vy--------k~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (295)
+.||.|.||+|| +.||||++.+. ......++++|++||.+++||.||.|.-.|++.+.++.|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 789999999999 38999999863 3445688999999999999999999999999999999999999 556
Q ss_pred HHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 234 LNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 234 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+.|.+ .....|++.....++.||+.||.|||.++ |+|+||||+|
T Consensus 649 MLEMILS-------------sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPEN 694 (888)
T KOG4236|consen 649 MLEMILS-------------SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPEN 694 (888)
T ss_pred HHHHHHH-------------hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchh
Confidence 6565532 24467888888999999999999999998 9999999998
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=163.09 Aligned_cols=118 Identities=25% Similarity=0.438 Sum_probs=101.6
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 223 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 223 (295)
+|++.+.||+|+||.||+ .||+|.+... .....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999996 6899988642 3345567889999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+||+. ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 81 lv~e~~~-~~l~~~~~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~N 133 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---------------SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGN 133 (372)
T ss_pred EEeeccc-cCHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHH
Confidence 9999996 57877663 2346889999999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=158.91 Aligned_cols=114 Identities=26% Similarity=0.319 Sum_probs=95.7
Q ss_pred eeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999996 59999986421 223345555654 56789999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 81 g~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~N 126 (323)
T cd05575 81 GELFFHLQ---------------RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPEN 126 (323)
T ss_pred CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHH
Confidence 99998884 2345888899999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=154.06 Aligned_cols=120 Identities=29% Similarity=0.518 Sum_probs=104.5
Q ss_pred cccccceeecccCccceeE------------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.+|++.+.||+|+||.||+ .+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 5678889999999999996 37888876533 3456788999999999999999999999887 78899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 86 v~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~n 139 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--------------HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARN 139 (279)
T ss_pred EEecCCCCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcce
Confidence 9999999999998842 2235899999999999999999999987 9999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=154.05 Aligned_cols=123 Identities=29% Similarity=0.531 Sum_probs=100.8
Q ss_pred ccceeecccCccceeE----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------Cee
Q 041718 161 SINNKLGEGGFGLVYK----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEK 222 (295)
Q Consensus 161 ~~~~~lg~G~~g~Vyk----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~ 222 (295)
.+.+.||+|+||.||+ .+|+|.++.. +....+.+..|+.+++.++|+||+++++.+... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4668999999999996 3899987642 345567899999999999999999999987532 356
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|||+++|+|.+++.... .......+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~N 142 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSR---------LGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARN 142 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhc---------ccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhh
Confidence 89999999999998874211 0122345899999999999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=156.07 Aligned_cols=120 Identities=28% Similarity=0.385 Sum_probs=105.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688889999999999995 6899988642 2334567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+|
T Consensus 81 e~~~~~~L~~~~~~---------------~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~n 131 (290)
T cd05580 81 EYVPGGELFSHLRK---------------SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPEN 131 (290)
T ss_pred ecCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHH
Confidence 99999999998842 246889999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-20 Score=154.41 Aligned_cols=118 Identities=31% Similarity=0.558 Sum_probs=103.7
Q ss_pred cccceeecccCccceeE--------EEEEEEeccccHHh--HHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG--LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~--~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
|++.+.||+|+||.||+ .+|+|.+....... ......|+.++.+++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56789999999999996 69999997643332 234456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++. ....+++..+..++.|+++||.|||+++ |+|+||||+|
T Consensus 81 ~~~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~N 128 (260)
T PF00069_consen 81 PGGSLQDYLQ---------------KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPEN 128 (260)
T ss_dssp TTEBHHHHHH---------------HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGG
T ss_pred cccccccccc---------------cccccccccccccccccccccccccccc---cccccccccc
Confidence 9999999984 2356799999999999999999999998 9999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=154.96 Aligned_cols=119 Identities=27% Similarity=0.508 Sum_probs=104.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
+|+..+.||+|++|.||+ .+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999996 58999886422 2245789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+++ ++|+||||+|
T Consensus 81 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~n 133 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---------------YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGAN 133 (268)
T ss_pred EEeccCCCcHHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999999999998842 235788999999999999999999998 9999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=170.49 Aligned_cols=119 Identities=29% Similarity=0.509 Sum_probs=108.1
Q ss_pred cccceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 160 FSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++.++||.|.||.|++ .||||.|+. ..++...+|+.|..||.+++||||++|.|+......++||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 45678999999999995 699999985 456778899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+||+|+.||+. ....+++.+...++.+||.||.||-+.+ .|||||.++|
T Consensus 711 yMENGsLDsFLR~--------------~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARN 761 (996)
T KOG0196|consen 711 YMENGSLDSFLRQ--------------NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARN 761 (996)
T ss_pred hhhCCcHHHHHhh--------------cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhh
Confidence 9999999999963 3356899999999999999999999988 9999999887
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=154.84 Aligned_cols=124 Identities=23% Similarity=0.435 Sum_probs=107.0
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|||.+... ......++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999996 6899987542 3344568899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++... ......+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 82 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~n 136 (267)
T cd08229 82 ELADAGDLSRMIKHF-----------KKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPAN 136 (267)
T ss_pred EecCCCCHHHHHHHh-----------hccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999988421 122356899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=159.17 Aligned_cols=114 Identities=26% Similarity=0.308 Sum_probs=97.1
Q ss_pred eeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|.++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999995 58999987521 2344566778888775 4899999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 g~L~~~i~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~N 126 (316)
T cd05620 81 GDLMFHIQ---------------DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDN 126 (316)
T ss_pred CcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 99998874 2245788999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=155.14 Aligned_cols=131 Identities=26% Similarity=0.455 Sum_probs=108.4
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|.+.+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46788899999999999994 4899988643 334556788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++........ .......++|..++.++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~n 149 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAE-----NNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchh-----hccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChhe
Confidence 999999999999999853211000 0012345889999999999999999999987 9999999997
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=154.15 Aligned_cols=115 Identities=26% Similarity=0.354 Sum_probs=101.2
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
+|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999996 6899988643 3445677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|
T Consensus 82 ~~~~l~~~~-------------------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 125 (279)
T cd06619 82 DGGSLDVYR-------------------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSN 125 (279)
T ss_pred CCCChHHhh-------------------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHH
Confidence 999986542 3577888899999999999999998 9999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=156.77 Aligned_cols=120 Identities=19% Similarity=0.327 Sum_probs=105.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|.+.+.||+|+||.||+ .||+|.+.... ......+.+|+.+++.++||||+++++.+.++++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688889999999999995 68999886532 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 e~~~g~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~N 131 (305)
T cd05609 81 EYVEGGDCATLLKN---------------IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDN 131 (305)
T ss_pred ecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHH
Confidence 99999999999842 245888999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-19 Score=156.90 Aligned_cols=123 Identities=23% Similarity=0.487 Sum_probs=108.8
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.....+|++.+.||.|+||.||+ .||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 33446799999999999999995 6899988754445567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||+++++|.+++. ...+++.++..++.|++.||+|||+++ ++|+||||+|
T Consensus 95 ~e~~~~~~L~~~~~----------------~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~N 145 (296)
T cd06655 95 MEYLAGGSLTDVVT----------------ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDN 145 (296)
T ss_pred EEecCCCcHHHHHH----------------hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999999998873 134889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=152.32 Aligned_cols=113 Identities=28% Similarity=0.512 Sum_probs=97.4
Q ss_pred eecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCC
Q 041718 165 KLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 165 ~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (295)
.||+|+||.||+ .||+|.+... .....+.+.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 389999999995 3899988653 3344577999999999999999999999875 567899999999999
Q ss_pred HHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 234 LNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 234 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+|
T Consensus 81 L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 125 (257)
T cd05115 81 LNKFLSG--------------KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARN 125 (257)
T ss_pred HHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchhe
Confidence 9998841 2346899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=167.76 Aligned_cols=130 Identities=21% Similarity=0.242 Sum_probs=108.2
Q ss_pred hhhhhccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE- 220 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~- 220 (295)
+.....++|.+.+.||+|+||.||+ .||||.+.. ........+.+|+.++..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3444567999999999999999995 699999864 34556677889999999999999999998776433
Q ss_pred -------eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 221 -------EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 221 -------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
.+++||||+++|+|.++|... ......+++.....++.|++.||.|||+++ |+||||||
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~-----------~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP 171 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSR-----------AKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKS 171 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHh-----------hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCH
Confidence 368999999999999988531 122346888999999999999999999987 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 172 ~N 173 (496)
T PTZ00283 172 AN 173 (496)
T ss_pred HH
Confidence 87
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=156.66 Aligned_cols=123 Identities=24% Similarity=0.402 Sum_probs=105.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.++.+++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 3678889999999999996 6899987642 344567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ......+++.....++.|++.||.|||+. + |+||||||+|
T Consensus 81 ~~~~~l~~~~~~------------~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~n 133 (286)
T cd06622 81 MDAGSLDKLYAG------------GVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTN 133 (286)
T ss_pred cCCCCHHHHHHh------------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHH
Confidence 999999988842 11134689999999999999999999964 5 9999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=154.37 Aligned_cols=120 Identities=28% Similarity=0.486 Sum_probs=101.3
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
++|++.+.||+|+||.||+ .+++|.+... ......++..|+.+++++.||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 5788889999999999996 2677777543 2334567888999999999999999999875 456789
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||+++|+|.+++.. ....+++.....++.||+.||+|||+++ ++||||||+|
T Consensus 86 i~e~~~~gsL~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~n 139 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--------------HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARN 139 (279)
T ss_pred EEEeCCCCcHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcce
Confidence 9999999999999842 2346899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=153.43 Aligned_cols=121 Identities=28% Similarity=0.482 Sum_probs=104.2
Q ss_pred ccccccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++|++.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788889999999999996 279998864 344556788999999999999999999999875 4578
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++||+++|+|.+++.. ....+++...+.++.|++.||+|||+++ |+||||||+|
T Consensus 85 l~~~~~~~g~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~N 139 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--------------NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARN 139 (279)
T ss_pred EEEEcCCCCCHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999998842 2346899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=164.86 Aligned_cols=119 Identities=24% Similarity=0.418 Sum_probs=106.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-C-----CcccceeeeEEeCCeeEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-H-----RNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h-----~niv~l~~~~~~~~~~~l 224 (295)
+|.+.+.||+|+||+|.| .||||+++. ......+-..|+.+|..|+ | -|+|+++++|...++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999997 699999976 4556777788999999997 4 489999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|.+ ..+|.++|.. ++...++......|+.||+.||.+||..+ |||+||||||
T Consensus 266 VfELL-~~NLYellK~-------------n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPEN 319 (586)
T KOG0667|consen 266 VFELL-STNLYELLKN-------------NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPEN 319 (586)
T ss_pred eehhh-hhhHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhh
Confidence 99999 5699999953 34456889999999999999999999988 9999999998
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-19 Score=151.03 Aligned_cols=122 Identities=23% Similarity=0.440 Sum_probs=108.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|.+.+.||.|+||.||+ .+|+|.+........+.+.+|+.++++++||||+++++.+...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 36788899999999999996 5899988765555678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ....+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 82 ~~~~~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~n 131 (262)
T cd06613 82 CGGGSLQDIYQV--------------TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGAN 131 (262)
T ss_pred CCCCcHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhh
Confidence 999999998742 2245888999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=161.01 Aligned_cols=116 Identities=22% Similarity=0.378 Sum_probs=100.0
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
...+|.+.+.||+|+||.||+ .||+|..... ....|+.++++++|+||+++++++...+..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999996 5888875432 23568999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+. ++|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 138 ~~~-~~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 187 (357)
T PHA03209 138 HYS-SDLYTYLTK--------------RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTEN 187 (357)
T ss_pred ccC-CcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 994 688887742 2356899999999999999999999998 9999999987
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.8e-20 Score=159.64 Aligned_cols=120 Identities=34% Similarity=0.590 Sum_probs=103.7
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhc--CCCCcccceeeeEEeCC----eeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~~l 224 (295)
....++.++||+|.||.||| .||||+++ .+..+.|.+|-.|.+. ++|+||++++++-.... ..+|
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34566778999999999997 79999986 4566778888777665 68999999999877665 8899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC------CCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD------SKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~------~~~~iiHrDlkp~N 295 (295)
|+||.+.|+|.+||. ...++|....+|+.-+++||+|||+. .+++|+|||||..|
T Consensus 286 Vt~fh~kGsL~dyL~----------------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkN 346 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----------------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKN 346 (534)
T ss_pred EeeeccCCcHHHHHH----------------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccc
Confidence 999999999999994 35799999999999999999999985 36789999999988
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=157.98 Aligned_cols=114 Identities=25% Similarity=0.298 Sum_probs=94.2
Q ss_pred eeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|++.... ......+..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999996 58999986421 222334455544 56889999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++.. ...+.+.....++.||+.||.|||+++ |+||||||+|
T Consensus 81 ~~L~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~N 126 (325)
T cd05602 81 GELFYHLQR---------------ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPEN 126 (325)
T ss_pred CcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHH
Confidence 999988842 234677888889999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=156.79 Aligned_cols=122 Identities=25% Similarity=0.304 Sum_probs=106.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .+|+|.+.... ....+.+..|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688889999999999995 68999886532 235667899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++. ......+++.....++.|++.||+|||+.+ ++|+||||+|
T Consensus 81 e~~~~~~L~~~~~-------------~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 133 (316)
T cd05574 81 DYCPGGELFRLLQ-------------RQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPEN 133 (316)
T ss_pred EecCCCCHHHHHH-------------hCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHH
Confidence 9999999999884 223356899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=151.73 Aligned_cols=121 Identities=21% Similarity=0.404 Sum_probs=106.2
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|+..+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999995 6899988642 344567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+|+||||+|
T Consensus 81 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~n 131 (256)
T cd08220 81 APGGTLAEYIQK-------------RCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQN 131 (256)
T ss_pred CCCCCHHHHHHH-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999999842 22345889999999999999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=151.76 Aligned_cols=121 Identities=25% Similarity=0.425 Sum_probs=103.7
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEE-eCCeeEEEEecC
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFM 229 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 229 (295)
.++|++.+.||+|+||.||+ .+|+|.++.. ...+.+.+|+.++++++|+|++++++++. +.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35788889999999999996 5899988643 23567899999999999999999999764 556789999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. .....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 83 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 132 (256)
T cd05082 83 AKGSLVDYLRS-------------RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARN 132 (256)
T ss_pred CCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeccccchhe
Confidence 99999998842 23345889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=153.55 Aligned_cols=121 Identities=24% Similarity=0.437 Sum_probs=104.0
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.++|.+.+.||+|+||.||+ .+|+|...... ....+.+.+|+.++++++|+||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688889999999999996 37888876533 4566789999999999999999999998865 56789
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~n 137 (270)
T cd05056 84 VMELAPLGELRSYLQV--------------NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARN 137 (270)
T ss_pred EEEcCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChhe
Confidence 9999999999999842 2235899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=155.55 Aligned_cols=131 Identities=27% Similarity=0.432 Sum_probs=108.0
Q ss_pred hhhhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEE---
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI--- 217 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~--- 217 (295)
+..+..+.++|++.+.||+|+||.||+ .+|+|.+... .....++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 345566788999999999999999996 5899987642 22345688899999999 6999999999874
Q ss_pred --eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 --QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++..++||||+++++|.+++... ......+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~n 154 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGF-----------LKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNN 154 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHh-----------hccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHh
Confidence 346789999999999999987421 112346788999999999999999999987 9999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=154.91 Aligned_cols=124 Identities=29% Similarity=0.453 Sum_probs=105.1
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC------
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~------ 219 (295)
.+.+.|++.+.||+|+||.||+ .+|+|.+... ......+.+|+.++.++ +|+||+++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4567788889999999999996 5899988643 23456788999999998 699999999998753
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++||||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~-------------~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~n 141 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN-------------TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQN 141 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHH
Confidence 468999999999999998842 22346889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=151.53 Aligned_cols=119 Identities=28% Similarity=0.512 Sum_probs=102.8
Q ss_pred cccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
++|++.+.||+|+||.||+ .+|+|.++.. ...+.+.+|+.++++++|||++++++++.. +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence 5788899999999999996 6899988643 234678999999999999999999999865 457999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++.. .....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 83 ~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~n 130 (254)
T cd05083 83 GNLVNFLRT-------------RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARN 130 (254)
T ss_pred CCHHHHHHh-------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcce
Confidence 999999842 22345889999999999999999999987 9999999987
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=153.66 Aligned_cols=121 Identities=31% Similarity=0.545 Sum_probs=105.1
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCee
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 222 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 222 (295)
+.|++.+.||+|+||.||+ .+|+|.+..... ...+.+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4677889999999999995 489999875433 256789999999999999999999999877 5678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+|+||||+|
T Consensus 84 ~lv~e~~~~~~l~~~l~~--------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~n 139 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR--------------HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARN 139 (284)
T ss_pred EEEEecCCCCCHHHHHHh--------------CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHh
Confidence 999999999999999842 1235899999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=155.26 Aligned_cols=135 Identities=28% Similarity=0.442 Sum_probs=107.6
Q ss_pred cccccceeecccCccceeE-------------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.+|.+.+.||.|+||.||+ .||+|.++... ....+.+..|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4577789999999999996 38999987532 334567899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++||+++++|.+++............. .......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~N 154 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRN 154 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhh
Confidence 9999999999999985321111100000 1112345889999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=155.09 Aligned_cols=121 Identities=26% Similarity=0.458 Sum_probs=97.0
Q ss_pred cccccceeecccCccceeE---------EEEEEEeccc--cHHhHHHHHHHHHHHhcC---CCCcccceeeeEE-----e
Q 041718 158 DNFSINNKLGEGGFGLVYK---------EIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCI-----Q 218 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~-----~ 218 (295)
++|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999996 4899988642 222334566777777665 6999999999885 3
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
....++||||++ ++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~N 140 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK-------------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 140 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHH
Confidence 456899999996 689888742 22345889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-20 Score=143.78 Aligned_cols=119 Identities=28% Similarity=0.448 Sum_probs=102.1
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|.-.++||+|.||+||| .||+|+++- .++.......+||.+|+.|+|+|||++++....+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 455668999999999997 699998763 3444566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+ ..+|..|.. .....++......++.|+++||.|.|+++ ++||||||+|
T Consensus 83 c-dqdlkkyfd--------------slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqn 131 (292)
T KOG0662|consen 83 C-DQDLKKYFD--------------SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQN 131 (292)
T ss_pred h-hHHHHHHHH--------------hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcce
Confidence 9 457777763 23456888889999999999999999998 9999999998
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=151.78 Aligned_cols=120 Identities=31% Similarity=0.475 Sum_probs=102.6
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
++|.+..+||+|++|.||+ .+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999996 5899987642 234567889999999999999999999875 567899999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. .....+++..+..++.|++.||+|||+.+ |+|+||||+|
T Consensus 84 ~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~N 132 (260)
T cd05069 84 KGSLLDFLKE-------------GDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAAN 132 (260)
T ss_pred CCCHHHHHhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcce
Confidence 9999999842 22345889999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=164.41 Aligned_cols=121 Identities=23% Similarity=0.426 Sum_probs=97.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-------- 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-------- 219 (295)
...+|++.+.||+|+||.||+ .||||++.... ....+|+.+|+.++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999996 68999885422 2345799999999999999999987432
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+++||||++ ++|.+++... ......+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~-----------~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~N 200 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHY-----------ARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQN 200 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHH-----------hhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHH
Confidence 24679999997 4777766421 123356889999999999999999999998 9999999998
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=155.97 Aligned_cols=121 Identities=27% Similarity=0.440 Sum_probs=103.6
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|.+.+.||.|+||.||+ .||+|.+... .......+.+|+.++++++|+||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 35788999999999999996 5899988642 22334567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.. ....+++.....++.|++.||+|||+++ |+|+||||+|
T Consensus 85 ~~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~N 134 (301)
T cd07873 85 YLD-KDLKQYLDD--------------CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQN 134 (301)
T ss_pred ccc-cCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHH
Confidence 997 588887742 2345788999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.9e-19 Score=164.31 Aligned_cols=115 Identities=24% Similarity=0.357 Sum_probs=99.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
...|.+.+.||+|+||.||+ .||||... ...+.+|+.+|++|+|+|||++++++..++..+||||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45799999999999999997 58888532 23457899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+. ++|.+++.. ....++|..++.|+.|++.||.|||+++ ||||||||+|
T Consensus 242 ~~-~~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~N 290 (461)
T PHA03211 242 YR-SDLYTYLGA--------------RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTEN 290 (461)
T ss_pred cC-CCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHH
Confidence 94 788887731 2236899999999999999999999998 9999999987
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.4e-19 Score=149.55 Aligned_cols=115 Identities=30% Similarity=0.509 Sum_probs=100.4
Q ss_pred eeecccCccceeE-------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHH
Q 041718 164 NKLGEGGFGLVYK-------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (295)
+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999996 5899988653 2344567899999999999999999999999999999999999999999
Q ss_pred HHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 236 SFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 236 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++.. ....+++.....++.|++.||.|||+++ ++||||||+|
T Consensus 81 ~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~n 123 (250)
T cd05085 81 SFLRK--------------KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARN 123 (250)
T ss_pred HHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChhe
Confidence 98842 2235789999999999999999999988 9999999987
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-19 Score=155.49 Aligned_cols=122 Identities=25% Similarity=0.491 Sum_probs=107.7
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
...++|.+.+.||+|+||.||+ .+|+|.+........+.+.+|+.++++++||||+++++.+...+..++|+
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 3346889999999999999996 58999886544455678899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+|
T Consensus 96 e~~~~~~L~~~~~~----------------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~N 145 (293)
T cd06647 96 EYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDN 145 (293)
T ss_pred ecCCCCcHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHH
Confidence 99999999998831 34788899999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=179.89 Aligned_cols=117 Identities=27% Similarity=0.491 Sum_probs=100.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
...|...+.||+|+||.||+ .||||+++..... ...|+.++++++|||||++++++.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 34567778999999999996 6899988653221 23468899999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++. .++|..+..|+.|+++||+|||+...++|+||||||+|
T Consensus 765 ~~~g~L~~~l~------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~N 813 (968)
T PLN00113 765 IEGKNLSEVLR------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813 (968)
T ss_pred CCCCcHHHHHh------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHh
Confidence 99999999883 37899999999999999999997655669999999987
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=151.17 Aligned_cols=120 Identities=32% Similarity=0.521 Sum_probs=104.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-----cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
++|.+.+.||+|++|.||+ .+|+|.+... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999996 5899987532 12234678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 82 v~e~~~~~~l~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~n 134 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---------------YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGAN 134 (263)
T ss_pred EEEECCCCcHHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999999999998842 235788888999999999999999998 9999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.2e-19 Score=153.32 Aligned_cols=120 Identities=27% Similarity=0.411 Sum_probs=103.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .+|+|++... .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3688889999999999996 5899988642 22334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~n 130 (286)
T cd07847 81 YCDHTVLNELEK---------------NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPEN 130 (286)
T ss_pred ccCccHHHHHHh---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhh
Confidence 999988877653 2245899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-19 Score=151.42 Aligned_cols=129 Identities=33% Similarity=0.578 Sum_probs=102.5
Q ss_pred eeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|.++.. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 3589999999996 3688887642 345567899999999999 899999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++..+......... ........+++.++..++.|++.||+|||+++ ++||||||+|
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~n 142 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 142 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccccce
Confidence 9999998643211100000 00112345889999999999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.1e-20 Score=160.07 Aligned_cols=121 Identities=26% Similarity=0.367 Sum_probs=106.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.-|.+.+-||+|-|..|-. .||||++.+ .+......+.+|++.|+.++|||||+||.+..+...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3466778899999998763 799999976 344556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+-.+|+|++||.++ ...+.+....+++.||+.|+.|.|... +|||||||+|
T Consensus 98 LGD~GDl~DyImKH--------------e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPEN 148 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKH--------------EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPEN 148 (864)
T ss_pred ecCCchHHHHHHhh--------------hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcce
Confidence 99999999999643 245888999999999999999999887 9999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.7e-20 Score=164.72 Aligned_cols=123 Identities=28% Similarity=0.421 Sum_probs=108.0
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCe
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 221 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~ 221 (295)
....++|.+.++||+|+||+|+. .+|||.+++. .....+..+.|..|+.... ||.|++|+..|.+.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 34567899999999999999995 6899999873 4567788899998888775 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++||||+.||++..+. ....+++..+..++..|+.||.|||+++ ||+||||.+|
T Consensus 444 l~fvmey~~Ggdm~~~~----------------~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdN 498 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI----------------HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDN 498 (694)
T ss_pred EEEEEEecCCCcEEEEE----------------ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhh
Confidence 99999999999954333 3467999999999999999999999998 9999999988
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=150.08 Aligned_cols=119 Identities=31% Similarity=0.485 Sum_probs=104.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc-----HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+|+..+.||+|+||.||+ .+++|.+.... ....+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 366778999999999996 58999875422 33567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+|+||+|+|
T Consensus 81 ~e~~~~~~L~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~n 132 (258)
T cd06632 81 LELVPGGSLAKLLKK---------------YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGAN 132 (258)
T ss_pred EEecCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999998842 235788999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=149.80 Aligned_cols=121 Identities=21% Similarity=0.368 Sum_probs=105.5
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|+||.||+ .+|+|.+.. .......++.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999995 689998864 2344567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++.+.+.++.|++.||.|||+++ ++|+||+|+|
T Consensus 81 ~~~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~n 131 (256)
T cd08218 81 CEGGDLYKKINA-------------QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQN 131 (256)
T ss_pred CCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 999999988842 22335788999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=152.99 Aligned_cols=121 Identities=28% Similarity=0.489 Sum_probs=103.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|++|.||+ .+|+|.+... .......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999997 5899988642 223356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++ ++|.+++.. ......+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~-~~l~~~~~~------------~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~n 131 (285)
T cd07861 81 LS-MDLKKYLDS------------LPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQN 131 (285)
T ss_pred CC-CCHHHHHhc------------CCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHH
Confidence 97 688887731 122356899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=153.00 Aligned_cols=133 Identities=31% Similarity=0.443 Sum_probs=110.2
Q ss_pred hhhhhhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEe
Q 041718 148 FELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 218 (295)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 218 (295)
+...++..+.++|.+.+.||+|+||.||+ .+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44556667789999999999999999996 58899886432 2345678899999998 89999999999875
Q ss_pred C-----CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 219 G-----EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 219 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
. ...++||||+++++|.+++... ......+++...+.++.|++.||+|||+.+ |+||||||
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~-----------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp 156 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGL-----------LICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKG 156 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHh-----------hhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCH
Confidence 4 3589999999999999988421 112356889999999999999999999987 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 157 ~n 158 (291)
T cd06639 157 NN 158 (291)
T ss_pred HH
Confidence 87
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=150.30 Aligned_cols=115 Identities=30% Similarity=0.453 Sum_probs=101.2
Q ss_pred eeecccCccceeE-----------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK-----------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-----------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
++||+|++|.||+ .+|+|.+..... ...+.+.+|+.++++++|+||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 4689999999996 379999876544 567789999999999999999999999988 899999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++.. .....++|.....++.|++.||+|||+++ ++|+||||+|
T Consensus 80 ~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~n 127 (257)
T cd05040 80 GSLLDRLRK-------------DALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARN 127 (257)
T ss_pred CcHHHHHHh-------------cccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCccc
Confidence 999998852 11146899999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.4e-19 Score=150.39 Aligned_cols=119 Identities=32% Similarity=0.541 Sum_probs=103.4
Q ss_pred ccccceeecccCccceeE-------EEEEEEeccc------cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 159 NFSINNKLGEGGFGLVYK-------EIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467789999999999996 5899987532 123346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+|
T Consensus 81 ~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 132 (265)
T cd06631 81 MEFVPGGSISSILNR---------------FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNN 132 (265)
T ss_pred EecCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHh
Confidence 999999999998842 235788899999999999999999988 9999999987
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-19 Score=155.99 Aligned_cols=118 Identities=26% Similarity=0.467 Sum_probs=103.8
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.|.....||+|+||.||+ .+|+|.+........+.+.+|+.++++++|+||+++++.+..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344457799999999996 689999876555667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++. ...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 103 ~~~L~~~~~----------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~N 148 (292)
T cd06658 103 GGALTDIVT----------------HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDS 148 (292)
T ss_pred CCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHH
Confidence 999998773 134788999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=151.71 Aligned_cols=119 Identities=29% Similarity=0.512 Sum_probs=102.6
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccH---------HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISE---------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
+|.+...||+|+||.||+ .+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999996 589998754211 223678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. ...+++.....++.|++.||+|||+++ ++||||||+|
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~n 136 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---------------YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGAN 136 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---------------ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHH
Confidence 9999999999999998842 245788889999999999999999988 9999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=153.61 Aligned_cols=119 Identities=31% Similarity=0.482 Sum_probs=103.1
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc-----HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+|.+.+.||+|+||.||+ .+|+|.+.... ......+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 377789999999999996 58999986532 22345677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+ +++|.+++.. ....+++..+..++.||++||.|||+++ |+|+||||+|
T Consensus 81 ~e~~-~~~L~~~i~~--------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~n 132 (298)
T cd07841 81 FEFM-ETDLEKVIKD--------------KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNN 132 (298)
T ss_pred Eccc-CCCHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhh
Confidence 9999 8999998842 1136899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.1e-19 Score=150.56 Aligned_cols=120 Identities=30% Similarity=0.494 Sum_probs=101.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-----cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--Cee
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 222 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 222 (295)
.+|++.+.||+|+||.||+ .||+|.+... .....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999995 5899987521 123456888999999999999999999988764 467
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++. ....+++.....++.|++.||+|||+.+ |+|+||||+|
T Consensus 82 ~~v~e~~~~~~L~~~l~---------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~n 136 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---------------SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGAN 136 (265)
T ss_pred EEEEEecCCCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 89999999999999884 1234788888999999999999999998 9999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=152.16 Aligned_cols=119 Identities=26% Similarity=0.400 Sum_probs=105.5
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
+|++.+.||.|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 478889999999999996 6899988642 23456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ...+++.....++.|+++||.|||+++ ++|+||||+|
T Consensus 81 ~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~n 130 (258)
T cd05578 81 LLLGGDLRYHLSQ---------------KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDN 130 (258)
T ss_pred CCCCCCHHHHHHh---------------cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 9999999998842 146888999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.6e-19 Score=151.12 Aligned_cols=130 Identities=29% Similarity=0.506 Sum_probs=106.6
Q ss_pred hccccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~ 221 (295)
..++|++.+.||+|+||.||+ .|++|++... .....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457889999999999999995 4678877643 34556778999999999999999999998766 577
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++++||+++++|.+++...... .......+++..+..++.|++.||+|||+++ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~-------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~n 147 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLG-------EANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARN 147 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhcccc-------ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhh
Confidence 89999999999999998532100 0011256899999999999999999999987 9999999987
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=156.70 Aligned_cols=112 Identities=23% Similarity=0.280 Sum_probs=94.1
Q ss_pred ecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcC---CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
||+|+||.||+ .+|+|++.... ......+..|..++..+ +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999996 69999986421 22334455677776665 699999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|..++. ....+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 81 g~L~~~l~---------------~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~N 126 (330)
T cd05586 81 GELFWHLQ---------------KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPEN 126 (330)
T ss_pred ChHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 99998874 2345889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-19 Score=149.36 Aligned_cols=112 Identities=30% Similarity=0.480 Sum_probs=97.0
Q ss_pred eecccCccceeE----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 165 KLGEGGFGLVYK----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 165 ~lg~G~~g~Vyk----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
+||+|+||.||+ .+|+|+++.. .....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999995 5899988642 3445678999999999999999999999875 56778999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|.+++. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~L~~~l~---------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~n 125 (257)
T cd05116 81 PLNKFLQ---------------KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARN 125 (257)
T ss_pred cHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecccchhh
Confidence 9999884 2235889999999999999999999998 9999999987
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.7e-19 Score=150.55 Aligned_cols=118 Identities=27% Similarity=0.464 Sum_probs=103.9
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
-|++.+.||.|+||.||+ .+|+|.+... .......+.+|+.++.+++|+||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778999999999996 5899987642 2345567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++. ...+++.....++.|++.||.|||+++ ++|+||||+|
T Consensus 85 ~~~~l~~~i~----------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~N 131 (277)
T cd06641 85 GGGSALDLLE----------------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAAN 131 (277)
T ss_pred CCCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHh
Confidence 9999998873 135789999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=153.55 Aligned_cols=121 Identities=23% Similarity=0.305 Sum_probs=105.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.+++.++||||+++++.+...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35788889999999999996 5888887542 34456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. ....+++.....++.+++.||.|||+ .+ |+||||||+|
T Consensus 84 ~~~~~~L~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~n 134 (284)
T cd06620 84 FMDCGSLDRIYK---------------KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSN 134 (284)
T ss_pred cCCCCCHHHHHH---------------hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHH
Confidence 999999998874 12458899999999999999999997 35 9999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-19 Score=151.03 Aligned_cols=119 Identities=29% Similarity=0.444 Sum_probs=102.4
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc----------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS----------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 220 (295)
+|.+.+.||.|+||.||+ .+|+|.++... ....+.+..|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 466779999999999996 58999875311 112356889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~n 138 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---------------YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADN 138 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---------------ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhh
Confidence 99999999999999998842 146888999999999999999999987 9999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.4e-19 Score=150.68 Aligned_cols=121 Identities=25% Similarity=0.453 Sum_probs=105.1
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|.+.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999996 5799988642 223456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ |+|+||||+|
T Consensus 81 ~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~n 131 (257)
T cd08225 81 CDGGDLMKRINR-------------QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQN 131 (257)
T ss_pred CCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHH
Confidence 999999998842 22345799999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=153.20 Aligned_cols=118 Identities=26% Similarity=0.475 Sum_probs=103.8
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
.|+..+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++|+||+++++.+...+..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466678899999999996 5899988643 2345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||+|+|
T Consensus 85 ~~~~L~~~~~----------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~n 131 (277)
T cd06642 85 GGGSALDLLK----------------PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAAN 131 (277)
T ss_pred CCCcHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChhe
Confidence 9999998873 135788999999999999999999988 9999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.5e-19 Score=149.03 Aligned_cols=120 Identities=27% Similarity=0.526 Sum_probs=104.4
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.+|++.+.||+|+||.||+ .+|+|.+... .....++.+|+.++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999996 5789987642 2234578999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ....+++.....++.|++.||+|||+.+ ++|+||||+|
T Consensus 83 ~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~n 130 (256)
T cd05112 83 HGCLSDYLRA--------------QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARN 130 (256)
T ss_pred CCcHHHHHHh--------------CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccce
Confidence 9999998842 2235789999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.9e-20 Score=153.89 Aligned_cols=121 Identities=26% Similarity=0.459 Sum_probs=103.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-----CC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-----GE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-----~~ 220 (295)
....|...+.||.|+||.|.+ .||||++.. ...-..++..+|+.+|+.++|+||+.+.+.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 334566678999999999985 699999873 355667888999999999999999999999875 45
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+|+|+|+| ..+|.+.|. ....|+......+++|+++||.|+|+.+ |+||||||+|
T Consensus 100 DvYiV~elM-etDL~~iik---------------~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsN 155 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIK---------------SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSN 155 (359)
T ss_pred eeEEehhHH-hhHHHHHHH---------------cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhh
Confidence 689999999 678888884 2344888999999999999999999998 9999999998
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.3e-20 Score=146.82 Aligned_cols=130 Identities=25% Similarity=0.352 Sum_probs=112.2
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----C
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 220 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 220 (295)
....++|.+.++||+|||+.||. .+|+|++.-...+..+..++|+..-++++||||++++++...+ .
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 34557899999999999999994 6899998776677888999999999999999999999986543 3
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..||+++|...|||.+.+.. ...+...+++.+.+.|+.+|++||++||+.. ++.+||||||.|
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~-----------~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~N 159 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIER-----------LKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPAN 159 (302)
T ss_pred eEEEEeehhccccHHHHHHH-----------HhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcce
Confidence 58999999999999998853 2234557999999999999999999999985 579999999998
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.9e-19 Score=151.66 Aligned_cols=119 Identities=28% Similarity=0.453 Sum_probs=104.9
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|+||.||+ .+|+|++.... ......+.+|+.++++++|+||+++++++..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999996 58999886532 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+ +++|.+++.. ....+++..+..++.|++.||+|||+++ |+|+||||+|
T Consensus 81 ~-~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~n 129 (286)
T cd07832 81 M-PSDLSEVLRD--------------EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPAN 129 (286)
T ss_pred c-CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHH
Confidence 9 9999998842 2256899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=156.95 Aligned_cols=120 Identities=31% Similarity=0.509 Sum_probs=101.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 219 (295)
..++|++.+.||.|+||.||+ .||||.+... .....+.+.+|+.+|++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999996 5899998652 223456678899999999999999999987543
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++++|++ +++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~N 148 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----------------CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSN 148 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhh
Confidence 4568999988 788887762 235889999999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-19 Score=162.58 Aligned_cols=118 Identities=28% Similarity=0.471 Sum_probs=98.6
Q ss_pred cceeecccCccceeE--------EEEEEE--ecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe--eEEEEe
Q 041718 162 INNKLGEGGFGLVYK--------EIAVKR--LSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--KLLIYE 227 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk--------~vavK~--l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 227 (295)
....||+|+|-+||| +||=-. +.. .++...++|..|+.+|+.|+|+|||+++.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 447899999999998 232111 111 245567899999999999999999999999987766 778999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++..|+|..|+.+ .+.++......|+.||++||.|||++. |||||||||-+|
T Consensus 124 L~TSGtLr~Y~kk---------------~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDN 175 (632)
T KOG0584|consen 124 LFTSGTLREYRKK---------------HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDN 175 (632)
T ss_pred cccCCcHHHHHHH---------------hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccce
Confidence 9999999999963 355778889999999999999999995 789999999987
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=155.30 Aligned_cols=116 Identities=31% Similarity=0.402 Sum_probs=99.1
Q ss_pred eeeccc--CccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEG--GFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G--~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
..||.| +||.||+ .||+|.+.. ......+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 8899995 689998864 2334557889999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++.. .....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 84 ~~l~~~l~~-------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~N 131 (328)
T cd08226 84 GSANSLLKT-------------YFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASH 131 (328)
T ss_pred CCHHHHHHh-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999998852 12235888999999999999999999988 9999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=147.48 Aligned_cols=121 Identities=26% Similarity=0.374 Sum_probs=103.5
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEEe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYE 227 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 227 (295)
+|++.+.||.|++|.||+ .+|+|.+... .....+.+.+|+.++++++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478889999999999995 5899988642 33456678999999999999999999998764 446789999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. .....+++.++..++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~~~~~l~~~l~~-------------~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~n 132 (257)
T cd08223 81 FCEGGDLYHKLKE-------------QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQN 132 (257)
T ss_pred ccCCCcHHHHHHH-------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchh
Confidence 9999999998842 23346899999999999999999999998 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8e-19 Score=149.01 Aligned_cols=119 Identities=31% Similarity=0.513 Sum_probs=105.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccH--HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|+||.||+ .+|+|.+..... ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999996 589998865333 4678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+|+||+|+|
T Consensus 81 ~~~~~L~~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~n 129 (264)
T cd06626 81 CSGGTLEELLE---------------HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPAN 129 (264)
T ss_pred CCCCcHHHHHh---------------hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999999884 2235788899999999999999999998 9999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=159.79 Aligned_cols=115 Identities=23% Similarity=0.325 Sum_probs=99.8
Q ss_pred ccccccceeecccCccceeE----------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..+|.+.+.||+|+||.||+ .||+|.+... ..+.+|+.+|++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 45799999999999999995 4788877542 23568999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++. ++|.+++. ....+++..++.|+.|++.||.|||+++ |+||||||+|
T Consensus 166 e~~~-~~l~~~l~---------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~N 215 (392)
T PHA03207 166 PKYK-CDLFTYVD---------------RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTEN 215 (392)
T ss_pred hhcC-CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 9995 68887773 2346899999999999999999999998 9999999987
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.9e-19 Score=152.54 Aligned_cols=120 Identities=30% Similarity=0.561 Sum_probs=101.4
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.+|+..+.||+|+||.||+ .+|+|.+... ......++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 5678889999999999996 2688887653 233445789999999999999999999998654 5679
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 v~e~~~~g~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~N 139 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--------------HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARN 139 (303)
T ss_pred eehhcCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccce
Confidence 9999999999998842 2235788999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.4e-19 Score=152.07 Aligned_cols=122 Identities=30% Similarity=0.407 Sum_probs=102.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++.+|.+.+.||+|+||.||+ .+|+|++.... ......+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999996 68999886432 233346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+. ++|.+++.. ....+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 83 e~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~N 133 (291)
T cd07870 83 EYMH-TDLAQYMIQ--------------HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQN 133 (291)
T ss_pred eccc-CCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHH
Confidence 9995 677776631 1234778888899999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=157.26 Aligned_cols=119 Identities=29% Similarity=0.466 Sum_probs=99.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 220 (295)
..++|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 347899999999999999996 5899998642 3345667889999999999999999999986543
Q ss_pred -eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 -EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++ +|.+.+. ..+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~N 153 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 153 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----------------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 57999999965 5655542 23778888899999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=147.36 Aligned_cols=120 Identities=39% Similarity=0.659 Sum_probs=104.0
Q ss_pred cccceeecccCccceeE------------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 160 FSINNKLGEGGFGLVYK------------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
|++.+.||.|+||.||+ .+|+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 35668999999999995 4899998654332 5678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 81 e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~n 133 (258)
T smart00219 81 EYMEGGDLLDYLRK-------------NRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARN 133 (258)
T ss_pred eccCCCCHHHHHHh-------------hhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccce
Confidence 99999999999842 11122899999999999999999999998 9999999997
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.1e-19 Score=150.73 Aligned_cols=121 Identities=28% Similarity=0.468 Sum_probs=103.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
+|++.+.||.|++|.||+ .+|+|.++... ......+.+|+.++++++|+||+++++++.+.+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478889999999999996 58999886532 233466788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++ +|.+++.. ......+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 81 ~~-~l~~~~~~------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~n 130 (284)
T cd07836 81 DK-DLKKYMDT------------HGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQN 130 (284)
T ss_pred Cc-cHHHHHHh------------cCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHH
Confidence 84 88887742 112345899999999999999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=149.52 Aligned_cols=119 Identities=25% Similarity=0.473 Sum_probs=104.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..|+..+.||.|+||.||+ .+|+|.+... .......+.+|+.+++++.|+||+++++.+.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3577778999999999996 5899988643 345567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+|
T Consensus 84 ~~~~~L~~~i~----------------~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~N 131 (277)
T cd06640 84 LGGGSALDLLR----------------AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAAN 131 (277)
T ss_pred CCCCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhh
Confidence 99999999873 134788888999999999999999987 9999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-20 Score=164.84 Aligned_cols=121 Identities=31% Similarity=0.492 Sum_probs=105.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..-|+.++.||.|+||.||- .||||.++- .+...++++..||..|.+|+|||+|.+.|+|......|||
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 34577778999999999993 799999863 3455678999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||| -||..++|- --.+.+.+..+..|..+++.||+|||+++ .||||||+.|
T Consensus 105 MEYC-lGSAsDlle--------------VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGN 156 (948)
T KOG0577|consen 105 MEYC-LGSASDLLE--------------VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGN 156 (948)
T ss_pred HHHH-hccHHHHHH--------------HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccc
Confidence 9999 567777773 12356888899999999999999999998 9999999987
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=148.12 Aligned_cols=120 Identities=30% Similarity=0.488 Sum_probs=101.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-----cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCee
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 222 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 222 (295)
.+|+..+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688889999999999996 5899987532 22345678999999999999999999998875 3678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|
T Consensus 82 ~l~~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~n 136 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---------------YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGAN 136 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 899999999999998842 234788889999999999999999987 9999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-18 Score=147.09 Aligned_cols=123 Identities=28% Similarity=0.465 Sum_probs=107.0
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.+.||.|+||.||+ .+|+|++... .......+.+|+.+++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788999999999999996 5889988642 233567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++... .....+++.....++.|++.||+|||+.+ |+||||||+|
T Consensus 81 ~~~~~l~~~~~~~------------~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~n 132 (267)
T cd06610 81 LSGGSLLDIMKSS------------YPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGN 132 (267)
T ss_pred cCCCcHHHHHHHh------------cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHh
Confidence 9999999998521 11246899999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-19 Score=147.92 Aligned_cols=119 Identities=30% Similarity=0.496 Sum_probs=106.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
++|++.+.||+|+||.||+ .+++|.++... ..+++.+|+.++++++|+||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 6788899999999999996 58899886532 2678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. ....+++.....++.|++.||.|||+.+ |+|+||+|+|
T Consensus 81 ~~~~L~~~l~~--------------~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~n 129 (256)
T cd06612 81 GAGSVSDIMKI--------------TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGN 129 (256)
T ss_pred CCCcHHHHHHh--------------CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcce
Confidence 99999998842 2356899999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=151.84 Aligned_cols=121 Identities=27% Similarity=0.420 Sum_probs=102.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|++|.||+ .+|+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36788899999999999996 58999886422 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.. ....+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 84 ~~~-~~L~~~~~~--------------~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~n 133 (291)
T cd07844 84 YLD-TDLKQYMDD--------------CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQN 133 (291)
T ss_pred cCC-CCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHH
Confidence 997 489888742 1235788999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=152.98 Aligned_cols=120 Identities=28% Similarity=0.450 Sum_probs=103.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.++||+|+||.||+ .+|+|++... .....+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688889999999999996 5899987642 22345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|..+.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+|
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~n 130 (286)
T cd07846 81 FVDHTVLDDLEK---------------YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPEN 130 (286)
T ss_pred cCCccHHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 999988887652 2234899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-18 Score=147.62 Aligned_cols=115 Identities=29% Similarity=0.509 Sum_probs=96.7
Q ss_pred eeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEE-eCCeeEEEEecCC
Q 041718 164 NKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGEEKLLIYEFMP 230 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 230 (295)
+.||+|+||.||+ .+|+|.+.. ......+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 3689999999995 489998854 23455678899999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ....+++...+.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 ~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~n 128 (262)
T cd05058 81 HGDLRNFIRS--------------ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARN 128 (262)
T ss_pred CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcce
Confidence 9999999842 2234677888899999999999999987 9999999998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.1e-19 Score=153.38 Aligned_cols=118 Identities=28% Similarity=0.444 Sum_probs=103.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.|.....||+|+||.||+ .+|+|.+........+.+.+|+.++..++||||+++++.+..++..++|+||++
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 344456899999999996 589999865444556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 102 ~~~L~~~~~----------------~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~N 147 (297)
T cd06659 102 GGALTDIVS----------------QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDS 147 (297)
T ss_pred CCCHHHHHh----------------hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999988763 135789999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-20 Score=152.07 Aligned_cols=119 Identities=29% Similarity=0.501 Sum_probs=107.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
.-|.++.+||+|+||.||| .+|+|.+.. ..+.+++..|+.+|.+.+.|++|+++|.+.....+|||||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 3567789999999999996 689998865 456789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..|++.++++ .+.+.|.+..+..++...++||+|||... -||||||+.|
T Consensus 111 GAGSiSDI~R--------------~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGN 159 (502)
T KOG0574|consen 111 GAGSISDIMR--------------ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGN 159 (502)
T ss_pred CCCcHHHHHH--------------HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhccccc
Confidence 9999999985 35578999999999999999999999875 8999999987
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.7e-19 Score=153.86 Aligned_cols=121 Identities=24% Similarity=0.393 Sum_probs=95.3
Q ss_pred ceeecccCccceeE----------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEecCC
Q 041718 163 NNKLGEGGFGLVYK----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMP 230 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 230 (295)
..+||+|+||.||+ .+|+|.+... .....+.+|+.+|++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 36899999999996 4799988642 223457789999999999999999998864 456889999995
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++....... .......+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 84 -~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~N 138 (317)
T cd07868 84 -HDLWHIIKFHRASK------ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPAN 138 (317)
T ss_pred -CCHHHHHHhccccc------ccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHH
Confidence 58887774221100 1112335888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.9e-19 Score=150.16 Aligned_cols=130 Identities=28% Similarity=0.458 Sum_probs=107.8
Q ss_pred hhhhhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEe-
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ- 218 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~- 218 (295)
++.++..+.+.|++.+.||.|+||.||+ .+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4445555678899999999999999996 5889987643 33456788999999998 69999999999853
Q ss_pred -----CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 219 -----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 219 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
.+..+++|||+++|+|.+++.. .....+++..+..++.|++.||.|||+++ |+|+||||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~ 149 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKN-------------TKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHH-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCH
Confidence 4678999999999999998842 22345788888999999999999999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 150 ~n 151 (282)
T cd06636 150 QN 151 (282)
T ss_pred HH
Confidence 87
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=150.07 Aligned_cols=123 Identities=27% Similarity=0.408 Sum_probs=100.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHH-HhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .||+|+++.. ......++..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688889999999999997 5899988653 22334556667664 666789999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++... ......+++.....++.|++.||.|||++ + ++||||||+|
T Consensus 81 ~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~n 134 (283)
T cd06617 81 VMD-TSLDKFYKKV-----------YDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSN 134 (283)
T ss_pred hhc-ccHHHHHHHh-----------ccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHH
Confidence 996 7888877421 11235689999999999999999999986 5 9999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=156.49 Aligned_cols=119 Identities=29% Similarity=0.456 Sum_probs=99.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 219 (295)
..++|++.+.||+|+||.||+ .+|||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999996 6899998642 334556788999999999999999999988643
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~N 149 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----------------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHH
Confidence 357999999964 6666552 23778888999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-20 Score=151.80 Aligned_cols=124 Identities=27% Similarity=0.427 Sum_probs=102.4
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCee
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 222 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~ 222 (295)
..|+....||+|.||.||| .+|+|.++.. .........+|+.+++.|+|+|||.|..++.+ +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4688889999999999997 3677777642 11233556789999999999999999999887 7889
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|++||.++ +|.++|+.++ ......++......|+.||+.|+.|||++ +|+||||||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr----------~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaN 162 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHR----------ASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPAN 162 (438)
T ss_pred EEEehhhhh-hHHHHHHHhc----------cchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcce
Confidence 999999975 8888886542 22345788889999999999999999987 59999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.2e-18 Score=147.21 Aligned_cols=124 Identities=30% Similarity=0.497 Sum_probs=100.6
Q ss_pred cccceeecccCccceeE-----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC------
Q 041718 160 FSINNKLGEGGFGLVYK-----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 220 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 220 (295)
|.+.+.||+|+||.||+ .+|||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 55678999999999995 4899988642 3445678899999999999999999999886543
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++++||+++|+|..++.... .......+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~---------~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~n 143 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSR---------IGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARN 143 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhc---------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecccchhh
Confidence 2478899999999998874211 0112235788999999999999999999988 9999999997
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=149.82 Aligned_cols=126 Identities=26% Similarity=0.475 Sum_probs=110.5
Q ss_pred hhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
+.....+.|++.+.||+|++|.||+ .+++|.+..... ..+.+.+|+.+++.++|+|++++++.+...+..+
T Consensus 13 ~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 13 SEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 3345677899999999999999996 589998875433 5678899999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+|
T Consensus 92 lv~e~~~~~~L~~~l~~--------------~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~n 146 (286)
T cd06614 92 VVMEYMDGGSLTDIITQ--------------NFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDN 146 (286)
T ss_pred EEEeccCCCcHHHHHHH--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhh
Confidence 99999999999999852 1136899999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=149.07 Aligned_cols=124 Identities=26% Similarity=0.314 Sum_probs=104.0
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 226 (295)
++|...+.||.|++|.||+ .+|+|.+... ......++.+|+.++++++||||+++++++... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3677889999999999995 6899988643 334567899999999999999999999988653 4689999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++... ......+++.....++.|++.||.|||+.+ ++|+||+|+|
T Consensus 81 e~~~~~~L~~~l~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~n 135 (287)
T cd06621 81 EYCEGGSLDSIYKKV-----------KKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSN 135 (287)
T ss_pred EecCCCCHHHHHHHH-----------HhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999887421 112345788899999999999999999988 9999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=159.60 Aligned_cols=118 Identities=24% Similarity=0.477 Sum_probs=104.9
Q ss_pred cccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 160 FSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
....+.||.|.||.||+ .||||..+. ......+.|.+|..+|++++|||||+|+|+|. ..+.||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence 44567899999999996 689999886 46677899999999999999999999999986 47899999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++-|.|..||. .+...|+..+...+++||..||+|||+.. +|||||..+|
T Consensus 470 EL~~~GELr~yLq--------------~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRN 521 (974)
T KOG4257|consen 470 ELAPLGELREYLQ--------------QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARN 521 (974)
T ss_pred ecccchhHHHHHH--------------hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhh
Confidence 9999999999994 34467888999999999999999999987 9999999877
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=147.56 Aligned_cols=124 Identities=23% Similarity=0.358 Sum_probs=105.9
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc--------cHHhHHHHHHHHHHHhcC-CCCcccceeeeE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--------SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 216 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--------~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 216 (295)
.....+|.-.+.||.|..+.|.+ +.|+|++... .....++.++|+.||+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 44556777788999999988874 7899988531 122356678999999998 599999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++...++|+|.|+.|.|+++|. ....+++....+|+.|+..|++|||.++ |+||||||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt---------------s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpEN 153 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT---------------SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPEN 153 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh---------------hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhh
Confidence 99999999999999999999995 3356889999999999999999999998 9999999998
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=148.99 Aligned_cols=119 Identities=28% Similarity=0.478 Sum_probs=105.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.+.||.|++|.||+ .+|+|.+... .......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3678889999999999996 6899988643 244556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ..+++.....++.|++.||.|||+++ |+|+||+|+|
T Consensus 81 ~~~~~L~~~~~~----------------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~n 128 (274)
T cd06609 81 CGGGSCLDLLKP----------------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAAN 128 (274)
T ss_pred eCCCcHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 999999998831 26889999999999999999999988 9999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=146.32 Aligned_cols=113 Identities=35% Similarity=0.559 Sum_probs=97.8
Q ss_pred eeecccCccceeE-----------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK-----------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-----------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
++||+|+||.||+ .+|+|.+..... ...+++.+|+.++++++|+|||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4699999999985 488998875332 35678999999999999999999999875 5678999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++.. ...+++..+..++.|++.||.|||..+ ++|+||||+|
T Consensus 80 ~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~n 125 (257)
T cd05060 80 GPLLKYLKK---------------RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARN 125 (257)
T ss_pred CcHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccce
Confidence 999999842 236889999999999999999999988 9999999997
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=146.52 Aligned_cols=123 Identities=34% Similarity=0.546 Sum_probs=101.9
Q ss_pred eeecccCccceeE-----------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK-----------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-----------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|.+...... ..+.+.+|+.++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4689999999996 4688888753322 468899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++....... .......+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~L~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~n 135 (262)
T cd00192 81 GDLLDYLRKSRPVF------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARN 135 (262)
T ss_pred CcHHHHHhhccccc------cccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcce
Confidence 99999985210000 0001367899999999999999999999988 9999999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=155.30 Aligned_cols=119 Identities=28% Similarity=0.449 Sum_probs=99.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 219 (295)
..++|++.+.||+|+||.||+ .+|||++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 346899999999999999996 5899998642 334456788999999999999999999987543
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++||||+++ +|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----------------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~N 156 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----------------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHH
Confidence 357999999964 6766652 23778888999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=146.71 Aligned_cols=120 Identities=28% Similarity=0.370 Sum_probs=106.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|.+.+.||+|++|.||+ .+++|++..... .....+.+|+.++.+++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 3678889999999999996 589998875433 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ...+++.....++.|+++||.|||+ .+ ++|+||+|+|
T Consensus 81 ~~~~~L~~~l~~---------------~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~n 130 (264)
T cd06623 81 MDGGSLADLLKK---------------VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSN 130 (264)
T ss_pred cCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHH
Confidence 999999999842 2568899999999999999999999 87 9999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=145.71 Aligned_cols=115 Identities=34% Similarity=0.570 Sum_probs=100.8
Q ss_pred eeecccCccceeE-------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHH
Q 041718 164 NKLGEGGFGLVYK-------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (295)
++||+|+||.||+ .+|+|.+..... .....+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999996 589998865333 35678999999999999999999999999999999999999999999
Q ss_pred HHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 236 SFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 236 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++.. ....+++.....++.+++.||.|||+++ ++||||||+|
T Consensus 81 ~~l~~--------------~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~n 123 (251)
T cd05041 81 TFLRK--------------KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARN 123 (251)
T ss_pred HHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcce
Confidence 98842 2235788999999999999999999998 9999999998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=147.41 Aligned_cols=126 Identities=30% Similarity=0.488 Sum_probs=106.6
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC-----
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE----- 220 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~----- 220 (295)
.++++|++.+.||+|++|.||+ .+++|.+.... ....++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4568999999999999999996 58899886533 3456799999999999 6999999999997644
Q ss_pred -eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 -EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++++|.+++... ......+++..+..++.|++.||.|||+++ |+|+||+|+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~n 143 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGL-----------RKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQN 143 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHH-----------hhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHH
Confidence 489999999999999988421 112356889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.5e-19 Score=150.68 Aligned_cols=120 Identities=29% Similarity=0.482 Sum_probs=102.8
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|+..+.||.|++|.||+ .+|||.+... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999996 5899988642 222345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+. ++|.+++. ......+++.....++.|++.||+|||+.+ ++|+||+|+|
T Consensus 81 ~~-~~l~~~~~-------------~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~n 130 (284)
T cd07860 81 LH-QDLKKFMD-------------ASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQN 130 (284)
T ss_pred cc-cCHHHHHH-------------hCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 95 68888874 223356899999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=146.12 Aligned_cols=120 Identities=30% Similarity=0.513 Sum_probs=102.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc-----ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--Cee
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEK 222 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-----~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~ 222 (295)
.+|.+.+.||+|+||.||+ .+|+|.+.. ........+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999996 589998742 1234556889999999999999999999998764 468
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+++ ++|+||||+|
T Consensus 82 ~~v~e~~~~~~L~~~~~~---------------~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~n 136 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---------------YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGAN 136 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 899999999999998841 234788889999999999999999998 9999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-19 Score=159.30 Aligned_cols=108 Identities=31% Similarity=0.483 Sum_probs=94.5
Q ss_pred ceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHH
Q 041718 163 NNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNS 236 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 236 (295)
++-||.|+.|.||. .||||+++... ..+|.-|++|+|+||+.+.|+|....-+.||||||+.|-|..
T Consensus 129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 47799999999995 79999876432 246777899999999999999999999999999999999999
Q ss_pred HHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 237 FIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 237 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+ ....++......+..+||.||.|||.+. |||||||.-|
T Consensus 202 VLk---------------a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPN 242 (904)
T KOG4721|consen 202 VLK---------------AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPN 242 (904)
T ss_pred HHh---------------ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCc
Confidence 995 3356777888899999999999999987 9999999876
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=151.42 Aligned_cols=120 Identities=26% Similarity=0.406 Sum_probs=95.0
Q ss_pred eeecccCccceeE----------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 231 (295)
.+||+|+||.||+ .+|+|.+.... ....+.+|+.++++++||||+++++++.. ....++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 6899999999996 48999886532 23467889999999999999999998853 567899999986
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++....... .......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~N 138 (317)
T cd07867 84 HDLWHIIKFHRASK------ANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPAN 138 (317)
T ss_pred CcHHHHHHhhhccc------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHH
Confidence 57777764221100 1112345889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.7e-19 Score=159.88 Aligned_cols=115 Identities=31% Similarity=0.514 Sum_probs=102.6
Q ss_pred eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHH
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLN 235 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 235 (295)
-+||+|.||+||- .+|||-+.....+..+.+..||.+-+.|+|.|||+++|.+.+..++-|+||-+|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3699999999994 69999998777778889999999999999999999999999999999999999999999
Q ss_pred HHHhhhhhhhhhhhcccccccCCC--CHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 236 SFIFENFVLTLMRSFVDQERCKIL--DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 236 ~~l~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|++ +-.++ .+.+.-.+..||++||.|||.+. |||||||-+|
T Consensus 661 sLLrs--------------kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDN 705 (1226)
T KOG4279|consen 661 SLLRS--------------KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDN 705 (1226)
T ss_pred HHHHh--------------ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCc
Confidence 99953 22334 66777888999999999999998 9999999887
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-18 Score=148.52 Aligned_cols=121 Identities=40% Similarity=0.599 Sum_probs=100.5
Q ss_pred eeecccCccceeE--------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 164 NKLGEGGFGLVYK--------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 3689999999995 3677876542 234567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++..... .......+++.+++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 81 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~n 136 (269)
T cd05044 81 MEGGDLLSYLRDARV--------ERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARN 136 (269)
T ss_pred cCCCcHHHHHHHhhh--------cccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhe
Confidence 999999999964211 0112345789999999999999999999987 9999999987
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=145.57 Aligned_cols=123 Identities=23% Similarity=0.426 Sum_probs=103.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLIY 226 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 226 (295)
+|++.+.||.|+||.||+ .+|+|.+.. ......+.+..|+.++++++|+||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999996 589998863 344556788999999999999999999998764 45679999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhh-----cCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLH-----QDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH-----~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++... ......+++...+.++.|++.||.||| +.+ |+|+||||+|
T Consensus 81 e~~~~~~L~~~l~~~-----------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~n 140 (265)
T cd08217 81 EYCEGGDLAQLIQKC-----------KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPAN 140 (265)
T ss_pred hhccCCCHHHHHHHH-----------hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHH
Confidence 999999999998531 122456899999999999999999999 555 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=147.65 Aligned_cols=118 Identities=25% Similarity=0.447 Sum_probs=103.5
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 226 (295)
.|+..+.||+|+||.||+ .+|+|.+... ......++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477789999999999996 5899988643 3345667889999999997 999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++. ...+++.....++.|++.||.|||+.+ |+|+||+|+|
T Consensus 82 e~~~~~~L~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~n 131 (277)
T cd06917 82 EYAEGGSVRTLMK----------------AGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAAN 131 (277)
T ss_pred ecCCCCcHHHHHH----------------ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHH
Confidence 9999999998873 125889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=146.93 Aligned_cols=118 Identities=25% Similarity=0.463 Sum_probs=104.2
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.|...+.||+|++|.||+ .+++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 455568999999999996 589998865555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++. . ..+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 100 ~~~L~~~~~-------------~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~N 145 (285)
T cd06648 100 GGALTDIVT-------------H---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDS 145 (285)
T ss_pred CCCHHHHHH-------------h---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhh
Confidence 999999873 1 35788999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=152.23 Aligned_cols=122 Identities=27% Similarity=0.449 Sum_probs=102.7
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC---
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--- 220 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--- 220 (295)
....++|++.+.||+|+||.||+ .||||++... .......+.+|+.+|++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 34567899999999999999996 5899988542 2334567889999999999999999999987554
Q ss_pred ---eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 ---EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~N 148 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----------------HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGN 148 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 458999999 778887762 235889999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=143.42 Aligned_cols=119 Identities=33% Similarity=0.556 Sum_probs=105.8
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccH--HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISE--QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|++|.||+ .+++|.+..... .....+.+|+.++++++|+|++++++++.+++..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 477889999999999996 589998875432 4667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~~~L~~~~~---------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~n 129 (254)
T cd06627 81 AENGSLRQIIK---------------KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAAN 129 (254)
T ss_pred CCCCcHHHHHH---------------hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHH
Confidence 99999999884 1246899999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=150.66 Aligned_cols=119 Identities=24% Similarity=0.260 Sum_probs=100.7
Q ss_pred ccceeecccCccceeE------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 161 SINNKLGEGGFGLVYK------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 161 ~~~~~lg~G~~g~Vyk------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
.+.+.+|.|+++.|++ .+|||++... .......+..|+.+++.++|+||+++++++...+..+++|||++++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 3445566667777775 7999998643 4556678999999999999999999999999999999999999999
Q ss_pred CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 233 SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 233 sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|.+++.. .....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~l~~~l~~-------------~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~N 131 (314)
T cd08216 85 SCEDLLKT-------------HFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASH 131 (314)
T ss_pred CHHHHHHH-------------hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcce
Confidence 99998852 12345788888999999999999999998 9999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=160.93 Aligned_cols=127 Identities=22% Similarity=0.360 Sum_probs=96.1
Q ss_pred hhccccccceeecccCccceeEEE---------EEEE--------------ec---cccHHhHHHHHHHHHHHhcCCCCc
Q 041718 155 NATDNFSINNKLGEGGFGLVYKEI---------AVKR--------------LS---KISEQGLKELKNEVILFSKLQHRN 208 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk~v---------avK~--------------l~---~~~~~~~~~~~~Ei~~l~~l~h~n 208 (295)
...++|++.+.||+|+||.||+.. ++|. +. .........+.+|+.+|++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 345789999999999999999521 1110 00 012234567889999999999999
Q ss_pred ccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEe
Q 041718 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIH 288 (295)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiH 288 (295)
||++++++...+..++|+|++. ++|.+++..... .............|+.|++.||.|||+++ |||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----------~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiH 290 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAF----------DWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIH 290 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccc----------cccccccHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999994 577777642110 01122345667789999999999999998 999
Q ss_pred ccCCCCC
Q 041718 289 RDLKASN 295 (295)
Q Consensus 289 rDlkp~N 295 (295)
|||||+|
T Consensus 291 rDLKP~N 297 (501)
T PHA03210 291 RDIKLEN 297 (501)
T ss_pred CCCCHHH
Confidence 9999987
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=147.61 Aligned_cols=114 Identities=28% Similarity=0.354 Sum_probs=98.1
Q ss_pred ecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||+|+||.||+ .+|+|.+.... ......+..|+.++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999995 68999886421 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. .....+++..+..++.|++.||.|||+++ ++||||+|+|
T Consensus 81 ~~~l~~-------------~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~N 125 (277)
T cd05577 81 KYHIYN-------------VGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPEN 125 (277)
T ss_pred HHHHHH-------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 998852 12246889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=148.09 Aligned_cols=119 Identities=23% Similarity=0.266 Sum_probs=102.2
Q ss_pred ccccceeecccCccceeE-----------EEEEEEecccc----HHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 041718 159 NFSINNKLGEGGFGLVYK-----------EIAVKRLSKIS----EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 222 (295)
+|++.+.||.|+||.||+ .+|+|++.... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999994 48999886422 22346788999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~n 135 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---------------RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLEN 135 (290)
T ss_pred EEEEecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 999999999999998842 235788888899999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.8e-18 Score=147.47 Aligned_cols=121 Identities=27% Similarity=0.439 Sum_probs=101.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|++|.||+ .+|+|.+... .......+.+|+.++++++|+||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688899999999999996 5899987542 22334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.. .....+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 82 ~~~-~~l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~n 132 (294)
T PLN00009 82 YLD-LDLKKHMDS-------------SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQN 132 (294)
T ss_pred ccc-ccHHHHHHh-------------CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcce
Confidence 996 578777631 12234677888899999999999999987 9999999997
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=148.67 Aligned_cols=120 Identities=27% Similarity=0.454 Sum_probs=95.6
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcC---CCCcccceeeeEEe-----CC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ-----GE 220 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~-----~~ 220 (295)
+|++.+.||+|+||.||+ .+|+|.++... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999996 58999886421 22234556677777665 69999999998764 34
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||++ ++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~N 138 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDK-------------VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPEN 138 (288)
T ss_pred eEEEEEcccc-cCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 5799999997 588887742 22345899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=148.47 Aligned_cols=122 Identities=30% Similarity=0.483 Sum_probs=103.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
....|+..+.||+|+||.||+ .||+|.+.. ......+++.+|+.+++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 445688889999999999996 589998753 233445678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||+|+|
T Consensus 93 v~e~~~-g~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~n 145 (307)
T cd06607 93 VMEYCL-GSASDILEV--------------HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGN 145 (307)
T ss_pred EHHhhC-CCHHHHHHH--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCccc
Confidence 999996 677666531 2245899999999999999999999988 9999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-18 Score=158.54 Aligned_cols=123 Identities=25% Similarity=0.355 Sum_probs=98.0
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCC------CcccceeeeEEe
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH------RNLVKLLGCCIQ 218 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h------~niv~l~~~~~~ 218 (295)
+....++|++.++||+|+||.||+ .||||+++.. ......+..|+.++..++| .+++++++++..
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 334567899999999999999996 5899998642 2334456667777777655 458889988875
Q ss_pred C-CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 219 G-EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
. .+.+||||++ +++|.+++.. ...+++.....|+.||+.||.|||++ + ||||||||+|
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~N 262 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMK---------------HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPEN 262 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 4 5788999988 7788887742 24588999999999999999999974 6 9999999998
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=147.72 Aligned_cols=124 Identities=27% Similarity=0.396 Sum_probs=101.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCe-----
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE----- 221 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~----- 221 (295)
++|++.+.||+|+||.||+ .||+|.+.... ......+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688889999999999996 68999876422 223467888999999995 6999999999887665
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++ +|.+++... .......+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~----------~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~n 140 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSN----------GRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQN 140 (295)
T ss_pred EEEEeeccCc-CHHHHHHHh----------cccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHH
Confidence 8999999985 888887431 1111346899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=149.49 Aligned_cols=120 Identities=28% Similarity=0.415 Sum_probs=102.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 225 (295)
++|++.+.||.|+||.||+ .+|+|.++... ......+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788889999999999996 58999886422 22334677899999999999999999998877 899999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||++ ++|.+++.. ....+++.....++.|++.||+|||+++ |+|+||||+|
T Consensus 85 ~e~~~-~~L~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~n 136 (293)
T cd07843 85 MEYVE-HDLKSLMET--------------MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSN 136 (293)
T ss_pred ehhcC-cCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHH
Confidence 99997 589887742 2236899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=139.66 Aligned_cols=113 Identities=19% Similarity=0.304 Sum_probs=89.5
Q ss_pred cceeecccCccceeE-----EEEEEEeccccHHhHHHHHHHHHHHhcC-----CCCcccceeeeEEeCC---eeE-EEEe
Q 041718 162 INNKLGEGGFGLVYK-----EIAVKRLSKISEQGLKELKNEVILFSKL-----QHRNLVKLLGCCIQGE---EKL-LIYE 227 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk-----~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~e 227 (295)
-.+.||+|+||.||. ..+||++........+.+.+|+.+++.+ .||||++++|++.++. .++ +|+|
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred CcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 347899999999996 3468877654344567899999999999 5799999999998864 333 7899
Q ss_pred c--CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHH-HhhhcCCCCCeEeccCCCCC
Q 041718 228 F--MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGV-MYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl-~yLH~~~~~~iiHrDlkp~N 295 (295)
| +++++|.+++.. ..+++. ..++.|++.++ +|||+++ |+||||||+|
T Consensus 86 ~~G~~~~tL~~~l~~----------------~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~N 135 (210)
T PRK10345 86 FDGKPSITLTEFAEQ----------------CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQN 135 (210)
T ss_pred CCCCcchhHHHHHHc----------------ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHH
Confidence 9 557999999941 124444 35678888888 9999998 9999999998
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=149.74 Aligned_cols=119 Identities=25% Similarity=0.438 Sum_probs=101.3
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.+.||+|+||.||+ .+|+|.++.. .......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999996 5899988642 222345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++ ++|.+++.. ....+++.....++.||++||.|||+++ |+||||||+|
T Consensus 81 ~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~n 129 (284)
T cd07839 81 CD-QDLKKYFDS--------------CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQN 129 (284)
T ss_pred CC-CCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHH
Confidence 96 578777631 2345899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=148.18 Aligned_cols=114 Identities=26% Similarity=0.443 Sum_probs=101.3
Q ss_pred ceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 163 NNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
..+||+|+||.||+ .+|+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 36799999999996 6899988654555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++. ...+++.....++.|++.||+|||+.+ |+|+||||+|
T Consensus 105 ~~~~~----------------~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~N 146 (292)
T cd06657 105 TDIVT----------------HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDS 146 (292)
T ss_pred HHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 98763 134788999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.9e-18 Score=142.04 Aligned_cols=123 Identities=25% Similarity=0.410 Sum_probs=107.2
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|.+.+.||.|+||.||+ .+++|++... .......+..|+.+++.++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 477889999999999995 6899988653 235667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++... ......+++.....++.+++.||.|||+++ ++|+||+|+|
T Consensus 81 ~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~n 133 (258)
T cd08215 81 ADGGDLSQKIKKQ-----------KKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQN 133 (258)
T ss_pred cCCCcHHHHHHHh-----------hccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHH
Confidence 9999999988531 112367899999999999999999999997 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-19 Score=161.64 Aligned_cols=121 Identities=30% Similarity=0.473 Sum_probs=106.1
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
....+.++||+|.||.|++ .||||.+...... ...+|++|+.+|.+|+|+|+|+|||...+ ....+|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3455668999999999996 6999999865443 67899999999999999999999999887 888999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+++.|||.+.|++ .....+-......++.|||.||.||.++. +|||||..+|
T Consensus 189 ~ELaplGSLldrLrk-------------a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARN 242 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-------------AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARN 242 (1039)
T ss_pred hhhcccchHHHHHhh-------------ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhh
Confidence 999999999999952 34456778888999999999999999987 9999999887
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=145.96 Aligned_cols=121 Identities=28% Similarity=0.379 Sum_probs=105.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|+..+.||.|+||.||+ .+|+|.+... .....+++.+|+.++++++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 3577789999999999996 5899988653 345567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ....+++.....++.|++.||+|||+ .+ ++|+||||+|
T Consensus 81 ~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~n 131 (265)
T cd06605 81 MDGGSLDKILKE--------------VQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSN 131 (265)
T ss_pred cCCCcHHHHHHH--------------ccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHH
Confidence 999999998842 11568889999999999999999999 77 9999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-19 Score=162.17 Aligned_cols=123 Identities=29% Similarity=0.470 Sum_probs=110.0
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..+.|.++..||.|+||.||| ..|.|++...+....+++.-||.||+..+||+||+|++.|...+.+||+.|
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 345667778999999999997 347788877778889999999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||.||-++.++.. ....|++.++..+.+|++.||.|||++. |||||||+.|
T Consensus 110 FC~GGAVDaimlE--------------L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGN 160 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLE--------------LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGN 160 (1187)
T ss_pred ecCCchHhHHHHH--------------hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccc
Confidence 9999999988742 3467999999999999999999999998 9999999987
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-18 Score=148.19 Aligned_cols=123 Identities=27% Similarity=0.444 Sum_probs=101.2
Q ss_pred ccccceeecccCccceeE----------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeE
Q 041718 159 NFSINNKLGEGGFGLVYK----------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 223 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk----------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (295)
.|.+.+.||+|+||.||+ .+|+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 377789999999999996 48999887522 33456778899999999999999999999988 8899
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++ +|.+++... .......+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 81 lv~e~~~~-~l~~~~~~~----------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~N 138 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFH----------RQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPAN 138 (316)
T ss_pred EEEeCCCc-CHHHHHHhh----------ccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHH
Confidence 99999974 676666321 1112236888999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.9e-18 Score=147.61 Aligned_cols=120 Identities=29% Similarity=0.509 Sum_probs=102.4
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..|...+.||+|+||.||+ .+|+|.+... .......+.+|+.++++++|+|++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477789999999999996 5899988642 3344567899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||+|+|
T Consensus 105 e~~~-g~l~~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~N 155 (317)
T cd06635 105 EYCL-GSASDLLEV--------------HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGN 155 (317)
T ss_pred eCCC-CCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCccc
Confidence 9996 577776631 2345899999999999999999999998 9999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-19 Score=156.03 Aligned_cols=120 Identities=28% Similarity=0.466 Sum_probs=105.0
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..|+..+.||+|+||.||| .||+|++.- ......+++.+|+.+|++++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3566779999999999997 699999974 3445678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+|++.+.|. ....+++....-|+.+++.||.|||.++ .||||||+.|
T Consensus 93 ~~gGsv~~lL~---------------~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaan 141 (467)
T KOG0201|consen 93 CGGGSVLDLLK---------------SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAAN 141 (467)
T ss_pred hcCcchhhhhc---------------cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccc
Confidence 99999999883 2334467777778999999999999998 9999999987
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=146.71 Aligned_cols=123 Identities=30% Similarity=0.465 Sum_probs=102.1
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc-----ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK-----ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-----~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+|.+.+.||+|+||.||+ .+++|.++. .......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 477889999999999996 245555543 1223445677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++... ......+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 81 ~e~~~~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~n 136 (260)
T cd08222 81 TEYCEGRDLDCKLEEL-----------KHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKN 136 (260)
T ss_pred EEeCCCCCHHHHHHHH-----------hhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhh
Confidence 9999999999988531 123356899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=147.41 Aligned_cols=120 Identities=26% Similarity=0.399 Sum_probs=103.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .||+|.++.. .....+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3688889999999999996 5899988642 23345788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++++.+..++. ....+++.....++.|++.||.|||+++ |+|+||+|+|
T Consensus 81 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~n 130 (288)
T cd07833 81 YVERTLLELLEA---------------SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPEN 130 (288)
T ss_pred cCCCCHHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999877665542 2245889999999999999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=147.18 Aligned_cols=120 Identities=33% Similarity=0.457 Sum_probs=105.8
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (295)
++|.+.+.||+|+||.||+ .+|+|++... .......+..|+.++.+++ |+||+++++.+...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688889999999999996 5899988642 2344577889999999999 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++.....++.|++.||.|||+++ ++|+||||+|
T Consensus 81 ~e~~~~~~L~~~l~~---------------~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~n 132 (280)
T cd05581 81 LEYAPNGELLQYIRK---------------YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPEN 132 (280)
T ss_pred EcCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHH
Confidence 999999999998842 236999999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-18 Score=148.61 Aligned_cols=131 Identities=26% Similarity=0.439 Sum_probs=104.6
Q ss_pred CCccchhhhhhhhhccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHh--cCCCCcccceee
Q 041718 143 LELPLFELATIANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFS--KLQHRNLVKLLG 214 (295)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~--~l~h~niv~l~~ 214 (295)
..+|.+-..++ .+...+.+.||+|.||.||+ .||||++...++ +.+.+|.+|.+ .|+|+||+.+++
T Consensus 199 SGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 199 SGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred CCchhHhHHhh---hheeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhh
Confidence 34555544443 34667889999999999997 799999975333 44555655544 579999999999
Q ss_pred eEEeCC----eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-----CCCC
Q 041718 215 CCIQGE----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-----SKLR 285 (295)
Q Consensus 215 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-----~~~~ 285 (295)
.-..+. .+|||++|.++|||++||. ...++-...++++.-+|.||++||.. ++|.
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~----------------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPa 336 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLN----------------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPA 336 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHh----------------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCch
Confidence 765443 6899999999999999994 25688899999999999999999974 7899
Q ss_pred eEeccCCCCC
Q 041718 286 IIHRDLKASN 295 (295)
Q Consensus 286 iiHrDlkp~N 295 (295)
|.|||||..|
T Consensus 337 IAHRDlKSKN 346 (513)
T KOG2052|consen 337 IAHRDLKSKN 346 (513)
T ss_pred hhcccccccc
Confidence 9999999987
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.7e-18 Score=143.54 Aligned_cols=123 Identities=28% Similarity=0.508 Sum_probs=106.1
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+|++.++||+|+||.||+ .+|+|.+... .......+..|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999996 5899988642 334566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++... ......+++...+.++.|++.||+|||+.+ ++|+||+|+|
T Consensus 81 ~~~~~L~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~n 133 (256)
T cd08530 81 APFGDLSKAISKR-----------KKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSAN 133 (256)
T ss_pred cCCCCHHHHHHHH-----------HhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcce
Confidence 9999999988531 122356899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.8e-18 Score=143.90 Aligned_cols=123 Identities=23% Similarity=0.494 Sum_probs=101.7
Q ss_pred ccccceeecccCccceeE---------EEEEEEecc----------ccHHhHHHHHHHHHHHhc-CCCCcccceeeeEEe
Q 041718 159 NFSINNKLGEGGFGLVYK---------EIAVKRLSK----------ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ 218 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk---------~vavK~l~~----------~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~ 218 (295)
+|++.+.||+|+||.||+ .+|+|.+.. .......++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 477889999999999995 488887742 123345667889988875 799999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
.+..+++|||+++++|.+++... ......+++..++.++.|++.||.|||+ .+ |+|+||||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~-----------~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~n 144 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSL-----------KEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNN 144 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHH-----------HhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHH
Confidence 99999999999999999987421 1223468889999999999999999996 45 9999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-18 Score=146.27 Aligned_cols=119 Identities=24% Similarity=0.295 Sum_probs=102.1
Q ss_pred ccccceeecccCccceeE-----------EEEEEEeccc----cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 041718 159 NFSINNKLGEGGFGLVYK-----------EIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 222 (295)
+|++.+.||+|+||.||+ .+|||.+... .......+.+|+.++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999995 4889988642 123446788999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++. ....+++.....++.|+++||.|||+.+ ++||||||+|
T Consensus 81 ~lv~e~~~~~~L~~~~~---------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~n 135 (288)
T cd05583 81 HLILDYVNGGELFTHLY---------------QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLEN 135 (288)
T ss_pred EEEEecCCCCcHHHHHh---------------hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 99999999999998874 1235788899999999999999999987 9999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=140.22 Aligned_cols=120 Identities=35% Similarity=0.569 Sum_probs=106.8
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
+|...+.||+|++|.||+ .+++|++..........+.+|+.++++++|+|++++++.+...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 467789999999999996 589999876554567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ....+++..+..++.|++.||.|||.++ ++|+||+|+|
T Consensus 81 ~~~L~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~n 128 (253)
T cd05122 81 GGSLKDLLKS--------------TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAAN 128 (253)
T ss_pred CCcHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHH
Confidence 9999998842 1246899999999999999999999987 9999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.9e-18 Score=145.87 Aligned_cols=119 Identities=29% Similarity=0.478 Sum_probs=101.7
Q ss_pred cccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
|++.+.||.|++|.||+ .+|+|++.... ......+.+|+.+++.++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56779999999999997 58999886432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+ ++|.+++.. .....+++..+..++.|++.||+|||+++ ++||||+|+|
T Consensus 81 ~-~~l~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~n 129 (283)
T cd07835 81 D-LDLKKYMDS-------------SPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQN 129 (283)
T ss_pred C-cCHHHHHhh-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHH
Confidence 5 689888742 22246899999999999999999999987 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=144.70 Aligned_cols=112 Identities=28% Similarity=0.393 Sum_probs=98.9
Q ss_pred ecccCccceeE--------EEEEEEeccccH---HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||.|+||.||+ .+++|.+..... ...+.+.+|+.++.+++|+||+++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68899999996 589998865322 4567889999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. ...+++..+..++.|++.||+|||+++ ++|+||+|+|
T Consensus 81 ~~~l~~---------------~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~n 123 (265)
T cd05579 81 ASLLEN---------------VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDN 123 (265)
T ss_pred HHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHH
Confidence 998842 236899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.7e-18 Score=141.46 Aligned_cols=119 Identities=30% Similarity=0.470 Sum_probs=105.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIY 226 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 226 (295)
+|+..+.||+|++|.||+ .+++|.+.... ....+.+.+|+.++++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 467779999999999996 58999886533 35578899999999999999999999999988 8999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+|
T Consensus 81 e~~~~~~L~~~~~~---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~n 131 (260)
T cd06606 81 EYVSGGSLSSLLKK---------------FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGAN 131 (260)
T ss_pred EecCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 99999999998842 227899999999999999999999987 9999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.7e-19 Score=162.86 Aligned_cols=117 Identities=32% Similarity=0.550 Sum_probs=102.5
Q ss_pred ccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 161 SINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 161 ~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
+..++||+|+||+||| .||+|++.. ...+...++..|+-+|++|+||||++|+|++..+. +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3458899999999997 589998865 34566789999999999999999999999998876 889999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+.|+|.+|++. ....+.....+.|..|||+||.|||.+. ++||||.++|
T Consensus 778 ~mP~G~LlDyvr~--------------hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRN 828 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--------------HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARN 828 (1177)
T ss_pred hcccchHHHHHHH--------------hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhh
Confidence 9999999999964 2345777888999999999999999887 9999999887
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.2e-18 Score=143.19 Aligned_cols=112 Identities=26% Similarity=0.318 Sum_probs=98.4
Q ss_pred ecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||.|+||.||+ .+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999996 6899988642 223457899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+|
T Consensus 81 ~~~l~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~n 123 (262)
T cd05572 81 WTILRD---------------RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPEN 123 (262)
T ss_pred HHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHH
Confidence 999842 234888999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-18 Score=149.90 Aligned_cols=120 Identities=23% Similarity=0.444 Sum_probs=100.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----Ce
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 221 (295)
.+++|++.+.||+|+||.||+ .||+|.++.. .......+..|+.++++++|+||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999996 5899988642 233456788899999999999999999987654 35
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++|+||++ ++|.+++. ...+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 83 ~~lv~e~~~-~~l~~~~~----------------~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~N 136 (336)
T cd07849 83 VYIVQELME-TDLYKLIK----------------TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSN 136 (336)
T ss_pred EEEEehhcc-cCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 799999996 47776662 245889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.2e-18 Score=147.07 Aligned_cols=123 Identities=27% Similarity=0.431 Sum_probs=102.4
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC----
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE---- 220 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~---- 220 (295)
...++|++.+.||+|+||.||+ .+|+|.++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3457899999999999999996 58999886422 233456788999999999999999999987655
Q ss_pred ------eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCC
Q 041718 221 ------EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294 (295)
Q Consensus 221 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~ 294 (295)
..++|+||+++ +|..++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~ 145 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--------------GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCS 145 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 78999999975 67666631 2346899999999999999999999998 999999998
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 146 n 146 (302)
T cd07864 146 N 146 (302)
T ss_pred H
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.1e-18 Score=144.29 Aligned_cols=118 Identities=25% Similarity=0.375 Sum_probs=97.7
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeC--CeeEEEEe
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLIYE 227 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 227 (295)
|++.+.||+|+||.||+ .+|+|.++.. ..........|+.++.++. |+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56779999999999996 5899988652 1222234457888899885 99999999999987 88999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.. ....++|..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 81 ~~~-~~l~~~l~~--------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~n 130 (282)
T cd07831 81 LMD-MNLYELIKG--------------RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPEN 130 (282)
T ss_pred cCC-ccHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHH
Confidence 996 588777731 2246899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=148.10 Aligned_cols=126 Identities=31% Similarity=0.483 Sum_probs=104.3
Q ss_pred hhhhhhhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
..++....++|.+.+.||+|+||.||+ .||+|++... .....+.+.+|+.++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445566778999999999999999996 5899988642 233456788999999999999999999988643
Q ss_pred ------CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 220 ------EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 220 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
...+++++++ +++|.+++. ...+++..+..++.|+++||.|||+++ |+||||||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp 148 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----------------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKP 148 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 3467888887 788887763 235889999999999999999999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 149 ~N 150 (345)
T cd07877 149 SN 150 (345)
T ss_pred HH
Confidence 87
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=148.03 Aligned_cols=122 Identities=27% Similarity=0.436 Sum_probs=102.5
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCee
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEK 222 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~ 222 (295)
...+++|++.+.||.|+||.||+ .+|+|++.. ......+.+..|+.++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 44678899999999999999996 589998754 223345678899999999999999999999865 5678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++||+ +++|.+++. ...+++.....++.|++.||.|||+.+ |+||||||+|
T Consensus 86 ~lv~e~~-~~~L~~~~~----------------~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~N 138 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----------------SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSN 138 (328)
T ss_pred EEEeehh-ccCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 9999998 568887763 234677888889999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.75 E-value=8e-18 Score=146.58 Aligned_cols=122 Identities=30% Similarity=0.469 Sum_probs=101.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~ 223 (295)
..++|++.+.||+|+||.||+ .||+|.++... ......+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346899999999999999996 58999886422 22234567899999999999999999998755 5689
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 85 lv~e~~~-~~l~~~l~~--------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 138 (309)
T cd07845 85 LVMEYCE-QDLASLLDN--------------MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSN 138 (309)
T ss_pred EEEecCC-CCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999996 588887742 1246899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-17 Score=142.06 Aligned_cols=121 Identities=22% Similarity=0.270 Sum_probs=95.2
Q ss_pred hhhhhccccccceee--cccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhc-CCCCcccceeeeEEeCC
Q 041718 152 TIANATDNFSINNKL--GEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 152 ~~~~~~~~~~~~~~l--g~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~ 220 (295)
+.....++|.+.+.+ |+|+||.||+ .+|+|.+....... . |+..... .+|+||+++++.+...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677776766 9999999996 57888875421111 1 2222222 27999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ |+||||||+|
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 139 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK---------------EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLEN 139 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 99999999999999998842 237899999999999999999999998 9999999987
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.9e-18 Score=143.98 Aligned_cols=113 Identities=25% Similarity=0.290 Sum_probs=91.4
Q ss_pred eecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHH---HhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 165 KLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVIL---FSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 165 ~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.||+|+||.||+ .+|+|.+.... ......+.+|..+ +...+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999995 68999885421 1222334444433 344579999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~~L~~~i~---------------~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~N 127 (279)
T cd05633 81 GGDLHYHLS---------------QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPAN 127 (279)
T ss_pred CCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHH
Confidence 999998874 2245899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.2e-18 Score=145.92 Aligned_cols=122 Identities=26% Similarity=0.454 Sum_probs=99.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 220 (295)
..++|++.+.||+|+||.||+ .+|||.+... .......+.+|+.++++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345799999999999999996 6899988542 2223345678999999999999999999987654
Q ss_pred ---eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 ---EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||++ ++|.+++.. ....+++.....++.|++.||.|||+++ |+|+||||+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~n 149 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN--------------KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAAN 149 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 3599999996 578777631 2235899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=143.67 Aligned_cols=118 Identities=28% Similarity=0.431 Sum_probs=101.4
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEEEe
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLIYE 227 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 227 (295)
|++.+.||.|+||.||+ .+|+|.+... .......+.+|+.++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 56779999999999997 5899998754 233456788999999999999999999999988 89999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++ +|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+|
T Consensus 81 ~~~~-~l~~~~~~--------------~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~n 130 (287)
T cd07840 81 YMDH-DLTGLLDS--------------PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSN 130 (287)
T ss_pred cccc-cHHHHHhc--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHH
Confidence 9974 88887731 2246899999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=8e-18 Score=154.02 Aligned_cols=138 Identities=22% Similarity=0.365 Sum_probs=100.0
Q ss_pred hhccccccceeecccCccceeE------------------------EEEEEEeccccHHhHHH--------------HHH
Q 041718 155 NATDNFSINNKLGEGGFGLVYK------------------------EIAVKRLSKISEQGLKE--------------LKN 196 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk------------------------~vavK~l~~~~~~~~~~--------------~~~ 196 (295)
...++|.+.++||+|+||.||+ .||||++........++ ...
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 3567999999999999999995 38999986533333333 334
Q ss_pred HHHHHhcCCCCcc-----cceeeeEEe--------CCeeEEEEecCCCCCHHHHHhhhhhh---hh---hh---hccccc
Q 041718 197 EVILFSKLQHRNL-----VKLLGCCIQ--------GEEKLLIYEFMPNKSLNSFIFENFVL---TL---MR---SFVDQE 254 (295)
Q Consensus 197 Ei~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~---~~---~~---~~~~~~ 254 (295)
|+.++.+++|.++ +++++++.. ....+|||||+++++|.++|...... .+ +. ......
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777778877654 677777653 35689999999999999999642110 00 00 000111
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 255 ~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
....++|..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~N 339 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPEN 339 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHh
Confidence 2234688899999999999999999987 9999999987
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.7e-19 Score=166.25 Aligned_cols=129 Identities=20% Similarity=0.236 Sum_probs=112.4
Q ss_pred hhhhhhhhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEE
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 217 (295)
...++....++|.+++.||+|+||.|.. .+|+|++++. ......-|+.|-.+|..-+.+.||+|+-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 3445566678999999999999999983 6899999873 3445677999999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++|+|||||+||+|..++.+ -..+++..+..++..|+.||.-||+.| .|||||||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---------------~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDN 205 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---------------FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDN 205 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---------------cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcce
Confidence 99999999999999999998842 126888888899999999999999988 9999999998
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.9e-18 Score=149.61 Aligned_cols=119 Identities=26% Similarity=0.417 Sum_probs=101.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC---------
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--------- 219 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--------- 219 (295)
..+|.+.+.||.|+||.||+ .||+|.+........+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999996 6899988665555667788999999999999999999876543
Q ss_pred -----CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCC
Q 041718 220 -----EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294 (295)
Q Consensus 220 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~ 294 (295)
...++||||++ ++|.+++. ...+++.....++.|++.||.|||+.+ |+||||||+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~ 143 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----------------QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence 35789999997 58877762 135788999999999999999999998 999999998
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 144 N 144 (342)
T cd07854 144 N 144 (342)
T ss_pred H
Confidence 7
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=146.42 Aligned_cols=113 Identities=19% Similarity=0.179 Sum_probs=88.7
Q ss_pred hhhccccccceeecccCccceeE---------EEEEEEeccc-----cHHhHHHHHHHHHHHhcCCCCcccc-eeeeEEe
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQ 218 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~ 218 (295)
....++|.+.+.||+|+||.||+ .+|||++... .....+.+.+|+.+|++++|+|++. +++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---- 89 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---- 89 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence 44557899999999999999996 3699986532 2234567999999999999999985 443
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC-CCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL-KASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl-kp~N 295 (295)
.+..+|||||+++++|.. +. . . . ...++.|+++||.|||+++ |+|||| ||+|
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~-------------~-~-~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~N 142 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-AR-------------P-H-G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQN 142 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hC-------------c-c-c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcce
Confidence 256899999999999962 20 0 0 0 1357889999999999998 999999 9998
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.1e-17 Score=142.50 Aligned_cols=119 Identities=30% Similarity=0.508 Sum_probs=101.1
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
-|...+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.++|+|++++++++.+.+..++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 366668899999999997 5899988642 23445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+++ |+|+||||+|
T Consensus 102 ~~~-~~l~~~l~~--------------~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~n 151 (313)
T cd06633 102 YCL-GSASDLLEV--------------HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGN 151 (313)
T ss_pred cCC-CCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhh
Confidence 996 577776631 2345889999999999999999999998 9999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-18 Score=152.42 Aligned_cols=121 Identities=27% Similarity=0.387 Sum_probs=102.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc--------HHhHHHHHHHHHHHhcCC---CCcccceeeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--------EQGLKELKNEVILFSKLQ---HRNLVKLLGCCI 217 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~ 217 (295)
..+|+.++.+|.|+||.|+. .|.||.+.+.. ....-..-.||.||+.|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 45689999999999999983 78999886521 112223567999999998 999999999999
Q ss_pred eCCeeEEEEecC-CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFM-PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.++.||+||-. ++.+|+++|. ..+.+++.....|+.||+-|+++||+++ |||||||-+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE---------------~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikden 700 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE---------------FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDEN 700 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh---------------ccCccchHHHHHHHHHHHhccccccccC---ceeccccccc
Confidence 999999999975 4668888883 4467999999999999999999999999 9999999987
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.74 E-value=7.3e-18 Score=148.50 Aligned_cols=120 Identities=22% Similarity=0.398 Sum_probs=101.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 222 (295)
.++|++.+.||+|+||.||+ .||+|++... .......+.+|+.+|.+++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36889999999999999996 6899988652 22345677889999999999999999998763 4568
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+. ++|.+++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~lv~e~~~-~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 137 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---------------SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSN 137 (334)
T ss_pred EEEEehhh-hhHHHHhc---------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 99999995 68888773 2245899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=146.86 Aligned_cols=119 Identities=29% Similarity=0.443 Sum_probs=99.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 219 (295)
..++|++.+.||+|+||.||+ .+|+|.+.. ........+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 347899999999999999996 689999864 2334456788899999999999999999987643
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++||||+. ++|.+.+. ..+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~-----------------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~N 148 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ-----------------MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 148 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh-----------------hcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 35799999995 57877663 12788888999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=147.12 Aligned_cols=120 Identities=30% Similarity=0.553 Sum_probs=100.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC--Cee
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG--EEK 222 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~--~~~ 222 (295)
..++|++.+.||+|+||.||+ .+|+|++.. ........+..|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 456889999999999999996 589998753 2233456677899999999 999999999988653 468
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||++ ++|.+++.. ..++|..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 85 ~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~n 137 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----------------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSN 137 (337)
T ss_pred EEEecccc-cCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 99999997 588887731 26788999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=146.72 Aligned_cols=120 Identities=25% Similarity=0.382 Sum_probs=99.6
Q ss_pred ccccc-cceeecccCccceeE--------EEEEEEeccccHHh--------------HHHHHHHHHHHhcCCCCccccee
Q 041718 157 TDNFS-INNKLGEGGFGLVYK--------EIAVKRLSKISEQG--------------LKELKNEVILFSKLQHRNLVKLL 213 (295)
Q Consensus 157 ~~~~~-~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~h~niv~l~ 213 (295)
.++|. +.+.||.|+||.||+ .+|+|.+....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 347799999999997 58999886422111 12577899999999999999999
Q ss_pred eeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
+++...+..++||||++ ++|.+++. ....+++.....++.|++.||.|||+.+ |+|+||||
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---------------~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~ 147 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVD---------------RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSP 147 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence 99999999999999996 68888773 2245888999999999999999999988 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 148 ~n 149 (335)
T PTZ00024 148 AN 149 (335)
T ss_pred HH
Confidence 87
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-17 Score=139.18 Aligned_cols=114 Identities=27% Similarity=0.323 Sum_probs=94.0
Q ss_pred eeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHH-HhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.||+|+||.||+ .+|+|.+.... ......+..|..+ ...++|+|++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5789999999996 58999886532 2223344555544 4456899999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+|
T Consensus 82 ~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~n 127 (260)
T cd05611 82 GDCASLIKT---------------LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPEN 127 (260)
T ss_pred CCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999998842 235788999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=142.29 Aligned_cols=119 Identities=29% Similarity=0.431 Sum_probs=100.4
Q ss_pred cccceeecccCccceeE--------EEEEEEeccccH-HhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISE-QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
|++.+.||+|++|.||+ .+|+|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56779999999999996 589998864221 22334557999999999 999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. .....+++..+..++.|++.+|.|||+++ ++|+||+|+|
T Consensus 81 -~~~l~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~n 129 (283)
T cd07830 81 -EGNLYQLMKD-------------RKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPEN 129 (283)
T ss_pred -CCCHHHHHHh-------------cccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhh
Confidence 8899888742 12346899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=140.11 Aligned_cols=113 Identities=25% Similarity=0.279 Sum_probs=91.6
Q ss_pred eecccCccceeE--------EEEEEEecccc---HHhHHHHHHHH---HHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 165 KLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEV---ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 165 ~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.||+|+||.||+ .||+|.+.... ......+..|. .+++...||||+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999995 69999886421 11122233343 34555689999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 81 g~~L~~~l~---------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~n 127 (278)
T cd05606 81 GGDLHYHLS---------------QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 127 (278)
T ss_pred CCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHH
Confidence 999998773 2246899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=145.72 Aligned_cols=120 Identities=24% Similarity=0.468 Sum_probs=100.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----Ce
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 221 (295)
.++|.+.+.||+|+||.||+ .||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999996 5899988642 233455678899999999999999999987654 35
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++|+||+. ++|.+++. ....+++.....++.|++.||.|||+++ ++||||||+|
T Consensus 84 ~~lv~e~~~-~~L~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~N 138 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---------------SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSN 138 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 799999995 68887773 2246889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=142.22 Aligned_cols=121 Identities=31% Similarity=0.508 Sum_probs=101.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
...|+..+.||+|+||.||+ .+|+|.+.. .......++.+|+.+++.++|+|++++++++...+..++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34577778999999999995 588998753 2334456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+++ ++||||||+|
T Consensus 94 ~e~~~-~~l~~~~~~--------------~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~n 145 (308)
T cd06634 94 MEYCL-GSASDLLEV--------------HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGN 145 (308)
T ss_pred EEccC-CCHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHh
Confidence 99996 688776631 2235788999999999999999999987 9999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.7e-17 Score=145.81 Aligned_cols=118 Identities=28% Similarity=0.477 Sum_probs=102.0
Q ss_pred ccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----eeE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-----EKL 223 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-----~~~ 223 (295)
+|.+.+.||.|++|.||+ .+|+|.+.... ....+.+..|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 477889999999999996 58999887532 445678999999999999999999999988775 789
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||++ ++|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 81 lv~e~~~-~~l~~~l~---------------~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~n 133 (330)
T cd07834 81 IVTELME-TDLHKVIK---------------SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSN 133 (330)
T ss_pred EEecchh-hhHHHHHh---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999997 57887773 2236899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=140.75 Aligned_cols=118 Identities=33% Similarity=0.506 Sum_probs=101.5
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
|++.+.||+|++|.||+ .+++|.+... .......+..|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 55678999999999997 5899988653 2234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+|+||||+|
T Consensus 81 ~~-~l~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~n 128 (283)
T cd05118 81 DT-DLYKLIKD--------------RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPEN 128 (283)
T ss_pred CC-CHHHHHHh--------------hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHH
Confidence 75 88887742 2246899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-17 Score=141.26 Aligned_cols=124 Identities=27% Similarity=0.362 Sum_probs=99.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|...+.||+|+||.||+ .+|+|.+... .......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3566678999999999996 6899988642 2345667899999999996 9999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
|++ ++|.++.... .......+++.....++.|++.||+|||+. + |+||||||+|
T Consensus 84 ~~~-~~l~~l~~~~----------~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~N 138 (288)
T cd06616 84 LMD-ISLDKFYKYV----------YEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSN 138 (288)
T ss_pred ccc-CCHHHHHHHH----------HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHH
Confidence 986 4655543210 111235689999999999999999999975 5 9999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.1e-17 Score=135.91 Aligned_cols=112 Identities=29% Similarity=0.345 Sum_probs=98.3
Q ss_pred ecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
||.|+||.||+ .+|+|.+.... ......+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999996 58899886532 23456889999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+|
T Consensus 81 ~~~l~~---------------~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~n 123 (250)
T cd05123 81 FSHLSK---------------EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPEN 123 (250)
T ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcce
Confidence 998842 235889999999999999999999987 9999999987
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-18 Score=140.80 Aligned_cols=119 Identities=29% Similarity=0.330 Sum_probs=96.5
Q ss_pred hccccccc-eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEe----CCe
Q 041718 156 ATDNFSIN-NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ----GEE 221 (295)
Q Consensus 156 ~~~~~~~~-~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~----~~~ 221 (295)
.+++|++. ++||-|-.|.|.. .+|+|+|.. ....++|+++--+. .|||||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56778775 5799999999874 467776643 23456777764444 59999999998764 456
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+|||.|+||.|++.+. ......+++.++-.|+.||..|+.|||+.+ |.||||||+|
T Consensus 134 LLiVmE~meGGeLfsriq-------------~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpEN 191 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQ-------------DRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPEN 191 (400)
T ss_pred eEeeeecccchHHHHHHH-------------HcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhh
Confidence 789999999999999884 345567999999999999999999999998 9999999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=148.61 Aligned_cols=131 Identities=28% Similarity=0.486 Sum_probs=109.9
Q ss_pred hhhhhhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEe
Q 041718 148 FELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 218 (295)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 218 (295)
.++..+...++.|.+...||.|.+|.||+ ..|+|++.. .....+++..|..+|+.+ +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34455566778899999999999999997 578887754 344556777888888887 59999999999874
Q ss_pred -----CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 219 -----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 219 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
++.+|||||||.+||..+++.. .....+.|..+..|+.++++||.+||.+. +||||||-
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn-------------~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG 151 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKN-------------TKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKG 151 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhh-------------hcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccC
Confidence 6789999999999999999952 33677999999999999999999999886 99999998
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
.|
T Consensus 152 ~N 153 (953)
T KOG0587|consen 152 QN 153 (953)
T ss_pred ce
Confidence 76
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.6e-17 Score=141.61 Aligned_cols=121 Identities=29% Similarity=0.464 Sum_probs=99.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC------
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 220 (295)
.++|++.++||.|+||.||+ .+|+|.+.... ......+.+|+.++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999996 58999885422 222346788999999999999999999875433
Q ss_pred --eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 --EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++|+||+.+ +|...+. .....+++..+..++.|+++||.|||+++ |+|+||||+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~--------------~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~n 145 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLE--------------NPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAAN 145 (311)
T ss_pred CceEEEEEecCCc-CHHHHHh--------------ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 46999999964 6666653 12346899999999999999999999998 9999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.4e-17 Score=144.81 Aligned_cols=121 Identities=30% Similarity=0.508 Sum_probs=102.7
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe---
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 221 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 221 (295)
...++|.+.+.||+|++|.||+ .+|+|.+... .......+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3457899999999999999996 6899988642 23345667889999999999999999998876655
Q ss_pred ---eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 ---KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++|+||+ +++|.+++. ...+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----------------~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~N 148 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----------------CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSN 148 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 89999999 679988873 145899999999999999999999988 9999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-18 Score=164.35 Aligned_cols=123 Identities=30% Similarity=0.447 Sum_probs=103.4
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..+-++.-..+||.|.||.||. ..|||-+.- ...........|+.++..|+|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3344566678999999999996 468887653 234455678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.||||++|+|.+.+. .....++.....+..|++.|+.|||+++ ||||||||+|
T Consensus 1312 FMEyC~~GsLa~ll~---------------~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aN 1364 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLE---------------HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPAN 1364 (1509)
T ss_pred HHHHhccCcHHHHHH---------------hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccc
Confidence 999999999999883 2344666666778899999999999998 9999999998
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.5e-17 Score=139.61 Aligned_cols=118 Identities=32% Similarity=0.484 Sum_probs=102.0
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
|+..+.||+|++|.||+ .+|+|.+... .....+.+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 45668899999999996 6899988753 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+ ++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||+|+|
T Consensus 81 ~-~~l~~~i~~--------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~n 128 (282)
T cd07829 81 D-MDLKKYLDK--------------RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQN 128 (282)
T ss_pred C-cCHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhe
Confidence 7 589998842 1146899999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=136.85 Aligned_cols=119 Identities=29% Similarity=0.461 Sum_probs=97.1
Q ss_pred cccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcC---CCCcccceeeeEEeCCe-----
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQGEE----- 221 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~~~~----- 221 (295)
|++.+.||+|+||.||+ .+|+|.+... .......+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 56779999999999996 6899998632 222345566788776655 69999999999988777
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++|||++ ++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 81 ~~l~~e~~~-~~l~~~l~~-------------~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~n 137 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSK-------------CPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQN 137 (287)
T ss_pred eEEEehhcc-cCHHHHHHH-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhh
Confidence 999999996 588887742 12235899999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-17 Score=142.37 Aligned_cols=123 Identities=28% Similarity=0.383 Sum_probs=103.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc---c----cHHhHHHHHHHHHHHhcCCCCcccceeeeEE-eCC
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---I----SEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGE 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~ 220 (295)
.++|-++.+||+|||+.||| .||||+-.. + .....+...+|-.|-+.|+||-||++++++. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35678889999999999997 689997532 1 1223456678999999999999999999986 556
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+.-|+||++|.+|+-||. ..+.+++..+..|+.||+.||.||... ++||||-||||.|
T Consensus 542 sFCTVLEYceGNDLDFYLK---------------QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgN 600 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK---------------QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGN 600 (775)
T ss_pred cceeeeeecCCCchhHHHH---------------hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCcc
Confidence 6789999999999999985 346788999999999999999999988 5889999999987
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-18 Score=140.42 Aligned_cols=122 Identities=23% Similarity=0.298 Sum_probs=106.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|..+++||+|.||.|.. .+|+|++++ ...........|-++|..-+||.+..|.-.|...+++.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 346888899999999999983 699999986 244556677889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||..||.|.-.|. +...+++.....+..+|+.||.|||+++ ||.||||.+|
T Consensus 246 VMeyanGGeLf~HLs---------------rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLEN 298 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---------------RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLEN 298 (516)
T ss_pred EEEEccCceEeeehh---------------hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhh
Confidence 999999999987773 3456777888889999999999999998 9999999987
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=137.89 Aligned_cols=122 Identities=22% Similarity=0.350 Sum_probs=99.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv 225 (295)
..++|.+.+.||+|+||.||+ .+|||.++.. .......+..|+.++.++. |+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 346788889999999999996 5899998653 2334456677887777765 99999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
|||++ ++|.+++.. ....+++..+..++.|++.||+|||+ .+ |+||||+|+|
T Consensus 93 ~e~~~-~~l~~l~~~--------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~n 145 (296)
T cd06618 93 MELMS-TCLDKLLKR--------------IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSN 145 (296)
T ss_pred eeccC-cCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHH
Confidence 99985 467666531 12368899999999999999999997 45 9999999987
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=140.45 Aligned_cols=118 Identities=26% Similarity=0.424 Sum_probs=96.7
Q ss_pred ccccceeecccCccceeE----------EEEEEEeccc--cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC----Ce
Q 041718 159 NFSINNKLGEGGFGLVYK----------EIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG----EE 221 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~----~~ 221 (295)
+|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++.++ +|+||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477789999999999995 4899988642 223356788899999999 599999999975432 45
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++++||+. ++|.+++. ....+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 81 ~~~~~e~~~-~~L~~~l~---------------~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~N 135 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---------------SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGN 135 (332)
T ss_pred EEEEEeccc-CCHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 788999985 68888773 2346889999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-17 Score=158.73 Aligned_cols=64 Identities=31% Similarity=0.532 Sum_probs=53.6
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 218 (295)
.-..+|..+..||+||||.||| .+|||++.-. +......+.+|+.+|++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 3456788899999999999997 6999998742 44556778899999999999999999987643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-17 Score=132.90 Aligned_cols=116 Identities=27% Similarity=0.434 Sum_probs=99.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCC--eeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~~l 224 (295)
..++|++.+++|+|.++.||. .+.||+++. -..+.+.+|+.+|..|. ||||++|++...++. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999996 578888764 45577899999999998 999999999987653 4579
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+||+.+.+...+. +.|+...+..++.+++.||.|.|+.| |+|||+||.|
T Consensus 113 iFE~v~n~Dfk~ly------------------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhN 162 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------------------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHN 162 (338)
T ss_pred HhhhhccccHHHHh------------------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcce
Confidence 99999887776544 35777788889999999999999998 9999999988
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.4e-17 Score=145.84 Aligned_cols=122 Identities=21% Similarity=0.330 Sum_probs=105.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccH---HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
....|..++.||-|+||.|-. .+|+|.|.+.+. ......+.|-.||+.-+++.||+|+-.|.+.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 345677788999999999974 578998876432 334567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||++||++..+|. +...+++..+..++.++..|+++.|.-| +|||||||+|
T Consensus 707 VMdYIPGGDmMSLLI---------------rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDN 759 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLI---------------RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDN 759 (1034)
T ss_pred EEeccCCccHHHHHH---------------HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccc
Confidence 999999999999985 3457888888889999999999999887 9999999998
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=141.00 Aligned_cols=118 Identities=29% Similarity=0.487 Sum_probs=97.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------C
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------E 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~ 220 (295)
.++|.+.+.||+|+||.||+ .+|+|.+... .......+.+|+.+++.++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 46899999999999999996 5899988642 233346688999999999999999999998754 3
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.++|+||+. .+|..++ ...+++.....++.|++.||+|||+++ |+||||||+|
T Consensus 94 ~~~lv~e~~~-~~l~~~~-----------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~N 147 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM-----------------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGN 147 (342)
T ss_pred eEEEEecccc-cCHHHHH-----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 4689999996 3665543 135788999999999999999999998 9999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.6e-17 Score=130.67 Aligned_cols=113 Identities=18% Similarity=0.110 Sum_probs=83.5
Q ss_pred ceeecccCccceeE-------EEEEEEeccccHH--h-------HH-----------------HHHHHHHHHhcCCCCcc
Q 041718 163 NNKLGEGGFGLVYK-------EIAVKRLSKISEQ--G-------LK-----------------ELKNEVILFSKLQHRNL 209 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk-------~vavK~l~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~h~ni 209 (295)
...||+|+||.||+ .||||+++..... . .. ....|+..|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46899999999996 6999998642110 0 11 22349999999988877
Q ss_pred cceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhh-hcCCCCCeEe
Q 041718 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYL-HQDSKLRIIH 288 (295)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yL-H~~~~~~iiH 288 (295)
....... ....+|||||++++++...+. ....+++.....++.|++.+|.|| |+.+ |+|
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiH 141 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---------------KDAPLSESKARELYLQVIQIMRILYQDCR---LVH 141 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---------------hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 5443322 223489999999877654431 124578889999999999999999 6777 999
Q ss_pred ccCCCCC
Q 041718 289 RDLKASN 295 (295)
Q Consensus 289 rDlkp~N 295 (295)
|||||+|
T Consensus 142 rDlkP~N 148 (190)
T cd05147 142 ADLSEYN 148 (190)
T ss_pred CCCCHHH
Confidence 9999998
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=139.27 Aligned_cols=121 Identities=26% Similarity=0.404 Sum_probs=102.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-----C---CcccceeeeEE----
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-----H---RNLVKLLGCCI---- 217 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----h---~niv~l~~~~~---- 217 (295)
.+|.+.++||-|-|++||. .||+|+.+. .+...+....||.+|++++ | .+||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788999999999999994 699999864 4566777889999999884 2 47999999987
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+.++.+|+|++ |-+|..+|.. ..-.-++.....+|+.||+.||.|||.++ .|||-||||+|
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-------------s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN 218 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-------------SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN 218 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-------------hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence 467899999999 6788888753 23355888999999999999999999987 69999999998
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.3e-17 Score=142.59 Aligned_cols=124 Identities=25% Similarity=0.387 Sum_probs=104.5
Q ss_pred hhhccccccceeecccCccceeE-------EEEEEEec--cccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK-------EIAVKRLS--KISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~--~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 223 (295)
......|+++++||.||.+.||+ .+|+|++. ..+.+....|++|+.+|.+|+ |.+||+|+++-..++.+|
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 34456799999999999999997 46777654 356778899999999999996 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||= ..+|..+|.. .......| .+..+..|+++++.++|.++ |||.||||+|
T Consensus 437 mvmE~G-d~DL~kiL~k-------------~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPAN 490 (677)
T KOG0596|consen 437 MVMECG-DIDLNKILKK-------------KKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPAN 490 (677)
T ss_pred EEeecc-cccHHHHHHh-------------ccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCccc
Confidence 999986 5799999842 22333445 66778999999999999998 9999999998
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.5e-17 Score=107.24 Aligned_cols=66 Identities=42% Similarity=0.931 Sum_probs=58.3
Q ss_pred cCCCCceeEEeeccCCCCcccccccCCChHHHHHHhhcCCCccceecccccCCCcceeeecccCCcc
Q 041718 51 YSRQDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDM 117 (295)
Q Consensus 51 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~g~~C~~w~~~L~~~ 117 (295)
|+.+|+|+++.+|++|+....+++.+.++++|+..|++||+|.||+|.++. ++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 555789999999999999887766779999999999999999999998665 568899999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=132.56 Aligned_cols=104 Identities=21% Similarity=0.174 Sum_probs=87.8
Q ss_pred cCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhh
Q 041718 169 GGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFE 240 (295)
Q Consensus 169 G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 240 (295)
|.+|.||+ .+|+|++.... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 78888985 69999986532 233455556667799999999999999999999999999999998842
Q ss_pred hhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 241 NFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 79 ---------------~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~N 115 (237)
T cd05576 79 ---------------FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNN 115 (237)
T ss_pred ---------------hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 134889999999999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.5e-17 Score=139.51 Aligned_cols=124 Identities=26% Similarity=0.335 Sum_probs=105.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..+.|+.-++||+|+||.|+- .+|.|.+.+. ..++..-..+|-.+|.+++.+.||.|--+|++.+.+.|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788889999999999993 5677777542 23455567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+..|.||+|.-.|.. -....+++.....++.+|+.||++||... ||.|||||+|
T Consensus 263 VLtlMNGGDLkfHiyn-------------~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeN 317 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYN-------------HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPEN 317 (591)
T ss_pred EEEeecCCceeEEeec-------------cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhh
Confidence 9999999999887742 23367899999999999999999999987 9999999998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=123.50 Aligned_cols=113 Identities=18% Similarity=0.165 Sum_probs=85.0
Q ss_pred ceeecccCccceeE-------EEEEEEeccccHH--------------------------hHHHHHHHHHHHhcCCCCcc
Q 041718 163 NNKLGEGGFGLVYK-------EIAVKRLSKISEQ--------------------------GLKELKNEVILFSKLQHRNL 209 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk-------~vavK~l~~~~~~--------------------------~~~~~~~Ei~~l~~l~h~ni 209 (295)
.+.||+|+||.||+ .||||+++..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 47899999999996 6999998642110 01234678999999999988
Q ss_pred cceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEe
Q 041718 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIH 288 (295)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiH 288 (295)
.....+... ..+|||||++++++..... ....++......++.|++.+|.+||+ .+ |+|
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivH 141 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---------------KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVH 141 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---------------hhccCCHHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 655544332 3489999999886543321 11346678888999999999999999 87 999
Q ss_pred ccCCCCC
Q 041718 289 RDLKASN 295 (295)
Q Consensus 289 rDlkp~N 295 (295)
|||||+|
T Consensus 142 rDlkP~N 148 (190)
T cd05145 142 GDLSEYN 148 (190)
T ss_pred CCCChhh
Confidence 9999998
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-15 Score=125.16 Aligned_cols=118 Identities=33% Similarity=0.482 Sum_probs=103.3
Q ss_pred cccceeecccCccceeE--------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
|.+.+.||.|++|.||+ .+|+|.+...... ..+.+.+|+..+.+++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45668999999999996 5899998764443 67889999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCC-CCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKI-LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ... +++.....++.+++.+|.|||..+ ++|+||+|.|
T Consensus 81 ~~~L~~~~~~---------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~n 128 (225)
T smart00221 81 GGDLFDYLRK---------------KGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPEN 128 (225)
T ss_pred CCCHHHHHHh---------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9999998842 122 788999999999999999999987 9999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.1e-16 Score=145.13 Aligned_cols=138 Identities=32% Similarity=0.445 Sum_probs=109.5
Q ss_pred hhccccccceeecccCccceeE---------------EEEEEEecc-ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK---------------EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 217 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 217 (295)
...++..+.+.||+|.||.|++ .||||.++. ......+.+..|+.+|..+ +|+||+.++|++.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 3344556667999999999985 589999875 3346778999999999998 5999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhh-hhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLM-RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.....++|+||++.|+|.++|+..+..... ..-........++....+.++.|||.||+||++.. +|||||.++|
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 999999999999999999999865500000 00000000134899999999999999999999987 9999999887
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.6e-16 Score=132.88 Aligned_cols=119 Identities=24% Similarity=0.476 Sum_probs=103.9
Q ss_pred hhhccccccceeecccCccceeE-----------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCe
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEE 221 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~ 221 (295)
....+.|...++||+|.|+.||+ .||+|.+.. ......+.+|+++|..+. +.||+++.+++...+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--TSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--ccCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 34456788899999999999995 589998864 234456899999999985 8999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+|+||+++-+..++++ .++......++..+..||.++|.+| ||||||||+|
T Consensus 110 v~ivlp~~~H~~f~~l~~------------------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsN 162 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR------------------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSN 162 (418)
T ss_pred eEEEecccCccCHHHHHh------------------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccc
Confidence 999999999999988874 3667888889999999999999999 9999999998
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.9e-15 Score=128.81 Aligned_cols=120 Identities=21% Similarity=0.284 Sum_probs=83.9
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccccHHh-----------HHHHHHHHHHHhcCCCCcccceee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKISEQG-----------LKELKNEVILFSKLQHRNLVKLLG 214 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~h~niv~l~~ 214 (295)
.+.|++.++||+|+||.||+ .+|+|......... ......+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999996 23555432111110 111223445567789999999999
Q ss_pred eEEeCC----eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEecc
Q 041718 215 CCIQGE----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRD 290 (295)
Q Consensus 215 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrD 290 (295)
...... ..++++|++. .++.+.+. .....++.....|+.|++.||+|||+++ |+|||
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrD 151 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFK---------------RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGD 151 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHH---------------hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 765543 3467788764 35555442 1123567788899999999999999988 99999
Q ss_pred CCCCC
Q 041718 291 LKASN 295 (295)
Q Consensus 291 lkp~N 295 (295)
|||+|
T Consensus 152 iKp~N 156 (294)
T PHA02882 152 IKPEN 156 (294)
T ss_pred CCHHH
Confidence 99998
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.4e-15 Score=122.23 Aligned_cols=120 Identities=21% Similarity=0.345 Sum_probs=100.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCC-CcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 226 (295)
...+|.++++||.|+||.+|. .||||.-+. ....-++..|..+...|++ ..|..+..+..+.++-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 356899999999999999995 799997543 2234467788888888875 57777788888899999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|.+ +-||++++. -....++..+.+-++-|++.-++|+|.++ .|||||||+|
T Consensus 91 dLL-GPsLEdLfn--------------fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdN 141 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN--------------FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDN 141 (341)
T ss_pred ecc-CccHHHHHH--------------HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccc
Confidence 999 789988773 23456888899999999999999999998 9999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.61 E-value=1e-14 Score=118.55 Aligned_cols=113 Identities=38% Similarity=0.587 Sum_probs=98.4
Q ss_pred ecccCccceeE--------EEEEEEeccccHH-hHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHH
Q 041718 166 LGEGGFGLVYK--------EIAVKRLSKISEQ-GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNS 236 (295)
Q Consensus 166 lg~G~~g~Vyk--------~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 236 (295)
||+|++|.||+ .+++|.+...... ....+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999996 4888988753322 45789999999999999999999999999999999999999999999
Q ss_pred HHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 237 FIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 237 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++.. ....+++..+..++.+++++|.|||+.+ ++|+||+|.|
T Consensus 81 ~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~n 122 (215)
T cd00180 81 LLKE--------------NEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPEN 122 (215)
T ss_pred HHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhh
Confidence 8842 1145889999999999999999999997 9999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.1e-15 Score=122.21 Aligned_cols=114 Identities=15% Similarity=0.172 Sum_probs=91.0
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccc---cHHhHHH------HHHHHHHHhcCCCCcccceeeeEEeC-
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKI---SEQGLKE------LKNEVILFSKLQHRNLVKLLGCCIQG- 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~---~~~~~~~------~~~Ei~~l~~l~h~niv~l~~~~~~~- 219 (295)
..++|++.+.+|.|+||.||. .+|+|.+... .+..... +.+|+..+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 357899999999999999996 6899998642 2222222 67999999999999999999986643
Q ss_pred -------CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCC
Q 041718 220 -------EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292 (295)
Q Consensus 220 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlk 292 (295)
...+|||||++|.+|.++.. ++. ....+++.+|..+|..+ ++|||+|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------------~~~----~~~~~i~~~l~~lH~~g---i~H~Dik 162 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------------------ISE----DVKAKIKASIESLHQHG---MVSGDPH 162 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------------------ccH----HHHHHHHHHHHHHHHcC---CccCCCC
Confidence 35789999999999977541 111 24568999999999998 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 163 p~N 165 (232)
T PRK10359 163 KGN 165 (232)
T ss_pred hHH
Confidence 998
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=131.09 Aligned_cols=120 Identities=27% Similarity=0.378 Sum_probs=99.1
Q ss_pred ccccceeecccCccceeE---------EEEEEEeccccHHhHHHHHHHHHHHhcCCC----CcccceeeeE-EeCCeeEE
Q 041718 159 NFSINNKLGEGGFGLVYK---------EIAVKRLSKISEQGLKELKNEVILFSKLQH----RNLVKLLGCC-IQGEEKLL 224 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h----~niv~l~~~~-~~~~~~~l 224 (295)
+|++.++||+|+||.||. .+|+|............+..|+.++..+.. +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999995 367776654322222378889999998873 6899999988 47788999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+.+ +.+|.++... .....++..+.+.|+.|++.+|++||+.+ +|||||||+|
T Consensus 99 VM~l~-G~sL~dl~~~-------------~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N 152 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKR-------------NPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPEN 152 (322)
T ss_pred EEecc-CccHHHHHHh-------------CCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHH
Confidence 99988 8899987632 12467899999999999999999999998 9999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-15 Score=118.71 Aligned_cols=124 Identities=26% Similarity=0.397 Sum_probs=100.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++......||+|++|.|-+ .+|+|++.. ...+..+++.+|+.+..+ ...|.+|.++|........||.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 4444457899999998864 689999874 455677888899986555 579999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.| ..||+.+-..- -.....+++...-+|+..|..||.|||++ +.|||||+||+|
T Consensus 126 ~M-~tSldkfy~~v-----------~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsN 179 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKV-----------LKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSN 179 (282)
T ss_pred Hh-hhhHHHHHHHH-----------HhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcce
Confidence 99 56888776431 13456788889999999999999999986 469999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.5e-16 Score=142.25 Aligned_cols=123 Identities=25% Similarity=0.423 Sum_probs=108.5
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
+..++|.+...+|.|.||.||| ..|+|+++-.......-+..|+-+++.-+|+|||.++|.+...+.+|+.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 5567899999999999999997 57899887655566777889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+.+|+|.++-+ .-..+++.+........++||.|||+.+ -+|||||-.|
T Consensus 92 EycgggslQdiy~---------------~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGan 142 (829)
T KOG0576|consen 92 EYCGGGSLQDIYH---------------VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGAN 142 (829)
T ss_pred EecCCCcccceee---------------ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccc
Confidence 9999999998763 2356788888888999999999999998 8999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-16 Score=127.66 Aligned_cols=124 Identities=31% Similarity=0.384 Sum_probs=98.9
Q ss_pred ccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhc-CCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
+.+.+..||.|+||+|+| .+|||+++. ......++++.|+.+..+ -+.||||+++|....+...||-||+
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 445567899999999996 789999975 345677889999976554 4689999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
| ..||+.+...-+ ..+...+++.-.-.|...++.||.||-.. +.|||||+||+|
T Consensus 145 M-d~SlDklYk~vy----------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSN 198 (361)
T KOG1006|consen 145 M-DISLDKLYKRVY----------SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSN 198 (361)
T ss_pred H-hhhHHHHHHHHH----------HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhh
Confidence 9 567776553221 12335678887888888999999999875 369999999998
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.7e-15 Score=127.73 Aligned_cols=121 Identities=21% Similarity=0.311 Sum_probs=103.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCC--C----cccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH--R----NLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~----niv~l~~~~~~~~~~ 222 (295)
+.+|.+.+.+|+|.||.|.+ .||||+++. .....+..+-|+.+|.+|.+ | -+|++.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 67899999999999999986 689998865 34556677889999999943 2 378888999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.||+|.+ |-|+.++|. .+.-..++...+..|+.|+++++.|||+.. ++|-||||+|
T Consensus 167 Civfell-G~S~~dFlk-------------~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPEN 222 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLK-------------ENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPEN 222 (415)
T ss_pred EEEEecc-ChhHHHHhc-------------cCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChhe
Confidence 9999999 679999994 345567888999999999999999999987 9999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=118.63 Aligned_cols=110 Identities=18% Similarity=0.234 Sum_probs=90.2
Q ss_pred eeecccCccceeE------EEEEEEecccc--------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 164 NKLGEGGFGLVYK------EIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 164 ~~lg~G~~g~Vyk------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
+.||+|++|.||+ .+++|...... ......+.+|+.++..+.|++++....++...+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 6799999999997 57888654211 112346788999999999999988888877888899999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. ..+ .+..++.+++.+|.+||+.+ ++|+|++|+|
T Consensus 82 ~G~~L~~~~~~------------------~~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~N 125 (211)
T PRK14879 82 EGEPLKDLINS------------------NGM-EELELSREIGRLVGKLHSAG---IIHGDLTTSN 125 (211)
T ss_pred CCcCHHHHHHh------------------ccH-HHHHHHHHHHHHHHHHHhCC---cccCCCCccc
Confidence 99999988731 112 77889999999999999998 9999999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.7e-14 Score=134.76 Aligned_cols=113 Identities=20% Similarity=0.266 Sum_probs=90.4
Q ss_pred ccccccceeecccCccceeE------EEEEEEe-cc-c------cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRL-SK-I------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l-~~-~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
...|...+.||+|+||.||+ .+++|+. .+ . .....+.+.+|+.++..++|++++....+....+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34456678999999999997 2344432 11 1 112346788999999999999999888887777888
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~N 458 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSN 458 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHH
Confidence 99999999999998772 24568999999999999998 9999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.8e-15 Score=121.70 Aligned_cols=119 Identities=23% Similarity=0.412 Sum_probs=98.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceee-eEEeCCeeEEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLG-CCIQGEEKLLIY 226 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~-~~~~~~~~~lv~ 226 (295)
.+.|.+.+.||+|.||.+.. .+++|.+.+ .....++|.+|...--.| .|.||+.-++ .|.+.+...+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 36788999999999999873 689998875 334567899998755455 5899998876 477888889999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+|.|+|.+-+. ...+.+....+++.|++.|++|+|+++ +||||||.+|
T Consensus 102 E~aP~gdL~snv~----------------~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eN 151 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----------------AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAEN 151 (378)
T ss_pred ccCccchhhhhcC----------------cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccce
Confidence 9999999987662 245777888899999999999999998 9999999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-16 Score=128.65 Aligned_cols=120 Identities=28% Similarity=0.504 Sum_probs=94.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--------C
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------G 219 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------~ 219 (295)
+.|.-..+||+|.||.||+ .||+|++-. ..........+|+.+|..|+|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566668999999999995 577775422 222334556789999999999999999998753 2
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+|||+.+++. +|.-+|. +....++..++.+++.++..||.|+|... |+|||+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLs--------------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaN 154 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLS--------------NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAAN 154 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhc--------------CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhh
Confidence 347999999964 7777762 23456889999999999999999999887 9999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=119.28 Aligned_cols=108 Identities=27% Similarity=0.395 Sum_probs=92.7
Q ss_pred CccceeE--------EEEEEEeccccHHh-HHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhh
Q 041718 170 GFGLVYK--------EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFE 240 (295)
Q Consensus 170 ~~g~Vyk--------~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 240 (295)
+||.||+ .+|+|++....... .+.+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 3566664 58999987543333 68899999999999999999999999999999999999999999998842
Q ss_pred hhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 241 NFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+++..+..++.+++.+|.|||..+ |+|+||+|+|
T Consensus 81 ---------------~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~n 117 (244)
T smart00220 81 ---------------RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPEN 117 (244)
T ss_pred ---------------ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHH
Confidence 122888999999999999999999987 9999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=136.23 Aligned_cols=133 Identities=20% Similarity=0.290 Sum_probs=83.4
Q ss_pred hccccccceeecccCccceeE------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeee------EE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGC------CI 217 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~------~~ 217 (295)
..++|.+.+.||+|+||.||+ .+|+|++...... +....| .+....+.+++.+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999996 4889987642211 111111 1122222233222221 24
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhccc-----ccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVD-----QERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~-----~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlk 292 (295)
.....+|||||+++++|.+++...........+.. ..............|+.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56789999999999999998864211100000000 001111223445679999999999999988 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 283 P~N 285 (566)
T PLN03225 283 PQN 285 (566)
T ss_pred HHH
Confidence 988
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.8e-15 Score=130.15 Aligned_cols=121 Identities=25% Similarity=0.318 Sum_probs=102.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (295)
..+|..+.+||+|+||.|.. .+|||++++. .....+-.+.|-++|+.. +-|.+++|+.+|.+-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 45788889999999999984 6899999862 334455667788888876 46899999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+.+|+|.-.|. +-..+.+..+..+|.+||.||-|||+++ ||.||||.+|
T Consensus 428 VMEyvnGGDLMyhiQ---------------Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDN 480 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQ---------------QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 480 (683)
T ss_pred EEEEecCchhhhHHH---------------HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccc
Confidence 999999999987763 3345777888899999999999999999 9999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.2e-16 Score=135.93 Aligned_cols=121 Identities=22% Similarity=0.260 Sum_probs=104.6
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..+++.+.-||-|+||.|-. .+|+|.+++ .+....+....|-.+|...+.|.||+|+.-|.+...+|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 45667778899999999863 267777765 3445567788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||-|-||.|...|+ ....++..+...++..+++|++|||+++ ||.|||||+|
T Consensus 499 mEaClGGElWTiLr---------------dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPEN 550 (732)
T KOG0614|consen 499 MEACLGGELWTILR---------------DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPEN 550 (732)
T ss_pred HHhhcCchhhhhhh---------------hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhh
Confidence 99999999999985 3356888888899999999999999998 9999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-14 Score=131.29 Aligned_cols=117 Identities=30% Similarity=0.390 Sum_probs=95.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (295)
.++.|.+...+|.|+|+.|-+ ..+||++.+. ..+...|+.++... +|+||+++++.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 467788888899999999875 6789988753 23345566555554 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++.++.|.+.++. ..... ..+..|+.+++.++.|||+++ ||||||||+|
T Consensus 396 e~l~g~ell~ri~~---------------~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~N 445 (612)
T KOG0603|consen 396 ELLDGGELLRRIRS---------------KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGN 445 (612)
T ss_pred hhccccHHHHHHHh---------------cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhh
Confidence 99999988777742 11222 677789999999999999998 9999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.51 E-value=5.5e-14 Score=114.58 Aligned_cols=106 Identities=23% Similarity=0.319 Sum_probs=84.1
Q ss_pred eecccCccceeE------EEEEEEecccc--------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 165 KLGEGGFGLVYK------EIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 165 ~lg~G~~g~Vyk------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.||+|+||.||+ .+++|...... .....++.+|+.++..++|+++.....+....+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 379999999997 57888754211 1123667899999999999877666666667777899999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. .. ..++.+++.+|.+||+.+ ++|+|++|+|
T Consensus 81 g~~l~~~~~~-------------~~---------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~N 120 (199)
T TIGR03724 81 GKPLKDVIEE-------------GN---------DELLREIGRLVGKLHKAG---IVHGDLTTSN 120 (199)
T ss_pred CccHHHHHhh-------------cH---------HHHHHHHHHHHHHHHHCC---eecCCCCcce
Confidence 9999887731 00 068999999999999998 9999999998
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-15 Score=125.19 Aligned_cols=117 Identities=27% Similarity=0.496 Sum_probs=91.8
Q ss_pred cccceeecccCcccee--------EEEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----CeeEE
Q 041718 160 FSINNKLGEGGFGLVY--------KEIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EEKLL 224 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vy--------k~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~~~l 224 (295)
.+-.+.||-|+||.|| +.||+|++... +....+.+.+|+.+|...+|.|++..++..... .++|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3445889999999999 36898887652 233457788999999999999999999876543 24567
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+| ..+|..+|- ....|+-....-+++||++||.|||+.+ |+||||||.|
T Consensus 135 ~TELm-QSDLHKIIV---------------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGN 186 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIV---------------SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGN 186 (449)
T ss_pred HHHHH-Hhhhhheec---------------cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCcc
Confidence 77877 456776663 2345666777778999999999999998 9999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=115.69 Aligned_cols=122 Identities=18% Similarity=0.163 Sum_probs=87.8
Q ss_pred hhhhccccccceeecccCccceeE---------EEEEEEeccccHH------------------------hHHHHHHHHH
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKISEQ------------------------GLKELKNEVI 199 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~~~------------------------~~~~~~~Ei~ 199 (295)
+......|.+.+.||+|+||.||+ .||+|.+...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 334445688899999999999996 5789987642110 1134578999
Q ss_pred HHhcCCCCc--ccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHh
Q 041718 200 LFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY 277 (295)
Q Consensus 200 ~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~y 277 (295)
++.++.+.. +.++++. ...+|||||+++.+|...+. ....+.......++.|++.+|.+
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~ 163 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---------------KDVEPEEEEEFELYDDILEEMRK 163 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---------------ccCCcchHHHHHHHHHHHHHHHH
Confidence 999997633 3344432 23589999999988865431 11234555667899999999999
Q ss_pred hhcCCCCCeEeccCCCCC
Q 041718 278 LHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 278 LH~~~~~~iiHrDlkp~N 295 (295)
||+++ .|+||||||+|
T Consensus 164 LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 164 LYKEG--ELVHGDLSEYN 179 (237)
T ss_pred HHhcC--CEEeCCCChhh
Confidence 99886 49999999998
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.9e-14 Score=120.98 Aligned_cols=123 Identities=21% Similarity=0.316 Sum_probs=102.0
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 222 (295)
...++|.++++||+|+|..|.. .+|+|++++. +.....-...|-.+..+. +||.+|.|+.+|.+...+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3457899999999999999873 6899988752 233445556666666665 699999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.||+++|+|.-.+ ++...|++..+..+..+|..||.|||+++ ||.||||..|
T Consensus 327 ffvieyv~ggdlmfhm---------------qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldn 381 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHM---------------QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDN 381 (593)
T ss_pred EEEEEEecCcceeeeh---------------hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccc
Confidence 9999999999996544 34456889999999999999999999999 9999999887
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.3e-14 Score=131.64 Aligned_cols=118 Identities=27% Similarity=0.355 Sum_probs=89.3
Q ss_pred cccceeecccCccce-eE------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 160 FSINNKLGEGGFGLV-YK------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 160 ~~~~~~lg~G~~g~V-yk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
|.-.+.+|.|+-|+| |+ .||||++-. ....-..+||..|..- .|||||++++.-.+...+||..|.| .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 344567889988854 54 799998743 3344567899988876 5999999999988999999999999 5
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+|.+++.... .......-.....+..|++.||++||+.+ ||||||||+|
T Consensus 587 ~sL~dlie~~~-----------~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQN 636 (903)
T KOG1027|consen 587 CSLQDLIESSG-----------LDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQN 636 (903)
T ss_pred hhHHHHHhccc-----------cchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCce
Confidence 79999995320 00000111334568899999999999987 9999999998
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.3e-13 Score=115.79 Aligned_cols=120 Identities=19% Similarity=0.352 Sum_probs=101.0
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 226 (295)
..-+|++.++||+|+||.++. .||||.-... ...-+++.|....+.|. .+.|...+-+-.++.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 345899999999999999995 6999975432 23456777887777774 689999988888889999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ |-||+++.. -....++..+...||.|++.-++|+|++. +|.|||||+|
T Consensus 104 dLL-GPSLEDLFD--------------~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdN 154 (449)
T KOG1165|consen 104 DLL-GPSLEDLFD--------------LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDN 154 (449)
T ss_pred hhh-CcCHHHHHH--------------HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 999 789988762 35567899999999999999999999998 9999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.5e-13 Score=107.21 Aligned_cols=105 Identities=19% Similarity=0.239 Sum_probs=78.7
Q ss_pred cceeecccCccceeE------EEEEEEeccccH----HhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCC
Q 041718 162 INNKLGEGGFGLVYK------EIAVKRLSKISE----QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk------~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
+...|++|+||+||. .++.+.+..... -....+.+|+.+|++|+ |+++++++++ +..+++|||++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 457899999999995 355455543211 11225789999999995 5889999886 45699999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC-CCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL-KASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl-kp~N 295 (295)
+.+|.+.+. . ....++.|++.+|.++|+++ |+|||| ||+|
T Consensus 82 G~~L~~~~~---------------~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~N 122 (218)
T PRK12274 82 GAAMYQRPP---------------R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEAN 122 (218)
T ss_pred CccHHhhhh---------------h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcce
Confidence 988865431 0 01346789999999999998 999999 7887
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.4e-13 Score=112.85 Aligned_cols=121 Identities=21% Similarity=0.329 Sum_probs=96.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 227 (295)
++...+..||.|+-|.|++ .+|||.+.+. .....+++++.+.++.+-+ .|.||+.+|+|.....+++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3445567899999999997 5899998763 4455677888888777665 8999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.|. .-++.+|.. -...+++...-++...++.||.||..+. .|||||+||+|
T Consensus 172 lMs-~C~ekLlkr--------------ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSN 222 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR--------------IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSN 222 (391)
T ss_pred HHH-HHHHHHHHH--------------hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccc
Confidence 994 445555531 2245777777889999999999999875 59999999998
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.2e-13 Score=90.67 Aligned_cols=71 Identities=20% Similarity=0.258 Sum_probs=61.2
Q ss_pred cCCCCceeEEeeccCCCCcccccccCCChHHHHHHhhc---CCCccceecccccCCCcceeeecccC-CcccccCCCCcc
Q 041718 51 YSRQDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLD---DSSCMAYTNSYIRGEGSGCAMWFGEL-IDMRDFPDAGQD 126 (295)
Q Consensus 51 c~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---~CsC~a~~~~~~~~~g~~C~~w~~~L-~~~~~~~~~~~~ 126 (295)
|...++|+++.++++|+... .+.++|++.|++ ||+|.||+|.+. +.+|++|.++| ++.+.+++.+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 34567899999999998765 488999999999 999999998753 46899999999 999988877889
Q ss_pred eEEE
Q 041718 127 LYIR 130 (295)
Q Consensus 127 ~~~~ 130 (295)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9987
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=106.10 Aligned_cols=116 Identities=17% Similarity=0.161 Sum_probs=84.7
Q ss_pred hhhhhccccccceeecccCccceeE-------EEEEEEeccccH----------------------HhHHHHHHHHHHHh
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISE----------------------QGLKELKNEVILFS 202 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~----------------------~~~~~~~~Ei~~l~ 202 (295)
++......|.+.+.||+|+||.||+ .+|||++..... .....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3444444577889999999999996 689998653110 01123677899999
Q ss_pred cCCCCc--ccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc
Q 041718 203 KLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280 (295)
Q Consensus 203 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~ 280 (295)
.+.|++ ++..++ ....++||||+++++|..+.. ......++.+++.++.++|+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------------------~~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------------------LEDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------------------cccHHHHHHHHHHHHHHHHH
Confidence 998874 444443 345689999999998876431 02345688999999999999
Q ss_pred CCCCCeEeccCCCCC
Q 041718 281 DSKLRIIHRDLKASN 295 (295)
Q Consensus 281 ~~~~~iiHrDlkp~N 295 (295)
.+ |+||||||+|
T Consensus 144 ~g---i~H~Dl~p~N 155 (198)
T cd05144 144 HG---IIHGDLSEFN 155 (198)
T ss_pred CC---CCcCCCCccc
Confidence 87 9999999998
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.9e-13 Score=91.76 Aligned_cols=80 Identities=38% Similarity=0.830 Sum_probs=64.6
Q ss_pred CcCcCCC---CceeEEeeccCCCCcccccccCCChHHHHHHhhcCCCccceecccccCCCcceeeecccCCcccccCCCC
Q 041718 48 SLNYSRQ---DGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGELIDMRDFPDAG 124 (295)
Q Consensus 48 ~~~c~~~---~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~g~~C~~w~~~L~~~~~~~~~~ 124 (295)
+++|..+ +.|..+.++++|+..... .++++++|++.|+.||+|.|++|.+ ++++|++|...+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567543 689999999999887653 6789999999999999999999875 2567999999998877655556
Q ss_pred cceEEEee
Q 041718 125 QDLYIRMS 132 (295)
Q Consensus 125 ~~~~~~~~ 132 (295)
..+|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78888863
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-13 Score=113.44 Aligned_cols=116 Identities=30% Similarity=0.443 Sum_probs=89.3
Q ss_pred ccccceeecccCccce------e-EEEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeE
Q 041718 159 NFSINNKLGEGGFGLV------Y-KEIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKL 223 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~V------y-k~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~~ 223 (295)
+|.-+..+|.|.-..| . +.||+|.+.. ......++..+|..++..++|+||++++.+|... .+.|
T Consensus 18 Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeeecccCCCCceEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 4444555666654222 2 2688887653 2344566778899999999999999999998743 4579
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||| ..+|.+.+. ..++-.+...|..|++.|+.|||+.+ |+||||||+|
T Consensus 98 ~v~e~m-~~nl~~vi~-----------------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsn 148 (369)
T KOG0665|consen 98 LVMELM-DANLCQVIL-----------------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSN 148 (369)
T ss_pred HHHHhh-hhHHHHHHH-----------------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 999999 568887763 23677888899999999999999998 9999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.8e-12 Score=97.73 Aligned_cols=110 Identities=21% Similarity=0.182 Sum_probs=89.4
Q ss_pred cceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCC--CcccceeeeEEeCCeeEEEEecCCCCC
Q 041718 162 INNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (295)
+.+.||+|.++.||+ .+++|....... ...+..|+.++..++| .++++++++....+..+++|||+++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 357899999999996 678888765322 5678899999999987 599999998888888999999998876
Q ss_pred HHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 234 LNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 234 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..+ +......++.+++.+|++||......++|+|++|+|
T Consensus 80 ~~~~----------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~N 119 (155)
T cd05120 80 LDEV----------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119 (155)
T ss_pred cccC----------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcce
Confidence 6421 445667788999999999998644459999999988
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1e-11 Score=107.54 Aligned_cols=121 Identities=32% Similarity=0.496 Sum_probs=100.5
Q ss_pred cccceeecccCccceeE-----EEEEEEeccccH---HhHHHHHHHHHHHhcCCCC-cccceeeeEEeCCeeEEEEecCC
Q 041718 160 FSINNKLGEGGFGLVYK-----EIAVKRLSKISE---QGLKELKNEVILFSKLQHR-NLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk-----~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
|.+.+.||.|+|+.||+ .+++|.+..... .....+.+|+.+++.+.|+ +++++.+.+......+++++++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 56778999999999996 468888865322 2477899999999999988 79999999987777899999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++.+++.... .. ..+.......++.|++.++.|+|..+ ++|||+||+|
T Consensus 82 ~~~l~~~~~~~~-----------~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~n 131 (384)
T COG0515 82 GGSLEDLLKKIG-----------RK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPEN 131 (384)
T ss_pred CCcHHHHHHhcc-----------cc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 999996663210 00 36888899999999999999999998 9999999986
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-11 Score=102.52 Aligned_cols=109 Identities=16% Similarity=0.199 Sum_probs=78.1
Q ss_pred eeec-ccCccceeE------EEEEEEeccc-------------cHHhHHHHHHHHHHHhcCCCCcc--cceeeeEEeCC-
Q 041718 164 NKLG-EGGFGLVYK------EIAVKRLSKI-------------SEQGLKELKNEVILFSKLQHRNL--VKLLGCCIQGE- 220 (295)
Q Consensus 164 ~~lg-~G~~g~Vyk------~vavK~l~~~-------------~~~~~~~~~~Ei~~l~~l~h~ni--v~l~~~~~~~~- 220 (295)
..|| .||.|.||. .++||+.... +......+.+|+.++..|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4566 677777775 6788877431 11233567889999999998875 67777644322
Q ss_pred ---eeEEEEecCCC-CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 ---EKLLIYEFMPN-KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++|||++++ .+|.+++.. ..++.. .+.+++.+|.+||+.+ |+||||||+|
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~----------------~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~N 172 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE----------------APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHN 172 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc----------------CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchh
Confidence 23599999997 688887731 123332 3578999999999998 9999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5e-12 Score=108.49 Aligned_cols=136 Identities=24% Similarity=0.321 Sum_probs=104.7
Q ss_pred hhhhhhhccccccceeecccCccceeEE-------------EEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeee
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYKE-------------IAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGC 215 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk~-------------vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 215 (295)
..++.....+++....+-+|.||.||+. |-+|.++. .++-....+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3445555667888889999999999973 34444432 233345668889999999999999999998
Q ss_pred EEe-CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCC
Q 041718 216 CIQ-GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294 (295)
Q Consensus 216 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~ 294 (295)
+.+ .+..+.+|.++.-|+|..||.--+.. +......++-.+...++.|++.||+|||.++ |||.||.++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~-------~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaR 425 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGD-------DPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAAR 425 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccC-------CCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhh
Confidence 765 56678889999999999999632211 2234456777788899999999999999998 999999988
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 426 N 426 (563)
T KOG1024|consen 426 N 426 (563)
T ss_pred c
Confidence 7
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.7e-12 Score=122.56 Aligned_cols=121 Identities=24% Similarity=0.363 Sum_probs=91.6
Q ss_pred hhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~ 223 (295)
......|.+.+.||+|+||.||+ .||+|+-+....-. |.--..++.+|+ -+.|..+..++...+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34456788899999999999996 69999765422110 111112223333 234555666666778889
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+||.+.|||.+++. ..+.++|...+.|+.|+++-++.||..+ |||+||||+|
T Consensus 771 lv~ey~~~Gtlld~~N---------------~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDN 824 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---------------TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDN 824 (974)
T ss_pred eeeeccccccHHHhhc---------------cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcce
Confidence 9999999999999983 4577999999999999999999999998 9999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.8e-11 Score=97.58 Aligned_cols=110 Identities=18% Similarity=0.192 Sum_probs=72.2
Q ss_pred ceeecccCccceeE-------EEEEEEeccccH--HhHHH----------------------HHHHHHHHhcCCCCc--c
Q 041718 163 NNKLGEGGFGLVYK-------EIAVKRLSKISE--QGLKE----------------------LKNEVILFSKLQHRN--L 209 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk-------~vavK~l~~~~~--~~~~~----------------------~~~Ei~~l~~l~h~n--i 209 (295)
.+.||+|+||.||+ .||||++..... ..... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 47899999999996 699998764211 11111 134555666664433 4
Q ss_pred cceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEe
Q 041718 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIH 288 (295)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiH 288 (295)
.+.++. ...++||||++++++...... . .... .....++.+++.++.++|. .+ |+|
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~------------~---~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH 138 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK------------D---VRLL-EDPEELYDQILELMRKLYREAG---LVH 138 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhh------------h---hhhc-ccHHHHHHHHHHHHHHHhhccC---cCc
Confidence 444432 346899999998654321110 0 0001 4567899999999999998 76 999
Q ss_pred ccCCCCC
Q 041718 289 RDLKASN 295 (295)
Q Consensus 289 rDlkp~N 295 (295)
+||||+|
T Consensus 139 ~Dl~p~N 145 (187)
T cd05119 139 GDLSEYN 145 (187)
T ss_pred CCCChhh
Confidence 9999998
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-11 Score=108.26 Aligned_cols=122 Identities=19% Similarity=0.241 Sum_probs=102.5
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC------CCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ------HRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~------h~niv~l~~~~~~~~~~ 222 (295)
...|.+....|+|-|+.|.+ .||||+|.. .+-..+.=+.|+++|++|+ --|.++|+..|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 36788888999999999986 799999976 3444556678999999996 35899999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||+|-+ ..+|.++|..+ .....|.......++.|+..||..|-..+ |+|.||||.|
T Consensus 510 ClVFE~L-slNLRevLKKy------------G~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDN 566 (752)
T KOG0670|consen 510 CLVFEPL-SLNLREVLKKY------------GRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDN 566 (752)
T ss_pred EEEehhh-hchHHHHHHHh------------CcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccc
Confidence 9999988 57899988643 23345777888899999999999999887 9999999998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=6e-11 Score=97.52 Aligned_cols=110 Identities=24% Similarity=0.444 Sum_probs=91.3
Q ss_pred cccceeecccCccceeE------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 160 FSINNKLGEGGFGLVYK------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
..+..+|.+...|..|+ .+.+|++.. ......++|..|...|+-+.||||+.++|.|..+.++.++..||+.
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34446777777788886 566777653 3445567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS 282 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~ 282 (295)
|||+..|++ .....++-.+..+++.++|+|++|||+..
T Consensus 272 gslynvlhe-------------~t~vvvd~sqav~faldiargmaflhsle 309 (448)
T KOG0195|consen 272 GSLYNVLHE-------------QTSVVVDHSQAVRFALDIARGMAFLHSLE 309 (448)
T ss_pred hHHHHHHhc-------------CccEEEecchHHHHHHHHHhhHHHHhhcc
Confidence 999999963 34456788899999999999999999975
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.7e-10 Score=112.92 Aligned_cols=76 Identities=20% Similarity=0.264 Sum_probs=61.3
Q ss_pred hcCCC-CcccceeeeE-------EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHH
Q 041718 202 SKLQH-RNLVKLLGCC-------IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR 273 (295)
Q Consensus 202 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 273 (295)
+.++| .||+++++++ .+.+.+++++||+ +++|.++|.. ....+++..++.|+.||++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~ 91 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--------------PDRSVDAFECFHVFRQIVE 91 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--------------ccccccHHHHHHHHHHHHH
Confidence 34556 5888888877 3335677888988 6699999841 2345899999999999999
Q ss_pred HHHhhhcCCCCCeEeccCCCCC
Q 041718 274 GVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 274 gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||.|||+++ ||||||||+|
T Consensus 92 al~~lH~~g---IvHrDlKP~N 110 (793)
T PLN00181 92 IVNAAHSQG---IVVHNVRPSC 110 (793)
T ss_pred HHHHHHhCC---eeeccCCchh
Confidence 999999998 9999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.9e-08 Score=79.55 Aligned_cols=106 Identities=23% Similarity=0.120 Sum_probs=74.4
Q ss_pred eeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCccc-ceeeeEEeCCeeEEEEecCCCCCHHH
Q 041718 164 NKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV-KLLGCCIQGEEKLLIYEFMPNKSLNS 236 (295)
Q Consensus 164 ~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL~~ 236 (295)
+.|+.|.++.||+ .+++|....... ....+..|+.++..+.+.+++ +++... .+..++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 6788899999995 689998754221 234567889999888765544 455443 344689999999987753
Q ss_pred HHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--CCCeEeccCCCCC
Q 041718 237 FIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS--KLRIIHRDLKASN 295 (295)
Q Consensus 237 ~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~iiHrDlkp~N 295 (295)
.. .....++.+++++|+.||+.+ ...++|+|++|.|
T Consensus 81 ~~-----------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~N 118 (170)
T cd05151 81 ED-----------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGN 118 (170)
T ss_pred cc-----------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCc
Confidence 10 001235678999999999886 2336999999998
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.74 E-value=4.8e-09 Score=98.64 Aligned_cols=115 Identities=27% Similarity=0.317 Sum_probs=85.4
Q ss_pred cceeecccCccceeEE--------EEEEEe-----cccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 162 INNKLGEGGFGLVYKE--------IAVKRL-----SKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk~--------vavK~l-----~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
....+|.|++|.|+.. .+.|.. .... .+....+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4478999999966531 122211 1111 1122236678888888999999988888777777766799
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++ +|..++.. ...+....+..++.|++.|+.|||+.+ |.||||||+|
T Consensus 402 ~~~~-Dlf~~~~~---------------~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~en 450 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---------------NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLEN 450 (601)
T ss_pred cccH-HHHHHHhc---------------ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCcccc
Confidence 9999 99988842 135777788889999999999999998 9999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.6e-08 Score=89.73 Aligned_cols=112 Identities=23% Similarity=0.231 Sum_probs=70.8
Q ss_pred eeecccCccceeE-------EEEEEEeccccHHh----------------------------------------HHHHHH
Q 041718 164 NKLGEGGFGLVYK-------EIAVKRLSKISEQG----------------------------------------LKELKN 196 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-------~vavK~l~~~~~~~----------------------------------------~~~~~~ 196 (295)
+.||.|++|+||+ .||||+........ .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999997 69999875421100 012444
Q ss_pred HHHHHhcC----CCCcccceeeeEE-eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHH
Q 041718 197 EVILFSKL----QHRNLVKLLGCCI-QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271 (295)
Q Consensus 197 Ei~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 271 (295)
|...+.++ +|.+-+.+-..+. .....+|||||++|++|.++.... . ... .+..++..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-------------~-~~~---~~~~ia~~~ 265 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-------------E-AGL---DRKALAENL 265 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-------------h-cCC---CHHHHHHHH
Confidence 55544444 2333333333332 244578999999999998876310 0 011 234566666
Q ss_pred HH-HHHhhhcCCCCCeEeccCCCCC
Q 041718 272 AR-GVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 272 ~~-gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+. .+..+|..+ ++|+|+||.|
T Consensus 266 ~~~~l~ql~~~g---~~H~D~hPgN 287 (437)
T TIGR01982 266 ARSFLNQVLRDG---FFHADLHPGN 287 (437)
T ss_pred HHHHHHHHHhCC---ceeCCCCccc
Confidence 65 467889887 9999999998
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.1e-08 Score=83.31 Aligned_cols=71 Identities=23% Similarity=0.417 Sum_probs=56.6
Q ss_pred CCCcccceeeeEEe---------------------------CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccC
Q 041718 205 QHRNLVKLLGCCIQ---------------------------GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257 (295)
Q Consensus 205 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 257 (295)
+|||||++.++|.+ +..+|+||.-.+ .+|.+++.. .
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----------------~ 336 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----------------R 336 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----------------C
Confidence 59999999998864 233578887774 588888842 2
Q ss_pred CCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 258 ~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+.....-|+.|+++|+.|||.++ |.|||+|.+|
T Consensus 337 ~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDN 371 (598)
T KOG4158|consen 337 HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDN 371 (598)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccc
Confidence 3555666778999999999999998 9999999988
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.51 E-value=9.6e-08 Score=88.36 Aligned_cols=119 Identities=19% Similarity=0.173 Sum_probs=66.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccH----------------------------------HhHH--
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE----------------------------------QGLK-- 192 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~----------------------------------~~~~-- 192 (295)
...|.. +.||.|++|+||+ .||||++..... ...+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 455665 7899999999996 699999864210 0011
Q ss_pred ----HHHHHHHHHhcCC----CCcccceeeeEEe-CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHH
Q 041718 193 ----ELKNEVILFSKLQ----HRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263 (295)
Q Consensus 193 ----~~~~Ei~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~ 263 (295)
++.+|..-+.++. +.+.+.+-..+.+ ....+|||||++|+.+.++-.-.. .......+....
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~---------~g~d~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA---------AGTDMKLLAERG 268 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---------cCCCHHHHHHHH
Confidence 2334444333332 3344444444332 456679999999999977431000 000001122222
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 264 ~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++.|+. ..+ ++|+|+||.|
T Consensus 269 v~~~~~Qif-------~~G---ffHaDpHPGN 290 (537)
T PRK04750 269 VEVFFTQVF-------RDG---FFHADMHPGN 290 (537)
T ss_pred HHHHHHHHH-------hCC---eeeCCCChHH
Confidence 333444443 355 9999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.47 E-value=9e-07 Score=72.94 Aligned_cols=75 Identities=16% Similarity=0.256 Sum_probs=54.1
Q ss_pred eeecccCccceeE-------EEEEEEeccccH-HhHHHHHHHHHHHhcCCC--CcccceeeeEEeCC---eeEEEEecCC
Q 041718 164 NKLGEGGFGLVYK-------EIAVKRLSKISE-QGLKELKNEVILFSKLQH--RNLVKLLGCCIQGE---EKLLIYEFMP 230 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 230 (295)
+.|+.|..+.||+ .+++|....... .....+..|+.++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 5688888999987 467777643221 245678999999999976 34677777765532 5689999999
Q ss_pred CCCHHHHH
Q 041718 231 NKSLNSFI 238 (295)
Q Consensus 231 ~gsL~~~l 238 (295)
+.++...+
T Consensus 84 G~~l~~~~ 91 (223)
T cd05154 84 GRVLRDRL 91 (223)
T ss_pred CEecCCCC
Confidence 98886644
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.8e-07 Score=61.24 Aligned_cols=72 Identities=38% Similarity=0.726 Sum_probs=53.3
Q ss_pred CCceeEEeeccCCCCcccccccCCChHHHHHHhhc-CCCccceecccccCCCcceeeec-ccCCcccccCCCCcceEE
Q 041718 54 QDGFIKFTAMKLPDATRSWVSKSMNLNECWEKCLD-DSSCMAYTNSYIRGEGSGCAMWF-GELIDMRDFPDAGQDLYI 129 (295)
Q Consensus 54 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-~CsC~a~~~~~~~~~g~~C~~w~-~~L~~~~~~~~~~~~~~~ 129 (295)
...|..+.++.+++..... ....+.++|++.|+. +|.|.++.|.+ .+.+|.+|. +.+.+....+..+.++|.
T Consensus 3 ~~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred CceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEE
Confidence 3568899999998655432 356799999999999 99999999864 356799999 666666544444445544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.4e-08 Score=89.98 Aligned_cols=112 Identities=26% Similarity=0.282 Sum_probs=89.3
Q ss_pred ecccCccceeE-----------EEEEEEeccccH--HhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCCC
Q 041718 166 LGEGGFGLVYK-----------EIAVKRLSKISE--QGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 166 lg~G~~g~Vyk-----------~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+|+|.||.|+. .+|+|.+.+... ........|..++...+ ||.+|+++-.+..+..++++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 68899999883 477887765221 11225567788888887 99999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|.|...+. .....++.....+...++.+++++|..+ |+|||+|++|
T Consensus 82 g~lft~l~---------------~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~en 127 (612)
T KOG0603|consen 82 GDLFTRLS---------------KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLEN 127 (612)
T ss_pred chhhhccc---------------cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccc
Confidence 99987663 3344566666677888999999999998 9999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.2e-06 Score=74.53 Aligned_cols=127 Identities=22% Similarity=0.359 Sum_probs=78.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCC----------Ccccceeee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQH----------RNLVKLLGC 215 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h----------~niv~l~~~ 215 (295)
...+...+.||.|+++.||+ .+|||+... ......+++++|.-.+..+.+ -.++--++.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~ 90 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL 90 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence 34556678999999999996 689997743 233456778888766655433 112222221
Q ss_pred ---------EEeCC--------eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhh
Q 041718 216 ---------CIQGE--------EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYL 278 (295)
Q Consensus 216 ---------~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yL 278 (295)
+.... +.+++|+-+ .++|.+++..-.. .......+....++.+..|+++.+++|
T Consensus 91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~--------~~~~~~~l~~~arl~lT~Q~I~lvA~L 161 (288)
T PF14531_consen 91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFS--------RAQTHSPLAFAARLSLTVQMIRLVANL 161 (288)
T ss_dssp EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHH--------HTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhh--------cccccchhHHHHHHHHHHHHHHHHHHH
Confidence 11111 235677777 5788777531100 011122345566778889999999999
Q ss_pred hcCCCCCeEeccCCCCC
Q 041718 279 HQDSKLRIIHRDLKASN 295 (295)
Q Consensus 279 H~~~~~~iiHrDlkp~N 295 (295)
|+++ |+|+||||+|
T Consensus 162 h~~G---lVHgdi~~~n 175 (288)
T PF14531_consen 162 HSYG---LVHGDIKPEN 175 (288)
T ss_dssp HHTT---EEEST-SGGG
T ss_pred hhcc---eEecccceee
Confidence 9999 9999999987
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.9e-07 Score=76.78 Aligned_cols=82 Identities=26% Similarity=0.295 Sum_probs=66.1
Q ss_pred HHhcCCCCcccceeeeEEeC-----CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHH
Q 041718 200 LFSKLQHRNLVKLLGCCIQG-----EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARG 274 (295)
Q Consensus 200 ~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~g 274 (295)
-|-++-|.|||+++.++.+. ....++.|||+.|+|.++|++. ....+.+......++..||+.|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt-----------~~~~~a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRT-----------KKNQKALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHH-----------HHhhhhhhHHHHHHHHHHHHhh
Confidence 34556799999999987654 3468899999999999999752 2345667777788899999999
Q ss_pred HHhhhcCCCCCeEeccCCC
Q 041718 275 VMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 275 l~yLH~~~~~~iiHrDlkp 293 (295)
|.|||+- .|+|+|+.+..
T Consensus 189 l~yLhs~-~PpiihgnlTc 206 (458)
T KOG1266|consen 189 LSYLHSC-DPPIIHGNLTC 206 (458)
T ss_pred hhhhhcc-CCccccCCcch
Confidence 9999997 57899998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.8e-06 Score=78.35 Aligned_cols=79 Identities=30% Similarity=0.492 Sum_probs=69.5
Q ss_pred HhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc
Q 041718 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280 (295)
Q Consensus 201 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~ 280 (295)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+.. ....++|.-...++.+|+.||+|||+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--------------~~~~~d~~F~~s~~rdi~~Gl~ylh~ 66 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--------------EDIKLDYFFILSFIRDISKGLAYLHN 66 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--------------cccCccHHHHHHHHHHHHHHHHHHhc
Confidence 4678999999999999999999999999999999999952 34568999999999999999999997
Q ss_pred CCCCCeEeccCCCCC
Q 041718 281 DSKLRIIHRDLKASN 295 (295)
Q Consensus 281 ~~~~~iiHrDlkp~N 295 (295)
-. -..|+.+++.|
T Consensus 67 s~--i~~hg~l~s~n 79 (484)
T KOG1023|consen 67 SP--IGYHGALKSSN 79 (484)
T ss_pred Cc--ceeeeeecccc
Confidence 53 23999999876
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=9.5e-06 Score=63.82 Aligned_cols=118 Identities=21% Similarity=0.194 Sum_probs=80.2
Q ss_pred cceeecccCccceeE------EEEEE-Eecc-------ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 162 INNKLGEGGFGLVYK------EIAVK-RLSK-------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk------~vavK-~l~~-------~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
....|-+|+=+.|++ ...|| ++.+ ...-..++..+|+.+|.++.--.|.-..=++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 346788888888875 22333 2222 122345678899999998875555544456667777889999
Q ss_pred cCCC-CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPN-KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++ .++.+++.+.. ...........++..|-+.+.-||.++ |||+||..+|
T Consensus 91 ~~~g~~~vk~~i~~~~-------------~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSN 143 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM-------------EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSN 143 (229)
T ss_pred eccchhHHHHHHHHHc-------------cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccc
Confidence 9976 47788875321 111222223567888888899999998 9999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-07 Score=88.25 Aligned_cols=123 Identities=25% Similarity=0.320 Sum_probs=95.3
Q ss_pred ccccccceeecccCccceeE---------EEEEEEeccc--cHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------EIAVKRLSKI--SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~l 224 (295)
...|.+.+.||+|+|+.|-. .+|+|.+... +.........|..+-..+. |+|++++++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 34677778899999998873 5677766543 2334455666777777776 9999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhh-cCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLH-QDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH-~~~~~~iiHrDlkp~N 295 (295)
++||..++++.+.+.. ......+......++.|+..++.|+| ..+ +.||||||+|
T Consensus 99 ~~~~s~g~~~f~~i~~-------------~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n 154 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH-------------PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSN 154 (601)
T ss_pred ccCccccccccccccc-------------CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCcc
Confidence 9999999999876620 11113455566778999999999999 777 9999999987
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=7.2e-06 Score=64.61 Aligned_cols=80 Identities=21% Similarity=0.316 Sum_probs=62.7
Q ss_pred HHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHH
Q 041718 191 LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270 (295)
Q Consensus 191 ~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 270 (295)
.+...+|..+|.+++--.|....=+..+++...|+|||+++-.|.+.|... +..++..
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------------------~~~~~r~ 100 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------------------RPDLLRE 100 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------------------chHHHHH
Confidence 456788999999987666655555667888889999999998888888421 2345666
Q ss_pred HHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 271 TARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 271 i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+=.-+.-||..+ |+|+||.++|
T Consensus 101 vG~~vg~lH~~g---ivHGDLTtsN 122 (204)
T COG3642 101 VGRLVGKLHKAG---IVHGDLTTSN 122 (204)
T ss_pred HHHHHHHHHhcC---eecCCCccce
Confidence 666778899998 9999999998
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.6e-07 Score=89.28 Aligned_cols=117 Identities=17% Similarity=0.217 Sum_probs=87.4
Q ss_pred ccccceeecccCccceeE------EEEEEEecccc----HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK------EIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++...+.||.+.|=+|.+ .|.||++-+.. -....+-..|+. ...++|||.+.+.-+.......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 455668899999988886 57888775422 223333444555 5667899999988877777777888888
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.. .+|.+.|. ..+-|...+..-|+.|++.||.=.|..+ |.|+|||.+|
T Consensus 103 vk-hnLyDRlS---------------TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsEN 150 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---------------TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSEN 150 (1431)
T ss_pred Hh-hhhhhhhc---------------cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccce
Confidence 84 47877762 2234556666779999999999999998 9999999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-05 Score=65.99 Aligned_cols=87 Identities=17% Similarity=0.113 Sum_probs=63.7
Q ss_pred HHHHHHHHHhcCCCC--cccceeeeEEe-----CCeeEEEEecCCCC-CHHHHHhhhhhhhhhhhcccccccCCCCHHHH
Q 041718 193 ELKNEVILFSKLQHR--NLVKLLGCCIQ-----GEEKLLIYEFMPNK-SLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264 (295)
Q Consensus 193 ~~~~Ei~~l~~l~h~--niv~l~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~ 264 (295)
.+.+|...+.++... ..++++++... ....+||||++++. +|.+++... .....+...+
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~-------------~~~~~~~~~~ 140 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADW-------------ATNPPDPRLK 140 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhh-------------cccCCCHHHH
Confidence 477888888888533 34445555543 23578999999876 888887310 1123445667
Q ss_pred HHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 265 ~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++.+++..+.-||..+ |+|+|+++.|
T Consensus 141 ~~ll~~la~~i~~LH~~G---i~HgDL~~~N 168 (268)
T PRK15123 141 RMLIKRVATMVRDMHAAG---INHRDCYICH 168 (268)
T ss_pred HHHHHHHHHHHHHHHHCc---CccCCCChhh
Confidence 789999999999999998 9999999987
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.3e-06 Score=79.42 Aligned_cols=122 Identities=24% Similarity=0.227 Sum_probs=91.1
Q ss_pred hccccccceeecccCccceeE---------EEEEEEeccccHHhH--HHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKISEQGL--KELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~~~~~--~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (295)
...+|..+..||.|.|+.|++ .+++|.+.+...... ..-..|+.+...+ .|.+++++...+..-++.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 345788889999999999986 466666544221111 1223455555554 5889999888888888889
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+-.||++++++...+. ....++...++.+..|++.++.++|+.. ++|+|+||+|
T Consensus 343 ip~e~~~~~s~~l~~~---------------~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psn 396 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV---------------TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSN 396 (524)
T ss_pred CchhhhcCcchhhhhH---------------HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccc
Confidence 9999999998876541 1234667778889999999999999887 9999999987
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.13 E-value=6e-06 Score=74.36 Aligned_cols=106 Identities=18% Similarity=0.211 Sum_probs=75.9
Q ss_pred EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEEecCCC-CCHHHHHhhhhhhhhhhhcc
Q 041718 177 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIYEFMPN-KSLNSFIFENFVLTLMRSFV 251 (295)
Q Consensus 177 ~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~ 251 (295)
.+.+|++.....+.......-++.++++.|+|||++..++.. ...+.|||+|.|+ ++|.++-+.+.+..-.....
T Consensus 303 ~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~ 382 (655)
T KOG3741|consen 303 AYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSF 382 (655)
T ss_pred eeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccc
Confidence 578888854333333333445678899999999999999873 4567899999986 68888776544333111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHHHHhhhcCC
Q 041718 252 DQERCKILDWSKRFHIICGTARGVMYLHQDS 282 (295)
Q Consensus 252 ~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~ 282 (295)
........++...+.++.|+..||.++|+.|
T Consensus 383 ~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG 413 (655)
T KOG3741|consen 383 YPSQNLKAPEEVLWSYISQLTAALYSIHSSG 413 (655)
T ss_pred cccCCCCchHHHHHHHHHHHHHHHHHHHhcC
Confidence 2234456888999999999999999999987
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.9e-06 Score=66.27 Aligned_cols=80 Identities=13% Similarity=0.157 Sum_probs=56.6
Q ss_pred HHHHHHHHHhcCCC--CcccceeeeEEeCCeeEEEEecCCCCCHHH-HHhhhhhhhhhhhcccccccCCCCHHHHHHHHH
Q 041718 193 ELKNEVILFSKLQH--RNLVKLLGCCIQGEEKLLIYEFMPNKSLNS-FIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269 (295)
Q Consensus 193 ~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 269 (295)
...+|...|.++.. -++.+++++ ...+|||||+.+..+.. .+ +...++......+..
T Consensus 72 wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----------------kd~~~~~~~~~~i~~ 131 (197)
T cd05146 72 WAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----------------KDAKLNDEEMKNAYY 131 (197)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----------------hccccCHHHHHHHHH
Confidence 34588999998864 466666654 56789999997654421 11 112244455667789
Q ss_pred HHHHHHHhh-hcCCCCCeEeccCCCCC
Q 041718 270 GTARGVMYL-HQDSKLRIIHRDLKASN 295 (295)
Q Consensus 270 ~i~~gl~yL-H~~~~~~iiHrDlkp~N 295 (295)
+++.+|..| |..+ |||+||+|.|
T Consensus 132 ~i~~~l~~l~H~~g---lVHGDLs~~N 155 (197)
T cd05146 132 QVLSMMKQLYKECN---LVHADLSEYN 155 (197)
T ss_pred HHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999999 7777 9999999987
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.3e-05 Score=74.20 Aligned_cols=95 Identities=16% Similarity=0.198 Sum_probs=70.0
Q ss_pred EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhccccccc
Q 041718 177 EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC 256 (295)
Q Consensus 177 ~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~ 256 (295)
.|.|...+...........+-+..|+.|+||||++++..+......|||+|-+. -|..++..
T Consensus 39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------------- 100 (690)
T KOG1243|consen 39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------------- 100 (690)
T ss_pred ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH----------------
Confidence 455555544333334556777888999999999999999999999999999874 45555531
Q ss_pred CCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 257 ~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
+......-.+.||+.||.|||+.+ .++|++|.-
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~ 133 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCK 133 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEee
Confidence 223344456789999999999776 499998753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00042 Score=56.15 Aligned_cols=110 Identities=17% Similarity=0.282 Sum_probs=76.9
Q ss_pred ceeecccCccceeE-----EEEEEEecccc----------------HHhHHHHHHHHHHHhcCC------CCcccceeee
Q 041718 163 NNKLGEGGFGLVYK-----EIAVKRLSKIS----------------EQGLKELKNEVILFSKLQ------HRNLVKLLGC 215 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk-----~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------h~niv~l~~~ 215 (295)
...||+|+.-.||. ...||+..... .....+..+|+.-...+. +.+|.+++|+
T Consensus 6 ~~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred CcccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 36799999999997 67888876533 123566777776555555 8899999999
Q ss_pred EEeCCeeEEEEecCCC------CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEec
Q 041718 216 CIQGEEKLLIYEFMPN------KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHR 289 (295)
Q Consensus 216 ~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHr 289 (295)
..++--.-+|+|.+.+ -||.+++.. ..++. ...+.+ -+-..||-.+. |+.+
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----------------~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~ 142 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE----------------GGLTE-ELRQAL---DEFKRYLLDHH---IVIR 142 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc----------------CCccH-HHHHHH---HHHHHHHHHcC---Ceec
Confidence 9999999999998753 356666631 23443 222233 33345666665 9999
Q ss_pred cCCCCC
Q 041718 290 DLKASN 295 (295)
Q Consensus 290 Dlkp~N 295 (295)
||+|.|
T Consensus 143 dl~~~N 148 (199)
T PF10707_consen 143 DLNPHN 148 (199)
T ss_pred CCCccc
Confidence 999998
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00017 Score=59.06 Aligned_cols=87 Identities=25% Similarity=0.279 Sum_probs=64.6
Q ss_pred HHHHHHHHHHHhcCC--CCcccceeeeEEeCC----eeEEEEecCCCC-CHHHHHhhhhhhhhhhhcccccccCCCCHHH
Q 041718 191 LKELKNEVILFSKLQ--HRNLVKLLGCCIQGE----EKLLIYEFMPNK-SLNSFIFENFVLTLMRSFVDQERCKILDWSK 263 (295)
Q Consensus 191 ~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~ 263 (295)
.....+|...+..|. .-.+.+.+++..... ..+||+|++++. +|.+++.. ...++...
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~---------------~~~~~~~~ 119 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ---------------WEQLDPSQ 119 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh---------------hcccchhh
Confidence 345677777777765 344566666665432 458999999874 78888742 11255566
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 264 ~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++.+++..+.-||..+ |+|+|++|.|
T Consensus 120 ~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~N 148 (206)
T PF06293_consen 120 RRELLRALARLIAKLHDAG---IYHGDLNPSN 148 (206)
T ss_pred HHHHHHHHHHHHHHHHHCc---CCCCCCCccc
Confidence 7889999999999999998 9999999988
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.71 E-value=2.4e-05 Score=71.41 Aligned_cols=119 Identities=25% Similarity=0.342 Sum_probs=88.1
Q ss_pred ccccceeecc--cCccceeE----------EEEEEEecc--ccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeE
Q 041718 159 NFSINNKLGE--GGFGLVYK----------EIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 159 ~~~~~~~lg~--G~~g~Vyk----------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~ 223 (295)
.|.+...+|. |.+|.||+ .+|+|.-+. ..++....=.+|+....+++ |+|.++.+..+.+++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556688999 99999995 578887432 22233333345666666664 999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHH----HHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR----GVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~----gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+-+|++ +.+|.++... ....++....+.+..+... ||.++|+.. |+|-|+||+|
T Consensus 195 iqtE~~-~~sl~~~~~~--------------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~ 252 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHT--------------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPAN 252 (524)
T ss_pred eeeccc-cchhHHhhhc--------------ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhh
Confidence 999998 4677776632 2234555666677777777 999999988 9999999987
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00075 Score=54.91 Aligned_cols=114 Identities=17% Similarity=0.136 Sum_probs=78.4
Q ss_pred ecccCccceeE------EEEEEEecc-----cc-HHhHHHHHHHHHHHhcCCCCc--ccceeeeEEe----CCeeEEEEe
Q 041718 166 LGEGGFGLVYK------EIAVKRLSK-----IS-EQGLKELKNEVILFSKLQHRN--LVKLLGCCIQ----GEEKLLIYE 227 (295)
Q Consensus 166 lg~G~~g~Vyk------~vavK~l~~-----~~-~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~----~~~~~lv~e 227 (295)
-|+||.+.|++ .+-+|+-.. .. +.+...|.+|+..|.+|...+ +.+....-.. .-..+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 45677777775 366776542 11 446778999999999986433 4444422111 123579999
Q ss_pred cCCC-CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPN-KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
-+++ .+|.+++.. ......+...+..++.+++..+.=||+.+ +.|+|+-+.|
T Consensus 106 ~L~g~~~L~~~l~~-------------~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~kh 158 (216)
T PRK09902 106 DMAGFISIADWYAQ-------------HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRH 158 (216)
T ss_pred eCCCCccHHHHHhc-------------CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhh
Confidence 7754 588888731 12234567778899999999999999998 9999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00024 Score=57.16 Aligned_cols=85 Identities=22% Similarity=0.258 Sum_probs=64.2
Q ss_pred HHHHHHHhcCCC-CcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHH
Q 041718 195 KNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTAR 273 (295)
Q Consensus 195 ~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~ 273 (295)
..|..+|..+++ +++.+++|+|- .++|.||.+.+++...-. .-..-...+|..|.+||.++++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~------------~l~~~~~~~w~~R~~iA~~lL~ 70 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR------------PLSQFLQSPWEQRAKIALQLLE 70 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc------------ccccccccCHHHHHHHHHHHHH
Confidence 357888888886 69999999983 367899998776542100 0001124789999999999999
Q ss_pred HHHhhhcCCCCCeEeccCCCCC
Q 041718 274 GVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 274 gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++|++.....+.-.|++|+|
T Consensus 71 ~l~~l~~~~~~~~~lcDv~~~n 92 (188)
T PF12260_consen 71 LLEELDHGPLGFFYLCDVSPDN 92 (188)
T ss_pred HHHHHhcCCCCcEEEeecchHH
Confidence 9999998655568889999987
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00059 Score=54.84 Aligned_cols=82 Identities=17% Similarity=0.179 Sum_probs=50.9
Q ss_pred hHHHHHHHHHHHhcCCCC--cccceeeeEEeCCeeEEEEecCC--CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHH
Q 041718 190 GLKELKNEVILFSKLQHR--NLVKLLGCCIQGEEKLLIYEFMP--NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265 (295)
Q Consensus 190 ~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~ 265 (295)
......+|...|.++... ++.+++++ ....|||||++ +..+..+.. ..++.....
T Consensus 51 ~~~~~~~E~~~L~~l~~~Gv~vP~p~~~----~~~~ivME~I~~~G~~~~~l~~-----------------~~~~~~~~~ 109 (188)
T PF01163_consen 51 IREWAKKEFRNLKRLYEAGVPVPKPYDY----NRNVIVMEYIGEDGVPLPRLKD-----------------VDLSPEEPK 109 (188)
T ss_dssp HHHHHHHHHHHHHHCCCTT-SS--EEEE----ETTEEEEE--EETTEEGGCHHH-----------------CGGGGSTHH
T ss_pred HHHHHHHHHHHHHHHHHCCccCCcEEEE----eCCEEEEEecCCCccchhhHHh-----------------ccccchhHH
Confidence 345678899999999866 56666654 24479999998 544543321 111133445
Q ss_pred HHHHHHHHHHHh-hhcCCCCCeEeccCCCCC
Q 041718 266 HIICGTARGVMY-LHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 266 ~i~~~i~~gl~y-LH~~~~~~iiHrDlkp~N 295 (295)
.++.+++..+.. +|..+ |+|+||.+.|
T Consensus 110 ~~~~~il~~~~~~~~~~g---ivHGDLs~~N 137 (188)
T PF01163_consen 110 ELLEEILEEIIKMLHKAG---IVHGDLSEYN 137 (188)
T ss_dssp HHHHHHHHHHHHHHHCTT---EEESS-STTS
T ss_pred HHHHHHHHHHHHHHHhcC---ceecCCChhh
Confidence 677777776555 56777 9999999987
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0038 Score=50.43 Aligned_cols=107 Identities=25% Similarity=0.389 Sum_probs=72.9
Q ss_pred cccccceeecccCc-cceeE------EEEEEEecc------------cc---H------HhHHHHHHHHHHHhcCC---C
Q 041718 158 DNFSINNKLGEGGF-GLVYK------EIAVKRLSK------------IS---E------QGLKELKNEVILFSKLQ---H 206 (295)
Q Consensus 158 ~~~~~~~~lg~G~~-g~Vyk------~vavK~l~~------------~~---~------~~~~~~~~Ei~~l~~l~---h 206 (295)
.+++.++.||.|.- |.||| .+|+|.... .. . .....|..|.+..++|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 78888999999999 99997 689998321 00 0 12345778888877775 4
Q ss_pred Ccc--cceeeeEEeC------------------CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHH
Q 041718 207 RNL--VKLLGCCIQG------------------EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266 (295)
Q Consensus 207 ~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 266 (295)
.++ |+.+|+..-. ....||.||++... .....
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------------------~~~~~ 168 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------------------PLQIR 168 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------------------ccchh
Confidence 455 9999986422 11245666664322 11223
Q ss_pred HHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 267 i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
-+.++.+-|.-+|..+ |+=+|+|+.|
T Consensus 169 ~~~~~~~dl~~~~k~g---I~~~Dv~~~n 194 (207)
T PF13095_consen 169 DIPQMLRDLKILHKLG---IVPRDVKPRN 194 (207)
T ss_pred HHHHHHHHHHHHHHCC---eeeccCcccc
Confidence 3456777788899887 9999999987
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.00082 Score=45.10 Aligned_cols=50 Identities=20% Similarity=0.364 Sum_probs=36.0
Q ss_pred EeeccCCCCcccccccCCChHHHHHHhhcCCCccceecccccCCCcceeeeccc
Q 041718 60 FTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFGE 113 (295)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~g~~C~~w~~~ 113 (295)
+.+++++..+.... ...+.++|++.|+.+++|.+|+|.. ....|+++...
T Consensus 9 ~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 9 GSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred cCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 34666666555433 3568899999999999999999863 23459887663
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.00036 Score=63.04 Aligned_cols=57 Identities=25% Similarity=0.323 Sum_probs=49.0
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++|.|+++...+|.++|.. .......++...+.++.|++.|++| ++ .+|||+||.|
T Consensus 330 ~lyI~Mn~c~~~tledWl~r------------r~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~n 386 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRR------------RRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSN 386 (516)
T ss_pred chhhhhhhhhhhhHHHHhhC------------CCcccccchhHHHHHHHhhccchhh---cc---chhhhccccc
Confidence 57899999999999999952 3345567888999999999999999 65 9999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.001 Score=64.99 Aligned_cols=21 Identities=52% Similarity=0.789 Sum_probs=19.7
Q ss_pred HHHHHhhhcCCCCCeEeccCCCCC
Q 041718 272 ARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 272 ~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+++|||+.+ |+|||+||+|
T Consensus 153 vla~Eylh~yg---ivhrdlkpdn 173 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDN 173 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCc
Confidence 67899999998 9999999998
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0084 Score=49.13 Aligned_cols=113 Identities=13% Similarity=0.135 Sum_probs=64.3
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHHhHHH---------HHHHHHHHhcCCC---CcccceeeeEE-
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKE---------LKNEVILFSKLQH---RNLVKLLGCCI- 217 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~---------~~~Ei~~l~~l~h---~niv~l~~~~~- 217 (295)
..+|...+.+.......|.+ .+.+|..........+. ..+++..+.+++. ...+.++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 35666666666666665553 46666654321111111 1233333333332 22222222222
Q ss_pred ----eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 218 ----QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 218 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
-....+|+|||++|..|.++.. ++. .++..+++++.=||..| +.|+|+.|
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-------------------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hp 163 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-------------------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHP 163 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-------------------cCH----HHHHHHHHHHHHHHHcC---CccCCCCc
Confidence 2244568999999988765431 221 24556777899999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
.|
T Consensus 164 gN 165 (229)
T PF06176_consen 164 GN 165 (229)
T ss_pred Cc
Confidence 98
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.018 Score=57.09 Aligned_cols=101 Identities=16% Similarity=0.224 Sum_probs=63.3
Q ss_pred ceeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCC-CCcc--cceeeeEEeC---CeeEEE
Q 041718 163 NNKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ-HRNL--VKLLGCCIQG---EEKLLI 225 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 225 (295)
.+.++.|.+..+|+ .+.+|+.... .......+.+|+.+|+.|. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46678888888774 2455554321 1223457889999999996 6665 7777777654 357899
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~ 280 (295)
|||+++..+.+- ....++...+..++.++++.|..||+
T Consensus 123 ME~v~G~~~~~~-----------------~~~~~~~~~r~~l~~~l~~~La~LH~ 160 (822)
T PLN02876 123 MEYLEGRIFVDP-----------------KLPGVAPERRRAIYRATAKVLAALHS 160 (822)
T ss_pred EEecCCcccCCc-----------------cCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence 999987543221 01123344455566666666666665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.03 Score=46.50 Aligned_cols=68 Identities=24% Similarity=0.233 Sum_probs=50.4
Q ss_pred eeecccCccceeE----EEEEEEeccccHHhHHHHHHHHHHHhcCCCCc--ccceeeeEEeCCeeEEEEecCCCCC
Q 041718 164 NKLGEGGFGLVYK----EIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs 233 (295)
..||+|..+.||+ .+++|..... .......+|..++..+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 6789999999998 4566665432 23455788999998886443 4677777777778889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.017 Score=48.64 Aligned_cols=119 Identities=21% Similarity=0.185 Sum_probs=72.0
Q ss_pred hhhhhhhccccccceeecccCccceeE-------EEEEEEeccc--------------------c--HHhHHHHHHHHHH
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKI--------------------S--EQGLKELKNEVIL 200 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~--------------------~--~~~~~~~~~Ei~~ 200 (295)
+..+.....-..+.+.||.|-=+.||. .+|||.-+.. + .-......+|..+
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 333333333455668999999999995 6788853210 0 1123345688999
Q ss_pred HhcCCCC--cccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhh
Q 041718 201 FSKLQHR--NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYL 278 (295)
Q Consensus 201 l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yL 278 (295)
|.+|.-. .+.+.+++ +.-.+||||+++-.|...- ++....-.|+..|++-+.-+
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------------------~~~en~~~il~~il~~~~~~ 218 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR--------------------LDVENPDEILDKILEEVRKA 218 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc--------------------CcccCHHHHHHHHHHHHHHH
Confidence 9998755 66666654 5567999999886654321 12222233344444433333
Q ss_pred hcCCCCCeEeccCCCCC
Q 041718 279 HQDSKLRIIHRDLKASN 295 (295)
Q Consensus 279 H~~~~~~iiHrDlkp~N 295 (295)
-..| |||+|+.+=|
T Consensus 219 ~~~G---iVHGDlSefN 232 (304)
T COG0478 219 YRRG---IVHGDLSEFN 232 (304)
T ss_pred HHcC---ccccCCchhe
Confidence 3455 9999998755
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.043 Score=47.60 Aligned_cols=71 Identities=11% Similarity=0.088 Sum_probs=51.0
Q ss_pred ceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCC---CcccceeeeEEe---CCeeEEEEecCC
Q 041718 163 NNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQH---RNLVKLLGCCIQ---GEEKLLIYEFMP 230 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~~ 230 (295)
.+.||.|..+.||+ .+.+|..+. ......+..|...|+.|.- ..+.++++.+.. .+..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 46799999999997 245555322 1133578899999888853 367888877654 356899999999
Q ss_pred CCCHH
Q 041718 231 NKSLN 235 (295)
Q Consensus 231 ~gsL~ 235 (295)
+.++.
T Consensus 97 G~~~~ 101 (297)
T PRK10593 97 GVSVE 101 (297)
T ss_pred CEecC
Confidence 87763
|
|
| >PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.0045 Score=36.54 Aligned_cols=32 Identities=28% Similarity=0.679 Sum_probs=25.7
Q ss_pred CCCCCC-CCCCCCccccc-CCCCccccCCCCeeC
Q 041718 1 DLCDTY-ALCGAYGICII-SGMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~-~~CG~~~~C~~-~~~~~C~C~~gf~~~ 32 (295)
|+|... ..|++++.|.. .++..|.|++||...
T Consensus 3 dEC~~~~~~C~~~~~C~N~~Gsy~C~C~~Gy~~~ 36 (42)
T PF07645_consen 3 DECAEGPHNCPENGTCVNTEGSYSCSCPPGYELN 36 (42)
T ss_dssp STTTTTSSSSSTTSEEEEETTEEEEEESTTEEEC
T ss_pred cccCCCCCcCCCCCEEEcCCCCEEeeCCCCcEEC
Confidence 467774 48999999975 467899999999854
|
Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A .... |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.082 Score=43.40 Aligned_cols=71 Identities=18% Similarity=0.322 Sum_probs=50.3
Q ss_pred eeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCC--cccceeeeEEe---CCeeEEEEecCCCC
Q 041718 164 NKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHR--NLVKLLGCCIQ---GEEKLLIYEFMPNK 232 (295)
Q Consensus 164 ~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~~g 232 (295)
+.|+.|..+.||+ .+++|..... .....+..|..++..+... .+.+++..... ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 6788898999996 5788886543 4567788899888888543 35667764432 33468999999988
Q ss_pred CHHH
Q 041718 233 SLNS 236 (295)
Q Consensus 233 sL~~ 236 (295)
++..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.099 Score=48.71 Aligned_cols=75 Identities=12% Similarity=0.121 Sum_probs=46.0
Q ss_pred eeecccCccceeE-------EEEEEEeccccHH------------------------------h----------HHHHHH
Q 041718 164 NKLGEGGFGLVYK-------EIAVKRLSKISEQ------------------------------G----------LKELKN 196 (295)
Q Consensus 164 ~~lg~G~~g~Vyk-------~vavK~l~~~~~~------------------------------~----------~~~~~~ 196 (295)
+.|+.++-|+||+ .||||+....-.. . .-++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999996 7999987531000 0 011334
Q ss_pred HHHHHhcC----CCCcccceeeeEE-eCCeeEEEEecCCCCCHHHHH
Q 041718 197 EVILFSKL----QHRNLVKLLGCCI-QGEEKLLIYEFMPNKSLNSFI 238 (295)
Q Consensus 197 Ei~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l 238 (295)
|..-+.++ ++..-+++-..+. -.....|+|||++|-.+.++.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~ 257 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIA 257 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHH
Confidence 54444443 2233333434333 356778999999998888774
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.25 Score=41.25 Aligned_cols=69 Identities=16% Similarity=0.174 Sum_probs=46.2
Q ss_pred ecccCc-cceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCCCCCHHHH
Q 041718 166 LGEGGF-GLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF 237 (295)
Q Consensus 166 lg~G~~-g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 237 (295)
|..|.. ..||+ .+.||+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444444 56675 36666654422 345678888888874 34456777777666678999999999888654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.034 Score=30.85 Aligned_cols=30 Identities=27% Similarity=0.713 Sum_probs=23.8
Q ss_pred CCCCCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 3 CDTYALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 3 C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|.....|..++.|... +...|.|++||...
T Consensus 2 C~~~~~C~~~~~C~~~~~~~~C~C~~g~~g~ 32 (36)
T cd00053 2 CAASNPCSNGGTCVNTPGSYRCVCPPGYTGD 32 (36)
T ss_pred CCCCCCCCCCCEEecCCCCeEeECCCCCccc
Confidence 5556789999999764 56899999999653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.0052 Score=60.33 Aligned_cols=123 Identities=15% Similarity=0.163 Sum_probs=78.0
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
...+.+.+.+-+..|+++.++- ..+.|.... ......+..+.+-.++-.-+||-+++....+.-..+.+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 3456677777788888888873 122232211 11122233333434444445677777666666778899
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||++|+.+++|...|+.. ..++..-.......+.++++|||+.. ++|||++|.|
T Consensus 881 L~~~~~~~~~~~Skl~~~---------------~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~ 934 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNS---------------GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDS 934 (1205)
T ss_pred hhhHHhccCCchhhhhcC---------------CCcccccccchhHHHHhhhhccccch---hhcccccccc
Confidence 999999999999887521 12222223335556788999999875 8999999976
|
|
| >smart00179 EGF_CA Calcium-binding EGF-like domain | Back alignment and domain information |
|---|
Probab=93.71 E-value=0.064 Score=30.54 Aligned_cols=30 Identities=30% Similarity=0.747 Sum_probs=23.3
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCe
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFK 30 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~ 30 (295)
|+|.....|...+.|... +...|.|++||.
T Consensus 3 ~~C~~~~~C~~~~~C~~~~g~~~C~C~~g~~ 33 (39)
T smart00179 3 DECASGNPCQNGGTCVNTVGSYRCECPPGYT 33 (39)
T ss_pred ccCcCCCCcCCCCEeECCCCCeEeECCCCCc
Confidence 457655679888899754 567899999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.69 E-value=0.0072 Score=56.52 Aligned_cols=108 Identities=15% Similarity=0.070 Sum_probs=71.5
Q ss_pred cccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCc-ccceeeeEEeCCeeEEEEecCCC
Q 041718 160 FSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN-LVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
+.....+++++++.++| .+..+.+.. ....+.++++|.+++||| .++.++.+..++..++++++...
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 33445577888999987 222333322 155677889999999999 88888888888999999999987
Q ss_pred C--CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEecc
Q 041718 232 K--SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRD 290 (295)
Q Consensus 232 g--sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrD 290 (295)
+ +..... .....+...+...+...-+++|+|||+.. -+|||
T Consensus 319 ~rs~~~~~~---------------~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d 361 (829)
T KOG0576|consen 319 GRSSALEMT---------------VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD 361 (829)
T ss_pred CccccccCC---------------hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc
Confidence 6 211110 01112333344455566678899999763 47886
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.33 E-value=0.38 Score=44.93 Aligned_cols=58 Identities=10% Similarity=0.153 Sum_probs=33.8
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.....|+||||+|..+.+.-. -....++......-+.++..-+-+-| | ++|.|-.|.|
T Consensus 274 st~RVLtME~~~G~~i~Dl~~--------------i~~~gi~~~~i~~~l~~~~~~qIf~~--G---ffHaDPHPGN 331 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDA--------------IDKRGISPHDILNKLVEAYLEQIFKT--G---FFHADPHPGN 331 (538)
T ss_pred CcceEEEEEecCCccCCCHHH--------------HHHcCCCHHHHHHHHHHHHHHHHHhc--C---CccCCCCCCc
Confidence 457889999999987776532 01122333333333333322222322 4 9999999988
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=92.83 E-value=1.3 Score=37.16 Aligned_cols=126 Identities=16% Similarity=0.168 Sum_probs=67.1
Q ss_pred hhhhhhhhcccccccee---ecccCccceeE-------EEEEEEeccccHHh------------------------HHHH
Q 041718 149 ELATIANATDNFSINNK---LGEGGFGLVYK-------EIAVKRLSKISEQG------------------------LKEL 194 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~---lg~G~~g~Vyk-------~vavK~l~~~~~~~------------------------~~~~ 194 (295)
++..+....+...+... |..|-=+.||+ .+|||+........ ....
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 33444444444444444 55566668886 68999876421111 0112
Q ss_pred HHHHHHHhcCC--CCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHH
Q 041718 195 KNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272 (295)
Q Consensus 195 ~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~ 272 (295)
..|+.-|.++. +-.+.+-+++ .+-.|||||+....+.- ...+...+.......+..+++
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pA---------------P~LkDv~~e~~e~~~~~~~~v 176 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPA---------------PRLKDVPLELEEAEGLYEDVV 176 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCC---------------CCcccCCcCchhHHHHHHHHH
Confidence 34555555553 3334444443 23469999996531100 011122233335666777888
Q ss_pred HHHHhhhcCCCCCeEeccCCCCC
Q 041718 273 RGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 273 ~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+.-|-... .+||+||..=|
T Consensus 177 ~~~~~l~~~a--~LVHgDLSEyN 197 (268)
T COG1718 177 EYMRRLYKEA--GLVHGDLSEYN 197 (268)
T ss_pred HHHHHHHHhc--Ccccccchhhh
Confidence 8888777632 39999997543
|
|
| >PF12661 hEGF: Human growth factor-like EGF; PDB: 2YGQ_A 2E26_A 3A7Q_A 2YGP_A 2YGO_A 1HRE_A 1HAE_A 1HAF_A 1HRF_A | Back alignment and domain information |
|---|
Probab=92.35 E-value=0.041 Score=23.57 Aligned_cols=11 Identities=36% Similarity=0.954 Sum_probs=7.9
Q ss_pred ccccCCCCeeC
Q 041718 22 VCQCLKGFKQK 32 (295)
Q Consensus 22 ~C~C~~gf~~~ 32 (295)
.|.|++||+..
T Consensus 1 ~C~C~~G~~G~ 11 (13)
T PF12661_consen 1 TCQCPPGWTGP 11 (13)
T ss_dssp EEEE-TTEETT
T ss_pred CccCcCCCcCC
Confidence 49999999753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.24 Score=39.30 Aligned_cols=72 Identities=18% Similarity=0.351 Sum_probs=51.4
Q ss_pred ccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccc-eeeeEEeCCeeEEEEecCCCCC
Q 041718 161 SINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK-LLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 161 ~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~gs 233 (295)
...+.|++|.+|.||. .+|+|+-.. ......+..|+.+|..++--++.. ++.+ +..++.|||+.|-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcc
Confidence 3457899999999997 788887654 345577889999998887655533 3322 33456699998878
Q ss_pred HHHHH
Q 041718 234 LNSFI 238 (295)
Q Consensus 234 L~~~l 238 (295)
|.+.-
T Consensus 99 L~~~~ 103 (201)
T COG2112 99 LGKLE 103 (201)
T ss_pred hhhhh
Confidence 76654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=92.29 E-value=0.61 Score=38.74 Aligned_cols=71 Identities=14% Similarity=0.269 Sum_probs=43.6
Q ss_pred eeecccCcc-ceeE---EEEEEEeccccHHhHHHHHHHHHHHhcCCCC---cccceeeeEEeC---CeeEEEEecCCCCC
Q 041718 164 NKLGEGGFG-LVYK---EIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQG---EEKLLIYEFMPNKS 233 (295)
Q Consensus 164 ~~lg~G~~g-~Vyk---~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~~~~gs 233 (295)
+.|+.|+.. .||+ .+.+|..+. ......+.+|..+|..|... -+.+.++..... ...+++||+++|.+
T Consensus 3 ~~~~~gG~~n~vy~~~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~ 80 (235)
T cd05155 3 EPVDSGGTDNATFRLGDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGET 80 (235)
T ss_pred eeccCCCcccceEEcCCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCC
Confidence 456766665 5886 466665443 22345788999988887532 334444432221 23488999999987
Q ss_pred HHH
Q 041718 234 LNS 236 (295)
Q Consensus 234 L~~ 236 (295)
+.+
T Consensus 81 l~~ 83 (235)
T cd05155 81 ATA 83 (235)
T ss_pred CCc
Confidence 754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12947 EGF_3: EGF domain; InterPro: IPR024731 This entry represents an EGF domain found in the the C terminus of malarial parasite merozoite surface protein 1 [], as well as other proteins | Back alignment and domain information |
|---|
Probab=91.93 E-value=0.039 Score=31.25 Aligned_cols=26 Identities=23% Similarity=0.609 Sum_probs=19.2
Q ss_pred CCCCCCCcccccC-CCCccccCCCCee
Q 041718 6 YALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 6 ~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
.+-|.++..|... +...|.|.+||..
T Consensus 5 ~~~C~~nA~C~~~~~~~~C~C~~Gy~G 31 (36)
T PF12947_consen 5 NGGCHPNATCTNTGGSYTCTCKPGYEG 31 (36)
T ss_dssp GGGS-TTCEEEE-TTSEEEEE-CEEEC
T ss_pred CCCCCCCcEeecCCCCEEeECCCCCcc
Confidence 4679999999865 5679999999965
|
; PDB: 2NPR_A 1N1I_C 1B9W_A 1YO8_A 2RHP_A. |
| >PF07974 EGF_2: EGF-like domain; InterPro: IPR013111 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
Probab=91.81 E-value=0.19 Score=27.56 Aligned_cols=25 Identities=24% Similarity=0.736 Sum_probs=20.1
Q ss_pred CCCCCCcccccCCCCccccCCCCeeC
Q 041718 7 ALCGAYGICIISGMPVCQCLKGFKQK 32 (295)
Q Consensus 7 ~~CG~~~~C~~~~~~~C~C~~gf~~~ 32 (295)
.+|+..|.|+.. ...|.|.+||...
T Consensus 6 ~~C~~~G~C~~~-~g~C~C~~g~~G~ 30 (32)
T PF07974_consen 6 NICSGHGTCVSP-CGRCVCDSGYTGP 30 (32)
T ss_pred CccCCCCEEeCC-CCEEECCCCCcCC
Confidence 479999999854 5679999999653
|
The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length. This entry contains EGF domains found in a variety of extracellular and membrane proteins |
| >cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.2 Score=28.04 Aligned_cols=31 Identities=29% Similarity=0.696 Sum_probs=22.8
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCee
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
++|.....|...+.|... +...|.|++||..
T Consensus 3 ~~C~~~~~C~~~~~C~~~~~~~~C~C~~g~~g 34 (38)
T cd00054 3 DECASGNPCQNGGTCVNTVGSYRCSCPPGYTG 34 (38)
T ss_pred ccCCCCCCcCCCCEeECCCCCeEeECCCCCcC
Confidence 356554578888899754 4568999999964
|
Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements. |
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=91.20 E-value=0.34 Score=32.87 Aligned_cols=52 Identities=13% Similarity=0.263 Sum_probs=35.3
Q ss_pred EeeccCCCCcccccccCCChHHHHHHhhcCCCccceecccccCCCcceeeecc
Q 041718 60 FTAMKLPDATRSWVSKSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFG 112 (295)
Q Consensus 60 ~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~g~~C~~w~~ 112 (295)
..+++++..+...+ ...+.++|++.|+.+-.|.+|+|.........|+++..
T Consensus 6 ~~~~df~G~Dl~~~-~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~s 57 (79)
T smart00223 6 YKNVDFRGSDINTV-YVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKDS 57 (79)
T ss_pred ccCccccCceeeee-ecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCcC
Confidence 34566666555422 45688999999999999999988643222226887543
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >PF00024 PAN_1: PAN domain This Prosite entry concerns apple domains, a subset of PAN domains; InterPro: IPR003014 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=91.08 E-value=0.41 Score=31.96 Aligned_cols=55 Identities=16% Similarity=0.410 Sum_probs=40.3
Q ss_pred ceeEEeeccCCCCcccccccCCChHHHHHHhhcCCC-ccceecccccCCCcceeeecccC
Q 041718 56 GFIKFTAMKLPDATRSWVSKSMNLNECWEKCLDDSS-CMAYTNSYIRGEGSGCAMWFGEL 114 (295)
Q Consensus 56 ~f~~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~~Cs-C~a~~~~~~~~~g~~C~~w~~~L 114 (295)
.|.++.+..+........ ...++++|...|+.+-. |.++.|.. ....|.++....
T Consensus 3 ~f~~~~~~~l~~~~~~~~-~v~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~L~~~~~ 58 (79)
T PF00024_consen 3 AFERIPGYRLSGHSIKEI-NVPSLEECAQLCLNEPRRCKSFNYDP---SSKTCYLSSSDR 58 (79)
T ss_dssp TEEEEEEEEEESCEEEEE-EESSHHHHHHHHHHSTT-ESEEEEET---TTTEEEEECSSS
T ss_pred CeEEECCEEEeCCcceEE-cCCCHHHHHhhcCcCcccCCeEEEEC---CCCEEEEcCCCC
Confidence 477778888777544433 45589999999999999 99998864 234598865543
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs It has been shown that, the N-terminal N domains of members of the plasminogen/hepatocyte growth factor family, the apple domains of the plasma prekallikrein/coagulation factor XI family, and domains of various nematode proteins belong to the same module superfamily, the PAN module []. PAN contains a conserved core of three disulphide bridges. In some members of the family there is an additional fourth disulphide bridge that links the N and C termini of the domain.; PDB: 1GP9_C 2QJ2_B 1GMO_H 1NK1_B 3MKP_B 1BHT_B 3HN4_A 1GMN_A 3HMS_A 3HMT_B .... |
| >PF01683 EB: EB module; InterPro: IPR006149 The EB domain has no known function | Back alignment and domain information |
|---|
Probab=90.98 E-value=0.26 Score=30.38 Aligned_cols=29 Identities=24% Similarity=0.662 Sum_probs=23.8
Q ss_pred CCCCCCCCCCCcccccCCCCccccCCCCeeCC
Q 041718 2 LCDTYALCGAYGICIISGMPVCQCLKGFKQKS 33 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~~~~~~C~C~~gf~~~~ 33 (295)
.|....-|-++++|.. ..|.|++||.+..
T Consensus 21 ~C~~~~qC~~~s~C~~---g~C~C~~g~~~~~ 49 (52)
T PF01683_consen 21 SCESDEQCIGGSVCVN---GRCQCPPGYVEVG 49 (52)
T ss_pred CCCCcCCCCCcCEEcC---CEeECCCCCEecC
Confidence 5888888889999953 6799999998764
|
It is found in several Caenorhabditis sp. and Drosophila sp. proteins. The domain contains 8 conserved cysteines that probably form four disulphide bridges and is found associated with kunitz domains IPR002223 from INTERPRO |
| >PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins | Back alignment and domain information |
|---|
Probab=90.90 E-value=0.086 Score=28.93 Aligned_cols=25 Identities=32% Similarity=0.691 Sum_probs=20.1
Q ss_pred CCCCCCcccccC--CCCccccCCCCee
Q 041718 7 ALCGAYGICIIS--GMPVCQCLKGFKQ 31 (295)
Q Consensus 7 ~~CG~~~~C~~~--~~~~C~C~~gf~~ 31 (295)
..|...|.|... ....|.|++||+.
T Consensus 4 ~~C~n~g~C~~~~~~~y~C~C~~G~~G 30 (32)
T PF00008_consen 4 NPCQNGGTCIDLPGGGYTCECPPGYTG 30 (32)
T ss_dssp TSSTTTEEEEEESTSEEEEEEBTTEES
T ss_pred CcCCCCeEEEeCCCCCEEeECCCCCcc
Confidence 378899999753 5689999999964
|
The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length.; GO: 0005515 protein binding; PDB: 1WHE_A 1CCF_A 1APO_A 1WHF_A 2VJ3_A 1TOZ_A 4D90_B 3CFW_A 1EDM_B 1IXA_A .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=90.88 E-value=0.14 Score=46.74 Aligned_cols=67 Identities=24% Similarity=0.473 Sum_probs=52.5
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
+....++|.....+|.|+||+|+. .+|||+|.. .......+..+|+..++++.|++++++...+...
T Consensus 44 ~sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 44 TSREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred hhhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 445567888899999999999995 578888753 2344556778888899999999999998877643
|
|
| >PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A | Back alignment and domain information |
|---|
Probab=90.38 E-value=0.22 Score=30.24 Aligned_cols=25 Identities=28% Similarity=0.561 Sum_probs=17.1
Q ss_pred cCCChHHHHHHhhcCCCccceeccc
Q 041718 75 KSMNLNECWEKCLDDSSCMAYTNSY 99 (295)
Q Consensus 75 ~~~~~~~C~~~Cl~~CsC~a~~~~~ 99 (295)
...+.++|.+.|..+-.|.++.+..
T Consensus 14 ~~~s~~~C~~~C~~~~~C~~~~~~~ 38 (51)
T PF14295_consen 14 TASSPEECQAACAADPGCQAFTFNP 38 (51)
T ss_dssp ----HHHHHHHHHTSTT--EEEEET
T ss_pred cCCCHHHHHHHccCCCCCCEEEEEC
Confidence 4568899999999999999988764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=90.36 E-value=3.2 Score=35.64 Aligned_cols=70 Identities=16% Similarity=0.174 Sum_probs=43.5
Q ss_pred ceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCc--ccceeee------EEeCCeeEEEEec
Q 041718 163 NNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGC------CIQGEEKLLIYEF 228 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e~ 228 (295)
.+.|..|....+|+ .+.+|+... .....+..|+.++..|.+.. +.+++.. ....+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 35566666667775 467777653 23456677888888775433 4444432 1234456899999
Q ss_pred CCCCCHH
Q 041718 229 MPNKSLN 235 (295)
Q Consensus 229 ~~~gsL~ 235 (295)
++|..+.
T Consensus 96 i~G~~~~ 102 (296)
T cd05153 96 LAGEHLT 102 (296)
T ss_pred CCCCCCC
Confidence 9987754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF09064 Tme5_EGF_like: Thrombomodulin like fifth domain, EGF-like; InterPro: IPR015149 This domain adopts a fold similar to other EGF domains, with a flat major and a twisted minor beta sheet | Back alignment and domain information |
|---|
Probab=89.60 E-value=0.2 Score=27.52 Aligned_cols=19 Identities=21% Similarity=0.438 Sum_probs=15.0
Q ss_pred ccccCCCCccccCCCCeeC
Q 041718 14 ICIISGMPVCQCLKGFKQK 32 (295)
Q Consensus 14 ~C~~~~~~~C~C~~gf~~~ 32 (295)
.|+.+....|.||.||...
T Consensus 11 ~CDpn~~~~C~CPeGyIld 29 (34)
T PF09064_consen 11 DCDPNSPGQCFCPEGYILD 29 (34)
T ss_pred ccCCCCCCceeCCCceEec
Confidence 5666666799999999763
|
Disulphide pairing, however, is not of the usual 1-3, 2-4, 5-6 type; rather 1-2, 3-4, 5-6 pairing is found. Its extended major sheet (strands beta-2 and beta-3 and the connecting loop) projects into thrombin's active site groove. This domain is required for interaction of thrombomodulin with thrombin, and subsequent activation of protein-C []. ; GO: 0004888 transmembrane signaling receptor activity, 0016021 integral to membrane |
| >PF12662 cEGF: Complement Clr-like EGF-like | Back alignment and domain information |
|---|
Probab=89.49 E-value=0.24 Score=25.19 Aligned_cols=13 Identities=23% Similarity=0.751 Sum_probs=10.6
Q ss_pred CccccCCCCeeCC
Q 041718 21 PVCQCLKGFKQKS 33 (295)
Q Consensus 21 ~~C~C~~gf~~~~ 33 (295)
..|+|++||....
T Consensus 2 y~C~C~~Gy~l~~ 14 (24)
T PF12662_consen 2 YTCSCPPGYQLSP 14 (24)
T ss_pred EEeeCCCCCcCCC
Confidence 4799999998753
|
|
| >smart00181 EGF Epidermal growth factor-like domain | Back alignment and domain information |
|---|
Probab=89.30 E-value=0.36 Score=26.66 Aligned_cols=28 Identities=29% Similarity=0.730 Sum_probs=21.2
Q ss_pred CCCCCCCCCCcccccC-CCCccccCCCCee
Q 041718 3 CDTYALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 3 C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
|.....|... .|... +...|.|++||..
T Consensus 2 C~~~~~C~~~-~C~~~~~~~~C~C~~g~~g 30 (35)
T smart00181 2 CASGGPCSNG-TCINTPGSYTCSCPPGYTG 30 (35)
T ss_pred CCCcCCCCCC-EEECCCCCeEeECCCCCcc
Confidence 4444668877 89754 5789999999965
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=86.16 E-value=6.2 Score=35.76 Aligned_cols=68 Identities=16% Similarity=0.250 Sum_probs=46.6
Q ss_pred eeecccCccceeE--------EEEEEEeccc-----c--HHhHHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEE
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKI-----S--EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~-----~--~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv 225 (295)
+.||.|.+..||+ .+.||.-... . +...+.+..|.+.|..+. -.++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6789999999996 4778864310 1 124566777888777753 3467777776 44667899
Q ss_pred EecCCCCC
Q 041718 226 YEFMPNKS 233 (295)
Q Consensus 226 ~e~~~~gs 233 (295)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=83.24 E-value=16 Score=31.56 Aligned_cols=67 Identities=19% Similarity=0.247 Sum_probs=42.3
Q ss_pred ceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEEEecCCCC
Q 041718 163 NNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNK 232 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 232 (295)
.+.|+.|....+|+ .+-||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEECCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 46788888888885 67888764 234456778887777773 456788888888778889999999754
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.87 E-value=5 Score=36.47 Aligned_cols=55 Identities=18% Similarity=0.145 Sum_probs=33.2
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHh-hhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMY-LHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~y-LH~~~~~~iiHrDlkp~N 295 (295)
..|+-+|+++.++..++.. +..++....+++.--++||-- |--.+ ++|.|+.|.|
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~----------------~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGN 375 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW----------------KSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGN 375 (565)
T ss_pred ceeeeeccccccHHhhhhc----------------ccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCc
Confidence 3566778888888888732 223334444555444444332 22223 9999999988
|
|
| >PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein | Back alignment and domain information |
|---|
Probab=82.00 E-value=0.51 Score=26.67 Aligned_cols=26 Identities=35% Similarity=0.768 Sum_probs=17.9
Q ss_pred CCCCCCccccc--CCCCccccCCCCeeC
Q 041718 7 ALCGAYGICII--SGMPVCQCLKGFKQK 32 (295)
Q Consensus 7 ~~CG~~~~C~~--~~~~~C~C~~gf~~~ 32 (295)
..|-.|+-|.. +++..|.|++||+..
T Consensus 5 ~~cP~NA~C~~~~dG~eecrCllgyk~~ 32 (37)
T PF12946_consen 5 TKCPANAGCFRYDDGSEECRCLLGYKKV 32 (37)
T ss_dssp S---TTEEEEEETTSEEEEEE-TTEEEE
T ss_pred ccCCCCcccEEcCCCCEEEEeeCCcccc
Confidence 56888999953 478899999999874
|
MSP1 is the merozoite surface protein 1. This domain is part of the C-terminal fragment that is proteolytically processed from the the rest of the protein and is left attached to the surface of the invading parasite [].; PDB: 1N1I_C 2FLG_A 1CEJ_A 2NPR_A 1B9W_A 1OB1_F. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=80.45 E-value=3.7 Score=41.89 Aligned_cols=77 Identities=18% Similarity=0.163 Sum_probs=55.4
Q ss_pred HHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE----EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHH
Q 041718 191 LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL----LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266 (295)
Q Consensus 191 ~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 266 (295)
.....-|+..+.++.|+|++.++.+-.+....- +..|+++.-++...+. ....++..+...
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---------------~v~~i~~~~~r~ 290 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---------------SVGSIPLETLRI 290 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---------------hccccCHHHHHH
Confidence 344456778899999999999999876544333 2345666666655552 234577788888
Q ss_pred HHHHHHHHHHhhhcCC
Q 041718 267 IICGTARGVMYLHQDS 282 (295)
Q Consensus 267 i~~~i~~gl~yLH~~~ 282 (295)
+..++..||.|+|+..
T Consensus 291 ~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 291 LHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHhhhHHHHHHhc
Confidence 8999999999999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 295 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-24 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-17 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-05 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-05 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-05 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-05 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-05 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-05 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-05 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-05 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-05 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-05 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-05 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-05 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-05 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-05 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-05 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-04 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-04 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-66
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 31/177 (17%)
Query: 135 EIENRNMDLELPLFELATIANATDNFS------INNKLGEGGFGLVYK------EIAVKR 182
D F + N T+NF NK+GEGGFG+VYK +AVK+
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK 61
Query: 183 LSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFI 238
L+ + +E+ ++ E+ + +K QH NLV+LLG G++ L+Y +MPN SL +
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 239 FENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ L W R I G A G+ +LH++ IHRD+K++N
Sbjct: 122 S------------CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-63
Identities = 65/156 (41%), Positives = 86/156 (55%), Gaps = 19/156 (12%)
Query: 148 FELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLK-ELKNEVI 199
F L + A+DNFS N LG GGFG VYK +AVKRL + QG + + + EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
+ S HRNL++L G C+ E+LL+Y +M N S+ S + E E L
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-----------RPESQPPL 128
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
DW KR I G+ARG+ YLH +IIHRD+KA+N
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 7e-58
Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 148 FELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVIL 200
L + AT+NF +G G FG VYK ++A+KR + S QG++E + E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
S +H +LV L+G C + E +LIY++M N +L ++ + +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-----------DLPTMSMS 137
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
W +R I G ARG+ YLH + IIHRD+K+ N
Sbjct: 138 WEQRLEICIGAARGLHYLHTRA---IIHRDVKSIN 169
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 34/165 (20%)
Query: 148 FELATIANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILF 201
+ + + G FG V+K +AVK +Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQS-WQNEYEVYSL 72
Query: 202 SKLQHRNLVKLLGCCIQGE----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
++H N+++ +G +G + LI F SL+ F+ N
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---------------- 116
Query: 258 ILDWSKRFHIICGTARGVMYLHQD-------SKLRIIHRDLKASN 295
++ W++ HI ARG+ YLH+D K I HRD+K+ N
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKN 161
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-35
Identities = 38/157 (24%), Positives = 59/157 (37%), Gaps = 34/157 (21%)
Query: 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
DN + +G G +G VYK +AVK S + Q K + ++H N+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNI 69
Query: 210 VKLLGCCIQGE-----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
+ + + E LL+ E+ PN SL ++ + DW
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----------------TSDWVSS 113
Query: 265 FHIICGTARGVMYLHQD------SKLRIIHRDLKASN 295
+ RG+ YLH + K I HRDL + N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-32
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 21/146 (14%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRL--SKISEQGLKELKNEVILFSKLQHRNL 209
+ +I K+G G FG V++ ++AVK L + + E EV + +L+H N+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V +G Q ++ E++ SL + + LD +R +
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLH------------KSGAREQLDERRRLSMAY 144
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ YLH I+HR+LK+ N
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPN 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-31
Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 26/144 (18%)
Query: 162 INNKLGEGGFGLVYK------EIAVKRLSKISEQ----GLKELKNEVILFSKLQHRNLVK 211
+ +G GGFG VY+ E+AVK ++ ++ ++ E LF+ L+H N++
Sbjct: 11 LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
L G C++ L+ EF LN + K + +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVL----------------SGKRIPPDILVNWAVQI 114
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
ARG+ YLH ++ + IIHRDLK+SN
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSN 138
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 34/170 (20%)
Query: 141 MDLELPLFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG-- 190
E P L T+A+ + ++G+GGFGLV+K +A+K L +G
Sbjct: 4 GGSEFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGET 61
Query: 191 -----LKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLT 245
+E + EV + S L H N+VKL G ++ EF+P L +
Sbjct: 62 EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL------- 112
Query: 246 LMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ + WS + ++ A G+ Y+ I+HRDL++ N
Sbjct: 113 -------LDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPN 154
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 37/144 (25%), Positives = 58/144 (40%), Gaps = 22/144 (15%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ +G G FG+V K ++A+K++ SE K E+ S++ H N+VK
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65
Query: 212 LLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGT 271
L G C+ L+ E+ SL + + E +
Sbjct: 66 LYGACLN--PVCLVMEYAEGGSLYNVLH------------GAEPLPYYTAAHAMSWCLQC 111
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
++GV YLH +IHRDLK N
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPN 135
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-30
Identities = 31/148 (20%), Positives = 52/148 (35%), Gaps = 24/148 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRL--SKISEQGLKELKNEVILFSKLQHRNL 209
+ KL E G ++K +I VK L S + ++ E H N+
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 210 VKLLGCCIQGEEKLL--IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
+ +LG C I +MP SL + + E ++D S+
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-------------TNFVVDQSQAVKF 116
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
ARG+ +LH + I L + +
Sbjct: 117 ALDMARGMAFLHT-LEPLIPRHALNSRS 143
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 34/174 (19%)
Query: 129 IRMSASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK-----EIAVKRL 183
AS+ + ++P +L I +G+G FG VY E+A++ +
Sbjct: 14 FPRKASQTSIFLQEWDIPFEQL----------EIGELIGKGRFGQVYHGRWHGEVAIRLI 63
Query: 184 --SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN 241
+ +E LK K EV+ + + +H N+V +G C+ +I ++L S +
Sbjct: 64 DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV--- 120
Query: 242 FVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ +LD +K I +G+ YLH I+H+DLK+ N
Sbjct: 121 -----------RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKN 160
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 35/146 (23%), Positives = 57/146 (39%), Gaps = 25/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+ LG+G FG K + +K L + E+ + EV + L+H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+K +G + + I E++ +L I + WS+R
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGII--------------KSMDSQYPWSQRVSFAK 115
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
A G+ YLH + IIHRDL + N
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHN 138
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-----EIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLV 210
++ ++G G FG VYK ++AVK L + + Q L+ KNEV + K +H N++
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+G + ++ ++ SL + + K I
Sbjct: 84 LFMGYSTA-PQLAIVTQWCEGSSLYHHL--------------HASETKFEMKKLIDIARQ 128
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
TARG+ YLH IIHRDLK++N
Sbjct: 129 TARGMDYLHA---KSIIHRDLKSNN 150
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 44/188 (23%), Positives = 79/188 (42%), Gaps = 23/188 (12%)
Query: 121 PDAGQDLYIRMSASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK---- 176
P G+ ++ E D + + I + +LGEG FG V+
Sbjct: 11 PTEGKGSGLQGHIIENPQYFSDACVHHIKRRDI-------VLKWELGEGAFGKVFLAECH 63
Query: 177 ---------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227
+AVK L + SE ++ + E L + LQH+++V+ G C +G L+++E
Sbjct: 64 NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123
Query: 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRII 287
+M + LN F+ + + + + L + + A G++YL + L +
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFV 180
Query: 288 HRDLKASN 295
HRDL N
Sbjct: 181 HRDLATRN 188
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-24
Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 17/152 (11%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSKL 204
+ + +LGEG FG V+ +AVK L + K+ + E L + L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN-FVLTLMRSFVDQERCKILDWSK 263
QH ++VK G C G+ ++++E+M + LN F+ + ++ ++ L S+
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
HI A G++YL + +HRDL N
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRN 163
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-24
Identities = 37/166 (22%), Positives = 64/166 (38%), Gaps = 35/166 (21%)
Query: 145 LPLFELATIANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEV 198
LPL TIA + ++G+G +G V+ ++AVK E + E+
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-SWFRETEI 82
Query: 199 ILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE 254
++H N++ + I+G LI ++ N SL ++
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---------------- 126
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQD-----SKLRIIHRDLKASN 295
+ LD + + G+ +LH + K I HRDLK+ N
Sbjct: 127 KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-23
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 39/161 (24%)
Query: 152 TIANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILF--SK 203
T+A + ++ +G+G +G V++ +AVK S + K E L+
Sbjct: 5 TVA---RDITLLECVGKGRYGEVWRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVM 58
Query: 204 LQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
L+H N++ + + LI + SL ++ + L
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL----------------QLTTL 102
Query: 260 DWSKRFHIICGTARGVMYLHQD-----SKLRIIHRDLKASN 295
D I+ A G+ +LH + K I HRDLK+ N
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 38/167 (22%), Positives = 64/167 (38%), Gaps = 37/167 (22%)
Query: 145 LPLFELATIANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQG-LKELKNE 197
LPL TIA + +G+G FG V++ E+AVK S E+ +E E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA--E 86
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEK----LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQ 253
+ L+H N++ + + L+ ++ + SL ++
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--------------- 131
Query: 254 ERCKILDWSKRFHIICGTARGVMYLHQD-----SKLRIIHRDLKASN 295
+ + TA G+ +LH + K I HRDLK+ N
Sbjct: 132 -NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 177
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 25/152 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
N ++ LG G FG VY+ ++AVK L ++ SEQ + E ++ SK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
H+N+V+ +G +Q + ++ E M L SF L + + L
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF--------LRETRPRPSQPSSLAMLD 182
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H+ A G YL + IHRD+ A N
Sbjct: 183 LLHVARDIACGCQYL---EENHFIHRDIAARN 211
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 41/152 (26%), Positives = 64/152 (42%), Gaps = 25/152 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
N ++ LG G FG VY+ ++AVK L ++ SEQ + E ++ SK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
H+N+V+ +G +Q + ++ E M L SF L + + L
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF--------LRETRPRPSQPSSLAMLD 141
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H+ A G YL + IHRD+ A N
Sbjct: 142 LLHVARDIACGCQYL---EENHFIHRDIAARN 170
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 22/152 (14%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
+ +++ +LG+G FG+VY+ +A+K +++ S + E NE + +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
++V+LLG QG+ L+I E M L S++ +L + + SK
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-----RSLRPAMANNPVLAPPSLSK 139
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A G+ YL + + +HRDL A N
Sbjct: 140 MIQMAGEIADGMAYL---NANKFVHRDLAARN 168
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 26/149 (17%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ KLGEGGF V A+KR+ +Q +E + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 211 KLLGCCIQ----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
+L+ C++ E L+ F +L + I + + + IL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQ---IL------W 138
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ G RG+ +H HRDLK +N
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTN 164
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 26/161 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
+N +GEG FG V++ +AVK L + S + + E L ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF---------IFENFVLTLMRSFVDQE 254
+ N+VKLLG C G+ L++E+M LN F + R+ V
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L +++ I A G+ YL S+ + +HRDL N
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRN 204
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-21
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
+LGE FG VYK +A+K L +E ++E +L ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK-ILDWS 262
LQH N+V LLG + + +I+ + + L+ F+ + + S D K L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H++ A G+ YL S ++H+DL N
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRN 158
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 26/161 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
N + LGEG FG V K +AVK L + S L++L +E + +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF---------IFENFVLTLMRSFVDQE 254
+ H +++KL G C Q LLI E+ SL F + + S +D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ L ++G+ YL ++++++HRDL A N
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARN 180
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 30/147 (20%), Positives = 54/147 (36%), Gaps = 26/147 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRL-SKISEQGLKELKNEVILFSKLQHRN 208
++ + ++G G FG V+ +AVK + + E + + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
+V+L+G C Q + ++ E + +F+ + L ++
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFL--------------RTEGARLRVKTLLQMV 219
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
A G+ YL IHRDL A N
Sbjct: 220 GDAAAGMEYLES---KCCIHRDLAARN 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILF 201
D ++ LGEG FG V +AVK L +E+ L +L +E+ +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 202 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC-KIL 259
+ +H+N++ LLG C Q +I E+ +L ++ + S+ + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ARG+ YL + + IHRDL A N
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 187
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 158 DNFSINNKLGEGGFGLVYK----------EIAVKRL-SKISEQGLKELKNEVILFSKL-Q 205
++ + +GEG FG V K + A+KR+ S+ ++ E+ + KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC-KILDWSKR 264
H N++ LLG C L E+ P+ +L F+ ++ VL +F L +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H ARG+ YL S+ + IHRDL A N
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARN 172
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-20
Identities = 38/157 (24%), Positives = 62/157 (39%), Gaps = 31/157 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSK--ISEQGLKELKNEVILFSKL 204
F++ LG+G FG V + ++AVK L I+ ++E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 205 QHRNLVKLLGCCIQGEEK------LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI 258
H ++ KL+G ++ K ++I FM + L++F+ + E
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL---------LASRIGENPFN 133
Query: 259 LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L + A G+ YL S IHRDL A N
Sbjct: 134 LPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARN 167
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-20
Identities = 37/150 (24%), Positives = 69/150 (46%), Gaps = 34/150 (22%)
Query: 162 INNKLGEGGFGLVYK--------EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ ++G G F VYK E+A + K+++ + K E + LQH N+V+
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 212 LLGCCI---QGEEKLLIY-EFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRF 265
+G++ +++ E M + +L +++ F+ + ++RS+ Q IL
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ----IL------ 139
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ +LH + IIHRDLK N
Sbjct: 140 -------KGLQFLHTRTP-PIIHRDLKCDN 161
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK---------------EIAVKRL-SKISEQGLKELKNEVILF 201
D ++ LGEG FG V +AVK L +E+ L +L +E+ +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 202 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKIL 259
+ +H+N++ LLG C Q +I E+ +L ++ + S+ +++ + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ARG+ YL + + IHRDL A N
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 233
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-20
Identities = 36/144 (25%), Positives = 63/144 (43%), Gaps = 35/144 (24%)
Query: 166 LGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI 217
LG+G +G+VY IA+K + + + + L E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF- 88
Query: 218 QGEEKLLIY-EFMPNKSLNSFI---FENFVLT--LMRSFVDQERCKILDWSKRFHIICGT 271
+ I+ E +P SL++ + + + + Q IL
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ----IL------------ 132
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH + +I+HRD+K N
Sbjct: 133 -EGLKYLHDN---QIVHRDIKGDN 152
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-20
Identities = 41/156 (26%), Positives = 62/156 (39%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRL-SKISEQGLKELKNEVILFSK 203
+ S LG G FG V + +AVK L + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN---FVLTLMRSFVDQERCKIL 259
L H N+V LLG C G L+I E+ L +F+ F+ + + ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D A+G+ +L + IHRDL A N
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARN 175
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-20
Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 30/156 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSK--ISEQGLKELKNEVILFSKL 204
+ + LGEG FG V + ++AVK + S++ ++E +E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 205 QHRNLVKLLGCCIQGE-----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
H N+++LLG CI+ + ++I FM L++++ + K +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL---------LYSRLETGPKHI 144
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A G+ YL S +HRDL A N
Sbjct: 145 PLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARN 177
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 31/152 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ +LG+G FG V +AVK+L +E+ L++ + E+ + LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 206 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
H N+VK G C + LI E++P SL ++ Q+ + +D K
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--------------QKHKERIDHIK 146
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL R IHRDL N
Sbjct: 147 LLQYTSQICKGMEYLGT---KRYIHRDLATRN 175
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 40/153 (26%), Positives = 59/153 (38%), Gaps = 19/153 (12%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRL-SKISEQGLKELKNEVILFSK 203
+N LG G FG V + ++AVK L S + L +E+ + S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
L QH N+V LLG C G L+I E+ L +F+ +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST-ASTR 164
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H A+G+ +L + IHRD+ A N
Sbjct: 165 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 37/161 (22%), Positives = 61/161 (37%), Gaps = 26/161 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRL-SKISEQGLKELKNEVILFSK 203
+N LG G FG V ++AVK L K + L +E+ + ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF--------IFENFVLTLMRSFVDQE 254
L H N+V LLG C LI+E+ L ++ + + ++E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L + A+G+ +L +HRDL A N
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARN 202
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-19
Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILF 201
D + LGEG FG V ++AVK L +E+ L +L +E+ +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 202 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
+ +H+N++ LLG C Q +I E+ +L ++ L S+ +
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 261 WSKRFHIICG-TARGVMYLHQDSKLRIIHRDLKASN 295
SK ARG+ YL + + IHRDL A N
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 31/153 (20%), Positives = 63/153 (41%), Gaps = 32/153 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK---------------EIAVKRLSKISEQGLKELKNEVILFS 202
++ N LG+G F ++K E+ +K L K + + S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
KL H++LV G C+ G+E +L+ EF+ SL++++ ++ ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--------------KKNKNCINIL 113
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + A + +L + +IH ++ A N
Sbjct: 114 WKLEVAKQLAAAMHFL---EENTLIHGNVCAKN 143
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 31/152 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ +LG+G FG V +AVK+L +E+ L++ + E+ + LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 206 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
H N+VK G C + LI E++P SL ++ Q+ + +D K
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--------------QKHKERIDHIK 115
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL R IHRDL N
Sbjct: 116 LLQYTSQICKGMEYLGT---KRYIHRDLATRN 144
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-19
Identities = 36/155 (23%), Positives = 62/155 (40%), Gaps = 20/155 (12%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRL-SKISEQGLKELKNEVILFSK 203
D + LG G FG V + +AVK L + + L +E+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 204 L-QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+ H N+V LLG C + L +I EF +L++++ + ++ K
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 262 SKRFHIICG-TARGVMYLHQDSKLRIIHRDLKASN 295
+ A+G+ +L + + IHRDL A N
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 178
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 34/152 (22%), Positives = 56/152 (36%), Gaps = 31/152 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ ++LG+G FG V +AVK+L ++ + E+ + L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 206 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
+VK G + L+ E++P+ L F+ Q LD S+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--------------QRHRARLDASR 128
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ YL R +HRDL A N
Sbjct: 129 LLLYSSQICKGMEYLGS---RRCVHRDLAARN 157
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 36/153 (23%), Positives = 52/153 (33%), Gaps = 34/153 (22%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRL-SKISEQGLKELKNEVILFSKL 204
LGEG FG V +AVK L + Q K E+ + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 205 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
H +++K GCC L+ E++P SL ++ + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----------------PRHSIGLA 134
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YLH IHRDL A N
Sbjct: 135 QLLLFAQQICEGMAYLHA---QHYIHRDLAARN 164
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-18
Identities = 32/145 (22%), Positives = 59/145 (40%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ ++G G FGLV+ ++A+K + + ++ E + KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L G C++ L+ EFM + L+ ++ + + + +
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYL--------------RTQRGLFAAETLLGMCLD 112
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
G+ YL + +IHRDL A N
Sbjct: 113 VCEGMAYL---EEACVIHRDLAARN 134
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-18
Identities = 36/148 (24%), Positives = 56/148 (37%), Gaps = 30/148 (20%)
Query: 161 SINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 208
N +G G FG VY AVK L++I + + E I+ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 209 LVKLLGCCIQGEEKLL-IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
++ LLG C++ E L + +M + L +FI +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--------------RNETHNPTVKDLIGF 133
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ YL + + +HRDL A N
Sbjct: 134 GLQVAKGMKYL---ASKKFVHRDLAARN 158
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 8e-18
Identities = 35/145 (24%), Positives = 58/145 (40%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ ++ +LG G FG+V ++AVK + K E E KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
K G C + ++ E++ N L +++ + K L+ S+ +
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYL--------------RSHGKGLEPSQLLEMCYD 112
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
G+ +L + IHRDL A N
Sbjct: 113 VCEGMAFL---ESHQFIHRDLAARN 134
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 9e-18
Identities = 32/145 (22%), Positives = 54/145 (37%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ +G+G FG V ++AVK + + + E + ++L+H NLV+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 212 LLGCCIQGEEKLLI-YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
LLG ++ + L I E+M SL ++ +L
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSL-------------VDYLRSRGRSVLGGDCLLKFSLD 125
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ YL +HRDL A N
Sbjct: 126 VCEAMEYL---EGNNFVHRDLAARN 147
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 37/153 (24%), Positives = 59/153 (38%), Gaps = 32/153 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRL-SKISEQGLKELKNEVILFSKL 204
LGEG FG V ++AVK L + + +LK E+ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 205 QHRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
H N+VK G C + LI EF+P+ SL ++ + ++
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--------------PKNKNKINLK 126
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ +G+ YL + +HRDL A N
Sbjct: 127 QQLKYAVQICKGMDYLGS---RQYVHRDLAARN 156
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 9e-18
Identities = 32/145 (22%), Positives = 54/145 (37%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ + +LG G FG+V ++A+K + K E E + L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L G C + +I E+M N L +++ +E + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYL--------------REMRHRFQTQQLLEMCKD 128
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ YL + +HRDL A N
Sbjct: 129 VCEAMEYL---ESKQFLHRDLAARN 150
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 35/148 (23%), Positives = 56/148 (37%), Gaps = 30/148 (20%)
Query: 161 SINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRN 208
N +G G FG VY AVK L++I + + E I+ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 209 LVKLLGCCIQGEEKLL-IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
++ LLG C++ E L + +M + L +FI +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI--------------RNETHNPTVKDLIGF 197
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ +L + + +HRDL A N
Sbjct: 198 GLQVAKGMKFL---ASKKFVHRDLAARN 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+ ++ +KLG G +G VY+ +AVK L K ++E E + +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V+LLG C + +I EFM +L + +R + + ++
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDY---------LRE----CNRQEVSAVVLLYMAT 325
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL K IHR+L A N
Sbjct: 326 QISSAMEYL---EKKNFIHRNLAARN 348
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+ ++ +KLG G +G VY+ +AVK L K ++E E + +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V+LLG C + +I EFM +L ++ + + + ++
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNL-------------LDYLRECNRQEVSAVVLLYMAT 118
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL K IHRDL A N
Sbjct: 119 QISSAMEYL---EKKNFIHRDLAARN 141
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 31/145 (21%), Positives = 55/145 (37%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ +G+G FG V ++AVK + + + E + ++L+H NLV+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 212 LLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
LLG ++ + L ++ E+M SL ++ +L
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSL-------------VDYLRSRGRSVLGGDCLLKFSLD 297
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ YL +HRDL A N
Sbjct: 298 VCEAMEYL---EGNNFVHRDLAARN 319
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 33/150 (22%), Positives = 61/150 (40%), Gaps = 29/150 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRL-SKISEQGLKELKNEVILFSKLQ 205
I +G G G V +A+K L + +E+ ++ +E + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N+++L G +G +++ E+M N SL++F+ + +
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--------------RTHDGQFTIMQLV 154
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ G G+ YL S L +HRDL A N
Sbjct: 155 GMLRGVGAGMRYL---SDLGYVHRDLAARN 181
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 35/147 (23%), Positives = 60/147 (40%), Gaps = 30/147 (20%)
Query: 162 INNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNL 209
+ +G+G FG+VY + A+K LS+I Q ++ E +L L H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 210 VKLLGCCIQGEE-KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
+ L+G + E ++ +M + L FI + +
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFI--------------RSPQRNPTVKDLISFG 130
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
ARG+ YL ++ + +HRDL A N
Sbjct: 131 LQVARGMEYL---AEQKFVHRDLAARN 154
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 29/150 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQ 205
N SI+ +G G FG V +A+K L +E+ ++ E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N+++L G + + +++ E+M N SL+SF+ ++ +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--------------RKHDAQFTVIQLV 150
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ G A G+ YL S + +HRDL A N
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARN 177
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 8e-17
Identities = 34/151 (22%), Positives = 63/151 (41%), Gaps = 30/151 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKL 204
+ +G G FG VYK +A+K L +E+ + E + +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
H N+++L G + + ++I E+M N +L+ F+ +E+ +
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--------------REKDGEFSVLQL 149
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ G A G+ YL + + +HRDL A N
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARN 177
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-17
Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 25/155 (16%)
Query: 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVIL 200
+ + + + I +LG+G FG VYK A K + SE+ L++ E+ +
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEI 69
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
+ H +VKLLG + ++ EF P ++++ + E + L
Sbjct: 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--------------LELDRGLT 115
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + + +LH RIIHRDLKA N
Sbjct: 116 EPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGN 147
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 37/151 (24%), Positives = 61/151 (40%), Gaps = 31/151 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKL 204
F LG G FG VYK +A+K L + S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
+ ++ +LLG C+ LI + MP L ++ +E +
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--------------REHKDNIGSQYL 119
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A+G+ YL R++HRDL A N
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARN 147
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 37/145 (25%), Positives = 57/145 (39%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ + KLG G FG V+ ++AVK + K ++ E + LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
KL + E +I EFM SL F+ + K
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-------------EGSKQPLPKLIDFSAQ 292
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ ++ + IHRDL+A+N
Sbjct: 293 IAEGMAFI---EQRNYIHRDLRAAN 314
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 34/145 (23%), Positives = 53/145 (36%), Gaps = 41/145 (28%)
Query: 164 NKLGEGGFGLVYK--------EIAVK--RLSKISEQGLKELKNEVILFSKLQHRNLVKLL 213
++G G FG V++ + AVK RL + E++ + L +V L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 214 GCCIQGEEKLLIY-EFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
G +G + I+ E + SL I ++ Q L
Sbjct: 117 GAVREG-PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ----AL----------- 160
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
G+ YLH RI+H D+KA N
Sbjct: 161 --EGLEYLHTR---RILHGDVKADN 180
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 36/193 (18%)
Query: 117 MRDFPDAGQDLYIRMSASEIENRNMDLELPLFELATIANATD---NFSINNKLGEGGFGL 173
M + + ++ + E L + + D K+GEG G+
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGI 60
Query: 174 VYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225
V ++AVK + +Q + L NEV++ QH N+V++ + GEE ++
Sbjct: 61 VCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI--IC-GTARGVMYLHQDS 282
EF+ +L ++ E I +C + + YLH
Sbjct: 121 MEFLQGGAL---------TDIVSQVRLNEE----------QIATVCEAVLQALAYLHAQ- 160
Query: 283 KLRIIHRDLKASN 295
+IHRD+K+ +
Sbjct: 161 --GVIHRDIKSDS 171
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 33/152 (21%), Positives = 60/152 (39%), Gaps = 33/152 (21%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRL-SKISEQGLKELKNEVILFSKL 204
LG G FG V+K + +K + K Q + + + ++ L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN-FVLTLMRSFVDQERCKILDWSK 263
H ++V+LLG C L+ +++P SL + ++ L +L+W
Sbjct: 73 DHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQL---------LLNWG- 121
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ YL + ++HR+L A N
Sbjct: 122 -----VQIAKGMYYL---EEHGMVHRNLAARN 145
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-16
Identities = 39/145 (26%), Positives = 59/145 (40%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ + +LG G FG V+ ++AVK L K E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L Q E +I E+M N SL F+ L +K +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSL-------------VDFLKTPSGIKLTINKLLDMAAQ 117
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ ++ + IHRDL+A+N
Sbjct: 118 IAEGMAFI---EERNYIHRDLRAAN 139
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-16
Identities = 31/148 (20%), Positives = 63/148 (42%), Gaps = 26/148 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVK--RLSKISEQGLKELKNEVILFSKLQHR 207
+ + K+GEG FG + +K +S++S + +E + EV + + ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+V+ + ++ ++ L I ++ +ILDW F
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ-----KGVLFQED--QILDW---FVQ 133
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
IC + ++H +I+HRD+K+ N
Sbjct: 134 IC---LALKHVHDR---KILHRDIKSQN 155
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-16
Identities = 31/150 (20%), Positives = 59/150 (39%), Gaps = 34/150 (22%)
Query: 159 NFSINNKLGEGGFGLVYK-------EIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 209
+SI ++G GG V++ A+K L + Q L +NE+ +KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 210 --VKLLGCCIQGEEKLLIYEFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKRF 265
++L ++ + + N LNS++ ++ +S+
Sbjct: 117 KIIRLYD-YEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKN------------ 163
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ V +HQ I+H DLK +N
Sbjct: 164 -MLE----AVHTIHQ---HGIVHSDLKPAN 185
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-16
Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 31/151 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRL-SKISEQGLKELKNEVILFSKL 204
F LG G FG VYK +A+K L S + KE+ +E + + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
+ ++ +LLG C+ LI + MP L ++ +E +
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV--------------REHKDNIGSQYL 119
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A+G+ YL R++HRDL A N
Sbjct: 120 LNWCVQIAKGMNYL---EDRRLVHRDLAARN 147
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 31/175 (17%)
Query: 132 SASEIENRNMDLELPLFELATIANATD---NFSINNKLGEGGFGLVYK--------EIAV 180
S ++ RN L +L + F + KLGEG +G VYK +A+
Sbjct: 1 SLETVQLRNPP-RRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAI 59
Query: 181 KRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFE 240
K++ E L+E+ E+ + + ++VK G + + ++ E+ S++ I
Sbjct: 60 KQVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII-- 115
Query: 241 NFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ R K L + I+ T +G+ YLH R IHRD+KA N
Sbjct: 116 ------------RLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGN 155
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 8e-16
Identities = 35/145 (24%), Positives = 60/145 (41%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ + KLG+G FG V+ +A+K L K + E + KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L + E ++ E+M SL F+ K L + +
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-------------TGKYLRLPQLVDMAAQ 371
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ Y+ ++ +HRDL+A+N
Sbjct: 372 IASGMAYV---ERMNYVHRDLRAAN 393
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 9e-16
Identities = 30/160 (18%), Positives = 71/160 (44%), Gaps = 33/160 (20%)
Query: 147 LFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEV 198
L + ++ + ++ K+G+G G VY E+A+++++ + + + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 199 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI 258
++ + ++ N+V L + G+E ++ E++ SL ++ E
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD---------VVTETCMDEG--- 116
Query: 259 LDWSKRFHI--IC-GTARGVMYLHQDSKLRIIHRDLKASN 295
I +C + + +LH + ++IHRD+K+ N
Sbjct: 117 -------QIAAVCRECLQALEFLHSN---QVIHRDIKSDN 146
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 33/151 (21%), Positives = 61/151 (40%), Gaps = 36/151 (23%)
Query: 159 NFSINNKLGEGGFGLVYK-------EIAVKR--LSKISEQGLKELKNEVILFSKLQHRNL 209
+SI ++G GG V++ A+K L + Q L +NE+ +KLQ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 210 --VKLLGCCIQGEEKL-LIYEFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILDWSKR 264
++L ++ + ++ E N LNS++ ++ +S+ +L
Sbjct: 89 KIIRLYD-YEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN----ML----- 137
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
V +HQ I+H DLK +N
Sbjct: 138 --------EAVHTIHQ---HGIVHSDLKPAN 157
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 37/153 (24%), Positives = 58/153 (37%), Gaps = 29/153 (18%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNL 209
+ L EGGF VY +E A+KRL E+ + + EV KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENF----VLTLMRSFVDQERCK---ILDWS 262
V+ G+E+ + ++ ++ + +L
Sbjct: 89 VQFCSAASIGKEE------SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI- 141
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
F+ C R V ++H+ K IIHRDLK N
Sbjct: 142 --FYQTC---RAVQHMHR-QKPPIIHRDLKVEN 168
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 35/145 (24%), Positives = 60/145 (41%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ + KLG+G FG V+ +A+K L K + E + KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L + E ++ E+M SL F+ K L + +
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-------------TGKYLRLPQLVDMAAQ 288
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ Y+ ++ +HRDL+A+N
Sbjct: 289 IASGMAYV---ERMNYVHRDLRAAN 310
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 32/150 (21%), Positives = 62/150 (41%), Gaps = 27/150 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRL---SKISEQGLKELKNEVILFSKLQH 206
NF I K+G G F VY+ +A+K++ + + + E+ L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 207 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N++K I+ + +L I E L+ I + + + + + F
Sbjct: 92 PNVIKYYASFIE-DNELNIVLELADAGDLSRMIKH---FKKQKRLIPER--TVWKY---F 142
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+C + ++H R++HRD+K +N
Sbjct: 143 VQLC---SALEHMHSR---RVMHRDIKPAN 166
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 32/148 (21%), Positives = 59/148 (39%), Gaps = 30/148 (20%)
Query: 159 NFSINNKLGEGGFGLVYK-------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 209
+SI ++G GG V++ A+K ++ Q L +NE+ +KLQ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 210 --VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
++L ++ + + N LNS++ ++ K +D +R
Sbjct: 70 KIIRLYD-YEITDQYIYMVMECGNIDLNSWL---------------KKKKSIDPWERKSY 113
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
V +HQ I+H DLK +N
Sbjct: 114 WKNMLEAVHTIHQ---HGIVHSDLKPAN 138
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 30/178 (16%)
Query: 130 RMSASEIENRNMDLELP-LFELATIANATDNFSINNKLGEGGFGLVYK--------EIAV 180
M R L+ P + EL + FS ++G G FG VY +A+
Sbjct: 25 AMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAI 84
Query: 181 KRLS---KISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF 237
K++S K S + +++ EV KL+H N ++ GC ++ L+ E+
Sbjct: 85 KKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-------- 136
Query: 238 IFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L+ + K L + + G +G+ YLH +IHRD+KA N
Sbjct: 137 --LGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGN 184
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 36/159 (22%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLS-KISEQGLKELKNEVILFSKLQHRN 208
+F LG GGFG+V++ A+KR+ E +++ EV +KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 209 LVKLLGCCI---------QGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERC 256
+V+ + K+ +Y + ++L ++ + ++ER
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR------CTIEERERS 118
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L F I V +LH ++HRDLK SN
Sbjct: 119 VCLHI---FLQIA---EAVEFLHS---KGLMHRDLKPSN 148
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-15
Identities = 32/150 (21%), Positives = 55/150 (36%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQ 205
+ + +GEG FG V++ +A+K S+ ++ E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H ++VKL+G + +I E L SF+ Q R LD +
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--------------QVRKYSLDLASLI 119
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL R +HRD+ A N
Sbjct: 120 LYAYQLSTALAYL---ESKRFVHRDIAARN 146
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 34/154 (22%)
Query: 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLS-KISEQGLKELKNEVILFSKL 204
A+ + F+ K+G+G FG V+K +A+K + + +E +++++ E+ + S+
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
+ K G ++ + +I E++ S L L+ E
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGS---------ALDLLEPGPLDET--------- 119
Query: 265 FHI--IC-GTARGVMYLHQDSKLRIIHRDLKASN 295
I I +G+ YLH + + IHRD+KA+N
Sbjct: 120 -QIATILREILKGLDYLHSE---KKIHRDIKAAN 149
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-15
Identities = 30/153 (19%), Positives = 57/153 (37%), Gaps = 28/153 (18%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKE-LKNEVILFSKLQ 205
+ + +++ LG+G V++ A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 206 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
H+N+VKL + EF P SL + + + L S
Sbjct: 66 HKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVL------------EEPSNAYGLPES 112
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ G+ +L + I+HR++K N
Sbjct: 113 EFLIVLRDVVGGMNHLR---ENGIVHRNIKPGN 142
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-15
Identities = 32/145 (22%), Positives = 61/145 (42%), Gaps = 29/145 (20%)
Query: 162 INNKLGEGGFGLVYK----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLV 210
+ +LG G FG V + ++A+K L + + +E+ E + +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L+G C Q E +L+ E L+ F+ + + + S ++
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFL--------------VGKREEIPVSNVAELLHQ 118
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YL + +HRDL A N
Sbjct: 119 VSMGMKYL---EEKNFVHRDLAARN 140
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 6e-15
Identities = 31/145 (21%), Positives = 60/145 (41%), Gaps = 29/145 (20%)
Query: 162 INNKLGEGGFGLVYK----------EIAVKRL-SKISEQGLKELKNEVILFSKLQHRNLV 210
+ +LG G FG V + ++A+K L + +E+ E + +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L+G C Q E +L+ E L+ F+ + + + S ++
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFL--------------VGKREEIPVSNVAELLHQ 444
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YL + +HR+L A N
Sbjct: 445 VSMGMKYL---EEKNFVHRNLAARN 466
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-15
Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 25/152 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVK--RLSKISEQGLKELKNEVILFSKLQHR 207
+++ + +G G +G K + K ++E + L +EV L +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 208 NLVKLLGCCIQGEEKLL--IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N+V+ I L + E+ L S I + T R ++D+E +L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK---GTKERQYLDEE--FVLRV---M 117
Query: 266 HIICGTARGVMYLHQ--DSKLRIIHRDLKASN 295
+ + H+ D ++HRDLK +N
Sbjct: 118 TQLT---LALKECHRRSDGGHTVLHRDLKPAN 146
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 7e-15
Identities = 35/150 (23%), Positives = 61/150 (40%), Gaps = 20/150 (13%)
Query: 158 DNFSINNKLGEGGFGLVYKEIAVKRLS-------KISEQGLKELKNEVILFSKLQHRNLV 210
+F +G GGFG V+K K K + ++ + EV +KL H N+V
Sbjct: 11 MDFKEIELIGSGGFGQVFK---AKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIV 67
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTL-----MRSFVDQERCKILDWSKRF 265
GC + ++S +F + + ++++ R + LD
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLF--IQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +GV Y+H ++I+RDLK SN
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSN 152
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-15
Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQ 205
++ +N LGEG FG VY+ +AVK K + ++ +E ++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H ++VKL+G + E +I E P L ++ + L
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYL--------------ERNKNSLKVLTLV 116
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL + +HRD+ N
Sbjct: 117 LYSLQICKAMAYL---ESINCVHRDIAVRN 143
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-15
Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 27/151 (17%)
Query: 157 TDNFSINNKLGEGGFGLVYKEI--------AVKR--LSKISEQGLKELKNEVILFSKL-Q 205
T F K+G G FG V+K + A+KR + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 206 HRNLVKLLGCCIQGEEKLLIY-EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
H ++V+ + + +LI E+ SL I EN +M F + E +L
Sbjct: 70 HSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAISEN--YRIMSYFKEAELKDLL----- 121
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ RG+ Y+H ++H D+K SN
Sbjct: 122 LQV----GRGLRYIHSM---SLVHMDIKPSN 145
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 36/178 (20%)
Query: 133 ASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLS 184
AS+ R++D +L+ + + F + +G G +G VYK A+K +
Sbjct: 3 ASDSPARSLDEI----DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM- 57
Query: 185 KISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG-----EEKL-LIYEFMPNKSLNSF 237
++ +E+K E+ + K HRN+ G I+ +++L L+ EF S
Sbjct: 58 DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS---- 113
Query: 238 IFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
V L+++ + L +I RG+ +LHQ ++IHRD+K N
Sbjct: 114 -----VTDLIKN----TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQN 159
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 34/143 (23%), Positives = 56/143 (39%), Gaps = 31/143 (21%)
Query: 165 KLGEGGFGLVYK----------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKL 212
+LG G FG V K +AVK L EL E + +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 213 LGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTA 272
+G C + E +L+ E LN ++ +N + I++ +
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKN---------IIELV------HQVS 127
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
G+ YL + +HRDL A N
Sbjct: 128 MGMKYL---EESNFVHRDLAARN 147
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 30/153 (19%), Positives = 57/153 (37%), Gaps = 28/153 (18%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKE-LKNEVILFSKLQ 205
+ + +++ LG+G V++ A+K + IS + E + KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 206 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
H+N+VKL + EF P SL + + + L S
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVL------------EEPSNAYGLPES 112
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ G+ +L + I+HR++K N
Sbjct: 113 EFLIVLRDVVGGMNHLR---ENGIVHRNIKPGN 142
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 42/167 (25%), Positives = 63/167 (37%), Gaps = 35/167 (20%)
Query: 144 ELPLFELATIANATDNFSINNKLGEGGFGLVYK-----------EIAVKRL---SKISEQ 189
E PL L + D + KLG+G FG+V + +AVK L +
Sbjct: 5 EGPLQSLTCLIGEKD-LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE 63
Query: 190 GLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN-FVLTLMR 248
+ + EV L HRNL++L G + ++ E P SL + ++ L
Sbjct: 64 AMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGT 122
Query: 249 SFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ A G+ YL R IHRDL A N
Sbjct: 123 ---------LSRYA------VQVAEGMGYL---ESKRFIHRDLAARN 151
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 32/150 (21%), Positives = 56/150 (37%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRL-SKISEQGLKELKNEVILFSKLQ 205
+ + +GEG FG V++ +A+K + S+ ++ E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H ++VKL+G + +I E L SF+ Q R LD +
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--------------QVRKFSLDLASLI 494
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL R +HRD+ A N
Sbjct: 495 LYAYQLSTALAYL---ESKRFVHRDIAARN 521
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 35/152 (23%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 206
+ LG+GGF + + A K + K + + +E + E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDWSK 263
+++V G + + + ++ E +SL LT R ++ Q
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---------- 149
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ G YLH+ R+IHRDLK N
Sbjct: 150 ---IVLG----CQYLHR---NRVIHRDLKLGN 171
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 35/160 (21%), Positives = 59/160 (36%), Gaps = 39/160 (24%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
+F LG+G FG V K A+K++ +E+ L + +EV+L + L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 209 LVKLLGC----------CIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQER 255
+V+ ++K ++ E+ N +L I ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS------ENLNQQRDE 117
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
F I + Y+H IIHRDLK N
Sbjct: 118 --YWRL---FRQIL---EALSYIHS---QGIIHRDLKPMN 146
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 28/159 (17%), Positives = 55/159 (34%), Gaps = 30/159 (18%)
Query: 150 LATIANATDNFSINNKLGEG--GFGLVYK--------EIAVKR--LSKISEQGLKELKNE 197
+++ + + +G+G V + V+R L S + + L+ E
Sbjct: 17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGE 76
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
+ + H N+V I E ++ FM S I +F+ + +
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI------ 130
Query: 258 ILDWSKRFHIIC-GTARGVMYLHQDSKLRIIHRDLKASN 295
I G + + Y+H +HR +KAS+
Sbjct: 131 --------AYILQGVLKALDYIHHMGY---VHRSVKASH 158
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-14
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 206
++F + N LG+G F VY E+A+K + K + + G+ + ++NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
++++L + + L+ E N +N ++ + R K ++
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYL--------------KNRVKPFSENEAR 115
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H + G++YLH I+HRDL SN
Sbjct: 116 HFMHQIITGMLYLHS---HGILHRDLTLSN 142
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLS-KISEQGLKELKNEVILFSKLQ 205
D++ + +G G +V ++A+KR++ + + + EL E+ S+
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK--ILDWSK 263
H N+V + +E L+ + + S VL +++ V + K +LD S
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGS---------VLDIIKHIVAKGEHKSGVLDEST 122
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ G+ YLH++ + IHRD+KA N
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGN 151
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-14
Identities = 34/152 (22%), Positives = 59/152 (38%), Gaps = 35/152 (23%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 206
+ LG+GGF + + A K + K + + +E + E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDWSK 263
+++V G + + + ++ E +SL LT R ++ Q
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ---------- 123
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ G YLH+ R+IHRDLK N
Sbjct: 124 ---IVLG----CQYLHR---NRVIHRDLKLGN 145
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-14
Identities = 42/162 (25%), Positives = 69/162 (42%), Gaps = 46/162 (28%)
Query: 155 NATDNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQG-----LKELKNEVILF 201
+++ F KLG G + VYK A+K + SE+G ++E+ L
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 202 SKLQHRNLVKLLGCCIQGEEKL-LIYEFMP-------NKSLNSFIFENFVLTLMRSFVDQ 253
+L+H N+V+L I E KL L++EFM + L L++ F Q
Sbjct: 58 KELKHENIVRLY-DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 254 ERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L +G+ + H++ +I+HRDLK N
Sbjct: 117 ----LL-------------QGLAFCHEN---KILHRDLKPQN 138
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 37/155 (23%), Positives = 59/155 (38%), Gaps = 32/155 (20%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKE-LKNEVILFSKLQHR 207
+ + +LG GGFG V + ++A+K+ + +E E+ + KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 208 NLVKLLGCCIQGEEKL-------LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
N+V G +KL L E+ L ++ E C L
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL------------NQFENCCGLK 119
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ + + YLH+ RIIHRDLK N
Sbjct: 120 EGPIRTLLSDISSALRYLHE---NRIIHRDLKPEN 151
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-13
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 43/156 (27%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQ------GLKELKNEVILFSK 203
+NF K+GEG +G+VYK E+ A+K++ +E ++E+ L +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKE 58
Query: 204 LQHRNLVKLLGCCIQGEEKL-LIYEFMPN---KSLNSFIFENFVLTLMRSFVDQERCKIL 259
L H N+VKLL I E KL L++EF+ K +++ L L++S++ Q +L
Sbjct: 59 LNHPNIVKLL-DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ----LL 113
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ + H R++HRDLK N
Sbjct: 114 -------------QGLAFCHSH---RVLHRDLKPQN 133
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 41/154 (26%)
Query: 158 DNFSINNKLGEGGFGLVYK------EI-AVKRLSKISEQ------GLKELKNEVILFSKL 204
+ + K+GEG +G+VYK I A+KR+ +E ++E+ L +L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKEL 76
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILDW 261
H N+V L+ I E L L++EFM K + + ++ ++ Q +L
Sbjct: 77 HHPNIVSLI-DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ----LL-- 129
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
RGV + HQ RI+HRDLK N
Sbjct: 130 -----------RGVAHCHQH---RILHRDLKPQN 149
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 41/154 (26%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQG-----LKELKNEVILFSKL 204
+ + +KLGEG + VYK + A+K + E+G ++E+ L L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+H N+V L I E+ L L++E++ K + ++ F+ Q
Sbjct: 58 KHANIVTLH-DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ-------- 108
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
RG+ Y H+ +++HRDLK N
Sbjct: 109 ---------LLRGLAYCHRQ---KVLHRDLKPQN 130
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 3e-13
Identities = 38/155 (24%), Positives = 68/155 (43%), Gaps = 42/155 (27%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQ------GLKELKNEVILFSK 203
+ K+GEG +G V+K EI A+KR+ + L+E+ L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKE 57
Query: 204 LQHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILD 260
L+H+N+V+L + ++KL L++EF K + +++SF+ Q +L
Sbjct: 58 LKHKNIVRLH-DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ----LL- 111
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ + H ++HRDLK N
Sbjct: 112 ------------KGLGFCHSR---NVLHRDLKPQN 131
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.5 bits (166), Expect = 3e-13
Identities = 39/154 (25%), Positives = 66/154 (42%), Gaps = 41/154 (26%)
Query: 158 DNFSINNKLGEGGFGLVYK------EI-AVKRLSKISEQ------GLKELKNEVILFSKL 204
+ + K+GEG +G+VYK E A+K++ E ++E+ + +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKEL 57
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+H N+VKL I +++L L++E + K L +SF+ Q +L
Sbjct: 58 KHSNIVKLY-DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ----LL-- 110
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ Y H R++HRDLK N
Sbjct: 111 -----------NGIAYCHDR---RVLHRDLKPQN 130
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 37/154 (24%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQGLKELKN-----EVILFSKL 204
+ + LGEG F VYK +I A+K++ K+ N E+ L +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILDW 261
H N++ LL + + L+++FM + + + +++++
Sbjct: 70 SHPNIIGLLD-AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-------- 120
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
T +G+ YLHQ I+HRDLK +N
Sbjct: 121 ---------TLQGLEYLHQH---WILHRDLKPNN 142
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 43/155 (27%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQ------GLKELKNEVILFSK 203
D + KLGEG +G VYK E A+KR+ E+ ++E+ L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKE 89
Query: 204 LQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFI--FENFVLTLMRSFVDQERCKILD 260
LQHRN+++L I +L LI+E+ L ++ + + +++SF+ Q
Sbjct: 90 LQHRNIIELK-SVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ------- 140
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
GV + H R +HRDLK N
Sbjct: 141 ----------LINGVNFCHSR---RCLHRDLKPQN 162
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 21/152 (13%), Positives = 41/152 (26%), Gaps = 26/152 (17%)
Query: 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSK 203
+ +++ LGEG F VY+ + +K + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
+K + +L+ E +L + I K++
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP----------EKVMPQGL 173
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +H IIH D+K N
Sbjct: 174 VISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 34/162 (20%)
Query: 158 DNFSINNKLGEGGFGLVY------KEIAVKRLSK-----------------ISEQGLKEL 194
+++ I L +G F + K A+K+ K + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 195 KNEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQ 253
KNE+ + + +++ + G I +++ +IYE+M N S+ F FVL
Sbjct: 91 KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLD------KN 143
Query: 254 ERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
C I + II Y+H ++ I HRD+K SN
Sbjct: 144 YTCFIPIQVIKC-IIKSVLNSFSYIH--NEKNICHRDVKPSN 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 28/157 (17%), Positives = 62/157 (39%), Gaps = 42/157 (26%)
Query: 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
++ +G G FG+V++ E+A+K++ + +EL+ + ++H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94
Query: 210 VKLLGCCIQGEEKL------LIYEFMP---NKSLNSFIFENFVLTLM--RSFVDQERCKI 258
V L +K L+ E++P ++ + + ++ + ++ Q
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ----- 149
Query: 259 LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R + Y+H + I HRD+K N
Sbjct: 150 ------------LLRSLAYIH---SIGICHRDIKPQN 171
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 31/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 206
++F I LG+G FG VY +A+K L K + + G++ L+ EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N+++L G ++ LI E+ P ++ + ++ D +
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYREL---------------QKLSKFDEQRTA 112
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I A + Y H R+IHRD+K N
Sbjct: 113 TYITELANALSYCH---SKRVIHRDIKPEN 139
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 36/150 (24%), Positives = 62/150 (41%), Gaps = 31/150 (20%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
D++ I+ +LG G FG+V++ A K + E + ++ E+ S L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSF---IFENFVLTLMRSFVDQERCKILDWSKRF 265
LV L E ++IYEFM L F E+ ++ E + +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNKMS--------ED----EAVEYM 261
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+C G+ ++H+ +H DLK N
Sbjct: 262 RQVCK---GLCHMHE---NNYVHLDLKPEN 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 35/155 (22%), Positives = 64/155 (41%), Gaps = 42/155 (27%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQGLKELKN-----EVILFSKL 204
+ + K+GEG +G+V+K +I A+K K E + E+ + +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFI---FENFVLTLMRSFVDQERCKILD 260
+H NLV LL + + +L L++E+ + ++ + L++S Q
Sbjct: 60 KHPNLVNLL-EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ------- 110
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
T + V + H+ IHRD+K N
Sbjct: 111 ----------TLQAVNFCHKH---NCIHRDVKPEN 132
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-12
Identities = 32/148 (21%), Positives = 62/148 (41%), Gaps = 28/148 (18%)
Query: 162 INNKLGEGGFGLVYKEIAVKRLSKISEQ-GLKELKNEVILFS---------KLQHRNLVK 211
K+G G +G VYK A ++ K + LK+++ I S +L+H N++
Sbjct: 25 EGCKVGRGTYGHVYK--AKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVIS 82
Query: 212 LLGCCIQ-GEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
L + + K+ L++++ + + F + +L + I
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL-----YQI 137
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YLH + ++HRDLK +N
Sbjct: 138 L----DGIHYLHAN---WVLHRDLKPAN 158
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 32/148 (21%), Positives = 61/148 (41%), Gaps = 23/148 (15%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 207
++ ++G G +G V K +AVKR+ S + E+ K+L ++ ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
+V+ G + + + E M + S + F +V ++ I
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----------KYVYSVLDDVIPEEILGKI 130
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
T + + +L L+IIHRD+K SN
Sbjct: 131 TLATVKALNHLK--ENLKIIHRDIKPSN 156
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 31/158 (19%), Positives = 61/158 (38%), Gaps = 43/158 (27%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
+++ +G G FG+VY+ +A+K++ + +EL+ + KL H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108
Query: 209 LVKLLGCCIQGEEKL------LIYEFMP---NKSLNSFIFENFVLTL--MRSFVDQERCK 257
+V+L EK L+ +++P + + L + ++ ++ Q
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ---- 164
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R + Y+H I HRD+K N
Sbjct: 165 -------------LFRSLAYIH---SFGICHRDIKPQN 186
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 29/146 (19%), Positives = 57/146 (39%), Gaps = 31/146 (21%)
Query: 159 NFSINNKLGEGGFGLVY-------KEIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLV 210
+F + LG G G + +++AVKR+ + EV L + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 211 KLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+ C + + + E +L ++ +++ + ++
Sbjct: 82 RYF-CTEKDRQFQYIAIELCA-ATLQEYV--------------EQKDFAHLGLEPITLLQ 125
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
T G+ +LH L I+HRDLK N
Sbjct: 126 QTTSGLAHLHS---LNIVHRDLKPHN 148
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 30/150 (20%), Positives = 51/150 (34%), Gaps = 31/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVYKEI--------AVKRLSK--ISEQGLKELKNEVILFSKL-QH 206
+F ++LG G +G V+K AVKR + EV K+ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 207 RNLVKLLGCCIQGEEKLLIY-EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
V+L + L + E SL + L ++ +
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHC--------------EAWGASLPEAQVW 160
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ T + +LH ++H D+K +N
Sbjct: 161 GYLRDTLLALAHLHS---QGLVHLDVKPAN 187
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 33/153 (21%), Positives = 60/153 (39%), Gaps = 31/153 (20%)
Query: 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ D + I +LG G FG+V++ K ++ +KNE+ + ++L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF---IFENFVLTLMRSFVDQERCKILDWS 262
H L+ L E +LI EF+ L F E++ ++ E +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGEL--FDRIAAEDYKMS--------EA----EVI 152
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
C G+ ++H+ I+H D+K N
Sbjct: 153 NYMRQACE---GLKHMHE---HSIVHLDIKPEN 179
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 40/154 (25%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQGLKELKN-----EVILFSKL 204
+ + +GEG +G+V K I A+K K E ++ E+ L +L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQL 81
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+H NLV LL + +++ L++EF+ + +++ ++ Q I+
Sbjct: 82 RHENLVNLL-EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ----II-- 134
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ + H IIHRD+K N
Sbjct: 135 -----------NGIGFCHSH---NIIHRDIKPEN 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 36/154 (23%), Positives = 62/154 (40%), Gaps = 36/154 (23%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRL-SKISEQGLKELKNEV-ILFSKLQHR 207
D+ +LG G +G+V K +AVKR+ + ++ Q K L ++ I +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF-- 265
V G + + + E M + SL+ F +++D +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----------------KQVIDKGQTIPE 108
Query: 266 ----HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I + + +LH SKL +IHRD+K SN
Sbjct: 109 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSN 140
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-11
Identities = 35/171 (20%), Positives = 60/171 (35%), Gaps = 58/171 (33%)
Query: 156 ATDNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQG---------------LK 192
AT + ++G G +G VYK A+K + + G L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 193 ELKNEVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPN---KSLNSFIFENFVL 244
L+ +H N+V+L+ E K+ L++E + L+
Sbjct: 67 RLEAF-------EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 119
Query: 245 TLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ + Q L RG+ +LH + I+HRDLK N
Sbjct: 120 ETIKDLMRQ----FL-------------RGLDFLHAN---CIVHRDLKPEN 150
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 18/178 (10%), Positives = 44/178 (24%), Gaps = 31/178 (17%)
Query: 146 PLFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKEL 194
+ ++ + L G +V+ + A+K + S L+ L
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 195 KNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIYEFMPN-----KSLNSFIFENFVLTLMR 248
++L + + + + + P + + N++L +
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 249 SFVD-----------QERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ VD + R L ++H N
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDN 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 33/147 (22%), Positives = 51/147 (34%), Gaps = 25/147 (17%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEIAVKRLSKISEQGLKELKNEV-ILFSKLQHRNL 209
+ LG G G V + +AVKR+ E+ +L H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNV 71
Query: 210 VKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
++ C + L + E N +L + V + ++
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI--------SLL 121
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
A GV +LH L+IIHRDLK N
Sbjct: 122 RQIASGVAHLHS---LKIIHRDLKPQN 145
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 36/175 (20%), Positives = 64/175 (36%), Gaps = 39/175 (22%)
Query: 137 ENRNMDLELPLFELATIANAT-DNFSINNKLGEGGFGLVYK--------EIAVKRLS-KI 186
E + LE L + + D+F ++LG G G+V+K +A K + +I
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 187 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTL 246
++ E+ + + +V G E + E M SL+
Sbjct: 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD----------- 119
Query: 247 MRSFVDQERCKILDWSKRF------HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++L + R + +G+ YL K +I+HRD+K SN
Sbjct: 120 ----------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSN 162
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-11
Identities = 37/150 (24%), Positives = 67/150 (44%), Gaps = 29/150 (19%)
Query: 154 ANATDNFSINNK--LGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSK 203
++++ LG G FG V+K ++A K + + +E+KNE+ + ++
Sbjct: 83 GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQ 142
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL-NSFIFENFVLTLMRSFVDQERCKILDWS 262
L H NL++L + +L+ E++ L + I E++ LT E D
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT--------EL----DTI 190
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
IC G+ ++HQ + I+H DLK
Sbjct: 191 LFMKQICE---GIRHMHQ---MYILHLDLK 214
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 38/162 (23%), Positives = 71/162 (43%), Gaps = 48/162 (29%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EI-AVKRLSKISEQ------GLKELKNEVILFSK 203
+ K+G+G FG V+K + A+K++ +E+ L+E+K IL
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK---IL-QL 72
Query: 204 LQHRNLVKLLGCCIQGEEKL--------LIYEFMPN--KSLNSFIFENFVLTLMRSFVDQ 253
L+H N+V L+ C L+++F + L S + F L+ ++ +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 254 ERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L G+ Y+H++ +I+HRD+KA+N
Sbjct: 133 ----LL-------------NGLYYIHRN---KILHRDMKAAN 154
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 7e-11
Identities = 34/167 (20%), Positives = 60/167 (35%), Gaps = 56/167 (33%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EI-AVKRLSKISEQG------------LKELKN 196
+ ++GEG +G V+K A+KR+ + + L+ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 197 EVILFSKLQHRNLVKLL----GCCIQGEEKL-LIYEFMPN---KSLNSFIFENFVLTLMR 248
+H N+V+L E KL L++E + L+ ++
Sbjct: 71 F-------EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 249 SFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ Q +L RG+ +LH R++HRDLK N
Sbjct: 124 DMMFQ----LL-------------RGLDFLHSH---RVVHRDLKPQN 150
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-10
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 32/153 (20%)
Query: 154 ANATDNFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKE-LKNEVI 199
+ D++ + +LG G F +V K I +RLS +E ++ EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
+ +++H N++ L + +LI E + L F+ E LT E
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT--------ED---- 108
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
+ ++ I GV YLH RI H DLK
Sbjct: 109 EATQFLKQILD---GVHYLHS---KRIAHFDLK 135
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 34/156 (21%), Positives = 56/156 (35%), Gaps = 32/156 (20%)
Query: 154 ANATDNFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKE-LKNEVI 199
D + I +LG G F +V K I ++ +E ++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
+ ++ H N++ L + +LI E + L F+ + L+ E
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--------EE---- 115
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + I GV YLH +I H DLK N
Sbjct: 116 EATSFIKQILD---GVNYLHT---KKIAHFDLKPEN 145
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 31/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQH 206
D+F I LG+G FG VY +A+K L K + ++G++ L+ E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N++++ +++ L+ EF P L + ++ F +Q S F
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKH------GRFDEQR-------SATF 119
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A + Y H + ++IHRD+K N
Sbjct: 120 --MEELADALHYCH---ERKVIHRDIKPEN 144
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 32/153 (20%)
Query: 154 ANATDNFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKE-LKNEVI 199
D + I +LG G F +V K I ++ +E ++ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
+ ++ H N++ L + +LI E + L F+ + L+ E
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--------EE---- 115
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
+ + I GV YLH +I H DLK
Sbjct: 116 EATSFIKQILD---GVNYLHT---KKIAHFDLK 142
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 31/165 (18%), Positives = 59/165 (35%), Gaps = 47/165 (28%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKN----EVILFS 202
D F + G+G FG V +A+K K+ + +N + +
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQD--PRFRNRELQIMQDLA 74
Query: 203 KLQHRNLVKLLGC-CIQGEEKL------LIYEFMP---NKSLNSFIFENFVLTL--MRSF 250
L H N+V+L GE ++ E++P ++ ++ ++ F
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 251 VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ Q ++ R + LH S + + HRD+K N
Sbjct: 135 LFQ----LI-------------RSIGCLHLPS-VNVCHRDIKPHN 161
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 32/197 (16%), Positives = 67/197 (34%), Gaps = 41/197 (20%)
Query: 137 ENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVY-------------KEIAVKRL 183
+ + E F+ ++ + + +G+G +G+V K + ++
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64
Query: 184 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFV 243
+I+ + ++ +K EV L KL H N+ +L + L+ E L +
Sbjct: 65 RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124
Query: 244 LTLMRSFVDQERCKILDWSKRF-------------------------HIICGTARGVMYL 278
+ + +D + +I + +I+ + YL
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184
Query: 279 HQDSKLRIIHRDLKASN 295
H I HRD+K N
Sbjct: 185 HN---QGICHRDIKPEN 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-10
Identities = 31/147 (21%), Positives = 55/147 (37%), Gaps = 28/147 (19%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH 206
+ + I LG G FG+V++ K + +K E+ + + +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFE-NFVLTLMRSFVDQERCKILDWSKRF 265
RN++ L EE ++I+EF+ + I F L ER +
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELN--------ER----EIVSYV 108
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLK 292
H +C + +LH I H D++
Sbjct: 109 HQVCE---ALQFLHS---HNIGHFDIR 129
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-10
Identities = 38/152 (25%), Positives = 58/152 (38%), Gaps = 32/152 (21%)
Query: 155 NATDNFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKE-LKNEVIL 200
N D + +LG G F +V K I +R +E ++ EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
++QH N++ L + +LI E + L F+ E LT E +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT--------EE----E 115
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
++ I GV YLH L+I H DLK
Sbjct: 116 ATEFLKQILN---GVYYLHS---LQIAHFDLK 141
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 34/155 (21%), Positives = 59/155 (38%), Gaps = 35/155 (22%)
Query: 157 TDNFSINNKLGEGGFGLVY--------KEIAVKRLSK--------ISEQGLKELKNEVIL 200
D + ++ LG G G V K++A++ +SK ++ E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
KL H ++K+ E+ ++ E M L + + + CK+
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVG-------NKRLKEATCKLY- 244
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
F+ + V YLH + IIHRDLK N
Sbjct: 245 ----FYQMLL---AVQYLH---ENGIIHRDLKPEN 269
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-10
Identities = 29/176 (16%), Positives = 56/176 (31%), Gaps = 42/176 (23%)
Query: 138 NRNMDLELPLF-ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRL-SKIS 187
+ L ++ ++G G G V+K IAVK++ +
Sbjct: 4 GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63
Query: 188 EQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF-------IF 239
++ K + ++ ++ +V+ G I + + E M I
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP 122
Query: 240 ENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
E + + + V + + YL K +IHRD+K SN
Sbjct: 123 ERILGKMTVAIV---------------------KALYYLK--EKHGVIHRDVKPSN 155
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 9e-10
Identities = 17/159 (10%), Positives = 38/159 (23%), Gaps = 32/159 (20%)
Query: 166 LGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQH-------R 207
LG+ + V +K++K EV+ L+ +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVD-----------QERC 256
++ + ++ + R +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
K L R + R + LH ++H L+ +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVD 241
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 1e-09
Identities = 36/152 (23%), Positives = 61/152 (40%), Gaps = 34/152 (22%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQH 206
+DN+ + +LG+G F +V + E A K ++ +S + ++L+ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 207 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
N+V+L +E+ Y + + L I + E D S
Sbjct: 65 PNIVRLHDSI---QEESFHYLVFDLVTGGELFEDIVAREFYS--------EA----DASH 109
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I + Y H I+HR+LK N
Sbjct: 110 CIQQILE---SIAYCH---SNGIVHRNLKPEN 135
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 25/101 (24%), Positives = 43/101 (42%), Gaps = 16/101 (15%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRL-SKISEQGLKELKNEVILFSK 203
D + LG G FG V + +AVK L + + L +E+ +
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 204 L-QHRNLVKLLGCCIQ-GEEKLLIYEFMPNKSLNSFIFENF 242
+ H N+V LLG C + G ++I EF +L++++
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 35/147 (23%), Positives = 56/147 (38%), Gaps = 29/147 (19%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
TD + + +G G + + + E AVK + K +E++ IL QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
++ L G+ ++ E M L I + F ++E + I
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILR------QKFFSEREASAV------LFTI 125
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
V YLH ++HRDLK SN
Sbjct: 126 TK---TVEYLH---AQGVVHRDLKPSN 146
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 37/155 (23%), Positives = 56/155 (36%), Gaps = 40/155 (25%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQH 206
++ + KLG G +G V E A+K + K +S +L EV + L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIF------ENFVLTLMRSFVDQERCKILD 260
N++KL L+ E L I E +++ ++L
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK--------QVL- 146
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
GV YLH+ I+HRDLK N
Sbjct: 147 ------------SGVTYLHK---HNIVHRDLKPEN 166
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 38/150 (25%), Positives = 57/150 (38%), Gaps = 29/150 (19%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 205
+D + LG+G FG V E AVK +SK + + L EV L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N++KL L+ E L I + E D ++
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--------EV----DAARII 132
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ Y+H+ +I+HRDLK N
Sbjct: 133 RQVLS---GITYMHK---NKIVHRDLKPEN 156
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 38/152 (25%), Positives = 59/152 (38%), Gaps = 34/152 (22%)
Query: 157 TDNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKELKNEVILFSKLQH 206
+ ++I LG+G FG V +E AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
N++KL E+ Y E L I + + E D ++
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFS--------EH----DAAR 125
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ Y+H+ I+HRDLK N
Sbjct: 126 IIKQVFS---GITYMHK---HNIVHRDLKPEN 151
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 34/154 (22%), Positives = 54/154 (35%), Gaps = 29/154 (18%)
Query: 154 ANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKE-LKNEVILFSKL 204
D F KLG G FG V+ E +K ++K Q E ++ E+ + L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 205 QHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
H N++K+ E+ +Y E L E V R E
Sbjct: 78 DHPNIIKIFEVF---EDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEG----YV 126
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ + + Y H ++H+DLK N
Sbjct: 127 AELMKQMMN---ALAYFHS---QHVVHKDLKPEN 154
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 39/152 (25%), Positives = 59/152 (38%), Gaps = 34/152 (22%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQH 206
+ ++I LG+G FG V K E AVK ++K + + EV L KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 207 RNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
N++KL E+ Y E L I + + E D ++
Sbjct: 81 PNIMKLFEIL---EDSSSFYIVGELYTGGELFDEIIKRKRFS--------EH----DAAR 125
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ Y+H+ I+HRDLK N
Sbjct: 126 IIKQVFS---GITYMHK---HNIVHRDLKPEN 151
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 32/153 (20%), Positives = 54/153 (35%), Gaps = 32/153 (20%)
Query: 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ 205
+ +++ N +G G +G V A K++ K + + K E+ + L
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 206 HRNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
H N+++L E+ IY E L + V E D +
Sbjct: 65 HPNIIRLYETF---EDNTDIYLVMELCTGGELFERVVHKRVFR--------ES----DAA 109
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + V Y H+ L + HRDLK N
Sbjct: 110 RIMKDVLS---AVAYCHK---LNVAHRDLKPEN 136
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 33/152 (21%), Positives = 53/152 (34%), Gaps = 27/152 (17%)
Query: 157 TDNFSINNKLGEGGFGLVY-------------KEIAVKRLSKISEQGLKELKNEVILFSK 203
D + + +G+G F +V K + V + + ++LK E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
L+H ++V+LL +++EFM L V FV E S
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEA----VASH 134
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I + Y H IIHRD+K
Sbjct: 135 YMRQILE---ALRYCHD---NNIIHRDVKPHC 160
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 19/159 (11%), Positives = 41/159 (25%), Gaps = 32/159 (20%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSK---ISEQGLKELKNEVI---LFSKLQHRNLVK 211
LG+ + V +K++K EV+ L ++++ K
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 212 LLGCCIQGEEKLLIYE----FMPNKSLNSFIFENFVLTLMRSFVD-----------QERC 256
+ I + + + + R +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 257 KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
K L R + R + LH ++H L+ +
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVD 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 5e-09
Identities = 38/147 (25%), Positives = 53/147 (36%), Gaps = 32/147 (21%)
Query: 157 TDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
F LG G F V+ K A+K + K L+NE+ + K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 209 LVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
+V L E Y + + L I E V T E+ D S
Sbjct: 68 IVTLEDIY---ESTTHYYLVMQLVSGGELFDRILERGVYT--------EK----DASLVI 112
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLK 292
+ V YLH + I+HRDLK
Sbjct: 113 QQVLS---AVKYLH---ENGIVHRDLK 133
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-09
Identities = 36/156 (23%), Positives = 58/156 (37%), Gaps = 39/156 (25%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRLSK--------ISEQGLKELKNEVILFS 202
+S + LG G FG V+ KE+ VK + K I + L ++ E+ + S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFV--LTLMRSFVDQERCKILD 260
+++H N++K+ + N+ + E L L R
Sbjct: 85 RVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL 131
Query: 261 WSKRFH-IICGTARGVMYLHQDSKLRIIHRDLKASN 295
S F ++ V YL IIHRD+K N
Sbjct: 132 ASYIFRQLVSA----VGYLRL---KDIIHRDIKDEN 160
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 30/147 (20%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQH 206
+DN+ + +LG+G F +V + E A K ++ +S + ++L+ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N+V+L IQ E L+++ + L I + E D S
Sbjct: 88 PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYS--------EA----DASHCI 134
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLK 292
I + Y H I+HR+LK
Sbjct: 135 QQILE---SIAYCHS---NGIVHRNLK 155
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 35/152 (23%)
Query: 157 TDNFSINNKLGEGGFGLVY--------KEIAVKRLSK--------ISEQGLKELKNEVIL 200
D + ++ LG G G V K++A+K +SK ++ E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
KL H ++K+ E+ ++ E M L + N L E
Sbjct: 69 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLK--------EA----T 115
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
F+ + V YLH + IIHRDLK
Sbjct: 116 CKLYFYQMLL---AVQYLH---ENGIIHRDLK 141
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 32/149 (21%)
Query: 159 NFSINNKLGEGGFGLVY--------KEIAVKRL--SKISEQGLKELKNEVILFSKLQHRN 208
N+ + +G+G F V +E+A+K + ++++ L++L EV + L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 209 LVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH- 266
+VKL I+ E+ L LI E+ + ++ + + ++E F
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMK------EKEARSK------FRQ 122
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ V Y HQ RI+HRDLKA N
Sbjct: 123 IVSA----VQYCHQ---KRIVHRDLKAEN 144
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 36/149 (24%), Positives = 58/149 (38%), Gaps = 28/149 (18%)
Query: 157 TDNFSINNK-LGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQ-H 206
D + + LGEG V +E AVK + K + EV + + Q H
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
RN+++L+ + + L++E M S+ S I + R F + E +
Sbjct: 71 RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK------RRHFNELEASVV------VQ 118
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + +LH I HRDLK N
Sbjct: 119 DVAS---ALDFLHN---KGIAHRDLKPEN 141
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-08
Identities = 30/152 (19%), Positives = 60/152 (39%), Gaps = 35/152 (23%)
Query: 155 NATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQ- 205
D++ + KLG G + V+ +++ VK L + + K++K E+ + L+
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRG 89
Query: 206 HRNLVKLLGCCIQGEEK--LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
N++ L + L++E + N + +R ++ + IL
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYE----IL---- 140
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + Y H S I+HRD+K N
Sbjct: 141 ---------KALDYCH--SM-GIMHRDVKPHN 160
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 44/153 (28%), Positives = 60/153 (39%), Gaps = 37/153 (24%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK---ISEQGLKELKNEVILFSKLQH 206
++F LGEG F V +E A+K L K I E + + E + S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
VKL Q +EKL + N L + + SF D+ RF
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGEL----L--KYIRKIGSF-DETCT-------RF 134
Query: 266 H---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ I+ + YLH IIHRDLK N
Sbjct: 135 YTAEIVSA----LEYLH---GKGIIHRDLKPEN 160
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 33/186 (17%), Positives = 60/186 (32%), Gaps = 41/186 (22%)
Query: 130 RMSASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVK 181
+ ++M E L + A + + +G G +V E AVK
Sbjct: 66 PKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVK 125
Query: 182 RLSK--------ISEQGLKELKNEV-ILFSKLQHRNLVKLLGCCIQGEEKLLIY---EFM 229
+ E+ + + E IL H +++ L+ E ++ + M
Sbjct: 126 IMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---ESSSFMFLVFDLM 182
Query: 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHR 289
L ++ E L+ E+ + + V +LH I+HR
Sbjct: 183 RKGELFDYLTEKVALS--------EK----ETRSIMRSLLE---AVSFLHA---NNIVHR 224
Query: 290 DLKASN 295
DLK N
Sbjct: 225 DLKPEN 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 32/173 (18%), Positives = 57/173 (32%), Gaps = 54/173 (31%)
Query: 146 PLFELATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNE 197
++ A D + LG G G V ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60
Query: 198 V-ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC 256
V + + Q ++V+++ +YE N + +L +M E
Sbjct: 61 VELHWRASQCPHIVRIVD----------VYE-------NLYAGRKCLLIVM------ECL 97
Query: 257 -------KILDWSKRF-------HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+I D + I+ + YLH + I HRD+K N
Sbjct: 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 147
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 32/155 (20%), Positives = 60/155 (38%), Gaps = 34/155 (21%)
Query: 151 ATIANATDNFSINNKLGEGGFGLVY--------KEIAVKRLSK--ISEQGLKELKNEVIL 200
T T+ + + +LG+G F +V +E A ++ +S + ++L+ E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
L+H N+V+L E+ Y + + L I + E
Sbjct: 64 CRLLKHPNIVRLHDSI---SEEGHHYLIFDLVTGGELFEDIVAREYYS--------EA-- 110
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
D S I V++ HQ + ++HR+LK
Sbjct: 111 --DASHCIQQILE---AVLHCHQ---MGVVHRNLK 137
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 46/160 (28%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
D + I + +G G +G V + +A+K++ ++ E L+E+ + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA----ILN 107
Query: 203 KLQHRNLVKLLGCCIQGEEKL-----LIYEFMPNKSLNSFIFENFVLT--LMRSFVDQER 255
+L H ++VK+L I + + ++ E LT +++ +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYN-- 164
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L GV Y+H I+HRDLK +N
Sbjct: 165 --LL-------------VGVKYVHSA---GILHRDLKPAN 186
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 4e-08
Identities = 33/177 (18%), Positives = 58/177 (32%), Gaps = 39/177 (22%)
Query: 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRL--------SKISEQGLKELKNEVILF 201
T+ K+GEG FG V++ +A+K + + ++ +E+ E+I+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 202 SKLQ---------HRNLVKLLGCCI-QGEE-KLLIYEFMPNKSLNSFIFEN--------- 241
+L + L QG LL+ + S +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 242 -FVLTLMRSFVDQERC--KILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
VL +D E+ K+ + I+ + LR HRDL N
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 31/182 (17%), Positives = 59/182 (32%), Gaps = 55/182 (30%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH 206
++ +S+ LG G FG+V + A+K++ + +EL + L H
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59
Query: 207 RNLVKLLGC--------------------CIQGEEKLLIYEFMPNKSLNSFIFENFVLTL 246
N++KL+ + + + + + N ++
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 247 MRSFVDQERCKILDWSKR-------FHI------ICGTARGVMYLHQDSKLRIIHRDLKA 293
+ K+L R I + R V ++H L I HRD+K
Sbjct: 120 V----PDTLHKVLKSFIRSGRSIPMNLISIYIYQLF---RAVGFIH---SLGICHRDIKP 169
Query: 294 SN 295
N
Sbjct: 170 QN 171
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 32/163 (19%), Positives = 59/163 (36%), Gaps = 55/163 (33%)
Query: 157 TDNFSINNK-LGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 206
D++ + ++ LG G G V ++ A+K L + + EV + + Q
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQC 114
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC-------KIL 259
++V+++ +YE N + +L +M E +I
Sbjct: 115 PHIVRIVD----------VYE-------NLYAGRKCLLIVM------ECLDGGELFSRIQ 151
Query: 260 D-WSKRF------HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D + F I+ + YLH + I HRD+K N
Sbjct: 152 DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 191
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-08
Identities = 37/146 (25%), Positives = 58/146 (39%), Gaps = 35/146 (23%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSK----ISEQGLKELKNEVILFSKLQHRNLVKLL 213
LGEG +G V AVK L K G +K E+ L +L+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 214 GCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH-IIC 269
+ EEK +Y E+ V ++R + F +I
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEML-----------DSVPEKRFPVCQAHGYFCQLID 120
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
G + YLH I+H+D+K N
Sbjct: 121 G----LEYLHS---QGIVHKDIKPGN 139
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 37/161 (22%), Positives = 59/161 (36%), Gaps = 41/161 (25%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK-------------ISEQGLKELK 195
+++ KLG G +G V E A+K + K E+ +E+
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 196 NEVILFSKLQHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQE 254
NE+ L L H N++KL + ++ L+ EF L I E
Sbjct: 95 NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGELFEQIINRHKFD--------E 145
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+I+ G+ YLH+ I+HRD+K N
Sbjct: 146 C-------DAANIMKQILSGICYLHK---HNIVHRDIKPEN 176
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 5e-08
Identities = 33/153 (21%), Positives = 57/153 (37%), Gaps = 35/153 (22%)
Query: 157 TDNFSINNK-LGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEV-ILFSKLQH 206
TD++ ++ + LG G G V ++ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 207 RNLVKLLGCC---IQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
++V +L G+ L +I E M L F ++F ++E +I
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEI---- 133
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I + +LH I HRD+K N
Sbjct: 134 --MRDIGT---AIQFLHS---HNIAHRDVKPEN 158
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 39/147 (26%), Positives = 59/147 (40%), Gaps = 34/147 (23%)
Query: 157 TDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQHRN 208
+D F + ++LG G +VY K A+K L K ++ K ++ E+ + +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 209 LVKLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
++KL E I E + L I E + ER D +
Sbjct: 110 IIKLKEIF---ETPTEISLVLELVTGGELFDRIVEKGYYS--------ER----DAADAV 154
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLK 292
I V YLH+ I+HRDLK
Sbjct: 155 KQILE---AVAYLHE---NGIVHRDLK 175
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 33/150 (22%), Positives = 57/150 (38%), Gaps = 28/150 (18%)
Query: 155 NATDNFSINNK-LGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSK 203
N + + + +K LG G F +V + E A K L K + E+ +E+ +
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 204 LQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
+ ++ L E +LI E+ + F + L + + +++
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVIRLI--- 137
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLK 292
I GV YLHQ I+H DLK
Sbjct: 138 ---KQILE---GVYYLHQ---NNIVHLDLK 158
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 39/153 (25%), Positives = 60/153 (39%), Gaps = 33/153 (21%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
D F LG GGFG V+ ++ A K+L+K +G + E + +K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
R +V L + + L L+ M + I+ V F + R F
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYN--VDEDNPGF-QEPRA-------IF 293
Query: 266 ---HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ G + +LHQ II+RDLK N
Sbjct: 294 YTAQIVSG----LEHLHQ---RNIIYRDLKPEN 319
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 4e-07
Identities = 35/157 (22%), Positives = 53/157 (33%), Gaps = 36/157 (22%)
Query: 157 TDNFSINNKLGEGGFGLVY--------KEIAVKRLSKISEQGLKE---------LKNEV- 198
+N+ LG G +V KE AVK + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 199 ILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKI 258
IL H N+++L L+++ M L ++ E L+ E+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS--------EK--- 124
Query: 259 LDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ K + + LH KL I+HRDLK N
Sbjct: 125 -ETRKIMRALLE---VICALH---KLNIVHRDLKPEN 154
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 33/153 (21%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
+ +G G G+V +A+K+LS+ + +EL L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMK 116
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
+ H+N++ LL F P K+L F V+ LM + + Q LD
Sbjct: 117 CVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE 164
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +++ G+ +LH IIHRDLK SN
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSN 194
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 8e-07
Identities = 32/144 (22%), Positives = 56/144 (38%), Gaps = 35/144 (24%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 214
LG G FG V ++AVK L++ I + +K E+ +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 215 CCIQGEEKLLIYEFMPNKSLNSFIFENFVLT--LMRSFVDQERCKILDWSKRFH-IICGT 271
Y+ + + + E +V L R + ++ + F I+
Sbjct: 77 -----------YQVISTPTDFFMVME-YVSGGELFDYICKHGRVEEMEARRLFQQILSA- 123
Query: 272 ARGVMYLHQDSKLRIIHRDLKASN 295
V Y H + ++HRDLK N
Sbjct: 124 ---VDYCH---RHMVVHRDLKPEN 141
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 37/156 (23%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK------ISEQGLKELKNEVILFSK 203
+ + LG GGFG VY +A+K + K + EV+L K
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 204 LQHR--NLVKLLGCCIQGEEKLLIYEF-MPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
+ +++LL + + +LI E P + L FI E L ++
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQ------EELARSF-- 154
Query: 261 WSKRFH-IICGTARGVMYLHQDSKLRIIHRDLKASN 295
F ++ V + H ++HRD+K N
Sbjct: 155 ----FWQVLE----AVRHCHN---CGVLHRDIKDEN 179
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 31/140 (22%), Positives = 50/140 (35%), Gaps = 30/140 (21%)
Query: 165 KLGEGGFGLVY--------KEIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGC 215
LGEG F + + AVK +SK + + E+ + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGV 275
L+ E + L I + + F + E I + V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKK------KKHFSETEASYI------MRKLVS---AV 119
Query: 276 MYLHQDSKLRIIHRDLKASN 295
++H + ++HRDLK N
Sbjct: 120 SHMHD---VGVVHRDLKPEN 136
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 32/143 (22%), Positives = 56/143 (39%), Gaps = 33/143 (23%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 214
LG G FG V ++AVK L++ I + ++ E+ +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 215 CCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH-IICGTA 272
I + ++ E++ L +I R + + F I+ G
Sbjct: 84 V-ISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQQILSG-- 128
Query: 273 RGVMYLHQDSKLRIIHRDLKASN 295
V Y H + ++HRDLK N
Sbjct: 129 --VDYCH---RHMVVHRDLKPEN 146
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 34/147 (23%), Positives = 63/147 (42%), Gaps = 42/147 (28%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLVKLLG 214
LGEG FG V +++A+K +S+ + + + ++ E+ L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 215 CCIQGEEKLLIYEFMPNKSLNSFIFENFVL-----TLMRSFVDQERCKILDWSKRFH-II 268
Y+ + + I V+ L V+++R + + F II
Sbjct: 75 -----------YDVITTPT---DIV--MVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
C + Y H + +I+HRDLK N
Sbjct: 119 CA----IEYCH---RHKIVHRDLKPEN 138
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 36/141 (25%), Positives = 52/141 (36%), Gaps = 31/141 (21%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 216
LGEG +G V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 217 IQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH-IICGTARG 274
+ L E+ L I D + FH ++ G
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMAG---- 117
Query: 275 VMYLHQDSKLRIIHRDLKASN 295
V+YLH + I HRD+K N
Sbjct: 118 VVYLHG---IGITHRDIKPEN 135
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 3e-06
Identities = 36/141 (25%), Positives = 52/141 (36%), Gaps = 31/141 (21%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 216
LGEG +G V + +AVK + E +K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73
Query: 217 IQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH-IICGTARG 274
+ L E+ L I D + FH ++ G
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQLMA----G 117
Query: 275 VMYLHQDSKLRIIHRDLKASN 295
V+YLH + I HRD+K N
Sbjct: 118 VVYLHG---IGITHRDIKPEN 135
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 35/153 (22%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
+ F LG+GGFG V ++ A K+L K +G NE + K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
R +V L + ++ L L+ M L I+ + ++ + R F
Sbjct: 244 RFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYH-----MGQAGFPEARA-------VF 290
Query: 266 ---HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I C G+ LH + RI++RDLK N
Sbjct: 291 YAAEICC----GLEDLH---RERIVYRDLKPEN 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 36/148 (24%), Positives = 64/148 (43%), Gaps = 35/148 (23%)
Query: 162 INNKLGEGGFGLVYK--------EIAVKRLS---KISEQGLKELKNEVILFSKLQHRNLV 210
I +KLG GG VY ++A+K + + E+ LK + EV S+L H+N+V
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 211 KLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
++ EE Y E++ +L+ +I + L++ + +
Sbjct: 75 SMID---VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI---------------NF 116
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ + H +RI+HRD+K N
Sbjct: 117 TNQILDGIKHAHD---MRIVHRDIKPQN 141
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 6e-06
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 46/160 (28%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
DN+ I + +G G +G VY +A+K+++++ E L+E+ + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT----ILN 80
Query: 203 KLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLNSFIFENFVLTL--MRSFVDQER 255
+L+ +++L I K ++ E L LT +++ +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYN-- 137
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L G ++H+ IIHRDLK +N
Sbjct: 138 --LL-------------LGENFIHESG---IIHRDLKPAN 159
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-06
Identities = 31/160 (19%), Positives = 58/160 (36%), Gaps = 43/160 (26%)
Query: 158 DNFSINNKLGEGGFGLVY--------KEIAVKRLSK------ISEQGLKELKNEV----I 199
+ + LG+GGFG V+ ++A+K + + EV
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKL-LIYEF-MPNKSLNSFIFENFVLT--LMRSFVDQER 255
+ + H +++LL + +E L+ E +P + L +I E L R F Q
Sbjct: 91 VGAGGGHPGVIRLLD-WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ-- 147
Query: 256 CKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ + + H ++HRD+K N
Sbjct: 148 -----------VVA----AIQHCHS---RGVVHRDIKDEN 169
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 35/154 (22%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
+ +G G +G V ++A+K+LS+ + +EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL----LLK 78
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE-RCKILDW 261
+QH N++ LL F P SL +F V+ M++ + + K +
Sbjct: 79 HMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE 126
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ ++ +G+ Y+H ++HRDLK N
Sbjct: 127 KIQY-LVYQMLKGLKYIHSAG---VVHRDLKPGN 156
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 40/156 (25%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKL-- 204
++FS++ +G GGFG VY ++ A+K L K +QG NE I+ S +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 205 -QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
+V + +KL I + M L+ + L+ F +
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLH------YHLSQHGVF-SEADM------ 294
Query: 263 KRFH---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
RF+ II G + ++H +++RDLK +N
Sbjct: 295 -RFYAAEIILG----LEHMHN---RFVVYRDLKPAN 322
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 22/152 (14%), Positives = 50/152 (32%), Gaps = 41/152 (26%)
Query: 162 INNKLGEGGFGLVYK---------EIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVK 211
+ + GG G +Y + +K L + + E +++ H ++V+
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 212 LLGCCIQGEE-----KLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
+ E + Y E++ +SL ++ L ++
Sbjct: 144 IFN---FVEHTDRHGDPVGYIVMEYVGGQSLKRSK--------------GQK---LPVAE 183
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YLH + +++ DLK N
Sbjct: 184 AIAYLLEILPALSYLHS---IGLVYNDLKPEN 212
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 66/189 (34%)
Query: 151 ATIANATDNFSINN-----KLGEGGFGLVY--------KEIAVKRLSK------------ 185
+ ++ D +N ++G+G +G+V A+K LSK
Sbjct: 1 GSSGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRR 60
Query: 186 --------------ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM-- 229
++++ E+ + KL H N+VKL E +
Sbjct: 61 PPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL-------------VEVLDD 107
Query: 230 PNKSLNSFIFENFVL--TLMRSFVDQERCKILDWSKRFH-IICGTARGVMYLHQDSKLRI 286
PN+ +FE V +M + F +I G + YLH +I
Sbjct: 108 PNEDHLYMVFE-LVNQGPVM-EVPTLKPLSEDQARFYFQDLIKG----IEYLH---YQKI 158
Query: 287 IHRDLKASN 295
IHRD+K SN
Sbjct: 159 IHRDIKPSN 167
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-05
Identities = 39/161 (24%), Positives = 60/161 (37%), Gaps = 49/161 (30%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
+ +G G G+V +A+K+LS+ + +EL L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV----LMK 79
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLM--------RSFVDQE 254
+ H+N++ LL F P KSL F V+ LM + +D E
Sbjct: 80 CVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 127
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R +++ G+ +LH IIHRDLK SN
Sbjct: 128 RMS--------YLLYQMLCGIKHLHSAG---IIHRDLKPSN 157
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 31/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
D+F I +G+G FG V K++ A+K ++K + ++ + E+ + L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
LV L Q EE + ++ + + L + L F +E K+
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL----R--YHLQQNVHF-KEETVKLF------ 120
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
IC + YL RIIHRD+K N
Sbjct: 121 --ICELVMALDYLQ---NQRIIHRDMKPDN 145
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 32/154 (20%), Positives = 63/154 (40%), Gaps = 34/154 (22%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
+ +G G +G V ++A+K+L + + +EL+ L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLK 79
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE-RCKILDW 261
++H N++ LL F P+++L+ F V+ M + + + + + L
Sbjct: 80 HMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 127
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ +G+ Y+H IIHRDLK N
Sbjct: 128 DRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGN 158
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 33/141 (23%), Positives = 54/141 (38%), Gaps = 33/141 (23%)
Query: 166 LGEGGFGLVY--------KEIAVKRLSKISEQGLKE-LKNEVILFSKLQHRNLVKLLGCC 216
+G G FG+ + +AVK + + + E ++ E+I L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKE-V 84
Query: 217 IQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH-IICGTARG 274
I L +I E+ L I + R + F ++ G
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS----G 128
Query: 275 VMYLHQDSKLRIIHRDLKASN 295
V Y H ++I HRDLK N
Sbjct: 129 VSYCH---SMQICHRDLKLEN 146
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 27/148 (18%), Positives = 50/148 (33%), Gaps = 35/148 (23%)
Query: 162 INNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKE-LKNEVILFSKLQHRNLV 210
+ +G GG G VY+ +A+K +S+ S+ + ++ E +LQ ++V
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 211 KLLGCCIQGEEKLLIY---EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
+ GE +Y + L + + L R+ I
Sbjct: 98 PIHD---FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAV---------------AI 139
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + H HRD+K N
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPEN 164
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 8e-05
Identities = 35/153 (22%), Positives = 62/153 (40%), Gaps = 37/153 (24%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 206
+F I LG G FG V+ A+K L K LK++ +E ++ S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
++++ G Q +++ +I +++ L F +L + F +F
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGEL----F--SLLRKSQRF-PNPVA-------KF 110
Query: 266 H---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + + YLH II+RDLK N
Sbjct: 111 YAAEVCLA----LEYLH---SKDIIYRDLKPEN 136
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 9e-05
Identities = 29/155 (18%), Positives = 65/155 (41%), Gaps = 38/155 (24%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG-----LKELKNEVILFSK 203
++ + +GEG +G+V +A+K++S Q L+E+K + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSF--IFENFVLTLMRSFVDQE-RCKILD 260
+H N++ + + + ++ ++ V LM + + + + + L
Sbjct: 82 FRHENIIGIN-------------DIIRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLS 126
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + RG+ Y+H + ++HRDLK SN
Sbjct: 127 NDHICYFLYQILRGLKYIHSAN---VLHRDLKPSN 158
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 38/153 (24%), Positives = 54/153 (35%), Gaps = 37/153 (24%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 206
D F LG G FG V A+K L K LK++ NE + +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
LVKL + L ++ E++ + F L + F + RF
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEM--F----SHLRRIGRF-SEPHA-------RF 145
Query: 266 ---HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ YLH L +I+RDLK N
Sbjct: 146 YAAQIVL----TFEYLH---SLDLIYRDLKPEN 171
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 40/154 (25%), Positives = 64/154 (41%), Gaps = 34/154 (22%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG------LKELKNEVILFS 202
+ + + +G G +G V +AVK+LS+ + +EL+ L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR----LLK 83
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE-RCKILDW 261
++H N++ LL F P +SL F V LM + ++ +C+ L
Sbjct: 84 HMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD 131
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+I RG+ Y+H IIHRDLK SN
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN 162
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 36/150 (24%), Positives = 58/150 (38%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
+ F LG+G FG V A+K L K +++ + E + +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
L L Q ++L + E+ L F F L+ R F ++R RF
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL----F--FHLSRERVF-SEDRA-------RF 252
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YLH S+ +++RDLK N
Sbjct: 253 YGAE-IVSALDYLH--SEKNVVYRDLKLEN 279
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 35/151 (23%), Positives = 58/151 (38%), Gaps = 22/151 (14%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKN---EVILFSKLQ 205
+ LG GG GLV+ +A+K KI + +K+ E+ + +L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLD 66
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQE-RCKILDWSKR 264
H N+VK+ + L + LNS V M + + L
Sbjct: 67 HDNIVKVFEI-LGPSGSQLTDDVGSLTELNSVYI---VQEYMETDLANVLEQGPLLEEHA 122
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ RG+ Y+H + ++HRDLK +N
Sbjct: 123 RLFMYQLLRGLKYIHSAN---VLHRDLKPAN 150
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 36/153 (23%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSKISEQGLKEL---KNEVILFSKLQH 206
++F I +G G FG V ++ A+K L+K E + E +
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
+ + L Q + L L+ ++ L LTL+ F E + + RF
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDL---------LTLLSKF---EDRLPEEMA-RF 179
Query: 266 H---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ ++ + +H +L +HRD+K N
Sbjct: 180 YLAEMVIA----IDSVH---QLHYVHRDIKPDN 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 36/153 (23%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
D+F I +G G F V ++ A+K ++K + + + E +
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
R + +L Q E L L+ E+ L LTL+ F + + RF
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDL---------LTLLSKF---GERIPAEMA-RF 166
Query: 266 H---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ I+ + +H+ L +HRD+K N
Sbjct: 167 YLAEIVMA----IDSVHR---LGYVHRDIKPDN 192
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 31/169 (18%), Positives = 58/169 (34%), Gaps = 55/169 (32%)
Query: 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQG---------------LKEL 194
+++ + G +G V +A+KR+ G L+E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 195 KNEVILFSKLQHRNLVKLLGCCI-QGEEKL----LIYEFMPNKSLNSFIF-ENFVLTL-- 246
+ L + H N++ L + E + L+ E M L I + V++
Sbjct: 81 R----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQH 135
Query: 247 MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ F+ IL G+ LH+ ++HRDL N
Sbjct: 136 IQYFMYH----IL-------------LGLHVLHEAG---VVHRDLHPGN 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 29/153 (18%), Positives = 54/153 (35%), Gaps = 41/153 (26%)
Query: 162 INNKLGEGGFGLVYK--------EIAVK----RLSKISEQGLKELKNEVILFSKLQHRNL 209
+ LG GG V+ ++AVK L++ + E + L H +
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAI 74
Query: 210 VKLLGCCIQGEEKL-------LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
V + GE + ++ E++ +L + +T R+
Sbjct: 75 VAVYD---TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI------------ 119
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+I + + + HQ IIHRD+K +N
Sbjct: 120 ---EVIADACQALNFSHQ---NGIIHRDVKPAN 146
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 4e-04
Identities = 40/155 (25%), Positives = 63/155 (40%), Gaps = 39/155 (25%)
Query: 158 DNFSINNKLGEGGFGLVY----------KEI-AVKRLSK--ISEQGLKELKNEVILFSKL 204
F + LG+G FG V+ +++ A+K L K + + K E + ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 205 QHRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
H +VKL Q E KL LI +F+ L F L+ F +E
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL--F----TRLSKEVMF-TEEDV------- 128
Query: 264 RFH---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+F+ + + +LH L II+RDLK N
Sbjct: 129 KFYLAELAL----ALDHLH---SLGIIYRDLKPEN 156
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 5e-04
Identities = 32/154 (20%), Positives = 61/154 (39%), Gaps = 40/154 (25%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
+++ + +G G FG V +++ A+K LSK I E + +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKR 264
+V+L Q + L ++ E+MP L + LM ++ V ++ R
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDL---------VNLMSNYDVPEKWA-------R 171
Query: 265 FH---IICGTARGVMYLHQDSKLRIIHRDLKASN 295
F+ ++ + +H + IHRD+K N
Sbjct: 172 FYTAEVVLA----LDAIHS---MGFIHRDVKPDN 198
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 21/112 (18%), Positives = 35/112 (31%), Gaps = 15/112 (13%)
Query: 184 SKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFV 243
S + ++ +N V L + + ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-- 155
Query: 244 LTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
S D+E L F I V +LH ++HRDLK SN
Sbjct: 156 ----CSLEDREHGVCLHI---FIQIAE---AVEFLHS---KGLMHRDLKPSN 194
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 38/154 (24%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNE-VILFSKLQ 205
+F +G+G FG V + AVK L K + ++ K + +E +L ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 206 HRNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
H LV L Q +KL + +++ L F + L R F + R R
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL----F--YHLQRERCF-LEPRA-------R 142
Query: 265 F---HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
F I + YLH L I++RDLK N
Sbjct: 143 FYAAEIASA----LGYLH---SLNIVYRDLKPEN 169
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 9e-04
Identities = 36/150 (24%), Positives = 57/150 (38%), Gaps = 31/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVY-------KEI-AVKRLSK---ISEQGLKELKNEVILFSKLQH 206
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 RNLVKLLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
L L Q ++L + E+ L F F L+ R F +ER RF
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL--F----FHLSRERVF-TEERA-------RF 109
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YLH +++RD+K N
Sbjct: 110 YGAE-IVSALEYLH---SRDVVYRDIKLEN 135
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 99.97 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 99.97 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 99.97 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 99.96 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 99.96 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.96 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 99.96 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.96 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.95 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.95 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.95 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.94 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.94 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.94 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.93 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.91 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.91 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.91 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.9 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.9 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.9 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.9 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.9 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.9 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.9 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.9 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.9 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.9 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.9 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.9 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.9 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.9 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.9 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.9 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.9 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.9 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.89 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.89 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.89 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.89 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.89 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.89 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.89 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.89 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.89 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.89 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.89 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.89 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.89 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.89 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.89 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.89 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.89 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.89 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.89 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.89 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.89 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.89 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.89 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.89 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.89 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.89 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.89 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.89 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.89 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.88 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.88 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.88 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.88 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.88 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.88 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.88 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.88 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.88 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.88 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.88 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.88 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.88 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.88 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.88 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.88 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.88 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.88 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.88 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.88 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.88 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.88 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.88 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.88 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.88 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.88 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.87 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.87 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.87 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.87 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.87 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.87 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.87 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.87 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.87 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.87 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.87 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.87 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.87 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.87 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.87 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.87 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.87 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.87 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.87 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.87 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.87 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.87 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.87 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.87 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.87 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.87 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.87 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.87 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.87 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.87 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.87 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.87 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.87 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.87 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.87 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.87 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.87 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.87 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.87 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.87 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.87 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.87 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.87 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.87 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.87 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.87 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.87 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.87 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.87 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.86 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.86 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.86 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.86 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.86 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.86 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.86 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.86 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.86 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.86 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.86 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.86 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.86 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.86 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.86 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.86 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.86 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.86 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.86 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.86 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.86 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.86 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.86 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.86 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.86 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.86 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.86 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.86 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.86 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.86 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.86 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.86 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.86 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.86 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.86 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.86 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.85 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.85 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.85 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.85 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.85 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.85 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.85 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.85 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.85 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.85 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.85 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.85 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.85 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.85 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.85 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.85 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.85 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.85 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.85 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.85 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.85 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.85 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.85 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.85 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.85 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.85 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.85 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.84 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.84 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.84 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.84 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.84 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.84 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.84 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.84 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.84 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.84 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.84 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.84 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.83 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.83 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.83 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.83 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.83 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.82 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.82 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.82 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.82 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.82 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.82 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.82 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.82 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.82 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.81 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.81 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.81 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.81 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.81 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.81 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.81 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.81 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.81 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.81 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.8 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.8 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.8 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.79 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.77 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.74 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.57 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.94 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.1 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.3 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.51 | |
| 1b9w_A | 95 | Protein (merozoite surface protein 1); MSP-1, cand | 93.48 | |
| 1edm_B | 39 | Factor IX; epidermal growth factor, EGF, calcium- | 93.16 | |
| 1egf_A | 53 | Epidermal growth factor; NMR {Mus musculus} SCOP: | 92.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.99 | |
| 1a3p_A | 45 | Epidermal growth factor; disulfide connectivities, | 90.68 | |
| 3u7u_G | 55 | Neuregulin 1; signaling protein, transferase-trans | 89.56 | |
| 1k36_A | 46 | Epiregulin; EGF-like fold, hormone/growth factor c | 89.24 | |
| 1apq_A | 53 | Complement protease C1R; EGF, calcium binding, ser | 89.16 | |
| 2jkh_L | 55 | Factor X light chain; plasma, calcium, zymogen, se | 88.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 88.84 | |
| 1n1i_A | 105 | Merozoite surface protein-1; MSP1, malaria, surfac | 88.04 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 87.42 | |
| 1emn_A | 82 | Fibrillin; extracellular matrix, calcium-binding, | 86.85 | |
| 1ob1_C | 99 | Major merozoite surface protein; immune system, im | 86.28 | |
| 2k2s_B | 61 | Micronemal protein 6; microneme protein complex, c | 86.0 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 85.62 | |
| 1hae_A | 63 | Heregulin-alpha; growth factor; NMR {Homo sapiens} | 84.96 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 84.95 | |
| 2vj3_A | 135 | Neurogenic locus notch homolog protein 1; transcri | 83.93 | |
| 3ltf_D | 58 | Protein spitz; receptor-ligand complex ectodomain | 83.86 | |
| 1nql_B | 53 | Epidermal growth factor; cell surface receptor, ty | 83.76 | |
| 2rnl_A | 50 | Amphiregulin; AR, colorectum cell-derived growth f | 83.73 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 82.84 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.58 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 82.27 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 81.51 | |
| 1nfu_B | 195 | Coagulation factor XA, light chain; hydrolase; HET | 80.28 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=228.73 Aligned_cols=134 Identities=31% Similarity=0.575 Sum_probs=112.9
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++|.+.++||+|+||.||+ .||||+++..+....++|.+|+.+|++|+|||||+++|++.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 35788899999999999996 38999998777777889999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.++|..+....... ........++|.+++.|+.|||.||+|||+++ ||||||||+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~--~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~N 158 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLM--AEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRN 158 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEEcCCCCcHHHHHHhcCcccccc--cccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhh
Confidence 9999999999999997543211110 01223457999999999999999999999998 9999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=231.16 Aligned_cols=136 Identities=28% Similarity=0.480 Sum_probs=113.4
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++|.+.++||+|+||.||+ .||||+++..+....++|.+|+.+|++|+|||||+++|++.+++..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35778889999999999996 38999998877778889999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.++|..+.................++|.+++.|+.|||.||+|||+++ ||||||||+|
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~N 188 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRN 188 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhh
Confidence 99999999999999975322111100011123456999999999999999999999987 9999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=225.29 Aligned_cols=122 Identities=19% Similarity=0.357 Sum_probs=104.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|+++++||+|+||.||+ .||||++.. ......+.+.+|+.+|++|+|||||++++++.+.+.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999996 699999964 345567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.++|.. .....+++.....|+.||+.||+|||+++ ||||||||+|
T Consensus 104 y~~gg~L~~~i~~-------------~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 155 (350)
T 4b9d_A 104 YCEGGDLFKRINA-------------QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQN 155 (350)
T ss_dssp CCTTCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGG
T ss_pred CCCCCcHHHHHHH-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHH
Confidence 9999999999942 23456789999999999999999999998 9999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-30 Score=220.72 Aligned_cols=122 Identities=28% Similarity=0.506 Sum_probs=108.2
Q ss_pred hccccccceeecccCccceeE-----EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-----EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-----~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..+++.+.++||+|+||.||+ .||||+++. .+....+.|.+|+.+|++++|||||+++|++. .+.++|||||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy 112 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQW 112 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEc
Confidence 446788889999999999998 699999864 34566788999999999999999999999875 4678999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.++|.. ....++|.++..|+.|||.||+|||+++ ||||||||+|
T Consensus 113 ~~gGsL~~~l~~--------------~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~N 162 (307)
T 3omv_A 113 CEGSSLYKHLHV--------------QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNN 162 (307)
T ss_dssp CSSCBHHHHHHT--------------SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSS
T ss_pred CCCCCHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHH
Confidence 999999999952 2346999999999999999999999987 9999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=220.74 Aligned_cols=135 Identities=27% Similarity=0.438 Sum_probs=109.3
Q ss_pred cccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++++.++||+|+||.||+ .||||+++.. .....++|.+|+.+|++|+|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4566779999999999996 4899999753 3345688999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||||++|+|.++|............ ........++|..++.|+.|||.||+|||+++ ||||||||+|
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~N 175 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRN 175 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccc
Confidence 999999999999999643211100000 01122356999999999999999999999998 9999999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=220.07 Aligned_cols=120 Identities=30% Similarity=0.378 Sum_probs=109.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.+|++|+|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999996 6999999752 2334678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.++|.. ...+++.....|+.||+.||+|||+++ ||||||||+|
T Consensus 112 Ey~~gG~L~~~i~~---------------~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeN 162 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---------------IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPEN 162 (311)
T ss_dssp CCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ecCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHH
Confidence 99999999999842 346899999999999999999999998 9999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=223.62 Aligned_cols=120 Identities=25% Similarity=0.419 Sum_probs=109.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
...|++.++||+|+||.||+ .||||+++.......+.+.+|+.+|++++|||||++++++.+.+.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45699999999999999996 6999999765445566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++.. ..+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 153 ~~gg~L~~~l~~----------------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 200 (346)
T 4fih_A 153 LEGGALTDIVTH----------------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDS 200 (346)
T ss_dssp CTTEEHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCcHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHH
Confidence 999999998831 35899999999999999999999998 9999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=225.21 Aligned_cols=121 Identities=25% Similarity=0.411 Sum_probs=109.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..+.|++.++||+|+||.||+ .||||++........+.+.+|+.+|++|+|||||++++++.+.+.+|||||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 346799999999999999996 699999976555556778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||++|+|.+++. ...+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 229 y~~gG~L~~~i~----------------~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~N 277 (423)
T 4fie_A 229 FLEGGALTDIVT----------------HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDS 277 (423)
T ss_dssp CCTTEEHHHHHH----------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTT
T ss_pred CCCCCcHHHHHh----------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHH
Confidence 999999999884 135899999999999999999999998 9999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-29 Score=212.74 Aligned_cols=119 Identities=27% Similarity=0.449 Sum_probs=104.1
Q ss_pred ccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEEE
Q 041718 161 SINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLIY 226 (295)
Q Consensus 161 ~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 226 (295)
++.++||+|+||.||+ .||+|.+.. ......+.|.+|+.+|++|+|||||++++++.+ .+.++|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999997 699999864 345567789999999999999999999999875 35689999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ++||||||||+|
T Consensus 109 Ey~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~N 161 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDN 161 (290)
T ss_dssp ECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGG
T ss_pred eCCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhh
Confidence 99999999999952 356899999999999999999999985 469999999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=209.22 Aligned_cols=120 Identities=26% Similarity=0.437 Sum_probs=102.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..+||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999996 6999999652 233456799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+ +|+|.+++. ....+++.....++.||+.||+|||+++ |+||||||+|
T Consensus 92 mEy~-~g~L~~~l~---------------~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~N 142 (275)
T 3hyh_A 92 IEYA-GNELFDYIV---------------QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPEN 142 (275)
T ss_dssp EECC-CEEHHHHHH---------------HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTT
T ss_pred EeCC-CCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHH
Confidence 9999 689999884 2346999999999999999999999998 9999999998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=211.37 Aligned_cols=123 Identities=27% Similarity=0.454 Sum_probs=103.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC--------
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-------- 220 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-------- 220 (295)
++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 5799999999999999996 6999998653 3445678999999999999999999999987544
Q ss_pred ----eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 ----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+||||||+++|+|.+++... ......++.....|+.||+.||+|||+++ ||||||||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~------------~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~N 148 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR------------CTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSN 148 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC------------CSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc------------CCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHH
Confidence 379999999999999999531 12234567778899999999999999998 9999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-29 Score=215.37 Aligned_cols=117 Identities=25% Similarity=0.360 Sum_probs=104.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..+.|.+.++||+|+||.||+ .||||+++.... ..+|+.+|++|+|||||++++++.+++.+|||||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 345788889999999999996 699999975221 2469999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.++|.. ...+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 131 y~~gg~L~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 180 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ---------------MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADN 180 (336)
T ss_dssp CCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGG
T ss_pred ccCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHH
Confidence 9999999999942 246999999999999999999999998 9999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-29 Score=216.15 Aligned_cols=120 Identities=26% Similarity=0.281 Sum_probs=102.0
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
++|++.+.||+|+||.||+ .||||++++. .......+.+|+.+|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999995 4899998652 22334568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 104 vmEy~~gg~L~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~N 156 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---------------EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPEN 156 (304)
T ss_dssp EECCCTTCEEHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGG
T ss_pred EEEcCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 9999999999999842 346899999999999999999999998 9999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=213.45 Aligned_cols=145 Identities=24% Similarity=0.369 Sum_probs=115.0
Q ss_pred hhhhhhhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCC-Ccccce
Q 041718 148 FELATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQH-RNLVKL 212 (295)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h-~niv~l 212 (295)
++..++....++|++.+.||+|+||.||+ .||||++... .....++|.+|+.+|+++.| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 44455566678999999999999999996 4899999753 34556789999999999965 899999
Q ss_pred eeeEEeC-CeeEEEEecCCCCCHHHHHhhhhhhhhhhh-cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEecc
Q 041718 213 LGCCIQG-EEKLLIYEFMPNKSLNSFIFENFVLTLMRS-FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRD 290 (295)
Q Consensus 213 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrD 290 (295)
+|+|.+. +.++||||||++|+|.++|........... .........++|..++.|+.|||.||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9998764 578999999999999999975322111000 001112356899999999999999999999998 99999
Q ss_pred CCCCC
Q 041718 291 LKASN 295 (295)
Q Consensus 291 lkp~N 295 (295)
|||+|
T Consensus 211 LK~~N 215 (353)
T 4ase_A 211 LAARN 215 (353)
T ss_dssp CSGGG
T ss_pred cCccc
Confidence 99998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=208.80 Aligned_cols=121 Identities=26% Similarity=0.379 Sum_probs=101.0
Q ss_pred cccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 227 (295)
++|.+.++||+|+||.||+ .||||+++.... ....+..|+..+.+++|||||++++++.+++ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4678889999999999997 799999975322 2223445777778899999999999998654 6899999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----CCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS-----KLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~iiHrDlkp~N 295 (295)
|+++|+|.++|.. ..++|..+.+|+.|++.||+|||++. .++||||||||+|
T Consensus 82 y~~~gsL~~~l~~----------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~N 138 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp CCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGG
T ss_pred CCCCCcHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCccc
Confidence 9999999999942 35899999999999999999999871 3459999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-26 Score=203.81 Aligned_cols=120 Identities=23% Similarity=0.390 Sum_probs=106.6
Q ss_pred hhhhccccccceeecccCccceeE-----------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 220 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 220 (295)
+....+.|++.++||+|+||.||+ .||+|.+... ....++.+|+.+|..+ +|||||++++++.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 344567899999999999999995 4899988653 2345688999999998 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+|||||+++|+|.+++. .+++.....++.|++.||+|||+++ ||||||||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~~------------------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeN 147 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN------------------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSN 147 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT------------------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEEEeCCCcccHHHHHc------------------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHH
Confidence 9999999999999999872 3888999999999999999999998 9999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=206.83 Aligned_cols=120 Identities=23% Similarity=0.451 Sum_probs=105.2
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe------CC
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GE 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~ 220 (295)
.++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999996 6999999752 34556788999999999999999999998764 36
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+||||||++ |+|.+++. ....+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 133 ~~~ivmE~~~-g~L~~~i~---------------~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~N 188 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH---------------SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSN 188 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT---------------SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEEEEEeCCC-CCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccc
Confidence 7899999995 78998884 2356999999999999999999999998 9999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=214.65 Aligned_cols=122 Identities=26% Similarity=0.457 Sum_probs=111.6
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|.+.+.||+|+||.||+ .||+|++........+.+.+|+.+|+.|+|||||++++++.+.+.++|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999996 6999999876666778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.++|.. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 236 ~~gg~L~~~i~~--------------~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~N 285 (573)
T 3uto_A 236 MSGGELFEKVAD--------------EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPEN 285 (573)
T ss_dssp CCCCBHHHHHTC--------------TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred cCCCcHHHHHHH--------------hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhh
Confidence 999999998841 2346889999999999999999999998 9999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=209.64 Aligned_cols=121 Identities=22% Similarity=0.270 Sum_probs=104.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|.+.+.||+|+||.||+ .||||++++.. .......+.++.+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 47899999999999999996 69999996421 11222334456778889999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||||++||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 268 ylVmEy~~GGdL~~~l~~---------------~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeN 322 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ---------------HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 322 (689)
T ss_dssp EEEECCCCSCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred EEEEecCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHH
Confidence 999999999999999842 346899999999999999999999998 9999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5e-24 Score=184.32 Aligned_cols=122 Identities=29% Similarity=0.482 Sum_probs=112.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|.+.+.||+|+||.||+ .+|+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 46789999999999999997 5899998776777888999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 89 ~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~N 138 (310)
T 3s95_A 89 IKGGTLRGIIKS--------------MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHN 138 (310)
T ss_dssp CTTCBHHHHHHH--------------CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred cCCCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCe
Confidence 999999999842 2356899999999999999999999998 9999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=183.02 Aligned_cols=123 Identities=23% Similarity=0.474 Sum_probs=110.8
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
....++|++.+.||+|+||.||+ .||||++........+.+.+|+.++++++||||+++++++..++..++|
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 34567899999999999999996 6999998765555567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 96 ~e~~~~~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~N 146 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE----------------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDN 146 (297)
T ss_dssp EECCTTCBHHHHHHH----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EECCCCCCHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHH
Confidence 999999999998842 35889999999999999999999998 9999999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=186.51 Aligned_cols=134 Identities=38% Similarity=0.679 Sum_probs=117.2
Q ss_pred hhhhhhhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 041718 148 FELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 220 (295)
+++.++...+++|++.+.||+|+||.||+ .||||++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44455667789999999999999999997 69999987665666788999999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++|+|.+++... ......++|..+..++.|++.||.|||+++ |+||||||+|
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~N 169 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGS-----------DLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSIN 169 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSS-----------CCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTT
T ss_pred eEEEEEEcCCCCcHHHHHhcc-----------CCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHH
Confidence 999999999999999988421 112346899999999999999999999998 9999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-24 Score=184.55 Aligned_cols=123 Identities=28% Similarity=0.408 Sum_probs=110.5
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
...++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 3457899999999999999996 6999998652 44567789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 92 v~e~~~~~~L~~~l~~---------------~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~N 144 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVA---------------HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAEN 144 (328)
T ss_dssp EECCCTTCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEECCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHH
Confidence 9999999999999842 245889999999999999999999998 9999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=180.38 Aligned_cols=122 Identities=25% Similarity=0.487 Sum_probs=110.5
Q ss_pred ccccccceeecccCccceeE---------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
.++|.+.+.||+|+||.||+ .||+|.+........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 46899999999999999996 289999977666777889999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 143 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--------------NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKN 143 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--------------TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CEEEEECCCCCCHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcce
Confidence 9999999999999999852 2234889999999999999999999998 9999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-24 Score=191.48 Aligned_cols=130 Identities=18% Similarity=0.209 Sum_probs=112.5
Q ss_pred hhhhhhhhccccccceeecccCccceeE--------EEEEEEeccccH---HhHHHHHHHHHHHhcCCCCcccceeeeEE
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE---QGLKELKNEVILFSKLQHRNLVKLLGCCI 217 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 217 (295)
.+.++....++|++.++||+|+||.||+ .||||++++... .....+.+|+.++..++|||||++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3445566678999999999999999996 699999975221 22334889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+..+|||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ||||||||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--------------~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~N 205 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--------------FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDN 205 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHH
Confidence 99999999999999999999842 2356899999999999999999999998 9999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=181.50 Aligned_cols=122 Identities=22% Similarity=0.340 Sum_probs=108.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..++|.+.+.||+|+||.||+ .+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 346899999999999999996 6899998753 3455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~~g~~L~~~l~--------------~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~N 132 (321)
T 1tki_A 82 FISGLDIFERIN--------------TSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPEN 132 (321)
T ss_dssp CCCCCBHHHHHT--------------SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred eCCCCCHHHHHH--------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHH
Confidence 999999999883 12346899999999999999999999998 9999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=185.00 Aligned_cols=122 Identities=30% Similarity=0.421 Sum_probs=108.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccH------HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
..+.|.+.+.||+|+||.||+ .+|+|.++.... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 456799999999999999996 699999875322 135789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~N 145 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA---------------QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPEN 145 (361)
T ss_dssp EEEEEECCCSCBHHHHHT---------------TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEEcCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999999999984 2346899999999999999999999998 9999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.6e-24 Score=184.38 Aligned_cols=140 Identities=46% Similarity=0.738 Sum_probs=118.6
Q ss_pred ccchhhhhhhhhccccccceeecccCccceeE-------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeE
Q 041718 145 LPLFELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCC 216 (295)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 216 (295)
+..+++.++....++|++.+.||+|+||.||+ .||||++.... ......+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45677888889999999999999999999997 59999987532 22334689999999999999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+.+..++||||+++|+|.+++... ......++|..+..|+.|++.||.|||++..++|+||||||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N 164 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRER-----------PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN 164 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCC-----------STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred ecCCceEEEEEeccCCCHHHHHHhc-----------cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence 9999999999999999999998531 1233459999999999999999999999922239999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=182.51 Aligned_cols=131 Identities=28% Similarity=0.504 Sum_probs=112.0
Q ss_pred hhhhhccccccceeecccCccceeE------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.+....++|++.+.||+|+||.||+ .||||++... .....+++.+|+.++++++||||+++++++.+.+..+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 3344567899999999999999996 6999998653 3455678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++... .....+++..++.++.|++.||+|||+++ ++|+||||||+|
T Consensus 111 lv~e~~~~~~L~~~l~~~------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~N 169 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKS------------GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPN 169 (309)
T ss_dssp EEEECCTTCBHHHHHHST------------THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGG
T ss_pred EEEecCCCCcHHHHHhhc------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhh
Confidence 999999999999998521 11234899999999999999999999875 359999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=184.74 Aligned_cols=125 Identities=24% Similarity=0.378 Sum_probs=108.5
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc-----HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.+.|++.+.||+|+||.||+ .||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999997 69999986421 124678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++++|.+++... ......+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 103 lv~e~~~g~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~N 160 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKR-----------ADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHC 160 (351)
T ss_dssp EEEECCSSCBHHHHHHHH-----------HHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEeCCCCCCHHHHHHHh-----------cccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHH
Confidence 999999999998887532 112345899999999999999999999998 9999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=182.16 Aligned_cols=123 Identities=25% Similarity=0.452 Sum_probs=110.1
Q ss_pred hccccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 346799999999999999996 3999999753 4556778999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++++|.+++.. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 127 lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 181 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT--------------HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARN 181 (325)
T ss_dssp EEEECCTTCBHHHHHHT--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEeeCCCCCcHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcce
Confidence 99999999999999842 2346899999999999999999999998 9999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=179.13 Aligned_cols=119 Identities=11% Similarity=0.089 Sum_probs=105.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 36799999999999999996 6999999753 244568899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. . ........|+.|++.||.|||+++ |+||||||+|
T Consensus 110 ~e~~~g~~L~~~l~~----------------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~N 159 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----------------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSR 159 (286)
T ss_dssp EECCCEEEHHHHHTT----------------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EEecCCCCHHHHHhc----------------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCccc
Confidence 999999999998831 1 344567889999999999999998 9999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=186.07 Aligned_cols=125 Identities=21% Similarity=0.282 Sum_probs=111.2
Q ss_pred hhccccccceeeccc--CccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 155 NATDNFSINNKLGEG--GFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G--~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
...++|++.+.||+| +||.||+ .||||++... .....+.+.+|+.++++++|||||++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 445789999999999 9999996 6999998642 345567889999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. .....+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~N 158 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICT-------------HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASH 158 (389)
T ss_dssp EEEEECCTTCBHHHHHHH-------------TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEccCCCCHHHHHhh-------------hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999999999999852 22345899999999999999999999998 9999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-23 Score=184.97 Aligned_cols=137 Identities=28% Similarity=0.491 Sum_probs=111.3
Q ss_pred hccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQ 218 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~ 218 (295)
..++|.+.+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|+++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 457899999999999999996 2899999753 445677899999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+..++||||+++|+|.+++............ ........+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999643211000000 00112345899999999999999999999998 9999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-23 Score=180.98 Aligned_cols=125 Identities=25% Similarity=0.431 Sum_probs=105.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 220 (295)
..++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 346899999999999999996 6999998642 3345678999999999999999999999986654
Q ss_pred ---------------------------------------------------eeEEEEecCCCCCHHHHHhhhhhhhhhhh
Q 041718 221 ---------------------------------------------------EKLLIYEFMPNKSLNSFIFENFVLTLMRS 249 (295)
Q Consensus 221 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 249 (295)
..++||||+++++|.+++..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--------- 154 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR--------- 154 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHT---------
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhc---------
Confidence 37999999999999999853
Q ss_pred cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 250 FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 250 ~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.......++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 155 ---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 194 (332)
T 3qd2_B 155 ---RCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSN 194 (332)
T ss_dssp ---CCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred ---ccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCccc
Confidence 122344677788999999999999999998 9999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-23 Score=180.97 Aligned_cols=117 Identities=28% Similarity=0.443 Sum_probs=106.5
Q ss_pred cccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
|...+.||+|+||.||+ .||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 66778999999999996 6999999765555677899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 127 ~~L~~~l~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 127 GALTDIVS----------------QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp CBHHHHHT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCHHHHHH----------------hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 99999873 235899999999999999999999998 9999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=185.30 Aligned_cols=122 Identities=29% Similarity=0.501 Sum_probs=109.7
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.++|++.+.||+|+||.||+ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.+..+|
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 46899999999999999996 3999998753 45567789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 124 v~e~~~~~sL~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 177 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK--------------HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARN 177 (373)
T ss_dssp EEECCTTCBHHHHHHT--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEeCCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcce
Confidence 9999999999999842 2346899999999999999999999998 9999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.4e-23 Score=184.60 Aligned_cols=123 Identities=25% Similarity=0.378 Sum_probs=110.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..+.|.+.+.||+|+||.||+ .+|+|.+..........+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 346899999999999999997 589999976655666789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 129 ~~~gg~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~N 179 (387)
T 1kob_A 129 FLSGGELFDRIAA--------------EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPEN 179 (387)
T ss_dssp CCCCCBHHHHTTC--------------TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred cCCCCcHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHH
Confidence 9999999998841 2346899999999999999999999998 9999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=188.88 Aligned_cols=130 Identities=18% Similarity=0.213 Sum_probs=113.0
Q ss_pred hhhhhhhhccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEE
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCI 217 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 217 (295)
.+.+.....++|++.+.||+|+||.||+ .||||++++.. ....+.+.+|+.++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 4455566678999999999999999996 69999997522 223456889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+..+|||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~--------------~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~N 192 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK--------------FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDN 192 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH--------------HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHH
Confidence 99999999999999999999842 2246899999999999999999999998 9999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=190.48 Aligned_cols=128 Identities=19% Similarity=0.237 Sum_probs=110.8
Q ss_pred hhhhhhhhccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEE
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCI 217 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~ 217 (295)
.+.++....++|.+.+.||+|+||.||+ .+|+|++.+.. ....+.+.+|+.+++.++|||||++++++.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445556678999999999999999996 68999986521 122345889999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+..+|||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~----------------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~N 198 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSN----------------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDN 198 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred ECCEEEEEEeCCCCCcHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 99999999999999999998841 34888999999999999999999998 9999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.9e-23 Score=182.97 Aligned_cols=121 Identities=20% Similarity=0.254 Sum_probs=108.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||+|++++. .......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 46899999999999999996 6999999752 233467789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 84 ~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 135 (337)
T 1o6l_A 84 MEYANGGELFFHLSR---------------ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135 (337)
T ss_dssp EECCTTCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EeCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHH
Confidence 999999999988842 246889999999999999999999998 9999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=184.33 Aligned_cols=128 Identities=32% Similarity=0.545 Sum_probs=110.9
Q ss_pred ccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|++.+.||+|+||.||+ .||||+++.. .......+.+|+.++++++|||||++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46899999999999999996 4899998653 455667899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++|+|.+++..... .......+++..++.++.||+.||.|||+++ |+||||||+|
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 211 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRP--------RPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARN 211 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSC--------CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEEEeCCCCCHHHHHHhhcc--------ccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhh
Confidence 999999999999999964211 0122346899999999999999999999998 9999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=183.18 Aligned_cols=122 Identities=27% Similarity=0.477 Sum_probs=109.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..++|.+.+.||+|+||.||+ .||+|++.. ......+.+.+|+.++++++|||||++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356899999999999999996 699999864 2445667899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 107 ~e~~~gg~L~~~l~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~N 158 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---------------AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPEN 158 (362)
T ss_dssp ECCCCSCBHHHHHT---------------TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGG
T ss_pred EecCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHH
Confidence 99999999998884 2346899999999999999999999998 9999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=177.37 Aligned_cols=121 Identities=27% Similarity=0.444 Sum_probs=108.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46799999999999999996 699998853 2445567899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 90 ~e~~~g~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~N 141 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---------------HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQN 141 (294)
T ss_dssp EECCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EeCCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 999999999999842 246899999999999999999999998 9999999998
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=192.29 Aligned_cols=126 Identities=28% Similarity=0.461 Sum_probs=111.3
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
+.....+|++.+.||+|+||.||+ .||||.++.. ....++|.+|+.+|++++|||||++++++...+..+|
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 344567899999999999999996 6999999753 2346789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. .....+++..++.|+.||+.||+|||+++ |+||||||+|
T Consensus 294 v~E~~~~g~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~N 348 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRE-------------CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARN 348 (495)
T ss_dssp EEECCTTCBHHHHHHH-------------SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEccCCCCHHHHHHh-------------cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhh
Confidence 9999999999999952 23346899999999999999999999998 9999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.5e-23 Score=176.55 Aligned_cols=136 Identities=40% Similarity=0.699 Sum_probs=117.7
Q ss_pred ccchhhhhhhhhccccccc------eeecccCccceeE------EEEEEEeccc----cHHhHHHHHHHHHHHhcCCCCc
Q 041718 145 LPLFELATIANATDNFSIN------NKLGEGGFGLVYK------EIAVKRLSKI----SEQGLKELKNEVILFSKLQHRN 208 (295)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vyk------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~h~n 208 (295)
.+.+.+.++..++++|... +.||+|+||.||+ .+|||.+... .....+.+.+|+.++++++|||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4567777778888887766 8999999999997 6999998642 2345678999999999999999
Q ss_pred ccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEe
Q 041718 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIH 288 (295)
Q Consensus 209 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiH 288 (295)
|+++++++.+.+..++||||+++++|.+++.. ......+++..+..++.|++.||.|||+++ |+|
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H 156 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC------------LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIH 156 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHT------------GGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHh------------ccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eec
Confidence 99999999999999999999999999999852 123356899999999999999999999998 999
Q ss_pred ccCCCCC
Q 041718 289 RDLKASN 295 (295)
Q Consensus 289 rDlkp~N 295 (295)
|||||+|
T Consensus 157 ~dlkp~N 163 (307)
T 2nru_A 157 RDIKSAN 163 (307)
T ss_dssp SCCCGGG
T ss_pred CCCCHHH
Confidence 9999987
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=179.80 Aligned_cols=122 Identities=27% Similarity=0.409 Sum_probs=108.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccH------HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
..+.|.+.+.||+|+||.||+ .+|+|.+..... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346799999999999999997 699999865321 146789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~N 144 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA---------------EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPEN 144 (326)
T ss_dssp EEEEEECCCSCBHHHHHT---------------TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEEEEcCCCCCHHHHHH---------------hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHH
Confidence 999999999999999984 2346899999999999999999999998 9999999998
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-23 Score=175.19 Aligned_cols=122 Identities=26% Similarity=0.512 Sum_probs=108.5
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.+.||+|+||.||+ .||+|++.... ...+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 346899999999999999996 69999987532 2346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 ~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~N 136 (269)
T 4hcu_A 87 MEHGCLSDYLRT--------------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARN 136 (269)
T ss_dssp CTTCBHHHHHHT--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred CCCCcHHHHHHh--------------cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchhe
Confidence 999999999842 2346899999999999999999999998 9999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=185.01 Aligned_cols=122 Identities=25% Similarity=0.386 Sum_probs=108.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.+|+.++|||||++++++.+.+..++
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 92 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 347899999999999999996 5999998652 22345788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 93 v~e~~~gg~L~~~l~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~N 145 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQ---------------QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDN 145 (384)
T ss_dssp EECCCTTEEHHHHHH---------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEecCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHH
Confidence 999999999999884 2346899999999999999999999998 9999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=175.46 Aligned_cols=123 Identities=23% Similarity=0.402 Sum_probs=110.7
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
...++|++.+.||+|+||.||+ .+|+|.+........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 3456899999999999999996 68999987655556788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 e~~~~~~L~~~~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 136 (277)
T 3f3z_A 86 ELCTGGELFERVVH---------------KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPEN 136 (277)
T ss_dssp ECCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eccCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHH
Confidence 99999999998842 245899999999999999999999998 9999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.5e-23 Score=186.93 Aligned_cols=123 Identities=24% Similarity=0.374 Sum_probs=108.1
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
...++|++.+.||+|+||.||+ .+|+|++... .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999996 6899998642 34456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 88 v~E~~~gg~L~~~i~---------------~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~N 140 (444)
T 3soa_A 88 IFDLVTGGELFEDIV---------------AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPEN 140 (444)
T ss_dssp EECCCBCCBHHHHHH---------------HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTT
T ss_pred EEEeCCCCCHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 999999999999884 2246899999999999999999999998 9999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=179.25 Aligned_cols=121 Identities=24% Similarity=0.369 Sum_probs=107.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .+|+|++++.. ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 46899999999999999996 69999987521 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 85 ~e~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 136 (318)
T 1fot_A 85 MDYIEGGELFSLLRK---------------SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPEN 136 (318)
T ss_dssp ECCCCSCBHHHHHHH---------------TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred EeCCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhe
Confidence 999999999999842 245889999999999999999999998 9999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.5e-23 Score=182.41 Aligned_cols=122 Identities=29% Similarity=0.394 Sum_probs=107.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 347899999999999999996 6999999752 234566788999999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 101 lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~N 154 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---------------SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDN 154 (353)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHH
Confidence 99999999999998842 246899999999999999999999998 9999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=178.65 Aligned_cols=122 Identities=31% Similarity=0.548 Sum_probs=108.7
Q ss_pred ccccccceeecccCccceeE------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 222 (295)
.++|++.+.||+|+||.||+ .||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46899999999999999985 589999987677777899999999999999999999999865 3568
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 89 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~N 144 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQK--------------HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRN 144 (295)
T ss_dssp EEEEECCTTCBHHHHHHH--------------CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEEEeCCCCCHHHHHHh--------------cccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhh
Confidence 999999999999999852 2235899999999999999999999998 9999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-23 Score=182.53 Aligned_cols=121 Identities=24% Similarity=0.350 Sum_probs=108.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..++|.+.+.||+|+||.||+ .||||++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 456899999999999999996 6999998753 2334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 97 ~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~N 146 (361)
T 3uc3_A 97 YASGGELYERICN---------------AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLEN 146 (361)
T ss_dssp CCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGG
T ss_pred eCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 9999999998842 245899999999999999999999998 9999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=185.97 Aligned_cols=125 Identities=24% Similarity=0.452 Sum_probs=110.3
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
....++|.+.+.||+|+||.||+ .||||.++.. .....+.+.+|+.+|++++|||||++++++...+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 34457899999999999999996 6999998753 34455678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 190 v~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~N 243 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRT--------------EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARN 243 (377)
T ss_dssp EEECCTTCBHHHHHHH--------------HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEcCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHH
Confidence 9999999999999852 2235889999999999999999999998 9999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=177.77 Aligned_cols=125 Identities=27% Similarity=0.403 Sum_probs=108.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC--eeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~l 224 (295)
..++|++.+.||+|+||.||+ .||||++.... ....+.+.+|+.++++++||||+++++++...+ ..+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 356899999999999999996 69999997532 344677889999999999999999999998765 7899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 v~e~~~~~~L~~~l~~------------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 142 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEE------------PSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGN 142 (319)
T ss_dssp EEECCTTCBHHHHHHS------------GGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEeCCCCCCHHHHHHH------------hccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHH
Confidence 9999999999999852 122334899999999999999999999998 9999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=174.35 Aligned_cols=126 Identities=29% Similarity=0.418 Sum_probs=110.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .||+|++... ......++.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 356899999999999999996 6999998752 334567888999999999 99999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.... .....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 89 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~N 145 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENY-----------RIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSN 145 (289)
T ss_dssp EEECCTTCBHHHHHHHHH-----------HHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEecCCCcHHHHHHhhc-----------ccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHH
Confidence 999999999999995321 12256899999999999999999999998 9999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=179.88 Aligned_cols=121 Identities=22% Similarity=0.326 Sum_probs=107.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~l 224 (295)
.++|++.+.||+|+||.||+ .+|+|++.+. .....+.+.+|+.++.++ +|||||++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46799999999999999996 6999999753 344567788999999987 89999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 88 v~e~~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 140 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR---------------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 140 (345)
T ss_dssp EECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHH
Confidence 9999999999998842 245899999999999999999999998 9999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6e-23 Score=186.73 Aligned_cols=124 Identities=25% Similarity=0.420 Sum_probs=108.7
Q ss_pred hhhccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-eeEEEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE-EKLLIY 226 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 226 (295)
....++|++.+.||+|+||.||+ .||||.++... ..+.|.+|+.+|++++|||||++++++.+.+ ..+|||
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567899999999999999996 69999997533 5578999999999999999999999987765 799999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.. .....+++..++.++.||+.||+|||+++ |+||||||+|
T Consensus 267 e~~~~g~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~N 319 (450)
T 1k9a_A 267 EYMAKGSLVDYLRS-------------RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 319 (450)
T ss_dssp ECCTTCBHHHHHHH-------------HCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred EecCCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhh
Confidence 99999999999953 22334789999999999999999999998 9999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=181.87 Aligned_cols=116 Identities=28% Similarity=0.407 Sum_probs=100.4
Q ss_pred ceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 163 NNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
.+.||+|+||.||+ .||+|+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 57899999999996 6999999876666778899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 174 ~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 217 (373)
T 2x4f_A 174 FDRIID--------------ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPEN 217 (373)
T ss_dssp HHHHHH--------------TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred HHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHH
Confidence 988842 2245889999999999999999999998 9999999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-23 Score=180.07 Aligned_cols=121 Identities=27% Similarity=0.384 Sum_probs=105.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46899999999999999996 6999998642 23345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 ~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~N 135 (323)
T 3tki_A 86 YCSGGELFDRIE---------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPEN 135 (323)
T ss_dssp CCTTEEGGGGSB---------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cCCCCcHHHHHh---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHH
Confidence 999999998873 2345899999999999999999999998 9999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=178.91 Aligned_cols=143 Identities=30% Similarity=0.495 Sum_probs=114.7
Q ss_pred hhhhhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeee
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 215 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 215 (295)
+..+....++|++.+.||+|+||.||+ .||||.++.. .....+.+.+|+.++++++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 444556678999999999999999995 4899998753 44556789999999999999999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHHhhhhhhhhh---------hhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCe
Q 041718 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLM---------RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRI 286 (295)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i 286 (295)
+.+.+..++||||+++++|.+++......... +..........+++..++.|+.||+.||.|||+++ |
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i 195 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 195 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 99999999999999999999999643111000 00000111257899999999999999999999998 9
Q ss_pred EeccCCCCC
Q 041718 287 IHRDLKASN 295 (295)
Q Consensus 287 iHrDlkp~N 295 (295)
+||||||+|
T Consensus 196 vH~Dlkp~N 204 (343)
T 1luf_A 196 VHRDLATRN 204 (343)
T ss_dssp CCSCCSGGG
T ss_pred ecCCCCcce
Confidence 999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-23 Score=180.48 Aligned_cols=121 Identities=24% Similarity=0.270 Sum_probs=108.2
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46899999999999999996 6999998652 223457789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 120 ~e~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 171 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR---------------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPEN 171 (350)
T ss_dssp EECCTTCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EcCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccce
Confidence 999999999999842 245889999999999999999999998 9999999998
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.5e-23 Score=173.53 Aligned_cols=122 Identities=28% Similarity=0.458 Sum_probs=108.7
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.+.||+|+||.||+ .||+|++... ....+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 457899999999999999996 6999998753 23456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N 134 (268)
T 3sxs_A 85 ISNGCLLNYLRS--------------HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARN 134 (268)
T ss_dssp CTTCBHHHHHHH--------------HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGG
T ss_pred cCCCcHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcce
Confidence 999999999852 2245899999999999999999999998 9999999988
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=174.47 Aligned_cols=126 Identities=25% Similarity=0.361 Sum_probs=109.7
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--CeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~~~lv 225 (295)
..++|++.+.||+|+||.||+ .+|||++... .....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 346899999999999999997 6899998752 455667899999999999999999999999877 788999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++. ......+++..+..++.|++.||.|||+++ ++|+||||||+|
T Consensus 88 ~e~~~~~~L~~~l~-------------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~N 143 (271)
T 3kmu_A 88 THWMPYGSLYNVLH-------------EGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRS 143 (271)
T ss_dssp EECCTTCBHHHHHH-------------SCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGG
T ss_pred ecccCCCcHHHHHh-------------hcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccce
Confidence 99999999999994 223346899999999999999999999874 459999999987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.89 E-value=6.9e-23 Score=175.16 Aligned_cols=126 Identities=25% Similarity=0.389 Sum_probs=110.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..++|.+.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 446899999999999999996 6899988653 2335678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++... ......+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 100 e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~N 154 (285)
T 3is5_A 100 ETCEGGELLERIVSA-----------QARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPEN 154 (285)
T ss_dssp CCCSCCBHHHHHHHH-----------HHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EeCCCCcHHHHHHhh-----------hhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHH
Confidence 999999999988532 123456899999999999999999999998 9999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.7e-23 Score=181.13 Aligned_cols=146 Identities=25% Similarity=0.382 Sum_probs=114.8
Q ss_pred chhhhhhhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccc
Q 041718 147 LFELATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVK 211 (295)
Q Consensus 147 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~ 211 (295)
.+....+....++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.++.++ +|||||+
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344556666788999999999999999996 4899999753 445567899999999999 7899999
Q ss_pred eeeeEEeCC-eeEEEEecCCCCCHHHHHhhhhhhhhh-----------------------h-------------------
Q 041718 212 LLGCCIQGE-EKLLIYEFMPNKSLNSFIFENFVLTLM-----------------------R------------------- 248 (295)
Q Consensus 212 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------------------~------------------- 248 (295)
+++++.+.+ ..++||||+++|+|.+++......... +
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988755 489999999999999999653210000 0
Q ss_pred ---------hcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 249 ---------SFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 249 ---------~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..........+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~N 223 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 223 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhh
Confidence 0000001223899999999999999999999998 9999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.8e-23 Score=180.44 Aligned_cols=123 Identities=25% Similarity=0.390 Sum_probs=107.4
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~ 222 (295)
...++|.+.+.||+|+||.||+ .||||++++.. ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4557899999999999999996 69999997531 23456788899999876 999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 94 ~lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 148 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS---------------CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDN 148 (345)
T ss_dssp EEEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEEEeCCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhh
Confidence 999999999999998842 245899999999999999999999998 9999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.3e-23 Score=178.11 Aligned_cols=120 Identities=30% Similarity=0.517 Sum_probs=104.1
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv 225 (295)
..++|++.+.||+|+||.||+ .||||++... ......+..|+.++++++|||||++++++.... ..++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 346899999999999999997 6999999753 334455667999999999999999999998744 47999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC----------CCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD----------SKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~----------~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+. + |+||||||+|
T Consensus 101 ~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~N 161 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKN 161 (322)
T ss_dssp EECCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGG
T ss_pred EecCCCCCHHHHHHh----------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHh
Confidence 999999999999842 3489999999999999999999998 6 9999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=7.8e-23 Score=176.85 Aligned_cols=139 Identities=31% Similarity=0.470 Sum_probs=111.7
Q ss_pred hhhccccccceeecccCccceeE-------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
....++|.+.+.||+|+||.||+ .||||++.. ......+.+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34567899999999999999996 489999875 3455668899999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhh---------hhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEecc
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTL---------MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRD 290 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrD 290 (295)
+..++||||+++++|.+++........ ............+++..+..++.|++.||.|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999964321100 000000012235889999999999999999999998 99999
Q ss_pred CCCCC
Q 041718 291 LKASN 295 (295)
Q Consensus 291 lkp~N 295 (295)
|||+|
T Consensus 176 ikp~N 180 (314)
T 2ivs_A 176 LAARN 180 (314)
T ss_dssp CSGGG
T ss_pred cchhe
Confidence 99998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=175.14 Aligned_cols=125 Identities=26% Similarity=0.436 Sum_probs=107.2
Q ss_pred hhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+....++|++.+.||+|+||.||+ .||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 344567899999999999999996 69999997532 2346789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 98 ~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N 150 (283)
T 3gen_A 98 TEYMANGCLLNYLRE--------------MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARN 150 (283)
T ss_dssp ECCCTTCBHHHHHHC--------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGG
T ss_pred EeccCCCcHHHHHHH--------------hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccce
Confidence 999999999999842 2345899999999999999999999998 9999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=188.57 Aligned_cols=127 Identities=30% Similarity=0.446 Sum_probs=110.3
Q ss_pred hhhhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 151 ATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 151 ~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
..+....++|++.+.||+|+||.||+ .||||.++... ...+.|.+|+.+|++++|||||++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34455678899999999999999996 69999997532 35678999999999999999999999986 67889
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.+++.. .....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 259 lv~e~~~~g~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~N 314 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKS-------------DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAAN 314 (454)
T ss_dssp EEECCCTTCBHHHHHHS-------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGG
T ss_pred EEEeecCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 99999999999999952 12235788999999999999999999998 9999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-23 Score=183.98 Aligned_cols=122 Identities=21% Similarity=0.324 Sum_probs=106.0
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .+|||++++. .....+.+..|..+|.++ +|||||++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 346899999999999999996 6999999753 223345688899999887 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 130 lV~E~~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~N 183 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR---------------QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDN 183 (396)
T ss_dssp EEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEEEcCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHH
Confidence 99999999999988842 246899999999999999999999998 9999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=5.1e-23 Score=175.90 Aligned_cols=127 Identities=28% Similarity=0.464 Sum_probs=112.3
Q ss_pred hhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
++....++|++.+.||+|+||.||+ .||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3445668899999999999999996 5999998753 345678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 ~v~e~~~~~~L~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~N 141 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRE-------------CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARN 141 (288)
T ss_dssp EEEECCTTEEHHHHHHH-------------CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGG
T ss_pred EEEEcCCCCcHHHHHHh-------------cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcce
Confidence 99999999999999842 23356899999999999999999999998 9999999998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=179.58 Aligned_cols=135 Identities=25% Similarity=0.288 Sum_probs=116.2
Q ss_pred CCccchhhhhhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-----CCcc
Q 041718 143 LELPLFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-----HRNL 209 (295)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----h~ni 209 (295)
.+...+.+.+.....++|.+.++||+|+||.||+ .||||++.. .....+.+..|+.++..++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3445556666667778999999999999999996 699999875 3455667888999999987 9999
Q ss_pred cceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEec
Q 041718 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHR 289 (295)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHr 289 (295)
|++++++...+..+|||||+ +++|.+++.. .....+++..+..++.||+.||.|||+++ |+||
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 161 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITR-------------NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHT 161 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeC
Confidence 99999999999999999999 9999999852 22345899999999999999999999998 9999
Q ss_pred cCCCCC
Q 041718 290 DLKASN 295 (295)
Q Consensus 290 Dlkp~N 295 (295)
||||+|
T Consensus 162 Dlkp~N 167 (360)
T 3llt_A 162 DLKPEN 167 (360)
T ss_dssp CCSGGG
T ss_pred CCCccc
Confidence 999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.7e-23 Score=181.52 Aligned_cols=139 Identities=29% Similarity=0.458 Sum_probs=113.2
Q ss_pred hhhccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCC 216 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~ 216 (295)
....++|.+.+.||+|+||.||+ .||||++... .....+.+.+|+.+++++ +|||||++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 34557899999999999999995 3899998753 455668899999999999 999999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+..++||||+++|+|.+++............. .......+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 99999999999999999999996432111000000 0112346999999999999999999999998 9999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=177.97 Aligned_cols=121 Identities=26% Similarity=0.369 Sum_probs=101.6
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc----cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
.++|++.+.||+|+||.||+ .+|+|++++. .......+.+|+.+|++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999995 5899998753 22345678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 96 ~~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~N 151 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER---------------EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPEN 151 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTT
T ss_pred EEEEEeCCCCCcHHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHH
Confidence 9999999999999998842 245888999999999999999999998 9999999998
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.7e-23 Score=175.54 Aligned_cols=120 Identities=27% Similarity=0.455 Sum_probs=101.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccH--------------------------HhHHHHHHHHHHHh
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE--------------------------QGLKELKNEVILFS 202 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 202 (295)
.++|++.+.||+|+||.||+ .||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999996 699999864221 12356899999999
Q ss_pred cCCCCcccceeeeEEe--CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc
Q 041718 203 KLQHRNLVKLLGCCIQ--GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280 (295)
Q Consensus 203 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~ 280 (295)
+++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.|++.||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----------------~~~~~~~~~~~~~~~qi~~~l~~lH~ 155 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----------------TLKPLSEDQARFYFQDLIKGIEYLHY 155 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----------------CSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----------------hcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999986 67899999999999997754 23468999999999999999999999
Q ss_pred CCCCCeEeccCCCCC
Q 041718 281 DSKLRIIHRDLKASN 295 (295)
Q Consensus 281 ~~~~~iiHrDlkp~N 295 (295)
++ |+||||||+|
T Consensus 156 ~~---ivH~Dlkp~N 167 (298)
T 2zv2_A 156 QK---IIHRDIKPSN 167 (298)
T ss_dssp TT---EECCCCCGGG
T ss_pred CC---eeccCCCHHH
Confidence 98 9999999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=175.49 Aligned_cols=121 Identities=27% Similarity=0.378 Sum_probs=107.4
Q ss_pred ccccccc-eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 041718 157 TDNFSIN-NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 157 ~~~~~~~-~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (295)
.+.|.+. +.||+|+||.||+ .||||++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567774 7899999999996 6999999765555677899999999885 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 91 e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~N 141 (316)
T 2ac3_A 91 EKMRGGSILSHIHK---------------RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPEN 141 (316)
T ss_dssp ECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EcCCCCcHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHH
Confidence 99999999999842 245889999999999999999999998 9999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=7.3e-23 Score=186.23 Aligned_cols=125 Identities=28% Similarity=0.458 Sum_probs=108.9
Q ss_pred hhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+....++|++.++||+|+||.||+ .||||.++... ...++|.+|+.+|++++||||+++++++.+ +..+||
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 344567899999999999999996 69999997532 345789999999999999999999999865 778999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. .....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 257 ~e~~~~gsL~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~N 310 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKG-------------ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 310 (452)
T ss_dssp ECCCTTCBHHHHHSH-------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ehhhcCCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhh
Confidence 999999999999942 22345899999999999999999999998 9999999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=188.48 Aligned_cols=125 Identities=26% Similarity=0.323 Sum_probs=109.5
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
...++|.+.+.||+|+||.||+ .||||++.+. .......+.+|+.+|+.++|||||++++++.+.+..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3457899999999999999996 6999998652 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.+++.. .....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 261 lVmEy~~gg~L~~~l~~-------------~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeN 316 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYH-------------MGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPEN 316 (576)
T ss_dssp EEECCCCSCBHHHHHHS-------------SSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEEcCCCCcHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchhe
Confidence 99999999999998842 22345899999999999999999999998 9999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=179.58 Aligned_cols=127 Identities=19% Similarity=0.214 Sum_probs=108.3
Q ss_pred hhhhccccccceeecccCccceeEE-------------EEEEEeccccHHhHHHHHHHHHHHhcCC---CCcccceeeeE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYKE-------------IAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCC 216 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk~-------------vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~ 216 (295)
+....++|.+.+.||+|+||.||+. ||||++.... ..++..|+.++..++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 3445678999999999999999973 7999987543 456777888887777 99999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+..+|||||+++|+|.+++.... ......+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~N 202 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYK----------NTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDN 202 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHH----------TSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhh----------cccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHH
Confidence 99999999999999999999995321 113456999999999999999999999998 9999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=172.76 Aligned_cols=123 Identities=24% Similarity=0.391 Sum_probs=107.2
Q ss_pred hhccccccceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
...++|++.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++++++||||+++++++ ..+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence 3457899999999999999996 389998865 3445567899999999999999999999997 45678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 146 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQV--------------RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARN 146 (281)
T ss_dssp EEEEECCTTEEHHHHHHH--------------TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEEecCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHH
Confidence 999999999999999842 2345899999999999999999999998 9999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.6e-22 Score=185.01 Aligned_cols=123 Identities=29% Similarity=0.423 Sum_probs=106.7
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccH-------------HhHHHHHHHHHHHhcCCCCccccee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE-------------QGLKELKNEVILFSKLQHRNLVKLL 213 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~h~niv~l~ 213 (295)
...++|.+.++||+|+||.||+ .+|+|++..... ...+.+.+|+.+|++++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3567899999999999999996 689999865221 3357889999999999999999999
Q ss_pred eeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
+++.+....+|||||+++|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp 174 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN---------------RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcH
Confidence 999999999999999999999998842 245899999999999999999999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 175 ~N 176 (504)
T 3q5i_A 175 EN 176 (504)
T ss_dssp GG
T ss_pred HH
Confidence 98
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=178.67 Aligned_cols=122 Identities=24% Similarity=0.293 Sum_probs=107.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (295)
..++|.+.+.||+|+||.||+ .||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 346899999999999999995 5999999753 223457788999999988 8999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 98 lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~N 151 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---------------VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDN 151 (353)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEEeCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHH
Confidence 99999999999998842 245899999999999999999999998 9999999998
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=178.74 Aligned_cols=121 Identities=28% Similarity=0.404 Sum_probs=101.8
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
...+.|.+.+.||+|+||.||+ .||||++... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 3457899999999999999996 5999998753 24567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 128 e~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 178 (349)
T 2w4o_A 128 ELVTGGELFDRIV---------------EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPEN 178 (349)
T ss_dssp CCCCSCBHHHHHT---------------TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EeCCCCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCccc
Confidence 9999999999884 2345899999999999999999999998 9999999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=172.04 Aligned_cols=123 Identities=34% Similarity=0.568 Sum_probs=104.6
Q ss_pred ccccccceeecccCccceeE------EEEEEEecccc----HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
.++|++.+.||+|+||.||+ .+|||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46889999999999999996 68999986422 234578999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++. ...+++..+..++.|++.||.|||+++..+|+||||||+|
T Consensus 86 e~~~~~~L~~~~~----------------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N 138 (271)
T 3dtc_A 86 EFARGGPLNRVLS----------------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138 (271)
T ss_dssp ECCTTEEHHHHHT----------------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred EcCCCCCHHHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence 9999999998873 2468999999999999999999999875569999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=174.73 Aligned_cols=126 Identities=27% Similarity=0.438 Sum_probs=108.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEE----eCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----QGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~----~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .||||++........+.+.+|+.++++++||||+++++++. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 457899999999999999996 69999987666677888999999999999999999999987 345789
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++... ......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 107 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~N 164 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERL-----------KDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTN 164 (317)
T ss_dssp EEEECCTTCBHHHHHHHH-----------HTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEEeCCCCcHHHHHHHH-----------HhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 999999999999998531 123456899999999999999999999998 9999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=172.43 Aligned_cols=120 Identities=27% Similarity=0.429 Sum_probs=104.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5789999999999999996 5999998642 33445788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~~~-~l~~~~~~--------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~N 131 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--------------CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQN 131 (292)
T ss_dssp CCSE-EHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred cCCC-CHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 9975 56555531 2356899999999999999999999998 9999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.7e-22 Score=175.65 Aligned_cols=132 Identities=27% Similarity=0.461 Sum_probs=104.7
Q ss_pred hhhhhccccccceeecccCccceeE-----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 218 (295)
++....++|++.+.||+|+||.||+ .||||.+... .....+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3344567899999999999999995 4899998653 34557889999999999999999999999988
Q ss_pred CCee------EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCC
Q 041718 219 GEEK------LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292 (295)
Q Consensus 219 ~~~~------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlk 292 (295)
.+.. ++||||+++++|.+++.... .......+++..+..|+.|++.||.|||+++ |+|||||
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dik 164 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASR---------IGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLA 164 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHH---------C---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhh---------ccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCC
Confidence 7665 99999999999999985321 1112236899999999999999999999998 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 165 p~N 167 (323)
T 3qup_A 165 ARN 167 (323)
T ss_dssp GGG
T ss_pred cce
Confidence 998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=173.67 Aligned_cols=138 Identities=28% Similarity=0.451 Sum_probs=114.4
Q ss_pred hhhhhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeee
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 215 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 215 (295)
..++....++|++.+.||+|+||.||+ .||+|.+... .......+.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 344456678999999999999999995 3899998653 34556779999999999999999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+.+..++||||+++++|.+++........ .......+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N 168 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMA-----NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARN 168 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHH-----HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGG
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhc-----cCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccce
Confidence 9999999999999999999999964321110 0111245789999999999999999999998 9999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-22 Score=184.16 Aligned_cols=122 Identities=24% Similarity=0.419 Sum_probs=108.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 346899999999999999996 69999996532 2345688999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 94 v~E~~~gg~L~~~l~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~N 146 (476)
T 2y94_A 94 VMEYVSGGELFDYIC---------------KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPEN 146 (476)
T ss_dssp EEECCSSEEHHHHTT---------------SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGG
T ss_pred EEeCCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHH
Confidence 999999999999884 2346899999999999999999999998 9999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-22 Score=170.18 Aligned_cols=122 Identities=27% Similarity=0.479 Sum_probs=109.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..++|++.+.||+|+||.||+ .||+|++.. ......+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999996 689999864 2445567889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~e~~~~~~l~~~~~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~N 135 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA---------------REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPEN 135 (284)
T ss_dssp ECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred EecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHH
Confidence 999999999888742 245899999999999999999999998 9999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.3e-22 Score=179.99 Aligned_cols=125 Identities=27% Similarity=0.403 Sum_probs=108.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC--eeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~~l 224 (295)
..++|.+.+.||+|+||.||+ .||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 356899999999999999996 69999997532 344677889999999999999999999998765 7899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 v~e~~~~g~L~~~l~~------------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 142 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEE------------PSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGN 142 (396)
T ss_dssp EECCCTTEEHHHHTTS------------GGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEecCCCCCHHHHHHh------------hhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHH
Confidence 9999999999999852 122334899999999999999999999998 9999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-22 Score=173.46 Aligned_cols=122 Identities=26% Similarity=0.427 Sum_probs=108.8
Q ss_pred ccccccceeecccCccceeE------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEE--eCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~ 222 (295)
.++|++.+.||+|+||.||+ .||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36889999999999999985 48999998766777788999999999999999999999887 45678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 102 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~N 157 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--------------HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARN 157 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--------------HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEeecCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhh
Confidence 999999999999999852 1235899999999999999999999998 9999999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=170.39 Aligned_cols=125 Identities=29% Similarity=0.526 Sum_probs=109.7
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
....++|++.+.||+|+||.||+ .||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 34557899999999999999996 69999986422 22357899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 142 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKN--------------RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSN 142 (278)
T ss_dssp EEEEECCTTEEHHHHHHT--------------CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGG
T ss_pred EEEEecCCCCcHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999999998842 2356899999999999999999999998 9999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=178.14 Aligned_cols=140 Identities=21% Similarity=0.281 Sum_probs=109.1
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEeccc-----cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-----SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
+....++|.+.+.||+|+||.||+ .+|+|++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345567899999999999999996 5899998642 334567899999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhh-----------------------hhc--ccccccCCCCHHHHHHHHHHHHHH
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLM-----------------------RSF--VDQERCKILDWSKRFHIICGTARG 274 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------------------~~~--~~~~~~~~l~~~~~~~i~~~i~~g 274 (295)
+..++||||+++|+|.+++......... ... ........+++..+..|+.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988421000000 000 000112234567788899999999
Q ss_pred HHhhhcCCCCCeEeccCCCCC
Q 041718 275 VMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 275 l~yLH~~~~~~iiHrDlkp~N 295 (295)
|.|||+++ |+||||||+|
T Consensus 181 l~~LH~~~---ivH~Dlkp~N 198 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPEN 198 (345)
T ss_dssp HHHHHHTT---EECCCCCGGG
T ss_pred HHHHHHCC---ccccCCChhh
Confidence 99999998 9999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.9e-23 Score=185.73 Aligned_cols=122 Identities=20% Similarity=0.248 Sum_probs=99.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .||||++... .......+.+|+.+++.++||||+++++++.+.+..+|
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 346899999999999999996 6999998752 33445678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|
T Consensus 226 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~N 279 (446)
T 4ejn_A 226 VMEYANGGELFFHLSR---------------ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLEN 279 (446)
T ss_dssp EECCCSSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGG
T ss_pred EEeeCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHH
Confidence 9999999999988842 2468999999999999999999998 77 9999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=173.74 Aligned_cols=124 Identities=32% Similarity=0.433 Sum_probs=106.0
Q ss_pred hhhccccccceeecccCccceeE-------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
....++|++.++||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34557899999999999999997 6999998642 22345778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||++ ++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 97 v~e~~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~N 149 (311)
T 3niz_A 97 VFEFME-KDLKKVLDE--------------NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQN 149 (311)
T ss_dssp EEECCS-EEHHHHHHT--------------CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEcCCC-CCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHh
Confidence 999997 578877742 2345899999999999999999999998 9999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-23 Score=176.70 Aligned_cols=122 Identities=21% Similarity=0.345 Sum_probs=106.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe---
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 221 (295)
..++|++.+.||+|+||.||+ .||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356899999999999999995 6999999753 34456789999999999999999999999876543
Q ss_pred -eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 -KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 146 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT---------------EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 146 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ccEEEEecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHH
Confidence 4999999999999999842 245899999999999999999999998 9999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=174.88 Aligned_cols=121 Identities=30% Similarity=0.514 Sum_probs=102.8
Q ss_pred ccccccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++|++.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 36799999999999999996 258888754 23456678999999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+||+++|+|.+++.. ....+++..++.|+.|++.||.|||+++ |+||||||+|
T Consensus 93 ~v~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~N 147 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARN 147 (327)
T ss_dssp EEEECCTTCBHHHHHHH--------------STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEEecCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChhe
Confidence 99999999999999852 2356899999999999999999999998 9999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=170.65 Aligned_cols=122 Identities=31% Similarity=0.464 Sum_probs=108.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .+|+|++... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 457899999999999999996 5999998642 22335678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 v~e~~~~~~l~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~N 139 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQK---------------LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPEN 139 (279)
T ss_dssp EECCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGG
T ss_pred EEecCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHh
Confidence 9999999999998842 245889999999999999999999988 9999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=172.57 Aligned_cols=124 Identities=30% Similarity=0.479 Sum_probs=108.1
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
...+.|++.+.||+|+||.||+ .+|+|.+........+.+.+|+.++++++||||+++++++...+..++||
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 3457899999999999999996 68999987655666788999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 96 e~~~~~~l~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~N 147 (302)
T 2j7t_A 96 EFCPGGAVDAIMLE--------------LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGN 147 (302)
T ss_dssp ECCTTEEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EeCCCCcHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHH
Confidence 99999999998842 2345899999999999999999999998 9999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=184.65 Aligned_cols=122 Identities=30% Similarity=0.398 Sum_probs=104.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..+.|++.+.||+|+||.||+ .+|+|++... .......+.+|+.+++.++|||||++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 446799999999999999996 6899998753 233467889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 115 ~e~~~~g~L~~~~~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~N 166 (494)
T 3lij_A 115 MECYKGGELFDEIIH---------------RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPEN 166 (494)
T ss_dssp EECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EecCCCCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhh
Confidence 999999999988842 245889999999999999999999998 9999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=174.51 Aligned_cols=122 Identities=30% Similarity=0.429 Sum_probs=108.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccH------HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE------QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
..+.|.+.+.||+|+||.||+ .+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 346799999999999999996 699999865221 136789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~N 145 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA---------------QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPEN 145 (321)
T ss_dssp EEEEECCCCSCBHHHHHH---------------TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEEcCCCCcHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHH
Confidence 999999999999999984 2245889999999999999999999998 9999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=176.93 Aligned_cols=121 Identities=25% Similarity=0.397 Sum_probs=106.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346899999999999999996 69999986421 2234578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+ +|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 v~E~~-~g~l~~~l~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~N 138 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVE---------------KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPEN 138 (336)
T ss_dssp EECCC-CEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTT
T ss_pred EEECC-CCcHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhh
Confidence 99999 7899888842 246899999999999999999999998 9999999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.3e-22 Score=188.39 Aligned_cols=126 Identities=28% Similarity=0.456 Sum_probs=109.2
Q ss_pred hhhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.+....++|++.++||+|+||.||+ .||||+++... ...++|.+|+.+|++++|+|||++++++.+ +..+|
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 3444567899999999999999996 69999997533 345789999999999999999999999865 77899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.++|.. .....+++..++.|+.||+.||+|||+++ |+||||||+|
T Consensus 339 v~e~~~~gsL~~~l~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~N 393 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKG-------------ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 393 (535)
T ss_dssp EECCCTTEEHHHHHSH-------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred eeehhcCCcHHHHHhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhh
Confidence 9999999999999942 22345899999999999999999999998 9999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=175.76 Aligned_cols=138 Identities=27% Similarity=0.455 Sum_probs=107.4
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 219 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 219 (295)
...++|.+.+.||+|+||.||+ .||||.+... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3557899999999999999996 4899998753 334557899999999999 899999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhh--------hhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTL--------MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl 291 (295)
+..++||||+++|+|.+++........ ............+++..++.++.|++.||.|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999964211000 000000111245899999999999999999999998 999999
Q ss_pred CCCC
Q 041718 292 KASN 295 (295)
Q Consensus 292 kp~N 295 (295)
||+|
T Consensus 199 kp~N 202 (344)
T 1rjb_A 199 AARN 202 (344)
T ss_dssp SGGG
T ss_pred Chhh
Confidence 9998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=179.26 Aligned_cols=122 Identities=23% Similarity=0.290 Sum_probs=98.0
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHH-HhcCCCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVIL-FSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~-l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .+|||++.+. .......+..|..+ ++.++|||||++++++.+.+..+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 457899999999999999996 6899999753 22344567777776 57789999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 116 lv~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~N 169 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQR---------------ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPEN 169 (373)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EEEeCCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHH
Confidence 99999999999998842 245888899999999999999999998 9999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=175.01 Aligned_cols=122 Identities=30% Similarity=0.444 Sum_probs=103.9
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
...++|++.+.||+|+||.||+ .||||++.... ....+.+.+|+.++++++||||+++++++.+.+..+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 4457899999999999999996 69999986432 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||++ ++|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 111 v~e~~~-~~L~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~N 162 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK---------------NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQN 162 (329)
T ss_dssp EEECCS-EEHHHHHHH---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEecCC-CCHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHH
Confidence 999997 599988842 245899999999999999999999998 9999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-22 Score=184.37 Aligned_cols=122 Identities=31% Similarity=0.447 Sum_probs=109.0
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..++|++.+.||+|+||.||+ .||||++... .......+.+|+.+|++++|||||++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999996 6999998642 233467899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 100 ~e~~~~~~L~~~~~~---------------~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~N 151 (486)
T 3mwu_A 100 GELYTGGELFDEIIK---------------RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPEN 151 (486)
T ss_dssp ECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEcCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHH
Confidence 999999999988842 246899999999999999999999998 9999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-22 Score=170.76 Aligned_cols=125 Identities=30% Similarity=0.459 Sum_probs=107.8
Q ss_pred hhhhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+....++|++.+.||+|+||.||+ .||+|.+... ....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 344567899999999999999996 6999998753 234578999999999999999999999876 5568999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 ~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~N 139 (279)
T 1qpc_A 86 TEYMENGSLVDFLKT-------------PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAAN 139 (279)
T ss_dssp EECCTTCBHHHHTTS-------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EecCCCCCHHHHHhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhh
Confidence 999999999999842 12236899999999999999999999998 9999999987
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.8e-22 Score=173.85 Aligned_cols=111 Identities=28% Similarity=0.355 Sum_probs=100.6
Q ss_pred eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
+.||+|+||.||+ .||||++.. .....+.+|+.++..+. ||||+++++++.+....+|||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 7899999999997 699999864 34467788999999997 99999999999999999999999999999
Q ss_pred HHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 235 NSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 235 ~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+++. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 94 ~~~l~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~N 136 (325)
T 3kn6_A 94 FERIK---------------KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPEN 136 (325)
T ss_dssp HHHHH---------------HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred HHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHH
Confidence 99984 2356899999999999999999999998 9999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.2e-22 Score=169.42 Aligned_cols=122 Identities=25% Similarity=0.369 Sum_probs=108.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 457899999999999999996 5899988642 34566789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 93 v~e~~~~~~L~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~N 145 (294)
T 2rku_A 93 VLELCRRRSLLELHK---------------RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGN 145 (294)
T ss_dssp EEECCTTCBHHHHHH---------------HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEecCCCCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHh
Confidence 999999999999874 2246899999999999999999999998 9999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-22 Score=173.22 Aligned_cols=122 Identities=24% Similarity=0.357 Sum_probs=109.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .+|+|++... .....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 457899999999999999996 5899998642 34566789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 119 v~e~~~~~~L~~~~~~---------------~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 171 (335)
T 2owb_A 119 VLELCRRRSLLELHKR---------------RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGN 171 (335)
T ss_dssp EECCCTTCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred EEecCCCCCHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchh
Confidence 9999999999998742 246899999999999999999999998 9999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=181.33 Aligned_cols=121 Identities=26% Similarity=0.389 Sum_probs=103.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc--------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
..++|.+.+.||+|+||.||+ .||||++.... ......+.+|+.+|++++|||||++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 457899999999999999996 69999986421 122335889999999999999999999975 5
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++||||+++|+|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~N 269 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---------------GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPEN 269 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred CceEEEEEcCCCCcHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHh
Confidence 66899999999999998873 2356899999999999999999999998 9999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.87 E-value=5e-22 Score=169.31 Aligned_cols=121 Identities=29% Similarity=0.446 Sum_probs=107.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|.+.+.||+|+||.||+ .+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 35799999999999999996 69999886421 12367899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~N 138 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---------------KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPEN 138 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEeecCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHH
Confidence 999999999999999842 246899999999999999999999998 9999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.9e-22 Score=170.44 Aligned_cols=122 Identities=30% Similarity=0.504 Sum_probs=104.6
Q ss_pred ccccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC--Ce
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG--EE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~--~~ 221 (295)
.+.|++.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++... +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35688999999999999985 5899998743 334567899999999999999999999999876 66
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 100 ~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~N 156 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK--------------NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARN 156 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH--------------HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEEEeCCCCcHHHHHHh--------------ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchhe
Confidence 8999999999999999842 2345899999999999999999999998 9999999998
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.87 E-value=4.7e-22 Score=173.82 Aligned_cols=138 Identities=28% Similarity=0.486 Sum_probs=110.8
Q ss_pred hhccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 217 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 217 (295)
...++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 3457899999999999999996 3899998753 445677899999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhc-ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSF-VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+..++||||+++++|.+++............ ........+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999643211000000 00011245899999999999999999999998 9999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.87 E-value=4.3e-22 Score=174.07 Aligned_cols=122 Identities=28% Similarity=0.461 Sum_probs=108.4
Q ss_pred ccccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
..+|++.+.||+|+||.||+ .||||.+... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 45788889999999999996 2899998753 4455678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 123 lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 177 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--------------KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARN 177 (333)
T ss_dssp EEEECCTTEEHHHHHHH--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEeCCCCCcHHHHHHh--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhe
Confidence 99999999999999842 2346899999999999999999999998 9999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=177.19 Aligned_cols=118 Identities=27% Similarity=0.463 Sum_probs=103.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..++|++.+.||+|+||.||+ .+|||+++.... ...+|+.++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 457899999999999999996 699999975322 245688888887 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 96 E~~~gg~L~~~i~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~N 146 (342)
T 2qr7_A 96 ELMKGGELLDKIL---------------RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSN 146 (342)
T ss_dssp CCCCSCBHHHHHH---------------TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred eCCCCCcHHHHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHH
Confidence 9999999999884 2346899999999999999999999998 9999999998
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=183.77 Aligned_cols=126 Identities=27% Similarity=0.346 Sum_probs=109.8
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .||+|++.+.. ....+.+.+|+.+|++++||||+++++++.+.+.++|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 347899999999999999996 69999996522 2345678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++... ......+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 263 VmE~~~gg~L~~~l~~~-----------~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~N 319 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNV-----------DEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPEN 319 (543)
T ss_dssp EECCCTTCBHHHHHHTS-----------STTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEeccCCCHHHHHHHh-----------hcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHH
Confidence 99999999999988521 112356899999999999999999999998 9999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-22 Score=172.74 Aligned_cols=126 Identities=27% Similarity=0.416 Sum_probs=93.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||+|.++... ....+.+.+|+.++++++||||+++++++.+++..+||||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46799999999999999996 69999986532 2344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.... .......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~~~-~~L~~~l~~~~---------~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~N 138 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRT---------VGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQN 138 (317)
T ss_dssp CCC-CBHHHHHHHHH---------SSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred ecC-CCHHHHHHhcc---------ccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHH
Confidence 998 69999885321 1112345899999999999999999999998 9999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=169.02 Aligned_cols=122 Identities=26% Similarity=0.493 Sum_probs=108.3
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.+.||+|+||.||+ .||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 346889999999999999996 69999997532 2346799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 ~~~~~L~~~~~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~N 134 (267)
T 3t9t_A 85 MEHGCLSDYLRT--------------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARN 134 (267)
T ss_dssp CTTCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGG
T ss_pred CCCCcHHHHHhh--------------CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchhe
Confidence 999999999842 2345889999999999999999999998 9999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=174.49 Aligned_cols=139 Identities=28% Similarity=0.405 Sum_probs=112.4
Q ss_pred hhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 217 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 217 (295)
+....++|.+.+.||+|+||.||+ .||+|.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567899999999999999996 4899998753 345567899999999999 8999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+..++||||+++|+|.+++............ .......+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 194 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA-FAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 194 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhccccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccce
Confidence 999999999999999999999643211100000 0011345899999999999999999999998 9999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=172.55 Aligned_cols=138 Identities=29% Similarity=0.412 Sum_probs=110.7
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQG 219 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~ 219 (295)
...++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999995 5899998753 334567899999999999 999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhh---hhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLM---RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~---~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++||||+++|+|.+++......... ...........+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 9999999999999999999643210000 00000112335899999999999999999999998 9999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-22 Score=171.10 Aligned_cols=120 Identities=26% Similarity=0.381 Sum_probs=106.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5799999999999999996 6999988542 33446778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 83 ~~~~~~l~~~~~---------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~N 132 (311)
T 4agu_A 83 YCDHTVLHELDR---------------YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPEN 132 (311)
T ss_dssp CCSEEHHHHHHH---------------TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eCCCchHHHHHh---------------hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhh
Confidence 999999988773 2345899999999999999999999998 9999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9e-22 Score=170.87 Aligned_cols=119 Identities=30% Similarity=0.497 Sum_probs=105.0
Q ss_pred ccc-ccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCe
Q 041718 158 DNF-SINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEE 221 (295)
Q Consensus 158 ~~~-~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~ 221 (295)
++| ++.+.||+|+||.||+ .||||++... .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 444 8899999999999963 5999999753 34567789999999999999999999999987 467
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 110 ~~lv~e~~~~~~L~~~l~~----------------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~N 164 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR----------------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARN 164 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEEecccCCcHHHHHhh----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchhe
Confidence 8999999999999998831 24899999999999999999999998 9999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=171.83 Aligned_cols=122 Identities=27% Similarity=0.388 Sum_probs=106.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..++|.+.+.||+|+||.||+ .||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 346899999999999999996 699999976544455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ...+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 87 ~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~N 136 (304)
T 2jam_A 87 LVSGGELFDRILE---------------RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPEN 136 (304)
T ss_dssp CCCSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGG
T ss_pred cCCCccHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHH
Confidence 9999999998842 245889999999999999999999998 9999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=171.45 Aligned_cols=120 Identities=26% Similarity=0.426 Sum_probs=104.9
Q ss_pred cccccceeecccCccceeE-------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.+.||+|+||.||+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999996 68999986432 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~~-~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 130 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--------------CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQN 130 (288)
T ss_dssp CSE-EHHHHHHT--------------STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cCC-CHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 975 89888741 2346889999999999999999999998 9999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=174.78 Aligned_cols=122 Identities=30% Similarity=0.505 Sum_probs=106.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..+.|++.+.||+|+||.||+ .||||++... .....+.+.+|+.++++++|||||++++++...+..+|
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 345689999999999999996 6999998642 33455789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||++ |+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 132 v~e~~~-g~l~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 184 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEV--------------HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGN 184 (348)
T ss_dssp EEECCS-EEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGG
T ss_pred EEecCC-CCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 999997 688877732 2356899999999999999999999998 9999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-22 Score=174.97 Aligned_cols=119 Identities=21% Similarity=0.292 Sum_probs=105.0
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||||.+.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999996 69999986432 234688999999999 99999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+ +++|.+++.. ....+++..+..|+.|++.||+|||+++ |+||||||+|
T Consensus 86 ~~-~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~N 135 (330)
T 2izr_A 86 LL-GPSLEDLFDL--------------CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPEN 135 (330)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred eC-CCCHHHHHHH--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHH
Confidence 99 9999999842 1356999999999999999999999998 9999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=8.4e-22 Score=171.65 Aligned_cols=135 Identities=31% Similarity=0.547 Sum_probs=107.4
Q ss_pred cccccceeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (295)
++|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 6789999999999999996 3589988652 344567799999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhh-cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRS-FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++........... .........+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 172 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 172 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence 999999999999964321110000 000122356899999999999999999999998 9999999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=182.84 Aligned_cols=122 Identities=32% Similarity=0.406 Sum_probs=109.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 446899999999999999996 6999998642 23456789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 104 v~e~~~~~~L~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~N 156 (484)
T 3nyv_A 104 VGEVYTGGELFDEII---------------SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPEN 156 (484)
T ss_dssp EECCCCSCBHHHHHH---------------TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEecCCCCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHH
Confidence 999999999999884 2346899999999999999999999998 9999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.3e-22 Score=172.45 Aligned_cols=129 Identities=32% Similarity=0.541 Sum_probs=109.0
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
..++|++.+.||+|+||.||+ .||||.+... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 347899999999999999996 3899998643 45567789999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++..... .......+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~N 170 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRP--------RPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARN 170 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSC--------CSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred cEEEEecCCCCcHHHHHHhhcc--------cccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhH
Confidence 9999999999999999964211 0112245899999999999999999999998 9999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-22 Score=170.73 Aligned_cols=125 Identities=27% Similarity=0.461 Sum_probs=107.7
Q ss_pred hhhccccccceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEE-eCC
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCI-QGE 220 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~-~~~ 220 (295)
......|++.+.||+|+||.||+ .+|+|.+.. ......+.+.+|+.++++++||||+++++++. ..+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 34456788999999999999996 379998875 34456678999999999999999999999864 456
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~N 158 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRN--------------ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARN 158 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHC--------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ceEEEEeCCCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchhe
Confidence 78999999999999999842 2356889999999999999999999998 9999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.87 E-value=4.8e-22 Score=170.21 Aligned_cols=123 Identities=33% Similarity=0.541 Sum_probs=106.1
Q ss_pred hhccccccceeecccCccceeE-----EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-----EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-----~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
...++|++.++||+|+||.||+ .+|+|+++. ......+.+.+|+.++++++||||++++++. ..+..++|||
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3457899999999999999997 689999864 3455678899999999999999999999964 5667899999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 100 ~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~N 150 (289)
T 3og7_A 100 WCEGSSLYHHLHA--------------SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNN 150 (289)
T ss_dssp CCCEEEHHHHHTT--------------C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ecCCCcHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccce
Confidence 9999999998842 2356899999999999999999999998 9999999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-23 Score=182.98 Aligned_cols=120 Identities=20% Similarity=0.280 Sum_probs=98.5
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccc--------cHHhHHHHHHHHHHHhcCC---------CCccccee
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKI--------SEQGLKELKNEVILFSKLQ---------HRNLVKLL 213 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~--------~~~~~~~~~~Ei~~l~~l~---------h~niv~l~ 213 (295)
.++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+++.++ |||||++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 46899999999999999996 6999999753 2233478889999988886 66666666
Q ss_pred eeE-----------------Ee-------------CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHH
Q 041718 214 GCC-----------------IQ-------------GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263 (295)
Q Consensus 214 ~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~ 263 (295)
+.+ .+ .+..+|||||+++|++.+.+. ...+++..
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----------------~~~~~~~~ 162 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----------------TKLSSLAT 162 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----------------TTCCCHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----------------hcCCCHHH
Confidence 653 32 788999999999997766552 14578999
Q ss_pred HHHHHHHHHHHHHhhh-cCCCCCeEeccCCCCC
Q 041718 264 RFHIICGTARGVMYLH-QDSKLRIIHRDLKASN 295 (295)
Q Consensus 264 ~~~i~~~i~~gl~yLH-~~~~~~iiHrDlkp~N 295 (295)
+..|+.||+.||.||| +++ |+||||||+|
T Consensus 163 ~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~N 192 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEASLR---FEHRDLHWGN 192 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHC---CBCSCCCGGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---EeECCCCHHH
Confidence 9999999999999999 888 9999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.7e-22 Score=171.18 Aligned_cols=121 Identities=26% Similarity=0.272 Sum_probs=102.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.++||+|+||.||+ .||||++.. ........+..|+..+.++ +|+||+++++++.+++..+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36899999999999999997 699998864 2334445566666666555 899999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+ +++|.+++.. ....++|..+..|+.|++.||+|||+++ |+||||||+|
T Consensus 136 ~e~~-~~~L~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 187 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--------------WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPAN 187 (311)
T ss_dssp EECC-CCBHHHHHHH--------------HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred Eecc-CCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHH
Confidence 9999 6799888742 2346999999999999999999999998 9999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=172.24 Aligned_cols=123 Identities=29% Similarity=0.504 Sum_probs=104.0
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.++|++.+.||+|+||.||+ .||||.+.. ....+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 36788999999999999996 699999864 345678999999999999999999999876 45899999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|.+++.. ......+++..++.++.|+++||+|||+.+..+|+||||||+|
T Consensus 83 ~~~L~~~l~~------------~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 83 GGSLYNVLHG------------AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp TCBHHHHHHC------------SSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred CCCHHHHHhc------------cCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 9999999852 1223457889999999999999999999322239999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=169.78 Aligned_cols=134 Identities=27% Similarity=0.480 Sum_probs=108.4
Q ss_pred hhhhhhhccccccceeecccCccceeE-----------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeE
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCC 216 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~ 216 (295)
+.++....++|.+.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 344455667899999999999999995 489999864 2455667899999999999999999999999
Q ss_pred EeCCe-----eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC
Q 041718 217 IQGEE-----KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291 (295)
Q Consensus 217 ~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl 291 (295)
.+.+. .++||||+++++|.+++.... .......+++..++.++.|++.||.|||+++ |+||||
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~di 173 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSR---------LETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDL 173 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTT---------BTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhh---------hhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 87653 499999999999999985321 1123456999999999999999999999998 999999
Q ss_pred CCCC
Q 041718 292 KASN 295 (295)
Q Consensus 292 kp~N 295 (295)
||+|
T Consensus 174 kp~N 177 (313)
T 3brb_A 174 AARN 177 (313)
T ss_dssp SGGG
T ss_pred Ccce
Confidence 9997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-21 Score=168.52 Aligned_cols=126 Identities=22% Similarity=0.429 Sum_probs=108.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .||+|++.. ......+.+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 446899999999999999996 699999864 245567789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++... ......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 110 v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~N 166 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHF-----------KKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPAN 166 (310)
T ss_dssp EEECCCSCBHHHHHHHH-----------HHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EEecCCCCCHHHHHHHh-----------cccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHH
Confidence 99999999999998531 123456899999999999999999999998 9999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-21 Score=167.89 Aligned_cols=123 Identities=27% Similarity=0.400 Sum_probs=105.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
++|.....||+|+||.||+ .||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455557999999999996 69999997655566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++++|.+++.. ......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 102 ~~~~L~~~l~~------------~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 152 (295)
T 2clq_A 102 PGGSLSALLRS------------KWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDN 152 (295)
T ss_dssp SEEEHHHHHHH------------TTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCHHHHHHh------------hccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhh
Confidence 99999999852 112335678889999999999999999998 9999999987
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.3e-22 Score=171.33 Aligned_cols=122 Identities=31% Similarity=0.549 Sum_probs=107.3
Q ss_pred ccccccceeecccCccceeE------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC--ee
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE--EK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~--~~ 222 (295)
.++|++.+.||+|+||.||+ .||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46789999999999999985 58999998766667788999999999999999999999987644 78
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|
T Consensus 120 ~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~N 175 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--------------HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRN 175 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--------------STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred EEEEECCCCCCHHHHHHh--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcce
Confidence 999999999999999852 2245899999999999999999999998 9999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=7.5e-22 Score=174.20 Aligned_cols=121 Identities=23% Similarity=0.327 Sum_probs=108.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46899999999999999997 6899998753 45566789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|
T Consensus 112 ~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~N 162 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---------------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSN 162 (360)
T ss_dssp CCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGG
T ss_pred CCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHH
Confidence 9999999999842 24588999999999999999999985 7 9999999988
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=9.9e-22 Score=166.79 Aligned_cols=121 Identities=27% Similarity=0.384 Sum_probs=108.0
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 46899999999999999996 6999998642 33456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 ~~~~~~L~~~l~---------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~N 135 (276)
T 2yex_A 86 YCSGGELFDRIE---------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPEN 135 (276)
T ss_dssp CCTTEEGGGGSB---------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ecCCCcHHHHHh---------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHH
Confidence 999999998873 2345899999999999999999999998 9999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=6.4e-22 Score=173.64 Aligned_cols=122 Identities=28% Similarity=0.389 Sum_probs=107.8
Q ss_pred hhccccccceeecccCccceeE-------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCC--CcccceeeeEEeCCeeE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------EIAVKRLSK--ISEQGLKELKNEVILFSKLQH--RNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~~~~~~~~~~ 223 (295)
...+.|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|.+++| +||+++++++.+.+..+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 3457899999999999999997 599999864 345566889999999999987 99999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||| +.+++|.+++. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 86 lv~e-~~~~~L~~~l~---------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~N 138 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLK---------------KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 138 (343)
T ss_dssp EEEC-CCSEEHHHHHH---------------HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EEEe-CCCCCHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcce
Confidence 9999 45889999984 2346889999999999999999999998 9999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=181.34 Aligned_cols=120 Identities=25% Similarity=0.454 Sum_probs=97.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----Ce
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 221 (295)
.++|.+.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999996 699999865 3445667899999999999999999999998543 57
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+ +++|.+++. ....+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~---------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~N 186 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---------------TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPAN 186 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EEEEEecc-ccchhhhcc---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhh
Confidence 89999998 578988874 2346899999999999999999999998 9999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=169.30 Aligned_cols=122 Identities=18% Similarity=0.233 Sum_probs=108.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 457899999999999999996 6999998753 23445789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 112 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 164 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR---------------QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPEN 164 (309)
T ss_dssp EEECCCCEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEecCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHH
Confidence 9999999999999842 245899999999999999999999998 9999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-22 Score=173.23 Aligned_cols=134 Identities=28% Similarity=0.453 Sum_probs=112.3
Q ss_pred ccchhhhhhhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeee
Q 041718 145 LPLFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGC 215 (295)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~ 215 (295)
++.+++.++....++|++.+.||+|+||.||+ .||||++... ....+.+.+|+.++.++ +||||++++++
T Consensus 11 ~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 89 (326)
T 2x7f_A 11 LDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89 (326)
T ss_dssp -----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred chhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence 34456666777888999999999999999996 6999998643 23456789999999999 79999999999
Q ss_pred EEe------CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEec
Q 041718 216 CIQ------GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHR 289 (295)
Q Consensus 216 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHr 289 (295)
+.. .+..++||||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 153 (326)
T 2x7f_A 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-------------TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHR 153 (326)
T ss_dssp EEECC--CCCCEEEEEEECCTTEEHHHHHHH-------------SGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred EeeccCccccceEEEEEEcCCCCcHHHHHHh-------------cccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 987 5688999999999999999852 22356889999999999999999999998 9999
Q ss_pred cCCCCC
Q 041718 290 DLKASN 295 (295)
Q Consensus 290 Dlkp~N 295 (295)
||||+|
T Consensus 154 dlkp~N 159 (326)
T 2x7f_A 154 DIKGQN 159 (326)
T ss_dssp CCSGGG
T ss_pred CCcHHH
Confidence 999987
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=4.4e-22 Score=176.72 Aligned_cols=121 Identities=28% Similarity=0.479 Sum_probs=104.9
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~l 224 (295)
..|.+.+.||+|+||.||+ .+|||.++.. .....+++.+|+.++++++||||+++++++.. .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4577789999999999995 3799988653 34567889999999999999999999998754 567899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 169 v~e~~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 222 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--------------ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARN 222 (373)
T ss_dssp EEECCTTCBHHHHHHC--------------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEECCCCCCHHHHHhh--------------cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchhe
Confidence 9999999999999842 2345789999999999999999999998 9999999998
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=166.87 Aligned_cols=121 Identities=29% Similarity=0.531 Sum_probs=105.6
Q ss_pred ccccccce-eecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINN-KLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~-~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.++|.+.+ .||+|+||.||+ .||||+++.. .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 999999999996 4899999763 445678899999999999999999999998 5667999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 140 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG--------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARN 140 (287)
T ss_dssp EEECCTTEEHHHHHTT--------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEeCCCCCHHHHHHh--------------CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchhe
Confidence 9999999999998841 2346899999999999999999999998 9999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=167.72 Aligned_cols=118 Identities=27% Similarity=0.443 Sum_probs=99.4
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhc--CCCCcccceeeeEEe----CCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQ----GEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~----~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .||||++... ....+..|.+++.. ++||||+++++++.. ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 457899999999999999997 6999998653 33455566666655 899999999998654 35689
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhh--------cCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLH--------QDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--------~~~~~~iiHrDlkp~N 295 (295)
+||||+++|+|.+++. ...+++..+..++.|++.||.||| +++ |+||||||+|
T Consensus 83 lv~e~~~~g~L~~~l~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 143 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----------------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKN 143 (301)
T ss_dssp EEECCCTTCBHHHHHT----------------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGG
T ss_pred EehhhccCCCHHHHHh----------------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHh
Confidence 9999999999999983 235899999999999999999999 776 9999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=167.90 Aligned_cols=121 Identities=26% Similarity=0.474 Sum_probs=104.5
Q ss_pred hccccccce-eecccCccceeE----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 156 ATDNFSINN-KLGEGGFGLVYK----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 156 ~~~~~~~~~-~lg~G~~g~Vyk----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
..++|.+.+ .||+|+||.||+ .||||++... .....+++.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 446788877 999999999996 4899998753 233467899999999999999999999998 66788
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 93 ~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~N 147 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---------------NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARN 147 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---------------CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEEeCCCCCHHHHHHh---------------CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcce
Confidence 999999999999999842 245889999999999999999999998 9999999997
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=9.5e-22 Score=167.83 Aligned_cols=121 Identities=30% Similarity=0.458 Sum_probs=107.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|.+.+.||+|+||.||+ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 46899999999999999996 58999986421 22356789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 93 ~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 144 (284)
T 2vgo_A 93 LEFAPRGELYKELQK---------------HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPEN 144 (284)
T ss_dssp ECCCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGG
T ss_pred EEeCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHH
Confidence 999999999998842 235889999999999999999999998 9999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.6e-22 Score=174.75 Aligned_cols=123 Identities=30% Similarity=0.410 Sum_probs=107.2
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecccc--------HHhHHHHHHHHHHHhcCCCCcccceeeeEEe
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 218 (295)
...++|++.+.||+|+||.||+ .||||++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3457899999999999999996 59999986521 1234467889999999999999999999999
Q ss_pred CCeeEEEEecCCCC-CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNK-SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+..++||||+.+| +|.+++. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 160 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFID---------------RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDEN 160 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHH---------------TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCEEEEEEEeCCCCccHHHHHH---------------hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHH
Confidence 99999999999777 9998884 2346899999999999999999999998 9999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=169.32 Aligned_cols=119 Identities=26% Similarity=0.417 Sum_probs=100.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEE-----------
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCI----------- 217 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~----------- 217 (295)
.++|.+.+.||+|+||.||+ .||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 46899999999999999996 69999987766777888999999999999999999999873
Q ss_pred ---eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCC
Q 041718 218 ---QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294 (295)
Q Consensus 218 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~ 294 (295)
+....++||||++ |+|.+++. ...+++..+..++.|++.||+|||+++ |+||||||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 149 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----------------QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 149 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGG
T ss_pred cccccCceeEEeeccC-CCHHHHhh----------------cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHH
Confidence 4478899999997 69998873 245889999999999999999999998 999999999
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 150 N 150 (320)
T 2i6l_A 150 N 150 (320)
T ss_dssp G
T ss_pred H
Confidence 8
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=168.72 Aligned_cols=122 Identities=26% Similarity=0.458 Sum_probs=106.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe---------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------- 218 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 218 (295)
..++|++.+.||+|+||.||+ .||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 346899999999999999996 689999865 34556789999999999999999999998865
Q ss_pred ----CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCC
Q 041718 219 ----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294 (295)
Q Consensus 219 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~ 294 (295)
.+..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~ 145 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--------------ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPM 145 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--------------SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--------------cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHH
Confidence 4568999999999999999852 2235678889999999999999999998 999999998
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 146 N 146 (303)
T 1zy4_A 146 N 146 (303)
T ss_dssp G
T ss_pred h
Confidence 7
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1e-21 Score=167.36 Aligned_cols=123 Identities=27% Similarity=0.422 Sum_probs=107.3
Q ss_pred hhccccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
...++|.+.+.||+|+||.||+ .||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 3457899999999999999996 3899998753 44567889999999999999999999999764 567
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 88 ~~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~N 143 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLER--------------NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRN 143 (281)
T ss_dssp EEEEECCTTCBHHHHHHH--------------HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EEEEecCCCCCHHHHHHh--------------ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccce
Confidence 899999999999999842 2345889999999999999999999998 9999999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-21 Score=166.96 Aligned_cols=123 Identities=24% Similarity=0.323 Sum_probs=107.9
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecccc---------HHhHHHHHHHHHHHhcCC-CCcccceeeeE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCC 216 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~ 216 (295)
...++|.+.+.||+|+||.||+ .||||++.... ....+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 4457899999999999999996 69999986421 233567889999999996 99999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 154 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE---------------KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPEN 154 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcce
Confidence 999999999999999999999842 246899999999999999999999998 9999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=167.12 Aligned_cols=120 Identities=31% Similarity=0.485 Sum_probs=104.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe---------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--------- 218 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--------- 218 (295)
...+|++.+.||+|+||.||+ .||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 346899999999999999996 69999987533 356789999999999999999998864
Q ss_pred -------CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC
Q 041718 219 -------GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291 (295)
Q Consensus 219 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl 291 (295)
....++||||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 148 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEK-------------RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDL 148 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHH-------------GGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 4558999999999999999852 23356899999999999999999999998 999999
Q ss_pred CCCC
Q 041718 292 KASN 295 (295)
Q Consensus 292 kp~N 295 (295)
||+|
T Consensus 149 kp~N 152 (284)
T 2a19_B 149 KPSN 152 (284)
T ss_dssp SGGG
T ss_pred CHHH
Confidence 9997
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=184.17 Aligned_cols=120 Identities=28% Similarity=0.515 Sum_probs=103.5
Q ss_pred cccccce-eecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINN-KLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~-~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+++.+.+ .||+|+||.||+ .||||+++.. .....+++.+|+.+|++++|||||++++++.. +..+||
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 799999999996 4899999753 33467889999999999999999999999876 669999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 414 ~E~~~~g~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~N 466 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARN 466 (613)
T ss_dssp EECCTTCBHHHHHTT--------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEeCCCCcHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHH
Confidence 999999999999842 2356899999999999999999999998 9999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=168.22 Aligned_cols=120 Identities=29% Similarity=0.443 Sum_probs=105.0
Q ss_pred ccccceeecccCccceeE-----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee-EEE
Q 041718 159 NFSINNKLGEGGFGLVYK-----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLI 225 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~-~lv 225 (295)
.|.+.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 456679999999999996 4899998753 445678899999999999999999999999876665 999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 102 ~e~~~~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~N 154 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--------------PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARN 154 (298)
T ss_dssp ECCCTTCBHHHHHHC--------------TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EecccCCCHHHHHhc--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcce
Confidence 999999999999842 2356889999999999999999999998 9999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.4e-21 Score=166.83 Aligned_cols=120 Identities=27% Similarity=0.463 Sum_probs=107.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.+.|.+.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45688999999999999997 6999998643 23456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 101 ~~~~~~L~~~~~----------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 149 (303)
T 3a7i_A 101 YLGGGSALDLLE----------------PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAAN 149 (303)
T ss_dssp CCTTEEHHHHHT----------------TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eCCCCcHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhe
Confidence 999999999883 245899999999999999999999998 9999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.6e-22 Score=169.65 Aligned_cols=132 Identities=25% Similarity=0.420 Sum_probs=97.7
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
....++|.+.+.||+|+||.||+ .||||++... .....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 34457899999999999999996 6999988643 23446778899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++...... .......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 91 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~N 151 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAK-------GEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGN 151 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHT-------TTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGG
T ss_pred EehhccCCchHHHHHHHhhc-------cccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhh
Confidence 99999999999998532110 0112356899999999999999999999998 9999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=177.15 Aligned_cols=121 Identities=25% Similarity=0.464 Sum_probs=106.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----C
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----E 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~ 220 (295)
..++|.+.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|++++|+||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 346899999999999999996 599999975 3445667899999999999999999999998766 5
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+|||||++ ++|.+++. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 104 ~~~lv~e~~~-~~L~~~~~---------------~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~N 159 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK---------------TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPAN 159 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH---------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred eEEEEEecCC-cCHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHH
Confidence 7899999996 69998884 2346899999999999999999999998 9999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=170.41 Aligned_cols=121 Identities=26% Similarity=0.376 Sum_probs=102.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc--------HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--------EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
..++|.+.+.||+|+||.||+ .||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 346899999999999999996 69999986421 12234688999999999999999999998765
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+ .++||||+++++|.+++. ....+++.....++.|++.||.|||+++ |+||||||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~N 144 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---------------GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPEN 144 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---------------TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred c-eEEEEecCCCCcHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 5 899999999999999883 2346899999999999999999999998 9999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=166.59 Aligned_cols=122 Identities=30% Similarity=0.607 Sum_probs=103.5
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccH----H---hHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE----Q---GLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~----~---~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
.++|++.+.||+|+||.||+ .||+|++..... . ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 46899999999999999996 699999854221 1 1268899999999999999999999986554
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ .+|+||||||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~N 154 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--------------KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPN 154 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--------------TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGG
T ss_pred -eEEEEecCCCCHHHHHhc--------------ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcce
Confidence 699999999999988842 3356899999999999999999999875 349999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=169.56 Aligned_cols=121 Identities=28% Similarity=0.478 Sum_probs=107.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
.++|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 46899999999999999996 699998854 23445667889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++++|..++. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 104 e~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~N 154 (331)
T 4aaa_A 104 EFVDHTILDDLEL---------------FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPEN 154 (331)
T ss_dssp ECCSEEHHHHHHH---------------STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ecCCcchHHHHHh---------------hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChhe
Confidence 9999998888763 2345899999999999999999999998 9999999988
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=166.01 Aligned_cols=122 Identities=22% Similarity=0.381 Sum_probs=108.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
..++|.+.+.||+|+||.||+ .||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 346899999999999999996 69999986422 2345688999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 89 v~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~N 141 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK---------------HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPEN 141 (276)
T ss_dssp EEECCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGG
T ss_pred EEeccCCCcHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhh
Confidence 9999999999999842 235889999999999999999999998 9999999987
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=165.14 Aligned_cols=129 Identities=23% Similarity=0.372 Sum_probs=107.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .+|+|.+.. ......+.+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 346899999999999999996 589999864 244567789999999999999999999998754 57899
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--CCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS--KLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++... ......+++..++.++.|++.||.|||+++ ..+|+||||||+|
T Consensus 84 lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~N 146 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKG-----------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 146 (279)
T ss_dssp EEEECCTTEEHHHHHHHH-----------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGG
T ss_pred EEEeCCCCCCHHHHHHhh-----------cccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhh
Confidence 999999999999998532 112345899999999999999999999875 2349999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.86 E-value=9.9e-22 Score=170.04 Aligned_cols=144 Identities=24% Similarity=0.365 Sum_probs=111.8
Q ss_pred hhhhhhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCccccee
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLL 213 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~ 213 (295)
...++....++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678999999999999999996 4899998753 344567899999999999 799999999
Q ss_pred eeEEeCC-eeEEEEecCCCCCHHHHHhhhhhhhhhhh-cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC
Q 041718 214 GCCIQGE-EKLLIYEFMPNKSLNSFIFENFVLTLMRS-FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291 (295)
Q Consensus 214 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl 291 (295)
+++...+ ..++||||+++++|.+++........... .........+++..+..++.|++.||.|||+++ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987754 58999999999999999964211000000 000001233789999999999999999999998 999999
Q ss_pred CCCC
Q 041718 292 KASN 295 (295)
Q Consensus 292 kp~N 295 (295)
||+|
T Consensus 175 kp~N 178 (316)
T 2xir_A 175 AARN 178 (316)
T ss_dssp SGGG
T ss_pred ccce
Confidence 9998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.3e-22 Score=173.43 Aligned_cols=120 Identities=26% Similarity=0.459 Sum_probs=102.8
Q ss_pred cccccceeecccCccceeE------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
++|++.+.||+|+||.||+ .||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5788999999999999997 2788887542 2233456788999999999999999999886 567899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 92 v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~N 145 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--------------HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARN 145 (325)
T ss_dssp EEECCTTCBSHHHHHS--------------SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTT
T ss_pred EEEeCCCCCHHHHHHH--------------ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchhe
Confidence 9999999999998842 2346889999999999999999999998 9999999998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-21 Score=164.96 Aligned_cols=123 Identities=26% Similarity=0.428 Sum_probs=106.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 222 (295)
.+.|.+.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++++++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 34578889999999999997 589998864 245567889999999999999999999999875 4568
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ .+|+||||||+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~N 161 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR---------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDN 161 (290)
T ss_dssp EEEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGG
T ss_pred EEEEEecCCCCHHHHHHH---------------ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHH
Confidence 999999999999999842 245889999999999999999999874 359999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=185.68 Aligned_cols=122 Identities=24% Similarity=0.293 Sum_probs=107.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~ 223 (295)
..++|.+.+.||+|+||.||+ .||||++++. .....+.+..|..+|..+ +||||+++++++.+.+.++
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 346899999999999999996 5999999752 233456788999999988 7999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||||+++|+|.+++.. ...+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 419 lV~E~~~gg~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~N 472 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---------------VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDN 472 (674)
T ss_dssp EEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTT
T ss_pred EEEeCcCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhh
Confidence 99999999999999842 246899999999999999999999998 9999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=170.16 Aligned_cols=121 Identities=30% Similarity=0.514 Sum_probs=105.3
Q ss_pred ccccccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
.++|++.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.++++++||||+++++++..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46799999999999999997 258888754 23456788999999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+||+++|+|.+++.. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 93 ~v~~~~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 147 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARN 147 (327)
T ss_dssp EEECCCSSCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEEecCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHH
Confidence 99999999999999852 2346899999999999999999999998 9999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=170.09 Aligned_cols=130 Identities=25% Similarity=0.411 Sum_probs=110.3
Q ss_pred hhhhhhhccccccc-eeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCC-CCcccceeeeEE
Q 041718 150 LATIANATDNFSIN-NKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQ-HRNLVKLLGCCI 217 (295)
Q Consensus 150 ~~~~~~~~~~~~~~-~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~ 217 (295)
+.......+.|.+. +.||+|+||.||+ .||+|++... .......+.+|+.++.++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 33444556678777 8899999999996 6999998752 2334678999999999995 699999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+..++||||+++|+|.+++. ......+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~-------------~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~N 161 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCL-------------PELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQN 161 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGS-------------SCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred eCCeEEEEEEecCCCcHHHHHH-------------HhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHH
Confidence 9999999999999999998873 233456899999999999999999999998 9999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=173.18 Aligned_cols=120 Identities=27% Similarity=0.550 Sum_probs=97.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCC--ee
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGE--EK 222 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~--~~ 222 (295)
..++|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999996 699999864 24556678889999999997 999999999997654 78
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 ~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~N 139 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA----------------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSN 139 (388)
T ss_dssp EEEEECCS-EEHHHHHHH----------------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEecccC-cCHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHH
Confidence 99999997 689888741 35889999999999999999999998 9999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=167.30 Aligned_cols=122 Identities=25% Similarity=0.477 Sum_probs=102.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc----HHhHHHHHHHHHHHhcCCCCcccceeeeEE--eCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS----EQGLKELKNEVILFSKLQHRNLVKLLGCCI--QGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~--~~~~~ 222 (295)
.++|.+.+.||+|+||.||+ .+|+|++.... ....+.+.+|+.++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999996 68999987532 234678999999999999999999999984 45678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||++++ |.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 84 ~lv~e~~~~~-l~~~~~~-------------~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~N 139 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-------------VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGN 139 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-------------STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEehhccCC-HHHHHHh-------------CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCccc
Confidence 9999999876 7666632 23456899999999999999999999998 9999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.3e-22 Score=172.62 Aligned_cols=129 Identities=26% Similarity=0.372 Sum_probs=108.0
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHH-----------------hHHHHHHHHHHHhcCCCCccccee
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQ-----------------GLKELKNEVILFSKLQHRNLVKLL 213 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~-----------------~~~~~~~Ei~~l~~l~h~niv~l~ 213 (295)
.++|.+.+.||+|+||.||+ .||||.+...... ..+.+.+|+.++++++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 46899999999999999996 6999998642211 127899999999999999999999
Q ss_pred eeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCC
Q 041718 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLK 292 (295)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlk 292 (295)
+++.+.+..++||||+++++|.+++..... ........+++..+..++.|++.||.|||+ ++ |+|||||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~ 179 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFV-------LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVK 179 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEES-------SCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhh-------hhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCC
Confidence 999999999999999999999988311000 022224679999999999999999999998 87 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 180 p~N 182 (348)
T 2pml_X 180 PSN 182 (348)
T ss_dssp GGG
T ss_pred hHh
Confidence 987
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=173.10 Aligned_cols=121 Identities=28% Similarity=0.390 Sum_probs=106.4
Q ss_pred hccccccceeecccCccceeE-------EEEEEEecc--ccHHhHHHHHHHHHHHhcCC--CCcccceeeeEEeCCeeEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~l 224 (295)
..++|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|.+++ |||||++++++...+..+|
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 345799999999999999997 599999864 34556788999999999996 5999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||| +.+++|.+++.. ...+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 134 v~E-~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~N 185 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK---------------KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 185 (390)
T ss_dssp EEE-CCSEEHHHHHHH---------------CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGG
T ss_pred EEe-cCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHH
Confidence 999 568899999842 246888899999999999999999998 9999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=170.53 Aligned_cols=127 Identities=22% Similarity=0.367 Sum_probs=110.0
Q ss_pred hhhhhhccccccceeecccCccceeE--------EEEEEEecccc--------HHhHHHHHHHHHHHhcC-CCCccccee
Q 041718 151 ATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--------EQGLKELKNEVILFSKL-QHRNLVKLL 213 (295)
Q Consensus 151 ~~~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l-~h~niv~l~ 213 (295)
.......++|.+.+.||+|+||.||+ .||||++.... ....+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 33445567899999999999999996 69999886421 12356788999999999 799999999
Q ss_pred eeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 214 GCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
+++......+|||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp 228 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE---------------KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKP 228 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSG
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 999999999999999999999998842 246899999999999999999999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 229 ~N 230 (365)
T 2y7j_A 229 EN 230 (365)
T ss_dssp GG
T ss_pred HH
Confidence 98
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=165.50 Aligned_cols=124 Identities=31% Similarity=0.443 Sum_probs=109.7
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
....++|++.+.||+|+||.||+ .||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 34457899999999999999996 6999998642 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 98 lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~N 151 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---------------RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPEN 151 (287)
T ss_dssp EEECCCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEEccCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhh
Confidence 99999999999988842 235889999999999999999999998 9999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=173.87 Aligned_cols=119 Identities=24% Similarity=0.322 Sum_probs=98.9
Q ss_pred hccccccc-eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHh-cCCCCcccceeeeEEe----CCe
Q 041718 156 ATDNFSIN-NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQ----GEE 221 (295)
Q Consensus 156 ~~~~~~~~-~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~----~~~ 221 (295)
..++|.+. +.||+|+||.||+ .||||++... ..+.+|+.++. .++||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 34567766 6899999999996 5999998642 35677888764 4589999999999876 567
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|||||+++|+|.+++.. .....+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 134 ~~lv~E~~~gg~L~~~l~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 191 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQD-------------RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191 (400)
T ss_dssp EEEEEECCCSEEHHHHHHC-------------C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEEEEeCCCCcHHHHHHH-------------hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcce
Confidence 8999999999999999842 22346899999999999999999999998 9999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=8e-22 Score=167.75 Aligned_cols=122 Identities=25% Similarity=0.419 Sum_probs=104.3
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-CeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-EEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 228 (295)
..++|++.+.||+|+||.||+ .||||.++.. ...+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457899999999999999996 6999998753 2457899999999999999999999987654 478999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|.+++... ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 97 ~~~~~L~~~l~~~-------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~N 147 (278)
T 1byg_A 97 MAKGSLVDYLRSR-------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 147 (278)
T ss_dssp CTTEEHHHHHHHH-------------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCCCHHHHHHhc-------------ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcce
Confidence 9999999998531 2234788999999999999999999998 9999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.6e-22 Score=174.43 Aligned_cols=121 Identities=22% Similarity=0.272 Sum_probs=106.2
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc----cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI----SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 220 (295)
.++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999995 5899998642 123445678899999999 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+|||||+++++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~N 189 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---------------RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLEN 189 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred eEEEEeecCCCCCHHHHHHH---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999999999999999842 245889999999999999999999998 9999999998
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=166.17 Aligned_cols=121 Identities=29% Similarity=0.487 Sum_probs=103.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEecccc--HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS--EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.+.||+|+||.||+ .||||.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 5789999999999999996 68999986432 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|++ ++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 83 ~~~-~~L~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~N 133 (299)
T 2r3i_A 83 FLH-QDLKKFMDA-------------SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQN 133 (299)
T ss_dssp CCS-EEHHHHHHH-------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ccc-CCHHHHHHh-------------hhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHH
Confidence 997 699998842 22345889999999999999999999998 9999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=182.92 Aligned_cols=113 Identities=28% Similarity=0.477 Sum_probs=99.8
Q ss_pred eeecccCccceeE----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
++||+|+||.||+ .||||+++.. .....+++.+|+.+|++++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999996 4899999753 3345688999999999999999999999986 4568899999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|.+++. ....+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 454 g~L~~~l~---------------~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~N 499 (635)
T 4fl3_A 454 GPLNKYLQ---------------QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARN 499 (635)
T ss_dssp EEHHHHHH---------------HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCHHHHHh---------------hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHh
Confidence 99999984 2346899999999999999999999998 9999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=169.65 Aligned_cols=128 Identities=32% Similarity=0.441 Sum_probs=107.8
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEE-------
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCI------- 217 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~------- 217 (295)
.....+|++.+.||+|+||.||+ .||||++........+.+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 33456899999999999999996 69999987666667788999999999996 999999999984
Q ss_pred -eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 -QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.....++||||+. |+|.+++... .....+++..+..|+.|++.||.|||+++ ++|+||||||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~N 168 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKM------------ESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVEN 168 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHH------------HTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGG
T ss_pred cCCceEEEEEEecC-CCHHHHHHHh------------hccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCccc
Confidence 3445799999995 7999888521 22346999999999999999999999874 359999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=168.01 Aligned_cols=123 Identities=24% Similarity=0.437 Sum_probs=100.9
Q ss_pred hhhccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhc--CCCCcccceeeeEEeC----Ce
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQG----EE 221 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~----~~ 221 (295)
....++|++.+.||+|+||.||+ .||||++... ....+..|.+++.. ++||||+++++++... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34457899999999999999996 7999998642 22344455555554 4999999999999887 78
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----CCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS-----KLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~iiHrDlkp~N 295 (295)
.++||||+++|+|.+++.. ..+++..+..++.|++.||.|||++. ..+|+||||||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~N 172 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS----------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGG
T ss_pred eEEEEeccCCCcHHHHhhc----------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHH
Confidence 9999999999999999842 35889999999999999999999880 1129999999998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.85 E-value=4.9e-21 Score=166.79 Aligned_cols=115 Identities=23% Similarity=0.424 Sum_probs=103.2
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEe--CCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ--GEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~--~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||||+++.. ..+.+.+|+.++.+++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999996 6999998753 3467899999999997 9999999999987 6678999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|.+++. .+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 112 ~e~~~~~~l~~~~~------------------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~N 160 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------------------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHN 160 (330)
T ss_dssp EECCCCCCHHHHGG------------------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EeccCchhHHHHHH------------------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 99999999998772 3788899999999999999999998 9999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-21 Score=165.18 Aligned_cols=126 Identities=25% Similarity=0.335 Sum_probs=103.2
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccc-cH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
...++|++.+.||+|+||.||+ .||+|++... .. ...+.+..+...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 3457899999999999999996 6999998653 22 233444555566888999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
||||++ |+|.+++... ......+++..+..|+.|++.||.|||++ + |+||||||+|
T Consensus 84 v~e~~~-~~l~~~l~~~-----------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~N 140 (290)
T 3fme_A 84 CMELMD-TSLDKFYKQV-----------IDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSN 140 (290)
T ss_dssp EEECCS-EEHHHHHHHH-----------HHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGG
T ss_pred EEehhc-cchHHHHHHH-----------HhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHH
Confidence 999997 5888877431 12345799999999999999999999997 7 9999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.9e-22 Score=171.70 Aligned_cols=120 Identities=28% Similarity=0.470 Sum_probs=102.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|.+.+.||+|+||.||+ .||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 5789999999999999996 599999864322 1222456799999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++ ++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 82 ~~-~~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~N 130 (324)
T 3mtl_A 82 LD-KDLKQYLDD--------------CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQN 130 (324)
T ss_dssp CS-EEHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGG
T ss_pred cc-cCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHH
Confidence 97 588888742 2346899999999999999999999998 9999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.7e-21 Score=181.65 Aligned_cols=126 Identities=24% Similarity=0.376 Sum_probs=108.6
Q ss_pred hhhhhccccccceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 152 TIANATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 152 ~~~~~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
......++|.+.+.||+|+||.||+ .||+|.+.. ......+.+.+|+.+|++++|||||++++++. .
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 3344567899999999999999996 489998865 34455678999999999999999999999984 5
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~N 521 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQV--------------RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARN 521 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHH--------------TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CceEEEEEcCCCCcHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHh
Confidence 678999999999999999842 2345899999999999999999999998 9999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.3e-21 Score=165.69 Aligned_cols=123 Identities=28% Similarity=0.452 Sum_probs=99.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecccc-----HHhHHHHHHHHHHHhcCC---CCcccceeeeEEeC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-----EQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQG 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~ 219 (295)
..++|++.+.||+|+||.||+ .||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999996 68999986321 112345667777776664 99999999999876
Q ss_pred C-----eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCC
Q 041718 220 E-----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKAS 294 (295)
Q Consensus 220 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~ 294 (295)
. ..++||||+. ++|.+++.. .....+++..+..++.|++.||+|||+++ |+||||||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~-------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~ 149 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK-------------APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPE 149 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT-------------CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHH
Confidence 5 5899999996 699998842 23344899999999999999999999998 999999999
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 150 N 150 (308)
T 3g33_A 150 N 150 (308)
T ss_dssp T
T ss_pred H
Confidence 8
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=171.54 Aligned_cols=130 Identities=20% Similarity=0.339 Sum_probs=110.0
Q ss_pred hhhhhhhhhccccccceeecccCccceeE-------EEEEEEeccc-----------cHHhHHHHHHHHHHHhcCCCCcc
Q 041718 148 FELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKI-----------SEQGLKELKNEVILFSKLQHRNL 209 (295)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~-----------~~~~~~~~~~Ei~~l~~l~h~ni 209 (295)
....++....++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 34566777889999999999999999997 5999988541 22234789999999999999999
Q ss_pred cceeeeEEe-----CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCC
Q 041718 210 VKLLGCCIQ-----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKL 284 (295)
Q Consensus 210 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~ 284 (295)
+++++++.. ....++||||++ |+|.+++. .....+++..+..++.|++.||.|||+++
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-- 154 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--------------DQRIVISPQHIQYFMYHILLGLHVLHEAG-- 154 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--------------CTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--------------hcccCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 999999854 336899999997 68888774 13346899999999999999999999998
Q ss_pred CeEeccCCCCC
Q 041718 285 RIIHRDLKASN 295 (295)
Q Consensus 285 ~iiHrDlkp~N 295 (295)
|+||||||+|
T Consensus 155 -ivH~Dlkp~N 164 (362)
T 3pg1_A 155 -VVHRDLHPGN 164 (362)
T ss_dssp -CCCCCCCGGG
T ss_pred -CEecCCChHH
Confidence 9999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.3e-21 Score=166.73 Aligned_cols=121 Identities=31% Similarity=0.493 Sum_probs=102.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..++|++.+.||+|+||.||+ .||+|.+... ...+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456899999999999999996 6999998653 245678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+|+||||+|
T Consensus 105 ~~~~~~L~~~~~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~N 155 (314)
T 3com_A 105 YCGAGSVSDIIRL--------------RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGN 155 (314)
T ss_dssp CCTTEEHHHHHHH--------------HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred cCCCCCHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHH
Confidence 9999999998841 2356899999999999999999999998 9999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=172.60 Aligned_cols=122 Identities=24% Similarity=0.395 Sum_probs=99.5
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-------
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------- 219 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------- 219 (295)
...++|++.+.||+|+||.||+ .||||++.... ....+|+.+|+.++|||||++++++...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4567899999999999999996 69999886432 1234699999999999999999998543
Q ss_pred -------------------------------CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHH
Q 041718 220 -------------------------------EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268 (295)
Q Consensus 220 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 268 (295)
...++||||++ ++|.+.+... ......+++..+..++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-----------~~~~~~l~~~~~~~i~ 147 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF-----------IRSGRSIPMNLISIYI 147 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHH-----------HHTTCCCCHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH-----------HhcCCCCCHHHHHHHH
Confidence 34889999997 6888887532 1234568999999999
Q ss_pred HHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 269 ~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.|++.||.|||+++ |+||||||+|
T Consensus 148 ~qi~~aL~~LH~~g---i~H~Dikp~N 171 (383)
T 3eb0_A 148 YQLFRAVGFIHSLG---ICHRDIKPQN 171 (383)
T ss_dssp HHHHHHHHHHHTTT---EECSCCCGGG
T ss_pred HHHHHHHHHHHHCc---CccCccCHHH
Confidence 99999999999998 9999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=170.21 Aligned_cols=122 Identities=21% Similarity=0.300 Sum_probs=100.4
Q ss_pred hccccccceeecccCccceeEE-------------EEEEEeccccHHh-----------HHHHHHHHHHHhcCCCCcccc
Q 041718 156 ATDNFSINNKLGEGGFGLVYKE-------------IAVKRLSKISEQG-----------LKELKNEVILFSKLQHRNLVK 211 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk~-------------vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~h~niv~ 211 (295)
..++|++.+.||+|+||.||+. ||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999999999973 7999986533211 123445667788899999999
Q ss_pred eeeeEEeC----CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeE
Q 041718 212 LLGCCIQG----EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRII 287 (295)
Q Consensus 212 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ii 287 (295)
+++++... ...+|||||+ +++|.+++.. ....+++..+..|+.||+.||.|||+++ |+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--------------~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--------------NAKRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 99998764 5589999999 9999999842 2356999999999999999999999998 99
Q ss_pred eccCCCCC
Q 041718 288 HRDLKASN 295 (295)
Q Consensus 288 HrDlkp~N 295 (295)
||||||+|
T Consensus 175 HrDlkp~N 182 (364)
T 3op5_A 175 HGDIKASN 182 (364)
T ss_dssp CCCCCGGG
T ss_pred EecCCHHH
Confidence 99999998
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-21 Score=177.56 Aligned_cols=119 Identities=29% Similarity=0.456 Sum_probs=102.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 219 (295)
..++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999996 6999999753 445677889999999999999999999999654
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...+|||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~-----------------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~N 194 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 194 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CeEEEEEeCCCC-CHHHHHh-----------------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHh
Confidence 467999999975 4655552 23889999999999999999999998 9999999998
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=171.85 Aligned_cols=120 Identities=28% Similarity=0.459 Sum_probs=98.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 220 (295)
..++|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|+.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 346899999999999999996 699999854 24455678899999999999999999999997653
Q ss_pred -eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 -EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~----------------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~N 158 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH----------------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGN 158 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred ceEEEEEecC-CCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHH
Confidence 469999999 8899988831 35889999999999999999999998 9999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4e-21 Score=165.31 Aligned_cols=119 Identities=24% Similarity=0.331 Sum_probs=101.5
Q ss_pred hccccccc-eeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHH-hcCCCCcccceeeeEEe----CCe
Q 041718 156 ATDNFSIN-NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILF-SKLQHRNLVKLLGCCIQ----GEE 221 (295)
Q Consensus 156 ~~~~~~~~-~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~h~niv~l~~~~~~----~~~ 221 (295)
..++|.+. +.||+|+||.||+ .||+|+++.. ..+.+|+.++ +.++||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 34667776 7799999999996 6999998642 3567788877 66699999999999887 678
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++++|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N 147 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQD-------------RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 147 (299)
T ss_dssp EEEEECCCCSCBHHHHHHH-------------CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEeecCCCcHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHH
Confidence 8999999999999999852 22346899999999999999999999998 9999999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.85 E-value=4.6e-22 Score=176.81 Aligned_cols=129 Identities=16% Similarity=0.203 Sum_probs=102.0
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecc---ccHHhHHHHHHHH---HHHhcCCCCccccee-------
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEV---ILFSKLQHRNLVKLL------- 213 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~---~~~~~~~~~~~Ei---~~l~~l~h~niv~l~------- 213 (295)
...++|.+.+.||+|+||.||+ .||||++.. ......+.+.+|+ .+|++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3457899999999999999996 699999863 2344568899999 556666899999998
Q ss_pred eeEEeCC-----------------eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHH
Q 041718 214 GCCIQGE-----------------EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276 (295)
Q Consensus 214 ~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~ 276 (295)
+++...+ ..+|||||+ +|+|.+++...... ......+++..++.|+.||+.||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~qi~~aL~ 220 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH--------SSTHKSLVHHARLQLTLQVIRLLA 220 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT--------TTTTHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc--------ccccccccHHHHHHHHHHHHHHHH
Confidence 6655443 278999999 68999999643111 011233557888899999999999
Q ss_pred hhhcCCCCCeEeccCCCCC
Q 041718 277 YLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 277 yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++ |+||||||+|
T Consensus 221 ~LH~~~---ivHrDikp~N 236 (377)
T 3byv_A 221 SLHHYG---LVHTYLRPVD 236 (377)
T ss_dssp HHHHTT---EECSCCCGGG
T ss_pred HHHhCC---eecCCCCHHH
Confidence 999998 9999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=164.50 Aligned_cols=121 Identities=29% Similarity=0.435 Sum_probs=99.0
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 46899999999999999996 3799988642 2345678999999999999999999999987655 8
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 96 ~~v~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~N 151 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--------------HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARN 151 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--------------HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred eeeEecccCCCHHHHHHh--------------ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchhe
Confidence 899999999999999852 2245889999999999999999999998 9999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.9e-21 Score=170.84 Aligned_cols=123 Identities=30% Similarity=0.436 Sum_probs=99.5
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEeccccH-----HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~ 221 (295)
...++|.+.+.||+|+||.||+ .||||++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999996 599999864211 123468899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 142 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--------------NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNN 142 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--------------CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh--------------cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHH
Confidence 9999999975 88887731 2346888999999999999999999998 9999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.4e-21 Score=164.56 Aligned_cols=120 Identities=18% Similarity=0.325 Sum_probs=105.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..++|++.+.||+|+||.||+ .||||++... ...+.+.+|+.++..+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 346799999999999999996 6899988642 2334678899999999 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+ +++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 86 e~~-~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~N 136 (298)
T 1csn_A 86 DLL-GPSLEDLLDL--------------CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDN 136 (298)
T ss_dssp ECC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred Eec-CCCHHHHHHH--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 999 9999999842 2345899999999999999999999998 9999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-22 Score=172.98 Aligned_cols=129 Identities=29% Similarity=0.529 Sum_probs=111.0
Q ss_pred hhhhhhhccccccceeecccCccceeE-----EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK-----EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk-----~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
..++....++|++.+.||+|+||.||+ .+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 344445568899999999999999997 5899988642 223345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 105 ~iv~e~~~~~~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~N 160 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--------------AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKN 160 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--------------SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTT
T ss_pred EEEeecccCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhh
Confidence 999999999999999841 2346899999999999999999999998 9999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.2e-21 Score=183.91 Aligned_cols=119 Identities=17% Similarity=0.324 Sum_probs=103.2
Q ss_pred ccccccceeecccCccceeE---------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe-----
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 221 (295)
.++|++.+.||+|+||.||+ .||||++.. ........+.+|+.++++++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 47899999999999999996 589998864 344566788999999999999999999999987665
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+|||||+++++|.+++. ..+++..++.|+.||+.||.|||+++ ||||||||+|
T Consensus 159 ~~lv~E~~~g~~L~~~~~-----------------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~N 212 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG-----------------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPEN 212 (681)
T ss_dssp EEEEEECCCCEECC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eEEEEEeCCCCcHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHH
Confidence 799999999999987662 25899999999999999999999998 9999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.6e-21 Score=167.16 Aligned_cols=122 Identities=25% Similarity=0.454 Sum_probs=102.7
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------- 218 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------- 218 (295)
..++|++.+.||+|+||.||+ .||||++... .......+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 346899999999999999996 6999988542 22335678899999999999999999999987
Q ss_pred -CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 -GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+..++||||+++ +|.+.+.. ....+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~N 154 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSN--------------VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAAN 154 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHC--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCceEEEEEeccCC-CHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHH
Confidence 4468999999974 77776631 2345899999999999999999999998 9999999998
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=6.4e-21 Score=168.62 Aligned_cols=120 Identities=21% Similarity=0.424 Sum_probs=104.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----Ce
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 221 (295)
..++|++.+.||+|+||.||+ .||||++... .....+.+.+|+.++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 346899999999999999996 5999998753 344567899999999999999999999998765 36
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||++ ++|.+++. ...+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 105 ~~iv~e~~~-~~L~~~l~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 158 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLK----------------TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSN 158 (364)
T ss_dssp EEEEEECCS-EEHHHHHH----------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEEEcccC-cCHHHHHH----------------hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHh
Confidence 899999997 58988873 135899999999999999999999998 9999999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.6e-21 Score=170.36 Aligned_cols=121 Identities=26% Similarity=0.397 Sum_probs=103.1
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC--------CCcccceeeeEE---
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ--------HRNLVKLLGCCI--- 217 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------h~niv~l~~~~~--- 217 (295)
.++|.+.++||+|+||.||+ .||||++.. .....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999996 699999975 3455678899999999986 788999999987
Q ss_pred -eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 218 -QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 218 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
.....+|||||+ +++|.+++.. .....+++..+..|+.||+.||.|||++ + |+||||||+|
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~N 177 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIK-------------SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPEN 177 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHH-------------TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGG
T ss_pred CCCceEEEEEecc-CccHHHHHHh-------------cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 566889999999 6677666632 2234689999999999999999999998 7 9999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=165.40 Aligned_cols=119 Identities=24% Similarity=0.427 Sum_probs=103.8
Q ss_pred hhccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhc--CCCCcccceeeeEEeCC----ee
Q 041718 155 NATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSK--LQHRNLVKLLGCCIQGE----EK 222 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~h~niv~l~~~~~~~~----~~ 222 (295)
...++|.+.+.||+|+||.||+ .||||++... ....+.+|+.++.. ++||||+++++++...+ ..
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3457899999999999999997 6999998642 34567788888877 79999999999998876 88
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhh--------cCCCCCeEeccCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLH--------QDSKLRIIHRDLKAS 294 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--------~~~~~~iiHrDlkp~ 294 (295)
++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +++ |+||||||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~ 176 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSK 176 (342)
T ss_dssp EEEECCCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGG
T ss_pred EEEEeecCCCcHHHHHhc----------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHH
Confidence 999999999999999842 35889999999999999999999 666 999999999
Q ss_pred C
Q 041718 295 N 295 (295)
Q Consensus 295 N 295 (295)
|
T Consensus 177 N 177 (342)
T 1b6c_B 177 N 177 (342)
T ss_dssp G
T ss_pred H
Confidence 8
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=167.28 Aligned_cols=118 Identities=28% Similarity=0.453 Sum_probs=102.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC------
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------ 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------ 220 (295)
.++|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999996 699999864 24455678899999999999999999999997655
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||++ ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~N 157 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 157 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ceEEEEEcCC-CCHHHHHh-----------------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHH
Confidence 7899999997 57777662 24888999999999999999999998 9999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-20 Score=169.98 Aligned_cols=122 Identities=20% Similarity=0.330 Sum_probs=105.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcC------CCCcccceeeeEEeCCe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKL------QHRNLVKLLGCCIQGEE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~h~niv~l~~~~~~~~~ 221 (295)
...+|++.+.||+|+||.||+ .||||++.. .....+++.+|+.++..+ .|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346799999999999999996 699999975 344556788888888877 57799999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+. ++|.+++.. .....+++..+..|+.||+.||+|||+++ |+||||||+|
T Consensus 174 ~~lv~e~~~-~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~N 230 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKK-------------NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPEN 230 (429)
T ss_dssp EEEEECCCC-CBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGG
T ss_pred EEEEEeccC-CCHHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999996 689988842 23345899999999999999999999998 9999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=164.88 Aligned_cols=122 Identities=23% Similarity=0.393 Sum_probs=106.2
Q ss_pred hccccccceeecccCccceeE---------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCc------ccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~ 220 (295)
..++|++.+.||+|+||.||+ .||||+++. .....+.+.+|+.++..++|++ ++++++++.+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 346899999999999999996 599999875 3455678899999999987665 999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+ +++|.+++.. .....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 148 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKE-------------NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPEN 148 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred cEEEEEcCC-CCCHHHHHHh-------------cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 999999999 8999998842 22345889999999999999999999998 9999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.1e-21 Score=166.59 Aligned_cols=118 Identities=31% Similarity=0.535 Sum_probs=95.9
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHH--HHHhcCCCCcccceeeeEEe-----CCee
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEV--ILFSKLQHRNLVKLLGCCIQ-----GEEK 222 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei--~~l~~l~h~niv~l~~~~~~-----~~~~ 222 (295)
..++|++.+.||+|+||.||+ .||||++.... ...+..|. ..+..++|+||+++++.+.. ....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 457899999999999999996 69999986432 23344444 44556899999999986542 3367
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC---------CCCCeEeccCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD---------SKLRIIHRDLKA 293 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~---------~~~~iiHrDlkp 293 (295)
+|||||+++|+|.+++.. ...++..+..|+.|++.||.|||++ + |+||||||
T Consensus 88 ~lv~e~~~~g~L~~~l~~----------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp 148 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----------------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNS 148 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSG
T ss_pred EEEEecCCCCcHHHHHhh----------------cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeeccccc
Confidence 899999999999999842 2348889999999999999999998 6 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 149 ~N 150 (336)
T 3g2f_A 149 RN 150 (336)
T ss_dssp GG
T ss_pred ce
Confidence 98
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.1e-20 Score=166.18 Aligned_cols=120 Identities=28% Similarity=0.447 Sum_probs=104.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----Ce
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 221 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 221 (295)
..++|.+.+.||+|+||.||+ .||||.+... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 457899999999999999996 6999998643 345567888999999999999999999987654 67
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~N 142 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----------------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSN 142 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred EEEEEeccC-ccHHHHHhh----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 899999996 689888731 35899999999999999999999998 9999999998
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.83 E-value=6e-21 Score=169.03 Aligned_cols=120 Identities=31% Similarity=0.508 Sum_probs=97.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------ 219 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------ 219 (295)
..++|++.+.||+|+||.||+ .||||++.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999996 699999864 2445667889999999999999999999998754
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++|+||+ +++|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~----------------~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~N 162 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK----------------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN 162 (367)
T ss_dssp CCCEEEEECC-CEECC---------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred CeEEEEeccc-CCCHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhh
Confidence 5679999999 789988773 145899999999999999999999998 9999999998
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=1.2e-20 Score=165.55 Aligned_cols=120 Identities=20% Similarity=0.312 Sum_probs=96.7
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccccHH-----------hHHHHHHHHHHHhcCCCCcccceee
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKISEQ-----------GLKELKNEVILFSKLQHRNLVKLLG 214 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~~~~-----------~~~~~~~Ei~~l~~l~h~niv~l~~ 214 (295)
.++|.+.+.||+|+||.||+ .+|+|.+...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 46899999999999999997 4799988653211 1234668889999999999999999
Q ss_pred eEEe----CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEecc
Q 041718 215 CCIQ----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRD 290 (295)
Q Consensus 215 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrD 290 (295)
++.. ....++||||+ +++|.+++.. ...+++..+..|+.||+.||.|||+++ |+|||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 176 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---------------NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGD 176 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---------------GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 9988 78899999999 9999998842 226899999999999999999999998 99999
Q ss_pred CCCCC
Q 041718 291 LKASN 295 (295)
Q Consensus 291 lkp~N 295 (295)
|||+|
T Consensus 177 lkp~N 181 (345)
T 2v62_A 177 IKAAN 181 (345)
T ss_dssp CSGGG
T ss_pred cCHHH
Confidence 99998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=162.95 Aligned_cols=129 Identities=26% Similarity=0.376 Sum_probs=110.6
Q ss_pred hhhhhhhhhccccccceeecccCccceeE-------EEEEEEecc--ccHHhHHHHHHHHHHHhcCC--CCcccceeeeE
Q 041718 148 FELATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSK--ISEQGLKELKNEVILFSKLQ--HRNLVKLLGCC 216 (295)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~ 216 (295)
+.+..+....++|++.+.||+|+||.||+ .||||.+.. ......+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 33444555678899999999999999997 599999864 34556788999999999997 59999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 217 IQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 217 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+.+..++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N 157 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKK---------------KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPAN 157 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHH---------------CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCccc
Confidence 99999999999 568899999842 246889999999999999999999998 9999999997
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=9.6e-21 Score=169.86 Aligned_cols=128 Identities=24% Similarity=0.396 Sum_probs=95.1
Q ss_pred hcccccc-ceeecccCccceeE----------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCee
Q 041718 156 ATDNFSI-NNKLGEGGFGLVYK----------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEK 222 (295)
Q Consensus 156 ~~~~~~~-~~~lg~G~~g~Vyk----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~ 222 (295)
..+.|.+ .++||+|+||.||+ .||||++.... ....+.+|+.+|++++|||||++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 3455665 45899999999996 48999987532 23467899999999999999999999964 6789
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||||++ ++|.+++....... .......+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~N 158 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASK------ANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPAN 158 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EEEEeCCC-CCHHHHHHHhcccc------ccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHH
Confidence 99999996 58888775322110 1112235899999999999999999999998 9999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8e-21 Score=178.39 Aligned_cols=124 Identities=27% Similarity=0.468 Sum_probs=105.5
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe------CCe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 221 (295)
.++|.+.+.||+|+||.||+ .||||++.. ......+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999996 699999865 355667889999999999999999999998765 677
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+++|+|.+++.. ......+++..+..|+.|++.||.|||+++ |+||||||+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~------------~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~N 151 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQ------------FENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPEN 151 (676)
T ss_dssp CCCEEECCSSCBHHHHHHS------------SSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTT
T ss_pred EEEEEEeCCCCCHHHHHHh------------cccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHH
Confidence 8999999999999999852 122345889999999999999999999998 9999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.7e-20 Score=165.05 Aligned_cols=119 Identities=27% Similarity=0.462 Sum_probs=103.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee---
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK--- 222 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~--- 222 (295)
..++|.+.+.||+|+||.||+ .||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 346899999999999999996 6999998752 445567889999999999999999999999877765
Q ss_pred ---EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 ---LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ---~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~N 174 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-----------------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGN 174 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred eeEEEEEcccc-ccHHHHhh-----------------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHH
Confidence 99999997 68877662 24899999999999999999999998 9999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-20 Score=166.42 Aligned_cols=117 Identities=18% Similarity=0.315 Sum_probs=101.8
Q ss_pred ccccccceeecccCccceeE----------------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccc---------
Q 041718 157 TDNFSINNKLGEGGFGLVYK----------------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK--------- 211 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk----------------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~--------- 211 (295)
.++|.+.+.||+|+||.||+ .||+|.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 46899999999999999996 2789988643 46889999999999999998
Q ss_pred ------eeeeEEe-CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCC
Q 041718 212 ------LLGCCIQ-GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKL 284 (295)
Q Consensus 212 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~ 284 (295)
+++++.. .+..+|||||+ +++|.+++.. .....+++..+..|+.||+.||.|||+++
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-- 179 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV-------------SPKHVLSERSVLQVACRLLDALEFLHENE-- 179 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHH-------------SGGGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHh-------------CCcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5677766 78899999999 9999999952 12356999999999999999999999998
Q ss_pred CeEeccCCCCC
Q 041718 285 RIIHRDLKASN 295 (295)
Q Consensus 285 ~iiHrDlkp~N 295 (295)
|+||||||+|
T Consensus 180 -ivH~Dikp~N 189 (352)
T 2jii_A 180 -YVHGNVTAEN 189 (352)
T ss_dssp -CBCSCCCGGG
T ss_pred -ccCCCCCHHH
Confidence 9999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.8e-21 Score=165.13 Aligned_cols=125 Identities=24% Similarity=0.363 Sum_probs=97.5
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEeccccH------HhHHHHHHHHHHHhcC----CCCcccceee
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE------QGLKELKNEVILFSKL----QHRNLVKLLG 214 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~------~~~~~~~~Ei~~l~~l----~h~niv~l~~ 214 (295)
.....++|++.+.||+|+||.||+ .||||++..... .....+.+|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999997 599999865321 2234566799999888 8999999999
Q ss_pred eEEeCCeeEEEEec-CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCC
Q 041718 215 CCIQGEEKLLIYEF-MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKA 293 (295)
Q Consensus 215 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp 293 (295)
++...+..++|+|| +++++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 167 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE---------------KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKD 167 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSG
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCh
Confidence 99999999999999 789999999842 235899999999999999999999998 99999999
Q ss_pred CC
Q 041718 294 SN 295 (295)
Q Consensus 294 ~N 295 (295)
+|
T Consensus 168 ~N 169 (312)
T 2iwi_A 168 EN 169 (312)
T ss_dssp GG
T ss_pred hh
Confidence 87
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.5e-20 Score=161.97 Aligned_cols=121 Identities=21% Similarity=0.363 Sum_probs=104.5
Q ss_pred ccccccceeecccCccceeE---------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCc------ccceeeeEEeCCe
Q 041718 157 TDNFSINNKLGEGGFGLVYK---------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN------LVKLLGCCIQGEE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n------iv~l~~~~~~~~~ 221 (295)
.++|++.+.||+|+||.||+ .||+|+++. .....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 46899999999999999995 599999875 3455678889999999998766 9999999999999
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+|||||+ +++|.+++.. .....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-------------~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~N 153 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-------------NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPEN 153 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-------------TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred EEEEEecc-CCChHHHHHh-------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 99999999 6677777642 22346899999999999999999999998 9999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.2e-20 Score=161.07 Aligned_cols=120 Identities=25% Similarity=0.289 Sum_probs=97.2
Q ss_pred hccccccce-eecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCee
Q 041718 156 ATDNFSINN-KLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEK 222 (295)
Q Consensus 156 ~~~~~~~~~-~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~ 222 (295)
..++|.+.+ .||+|+||.||+ .||||++... ....++ ....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456888855 699999999996 6999998652 222222 2234567799999999999876 4568
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++|+|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 102 ~lv~e~~~gg~L~~~l~~-------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~N 158 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQE-------------RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 158 (336)
T ss_dssp EEEEECCTTEEHHHHHHT-------------C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEEEeccCCCCHHHHHHh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999999999999842 23346899999999999999999999998 9999999988
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=168.13 Aligned_cols=120 Identities=23% Similarity=0.349 Sum_probs=97.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------Cee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~ 222 (295)
..+|++.+.||+|+||.||+ .||||++.... ....+|+.+|++++|+|||++++++... ..+
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 34788999999999999996 69999986532 2234699999999999999999988542 236
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||||+++ +|.+++... ......+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 129 ~lv~e~~~~-~l~~~~~~~-----------~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 186 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHY-----------SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQN 186 (420)
T ss_dssp EEEEECCCE-EHHHHHHHH-----------HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGG
T ss_pred Eeehhcccc-cHHHHHHHH-----------hhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhh
Confidence 799999975 666665321 123456899999999999999999999998 9999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.82 E-value=1.7e-20 Score=163.04 Aligned_cols=124 Identities=26% Similarity=0.457 Sum_probs=101.7
Q ss_pred hhccccccceeecccCccceeE---------EEEEEEecccc--HHhHHHHHHHHHHHhcC---CCCcccceeeeEE---
Q 041718 155 NATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKIS--EQGLKELKNEVILFSKL---QHRNLVKLLGCCI--- 217 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~--- 217 (295)
...++|++.+.||+|+||.||+ .||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4557899999999999999996 58999886422 22233566777777666 8999999999987
Q ss_pred --eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 --QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.....++||||++ |+|.+++.. .....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~N 150 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDK-------------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 150 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHH-------------SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cCCCceEEEEEecCC-CCHHHHHHh-------------cccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHH
Confidence 5667899999997 699998842 22345899999999999999999999998 9999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.4e-20 Score=166.70 Aligned_cols=120 Identities=21% Similarity=0.321 Sum_probs=95.9
Q ss_pred ccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC------eeE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE------EKL 223 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~------~~~ 223 (295)
..+|++.+.||+|+||.||+ .+|+|++..... ...+|+.+|+.++|||||++++++.... ..+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45799999999999999996 588888754221 1236999999999999999999986543 378
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||++++ +.+.+... ......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 115 lv~e~~~~~-l~~~~~~~-----------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 171 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHY-----------AKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171 (394)
T ss_dssp EEEECCSEE-HHHHHHHH-----------HHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEeeccCcc-HHHHHHHH-----------HhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHH
Confidence 999999764 44333211 123456899999999999999999999998 9999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.5e-20 Score=158.01 Aligned_cols=120 Identities=21% Similarity=0.397 Sum_probs=98.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeE-EeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 226 (295)
..++|++.+.||+|+||.||+ .||||++... .....+.+|+.++..++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999996 6899986542 2234588899999999988877766655 6778889999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+ +++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 e~~-~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~N 135 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--------------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDN 135 (296)
T ss_dssp ECC-CCBHHHHHHH--------------TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred Ecc-CCCHHHHHHH--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999 9999998842 2345899999999999999999999998 9999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=168.82 Aligned_cols=120 Identities=23% Similarity=0.294 Sum_probs=99.1
Q ss_pred hhccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 226 (295)
....+|.+.+.||+|+||.|+. .||||++..... ..+.+|+.+|+.+ +|||||++++++.+.+..+|||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3445789999999999999653 799999864221 2356799999999 7999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||++ |+|.+++.. ....+.+..+..++.||+.||.|||+++ |+||||||+|
T Consensus 98 E~~~-g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~N 148 (432)
T 3p23_A 98 ELCA-ATLQEYVEQ--------------KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHN 148 (432)
T ss_dssp ECCS-EEHHHHHHS--------------SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTS
T ss_pred ECCC-CCHHHHHHh--------------cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHH
Confidence 9996 699998842 1223444556789999999999999998 9999999998
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.7e-20 Score=162.93 Aligned_cols=118 Identities=27% Similarity=0.467 Sum_probs=102.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe-----
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE----- 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~----- 221 (295)
.++|.+.+.||+|+||.||+ .||||.+.. ......+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999996 699999865 234456788999999999999999999999987654
Q ss_pred -eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 -KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 156 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----------------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGN 156 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGG
T ss_pred eEEEEecccc-CCHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHH
Confidence 499999997 68876652 24889999999999999999999998 9999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=163.97 Aligned_cols=121 Identities=21% Similarity=0.346 Sum_probs=104.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-----------CCcccceeeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCI 217 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~ 217 (295)
.++|.+.+.||+|+||.||+ .||||++.. .....+.+.+|+.++.+++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36899999999999999996 699999875 3445677889999999887 899999999988
Q ss_pred eCC----eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCC
Q 041718 218 QGE----EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLK 292 (295)
Q Consensus 218 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlk 292 (295)
..+ ..++||||+ +++|.+++.. .....+++..+..++.||+.||.|||++ + |+|||||
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dik 159 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKK-------------YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIK 159 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHH-------------TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCS
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHH-------------hhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCC
Confidence 654 789999999 8999998842 2234589999999999999999999998 7 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 160 p~N 162 (373)
T 1q8y_A 160 PEN 162 (373)
T ss_dssp GGG
T ss_pred hHH
Confidence 998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.9e-20 Score=158.45 Aligned_cols=126 Identities=23% Similarity=0.325 Sum_probs=103.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHH-HHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVI-LFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~-~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..++|++.+.||+|+||.||+ .||||++... ......++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 347889999999999999996 6999998653 3344556666666 77888999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
|||+++ +|.+++... .......+++..+..++.|++.||.|||++ + |+||||||+|
T Consensus 100 ~e~~~~-~l~~~~~~~----------~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~N 156 (327)
T 3aln_A 100 MELMST-SFDKFYKYV----------YSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSN 156 (327)
T ss_dssp ECCCSE-EHHHHHHHH----------HHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGG
T ss_pred EeecCC-ChHHHHHHH----------HhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHH
Confidence 999974 888777421 111245689999999999999999999998 7 9999999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.7e-20 Score=171.90 Aligned_cols=98 Identities=18% Similarity=0.250 Sum_probs=84.3
Q ss_pred EEEEEEeccc----------cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhh
Q 041718 177 EIAVKRLSKI----------SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLT 245 (295)
Q Consensus 177 ~vavK~l~~~----------~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~ 245 (295)
.+|+|.+.+. .+...++|.+|+.+|+++ .|+||++++++++++...||||||++|++|.++|..
T Consensus 261 ~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~----- 335 (569)
T 4azs_A 261 DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA----- 335 (569)
T ss_dssp SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-----
T ss_pred eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-----
Confidence 5899988642 234567899999999999 799999999999999999999999999999999952
Q ss_pred hhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 246 LMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 246 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
...++.. +|+.||+.||+|+|+++ ||||||||+|
T Consensus 336 ----------~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeN 369 (569)
T 4azs_A 336 ----------GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWN 369 (569)
T ss_dssp ----------TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGG
T ss_pred ----------CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHh
Confidence 2345543 58999999999999998 9999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.5e-20 Score=157.11 Aligned_cols=120 Identities=21% Similarity=0.401 Sum_probs=101.6
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeE-EeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCC-IQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 226 (295)
..++|++.+.||+|+||.||+ .||||++.... ..+++.+|+.++..++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999996 69999886432 234688999999999998876666654 6778889999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+ +++|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 85 e~~-~~~L~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~N 135 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF--------------CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDN 135 (296)
T ss_dssp ECC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred Eec-CCCHHHHHHh--------------hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 999 9999999842 2346899999999999999999999998 9999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.9e-20 Score=163.98 Aligned_cols=122 Identities=13% Similarity=0.153 Sum_probs=87.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcC--CCCccccee-------ee
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKL--QHRNLVKLL-------GC 215 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l--~h~niv~l~-------~~ 215 (295)
...+|.+.+.||+|+||.||+ .||||++... .....+.+.+|+.++..| +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 345689999999999999996 6999999763 234566788885444444 699988755 44
Q ss_pred EEeC-----------------CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHH------HHHHHHHH
Q 041718 216 CIQG-----------------EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR------FHIICGTA 272 (295)
Q Consensus 216 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~i~ 272 (295)
+... ...+|||||++ |+|.+++... ...+++..+ ..++.||+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--------------~~~~~~~~~~~~~vk~~i~~qi~ 204 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--------------DFVYVFRGDEGILALHILTAQLI 204 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--------------HHSCCCCHHHHHHHHHHHHHHHH
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--------------ccccchhhhhhhhhHHHHHHHHH
Confidence 4332 34899999998 8999999532 123455666 78889999
Q ss_pred HHHHhhhcCCCCCeEeccCCCCC
Q 041718 273 RGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 273 ~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.||+|||+++ |+||||||+|
T Consensus 205 ~aL~~LH~~~---ivHrDikp~N 224 (371)
T 3q60_A 205 RLAANLQSKG---LVHGHFTPDN 224 (371)
T ss_dssp HHHHHHHHTT---EEETTCSGGG
T ss_pred HHHHHHHHCC---CccCcCCHHH
Confidence 9999999998 9999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.2e-20 Score=166.05 Aligned_cols=122 Identities=25% Similarity=0.245 Sum_probs=94.5
Q ss_pred ccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEEEecCC
Q 041718 159 NFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
.|...+.||+|+||.||. .||||++... ..+.+.+|+.+|.++ +|||||++++++.+.+..+|||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345568899999999973 7999998642 345678899999876 89999999999999999999999995
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|.+++....... .......+..+..|+.||+.||+|||+++ |+||||||+|
T Consensus 93 -gsL~~~l~~~~~~~--------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~N 145 (434)
T 2rio_A 93 -LNLQDLVESKNVSD--------ENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQN 145 (434)
T ss_dssp -EEHHHHHHTC--------------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred -CCHHHHHhccCCCc--------hhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHh
Confidence 69999985321100 00111234456789999999999999998 9999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.1e-20 Score=162.25 Aligned_cols=127 Identities=21% Similarity=0.251 Sum_probs=91.7
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCe---
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEE--- 221 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~--- 221 (295)
.....++|++.+.||+|+||.||+ .||||++... .........|+..++.++||||+++++++.....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 345568999999999999999996 6999988542 2333456778888899999999999999876433
Q ss_pred ----eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCCCCeEeccCCCCC
Q 041718 222 ----KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLH--QDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH--~~~~~~iiHrDlkp~N 295 (295)
.++||||+++ +|...+... ......+++..+..++.|++.||.||| +++ |+||||||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~N 161 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNY-----------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHN 161 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHH-----------HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGG
T ss_pred cceeEEEEeecccc-cHHHHHHHH-----------hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHH
Confidence 7899999975 555554321 123456889999999999999999999 777 9999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.4e-19 Score=161.05 Aligned_cols=126 Identities=23% Similarity=0.363 Sum_probs=104.8
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CC-----cccceeeeEEeC
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HR-----NLVKLLGCCIQG 219 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~-----niv~l~~~~~~~ 219 (295)
....++|++.+.||+|+||.||+ .||||+++. ......++..|+.++..++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34567899999999999999996 699999975 3445677888999888885 44 499999999999
Q ss_pred CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 220 EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+..+|||||++ ++|.+++.. .....+++..+..++.|++.||.|||++ ..+|+||||||+|
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~-------------~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~N 189 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRN-------------TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPEN 189 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHH-------------TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGG
T ss_pred CceEEEEecCC-CCHHHHHhh-------------cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCccc
Confidence 99999999996 599998852 2234589999999999999999999953 1239999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-20 Score=160.95 Aligned_cols=124 Identities=26% Similarity=0.364 Sum_probs=105.8
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccccH------HhHHHHHHHHHHHhcCC--CCcccceeeeEE
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISE------QGLKELKNEVILFSKLQ--HRNLVKLLGCCI 217 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~ 217 (295)
....++|++.+.||+|+||.||+ .||||.+..... ...+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999996 599999865221 12355778999999996 599999999999
Q ss_pred eCCeeEEEEecCCC-CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPN-KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+..++|+|++.+ ++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 179 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---------------RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDEN 179 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHH
Confidence 99999999999976 899998842 246889999999999999999999998 9999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.1e-19 Score=166.30 Aligned_cols=120 Identities=23% Similarity=0.393 Sum_probs=101.9
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCC-CcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 226 (295)
..++|++.++||+|+||.||+ .||||++.... ...++..|+.++..|+| +++..+..+....+..+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 346899999999999999997 69999876422 22457889999999987 56666677778889999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+ +++|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+|
T Consensus 83 e~~-g~sL~~ll~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~N 133 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF--------------CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDN 133 (483)
T ss_dssp ECC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred ECC-CCCHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcce
Confidence 999 9999999842 2346999999999999999999999998 9999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=154.70 Aligned_cols=122 Identities=20% Similarity=0.324 Sum_probs=93.1
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cH-HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SE-QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~-~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
..++|++.+.||+|+||.||+ .||||.+... .. ...+.+..+..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 456889999999999999996 6999998653 22 2334445555678889999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
|||+ ++.+..+.. .....+++..+..++.|++.||.|||++ + |+||||||+|
T Consensus 103 ~e~~-~~~~~~l~~--------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~N 155 (318)
T 2dyl_A 103 MELM-GTCAEKLKK--------------RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSN 155 (318)
T ss_dssp ECCC-SEEHHHHHH--------------HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGG
T ss_pred Eecc-CCcHHHHHH--------------HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHH
Confidence 9999 445544432 1235689999999999999999999985 7 9999999987
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.4e-19 Score=164.44 Aligned_cols=108 Identities=17% Similarity=0.215 Sum_probs=84.1
Q ss_pred cceeecccCccceeE------EEEEEEeccc--------cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 162 INNKLGEGGFGLVYK------EIAVKRLSKI--------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk------~vavK~l~~~--------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..+.||+|+||.||+ .+++|..... .....+.+.+|+.+|++++||||+++..+....++.+||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 357899999999995 6888875321 11224568999999999999999977666678888899999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++++|.+++. . +..++.|++.||.|||+++ |+||||||+|
T Consensus 420 ~~~ggsL~~~l~-------------~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~N 461 (540)
T 3en9_A 420 YINGKLAKDVIE-------------D----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSN 461 (540)
T ss_dssp CCCSEEHHHHST-------------T----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTS
T ss_pred CCCCCCHHHHHH-------------H----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHH
Confidence 999999999883 1 4579999999999999998 9999999998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.3e-18 Score=144.64 Aligned_cols=116 Identities=20% Similarity=0.213 Sum_probs=90.4
Q ss_pred hhhhhhccccccceeecccCccceeE-------EEEEEEeccccH------------------HhHHHHHHHHHHHhcCC
Q 041718 151 ATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISE------------------QGLKELKNEVILFSKLQ 205 (295)
Q Consensus 151 ~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~ 205 (295)
..+......|.+.+.||+|+||.||+ .||+|.++.... .....+.+|+.+|++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 34444455677779999999999996 699999864211 23567899999999999
Q ss_pred CCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCC
Q 041718 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLR 285 (295)
Q Consensus 206 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~ 285 (295)
| +++.+++.. +..++||||+++++|.+ +. ......++.|++.||.|||+++
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------------------~~~~~~i~~qi~~~l~~lH~~g--- 213 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------------------VENPDEVLDMILEEVAKFYHRG--- 213 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------------------CSCHHHHHHHHHHHHHHHHHTT---
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------------------hhhHHHHHHHHHHHHHHHHHCC---
Confidence 5 667775543 56799999999999987 41 1123469999999999999998
Q ss_pred eEeccCCCCC
Q 041718 286 IIHRDLKASN 295 (295)
Q Consensus 286 iiHrDlkp~N 295 (295)
|+||||||+|
T Consensus 214 iiHrDlkp~N 223 (282)
T 1zar_A 214 IVHGDLSQYN 223 (282)
T ss_dssp EECSCCSTTS
T ss_pred CEeCCCCHHH
Confidence 9999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-17 Score=147.14 Aligned_cols=130 Identities=16% Similarity=0.191 Sum_probs=91.6
Q ss_pred hhhccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCC-Cccccee--------
Q 041718 154 ANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQH-RNLVKLL-------- 213 (295)
Q Consensus 154 ~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h-~niv~l~-------- 213 (295)
......|...+.||+|+||.||+ .||||++... .....+.+.+|+.+++.++| +|.....
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 34456788889999999999997 6999998732 22346789999999999987 3221111
Q ss_pred -------------eeEEe-----CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHH
Q 041718 214 -------------GCCIQ-----GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGV 275 (295)
Q Consensus 214 -------------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl 275 (295)
.+... ....+++|+++ +++|.+++..... .......+++..++.|+.|++.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~--------~~~~~~~l~~~~~~~i~~qi~~aL 224 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--------HSSTHKSLVHHARLQLTLQVIRLL 224 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH--------HTTTSHHHHHHHHHHHHHHHHHHH
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc--------ccccCCCCCHHHHHHHHHHHHHHH
Confidence 11111 22356777765 6899988842110 012234578889999999999999
Q ss_pred HhhhcCCCCCeEeccCCCCC
Q 041718 276 MYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 276 ~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||+++ ||||||||+|
T Consensus 225 ~~LH~~~---iiHrDiKp~N 241 (413)
T 3dzo_A 225 ASLHHYG---LVHTYLRPVD 241 (413)
T ss_dssp HHHHHTT---EECSCCCGGG
T ss_pred HHHHhCC---cccCCcccce
Confidence 9999998 9999999998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=3e-16 Score=132.08 Aligned_cols=113 Identities=17% Similarity=0.147 Sum_probs=83.4
Q ss_pred cccccceeecccCccceeE--------E--EEEEEeccccH------------------------HhHHHHHHHHHHHhc
Q 041718 158 DNFSINNKLGEGGFGLVYK--------E--IAVKRLSKISE------------------------QGLKELKNEVILFSK 203 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~--vavK~l~~~~~------------------------~~~~~~~~Ei~~l~~ 203 (295)
.-|.+.+.||+|+||.||+ . ||||+++.... .....+.+|+.+|.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467789999999999996 5 99998653211 112468899999999
Q ss_pred CCCCcc--cceeeeEEeCCeeEEEEecCCC-C----CHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHH
Q 041718 204 LQHRNL--VKLLGCCIQGEEKLLIYEFMPN-K----SLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVM 276 (295)
Q Consensus 204 l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~ 276 (295)
++|+++ ..+++. +..+|||||+.+ | +|.+++.. .++.....++.|++.||.
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------------~~~~~~~~i~~qi~~~l~ 184 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------------LKELDVEGIFNDVVENVK 184 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------------GGGSCHHHHHHHHHHHHH
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------------cChHHHHHHHHHHHHHHH
Confidence 988864 344432 456899999942 4 55554310 124456789999999999
Q ss_pred hhh-cCCCCCeEeccCCCCC
Q 041718 277 YLH-QDSKLRIIHRDLKASN 295 (295)
Q Consensus 277 yLH-~~~~~~iiHrDlkp~N 295 (295)
||| +.+ |+||||||+|
T Consensus 185 ~lH~~~g---ivHrDlkp~N 201 (258)
T 1zth_A 185 RLYQEAE---LVHADLSEYN 201 (258)
T ss_dssp HHHHTSC---EECSSCSTTS
T ss_pred HHHHHCC---EEeCCCCHHH
Confidence 999 887 9999999998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=5.5e-15 Score=130.09 Aligned_cols=119 Identities=13% Similarity=0.121 Sum_probs=78.0
Q ss_pred hhhhhhccccccceeecccCccceeE-------EEEEEEecccc--------------HHhHHH--------HHHHHHHH
Q 041718 151 ATIANATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKIS--------------EQGLKE--------LKNEVILF 201 (295)
Q Consensus 151 ~~~~~~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~--------------~~~~~~--------~~~Ei~~l 201 (295)
..+.....-|.+.+.||.|+||.||+ .||||+++... ...... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 34444445589999999999999996 69999875210 001111 23455566
Q ss_pred hcCCCCcccceeeeEEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC
Q 041718 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD 281 (295)
Q Consensus 202 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~ 281 (295)
.++.+.++.-.. .+.. ...+|||||+++++|.++.. ......++.|++.+|.|||..
T Consensus 168 ~rL~~~gv~vp~-p~~~-~~~~LVME~i~G~~L~~l~~---------------------~~~~~~l~~qll~~l~~lH~~ 224 (397)
T 4gyi_A 168 KALYEEGFPVPE-PIAQ-SRHTIVMSLVDALPMRQVSS---------------------VPDPASLYADLIALILRLAKH 224 (397)
T ss_dssp HHHHHTTCSCCC-EEEE-ETTEEEEECCSCEEGGGCCC---------------------CSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhcCCCCCe-eeec-cCceEEEEecCCccHhhhcc---------------------cHHHHHHHHHHHHHHHHHHHC
Confidence 666444332111 1111 22369999999888765331 112346789999999999999
Q ss_pred CCCCeEeccCCCCC
Q 041718 282 SKLRIIHRDLKASN 295 (295)
Q Consensus 282 ~~~~iiHrDlkp~N 295 (295)
+ ||||||||.|
T Consensus 225 g---IVHrDLKp~N 235 (397)
T 4gyi_A 225 G---LIHGDFNEFN 235 (397)
T ss_dssp T---EECSCCSTTS
T ss_pred C---CcCCCCCHHH
Confidence 8 9999999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.09 E-value=3e-10 Score=95.23 Aligned_cols=105 Identities=13% Similarity=-0.002 Sum_probs=79.5
Q ss_pred hccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
....|.+...++.|+.+.||+ .+++|+...........+.+|+.+|+.+. +..+.+++++....+..++||||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred HhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 345688778888888899997 68999886422123346889999999885 67888999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~ 280 (295)
++|.+|.+.+. +......++.+++++|..||+
T Consensus 92 i~G~~l~~~~~--------------------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 92 ADGVLCSEEYE--------------------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp CSSEEHHHHCC--------------------TTTCHHHHHHHHHHHHHHHHH
T ss_pred cCCeehhhccC--------------------CcccHHHHHHHHHHHHHHHhC
Confidence 99999876431 111223577788888888887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.57 E-value=1.8e-07 Score=81.98 Aligned_cols=102 Identities=15% Similarity=0.175 Sum_probs=72.1
Q ss_pred cceeecccCccceeE------EEEEEEec--ccc-HHhHHHHHHHHHHHhcCC--CCcccceeeeEEeC---CeeEEEEe
Q 041718 162 INNKLGEGGFGLVYK------EIAVKRLS--KIS-EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQG---EEKLLIYE 227 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk------~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 227 (295)
..+.|+.|.++.||+ .+++|+.. ... ......+.+|+.+++.|. +..+.+++.++.+. ...++|||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 357889999999997 47777765 211 123457888999999987 45688899888766 34799999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ 280 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~ 280 (295)
|+++..+.+.. ...++...+..++.++++.|..||+
T Consensus 122 ~v~G~~l~~~~-----------------~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 122 FVSGRVLWDQS-----------------LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp CCCCBCCCCTT-----------------CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCeecCCCc-----------------cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 99987774311 1236677788888999999999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.57 E-value=7.5e-08 Score=80.07 Aligned_cols=75 Identities=17% Similarity=0.159 Sum_probs=53.8
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCc--ccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRN--LVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~ 228 (295)
.++.+....+.|..+.||+ .+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3455433334555688996 3788886542 2346788999998886544 56788888888889999999
Q ss_pred CCCCCHH
Q 041718 229 MPNKSLN 235 (295)
Q Consensus 229 ~~~gsL~ 235 (295)
++|.+|.
T Consensus 97 i~G~~l~ 103 (264)
T 1nd4_A 97 VPGQDLL 103 (264)
T ss_dssp CSSEETT
T ss_pred cCCcccC
Confidence 9998874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.97 E-value=2.2e-05 Score=66.96 Aligned_cols=71 Identities=17% Similarity=0.246 Sum_probs=49.5
Q ss_pred eeecccCccceeE---EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCc--ccceeeeEEeCC---eeEEEEecCCCCCH
Q 041718 164 NKLGEGGFGLVYK---EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN--LVKLLGCCIQGE---EKLLIYEFMPNKSL 234 (295)
Q Consensus 164 ~~lg~G~~g~Vyk---~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~gsL 234 (295)
+.++.|....||+ .+++|+... ......+.+|..+|..+. +.. +.+.+......+ ..|+|||+++|.+|
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l 103 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPL 103 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEEC
T ss_pred EecCCCCcceEEEECCEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeEC
Confidence 5688999999997 578887643 345678899999998884 333 344444433332 34889999999887
Q ss_pred HH
Q 041718 235 NS 236 (295)
Q Consensus 235 ~~ 236 (295)
..
T Consensus 104 ~~ 105 (304)
T 3sg8_A 104 TP 105 (304)
T ss_dssp CH
T ss_pred Cc
Confidence 65
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00027 Score=60.30 Aligned_cols=71 Identities=21% Similarity=0.228 Sum_probs=51.7
Q ss_pred eeecccCccceeE---EEEEEEeccccHHhHHHHHHHHHHHhcCCCC---cccceeeeEE-eCCeeEEEEecCCCCCHHH
Q 041718 164 NKLGEGGFGLVYK---EIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCI-QGEEKLLIYEFMPNKSLNS 236 (295)
Q Consensus 164 ~~lg~G~~g~Vyk---~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~gsL~~ 236 (295)
+.++.|....||+ .+++|+.. .......+..|..+|..|.+. .+.+.+.+.. ..+..++||||++|.+|..
T Consensus 25 ~~l~~G~~n~v~~vg~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 25 ESLGEGFRNYAILVNGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp EEEEECSSEEEEEETTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred eecCCCcceeEEEECCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 5677787788887 47777743 234567899999999999753 3566666654 3455789999999988865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=0.0016 Score=54.12 Aligned_cols=71 Identities=15% Similarity=0.236 Sum_probs=51.2
Q ss_pred eecccCcc-ceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 165 KLGEGGFG-LVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 165 ~lg~G~~g-~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
.+..|..+ .||+ .+.+|+-.. .....+.+|..+|+.|. +--+.+++++..+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34445544 5776 367776543 34567888999888774 33477888888899999999999999887
Q ss_pred HHHH
Q 041718 235 NSFI 238 (295)
Q Consensus 235 ~~~l 238 (295)
.+..
T Consensus 108 ~~~~ 111 (272)
T 4gkh_A 108 FQVL 111 (272)
T ss_dssp HHHH
T ss_pred cccc
Confidence 6644
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.30 E-value=0.0052 Score=53.20 Aligned_cols=73 Identities=4% Similarity=0.002 Sum_probs=46.1
Q ss_pred eee-cccCccceeEE--------------EEEEEecccc---HHhHHHHHHHHHHHhcCCC---CcccceeeeEEeC---
Q 041718 164 NKL-GEGGFGLVYKE--------------IAVKRLSKIS---EQGLKELKNEVILFSKLQH---RNLVKLLGCCIQG--- 219 (295)
Q Consensus 164 ~~l-g~G~~g~Vyk~--------------vavK~l~~~~---~~~~~~~~~Ei~~l~~l~h---~niv~l~~~~~~~--- 219 (295)
+.| +.|....+|+. +.+|+..... ......+..|+.+|+.|.. ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 566 67777777752 3455433211 0012467788888888753 3577788776554
Q ss_pred CeeEEEEecCCCCCHHH
Q 041718 220 EEKLLIYEFMPNKSLNS 236 (295)
Q Consensus 220 ~~~~lv~e~~~~gsL~~ 236 (295)
...++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.084 Score=44.90 Aligned_cols=67 Identities=18% Similarity=0.378 Sum_probs=36.7
Q ss_pred eeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCC--Ccccceee------eEEeCCeeEEEEecC
Q 041718 164 NKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQH--RNLVKLLG------CCIQGEEKLLIYEFM 229 (295)
Q Consensus 164 ~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~~ 229 (295)
+.|+.|..+.||+ .+++|+... .. ..+..|+.++..|.. -.+.+++. +....+..+++|||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4565566788886 478888764 22 233445555554431 12333332 123467789999999
Q ss_pred CCCCH
Q 041718 230 PNKSL 234 (295)
Q Consensus 230 ~~gsL 234 (295)
+|.++
T Consensus 114 ~G~~~ 118 (346)
T 2q83_A 114 EGRPF 118 (346)
T ss_dssp CCBCC
T ss_pred cCccC
Confidence 98655
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.90 E-value=0.038 Score=46.19 Aligned_cols=73 Identities=14% Similarity=0.175 Sum_probs=49.4
Q ss_pred ccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCC---cccceeeeEEeCCeeEEEEec
Q 041718 159 NFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHR---NLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~ 228 (295)
.....+.+|.|..+.||+ .+.+|+...........|..|...|+.|.-. -+.+.++. +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 444567899999999997 5888876543333345678899988887532 34455543 234789999
Q ss_pred CCCCCHH
Q 041718 229 MPNKSLN 235 (295)
Q Consensus 229 ~~~gsL~ 235 (295)
++.+...
T Consensus 92 l~~~~~~ 98 (288)
T 3f7w_A 92 VDERPPT 98 (288)
T ss_dssp CCCCCCC
T ss_pred ecccCCC
Confidence 9876543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.51 E-value=0.072 Score=45.30 Aligned_cols=88 Identities=17% Similarity=0.132 Sum_probs=66.4
Q ss_pred ceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCC---CCcccceeeeEEeCCeeEEEEecCCCCC
Q 041718 163 NNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQ---HRNLVKLLGCCIQGEEKLLIYEFMPNKS 233 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gs 233 (295)
.+.|+.|....+|+ .+.+|+... .....+..|...|+.|. ...+.+.+++....+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46789999999996 577887653 23567888988888874 3678889988887888999999998865
Q ss_pred HHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC
Q 041718 234 LNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS 282 (295)
Q Consensus 234 L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~ 282 (295)
+.. ..+.++.+.|+-||...
T Consensus 118 ~~~-----------------------------~~~~~lG~~LA~LH~~~ 137 (312)
T 3jr1_A 118 NKQ-----------------------------SSFTIFAEKIAQLHQIQ 137 (312)
T ss_dssp CCT-----------------------------THHHHHHHHHHHHHHCC
T ss_pred CCc-----------------------------hhHHHHHHHHHHHHcCC
Confidence 310 13456788889999864
|
| >1b9w_A Protein (merozoite surface protein 1); MSP-1, candidate malaria vaccine, surface antigen; 1.80A {Plasmodium cynomolgi} SCOP: g.3.11.4 g.3.11.4 PDB: 2npr_A | Back alignment and structure |
|---|
Probab=93.48 E-value=0.039 Score=37.08 Aligned_cols=44 Identities=20% Similarity=0.384 Sum_probs=34.4
Q ss_pred CCCCCCCCCCCccccc--CCCCccccCCCCeeCCCCCCCCCCCceeCCCcCcCC
Q 041718 2 LCDTYALCGAYGICII--SGMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNYSR 53 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~--~~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c~~ 53 (295)
.| +...|+.|+.|-. ++...|.|++||... ...|.++...+|..
T Consensus 6 ~C-~~tkcp~NA~Cyr~~dg~EecRCllnykk~-------~~kCV~~~~~~C~~ 51 (95)
T 1b9w_A 6 RC-IDTNVPENAACYRYLDGTEEWRCLLYFKED-------AGKCVPAPNMTCKD 51 (95)
T ss_dssp SC-SSCCCCTTEEEEECTTSCEEEEECTTEEEE-------TTEEEECTTCCTTT
T ss_pred cc-ccCCCCCCcCeEEEcCCCEEEEEECCeEec-------CCEEEcCCCCCccc
Confidence 46 5668999999953 578999999999874 24688888777764
|
| >1edm_B Factor IX; epidermal growth factor, EGF, calcium- binding, EGF-like domain, structure and function, coagulation factor; 1.50A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ixa_A | Back alignment and structure |
|---|
Probab=93.16 E-value=0.032 Score=31.25 Aligned_cols=31 Identities=32% Similarity=0.562 Sum_probs=23.3
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|. ...|-..|.|... +...|.|++||...
T Consensus 4 d~C~-~~pC~ngg~C~~~~~~~~C~C~~G~~G~ 35 (39)
T 1edm_B 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred ccCC-CCCCCCCCEeEcCCCceEeECCCCCcCC
Confidence 4575 4678888999753 56789999999653
|
| >1egf_A Epidermal growth factor; NMR {Mus musculus} SCOP: g.3.11.1 PDB: 1epg_A 1eph_A 1epi_A 1epj_A 3egf_A 1gk5_A | Back alignment and structure |
|---|
Probab=92.04 E-value=0.11 Score=31.35 Aligned_cols=33 Identities=21% Similarity=0.582 Sum_probs=24.2
Q ss_pred CCCCCC--CCCCCCcccc--c-CCCCccccCCCCeeCC
Q 041718 1 DLCDTY--ALCGAYGICI--I-SGMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~--~~CG~~~~C~--~-~~~~~C~C~~gf~~~~ 33 (295)
++|... ..|-..|.|. . .+...|.|++||....
T Consensus 4 ~~C~~~~~~pC~ngg~C~~~~~~~~~~C~C~~G~~G~~ 41 (53)
T 1egf_A 4 PGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDR 41 (53)
T ss_dssp CCCCTTSSCSSCSSCEEEEESSSSCEEEECCTTCCSSS
T ss_pred ccCCCCCCCcCCCCcEEEeeCCCCCEEEECCCCCcCCc
Confidence 356653 4788889997 3 3567899999997643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.99 E-value=0.12 Score=45.29 Aligned_cols=68 Identities=10% Similarity=0.217 Sum_probs=44.8
Q ss_pred ceeecccCccceeE--------EEEEEEeccccH-------HhHHHHHHHHHHHhcCCC--C-cccceeeeEEeCCeeEE
Q 041718 163 NNKLGEGGFGLVYK--------EIAVKRLSKISE-------QGLKELKNEVILFSKLQH--R-NLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk--------~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~h--~-niv~l~~~~~~~~~~~l 224 (295)
.+.||.|.++.||+ .++||....... .....+..|..+|..+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 46789999999996 378886542111 123456778888887742 3 34456543 4556789
Q ss_pred EEecCCCC
Q 041718 225 IYEFMPNK 232 (295)
Q Consensus 225 v~e~~~~g 232 (295)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >1a3p_A Epidermal growth factor; disulfide connectivities, EGF-like domain, repeat; HET: ABA; NMR {Mus musculus} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=90.68 E-value=0.14 Score=29.60 Aligned_cols=25 Identities=20% Similarity=0.538 Sum_probs=19.6
Q ss_pred CCCCCcccc--c-CCCCccccCCCCeeC
Q 041718 8 LCGAYGICI--I-SGMPVCQCLKGFKQK 32 (295)
Q Consensus 8 ~CG~~~~C~--~-~~~~~C~C~~gf~~~ 32 (295)
.|-..|.|. . .+...|.|++||...
T Consensus 10 pC~ngg~C~~~~~~~~~~C~C~~G~~G~ 37 (45)
T 1a3p_A 10 YCLNGGVXMHIESLDSYTCNCVIGYSGD 37 (45)
T ss_dssp CCSSSCEEEECTTTSSEEEECCTTEETT
T ss_pred CCCCCCEEEeecCCCCEEEEcCCCCcCC
Confidence 688889996 2 356789999999754
|
| >3u7u_G Neuregulin 1; signaling protein, transferase-transferase regulator complex glycosylation; HET: NAG; 3.03A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.56 E-value=0.17 Score=30.80 Aligned_cols=31 Identities=19% Similarity=0.458 Sum_probs=22.5
Q ss_pred CCCCCCCCCCCcccc-----c-CCCCccccCCCCeeCC
Q 041718 2 LCDTYALCGAYGICI-----I-SGMPVCQCLKGFKQKS 33 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~-----~-~~~~~C~C~~gf~~~~ 33 (295)
+|+ ...|-..|.|. . .....|.|++||....
T Consensus 10 eC~-s~pC~NgGtC~~~~~~d~~~~y~C~C~~g~~G~~ 46 (55)
T 3u7u_G 10 EKE-KTFCVNGGECFMVKDLSNPSRYLCKCPNEFTGDR 46 (55)
T ss_dssp STT-TTTSCTTCEEEEECCC--CCCEEEEECTTEESTT
T ss_pred CCc-CCCCCCCCCcCCCCccCCCCCEeEeCCCCCcCCC
Confidence 443 46798999993 2 2467999999997653
|
| >1k36_A Epiregulin; EGF-like fold, hormone/growth factor complex; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1k37_A | Back alignment and structure |
|---|
Probab=89.24 E-value=0.083 Score=30.88 Aligned_cols=31 Identities=26% Similarity=0.651 Sum_probs=21.9
Q ss_pred CCCC--CCCCCCCcccccC---CCCccccCCCCeeCC
Q 041718 2 LCDT--YALCGAYGICIIS---GMPVCQCLKGFKQKS 33 (295)
Q Consensus 2 ~C~~--~~~CG~~~~C~~~---~~~~C~C~~gf~~~~ 33 (295)
+|.. ...|-. |.|... +...|.|++||....
T Consensus 5 ~C~~~~~~pC~n-G~C~~~~~~~~~~C~C~~GytG~~ 40 (46)
T 1k36_A 5 KCSSDMNGYCLH-GQCIYLVDMSQNYCRCEVGYTGVR 40 (46)
T ss_dssp CCCTTCCSSCSS-EEEEEETTTTEEEEEECTTCSSTT
T ss_pred cCCCCCCCCCCC-CEeeccCCCCCEEEECCCCCccCC
Confidence 4554 267876 999742 467899999997643
|
| >1apq_A Complement protease C1R; EGF, calcium binding, serine protease; NMR {Homo sapiens} SCOP: g.3.11.1 | Back alignment and structure |
|---|
Probab=89.16 E-value=0.22 Score=29.79 Aligned_cols=25 Identities=24% Similarity=0.650 Sum_probs=19.1
Q ss_pred CCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 7 ALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 7 ~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
+.|. ..|... ++..|.|++||....
T Consensus 20 ~~C~--~~C~n~~Gsy~C~C~~Gy~~~~ 45 (53)
T 1apq_A 20 PQCQ--HLCHNYVGGYFCSCRPGYELQE 45 (53)
T ss_dssp CTTS--SEEEEETTEEEEECSTTCEECT
T ss_pred CCCC--CEeECCCCCeEEECCCCCeECC
Confidence 6785 489654 568999999998753
|
| >2jkh_L Factor X light chain; plasma, calcium, zymogen, secreted, protease, hydrolase, polymorphism, glycoprotein, gamma-carboxyglutamic acid; HET: BI7; 1.25A {Homo sapiens} PDB: 2bok_L* 2vvc_K* 2vvu_L* 2vvv_L* 2vwl_L* 2vwm_K* 2vwn_L* 2vwo_L* 2xbv_L* 2xbw_L* 2xbx_L* 2xby_L* 2xc0_L* 2xc4_L* 2xc5_L* 2gd4_L* 3kl6_B* 2y5f_L* 2y5g_L* 2y5h_L* ... | Back alignment and structure |
|---|
Probab=88.93 E-value=0.24 Score=30.07 Aligned_cols=45 Identities=22% Similarity=0.637 Sum_probs=29.2
Q ss_pred CCCCC-CCCCCCCcccccC-CCCccccCCCCeeCCCCCCCCCCCceeCCCcCcC
Q 041718 1 DLCDT-YALCGAYGICIIS-GMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNYS 52 (295)
Q Consensus 1 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c~ 52 (295)
|.|.. .+.|.. +|... ++..|.|++||...... .-|....+-.|.
T Consensus 2 dEC~~~~~~C~~--~C~nt~Gsy~C~C~~Gy~L~~d~-----~~C~didec~cg 48 (55)
T 2jkh_L 2 KLCSLDNGDCDQ--FCHEEQNSVVCSCARGYTLADNG-----KACIPTGPYPCG 48 (55)
T ss_dssp CCTTTGGGGCSS--EEEEETTEEEEECCTTEEECTTS-----SCEEESSSSCTT
T ss_pred ccccCCCCCcCc--EeEcCCCCeEEeCCCCCEECCCC-----CeeccCccccCC
Confidence 46764 456764 78653 56889999999875332 347765554453
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=88.84 E-value=0.85 Score=38.05 Aligned_cols=70 Identities=11% Similarity=0.206 Sum_probs=40.7
Q ss_pred ceeecccCccceeE--EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEecC-CCCCHH
Q 041718 163 NNKLGEGGFGLVYK--EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEFM-PNKSLN 235 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk--~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gsL~ 235 (295)
.+.|+.|....+|+ .+.+|+....... .....+|+.++..+....+ .++++. ..+.-++++||+ ++.+|.
T Consensus 23 i~~l~gG~tN~~~~~~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 23 PLERLGGLTNLVFRAGDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp CEEEESCSSEEEEEETTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred eeEcCCccccccceeeeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 57788888888887 4666665432111 1123457777766643333 455543 344467899999 665553
|
| >1n1i_A Merozoite surface protein-1; MSP1, malaria, surface antigen, glycoprotein, EGF domain, cell adhesion; HET: HIS; 2.40A {Plasmodium knowlesi strain H} SCOP: g.3.11.4 g.3.11.4 | Back alignment and structure |
|---|
Probab=88.04 E-value=0.45 Score=32.86 Aligned_cols=41 Identities=27% Similarity=0.493 Sum_probs=29.6
Q ss_pred CCCCCCCCCCCccccc--CCCCccccCCCCeeCCCCCCCCCCCceeCCCcCc
Q 041718 2 LCDTYALCGAYGICII--SGMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNY 51 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~--~~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c 51 (295)
.| +...|++|+.|.. .+...|.|++||... ...|... .+.|
T Consensus 12 ~C-~~t~Cp~NA~C~r~~~G~e~CrCl~gY~~d-------g~~Cv~~-Np~C 54 (105)
T 1n1i_A 12 KC-IDTNVPENAACYRYLDGTEEWRCLLGFKEV-------GGKCVPA-SITC 54 (105)
T ss_dssp SC-CSSCCCTTEEEEECTTSCEEEEECTTEEEC-------SSSEEEC-CCCT
T ss_pred Ee-cCCCCCCCCCeEECCCCCEeEEEECCeecc-------CCEEEEC-Ccch
Confidence 46 4558999999964 467899999999874 2457766 4444
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=87.42 E-value=0.22 Score=33.02 Aligned_cols=29 Identities=34% Similarity=0.783 Sum_probs=23.3
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCe
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFK 30 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~ 30 (295)
|+|.....|. ++.|... ++..|.|++||.
T Consensus 6 deC~~~~~C~-~g~C~n~~g~y~C~C~~Gy~ 35 (82)
T 1emn_A 6 DECKEPDVCK-HGQCINTDGSYRCECPFGYI 35 (82)
T ss_dssp CSSSSTTSCS-SSEECCCSSCCCEECCTTEE
T ss_pred ccCCCCCCcC-CCEEEecCCCEEEECCCCeE
Confidence 5787777886 5999764 678999999996
|
| >1emn_A Fibrillin; extracellular matrix, calcium-binding, glycoprotein, repeat, signal, multigene family, disease mutation, matrix protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 1emo_A | Back alignment and structure |
|---|
Probab=86.85 E-value=0.4 Score=31.68 Aligned_cols=28 Identities=36% Similarity=0.799 Sum_probs=13.7
Q ss_pred CCCCCCCCCCcccccC-CCCccccCCCCee
Q 041718 3 CDTYALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 3 C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
|.....|. ++.|... ++..|.|++||..
T Consensus 47 C~~~~~C~-~~~C~n~~g~y~C~C~~G~~g 75 (82)
T 1emn_A 47 CSVGNPCG-NGTCKNVIGGFECTCEEGFEP 75 (82)
T ss_dssp GGTCCTTS-SSCEEECSSSEEECCSSSSCC
T ss_pred ccCCCCCC-CCEeECCCCCEEeECCCCeEe
Confidence 44344454 3555432 3455666666543
|
| >1ob1_C Major merozoite surface protein; immune system, immunoglobulin/complex, immunoglobulin, antib fragment, MSP1-19, EGF-like domain; 2.90A {Plasmodium falciparum} SCOP: g.3.11.4 g.3.11.4 PDB: 1cej_A 2flg_A | Back alignment and structure |
|---|
Probab=86.28 E-value=0.51 Score=32.31 Aligned_cols=43 Identities=23% Similarity=0.553 Sum_probs=31.8
Q ss_pred CCCCCCCCCCCccccc--CCCCccccCCCCeeCCCCCCCCCCCceeCCCcCcC
Q 041718 2 LCDTYALCGAYGICII--SGMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNYS 52 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~--~~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c~ 52 (295)
.| +...|.+|+.|.. .+...|.|++||+... ..|..+...+|.
T Consensus 6 ~C-~~~~C~~NA~C~r~~~g~e~C~C~~gy~gdg-------~~Cv~~~~~sC~ 50 (99)
T 1ob1_C 6 QC-VKKQCPQNSGCFRHLDEREECKCLLNYKQEG-------DKCVENPNPTCN 50 (99)
T ss_dssp CC-CSCCCCTTEEEECCTTSCCEEEECTTEEEET-------TEEEECSCCCST
T ss_pred Ee-ccCCCCCCCCeEEcCCCCEEEEecCCeecCC-------CeEeeCCCCChh
Confidence 46 5578999999954 3678999999998731 468777655664
|
| >2k2s_B Micronemal protein 6; microneme protein complex, cell adhesion, cytoplasmic vesicl lectin, virulence, EGF-like domain, membrane; NMR {Toxoplasma gondii} PDB: 2k2t_A | Back alignment and structure |
|---|
Probab=86.00 E-value=0.086 Score=32.93 Aligned_cols=26 Identities=27% Similarity=0.765 Sum_probs=19.8
Q ss_pred CCCCCC--cccccC-CCCccccCCCCe-eC
Q 041718 7 ALCGAY--GICIIS-GMPVCQCLKGFK-QK 32 (295)
Q Consensus 7 ~~CG~~--~~C~~~-~~~~C~C~~gf~-~~ 32 (295)
..|... |.|... ++..|.|++||. ..
T Consensus 17 nPC~nga~gtC~~~~g~y~C~C~~Gy~~G~ 46 (61)
T 2k2s_B 17 NPCGPEAAGTCKETNSGYICRCNQGYRISL 46 (61)
T ss_dssp CSSCSSSCCEEEECSSEEEEECCTTEEEEE
T ss_pred CCCcCCCccccccCCCceEeECCCCCccCC
Confidence 457766 799764 467999999998 44
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=85.62 E-value=0.33 Score=36.12 Aligned_cols=30 Identities=30% Similarity=0.608 Sum_probs=23.3
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCee
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
|.|. ...|..+|.|... ++..|.|++||..
T Consensus 49 deC~-~~pC~n~g~C~~~~~~y~C~C~~G~~G 79 (146)
T 1x7a_L 49 DQCE-PNPCLNGGLCKDDINSYECWCQVGFEG 79 (146)
T ss_dssp -CCS-SCSSCTTCEEEECSSCEEEECCSSEES
T ss_pred CcCC-CCCCCCCCEeECCCCCEEEecCCCCcC
Confidence 3576 5679999999754 5678999999974
|
| >1hae_A Heregulin-alpha; growth factor; NMR {Homo sapiens} SCOP: g.3.11.1 PDB: 1haf_A 1hre_A 1hrf_A | Back alignment and structure |
|---|
Probab=84.96 E-value=0.39 Score=29.95 Aligned_cols=27 Identities=26% Similarity=0.688 Sum_probs=20.3
Q ss_pred CCCCCCCccccc------CCCCccccCCCCeeC
Q 041718 6 YALCGAYGICII------SGMPVCQCLKGFKQK 32 (295)
Q Consensus 6 ~~~CG~~~~C~~------~~~~~C~C~~gf~~~ 32 (295)
...|-..|.|.. .+...|.|++||...
T Consensus 11 ~~pC~ngG~C~~~~~~~~~~~y~C~C~~Gf~G~ 43 (63)
T 1hae_A 11 KTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGA 43 (63)
T ss_dssp HTTSCTTCEEEEEESSSSSCCEEEECCTTEEST
T ss_pred CCcCCCCcEEecCCccCCCCCEEEECCCCCcCC
Confidence 356888899974 246789999999754
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.95 E-value=0.57 Score=31.30 Aligned_cols=31 Identities=26% Similarity=0.730 Sum_probs=22.7
Q ss_pred CCCCCC-CCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDTY-ALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~-~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|... ..| .++.|... ++..|.|++||+..
T Consensus 4 deC~~~~~~C-~~~~C~n~~g~y~C~C~~G~~~~ 36 (87)
T 1z6c_A 4 DECSLKPSIC-GTAVCKNIPGDFECECPEGYRYN 36 (87)
T ss_dssp CSSSSSSSSB-TTSSCCCBTTBCCCSSSTTCEEE
T ss_pred ccccCCCCCC-CCCEeECCCCCEEEECCCCceEC
Confidence 456553 458 78999754 56899999999864
|
| >2vj3_A Neurogenic locus notch homolog protein 1; transcription, metal-binding, transmembrane, developmental protein, notch signaling pathway; 2.60A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 g.3.11.1 PDB: 1toz_A 2rqz_A* 2rr0_A 2rr2_A* | Back alignment and structure |
|---|
Probab=83.93 E-value=0.47 Score=34.66 Aligned_cols=32 Identities=38% Similarity=0.782 Sum_probs=25.3
Q ss_pred CCCCC-CCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDT-YALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|.. ...|..+|.|... +...|.|++||...
T Consensus 6 deC~~~~~~C~~~g~C~~~~g~~~C~C~~Gy~G~ 39 (135)
T 2vj3_A 6 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 39 (135)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCCEeECCCCCEEEECCCCCcCC
Confidence 46765 5789999999764 56799999999754
|
| >3ltf_D Protein spitz; receptor-ligand complex ectodomain cysteine rich domain EGF ATP-binding, kinase, nucleotide-binding, receptor; HET: NAG MAN; 3.20A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=83.86 E-value=0.25 Score=30.40 Aligned_cols=27 Identities=22% Similarity=0.488 Sum_probs=19.4
Q ss_pred CCCCCccccc-----CCCCccccCCCCeeCCC
Q 041718 8 LCGAYGICII-----SGMPVCQCLKGFKQKSR 34 (295)
Q Consensus 8 ~CG~~~~C~~-----~~~~~C~C~~gf~~~~~ 34 (295)
.|-..|.|.. .....|.|++||....-
T Consensus 15 pC~NGGtC~~~~~~~~~~~~C~C~~Gf~G~~C 46 (58)
T 3ltf_D 15 YCLNDAHCFAVKIADLPVYSCECAIGFMGQRC 46 (58)
T ss_dssp TSCSSCEEEEEEETTEEEEEEEECTTEESSSS
T ss_pred cCCCCCEEeCCccCCCCCEEeECCCCCccCCC
Confidence 5777788962 23468999999976543
|
| >1nql_B Epidermal growth factor; cell surface receptor, tyrosine kinase, glycoprotein, endoso growth factor, auto-inhibition; HET: NAG BMA; 2.80A {Homo sapiens} SCOP: g.3.11.1 PDB: 1ivo_C* 2kv4_A 1jl9_A 1p9j_A 3njp_C* | Back alignment and structure |
|---|
Probab=83.76 E-value=0.28 Score=29.54 Aligned_cols=29 Identities=21% Similarity=0.541 Sum_probs=21.5
Q ss_pred CCCCCCCcccc--c-CCCCccccCCCCeeCCC
Q 041718 6 YALCGAYGICI--I-SGMPVCQCLKGFKQKSR 34 (295)
Q Consensus 6 ~~~CG~~~~C~--~-~~~~~C~C~~gf~~~~~ 34 (295)
...|-..|.|. . .+...|.|++||....-
T Consensus 11 ~~pC~nGG~C~~~~~~~~~~C~C~~GytG~~C 42 (53)
T 1nql_B 11 DGYCLHDGVCMYIEALDKYACNCVVGYIGERC 42 (53)
T ss_dssp CCEECTTCEEEEETTTTEEEEEECTTEESTTS
T ss_pred CCCCCCCeEEeeecCCCCEEEecCCCCcCCCC
Confidence 35687889996 2 24679999999987543
|
| >2rnl_A Amphiregulin; AR, colorectum cell-derived growth factor, EGF-like domain, CRDGF, cytokine, glycoprotein, membrane, polymorphism, transmembrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.73 E-value=0.4 Score=28.49 Aligned_cols=30 Identities=20% Similarity=0.552 Sum_probs=20.8
Q ss_pred CCCC--CCCCCCCccccc---CCCCccccCCCCeeC
Q 041718 2 LCDT--YALCGAYGICII---SGMPVCQCLKGFKQK 32 (295)
Q Consensus 2 ~C~~--~~~CG~~~~C~~---~~~~~C~C~~gf~~~ 32 (295)
+|.. .++|- +|.|.+ .+.+.|.|++||...
T Consensus 11 ~C~~~~~~yC~-nG~C~~i~~~~~~~C~C~~gy~G~ 45 (50)
T 2rnl_A 11 PCNAEFQNFCI-HGECKYIEHLEAVTCKCQQEYFGE 45 (50)
T ss_dssp TTTTTGGGTCS-SSEEEEETTTTEEEEECCSSCCSS
T ss_pred ccCchhhCcCC-CCEEEEecCCCCeeEECCCCcccc
Confidence 4553 46676 478863 246899999999653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=82.84 E-value=0.059 Score=48.80 Aligned_cols=32 Identities=16% Similarity=0.010 Sum_probs=25.1
Q ss_pred HHhHHHHHHHHHHHhcCCCCcccceeeeEEeC
Q 041718 188 EQGLKELKNEVILFSKLQHRNLVKLLGCCIQG 219 (295)
Q Consensus 188 ~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~ 219 (295)
.++.++|..|++++++++|+|||+++|||...
T Consensus 320 ~~g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 320 GQGSETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp -----CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred cccHHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 34567899999999999999999999998654
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.58 E-value=0.18 Score=45.36 Aligned_cols=54 Identities=17% Similarity=0.234 Sum_probs=16.5
Q ss_pred cceeecccCccceeE--------EEEE------EEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe
Q 041718 162 INNKLGEGGFGLVYK--------EIAV------KRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ 218 (295)
Q Consensus 162 ~~~~lg~G~~g~Vyk--------~vav------K~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~ 218 (295)
+.++|| ||.||+ .||| |.... .+......+.+|..++..++|+|+++.+++-..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345666 999996 3566 54432 122334568889999999999999999998654
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=82.27 E-value=1.3 Score=29.23 Aligned_cols=35 Identities=26% Similarity=0.566 Sum_probs=27.6
Q ss_pred cCCChHHHHHHhhcCCCccceecccccCCCcceeeecc
Q 041718 75 KSMNLNECWEKCLDDSSCMAYTNSYIRGEGSGCAMWFG 112 (295)
Q Consensus 75 ~~~~~~~C~~~Cl~~CsC~a~~~~~~~~~g~~C~~w~~ 112 (295)
..+++++|+..|+.+-.|.+|.|.- ....|.++.+
T Consensus 28 ~~~sl~~Cq~aC~a~~~C~aFTyN~---~s~~CflKs~ 62 (82)
T 2ll3_A 28 RASSLSECRARCQAEKECSHYTYNV---KSGLCYPKRG 62 (82)
T ss_dssp ECSSHHHHHHHHHHCTTEEEEEEET---TTTEEEEEES
T ss_pred cCCCHHHHHHHhhccCCCCeEEecc---CCCceEcccC
Confidence 3568999999999999999999853 2345888654
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=81.51 E-value=0.45 Score=31.70 Aligned_cols=31 Identities=35% Similarity=0.849 Sum_probs=22.7
Q ss_pred CCCCC-CCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDT-YALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|.. +..|. ++.|... ++..|.|++||+..
T Consensus 4 deC~~~~~~C~-~g~C~n~~g~y~C~C~~Gy~~~ 36 (86)
T 1lmj_A 4 DECRISPDLCG-RGQCVNTPGDFECKCDEGYESG 36 (86)
T ss_dssp CTTTTCSSTTT-TSCEEEETTEEEECCCSSEEEC
T ss_pred ccccCCCCCCC-CCEEECCCCCEEeeCCCCcCcc
Confidence 46765 45685 5799754 56799999999864
|
| >1nfu_B Coagulation factor XA, light chain; hydrolase; HET: RRP; 2.05A {Homo sapiens} SCOP: g.3.11.1 PDB: 2h9e_L* | Back alignment and structure |
|---|
Probab=80.28 E-value=0.34 Score=38.01 Aligned_cols=29 Identities=34% Similarity=0.827 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCcccccC-CCCccccCCCCee
Q 041718 2 LCDTYALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
.|. ...|..+|.|... ++..|.|++||..
T Consensus 44 eC~-~~pC~ngg~C~n~~g~y~C~C~~Gf~G 73 (195)
T 1nfu_B 44 QCE-TSPCQNQGKCKDGLGEYTCTCLEGFEG 73 (195)
T ss_dssp -------------------------------
T ss_pred ccC-CCCCCCCCEeECCCCCeeEeCCCCcee
Confidence 565 4569889999754 5678999999974
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 295 | ||||
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-29 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-29 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-29 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-28 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-27 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-26 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-26 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-25 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-25 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-24 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-23 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-22 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-22 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-22 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-21 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-21 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-20 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-20 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-20 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-19 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-18 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-17 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-17 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-16 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-15 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-15 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-14 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-14 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-11 |
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-30
Identities = 41/156 (26%), Positives = 62/156 (39%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQG-LKELKNEVILFSK 203
+ S LG G FG V + +AVK L + + L +E+ + S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN---FVLTLMRSFVDQERCKIL 259
L H N+V LLG C G L+I E+ L +F+ F+ + + ++ L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
D A+G+ +L IHRDL A N
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARN 175
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 8e-30
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 16/151 (10%)
Query: 158 DNFSINNKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKL-Q 205
++ + +GEG FG V K + A+KR+ + S+ ++ E+ + KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKR 264
H N++ LLG C L E+ P+ +L F+ ++ VL +F L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
H ARG+ YL Q + IHRDL A N
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARN 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-29
Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 25/149 (16%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH 206
N D + I +LG+G FG VYK A K + SE+ L++ E+ + + H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
N+VKLL ++ EF ++++ + E + L S+
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--------------ELERPLTESQIQV 114
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ T + YLH +IIHRDLKA N
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGN 140
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-29
Identities = 30/149 (20%), Positives = 54/149 (36%), Gaps = 26/149 (17%)
Query: 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQH 206
D+F ++LG G G+V+K +A K + I ++ E+ + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
+V G E + E M SL+ + + +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA---------------GRIPEQILGK 108
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +G+ YL K +I+HRD+K SN
Sbjct: 109 VSIAVIKGLTYLR--EKHKIMHRDVKPSN 135
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 3e-29
Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-----EIAVKRL--SKISEQGLKELKNEVILFSKLQHRNLV 210
++ ++G G FG VYK ++AVK L + + Q L+ KNEV + K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+G + ++ ++ SL + + K I
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHL--------------HIIETKFEMIKLIDIARQ 112
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
TA+G+ YLH S IIHRDLK++N
Sbjct: 113 TAQGMDYLHAKS---IIHRDLKSNN 134
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (272), Expect = 8e-29
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ + +LG G FG V+ ++AVK L + E L +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L Q E +I E+M N SL F+ L +K +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-------------SGIKLTINKLLDMAAQ 117
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ ++ + + IHRDL+A+N
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAAN 139
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-28
Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 26/161 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQG-LKELKNEVILFSK 203
+N LG G FG V ++AVK L + ++ + L +E+ + ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 204 L-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFEN--------FVLTLMRSFVDQE 254
L H N+V LLG C LI+E+ L +++ + ++E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 255 RCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+L + A+G+ +L +HRDL A N
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN 194
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 4e-28
Identities = 36/152 (23%), Positives = 66/152 (43%), Gaps = 30/152 (19%)
Query: 156 ATDNFSI-NNKLGEGGFGLVYK----------EIAVKRLSKISEQG-LKELKNEVILFSK 203
DN I + +LG G FG V + ++A+K L + +E+ +E+ E + +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
L + +V+L+G C Q E +L+ E L+ F+ + + + S
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV--------------GKREEIPVSN 110
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ + G+ YL + +HRDL A N
Sbjct: 111 VAELLHQVSMGMKYLEE---KNFVHRDLAARN 139
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-28
Identities = 31/145 (21%), Positives = 55/145 (37%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ +G+G FG V ++AVK + + + E + ++L+H NLV+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 64
Query: 212 LLGCCIQGEEKL-LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
LLG ++ + L ++ E+M SL ++ +L
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-------------GRSVLGGDCLLKFSLD 111
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ YL +HRDL A N
Sbjct: 112 VCEAMEYLE---GNNFVHRDLAARN 133
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 1e-27
Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 29/158 (18%)
Query: 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNE 197
EL + FS ++G G FG VY +A+K++S S + +++ E
Sbjct: 6 ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 198 VILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCK 257
V KL+H N ++ GC ++ L+ E+ + + K
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---------------K 110
Query: 258 ILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
L + + G +G+ YLH +IHRD+KA N
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGN 145
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 3e-27
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 149 ELATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKEL 194
+L ++ +N +GEG FG V++ +AVK L + S +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 195 KNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLM------- 247
+ E L ++ + N+VKLLG C G+ L++E+M LN F+ T+
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 248 --RSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R+ V L +++ I A G+ YL + + +HRDL N
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN 170
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 105 bits (262), Expect = 8e-27
Identities = 32/146 (21%), Positives = 58/146 (39%), Gaps = 25/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
D++ I+ +LG G FG+V++ A K + E + ++ E+ S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V L E ++IYEFM L + + + + +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA--------------DEHNKMSEDEAVEYMR 131
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ ++H + +H DLK N
Sbjct: 132 QVCKGLCHMH---ENNYVHLDLKPEN 154
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (259), Expect = 9e-27
Identities = 28/155 (18%), Positives = 69/155 (44%), Gaps = 27/155 (17%)
Query: 149 ELATIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVIL 200
+ ++ + ++ K+G+G G VY E+A+++++ + + + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
+ ++ N+V L + G+E ++ E++ SL + E + D
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------------D 114
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + + + +LH ++IHRD+K+ N
Sbjct: 115 EGQIAAVCRECLQALEFLHS---NQVIHRDIKSDN 146
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-26
Identities = 30/145 (20%), Positives = 57/145 (39%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ ++G G FGLV+ ++A+K + + ++ E + KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L G C++ L++EFM + L+ + + + + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY--------------LRTQRGLFAAETLLGMCLD 109
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
G + + +IHRDL A N
Sbjct: 110 VCEG---MAYLEEACVIHRDLAARN 131
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-26
Identities = 30/152 (19%), Positives = 58/152 (38%), Gaps = 25/152 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 207
+++ + +G G +G K + K L ++E + L +EV L +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 208 NLVKLLGCCIQGEEKL--LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
N+V+ I ++ E+ L S I + + + LD
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG-----------TKERQYLDEEFVL 112
Query: 266 HIICGTARGVMYLHQ--DSKLRIIHRDLKASN 295
++ + H+ D ++HRDLK +N
Sbjct: 113 RVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 102 bits (256), Expect = 7e-26
Identities = 30/146 (20%), Positives = 56/146 (38%), Gaps = 25/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
D + I +LG G FG+V++ K ++ +KNE+ + ++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+ L E +LI EF+ L I + ++ + +
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--------------AAEDYKMSEAEVINYMR 134
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
G+ ++H+ I+H D+K N
Sbjct: 135 QACEGLKHMHE---HSIVHLDIKPEN 157
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 7e-26
Identities = 31/145 (21%), Positives = 53/145 (36%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
+ + +LG G FG+V ++A+K + + E E + L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L G C + +I E+M N L +++ E + +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR--------------EMRHRFQTQQLLEMCKD 108
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ YL + +HRDL A N
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARN 130
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-26
Identities = 37/152 (24%), Positives = 68/152 (44%), Gaps = 22/152 (14%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSK 203
+ +++ +LG+G FG+VY+ +A+K +++ S + E NE + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
++V+LLG QG+ L+I E M L S++ + + SK
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL-----RPAMANNPVLAPPSLSK 134
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A G+ YL+ + + +HRDL A N
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARN 163
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 9e-26
Identities = 33/147 (22%), Positives = 54/147 (36%), Gaps = 27/147 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRN 208
+++ + LGEG +G V +AVK + + + +K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
+VK G +G + L E+ L I + +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---------------IGMPEPDAQRFF 109
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKASN 295
GV+YLH + I HRD+K N
Sbjct: 110 HQLMAGVVYLHG---IGITHRDIKPEN 133
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (252), Expect = 1e-25
Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+ ++ +KLG G +G VY+ +AVK L + ++E E + +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
V+LLG C + +I EFM +L ++ E + + ++
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-------------NRQEVSAVVLLYMAT 122
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL + IHRDL A N
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARN 145
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-25
Identities = 38/149 (25%), Positives = 60/149 (40%), Gaps = 29/149 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQH 206
++F I LG+G FG VY +A+K L K +L+ EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
N+++L G LI E+ P ++ + ++ D +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---------------QKLSKFDEQRTAT 110
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
I A + Y H R+IHRD+K N
Sbjct: 111 YITELANALSYCHS---KRVIHRDIKPEN 136
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (249), Expect = 3e-25
Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 38/169 (22%)
Query: 148 FELATIANATDNFS---------INNKLGEGGFGLVYK-----------EIAVKRLSK-I 186
F A F+ I +G G FG V +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 187 SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTL 246
+E+ ++ +E + + H N++ L G + ++I EFM N SL+SF+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR------- 119
Query: 247 MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + ++ G A G+ YL + +HRDL A N
Sbjct: 120 -------QNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARN 158
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 4e-25
Identities = 41/156 (26%), Positives = 64/156 (41%), Gaps = 21/156 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK---------------EIAVKRLSK-ISEQGLKELKNEVILF 201
D + LGEG FG V ++AVK L +E+ L +L +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 202 SKL-QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERC-KIL 259
+ +H+N++ LLG C Q +I E+ +L ++ L S+ + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
ARG+ YL + IHRDL A N
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 165
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.2 bits (244), Expect = 1e-24
Identities = 37/149 (24%), Positives = 50/149 (33%), Gaps = 29/149 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQH 206
++F LGEG F V E A+K L K I E + + E + S+L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
VKL E+ + N L +I + D +
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---------------KIGSFDETCTRF 112
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ YLH IIHRDLK N
Sbjct: 113 YTAEIVSALEYLH---GKGIIHRDLKPEN 138
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 3e-24
Identities = 35/145 (24%), Positives = 60/145 (41%), Gaps = 25/145 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLV 210
++ + KLG+G FG V+ +A+K L + E + KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+L + E ++ E+M SL F+ E K L + +
Sbjct: 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLK-------------GETGKYLRLPQLVDMAAQ 121
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
A G+ Y+ + + +HRDL+A+N
Sbjct: 122 IASGMAYVER---MNYVHRDLRAAN 143
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (237), Expect = 8e-24
Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 30/150 (20%)
Query: 160 FSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNL 209
+ ++G G F VYK E+A L +++ + K E + LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 210 VKLLGCCIQGEEK----LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
V+ + +L+ E M + +L +++ R K++
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---------------RFKVMKIKVLR 115
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+G+ +LH + IIHRDLK N
Sbjct: 116 SWCRQILKGLQFLHTRTP-PIIHRDLKCDN 144
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 4e-23
Identities = 37/152 (24%), Positives = 54/152 (35%), Gaps = 32/152 (21%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSK---ISEQGLKELKNEVILFSK 203
+ + KLG+G FG+V + +AVK L + + + EV
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
L HRNL++L G + K ++ E P SL + +
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR--------------KHQGHFLLGT 112
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
A G+ YL R IHRDL A N
Sbjct: 113 LSRYAVQVAEGMGYLES---KRFIHRDLAARN 141
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 4e-23
Identities = 33/145 (22%), Positives = 57/145 (39%), Gaps = 31/145 (21%)
Query: 163 NNKLGEGGFGLVYK----------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLV 210
+ +LG G FG V K +AVK L EL E + +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
+++G C + E +L+ E LN ++ +N + + ++
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQN---------------RHVKDKNIIELVHQ 115
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ YL + +HRDL A N
Sbjct: 116 VSMGMKYLEE---SNFVHRDLAARN 137
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.2 bits (236), Expect = 5e-23
Identities = 31/152 (20%), Positives = 56/152 (36%), Gaps = 32/152 (21%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVI---LFSK 203
++FS++ +G GGFG VY A+K L K +QG NE I L S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
+V + ++ I + M L+ + ++ + +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---------------GVFSEAD 108
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ ++H +++RDLK +N
Sbjct: 109 MRFYAAEIILGLEHMHN---RFVVYRDLKPAN 137
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.4 bits (231), Expect = 8e-23
Identities = 31/153 (20%), Positives = 57/153 (37%), Gaps = 32/153 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ +G+G FG V++ E+AVK S E+ + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILG 61
Query: 212 LLGCCIQGEEKL----LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
+ + L+ ++ + SL ++ + +
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----------------NRYTVTVEGMIKL 105
Query: 268 ICGTARGVMYLHQD-----SKLRIIHRDLKASN 295
TA G+ +LH + K I HRDLK+ N
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 2e-22
Identities = 28/146 (19%), Positives = 54/146 (36%), Gaps = 26/146 (17%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+ + I LG G FG+V++ K + K+ +K E+ + + +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNI 63
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+ L EE ++I+EF+ + I L+ + +
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--------------NTSAFELNEREIVSYVH 109
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+ +LH I H D++ N
Sbjct: 110 QVCEALQFLHS---HNIGHFDIRPEN 132
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 2e-22
Identities = 31/150 (20%), Positives = 54/150 (36%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKISEQGLKE-LKNEVILFSKLQ 205
+ + +GEG FG V++ +A+K + ++E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H ++VKL+G + +I E L SF+ R LD +
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQ--------------VRKYSLDLASLI 111
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + YL R +HRD+ A N
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARN 138
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 3e-22
Identities = 41/184 (22%), Positives = 70/184 (38%), Gaps = 40/184 (21%)
Query: 127 LYIRMSA--SEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK-------- 176
++I +SA E+ + + L +F N +G G FG VY
Sbjct: 2 VHIDLSALNPELVQAVQHVVIGPSSL------IVHF--NEVIGRGHFGCVYHGTLLDNDG 53
Query: 177 ---EIAVKRLSKISEQG-LKELKNEVILFSKLQHRNLVKLLGCCIQGEEK-LLIYEFMPN 231
AVK L++I++ G + + E I+ H N++ LLG C++ E L++ +M +
Sbjct: 54 KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH 113
Query: 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291
L +FI A+G + + + +HRDL
Sbjct: 114 GDLRNFIR--------------NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDL 156
Query: 292 KASN 295
A N
Sbjct: 157 AARN 160
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 9e-22
Identities = 24/153 (15%), Positives = 60/153 (39%), Gaps = 24/153 (15%)
Query: 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG-LKELKNEVILFS 202
+ + ++ + +GEG +G+V +A+K++S Q + E+ +
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 203 KLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWS 262
+ +H N++ + + + ++ + + ++ + + L
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY------------KLLKTQHLSND 109
Query: 263 KRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + RG+ Y+H ++HRDLK SN
Sbjct: 110 HICYFLYQILRGLKYIHS---ANVLHRDLKPSN 139
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-21
Identities = 36/155 (23%), Positives = 58/155 (37%), Gaps = 20/155 (12%)
Query: 158 DNFSINNKLGEGGFGLVYK-------------EIAVKRLSKISEQGLKE--LKNEVILFS 202
D + LG G FG V + +AVK L + + + IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 203 KLQHRNLVKLLGCCIQGEEKLLI-YEFMPNKSLNSFIFENFVLTLMRSFVDQERCK-ILD 260
H N+V LLG C + L++ EF +L++++ + ++ K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
A+G+ +L + IHRDL A N
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARN 164
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 89.0 bits (220), Expect = 2e-21
Identities = 27/154 (17%), Positives = 51/154 (33%), Gaps = 33/154 (21%)
Query: 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQ 205
+D + + LG GG V+ ++AVK L + E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 206 HRNLVKLLGCCI----QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
H +V + G ++ E++ +L + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---------------HTEGPMTP 110
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +I + + + HQ IIHRD+K +N
Sbjct: 111 KRAIEVIADACQALNFSHQ---NGIIHRDVKPAN 141
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 7e-21
Identities = 39/156 (25%), Positives = 63/156 (40%), Gaps = 32/156 (20%)
Query: 153 IANATDNFSINNKLGEGGFGLVYK------------EIAVKRLSKI-SEQGLKELKNEVI 199
I T+ F LG G FG VYK +A+K L + S + KE+ +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 200 LFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
+ + + + ++ +LLG C+ LI + MP L ++ E +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVR--------------EHKDNI 108
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ A+G+ YL R++HRDL A N
Sbjct: 109 GSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARN 141
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-20
Identities = 34/151 (22%), Positives = 61/151 (40%), Gaps = 30/151 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKL 204
+ +G G FG VYK +A+K L +E+ + E + +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 205 QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKR 264
H N+++L G + + ++I E+M N +L+ F +E+ +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKF--------------LREKDGEFSVLQL 112
Query: 265 FHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ G A G+ YL + +HRDL A N
Sbjct: 113 VGMLRGIAAGMKYLA---NMNYVHRDLAARN 140
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 87.8 bits (217), Expect = 1e-20
Identities = 35/150 (23%), Positives = 55/150 (36%), Gaps = 27/150 (18%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQG-LKELKNEVILFSKLQ 205
+ D + + LG G F V +A+K ++K + +G ++NE+ + K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H N+V L G LI + + L I E
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---------------GFYTERDAS 110
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+I V YLH I+HRDLK N
Sbjct: 111 RLIFQVLDAVKYLHDL---GIVHRDLKPEN 137
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.5 bits (216), Expect = 1e-20
Identities = 29/149 (19%), Positives = 56/149 (37%), Gaps = 29/149 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQH 206
+F I LG G FG V+ A+K L K + + ++ +E ++ S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
++++ G ++ +I +++ L S + ++ R
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ------------RFPNPVAKFYAA 111
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+C + L II+RDLK N
Sbjct: 112 EVC------LALEYLHSKDIIYRDLKPEN 134
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 2e-20
Identities = 29/152 (19%), Positives = 54/152 (35%), Gaps = 33/152 (21%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+++ +G G FG+VY+ +A+K++ + E+ + KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNI 75
Query: 210 VKLLGCCIQGEEK------LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
V+L EK L+ +++P + + L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS------------RAKQTLPVIY 123
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ R + Y+H I HRD+K N
Sbjct: 124 VKLYMYQLFRSLAYIHS---FGICHRDIKPQN 152
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 6e-20
Identities = 38/148 (25%), Positives = 60/148 (40%), Gaps = 27/148 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVK--RLSKISEQGLKELKNEVILFSKLQHR 207
+NF K+GEG +G+VYK +A+K RL +E E+ L +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+VKLL + L++EF+ F+D +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--------------KFMDASALTGIPLPLIKSY 107
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +G+ + H R++HRDLK N
Sbjct: 108 LFQLLQGLAFCH---SHRVLHRDLKPQN 132
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.4 bits (208), Expect = 2e-19
Identities = 31/150 (20%), Positives = 54/150 (36%), Gaps = 30/150 (20%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEV-ILFSKLQ 205
++F ++ LG+G FG V+ A+K L K + + ++ E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 206 HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRF 265
H L + E + E++ L I + C D S+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---------------QSCHKFDLSRAT 106
Query: 266 HIICGTARGVMYLHQDSKLRIIHRDLKASN 295
G+ +LH I++RDLK N
Sbjct: 107 FYAAEIILGLQFLH---SKGIVYRDLKLDN 133
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 82.4 bits (203), Expect = 6e-19
Identities = 31/156 (19%), Positives = 53/156 (33%), Gaps = 36/156 (23%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---------ISEQGLKELKNEVIL 200
+N+ LG G +V + E AVK + ++ + EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 201 FSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKIL 259
K+ H N+++L L+++ M L ++ L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---------------TEKVTL 107
Query: 260 DWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ I+ + LH KL I+HRDLK N
Sbjct: 108 SEKETRKIMRALLEVICALH---KLNIVHRDLKPEN 140
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.5 bits (200), Expect = 2e-18
Identities = 31/154 (20%), Positives = 59/154 (38%), Gaps = 26/154 (16%)
Query: 156 ATDNFSINNKLGEGGFGLVYK---------EIAVKRLSK--ISEQGLKELKNEVILFSKL 204
A + ++GEG +G V+K +A+KR+ E EV + L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 205 ---QHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+H N+V+L C + + ++ + +++D+ +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD---------LTTYLDKVPEPGVPT 115
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ RG+ +LH R++HRDLK N
Sbjct: 116 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQN 146
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 80.7 bits (198), Expect = 3e-18
Identities = 33/145 (22%), Positives = 54/145 (37%), Gaps = 27/145 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK-------EIAVK--RLSKISEQGLKELKNEVILFSKLQHRN 208
+ + K+GEG +G+VYK A+K RL K E E+ + +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 209 LVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHII 268
+VKL + +L++E + L+ +
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---------------GGLESVTAKSFL 106
Query: 269 CGTARGVMYLHQDSKLRIIHRDLKA 293
G+ Y H R++HRDLK
Sbjct: 107 LQLLNGIAYCHD---RRVLHRDLKP 128
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 80.6 bits (198), Expect = 6e-18
Identities = 36/177 (20%), Positives = 53/177 (29%), Gaps = 33/177 (18%)
Query: 130 RMSASEIENRNMDLELPLFELATIANATDNFSINNKLGEGGFGLVYK--------EIAVK 181
A E+ E P A + D F LG G FG V A+K
Sbjct: 17 EFLAKAKEDFLKKWETPSQNTAQL----DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72
Query: 182 RLSK---ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFI 238
L K + + ++ NE + + LVKL ++ E++ + S +
Sbjct: 73 ILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132
Query: 239 FENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
R YLH L +I+RDLK N
Sbjct: 133 R---------------RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPEN 171
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 9e-18
Identities = 33/148 (22%), Positives = 59/148 (39%), Gaps = 24/148 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 207
+ +G G +G V ++A+K+L + SE K E+ L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N++ LL E +F ++ F+ T + + E+ L + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDF--------YLVMPFMGTDLGKLMKHEK---LGEDRIQFL 126
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +G+ Y+H IIHRDLK N
Sbjct: 127 VYQMLKGLRYIH---AAGIIHRDLKPGN 151
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.4 bits (195), Expect = 1e-17
Identities = 28/152 (18%), Positives = 55/152 (36%), Gaps = 35/152 (23%)
Query: 158 DNFSINNK-LGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEV-ILFSKLQHR 207
D++ + ++ LG G G V + + A+K L + + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 208 NLVKLLGCCIQGEEK----LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
++V+++ L++ E + L S I + + +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-------------GDQAFTERE 112
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
I+ + YLH + I HRD+K N
Sbjct: 113 ASEIMKSIGEAIQYLH---SINIAHRDVKPEN 141
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.2 bits (189), Expect = 5e-17
Identities = 36/145 (24%), Positives = 58/145 (40%), Gaps = 31/145 (21%)
Query: 164 NKLGEGGFGLVYK--------EIAVKRLSKISEQGLKE-----LKNEVILFSKLQHRNLV 210
+ LGEG F VYK +A+K++ K+ E+ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 211 KLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
LL L+++FM + ++ +L S +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE---------------VIIKDNSLVLTPSHIKAYMLM 108
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
T +G+ YLHQ I+HRDLK +N
Sbjct: 109 TLQGLEYLHQH---WILHRDLKPNN 130
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.7 bits (188), Expect = 1e-16
Identities = 28/149 (18%), Positives = 45/149 (30%), Gaps = 29/149 (19%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK---ISEQGLKELKNEVILFSKLQH 206
++F LG+G FG V A+K L K I++ + E + +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 207 RNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
L L + + E+ L + V T R
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------------------ 106
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
A V L +++RD+K N
Sbjct: 107 ARFYGAEIVSALEYLHSRDVVYRDIKLEN 135
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 2e-16
Identities = 36/155 (23%), Positives = 58/155 (37%), Gaps = 32/155 (20%)
Query: 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS------EQGLKELKNEVIL 200
N D + +LG G F +V K + A K + K ++++ EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 201 FSKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILD 260
++QH N++ L + +LI E + L F+ E + L
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---------------ESLT 111
Query: 261 WSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + GV YLH L+I H DLK N
Sbjct: 112 EEEATEFLKQILNGVYYLH---SLQIAHFDLKPEN 143
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 75.6 bits (185), Expect = 2e-16
Identities = 23/146 (15%), Positives = 48/146 (32%), Gaps = 27/146 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
+ + + K+G G FG +Y E+A+K ++ +L E ++ +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+ + C + ++ + SL + + +
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSL--------------EDLFNFCSRKFSLKTVLLLAD 110
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
+ Y+H IHRD+K N
Sbjct: 111 QMISRIEYIHS---KNFIHRDVKPDN 133
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 1e-15
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 24/154 (15%)
Query: 152 TIANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILF 201
TI + + + +G G +G V +AVK+LS+ S K E+ L
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 202 SKLQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
++H N++ LL + ++ + + + + +C+ L
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDV--------YLVTHLMGADLN---NIVKCQKLTD 120
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+I RG+ Y+H IIHRDLK SN
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSN 151
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.7 bits (177), Expect = 2e-15
Identities = 33/148 (22%), Positives = 56/148 (37%), Gaps = 28/148 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 207
+ K+GEG +G V+K +A+KR+ E E+ L +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+V+L ++ L++EF F N LD
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN---------------GDLDPEIVKSF 106
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ +G+ + H ++HRDLK N
Sbjct: 107 LFQLLKGLGFCHS---RNVLHRDLKPQN 131
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 72.9 bits (178), Expect = 2e-15
Identities = 20/146 (13%), Positives = 51/146 (34%), Gaps = 27/146 (18%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL 209
++ + ++GEG FG++++ ++A+K + S+ +L++E + L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 210 VKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIIC 269
+ + Q ++ + SL + +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLL--------------DLCGRKFSVKTVAMAAK 108
Query: 270 GTARGVMYLHQDSKLRIIHRDLKASN 295
V +H+ +++RD+K N
Sbjct: 109 QMLARVQSIHE---KSLVYRDIKPDN 131
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 6e-15
Identities = 31/154 (20%), Positives = 48/154 (31%), Gaps = 33/154 (21%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKN------EVILFSK 203
+ + LG GGFG VY +A+K + K EL N EV+L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 204 LQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
+ +++LL + + +LI E L
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--------------TERGALQE 109
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
V + H ++HRD+K N
Sbjct: 110 ELARSFFWQVLEAVRHCH---NCGVLHRDIKDEN 140
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 8e-15
Identities = 30/148 (20%), Positives = 56/148 (37%), Gaps = 20/148 (13%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 207
+ K+G+G FG V+K ++A+K++ E E+ + L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N+V L+ C + +F+ L + L KR
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIY-----LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + L+ + +I+HRD+KA+N
Sbjct: 125 ML-----LNGLYYIHRNKILHRDMKAAN 147
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 9e-15
Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 25/148 (16%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHR 207
+ +G G G+V +A+K+LS+ ++ K E++L + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 208 NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHI 267
N++ LL F P K+L F V+ LM + + Q LD + ++
Sbjct: 77 NIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 268 ICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ G+ +LH IIHRDLK SN
Sbjct: 125 LYQMLCGIKHLHSA---GIIHRDLKPSN 149
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.6 bits (172), Expect = 1e-14
Identities = 29/154 (18%), Positives = 52/154 (33%), Gaps = 34/154 (22%)
Query: 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKIS----EQGLKELKNEVILFS 202
+NF + LG G +G V+ A+K L K + + + + E +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 203 KLQHR-NLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDW 261
++ LV L + LI +++ L + + + T
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH-------------- 129
Query: 262 SKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ V+ L KL II+RD+K N
Sbjct: 130 ----EVQIYVGEIVLALEHLHKLGIIYRDIKLEN 159
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.1 bits (170), Expect = 3e-14
Identities = 24/145 (16%), Positives = 54/145 (37%), Gaps = 12/145 (8%)
Query: 160 FSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVK 211
+ + KLG G F V+ +A+K + + + ++E+ L ++ + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 212 LLGCCIQGEEKLLIY-EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICG 270
KLL + ++ + + + + + + + + I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 271 TARGVMYLHQDSKLRIIHRDLKASN 295
G+ Y+H+ + IIH D+K N
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPEN 156
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 68.7 bits (167), Expect = 6e-14
Identities = 27/149 (18%), Positives = 55/149 (36%), Gaps = 35/149 (23%)
Query: 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRN 208
D++ + KLG G + V++ ++ VK L + + K++K E+ + L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPN 91
Query: 209 LVKLLGCCIQGEEKL--LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFH 266
++ L + L++E + N + L
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------------------QTLTDYDIRF 133
Query: 267 IICGTARGVMYLHQDSKLRIIHRDLKASN 295
+ + + Y H + I+HRD+K N
Sbjct: 134 YMYEILKALDYCH---SMGIMHRDVKPHN 159
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 58.3 bits (140), Expect = 5e-11
Identities = 23/152 (15%), Positives = 44/152 (28%), Gaps = 38/152 (25%)
Query: 161 SINNKLGEGGFGLVYK-------EIAVK--RLSKIS--------EQGLKELKNEVILFSK 203
+I +GEG V+ E VK ++ S + G I ++
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 204 LQHRNLVKLLGCCIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSK 263
+ R L KL G + + +E + + + ++
Sbjct: 63 NEFRALQKLQGLAVP----------------KVYAWEGNAVLMELIDAKELYRVRVENPD 106
Query: 264 RFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295
++ V + I+H DL N
Sbjct: 107 E--VLDMILEEVAKFYHR---GIVHGDLSQYN 133
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 295 | |||
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.96 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.96 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 99.96 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.95 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.95 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.95 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.95 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.95 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.95 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.95 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.95 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.95 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.95 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.95 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.95 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.94 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.94 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.94 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.94 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.94 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.94 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.94 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.94 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.94 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.94 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.94 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.94 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.93 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.93 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.93 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.93 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.93 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.93 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.93 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.93 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.93 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.92 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.92 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.92 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.92 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.92 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.92 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.91 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.91 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.91 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.91 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.91 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.91 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.9 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.9 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.89 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.89 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.89 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.88 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.88 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.76 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.73 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.68 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 96.13 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 95.57 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 95.12 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 95.05 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 95.01 | |
| d1uzka1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.91 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.89 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.71 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 94.31 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.0 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 93.95 | |
| d2c4fl1 | 37 | Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | 93.21 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 92.55 | |
| d1szba2 | 45 | Mannose-binding protein associated serine protease | 92.52 | |
| d1nt0a3 | 45 | Mannose-binding protein associated serine protease | 92.5 | |
| d3egfa_ | 53 | Epidermal growth factor, EGF {Mouse (Mus musculus) | 92.41 | |
| d1apqa_ | 53 | Complement protease C1R {Human (Homo sapiens) [Tax | 92.38 | |
| d1g1ta2 | 39 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 91.94 | |
| d1dx5i3 | 40 | Thrombomodulin, different EGF-like domains {Human | 91.74 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.35 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 91.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 91.0 | |
| d1g1sa2 | 40 | E-selectin, EGF-domain {Human (Homo sapiens) [TaxI | 90.73 | |
| d1nzia2 | 42 | Complement C1S component {Human (Homo sapiens) [Ta | 89.25 | |
| d1dx5i2 | 35 | Thrombomodulin, different EGF-like domains {Human | 88.04 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 87.99 | |
| d1mcvi_ | 28 | Trypsin inhibitor {Jumping cucumber (Ecballium ela | 87.78 | |
| d1autl2 | 50 | Activated protein c (autoprothrombin IIa) {Human ( | 87.54 | |
| d1tpga1 | 41 | Plasminogen activator (tissue-type), t-PA {Human ( | 87.53 | |
| d1haea_ | 63 | Heregulin-alpha, EGF-like domain {Human (Homo sapi | 85.94 | |
| d1kigl_ | 51 | Factor X, N-terminal module {Cow (Bos taurus) [Tax | 85.35 | |
| d1cvua2 | 41 | Prostaglandin H2 synthase-1, EGF-like module {Mous | 85.05 | |
| d1nqlb_ | 48 | Epidermal growth factor, EGF {Human (Homo sapiens) | 84.96 | |
| d2c4ba2 | 28 | Trypsin inhibitor {Jumping cucumber (Ecballium ela | 84.89 | |
| d2p3ua1 | 51 | Factor X, N-terminal module {Human (Homo sapiens) | 83.69 | |
| d3bpse1 | 40 | Low density lipoprotein (LDL) receptor, different | 83.53 | |
| d1xdtr_ | 41 | Heparin-binding epidermal growth factor, HBEGF {Hu | 82.86 |
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=5.5e-30 Score=217.48 Aligned_cols=126 Identities=29% Similarity=0.468 Sum_probs=112.0
Q ss_pred hhhhccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 153 IANATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 153 ~~~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
+....++|++.++||+|+||.||+ .||||+++.. ....++|.+|+.+|++++|||||++++++.+++..+|
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 334557899999999999999997 6999999753 3346789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. .....+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 91 v~E~~~~g~l~~~l~~-------------~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~N 145 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE-------------CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARN 145 (287)
T ss_dssp EEECCTTCBHHHHHHH-------------SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EeecccCcchHHHhhh-------------ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCe
Confidence 9999999999999852 23457899999999999999999999998 9999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.4e-29 Score=212.88 Aligned_cols=120 Identities=23% Similarity=0.459 Sum_probs=109.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|++.++||+|+||.||+ .||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 45799999999999999997 6999999765455567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++. ...+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 99 ~~gg~L~~~~~----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~N 146 (293)
T d1yhwa1 99 LAGGSLTDVVT----------------ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDN 146 (293)
T ss_dssp CTTCBHHHHHH----------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred cCCCcHHHHhh----------------ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHH
Confidence 99999998773 135899999999999999999999998 9999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-29 Score=213.93 Aligned_cols=122 Identities=33% Similarity=0.477 Sum_probs=111.0
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.+.|++.+.||+|+||.||+ .||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35689999999999999997 6999999876666678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++.. ....+++..+..|+.||+.||.|||+++ |+||||||+|
T Consensus 91 ~~~g~L~~~~~~--------------~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~N 140 (288)
T d2jfla1 91 CAGGAVDAVMLE--------------LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGN 140 (288)
T ss_dssp CTTEEHHHHHHH--------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhh
Confidence 999999998742 2346899999999999999999999998 9999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=211.38 Aligned_cols=121 Identities=27% Similarity=0.384 Sum_probs=106.2
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 46899999999999999996 6999998653 23345678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.++|. ....+++..+..|+.|++.||.|||+++ ||||||||+|
T Consensus 84 y~~gg~L~~~l~---------------~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~N 133 (271)
T d1nvra_ 84 YCSGGELFDRIE---------------PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPEN 133 (271)
T ss_dssp CCTTEEGGGGSB---------------TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCcHHHHHh---------------cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHH
Confidence 999999999883 2346899999999999999999999998 9999999998
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.7e-29 Score=207.63 Aligned_cols=121 Identities=31% Similarity=0.461 Sum_probs=108.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||+|++.+. .....+.+.+|+.+|++++|||||++++++.+++..+||
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999996 6999998642 223467889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ...+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 85 mEy~~~g~L~~~l~~---------------~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~N 136 (263)
T d2j4za1 85 LEYAPLGTVYRELQK---------------LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPEN 136 (263)
T ss_dssp EECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred EeecCCCcHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeecccc
Confidence 999999999999842 246899999999999999999999998 9999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.95 E-value=1.5e-28 Score=214.01 Aligned_cols=122 Identities=26% Similarity=0.457 Sum_probs=111.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|++.+.||+|+||.||+ .||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999996 6999999876667778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++.. ....+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 105 ~~gg~L~~~l~~--------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~N 154 (350)
T d1koaa2 105 MSGGELFEKVAD--------------EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPEN 154 (350)
T ss_dssp CCSCBHHHHHTC--------------TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCCCHHHHHHh--------------hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhH
Confidence 999999998841 2346899999999999999999999998 9999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.2e-29 Score=209.31 Aligned_cols=122 Identities=33% Similarity=0.524 Sum_probs=107.9
Q ss_pred hccccccceeecccCccceeE-----EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-----EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-----~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.+.||+|+||.||+ .||||+++. .+....+.|.+|+.+|++++|||||++++++. .+..+|||||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey 84 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQW 84 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEec
Confidence 356899999999999999997 699999864 34556789999999999999999999999875 4678999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.++|.. ....+++..+..|+.||++||+|||+++ ||||||||+|
T Consensus 85 ~~~g~L~~~l~~--------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~N 134 (276)
T d1uwha_ 85 CEGSSLYHHLHI--------------IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNN 134 (276)
T ss_dssp CCEEEHHHHHHT--------------SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred CCCCCHHHHHhh--------------ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHH
Confidence 999999999842 2346999999999999999999999998 9999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.95 E-value=1.2e-28 Score=210.29 Aligned_cols=122 Identities=29% Similarity=0.472 Sum_probs=108.8
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.++|++.+.||+|+||.||+ .||||.+.. ......++|.+|+.+|++++|||||+++|++.+++..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 35688889999999999996 388998864 355567789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....++|.++..|+.||+.||.|||+++ ||||||||+|
T Consensus 105 v~Ey~~~g~L~~~~~~--------------~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~N 158 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQ--------------NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARN 158 (299)
T ss_dssp EEECCTTEEHHHHHHT--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEecCCCcceeeecc--------------ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccce
Confidence 9999999999998842 2346899999999999999999999998 9999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-28 Score=206.70 Aligned_cols=120 Identities=27% Similarity=0.518 Sum_probs=108.3
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
++|++.+.||+|+||.||+ .||||+++.. ....++|.+|+.++++++|||||+++|++.+++..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999997 6999999753 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+|.+++.. ....++|..++.|+.|||.||.|||+++ |+||||||+|
T Consensus 84 ~g~L~~~l~~--------------~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~N 131 (263)
T d1sm2a_ 84 HGCLSDYLRT--------------QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARN 131 (263)
T ss_dssp TCBHHHHHHT--------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGG
T ss_pred CCcHHHHhhc--------------cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhh
Confidence 9999998842 3356899999999999999999999998 9999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8.3e-29 Score=213.63 Aligned_cols=122 Identities=23% Similarity=0.323 Sum_probs=109.5
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..++|++.++||+|+||.||+ .||+|+++.. .....+.+.+|+.+|++++|||||++++++.+.++.+|||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 357899999999999999997 6999998653 3445678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQD-SKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~-~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++.+ ...+++..+..++.|++.||.|||++ + |+||||||+|
T Consensus 84 Ey~~gg~L~~~l~~---------------~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~N 135 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK---------------AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSN 135 (322)
T ss_dssp ECCTTEEHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGG
T ss_pred EcCCCCcHHHHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHH
Confidence 99999999999852 24689999999999999999999974 6 9999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.95 E-value=3.1e-28 Score=212.09 Aligned_cols=122 Identities=25% Similarity=0.381 Sum_probs=110.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
.++|++.+.||+|+||.||+ .||||+++.......+.+.+|+.+|++|+|||||++++++.+++..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999997 6999999876666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++. .....+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 108 ~~gg~L~~~~~--------------~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~N 157 (352)
T d1koba_ 108 LSGGELFDRIA--------------AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPEN 157 (352)
T ss_dssp CCCCBHHHHTT--------------CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CCCChHHHHHH--------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccccccc
Confidence 99999988773 23346899999999999999999999998 9999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.1e-28 Score=208.01 Aligned_cols=122 Identities=30% Similarity=0.481 Sum_probs=106.7
Q ss_pred hccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
..++|++.+.||+|+||.||+ .||||+++.. ....++|.+|+.+|++++|||||+++|++. .+..+|||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEe
Confidence 456899999999999999997 6999999753 334578999999999999999999999875 4678999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++|+|.+++.. .....++|..++.|+.||++||.|||+++ |+||||||+|
T Consensus 89 ~~~g~L~~~~~~-------------~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~N 139 (272)
T d1qpca_ 89 MENGSLVDFLKT-------------PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAAN 139 (272)
T ss_dssp CTTCBHHHHTTS-------------HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCcHHHHHhh-------------cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhh
Confidence 999999998742 23345899999999999999999999998 9999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.2e-28 Score=209.62 Aligned_cols=122 Identities=22% Similarity=0.344 Sum_probs=109.4
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
..++|.+.+.||+|+||.||+ .||||.++... .....+.+|+.+|++++|||||++++++.+.+.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357899999999999999996 69999997643 344668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+++|+|.++|.. ....+++.+...|+.||+.||+|||+++ |+||||||+|
T Consensus 82 ~~~gg~L~~~i~~--------------~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~N 132 (321)
T d1tkia_ 82 FISGLDIFERINT--------------SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPEN 132 (321)
T ss_dssp CCCCCBHHHHHTS--------------SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred cCCCCcHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccc
Confidence 9999999999841 2346899999999999999999999998 9999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=1.5e-28 Score=210.29 Aligned_cols=123 Identities=28% Similarity=0.393 Sum_probs=105.2
Q ss_pred hhccccccceeecccCccceeE--------EEEEEEecccc-HHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS-EQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
+..+.|++.+.||+|+||.||+ .||||++.... ......+.+|+.+|++++|||||++++++.+++..+||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456799999999999999997 69999987532 23346788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.++|. ....+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 86 mE~~~gg~L~~~l~---------------~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~N 137 (307)
T d1a06a_ 86 MQLVSGGELFDRIV---------------EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPEN 137 (307)
T ss_dssp ECCCCSCBHHHHHH---------------TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EeccCCCcHHHhhh---------------cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccc
Confidence 99999999999984 2356999999999999999999999998 9999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.9e-28 Score=205.93 Aligned_cols=127 Identities=24% Similarity=0.360 Sum_probs=101.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--CCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ--GEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~--~~~~~lv 225 (295)
++|++.+.||+|+||.||+ .||||.+... .....+.+.+|+.+|++++|||||++++++.+ .+.++||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999997 6999998653 45556789999999999999999999999865 4568999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--CCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS--KLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~--~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++... ......+++..++.++.|++.||.|||+++ ..+||||||||+|
T Consensus 84 mEy~~~g~L~~~i~~~-----------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~N 144 (269)
T d2java1 84 MEYCEGGDLASVITKG-----------TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144 (269)
T ss_dssp EECCTTEEHHHHHHHH-----------HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGG
T ss_pred EecCCCCcHHHHHHhc-----------cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhh
Confidence 9999999999998532 123457999999999999999999999864 2359999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.8e-28 Score=206.82 Aligned_cols=121 Identities=28% Similarity=0.419 Sum_probs=108.6
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc------cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI------SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.+.|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999997 6999998642 122467899999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||||+++|+|.++|.. ...+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~---------------~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~N 143 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE---------------KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPEN 143 (293)
T ss_dssp EEEEECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEcCCCccccchhcc---------------ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccce
Confidence 999999999999999842 246999999999999999999999998 9999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=2.9e-28 Score=208.66 Aligned_cols=120 Identities=30% Similarity=0.509 Sum_probs=107.0
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
..|+..+.||+|+||.||+ .||||+++.. .....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999996 6999998653 3345577999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|..++. ....+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 95 E~~~~g~l~~~~~---------------~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~N 145 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---------------HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGN 145 (309)
T ss_dssp ECCSEEHHHHHHH---------------HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGG
T ss_pred EecCCCchHHHHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcce
Confidence 9999999876653 2356899999999999999999999998 9999999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.7e-28 Score=205.12 Aligned_cols=121 Identities=28% Similarity=0.517 Sum_probs=105.3
Q ss_pred ccccccce-eecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 157 TDNFSINN-KLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 157 ~~~~~~~~-~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.++|.+.+ +||+|+||.||+ .||||+++.. .....++|.+|+.+|++++|||||+++|++.+ +..+|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35677777 499999999997 4899999753 45567889999999999999999999999864 56899
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+++|+|.+++.. ....+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 86 vmE~~~~g~L~~~l~~--------------~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~N 139 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--------------KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARN 139 (285)
T ss_dssp EEECCTTEEHHHHHTT--------------CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEeCCCCcHHHHhhc--------------cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhh
Confidence 9999999999998742 2356899999999999999999999998 9999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.1e-28 Score=206.50 Aligned_cols=120 Identities=30% Similarity=0.382 Sum_probs=108.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999996 6999998642 2334577999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ ||||||||+|
T Consensus 88 Ey~~gg~L~~~~~---------------~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~N 138 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---------------KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPEN 138 (288)
T ss_dssp CCCTTEEHHHHHH---------------HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EccCCCCHHHhhh---------------ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccc
Confidence 9999999999884 2356899999999999999999999998 9999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-27 Score=201.12 Aligned_cols=120 Identities=27% Similarity=0.451 Sum_probs=103.9
Q ss_pred cccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe----CCeeEEE
Q 041718 160 FSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ----GEEKLLI 225 (295)
Q Consensus 160 ~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~----~~~~~lv 225 (295)
|++.++||+|+||.||+ .||+|.+.. ......+.+.+|+.+|++++|||||++++++.+ ...++||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 35667899999999997 699999864 245566789999999999999999999999875 4568999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ++||||||||+|
T Consensus 91 mE~~~~g~L~~~l~~---------------~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~N 144 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR---------------FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDN 144 (270)
T ss_dssp EECCCSCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGG
T ss_pred EeCCCCCcHHHHHhc---------------cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhh
Confidence 999999999999852 246899999999999999999999874 459999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7e-28 Score=201.24 Aligned_cols=120 Identities=26% Similarity=0.462 Sum_probs=108.3
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
++|++.++||+|+||.||+ .||||.++.. ....++|.+|+.++++++|||||+++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5889999999999999997 7999999763 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 231 NKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 231 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|+|.+++.. ....+++..+..|+.|+++||.|||+++ |+||||||+|
T Consensus 83 ~g~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~N 130 (258)
T d1k2pa_ 83 NGCLLNYLRE--------------MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARN 130 (258)
T ss_dssp TEEHHHHHHS--------------GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGG
T ss_pred CCcHHHhhhc--------------cccCCcHHHHHHHHHHHHHHHHHHhhcC---ccccccccee
Confidence 9999998742 3356889999999999999999999998 9999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.4e-27 Score=201.41 Aligned_cols=113 Identities=28% Similarity=0.475 Sum_probs=98.4
Q ss_pred eeecccCccceeE----------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecCCC
Q 041718 164 NKLGEGGFGLVYK----------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFMPN 231 (295)
Q Consensus 164 ~~lg~G~~g~Vyk----------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 231 (295)
++||+|+||.||+ .||||+++.. +....++|.+|+.+|++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 5799999999996 4899998642 33446789999999999999999999999864 567899999999
Q ss_pred CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 232 KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 232 gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+|.+++. ....++|..++.|+.||+.||+|||+++ ||||||||+|
T Consensus 92 g~L~~~l~---------------~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~N 137 (277)
T d1xbba_ 92 GPLNKYLQ---------------QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARN 137 (277)
T ss_dssp EEHHHHHH---------------HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CcHHHHHh---------------hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchh
Confidence 99999884 2346899999999999999999999998 9999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.4e-28 Score=203.50 Aligned_cols=121 Identities=29% Similarity=0.474 Sum_probs=107.2
Q ss_pred ccccccceeecccCccceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 157 TDNFSINNKLGEGGFGLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
.++|++.+.||+|+||.||+ .||||+++.. ....+.|.+|+.+|++++|||||+++|++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 46899999999999999996 6999999753 344578999999999999999999999985 56789999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+|..++.. .....++|..++.|+.||+.||.|||+++ |+||||||+|
T Consensus 94 ~~g~l~~~~~~-------------~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~N 143 (285)
T d1fmka3 94 SKGSLLDFLKG-------------ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 143 (285)
T ss_dssp TTCBHHHHHSH-------------HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCchhhhhhh-------------cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceE
Confidence 99999998842 23456999999999999999999999998 9999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.94 E-value=2.7e-27 Score=199.65 Aligned_cols=121 Identities=25% Similarity=0.333 Sum_probs=107.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc---------HHhHHHHHHHHHHHhcCC-CCcccceeeeEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---------EQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQ 218 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~ 218 (295)
.++|++.+.||+|+||+||+ .+|||+++... ....+.+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999996 79999986421 223456889999999997 9999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++.+|||||+++|+|.++|.. ...+++..+..++.||++||+|||+++ |+||||||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---------------~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~N 140 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---------------KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPEN 140 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CcceEEEEEcCCCchHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccce
Confidence 9999999999999999999952 246899999999999999999999998 9999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-27 Score=205.88 Aligned_cols=137 Identities=27% Similarity=0.466 Sum_probs=106.7
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 220 (295)
..++|++.++||+|+||.||+ .||+|.+... .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 346899999999999999996 3899988642 344557899999999998 8999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhh--------hhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTL--------MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLK 292 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlk 292 (295)
..+|||||+++|+|.++|........ ............++|..++.|+.||+.||.|||+++ |||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999964321100 000011122356899999999999999999999998 9999999
Q ss_pred CCC
Q 041718 293 ASN 295 (295)
Q Consensus 293 p~N 295 (295)
|+|
T Consensus 192 p~N 194 (325)
T d1rjba_ 192 ARN 194 (325)
T ss_dssp GGG
T ss_pred hhc
Confidence 998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.1e-27 Score=205.48 Aligned_cols=121 Identities=21% Similarity=0.266 Sum_probs=108.9
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv 225 (295)
.++|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.+|++++|||||++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999996 7999999752 233467889999999999999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++. ....+++.....++.||+.||+|||+++ ||||||||+|
T Consensus 84 ~ey~~gg~L~~~~~---------------~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~N 135 (337)
T d1o6la_ 84 MEYANGGELFFHLS---------------RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 135 (337)
T ss_dssp EECCTTCBHHHHHH---------------HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred eeccCCCchhhhhh---------------cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHH
Confidence 99999999999884 2346888999999999999999999998 9999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.94 E-value=2.4e-27 Score=200.23 Aligned_cols=121 Identities=21% Similarity=0.344 Sum_probs=106.8
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC----e
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----E 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~ 221 (295)
.++|++.+.||+|+||.||+ .||||+++.. +....+.+.+|+.+|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999996 7999999652 3455678999999999999999999999987654 3
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.||||||+++++|.+++. ....+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 86 ~~lvmE~~~g~~L~~~~~---------------~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~N 141 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---------------TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPAN 141 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---------------HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEECCCCCEehhhhc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcc
Confidence 789999999999998874 2346899999999999999999999998 9999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.94 E-value=3.7e-27 Score=202.47 Aligned_cols=120 Identities=24% Similarity=0.385 Sum_probs=107.7
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++.+.||+|+||.||+ .||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 6799999999999999996 6999999742 2334678999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+++|+|..++. ....+++.....++.||+.||+|||+++ ||||||||+|
T Consensus 84 E~~~gg~l~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~N 134 (316)
T d1fota_ 84 DYIEGGELFSLLR---------------KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPEN 134 (316)
T ss_dssp CCCCSCBHHHHHH---------------HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred eecCCcccccccc---------------ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchh
Confidence 9999999998874 3356788888999999999999999998 9999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.6e-27 Score=199.03 Aligned_cols=121 Identities=28% Similarity=0.475 Sum_probs=107.8
Q ss_pred cccccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
+.|++.++||+|+||.||+ .||||+++. .......+|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999996 389999865 344556789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||+.++++.+++.. ....++|..+..++.||+.||+|||+++ ||||||||+|
T Consensus 87 v~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~N 140 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--------------KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARN 140 (283)
T ss_dssp EEECCTTEEHHHHHHH--------------TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEecccCcchhhhhc--------------ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccce
Confidence 9999999999987742 3356999999999999999999999998 9999999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.4e-28 Score=200.83 Aligned_cols=121 Identities=25% Similarity=0.423 Sum_probs=104.4
Q ss_pred ccccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEEecC
Q 041718 157 TDNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFM 229 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 229 (295)
.++|++.+.||+|+||.||+ .||||+++.. ...++|.+|+.++++++|||||+++|++.+ .+.++|||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999996 7999999753 345789999999999999999999999865 45689999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+|.++|... ....++|..++.|+.||+.||.|||+++ |+||||||+|
T Consensus 84 ~~g~L~~~l~~~-------------~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~N 133 (262)
T d1byga_ 84 AKGSLVDYLRSR-------------GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARN 133 (262)
T ss_dssp TTEEHHHHHHHH-------------HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCCHHHHHHhc-------------CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHh
Confidence 999999999532 2235899999999999999999999987 9999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=8.5e-27 Score=199.83 Aligned_cols=135 Identities=31% Similarity=0.537 Sum_probs=109.9
Q ss_pred cccccceeecccCccceeE----------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK----------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk----------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~~~~lv 225 (295)
++|++.++||+|+||.||+ .||||+++.. .....+.|.+|+.+|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6888999999999999996 4788888643 344567899999999999 799999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhh-hcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMR-SFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~-~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.++|.......... ..........++|..++.++.|||.||.|||+++ ||||||||+|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~N 157 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN 157 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccce
Confidence 99999999999997543222110 0111234567999999999999999999999998 9999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.3e-27 Score=197.67 Aligned_cols=122 Identities=25% Similarity=0.401 Sum_probs=106.9
Q ss_pred hccccccceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
..++|++.+.||+|+||.||+ .||||.++. ......+.+.+|+.+|++++|||||++++++. .+..+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 346899999999999999996 388998865 34455678999999999999999999999985 57789
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ ||||||||+|
T Consensus 84 iv~E~~~~g~l~~~~~~--------------~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~N 138 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQV--------------RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARN 138 (273)
T ss_dssp EEEECCTTEEHHHHHHH--------------TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEEeccCCcHHhhhhc--------------cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhh
Confidence 99999999999988742 3356899999999999999999999998 9999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1e-26 Score=198.44 Aligned_cols=121 Identities=29% Similarity=0.484 Sum_probs=103.2
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.++||+|+||.||+ .||||+++.. .....+++.+|+.+|++++|||||++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999997 6999999643 22346789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+.+ ++.+++. ......+++..+..++.|++.||.|||+++ ||||||||+|
T Consensus 82 ~~~~-~~~~~~~-------------~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeN 132 (298)
T d1gz8a_ 82 FLHQ-DLKKFMD-------------ASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQN 132 (298)
T ss_dssp CCSE-EHHHHHH-------------HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ecCC-chhhhhh-------------hhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchh
Confidence 9965 4444442 223456999999999999999999999998 9999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.93 E-value=1.9e-26 Score=196.96 Aligned_cols=143 Identities=30% Similarity=0.496 Sum_probs=114.6
Q ss_pred hhhhhhhccccccceeecccCccceeE-------------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeee
Q 041718 150 LATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGC 215 (295)
Q Consensus 150 ~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 215 (295)
+.+++...++|++.+.||+|+||.||+ .||||+++.. .....++|.+|+.+|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 344555678899999999999999995 4899999753 44456789999999999999999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHHhhhhhhhh---------hhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCe
Q 041718 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTL---------MRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRI 286 (295)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~---------~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~i 286 (295)
+.+.+..++||||+++|+|.++|........ ............+++..++.|+.|++.||+|||+++ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 9999999999999999999999964321110 000111223346899999999999999999999998 9
Q ss_pred EeccCCCCC
Q 041718 287 IHRDLKASN 295 (295)
Q Consensus 287 iHrDlkp~N 295 (295)
|||||||+|
T Consensus 162 vHrDlKp~N 170 (301)
T d1lufa_ 162 VHRDLATRN 170 (301)
T ss_dssp CCSCCSGGG
T ss_pred EeeEEcccc
Confidence 999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=8.6e-27 Score=196.22 Aligned_cols=120 Identities=29% Similarity=0.442 Sum_probs=98.9
Q ss_pred cccccceeecccCccceeE-----------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeE
Q 041718 158 DNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKL 223 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~ 223 (295)
++|++.+.||+|+||.||+ .||||+++.. .....++|.+|+.+|++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999996 4899998652 33456789999999999999999999999965 5778
Q ss_pred EEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 224 LIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 224 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 87 lv~e~~~~~~l~~~~~~--------------~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~N 141 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--------------HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARN 141 (273)
T ss_dssp EEEECCTTCBHHHHHHH--------------HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred eeeeeecCcchhhhhhc--------------ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHH
Confidence 99999999999988742 2345899999999999999999999998 9999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.2e-26 Score=197.91 Aligned_cols=120 Identities=26% Similarity=0.416 Sum_probs=105.1
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHh-cCCCCcccceeeeEEeCCeeEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFS-KLQHRNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~-~l~h~niv~l~~~~~~~~~~~lv 225 (295)
++|.+.+.||+|+||.||+ .||||++++. .....+.+..|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999996 6999999752 2234566777777765 68999999999999999999999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ ||||||||+|
T Consensus 82 mEy~~~g~L~~~i~~---------------~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~N 133 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---------------CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDN 133 (320)
T ss_dssp EECCTTCBHHHHHHH---------------HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGG
T ss_pred EeecCCCcHHHHhhc---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccc
Confidence 999999999999852 245888999999999999999999998 9999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.93 E-value=2.6e-26 Score=199.74 Aligned_cols=120 Identities=24% Similarity=0.276 Sum_probs=108.3
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccc---cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEE
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKI---SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIY 226 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~ 226 (295)
++|++++.||+|+||.||+ .||||++++. .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999997 6999998642 2234577899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 227 EFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 227 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||+.+|+|.+++.. ...+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 121 e~~~~g~l~~~l~~---------------~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~N 171 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---------------IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPEN 171 (350)
T ss_dssp ECCTTCBHHHHHHH---------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred ccccccchhhhHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHH
Confidence 99999999998842 246899999999999999999999998 9999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.2e-26 Score=197.45 Aligned_cols=137 Identities=29% Similarity=0.425 Sum_probs=111.4
Q ss_pred hccccccceeecccCccceeE-------------EEEEEEecc-ccHHhHHHHHHHHHHHhcC-CCCcccceeeeEEeCC
Q 041718 156 ATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLLGCCIQGE 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~~~~ 220 (295)
..++|++.++||+|+||.||+ .||||+++. .......+|.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 447899999999999999996 489999975 3445667899999999999 6999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhc---ccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSF---VDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+|||||+++|+|.++|............ ........+++..+..|+.||+.||.|||+++ ||||||||+|
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 999999999999999999754322111000 01123346999999999999999999999998 9999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.4e-26 Score=195.19 Aligned_cols=133 Identities=29% Similarity=0.479 Sum_probs=112.5
Q ss_pred hhccccccceeecccCccceeE-------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC
Q 041718 155 NATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE 220 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~ 220 (295)
...++|.+.+.||+|+||.||+ .||||+++. ........|.+|+.++++++|||||++++++...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 3457889999999999999995 489999975 34455678999999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+++|+|.+++........ .......+++..+..|+.|+|+||.|||+++ |+||||||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~N 163 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMA-----NNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARN 163 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHH-----HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGG
T ss_pred ceeEEEeecCCCCHHHHHHhcccccc-----cccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCc
Confidence 99999999999999999975322211 1122345799999999999999999999997 9999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.6e-26 Score=196.61 Aligned_cols=120 Identities=30% Similarity=0.519 Sum_probs=104.1
Q ss_pred cccccceeecccCccceeE------------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEE
Q 041718 158 DNFSINNKLGEGGFGLVYK------------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLL 224 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~l 224 (295)
.+|++.+.||+|+||.||+ .||+|.++. .+....++|.+|+.+|++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4699999999999999996 389998865 3445678899999999999999999999999764 5678
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++||+.+|+|.+++.. ....+++..++.|+.||+.||+|||+++ ||||||||+|
T Consensus 88 v~e~~~~~~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~N 141 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--------------HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARN 141 (317)
T ss_dssp EEECCTTCBHHHHHHH--------------TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred EEEeccCCcccccccc--------------cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhc
Confidence 8999999999988742 3457899999999999999999999998 9999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=5.8e-26 Score=198.56 Aligned_cols=121 Identities=23% Similarity=0.284 Sum_probs=103.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc---HHhHHHHH---HHHHHHhcCCCCcccceeeeEEeCCee
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS---EQGLKELK---NEVILFSKLQHRNLVKLLGCCIQGEEK 222 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~---~~~~~~~~---~Ei~~l~~l~h~niv~l~~~~~~~~~~ 222 (295)
.++|++.+.||+|+||.||+ .||||++.+.. ......+. .|+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999996 69999986421 12223333 457788888999999999999999999
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||||+++|+|.++|.. ...+++..+..++.||+.||.|||+++ ||||||||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~---------------~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~N 137 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---------------HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPAN 137 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---------------HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEEecCCCcHHHHHHh---------------cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccce
Confidence 999999999999999842 246788999999999999999999998 9999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=3.1e-26 Score=195.37 Aligned_cols=138 Identities=30% Similarity=0.443 Sum_probs=106.5
Q ss_pred hhccccccceeecccCccceeE---------------EEEEEEeccc-cHHhHHHHHHHHHHHhcC-CCCcccceeeeEE
Q 041718 155 NATDNFSINNKLGEGGFGLVYK---------------EIAVKRLSKI-SEQGLKELKNEVILFSKL-QHRNLVKLLGCCI 217 (295)
Q Consensus 155 ~~~~~~~~~~~lg~G~~g~Vyk---------------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~h~niv~l~~~~~ 217 (295)
...++|.+.+.||+|+||.||+ .||||+++.. ......++.+|+..+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3457899999999999999996 4899999753 445668899999999888 7999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHHhhhhhhhhhhh-cccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 218 QGEEKLLIYEFMPNKSLNSFIFENFVLTLMRS-FVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 218 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++..++||||+++|+|.++|........... .........+++..++.++.||+.||.|||+++ ||||||||+|
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~N 165 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 165 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccc
Confidence 99999999999999999999964321111000 001123456999999999999999999999998 9999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.1e-26 Score=196.36 Aligned_cols=118 Identities=25% Similarity=0.331 Sum_probs=100.9
Q ss_pred ccccccce-eecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhc-CCCCcccceeeeEEe----CCee
Q 041718 157 TDNFSINN-KLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSK-LQHRNLVKLLGCCIQ----GEEK 222 (295)
Q Consensus 157 ~~~~~~~~-~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~h~niv~l~~~~~~----~~~~ 222 (295)
.++|.+.+ .||+|+||.||+ .||||+++.. ..+.+|+.++.+ ++|||||++++++.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46898875 599999999997 7999998642 356789988765 489999999999875 4678
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+|||||+++|+|.++|. ......+++..+..|+.||+.||+|||+++ |+||||||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~-------------~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~N 141 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQ-------------DRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 141 (335)
T ss_dssp EEEEECCCSEEHHHHHH-------------SCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EEEEECCCCCcHHHHHH-------------hcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccc
Confidence 99999999999999984 222356899999999999999999999998 9999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.2e-25 Score=191.69 Aligned_cols=144 Identities=24% Similarity=0.384 Sum_probs=108.8
Q ss_pred hhhhhhhhccccccceeecccCccceeE-------------EEEEEEecc-ccHHhHHHHHHHHHHHhcC-CCCccccee
Q 041718 149 ELATIANATDNFSINNKLGEGGFGLVYK-------------EIAVKRLSK-ISEQGLKELKNEVILFSKL-QHRNLVKLL 213 (295)
Q Consensus 149 ~~~~~~~~~~~~~~~~~lg~G~~g~Vyk-------------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l-~h~niv~l~ 213 (295)
+..++....++|++.++||+|+||.||+ .||||+++. ......+.+.+|+.++.++ +|+|||+++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3444545567899999999999999996 589999875 3445567788888888877 689999999
Q ss_pred eeEEeC-CeeEEEEecCCCCCHHHHHhhhhhhhhhhhcc-cccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccC
Q 041718 214 GCCIQG-EEKLLIYEFMPNKSLNSFIFENFVLTLMRSFV-DQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDL 291 (295)
Q Consensus 214 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~-~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDl 291 (295)
+++.+. ...++||||+++|+|.++|............. .......+++..+..++.||+.||.|||+++ ||||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 988764 46899999999999999997532211100000 0112346899999999999999999999998 999999
Q ss_pred CCCC
Q 041718 292 KASN 295 (295)
Q Consensus 292 kp~N 295 (295)
||+|
T Consensus 161 Kp~N 164 (299)
T d1ywna1 161 AARN 164 (299)
T ss_dssp CGGG
T ss_pred Cccc
Confidence 9998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.9e-25 Score=191.39 Aligned_cols=116 Identities=28% Similarity=0.504 Sum_probs=102.5
Q ss_pred ceeecccCccceeE-----------EEEEEEecc-ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe-CCeeEEEEecC
Q 041718 163 NNKLGEGGFGLVYK-----------EIAVKRLSK-ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-GEEKLLIYEFM 229 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk-----------~vavK~l~~-~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 229 (295)
.++||+|+||+||+ .||||+++. ......++|.+|+.+|++++|||||+++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999996 389999975 456667899999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++|+|.+++. .....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 112 ~~g~l~~~~~--------------~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~N 160 (311)
T d1r0pa_ 112 KHGDLRNFIR--------------NETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARN 160 (311)
T ss_dssp TTCBHHHHHH--------------CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred ecCchhhhhc--------------cccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHh
Confidence 9999999884 23456788899999999999999999998 9999999998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.92 E-value=9.8e-26 Score=191.11 Aligned_cols=120 Identities=25% Similarity=0.398 Sum_probs=106.2
Q ss_pred cccccceeecccCccceeE-------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK-------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk-------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.++||+|+||.||+ .||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999997 6999999653 333467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.++.+..+.. ....+++..+..|+.||+.||+|||+++ ||||||||+|
T Consensus 82 ~~~~~~~~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~N 130 (286)
T d1ob3a_ 82 LDQDLKKLLDV---------------CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQN 130 (286)
T ss_dssp CSEEHHHHHHT---------------STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ehhhhHHHHHh---------------hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCce
Confidence 98776665542 3456999999999999999999999998 9999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.4e-25 Score=188.17 Aligned_cols=120 Identities=27% Similarity=0.397 Sum_probs=107.5
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e 227 (295)
++|++.++||+|+||+||+ .||||+++. .......++.+|+.+|+.++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999997 689999864 234557889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
++.+++|..++. ....+++..+..++.|++.||+|||+++ |+||||||+|
T Consensus 82 ~~~~~~l~~~~~---------------~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~N 131 (292)
T d1unla_ 82 FCDQDLKKYFDS---------------CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQN 131 (292)
T ss_dssp CCSEEHHHHHHH---------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred eccccccccccc---------------cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcc
Confidence 999998887763 3356889999999999999999999998 9999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.1e-25 Score=192.01 Aligned_cols=115 Identities=30% Similarity=0.386 Sum_probs=97.1
Q ss_pred ceeecccCccceeE--------EEEEEEeccccH-----HhHHHHHHHHHHHhcCCCCcccceeeeEEeCCeeEEEEecC
Q 041718 163 NNKLGEGGFGLVYK--------EIAVKRLSKISE-----QGLKELKNEVILFSKLQHRNLVKLLGCCIQGEEKLLIYEFM 229 (295)
Q Consensus 163 ~~~lg~G~~g~Vyk--------~vavK~l~~~~~-----~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 229 (295)
+++||+|+||+||+ .||||+++.... ...+.+.+|+.+|++++|||||++++++.++++.+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 47899999999997 699999864221 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 230 PNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 230 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++..++. ....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 83 ~~~~~~~~~~---------------~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~N 130 (299)
T d1ua2a_ 83 ETDLEVIIKD---------------NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNN 130 (299)
T ss_dssp SEEHHHHHTT---------------CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cchHHhhhhh---------------cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcce
Confidence 8877665442 3456888999999999999999999998 9999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=6.7e-25 Score=187.31 Aligned_cols=121 Identities=26% Similarity=0.379 Sum_probs=99.0
Q ss_pred cccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC----eeEEEEe
Q 041718 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EKLLIYE 227 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~~lv~e 227 (295)
++|.+.+.||+|+||.||+ .||||+++.... .......|+..+.+++|||||++++++.+.+ ..+||||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 5678889999999999996 799999865322 2222334566667889999999999998654 6899999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCC-----CCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDS-----KLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~-----~~~iiHrDlkp~N 295 (295)
|+++|+|.++|.+ ..++|..++.++.|+|.||+|||+.. ..+||||||||+|
T Consensus 82 y~~~g~L~~~l~~----------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~N 138 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN 138 (303)
T ss_dssp CCTTCBHHHHHHH----------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGG
T ss_pred cccCCCHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccc
Confidence 9999999999942 35899999999999999999999741 2359999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.91 E-value=6.6e-25 Score=189.53 Aligned_cols=115 Identities=23% Similarity=0.430 Sum_probs=101.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeC--CeeEEE
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQG--EEKLLI 225 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~--~~~~lv 225 (295)
.++|++.++||+|+||+||+ .||||+++.. ..+++.+|+.+|..++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 36899999999999999996 6999998753 3467889999999995 99999999999744 568999
Q ss_pred EecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 226 YEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 226 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|||+++++|..+. ..+++..+..++.||+.||.|||+++ ||||||||+|
T Consensus 111 ~e~~~~~~L~~~~------------------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~N 159 (328)
T d3bqca1 111 FEHVNNTDFKQLY------------------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHN 159 (328)
T ss_dssp EECCCSCBGGGTT------------------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred EeecCCCcHHHHh------------------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccc
Confidence 9999999987543 35889999999999999999999998 9999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.8e-25 Score=189.70 Aligned_cols=121 Identities=20% Similarity=0.395 Sum_probs=100.3
Q ss_pred hccccccceeecccCccceeE--------EEEEEEeccc-cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC----ee
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI-SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----EK 222 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----~~ 222 (295)
.+++|+++++||+|+||.||+ .||||+++.. .....+.+.+|+.+|++++|||||++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346799999999999999997 6999999753 3455678999999999999999999999987643 23
Q ss_pred EEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 223 LLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 223 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+++++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++ ||||||||+|
T Consensus 86 ~~l~~~~~~g~L~~~l~~----------------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~N 139 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT----------------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSN 139 (345)
T ss_dssp EEEEEECCCEEHHHHHHH----------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred EEEEEeecCCchhhhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcce
Confidence 455566779999999841 35899999999999999999999998 9999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=8.3e-25 Score=190.29 Aligned_cols=120 Identities=28% Similarity=0.454 Sum_probs=98.2
Q ss_pred hccccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeCC-----
Q 041718 156 ATDNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQGE----- 220 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~~----- 220 (295)
..++|++.++||+|+||.||+ .||||+++. ......+.+.+|+.+|++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 356899999999999999997 699999974 34455678999999999999999999999998655
Q ss_pred -eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 -EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+.+|||||+ +.+|..++. ...+++..+..++.||+.||.|||+++ ||||||||+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----------------~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~N 151 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----------------HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGN 151 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----------------HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred ceEEEEEecc-cccHHHHHH----------------hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcch
Confidence 579999999 567776652 245899999999999999999999998 9999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.5e-25 Score=187.30 Aligned_cols=121 Identities=26% Similarity=0.370 Sum_probs=103.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEecccc------HHhHHHHHHHHHHHhcCC--CCcccceeeeEEeCC
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKIS------EQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGE 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~ 220 (295)
.++|++.+.||+|+||.||+ .||||++++.. .....++.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 35799999999999999996 69999986421 112344678999999997 899999999999999
Q ss_pred eeEEEEecCCC-CCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPN-KSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..++||||+.+ +++.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~---------------~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~N 140 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFIT---------------ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDEN 140 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHH---------------HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred eEEEEEEeccCcchHHHHHh---------------ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccc
Confidence 99999999976 57777763 2356899999999999999999999998 9999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.2e-24 Score=189.45 Aligned_cols=120 Identities=29% Similarity=0.471 Sum_probs=103.7
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC-----Ce
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG-----EE 221 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~-----~~ 221 (295)
.++|++.++||+|+||+||+ .||||+++.. +....+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46799999999999999996 6999999753 345567889999999999999999999998643 33
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++++||+.+|+|.+++. ...+++..+..++.||+.||.|||+++ |+||||||+|
T Consensus 97 ~~~i~~~~~gg~L~~~~~----------------~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~N 151 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----------------CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSN 151 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----------------TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred eEEEEEeecCCchhhhcc----------------cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcc
Confidence 467778888999999883 235899999999999999999999998 9999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=9.4e-25 Score=190.20 Aligned_cols=118 Identities=23% Similarity=0.340 Sum_probs=96.5
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcccceeeeEEeC------CeeEE
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQG------EEKLL 224 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~~------~~~~l 224 (295)
+|+..++||+|+||+||+ .||||++..... ...+|+.+|++++|+|||++++++... .+++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 688889999999999996 699999965322 234799999999999999999998643 35789
Q ss_pred EEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 225 IYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 225 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
||||++++.+..+.. .......+++..+..|+.||+.||+|||+++ |+||||||+|
T Consensus 97 v~Ey~~~~~~~~l~~------------~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~N 152 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH------------YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQN 152 (350)
T ss_dssp EEECCSEEHHHHHHH------------HHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred EEeccCCccHHHHHh------------hhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcce
Confidence 999998654433321 1123456999999999999999999999998 9999999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.7e-24 Score=186.07 Aligned_cols=117 Identities=28% Similarity=0.441 Sum_probs=98.9
Q ss_pred cccccceeecccCccceeE--------EEEEEEecc--ccHHhHHHHHHHHHHHhcCCCCcccceeeeEEe------CCe
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSK--ISEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ------GEE 221 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~------~~~ 221 (295)
++|++.++||+|+||+||+ .||||++.. ........+.+|+.+|++++|||||++++++.. ..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999996 699999974 244556788999999999999999999999964 468
Q ss_pred eEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 222 KLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 222 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.++||||+.++.+ +.+. ..+++.....++.||+.||.|||+++ |+||||||+|
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----------------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~N 149 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----------------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----------------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred eEEEEeccchHHH-Hhhh-----------------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccc
Confidence 8999999976544 4331 34789999999999999999999998 9999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=2.1e-24 Score=185.71 Aligned_cols=121 Identities=21% Similarity=0.272 Sum_probs=106.0
Q ss_pred ccccccceeecccCccceeE-----------EEEEEEeccc----cHHhHHHHHHHHHHHhcCCC-CcccceeeeEEeCC
Q 041718 157 TDNFSINNKLGEGGFGLVYK-----------EIAVKRLSKI----SEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGE 220 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk-----------~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~ 220 (295)
.++|++.+.||+|+||.||+ .||||.+++. .....+.+.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 37899999999999999997 4899998642 22345678899999999976 89999999999999
Q ss_pred eeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 221 EKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 221 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
..+++|||+.+|+|.+++.. ...+.......++.|++.||.|||+++ |+||||||+|
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~---------------~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~N 159 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQ---------------RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLEN 159 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHH---------------HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ceeeeeecccccHHHHHHHh---------------cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccc
Confidence 99999999999999998842 245678888999999999999999998 9999999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=8.3e-24 Score=181.77 Aligned_cols=121 Identities=25% Similarity=0.428 Sum_probs=100.4
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccc--cHHhHHHHHHHHHHHhcCCCCcccceeeeEEe--------
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKI--SEQGLKELKNEVILFSKLQHRNLVKLLGCCIQ-------- 218 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~h~niv~l~~~~~~-------- 218 (295)
.++|++.++||+|+||+||+ .||||++... ......++.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999997 6999998542 33445778999999999999999999999865
Q ss_pred CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
.+..++||||++++.+..+. .....++......|+.|++.||.|||+++ |+||||||+|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---------------~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~N 147 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---------------NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAAN 147 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---------------CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CceEEEEEeccCCCccchhh---------------hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchh
Confidence 34689999999877665443 23356888899999999999999999998 9999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=4.3e-24 Score=182.52 Aligned_cols=123 Identities=25% Similarity=0.391 Sum_probs=98.6
Q ss_pred hccccccceeecccCccceeE---------EEEEEEeccc--cHHhHHHHHHHHHHHhcC---CCCcccceeeeEEe---
Q 041718 156 ATDNFSINNKLGEGGFGLVYK---------EIAVKRLSKI--SEQGLKELKNEVILFSKL---QHRNLVKLLGCCIQ--- 218 (295)
Q Consensus 156 ~~~~~~~~~~lg~G~~g~Vyk---------~vavK~l~~~--~~~~~~~~~~Ei~~l~~l---~h~niv~l~~~~~~--- 218 (295)
..++|++.++||+|+||.||+ .||||+++.. .......+.+|+.+|+.| +|||||++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 347899999999999999996 5899998642 222234566777776665 79999999999863
Q ss_pred --CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 219 --GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 219 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
....+++|||++++.+..... .....+++.....++.|++.||+|||+++ ||||||||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~N 146 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--------------VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 146 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--------------SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred ccCceEEEEEEeccCCchhhhhh--------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccE
Confidence 346899999998876654332 23456899999999999999999999998 9999999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.88 E-value=3.3e-23 Score=175.96 Aligned_cols=119 Identities=18% Similarity=0.335 Sum_probs=103.3
Q ss_pred ccccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCC-CcccceeeeEEeCCeeEEEEe
Q 041718 157 TDNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQH-RNLVKLLGCCIQGEEKLLIYE 227 (295)
Q Consensus 157 ~~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 227 (295)
.++|++.+.||+|+||.||+ .||||+++... ....+.+|+.+++.|+| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 46899999999999999996 69999886532 23457788999999976 899999999999999999999
Q ss_pred cCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 228 FMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 228 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
|+ +++|.+++.. ....+++.+...++.|++.||+|||+++ ||||||||+|
T Consensus 82 ~~-~~~l~~~~~~--------------~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~N 131 (293)
T d1csna_ 82 LL-GPSLEDLLDL--------------CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDN 131 (293)
T ss_dssp CC-CCBHHHHHHH--------------TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGG
T ss_pred ec-CCCHHHHHHh--------------hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccc
Confidence 99 6899888742 3346899999999999999999999998 9999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.88 E-value=7.1e-23 Score=174.41 Aligned_cols=118 Identities=21% Similarity=0.385 Sum_probs=97.6
Q ss_pred cccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCCCCcc-cceeeeEEeCCeeEEEEec
Q 041718 158 DNFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQHRNL-VKLLGCCIQGEEKLLIYEF 228 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 228 (295)
++|++.+.||+|+||.||+ .||||++.... ...++..|+.++++++|+|+ +.+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999996 69999886532 23457889999999987765 5555666788899999999
Q ss_pred CCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 229 MPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 229 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
+ +++|...+. .....+++..+..++.|++.||+|||+++ ||||||||+|
T Consensus 85 ~-~~~l~~~~~--------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~N 133 (299)
T d1ckia_ 85 L-GPSLEDLFN--------------FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDN 133 (299)
T ss_dssp C-CCBHHHHHH--------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred c-CCchhhhhh--------------hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhh
Confidence 9 566666553 13356899999999999999999999998 9999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.76 E-value=7.7e-19 Score=152.95 Aligned_cols=121 Identities=20% Similarity=0.239 Sum_probs=95.2
Q ss_pred ccccceeecccCccceeE--------EEEEEEeccccHHhHHHHHHHHHHHhcCC-----------CCcccceeeeEEe-
Q 041718 159 NFSINNKLGEGGFGLVYK--------EIAVKRLSKISEQGLKELKNEVILFSKLQ-----------HRNLVKLLGCCIQ- 218 (295)
Q Consensus 159 ~~~~~~~lg~G~~g~Vyk--------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------h~niv~l~~~~~~- 218 (295)
+|++.++||+|+||+||+ .||||+++.. ....+.+.+|+.+++.++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 599999999999999996 6999999763 334567788999888875 5789999998764
Q ss_pred -CCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCCCCeEeccCCCCC
Q 041718 219 -GEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQ-DSKLRIIHRDLKASN 295 (295)
Q Consensus 219 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~-~~~~~iiHrDlkp~N 295 (295)
....+++++++..+....... .......+++..+..++.||+.||+|||+ .+ |+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~N 156 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALI------------KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPEN 156 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHH------------HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGG
T ss_pred cccceeeeeeeccccccccccc------------ccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhH
Confidence 456677777776554333221 12344678889999999999999999998 66 9999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.73 E-value=4.4e-18 Score=134.88 Aligned_cols=106 Identities=23% Similarity=0.246 Sum_probs=82.0
Q ss_pred ccceeecccCccceeE-------EEEEEEeccc------------------cHHhHHHHHHHHHHHhcCCCCcccceeee
Q 041718 161 SINNKLGEGGFGLVYK-------EIAVKRLSKI------------------SEQGLKELKNEVILFSKLQHRNLVKLLGC 215 (295)
Q Consensus 161 ~~~~~lg~G~~g~Vyk-------~vavK~l~~~------------------~~~~~~~~~~Ei~~l~~l~h~niv~l~~~ 215 (295)
.+.++||+|+||.||+ .||||+++.. ..........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4679999999999996 7999986421 01112345678899999999999998865
Q ss_pred EEeCCeeEEEEecCCCCCHHHHHhhhhhhhhhhhcccccccCCCCHHHHHHHHHHHHHHHHhhhcCCCCCeEeccCCCCC
Q 041718 216 CIQGEEKLLIYEFMPNKSLNSFIFENFVLTLMRSFVDQERCKILDWSKRFHIICGTARGVMYLHQDSKLRIIHRDLKASN 295 (295)
Q Consensus 216 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~gl~yLH~~~~~~iiHrDlkp~N 295 (295)
. ..+++|||+++..+.+ +++.....++.|++++|.|||+++ |+||||||+|
T Consensus 83 ~----~~~lvme~~~~~~~~~----------------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~N 133 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 133 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred c----CCEEEEEeeccccccc----------------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhh
Confidence 3 2379999998754422 333445679999999999999998 9999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.68 E-value=9.2e-05 Score=59.38 Aligned_cols=81 Identities=11% Similarity=-0.002 Sum_probs=55.4
Q ss_pred cccccceeecccCccceeE------EEEEEEeccccHHhHHHHHHHHHHHhcCC-CCcccceeeeEEeCCeeEEEEecCC
Q 041718 158 DNFSINNKLGEGGFGLVYK------EIAVKRLSKISEQGLKELKNEVILFSKLQ-HRNLVKLLGCCIQGEEKLLIYEFMP 230 (295)
Q Consensus 158 ~~~~~~~~lg~G~~g~Vyk------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 230 (295)
..|+..+..+.++.+.||+ .+.+|+...........+.+|..++..|. +--+.+++.+...++..++||++++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~ 93 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence 4555545444444467886 57788776543334445777888877664 4446788888888899999999999
Q ss_pred CCCHHHHH
Q 041718 231 NKSLNSFI 238 (295)
Q Consensus 231 ~gsL~~~l 238 (295)
+.++.+..
T Consensus 94 G~~~~~~~ 101 (263)
T d1j7la_ 94 GVLCSEEY 101 (263)
T ss_dssp SEEHHHHT
T ss_pred cccccccc
Confidence 88775543
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.13 E-value=0.0012 Score=36.73 Aligned_cols=32 Identities=38% Similarity=0.782 Sum_probs=25.5
Q ss_pred CCCCC-CCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDT-YALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|.. ...|..+|.|... ++..|.|++||+..
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~G~ 37 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYTGP 37 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEEST
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCcCC
Confidence 46765 5679999999764 57899999999754
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.57 E-value=0.0042 Score=33.73 Aligned_cols=32 Identities=38% Similarity=0.841 Sum_probs=25.4
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|.|. ...|-..|.|... +...|.|++||+...
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~~ 33 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGKN 33 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence 5676 4789999999864 578999999997653
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.12 E-value=0.0085 Score=33.22 Aligned_cols=30 Identities=30% Similarity=0.577 Sum_probs=23.7
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCee
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
|+|.... |+.++.|... ++..|.|++||..
T Consensus 6 dEC~~~~-~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKEPD-VCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSSTT-SCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eccCCcC-CCCCCEeECCCCCeEeECCCCccc
Confidence 5787654 5578999764 6789999999987
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.05 E-value=0.011 Score=32.33 Aligned_cols=31 Identities=32% Similarity=0.750 Sum_probs=24.3
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|+|...+.|. .+|... ++..|.|++||....
T Consensus 2 dEC~~~~~C~--~~C~n~~Gsy~C~C~~Gy~L~~ 33 (41)
T d1i0ua2 2 DECQDPDTCS--QLCVNLEGGYKCQCEEGFQLDP 33 (41)
T ss_dssp CTTTTTTSCS--SCEECSSSCCEECCCTTEEECT
T ss_pred ccCCCCCCCC--CEeECCCCCEEeECCCCCeECC
Confidence 6788877774 489754 678999999998753
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.01 E-value=0.006 Score=33.07 Aligned_cols=32 Identities=22% Similarity=0.564 Sum_probs=24.7
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|+|. ...|...|.|... ++..|.|++||....
T Consensus 2 d~C~-~~PC~n~g~C~~~~~~y~C~C~~G~~G~~ 34 (39)
T d2vj3a2 2 NECV-SNPCQNDATCLDQIGEFQCICMPGYEGVH 34 (39)
T ss_dssp CTTT-TCCCCSSCEEEECSSCEEEECCTTEESSS
T ss_pred cCCc-CCCCCCCCEEECCCCCEEEeCCCCCccCc
Confidence 4564 3679999999864 578999999997653
|
| >d1uzka1 g.3.11.1 (A:1486-1528) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.91 E-value=0.0039 Score=34.73 Aligned_cols=32 Identities=25% Similarity=0.657 Sum_probs=24.6
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|+|.....| -.+.|... ++..|.|++||....
T Consensus 4 dEC~~~~~~-c~~~C~Nt~G~y~C~C~~Gy~l~~ 36 (43)
T d1uzka1 4 NECLDPTTC-ISGNCVNTPGSYICDCPPDFELNP 36 (43)
T ss_dssp CGGGSTTSS-BTSEEEEETTEEEEECCTTCEECT
T ss_pred cccCCCCcC-cCCEeECCCCCEEEecCCCCEECC
Confidence 578776665 46899754 678999999998853
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.89 E-value=0.0047 Score=31.94 Aligned_cols=31 Identities=35% Similarity=0.733 Sum_probs=25.8
Q ss_pred CCCCCCCCCCCCccccc-CCCCccccCCCCeeC
Q 041718 1 DLCDTYALCGAYGICII-SGMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~-~~~~~C~C~~gf~~~ 32 (295)
|.|.+-..||. |-|+. -+.-.|.|-.||+|-
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCC
Confidence 57999999996 88975 467789999999874
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.71 E-value=0.0083 Score=33.41 Aligned_cols=33 Identities=30% Similarity=0.691 Sum_probs=24.2
Q ss_pred CCCCC-CCCCCCCcccccC-CCCccccCCCCeeCCC
Q 041718 1 DLCDT-YALCGAYGICIIS-GMPVCQCLKGFKQKSR 34 (295)
Q Consensus 1 ~~C~~-~~~CG~~~~C~~~-~~~~C~C~~gf~~~~~ 34 (295)
|+|.. ...| .++.|... ++..|.|++||+...+
T Consensus 4 dEC~~~~~~C-~~~~C~Nt~Gsy~C~C~~Gy~~~~~ 38 (44)
T d1lmja1 4 DECRISPDLC-GRGQCVNTPGDFECKCDEGYESGFM 38 (44)
T ss_dssp CTTTTCSSTT-TTSCEEEETTEEEECCCSSEEECTT
T ss_pred cccCCCCCCC-CCCEeEcCCCCeEEeCCCCCccCCC
Confidence 57876 4456 47899754 6789999999987543
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.31 E-value=0.0071 Score=32.76 Aligned_cols=31 Identities=32% Similarity=0.562 Sum_probs=24.4
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|. ...|-..|.|... +...|.|++||+..
T Consensus 4 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 35 (39)
T d1edmb_ 4 DQCE-SNPCLNGGSCKDDINSYECWCPFGFEGK 35 (39)
T ss_dssp CTTT-TCCCCTTCEEEEETTEEEEECCTTCCST
T ss_pred ccCC-CCCCCCCcEEEcCCCCEEEECCCCCCCC
Confidence 4666 4679999999764 56899999999754
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.00 E-value=0.0092 Score=32.90 Aligned_cols=27 Identities=30% Similarity=0.651 Sum_probs=21.0
Q ss_pred CCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 6 YALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 6 ~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
++.|. +++|... ++..|.|++||....
T Consensus 9 ~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 36 (42)
T d1lmja2 9 PLLCR-GGVCHNTEGSYRCECPPGHQLSP 36 (42)
T ss_dssp SSTTT-TSEEEEETTEEEEESCTTSCCCS
T ss_pred CCCCC-CCEeECCCCCeEEeCCCCCeECc
Confidence 56674 7899754 678999999998753
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.95 E-value=0.015 Score=30.57 Aligned_cols=31 Identities=29% Similarity=0.630 Sum_probs=24.0
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|. ...|-..|.|... ....|.|++||...
T Consensus 1 d~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 32 (35)
T d2vj3a3 1 DECA-SSPCLHNGRCLDKINEFQCECPTGFTGH 32 (35)
T ss_dssp CTTT-TCCSTTTCEEEECSSCEEEECCTTEESS
T ss_pred CCCC-CCCCCCCcEEECCCCCeEEECCCCCCCC
Confidence 4564 4679999999754 57899999999754
|
| >d2c4fl1 g.3.11.1 (L:46-82) Factor IX (IXa) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=93.21 E-value=0.0079 Score=32.15 Aligned_cols=30 Identities=27% Similarity=0.613 Sum_probs=23.1
Q ss_pred CCCCCCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 2 LCDTYALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
+|. ...|-..|.|... ....|.|++||+..
T Consensus 4 ~C~-~~PC~ngg~C~~~~~~y~C~C~~g~~G~ 34 (37)
T d2c4fl1 4 QCA-SSPCQNGGSCKDQLQSYICFCLPAFEGR 34 (37)
T ss_dssp GGG-GCCCCTTCEEEEETTEEEEECCTTEEST
T ss_pred cCC-CCCCCCCCEEECCCCCeEEECCCCCcCC
Confidence 453 5678889999764 56899999999764
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.55 E-value=0.015 Score=31.57 Aligned_cols=25 Identities=16% Similarity=0.410 Sum_probs=20.8
Q ss_pred CCCCCCcccccC-CCCccccCCCCee
Q 041718 7 ALCGAYGICIIS-GMPVCQCLKGFKQ 31 (295)
Q Consensus 7 ~~CG~~~~C~~~-~~~~C~C~~gf~~ 31 (295)
..|.+++.|... ++..|.|.+||..
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~G 32 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYTG 32 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEE
T ss_pred CCCCCCCEeecCCCCeEeECCCCCcC
Confidence 468999999754 5789999999975
|
| >d1szba2 g.3.11.1 (A:124-168) Mannose-binding protein associated serine protease 2, MASP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.52 E-value=0.034 Score=31.00 Aligned_cols=34 Identities=21% Similarity=0.367 Sum_probs=23.7
Q ss_pred CCCCCCC-CC-CCCcccccC-CCCccccCCCCeeCCC
Q 041718 1 DLCDTYA-LC-GAYGICIIS-GMPVCQCLKGFKQKSR 34 (295)
Q Consensus 1 ~~C~~~~-~C-G~~~~C~~~-~~~~C~C~~gf~~~~~ 34 (295)
|+|.... .+ |-..+|... ++..|.|++||+....
T Consensus 2 dEC~~~~~~~~~C~~~C~Nt~Gsy~C~C~~Gy~l~~d 38 (45)
T d1szba2 2 DECQVAPGEAPTCDHHCHNHLGGFYCSCRAGYVLHRN 38 (45)
T ss_dssp CTTCCCTTSCCSSSSEEEEETTEEEEECCTTEEECTT
T ss_pred cCCcCCCCCCCCCCCCCccCCCCeEEECCCCCeECCC
Confidence 5676642 23 446689754 6789999999998654
|
| >d1nt0a3 g.3.11.1 (A:120-164) Mannose-binding protein associated serine protease 2, MASP2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Mannose-binding protein associated serine protease 2, MASP2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.50 E-value=0.022 Score=31.80 Aligned_cols=33 Identities=24% Similarity=0.363 Sum_probs=21.1
Q ss_pred CCCCCC-CC-CCCCcccccC-CCCccccCCCCeeCC
Q 041718 1 DLCDTY-AL-CGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~-~~-CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|+|... +- ++-..+|... ++..|+|++||....
T Consensus 2 dEC~~~~~~~~~C~~~C~Nt~gsy~C~C~~Gy~L~~ 37 (45)
T d1nt0a3 2 DECRTSLGDSVPCDHYCHNYLGGYYCSCRVGYILHQ 37 (45)
T ss_dssp CTTC-------CCSSEEEEETTEEEEECCTTEEECT
T ss_pred cCCccCCCCcCCCCCEeecCCCCEEEeCCCCCEECC
Confidence 567664 33 3346689754 678999999998864
|
| >d3egfa_ g.3.11.1 (A:) Epidermal growth factor, EGF {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.41 E-value=0.04 Score=31.87 Aligned_cols=30 Identities=20% Similarity=0.511 Sum_probs=23.6
Q ss_pred CCCCCCCCccccc---CCCCccccCCCCeeCCC
Q 041718 5 TYALCGAYGICII---SGMPVCQCLKGFKQKSR 34 (295)
Q Consensus 5 ~~~~CG~~~~C~~---~~~~~C~C~~gf~~~~~ 34 (295)
..+.|-..|.|.. .....|.|++||....-
T Consensus 10 ~~~~C~NgG~C~~~~~~~~~~C~C~~gy~G~~C 42 (53)
T d3egfa_ 10 YDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRC 42 (53)
T ss_dssp SSCCSCSSCEEEEESSSSCEEEECCTTCCSSSS
T ss_pred CCCCCCCCcEeeccCCCCCeEeECCCCCcCCCC
Confidence 4678999999963 24689999999976543
|
| >d1apqa_ g.3.11.1 (A:) Complement protease C1R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement protease C1R species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.38 E-value=0.037 Score=32.06 Aligned_cols=25 Identities=20% Similarity=0.457 Sum_probs=18.5
Q ss_pred CCCCcccccC-CCCccccCCCCeeCC
Q 041718 9 CGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 9 CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|+...+|... ++..|+|++||+...
T Consensus 20 ~~c~~~C~Nt~GsY~C~C~~Gy~l~~ 45 (53)
T d1apqa_ 20 PQCQHLCHNYVGGYFCSCRPGYELQE 45 (53)
T ss_dssp CTTSSEEEEETTEEEEECSTTCEECT
T ss_pred CCccCEeEcCCCCeEeECCCCCeECC
Confidence 4444578754 678999999999764
|
| >d1g1ta2 g.3.11.1 (A:119-157) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.94 E-value=0.012 Score=31.77 Aligned_cols=31 Identities=26% Similarity=0.652 Sum_probs=23.7
Q ss_pred CCCCCCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 2 LCDTYALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
.|. ...|...|.|... +...|.|++||....
T Consensus 3 ~C~-~~pC~ngg~C~~~~~~~~C~C~~g~~G~~ 34 (39)
T d1g1ta2 3 ACT-NTSCSGHGECVETINNYTCKCDPGFSGLK 34 (39)
T ss_dssp CCC-TTGGGGSEEEEEETTEEEEEECTTEESTT
T ss_pred ccc-CCcCCCCcEEECCCCCEEEeCCCCCcCcC
Confidence 454 4679999999764 568899999997653
|
| >d1dx5i3 g.3.11.1 (I:423-462) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.74 E-value=0.0089 Score=32.46 Aligned_cols=30 Identities=27% Similarity=0.583 Sum_probs=21.7
Q ss_pred CCCCCCCCCCCCcccccC-CCCccccCCCCeeC
Q 041718 1 DLCDTYALCGAYGICIIS-GMPVCQCLKGFKQK 32 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~ 32 (295)
|+|...+.|. .+|... ++..|.|+|||+..
T Consensus 3 dEC~~~~~C~--~~C~N~~Gsy~C~C~~Gy~l~ 33 (40)
T d1dx5i3 3 DECENGGFCS--GVCHNLPGTFECICGPDSALA 33 (40)
T ss_dssp CHHHHCSSCS--SEEEECSSSEEEEECSSSSCE
T ss_pred cccCCCcCcc--CEeeCCCCCeEeECCCCCeeC
Confidence 3455556674 588754 67899999999874
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.35 E-value=0.011 Score=32.69 Aligned_cols=27 Identities=33% Similarity=0.714 Sum_probs=21.0
Q ss_pred CCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 6 YALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 6 ~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
.+.|. ++.|... ++..|.|++||....
T Consensus 10 ~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 10 PGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp GGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred CCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 55675 6899754 678999999998754
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.15 E-value=0.063 Score=30.25 Aligned_cols=30 Identities=33% Similarity=0.824 Sum_probs=21.9
Q ss_pred CCCCCCCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 2 LCDTYALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 2 ~C~~~~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
+|.- .-|. ||.|... ++..|.|++||....
T Consensus 10 ~C~~-~PC~-nG~C~~~~~~y~C~C~~G~~G~~ 40 (48)
T d1autl1 10 PCAS-LCCG-HGTCIDGIGSFSCDCRSGWEGRF 40 (48)
T ss_dssp SSSS-TTTT-SEEECCCSSCCCEEECTTEESTT
T ss_pred cccC-CCCC-CCEEECCCCCCeEeCCCCCcCCC
Confidence 4443 6686 4999754 678999999997643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=91.00 E-value=0.29 Score=40.75 Aligned_cols=68 Identities=12% Similarity=0.249 Sum_probs=42.3
Q ss_pred eeecccCccceeE--------EEEEEEecc---c----cHHhHHHHHHHHHHHhcCC-C--CcccceeeeEEeCCeeEEE
Q 041718 164 NKLGEGGFGLVYK--------EIAVKRLSK---I----SEQGLKELKNEVILFSKLQ-H--RNLVKLLGCCIQGEEKLLI 225 (295)
Q Consensus 164 ~~lg~G~~g~Vyk--------~vavK~l~~---~----~~~~~~~~~~Ei~~l~~l~-h--~niv~l~~~~~~~~~~~lv 225 (295)
+.||.|....||+ .+.||.-.. . -+....+...|...|..+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 5789999999996 467775321 0 0112234556777776552 2 345666654 55667899
Q ss_pred EecCCCCC
Q 041718 226 YEFMPNKS 233 (295)
Q Consensus 226 ~e~~~~gs 233 (295)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998654
|
| >d1g1sa2 g.3.11.1 (A:119-158) E-selectin, EGF-domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: E-selectin, EGF-domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.73 E-value=0.025 Score=30.64 Aligned_cols=27 Identities=30% Similarity=0.716 Sum_probs=21.6
Q ss_pred CCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 7 ALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 7 ~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
..|-..|.|... +...|.|++||....
T Consensus 7 ~pC~ngg~C~~~~~~y~C~C~~g~~G~~ 34 (40)
T d1g1sa2 7 MSCSKQGECLETIGNYTCSCYPGFYGPE 34 (40)
T ss_dssp TGGGGSEEEEECSSSEEEEECTTEESTT
T ss_pred CcCCCCcEEECCCCCeEEeCCCCccCCC
Confidence 568888999764 578999999997643
|
| >d1nzia2 g.3.11.1 (A:118-159) Complement C1S component {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Complement C1S component species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.25 E-value=0.12 Score=28.10 Aligned_cols=31 Identities=19% Similarity=0.537 Sum_probs=21.7
Q ss_pred CCCCCC--CCCCCCcccccC-CCCccccCCCCeeCC
Q 041718 1 DLCDTY--ALCGAYGICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 1 ~~C~~~--~~CG~~~~C~~~-~~~~C~C~~gf~~~~ 33 (295)
|+|... +.|.. +|... ++..|.|++||....
T Consensus 1 dEC~~~~~~~C~~--~C~n~~Gsy~C~C~~Gy~L~~ 34 (42)
T d1nzia2 1 NECTDFVDVPCSH--FCNNFIGGYFCSCPPEYFLHD 34 (42)
T ss_dssp CTTTC-CCCCSSS--EEEEETTEEEEECCTTCEECT
T ss_pred CCCCCCCCcCCCC--EeecCCCCEEEeCCCCCEECC
Confidence 567532 45654 78654 678999999999864
|
| >d1dx5i2 g.3.11.1 (I:388-422) Thrombomodulin, different EGF-like domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Thrombomodulin, different EGF-like domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.04 E-value=0.079 Score=26.62 Aligned_cols=19 Identities=21% Similarity=0.553 Sum_probs=14.1
Q ss_pred ccccCCCCccccCCCCeeC
Q 041718 14 ICIISGMPVCQCLKGFKQK 32 (295)
Q Consensus 14 ~C~~~~~~~C~C~~gf~~~ 32 (295)
.|+.+.-..|+||.||...
T Consensus 11 dCdP~~p~~C~CPeGyIld 29 (35)
T d1dx5i2 11 DCDPNTQASCECPEGYILD 29 (35)
T ss_dssp EECTTSTTCEECCTTEEEE
T ss_pred ccCCCCCCcccCCCceEec
Confidence 4555556789999999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=87.99 E-value=1.4 Score=33.43 Aligned_cols=69 Identities=22% Similarity=0.207 Sum_probs=44.7
Q ss_pred eecccCc-cceeE-------EEEEEEeccccHHhHHHHHHHHHHHhcCC--CCcccceeeeEEeCCeeEEEEecCCCCCH
Q 041718 165 KLGEGGF-GLVYK-------EIAVKRLSKISEQGLKELKNEVILFSKLQ--HRNLVKLLGCCIQGEEKLLIYEFMPNKSL 234 (295)
Q Consensus 165 ~lg~G~~-g~Vyk-------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL 234 (295)
.+..|.. ..||+ .+.+|..... ....+..|...++.|. .-.+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444443 46675 3667765432 2234667777776664 33467788888888889999999988665
Q ss_pred HH
Q 041718 235 NS 236 (295)
Q Consensus 235 ~~ 236 (295)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >d1mcvi_ g.3.2.1 (I:) Trypsin inhibitor {Jumping cucumber (Ecballium elaterium) [TaxId: 3679]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: Plant inhibitors of proteinases and amylases family: Plant inhibitors of proteinases and amylases domain: Trypsin inhibitor species: Jumping cucumber (Ecballium elaterium) [TaxId: 3679]
Probab=87.78 E-value=0.12 Score=24.07 Aligned_cols=13 Identities=38% Similarity=1.088 Sum_probs=9.5
Q ss_pred CCCCCCCCCCccc
Q 041718 3 CDTYALCGAYGIC 15 (295)
Q Consensus 3 C~~~~~CG~~~~C 15 (295)
|-.-.+|||||.|
T Consensus 15 clagcvcgpngfc 27 (28)
T d1mcvi_ 15 CLAGCVCGPNGFC 27 (28)
T ss_dssp SCTTCCBCTTSBB
T ss_pred ccccceecCCCcC
Confidence 4455678888888
|
| >d1autl2 g.3.11.1 (L:97-146) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.54 E-value=0.16 Score=28.72 Aligned_cols=34 Identities=21% Similarity=0.474 Sum_probs=24.2
Q ss_pred ccccC-CCCccccCCCCeeCCCCCCCCCCCceeCCCcCcC
Q 041718 14 ICIIS-GMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNYS 52 (295)
Q Consensus 14 ~C~~~-~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c~ 52 (295)
+|... ++..|+|++||+..... ..|....+..|.
T Consensus 12 ~C~~~~g~~~C~C~~Gy~L~~D~-----~tC~~~~~~pCg 46 (50)
T d1autl2 12 YCLEEVGWRRCSCAPGYKLGDDL-----LQCHPAVKFPCG 46 (50)
T ss_dssp EEEECSSSEEEECCTTEEECTTS-----SCEEECSSSCTT
T ss_pred EeecCCCCeEEECCCCCEECCCC-----CccccCCCCCCC
Confidence 45433 56899999999987543 578777666664
|
| >d1tpga1 g.3.11.1 (A:51-91) Plasminogen activator (tissue-type), t-PA {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Plasminogen activator (tissue-type), t-PA species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.53 E-value=0.15 Score=27.55 Aligned_cols=28 Identities=39% Similarity=0.612 Sum_probs=21.2
Q ss_pred CCCCCCCcccccC---CCCccccCCCCeeCC
Q 041718 6 YALCGAYGICIIS---GMPVCQCLKGFKQKS 33 (295)
Q Consensus 6 ~~~CG~~~~C~~~---~~~~C~C~~gf~~~~ 33 (295)
...|-..|.|... ....|.|++||....
T Consensus 3 ~nPC~ngG~C~~~~~~~~y~C~C~~g~~G~~ 33 (41)
T d1tpga1 3 EPRCFNGGTCQQALYFSDFVCQCPEGFAGKS 33 (41)
T ss_dssp SCCSCTTCEEEEESSSSCEEEECCTTCBSSS
T ss_pred CCCCCCCCEEecCCCCCCeEECCCCCCCCCC
Confidence 4568888999742 356899999997654
|
| >d1haea_ g.3.11.1 (A:) Heregulin-alpha, EGF-like domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heregulin-alpha, EGF-like domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.94 E-value=0.17 Score=30.20 Aligned_cols=28 Identities=25% Similarity=0.661 Sum_probs=20.9
Q ss_pred CCCCCCCccccc------CCCCccccCCCCeeCC
Q 041718 6 YALCGAYGICII------SGMPVCQCLKGFKQKS 33 (295)
Q Consensus 6 ~~~CG~~~~C~~------~~~~~C~C~~gf~~~~ 33 (295)
...|...|.|.. .+...|.|++||....
T Consensus 11 ~~~C~NgG~C~~~~~~~~~~~y~C~C~~gy~G~~ 44 (63)
T d1haea_ 11 KTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGAR 44 (63)
T ss_dssp HTTSCTTCEEEEEESSSSSCCEEEECCTTEESTT
T ss_pred CCcCCCCCEEeecccccCCCCEEeECCCCCCCCC
Confidence 467889999942 2456899999997753
|
| >d1kigl_ g.3.11.1 (L:) Factor X, N-terminal module {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Cow (Bos taurus) [TaxId: 9913]
Probab=85.35 E-value=0.19 Score=28.55 Aligned_cols=34 Identities=18% Similarity=0.500 Sum_probs=23.8
Q ss_pred cccc-CCCCccccCCCCeeCCCCCCCCCCCceeCCCcCcC
Q 041718 14 ICII-SGMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNYS 52 (295)
Q Consensus 14 ~C~~-~~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c~ 52 (295)
+|.. .+...|.|++||+..... ..|....+-+|.
T Consensus 11 ~C~~~~~~~~C~C~~Gy~L~~D~-----~tC~~~~~~pcG 45 (51)
T d1kigl_ 11 FCREERSEVRCSCAHGYVLGDDS-----KSCVSTERFPCG 45 (51)
T ss_dssp CCCEETTEECCCCCTTEEECTTS-----SCEEECSSSCTT
T ss_pred EeEcCCCcEEeEcCCCCEECCCC-----CccccCCccCCC
Confidence 3543 356789999999886432 578877766664
|
| >d1cvua2 g.3.11.1 (A:33-73) Prostaglandin H2 synthase-1, EGF-like module {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Prostaglandin H2 synthase-1, EGF-like module species: Mouse (Mus musculus) [TaxId: 10090]
Probab=85.05 E-value=0.17 Score=27.33 Aligned_cols=32 Identities=25% Similarity=0.573 Sum_probs=23.8
Q ss_pred CCCCCCCCCCCCccccc--CCCCccccC-CCCeeCC
Q 041718 1 DLCDTYALCGAYGICII--SGMPVCQCL-KGFKQKS 33 (295)
Q Consensus 1 ~~C~~~~~CG~~~~C~~--~~~~~C~C~-~gf~~~~ 33 (295)
|+|. ...|-..|.|.. .....|.|+ +||....
T Consensus 2 d~C~-~~PC~ngG~C~~~~~~~y~C~C~~~gy~G~~ 36 (41)
T d1cvua2 2 NPCC-SNPCQNRGECMSTGFDQYKCDCTRTGFYGEN 36 (41)
T ss_dssp CTTT-TCCCCTTCEEEEEETTEEEEECTTSSEETTT
T ss_pred CcCc-CCCCCCCCEEEECCCCCEEEeCcCCCcCCcC
Confidence 4665 468999999964 356789997 7997653
|
| >d1nqlb_ g.3.11.1 (B:) Epidermal growth factor, EGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Epidermal growth factor, EGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.96 E-value=0.099 Score=29.42 Aligned_cols=28 Identities=21% Similarity=0.610 Sum_probs=22.0
Q ss_pred CCCCCCCccccc---CCCCccccCCCCeeCC
Q 041718 6 YALCGAYGICII---SGMPVCQCLKGFKQKS 33 (295)
Q Consensus 6 ~~~CG~~~~C~~---~~~~~C~C~~gf~~~~ 33 (295)
.+.|-..|.|.. .+.+.|.|++||....
T Consensus 9 ~~~C~ngG~C~~~~~~~~~~C~C~~gy~G~~ 39 (48)
T d1nqlb_ 9 DGYCLHDGVCMYIEALDKYACNCVVGYIGER 39 (48)
T ss_dssp CCEECTTCEEEEETTTTEEEEEECTTEESTT
T ss_pred CCCCCCCcEEeeeCCCCCeEEeCCCCcccCC
Confidence 567988999964 2468999999997653
|
| >d2c4ba2 g.3.2.1 (A:117-144) Trypsin inhibitor {Jumping cucumber (Ecballium elaterium) [TaxId: 3679]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: Plant inhibitors of proteinases and amylases family: Plant inhibitors of proteinases and amylases domain: Trypsin inhibitor species: Jumping cucumber (Ecballium elaterium) [TaxId: 3679]
Probab=84.89 E-value=0.12 Score=23.91 Aligned_cols=14 Identities=36% Similarity=0.904 Sum_probs=10.0
Q ss_pred CCCCCCCCCCcccc
Q 041718 3 CDTYALCGAYGICI 16 (295)
Q Consensus 3 C~~~~~CG~~~~C~ 16 (295)
|-.-.+|||||.|.
T Consensus 14 clagcvcgpngfcg 27 (28)
T d2c4ba2 14 CLAGCVCGPNGFCG 27 (28)
T ss_dssp SCTTCEECTTSBEE
T ss_pred ccccceecCCCcCC
Confidence 44556788888884
|
| >d2p3ua1 g.3.11.1 (A:87-137) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.69 E-value=0.2 Score=28.45 Aligned_cols=34 Identities=21% Similarity=0.631 Sum_probs=24.0
Q ss_pred cccc-CCCCccccCCCCeeCCCCCCCCCCCceeCCCcCcC
Q 041718 14 ICII-SGMPVCQCLKGFKQKSRGYVDWSQGCVRDKSLNYS 52 (295)
Q Consensus 14 ~C~~-~~~~~C~C~~gf~~~~~~~~~~~~GC~~~~~~~c~ 52 (295)
+|.. .++..|.|++||+..+.. .-|.+..+..|.
T Consensus 13 ~C~n~~g~~~C~C~~Gy~L~~D~-----~tC~~~~~~pCG 47 (51)
T d2p3ua1 13 FCHEEQNSVVCSCARGYTLADNG-----KACIPTGPYPCG 47 (51)
T ss_dssp EEEEETTEEEEECCTTEEECTTS-----SCEEESSSSCTT
T ss_pred EeecCCCCeEeEcCCCCEECCCC-----CccccCCccCCC
Confidence 4543 356799999999987532 578877766664
|
| >d3bpse1 g.3.11.1 (E:293-332) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.53 E-value=0.14 Score=27.46 Aligned_cols=20 Identities=25% Similarity=0.424 Sum_probs=15.5
Q ss_pred ccccC-CCCccccCCCCeeCC
Q 041718 14 ICIIS-GMPVCQCLKGFKQKS 33 (295)
Q Consensus 14 ~C~~~-~~~~C~C~~gf~~~~ 33 (295)
+|... ++..|.|++||...|
T Consensus 15 ~C~n~~g~~~C~C~~Gy~L~d 35 (40)
T d3bpse1 15 VCNDLKIGYECLCPDGFQLVA 35 (40)
T ss_dssp EEEECSSSEEEECCTTCCEET
T ss_pred EEEcCCCCEEEECCCCCEECC
Confidence 67654 567999999998854
|
| >d1xdtr_ g.3.11.1 (R:) Heparin-binding epidermal growth factor, HBEGF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Heparin-binding epidermal growth factor, HBEGF species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.86 E-value=0.27 Score=26.44 Aligned_cols=28 Identities=25% Similarity=0.619 Sum_probs=21.3
Q ss_pred CCCCCCCCCcccccC---CCCccccCCCCeeC
Q 041718 4 DTYALCGAYGICIIS---GMPVCQCLKGFKQK 32 (295)
Q Consensus 4 ~~~~~CG~~~~C~~~---~~~~C~C~~gf~~~ 32 (295)
+..++|=. |.|.+- ..+.|.|++||...
T Consensus 5 ~~~~yCih-G~C~~i~~l~~~~C~C~~gY~G~ 35 (41)
T d1xdtr_ 5 KYKDFCIH-GECKYVKELRAPSCICHPGYHGE 35 (41)
T ss_dssp TTTTCCSS-EEECCBGGGTBCCEEECTTEEST
T ss_pred ccCCEeEC-cEEeecCcCCCceeECCCCCeec
Confidence 44678876 999752 56899999999753
|